,filename,label,label_predict,score,precision_5,precision_10,precision_15
0,Arch_Gynecol_Obstet-2-2-1705528.txt,symptom||day||viral replic||genit herp||full outbreak||recurr genit herp outbreak||patient||single-day treatment||recurr||onset||treatment||progress||patient-initi episod therapi,herp||genit herp||recurr genit herp||recurr herp||famciclovir genit||herp outbreak||genit herp lesion||full genit herp||herp virus||famciclovir||recurr genit herp outbreak||recurr genit herp infect||genit herp drug treatment regimen||single-day famciclovir treatment||genit herp 4 5 14,0.598||0.494||0.372||0.363||0.348||0.347||0.34||0.336||0.321||0.305||0.303||0.297||0.215||0.201||0.198,0.2,0.1,0.13333333333333333
1,Eur_J_Pharmacol-2-1-2258315.txt,serum||studi||reactiv oxygen speci||effect||biolog activ||hepat stellat cell||anti-fibrot agent||hepatocyt injuri||treatment||cell||mice||cell death||liver fibrosi||death||liver||anti-fibrot activ||hepatocyt||fucoidan||hepat fibrosi||fibrosi||result,fucoidan||al.||hepat stellat||crude fucoidan||pure fucoidan||hepat||hepat fibrosi||hepat stellat cell||fibrosi||stellat cell||liver fibrosi||hepat stellat cell prolifer||hepat stellat cell apoptosi||hepat stellat cell activ||fucoidan-tr hepat stellat cell,0.567||0.31||0.302||0.288||0.287||0.26||0.236||0.225||0.212||0.208||0.182||0.176||0.175||0.175||0.174,0.2,0.4,0.3333333333333333
2,Pediatr_Radiol-4-1-2367394.txt,rare tumour||follow-up||soft-tissu sarcoma||protocol||mri||imag||locat||studi||seri||patient||present||child||chemotherapi||transfus||rm||rhabdomyosarcoma||site||paediatr oncologist||bone scintigraphi||cell||treatment||metastat diseas||tumour||intergroup rhabdomyosarcoma studi group||alveolar histolog||case report||prognosi||surgeri||primari site||epssg protocol||primari tumour||group||biopsi||order||bone||malign tumour||pet||BP tumour||diseas||diagnosi||work-up||children,rhabdomyosarcoma||embryon rhabdomyosarcoma||alveolar rhabdomyosarcoma||childhood rhabdomyosarcoma||genitourinari rhabdomyosarcoma||metastat rhabdomyosarcoma||bladder rhabdomyosarcoma||nonmetastat rhabdomyosarcoma||pelvic rhabdomyosarcoma||primari rhabdomyosarcoma||vagin rhabdomyosarcoma||orbit rhabdomyosarcoma||neck rhabdomyosarcoma||adult rhabdomyosarcoma||vesico-prostat rhabdomyosarcoma,0.723||0.416||0.409||0.397||0.392||0.386||0.384||0.381||0.377||0.376||0.372||0.372||0.37||0.369||0.368,0.2,0.1,0.06666666666666667
3,Evid_Based_Complement_Alternat_Med-3-4-1697739.txt,herb||studi||effect||review||articl||cognit impair||clinic trial||dementia||treatment||psycholog symptom||product||research||herbal medicin||melissa||symptom||random clinic trial||drug||formul||trial||diseas||systemat review||result,officinali||melissa||scholey AB melissa officinali||dementia||ginkgo biloba M. officinali||che-i||salvia||herbal medicin||11 melissa||brasilia||memantin||herbal remedi||herbal product||impair dementia||herbal intervent,0.499||0.234||0.2||0.192||0.179||0.146||0.136||0.12||0.119||0.117||0.117||0.116||0.11||0.109||0.108,0.4,0.3,0.2
4,Bioinformation-2-1-2139988.txt,inform||diabet||medicin plant||databas||antimicrobi properti||literatur||plant,plant||antidiabet plant||medicin plant||indigen plant||databas||plant research||plant control||plant product||diabet||diab||web databas||bioinform bioinform bioinform||databas design||antimicrobi effect||antimicrobi properti,0.482||0.33||0.298||0.271||0.253||0.25||0.249||0.247||0.241||0.2||0.16||0.15||0.132||0.11||0.109,0.6,0.4,0.3333333333333333
5,J_Immunol_Methods-2-1-2225449.txt,glass coverslip||imag analysi softwar||primari human macrophag||method||dapi||lp||analysi||cell line||data||macrophag||nuclear||cell||binari mask,nf-κb||nf-κb nuclear transloc||nuclear||nf-κb quantit||nf-κb rel||nf-κb assay||nf-κb activ||nf-κb pathway||cytoplasm nf-κb stain||nf-κb promot||nf-κb express||nuclear transloc||origin nf-κb rel||transloc||fusel,0.565||0.366||0.323||0.317||0.317||0.304||0.295||0.292||0.291||0.286||0.284||0.267||0.212||0.21||0.209,0.2,0.1,0.06666666666666667
6,Invert_Neurosci-4-1-2257991.txt,cys-loop lgic||subunit||glutam acid||receptor||cys-loop lgic superfamili||ion channel||cation channel||nematod||glutamate-g chlorid channel||gaba||function||group,caenorhabd elegan embo||sattel DB caenorhabd elegan||caenorhabd||C. briggsa C. elegan||glc-1 elegan C. briggsa||dent JA caenorhabd elegan||springer-verlag 2008 caenorhabd elegan C.||1 1 C. elegan C.||C.||note fig. 1 C. elegan C.||cys-loop lgic||lgc-23 lgc-24 lgc-28 C. elegan 2007||nematod speci caenorhabd briggsa C.||pnas.0509024102 16319224 caenorhabd briggsa||C. briggsa 2007 C.,0.296||0.295||0.28||0.278||0.245||0.232||0.214||0.183||0.157||0.154||0.153||0.148||0.138||0.131||0.13,0.0,0.0,0.06666666666666667
7,Surg_Endosc-4-1-2292805.txt,type||cardin health||urinari tract||data||appendectomi||patient||admiss||risk||present||complex||nim rate||open surgeri||infect||cmi||approach||hospit||insur||analysi||odd||cholecystectomi||respiratori tract||differ||laparoscop||nim||multivari logist regress analys||nosocomi infect||procedur||laparoscop approach||hysterectomi||nosocomi infect risk||result,nim||appendectomi||laparoscop appendectomi||laparoscop||laparoscop cholecystectomi||laparoscop hysterectomi||cholecystectomi||keyword nosocomi laparoscop cholecystectomi appendectomi hysterectomi||hysterectomi||nosocomi infect||post-discharg nim||nim 0.48||open appendectomi||nim rate||nim 0.91,0.429||0.402||0.355||0.307||0.285||0.284||0.263||0.263||0.261||0.258||0.24||0.227||0.225||0.221||0.218,0.6,0.6,0.4666666666666667
8,Exp_Brain_Res-4-1-2373857.txt,vertic||condit||cue||obliqu effect||respons||system||streri||product task||find||exploratori movement||horizont||anisotrop||obliqu orient||studi||hypothesi||stimulu||spatial orient||sensori motor trace||contralater hand||orient||refer frame||haptic||effect||space||process||sagitt plane||reproduct||percept||review||discrimin||plane||test||cognit resourc||adult||visual system||frontal plane||sensori modal||hatwel||haptic modal||frame||haptic discrimin||subjective-refer frame||paramet||cognit level||haptic percept||task||modal||bodi||diagon||gravit cue||rod||refer||visual modal||systemat bia||obliqu||error||gravit forc||hand||angl||gentaz||result,haptic||obliqu||haptic orient||obliqu orient||haptic percept||haptic obliqu effect||orient||haptic spatial||haptic space||haptic explor||haptic reproduct||haptic discrimin||obliqu rod||haptic modal||haptic SV,0.535||0.474||0.432||0.402||0.357||0.343||0.33||0.302||0.299||0.291||0.29||0.285||0.282||0.281||0.28,0.8,0.5,0.4666666666666667
9,Breast_Cancer_Res_Treat-3-1-2001225.txt,follow-up||time||contralater breast||letrozol||lymph node-posit breast cancer||breast cancer||elig patient||initi therapi||tamoxifen||studi||year||recurr||distant metastas||risk||exclus criteria||aromatas inhibitor||ai||secondari end point||event||postmenopaus women||treatment||therapi||primari object||random||face trial||analysi||greater clinic benefit||anastrozol||differ||tumor||earli breast cancer||contralater breast cancer,anastrozol||letrozol||breast cancer||breast cancer breast cancer||cancer||tamoxifen||contralater breast cancer||earli breast cancer||postmenopaus breast cancer women||invas breast cancer||receptor-posit breast cancer||contralater breast||breast cancer chemoprevent||primari breast cancer||posit breast cancer,0.35||0.336||0.332||0.332||0.266||0.255||0.242||0.24||0.233||0.231||0.23||0.229||0.226||0.226||0.226,0.6,0.6,0.4666666666666667
10,Plant_Mol_Biol-3-1-2140092.txt,smallest polypeptid||transit||protein level||dormanc||dormancy-to-growth transit||pea||prb||observ||amino acid sequenc||similar||signal||phosphoryl||cell||gene||transcript||protein||experi||molecular mass||cell cycl||intact plant||cdna||axillari bud||hp-form||retinoblastoma-rel protein||plant||result,psrbr1||psrbr1 psrbr1 psrbr1 psrbr1 gene||psrbr1 35 psrbr1||psrbr1 protein||psrbr1 0.11||translat psrbr1||0.2 psrbr1||rb-relat protein psrbr1 psrbr1 cdna||phosphoryl psrbr1 protein||authent psrbr1 protein||vitro-dephosphoryl psrbr1 protein||non-modifi psrbr1 protein||vivo-dephosphoryl psrbr1 protein||psrbr1 protein undergo||phosphoryl psrbr1 protein pcna,0.756||0.61||0.505||0.441||0.38||0.38||0.38||0.361||0.329||0.302||0.302||0.298||0.298||0.295||0.281,0.0,0.0,0.0
11,J_Hum_Genet-3-1-1915643.txt,effect||risk||snp||femal control||TT genotyp||plasma folat concentr||mother||plasma homocystein||risk factor||spina bifida||studi||pediatr control||children,nos3 nos3 nos3 894g||nos3 nos3 nos3 mthfr 677c||mthfr nos3 nos3 894gt||refer group nos3 nos3||keyword nos3 894g||nos3 1999 2003 nos3 2004||nos3 894tt genotyp||nos3 locu birth defect||result case-control studi nos3||genotyp determin nos3 1999 mbo||refer group nos3 mthfr 677tt genotyp||894g||transmiss disequilibrium test nos3 1993 2003||refer group transmiss disequilibrium test nos3||homocystein,0.709||0.577||0.496||0.444||0.356||0.356||0.317||0.226||0.225||0.191||0.19||0.182||0.16||0.159||0.138,0.0,0.0,0.0
12,Purinergic_Signal-4-1-2246001.txt,rip||anim||oligodendrocyt||endogen progenitor cell||matur oligodendrocyt||spinal cord injuri||function recoveri||section||increas||spinal cord||lesion||astrocyt||cell prolifer||guanosin||treatment||cell||rat||day||myelin||prolifer||function improv||guanin||analysi||remyelin||usa||cord||brdu||open field||number||sci,guanosin||oligodendrocyt||oligodendrocyt progenitor||oligodendrocyt myelin||remyelin||matur oligodendrocyt||adult oligodendrocyt||cord||oligodendrocyt precursor||rathbon MP guanosin||spinal cord||oligodendrocyt progenitor cell||extracellular guanosin||guanosin treatment||post-mitot oligodendrocyt,0.403||0.399||0.284||0.283||0.257||0.232||0.226||0.223||0.221||0.219||0.217||0.21||0.209||0.207||0.206,0.6,0.5,0.4
13,Matern_Child_Health_J-2-2-1592156.txt,birth||pregnanc||rate||normal immun function||risk||human||listeria||infect||preconcept care||educ||toxoplasmosi||pregnant women||women||age||food||listeriosi||cmv||cytomegaloviru||transmiss||diseas||viru,cytomegaloviru||toxoplasmosi||cytomegaloviru infect||congenit toxoplasmosi||congenit cytomegaloviru infect||cytomegaloviru diseas||congenit cytomegaloviru diseas||primari cytomegaloviru infect||http://www.cdc.gov/ncidod/dpd/parasites/ toxoplasmosi||listeriosi||congenit cytomegaloviru infect pediatr 1985||infect||cytomegaloviru field virolog||toxoplasmosi toxoplasma gondii T. gondii T.||congenit toxoplasma gondii infect,0.515||0.447||0.353||0.312||0.294||0.272||0.24||0.237||0.233||0.223||0.191||0.191||0.184||0.182||0.181,0.4,0.3,0.26666666666666666
14,Environ_Manage-4-1-2233706.txt,ecolog investig||flow||histori||snake river||data||model||studi||comparison||compar studi||strategi||river dam||riparian ecosystem||landscap||aerial photograph||veget||spatial comparison||similar||analys||impact||downstream||natur||ecolog consequ||dam||approach||coincident influenc||valley characterist||research||snake||research strategi||hell canyon||sediment||natur variat||multipl reach||river,river||river canyon||river dam||snake river||free-flow river||salmon river||river flow||river ecosystem||colorado river||river regul||alluvi river||river reach||river channel||weiser river||river environ,0.614||0.484||0.454||0.402||0.345||0.343||0.34||0.337||0.329||0.326||0.325||0.323||0.32||0.32||0.315,0.6,0.3,0.2
15,Histochem_Cell_Biol-4-1-2386527.txt,role||muscl||eukaryot cell||chromatin||nucleu||larg famili||review||structur||actin||form||nucleocytoplasm traffick||non-muscl cell||cell||gene||arp||transcript||protein||chromatin remodel||activ||jockusch||cytoplasm||nuclear actin||myosin||function,actin||nuclear actin||cytoplasm actin||actin polymer||actin filament||muscl actin||actin antibodi||actin pioneer||actin exist||actin polym||actin bound||actin mutant||RR actin||nuclear actin export||widespread nuclear actin,0.685||0.435||0.382||0.363||0.362||0.361||0.352||0.349||0.348||0.347||0.346||0.346||0.345||0.307||0.293,0.4,0.2,0.13333333333333333
16,Surg_Endosc-3-1-2169271.txt,endoscopist||level||endoscopi||case||time||expert||data||studi||represent||intermedi||colonoscopi||GI mentor II simul||valid||train||GI mentor II||task||simul||group||number||particip||novic||novic endoscopist,"colonoscopi||colonoscopi simul||endoscopist||simul||novic endoscopist||expert endoscopist||colonoscopi simul 2.95||VR colonoscopi||colonoscopi task||real-lif colonoscopi||straightforward colonoscopi||1,000 colonoscopi||easi colonoscopi||train endoscopist||novic flexibl endoscopist",0.47||0.391||0.371||0.312||0.288||0.287||0.27||0.266||0.252||0.244||0.241||0.24||0.239||0.221||0.206,0.8,0.4,0.26666666666666666
17,Clin_Auton_Res-3-1-1797061.txt,discharg||muscl||respons||experiment anim||paravertebr chain||spinal cord injuri||vasoconstrictor pathway||autonom nervou system||cutan||nerv||increas||spinal transect||natur activ||postganglion neuron||ongo||axon||sympathet nervou system||short burst||signal||vasoconstrict||perivascular nerv||preganglion input||vascular bed||injuri||activ||ganglia||arteri||autonom dysreflexia||vessel||input||transmiss||segment||tail arteri||sympathet ganglia||neurovascular transmiss,sympathet preganglion neuron||sympathet neuron||sympathet vasoconstrictor||sympathet ganglia||preganglion neuron||sympathet innerv||sympathet discharg||sympathet axon||spinal cord||sympathet activ||sympathet inhibit||preganglion input||sympathet vasoconstrictor pathway||singl sympathet vasoconstrictor||gener sympathet vasoconstrictor,0.33||0.319||0.301||0.278||0.274||0.25||0.245||0.243||0.242||0.235||0.23||0.211||0.209||0.201||0.201,0.2,0.1,0.13333333333333333
18,J_Abnorm_Child_Psychol-4-1-2268722.txt,computer task||delay||low arous||measur||respons||behavior||mother||affect||pregnanc||problem||comput||inhibitori control||studi||prenat smoke||question||extern behavior||cool EF||exampl||domin hand respons||frustrat||prepot respons||smoke||hyperact||hot||trial delay||button||task||associ||ambigu||conduct problem||prenat||order||trial||signific differ||adhd||particip||score||emot||children,hot||smoke||prenat smoke||hot EF||prenat||hot EF task||cool execut||cool EF||keyword prenat smoke hot||matern prenat smoke||task||cognit task||cognit||execut||children,0.265||0.213||0.203||0.201||0.194||0.189||0.177||0.168||0.168||0.165||0.164||0.159||0.155||0.154||0.151,0.8,0.5,0.4666666666666667
19,Osteoporos_Int-3-1-1820755.txt,program||balanc train program||visual conflict||home-bas exercis program||studi||patient||initi evalu||final evalu||effect||risk||condit 5||walk||test||improv||intervent||signific||fractur||unstabl surfac||eye||fall||control||exercis program||train||women||research||ctsib||mobil||exercis||clinic data||group||differ||osteoporosi||sensori condit||number||adher||firm surfac||balanc||result,balanc||fall||balanc exercis||balanc train||static balanc||static balanc static balanc||osteoporosi||balanc train program||balanc consist||enhanc balanc||dynam balanc||balanc deficit||balanc instrument||exercis||fall risk,0.42||0.389||0.316||0.305||0.259||0.259||0.248||0.226||0.218||0.216||0.215||0.214||0.213||0.212||0.211,0.4,0.4,0.3333333333333333
20,Eur_J_Epidemiol-4-1-2190782.txt,follow-up||diabet||patient||risk differ||year||admiss||mortal||risk||inform||epidemiolog||netherland||long-term mortal||acut myocardi infarct||signific||analys||popul regist||diabet men||day||hospit||women||result||prognosi||gender||coronari heart diseas||death||myocardi infarct||surviv||differ||date||nation hospit discharg regist||diabet mellitu||ami||cardiovascular diseas,diabet||myocardi infarct||ami||diabet mellitu||acut myocardi infarct||diabet men||diabet patient||diabet women||mortal||diabet mellitu men||acut myocardi infarct patient||nondiabet men||hospitalis acut myocardi infarct||diabet distribut||ami patient,0.355||0.299||0.261||0.252||0.238||0.236||0.225||0.225||0.212||0.207||0.202||0.183||0.182||0.179||0.178,1.0,0.7,0.4666666666666667
21,Pediatr_Nephrol-4-1-2214827.txt,chronic kidney diseas||hypertens||ckd||patient||renal diseas||calcium channel antagonist||effect||risk||sympathet hyperactiv||increas||blood pressur||renal||adult||antihypertens treatment||beta blocker||treatment||therapi||control||esrd||end-organ damag||chronic hyperparathyroid||antihypertens drug||fluid||first-lin therapi||import factor||activ||multipl drug therapi||antihypertens therapi||ace||pathophysiolog||import||fluid overload||drug||low sodium dialys||children,hypertens||renal hypertens||renal||hypertens children||renal nerve-depend hypertens||ckd||epo-induc hypertens||erythropoietin-induc hypertens||ckd-associ hypertens||renovascular hypertens||hypertens 45:493||hypertens nephrosclerosi||mask hypertens||cyclosporine-induc hypertens||rebound hypertens,0.386||0.352||0.318||0.28||0.241||0.225||0.213||0.213||0.203||0.203||0.203||0.203||0.202||0.202||0.2,0.4,0.3,0.2
22,Exp_Brain_Res-4-1-2248215.txt,condit||main find||sham condit||subject pain rate score||acut pain percept||time||magnet stimul||experiment session||studi||subject pain percept||effect||left SI||theta burst stimul||tb||amplitud||primari somatosensori cortex||signific effect||pain process||stimul||lep||result||eeg||pain||yag laser stimul||subject||low-intens stimuli||laser-evok potenti||ctb||germani||peak||hand||itb||compon,tb||somatosensori||pain||transcrani||somatosensori cortex||lep||transcrani stimul||stimul cortex||stimul||N2||transcrani magnet stimul||transcrani magnet stimul primari somatosensori cortex||primari somatosensori cortex||neuronavig tb||tb stimul 2005,0.263||0.234||0.226||0.224||0.214||0.199||0.199||0.184||0.173||0.169||0.161||0.157||0.152||0.151||0.148,0.4,0.4,0.3333333333333333
23,Ulster_Med_J-76-3-2075581.txt,standard practic||author||mechan bowel prepar||practic||rate||studi||patient||colorect surgeri||primari anastomosi||anastomot leakag||anastomosi||clinic practic||rectal carcinoma||signific||evid||infect||mbp group||relev journal||elect procedur||small tumour||small sampl size||surgeri||bowel prepar||mbp||medic literatur||pre-op prepar||infecti complic||group||differ||number||trial||randomis||post-op infecti complic||rct||result,mbp||pre-op mbp||mbp regim||mbp group||bowel||elect colorect surgeri||colorect surgeri||bowel prepar||elect left-sid colorect surgeri||elect colon surgeri||surgeri||bowel resect||elect left-sid colorect surgeri brit||colon surgeri||rectal surgeri,0.75||0.412||0.387||0.383||0.233||0.2||0.191||0.168||0.167||0.163||0.152||0.145||0.136||0.135||0.129,0.4,0.4,0.3333333333333333
24,Environ_Manage-3-1-1866215.txt,weed||time||commun||speci rich||xeric condit||drawdown||year||valu||horsetooth site||remov||water||total cover||colorado||drawdown rate||total||seedl||site||water surfac||veget||recruit||plant||cottonwood||establish||elev||dam||veget colon||dam remov||upland veget||zone||recruit box model||surfac||cover||nativ||sediment||upland||exposur||bare ground||dam construct||number||perenni||speci||plot||horsetooth reservoir||upland plant commun,dam||veget||rood||cottonwood||wetland||upland veget||drawdown||dam remov||reservoir drawdown||riparian veget||reservoir||riparian cottonwood||populu deltoid monilifera||upland||veget cover,0.289||0.245||0.234||0.231||0.207||0.205||0.186||0.185||0.181||0.179||0.175||0.172||0.166||0.165||0.162,0.6,0.6,0.4666666666666667
25,Arch_Dermatol_Res-2-2-1705513.txt,condit||inflamm||psoriasi||lipoprotein||atherosclerosi||preval||studi||diseas associ||patient||common inflammatori pathway||effect||mortal||risk||marker||comorbid||common||synthet antimalari drug||treatment||cell||concomit therapi||inflammatori condit||psoriasi patient||popul||methotrex||psoriasi treatment||atop dermat||drug||cardiovascular event||diseas||diagnosi||cardiovascular diseas,psoriasi||psoriasi patient||psoriasi drug||psoriasi vulgari||psoriasi treatment||psoriasi therapi||psoriasi Br||trigger’ psoriasi||drug-induc psoriasi||psoriasi inpati||psoriasi exist||sever psoriasi||psoriasi eur||psoriasi present||conclus psoriasi,0.819||0.429||0.427||0.422||0.422||0.422||0.419||0.417||0.414||0.413||0.412||0.412||0.411||0.41||0.41,0.6,0.3,0.2
26,Ann_Biomed_Eng-2-2-1705482.txt,thermal histori||arrheniu paramet||hr||time||data||studi||valu||signific amount||hold period||increas||optim clinic protocol||total time||rise||pt||temperatur||signific||clinic thermal therapi protocol||hold time||treatment||cell||non-isotherm portion||applic||tissu||heat rate||drop||hold||break point||total number||total treatment time||injuri||min||cell surviv||energi sourc||tumor||surviv||differ||activ energi||data point||thermal therapi||heat||result,thermal injuri||heat||rm||suspend||thermal therapi||isotherm heat||suspend cell||hyperthermia||injuri||thermal damag||thermal dosimetri||thermal histori||thermal applic||G. thermal||thermal threshold,0.142||0.133||0.131||0.114||0.102||0.101||0.101||0.1||0.099||0.097||0.097||0.096||0.096||0.095||0.094,0.4,0.3,0.26666666666666666
27,Osteoporos_Int-3-1-1766477.txt,signific risk factor||vertebr fractur||grade||deform||preval||studi||vertebr deform||patient||lumbar spine||risk||fractur||bmd||women||multipl||age||popul||mxa||scan||dxa||osteoporosi||normal lumbar spine bmd||hip fractur||normal bmd||vertebr morphometri,fractur||vertebr fractur||deform fractur||vertebr deform||non-vertebr fractur||unrecognis vertebr fractur||prior vertebr fractur||preval vertebr fractur||multipl vertebr fractur||deform||vertebr fractur assess||vertebr fractur statu||vertebr crush fractur||addit vertebr fractur||unrecognis vertebr deform,0.595||0.563||0.487||0.456||0.409||0.394||0.389||0.388||0.382||0.379||0.379||0.378||0.378||0.376||0.323,0.6,0.4,0.26666666666666666
28,Law_Hum_Behav-4-1-2175020.txt,eyewit identif||field studi,mecklenburg||lineup||sequenti lineup||simultan lineup||mecklenburg report||non-blind||mecklenburg state||lineup administr||mecklenburg studi||mecklenburg 2006||eyewit identif||sequenti double-blind lineup procedur||eyewit identif procedur||eyewit memori||sequenti lineup pilot project,0.422||0.396||0.306||0.252||0.228||0.227||0.22||0.219||0.216||0.216||0.202||0.198||0.176||0.175||0.175,0.0,0.0,0.06666666666666667
29,Diabetologia-4-1-2292427.txt,type||diabet patient||level||progress renal impair||glomerular filtrat barrier||diabet||vegf||hypertens||key player||hyperglycaemia||metabol pathway||filtrat rate||permeabl||develop||observ||normal gfb||increas||glomerular endotheli cell||key||direct cellular effect||signific||vascular diseas||podocyt loss||glycocalyx||diabet nephropathi||genet risk||protein||microalbuminuria||albumin||factor||podocyt||import||gfb||risk factor||import contributor||diabet popul||diseas||diabet complic||inflammatori cytokin,microalbuminuria||diabet microalbuminuria||diabet||diabet nephropathi||HH microalbuminuria||glomerular endotheli glycocalyx||2008 microalbuminuria||microalbuminuria eur||persist microalbuminuria||microalbuminuria reveal||glomerular permeabl||glomerular endotheli dysfunct||endotheli glycocalyx||glomerular barrier||glomerular filtrat,0.508||0.44||0.371||0.281||0.266||0.264||0.257||0.257||0.256||0.255||0.241||0.221||0.217||0.216||0.211,0.6,0.3,0.2
30,Pediatr_Radiol-3-1-1950217.txt,follow-up||level||inhal CS||signific reduct||reduct||growth hormon||low bmd||patient||year||cranial irradi||oral contracept||full bmd recoveri||idiopath short statur||bone miner||correl||normal hormon level||pediatr||lower extrem||increas||matur||nonambulatori||improv||fractur||treatment||therapi||calcium||CS therapi||bmd||lean tissu mass||chronic condit||normal valu||result||low bone mass||short statur||peak bone mass||normal||puberti||LS bmd||factor||height||dxa||osteoporosi||physic activ||bone deposit||hip bmd||abnorm dxa find||diseas||diagnosi||bone diseas||bone miner densiti||children||dxa find,bone||bone miner||bone miner densiti||bone densiti||miner densiti||bone miner accrual||bone miner metabol||normal bone miner||bone miner content||abnorm bone miner||inadequ bone miner||reduc bone miner densiti||low bone miner densiti||bone miner densiti loss||lower bone miner densiti,0.514||0.476||0.403||0.386||0.348||0.338||0.333||0.328||0.325||0.321||0.319||0.308||0.306||0.304||0.303,0.4,0.2,0.13333333333333333
31,Purinergic_Signal-3-4-2072927.txt,role||extracellular concentr||human mesenchym stem cell||releas||data||adenosin||neurotransmiss||atp||effect||increas||cell divis||receptor||evid||inhibit||cell||rat||brain||stimul||hippocampu||action||ischemia||tonic activ||activ||extracellular space||ntpdase||glutam||antagonist||protect,adenosin||adenosin receptor||adenosin a2a receptor||brain adenosin||2A||extracellular adenosin||adenosin releas||adenosin A1||adenosin outflow||adenosin inhibit||adenosin modul||adenosin A3 receptor||A3 adenosin receptor||adenosin a2a receptor antagonist||adenosin A1 receptor,0.518||0.369||0.325||0.313||0.302||0.297||0.293||0.289||0.288||0.282||0.274||0.273||0.273||0.269||0.266,0.2,0.1,0.06666666666666667
32,Purinergic_Signal-4-2-2377322.txt,muscl||respons||stimulatori effect||releas||human plasma||perfus||atp||activ skelet muscl||potassium channel||effect||purin||bodi exercis||extracellular atp||cell||acetylcholin||hypoxia||solut||tissu||exercis||depolar||identif||erythrocyt||human muscl||bath solut||motor nerv||substanc||serendip||human erythrocyt||procedur||heart||membran,atp||atp releas||adenosin||forrest||atp channel||adenosin triphosph||extracellular atp||adenosin triphosph releas||triphosph||schwiebert EM atp||atp content||atp expans||keyword atp releas||releas||separ atp releas channel,0.383||0.285||0.253||0.239||0.234||0.233||0.229||0.217||0.213||0.209||0.201||0.197||0.19||0.186||0.164,0.2,0.2,0.2
33,Sci_Eng_Ethics-4-1-2225997.txt,independ physician||clinic test||case||critic care situat||time||intens care condit||risk-benefit ratio||prospect||efficaci||brain injuri||studi||good clinic practic||patient||agent||inclus||elderli peopl||short therapeut time window||clinic trial||pharmacolog trial||countri||treatment||tbi||defer consent||acut neurolog||specif ethic issu||emerg research||pharmacolog neuroprotect agent||random||sever traumat brain injuri||consent||acut emerg situat||european||proxi||direct||injuri||time window||proxi consent||clinic research||ethic||sever tbi||trial||signific advers side effect||benefit||waiver,consent||defer consent||proxi consent||inform consent||consent patient||emerg||consent procedur||kin proxi consent||prior consent||accur consent||tbi||F. J. A. defer consent||proxi||D. inform consent||W. surrog consent,0.392||0.304||0.285||0.224||0.22||0.206||0.205||0.204||0.201||0.199||0.192||0.179||0.178||0.173||0.161,0.6,0.3,0.3333333333333333
34,Surg_Endosc-4-1-2358937.txt,blood loss||transect||anim||materi||time||routin blood test||complic||stapl line reinforc||liver resect||surgeri||substanti liver parenchyma||devic||bile leak||addit||liver,laparoscop||stapl laparoscop||stapl||laparoscop resect||stapl laparoscop liver resect||laparoscop liver resect||resect||laparoscop devic||laparoscop roux-en-i||liver resect||stapl metalloptysi||stapl pulmonari resect||stapl line||liver||standard laparoscop stapl devic,0.419||0.41||0.4||0.329||0.32||0.293||0.239||0.232||0.231||0.23||0.228||0.225||0.221||0.22||0.22,0.0,0.1,0.13333333333333333
35,Skeletal_Radiol-4-1-2271083.txt,bone marrow-stimul agent||case||spine||mri||imag||histori||patholog report||studi||patient||benign||fdg uptak||pet imag||lesion||fractur||neg predict valu||CT find||patholog result||repeat imag||clinic follow-up||uptak||acut benign fractur||report||compress fractur||suv||benign fractur||malign||emiss imag||fdg-pet,fractur||benign fractur||compress fractur||benign compress fractur||malign fractur||malign compress fractur||benign||malign benign fdg-pet||fdg-pet||malign||malign vertebr compress fractur||vertebr compress fractur||acut benign fractur||acut compress fractur||bodi compress fractur,0.44||0.385||0.377||0.361||0.357||0.343||0.329||0.298||0.292||0.273||0.272||0.272||0.266||0.261||0.256,0.6,0.6,0.4666666666666667
36,Brain_Struct_Funct-4-1-2226080.txt,maze test||anim||stereolog||time||revers trial||total neuron number||matern separ||open arm||section||volum||test||anxieti||total||hole||dentat gyru||escap box||behaviour||maze||day||distanc||open field test||paramet||separ||estim||hippocampu||total distanc||mice||neuron||total number||pnd||experiment group||arm||group||open field||number||barn maze||trial||signific differ||box,0.07||maze||0.07 section||ellenbroek||hippocampu||barn maze||stereolog||maze test||radial maze||neurogenesi||anim||dentat||barn maze test||dentat gyru||barn platform maze,0.246||0.175||0.135||0.122||0.113||0.112||0.098||0.097||0.09||0.089||0.088||0.085||0.081||0.08||0.08,0.4,0.5,0.4666666666666667
37,Appl_Psychophysiol_Biofeedback-4-1-2259255.txt,condit||find||eeg abnorm||delta activ||behavior||eeg biofeedback||depend||problem||data||alpha absolut power||studi||patient||clinic outcom||alpha||state||chronic||function brain activ||cortic area||effect||sud||quantit eeg||frequenc||section||femal||beta||scale||increas||criteria||amplitud||slow-beta coher||abstin||low-voltag background activ||qeeg alter||disord||frontal||evid||mix substanc abus||classif||treatment||therapi||eeg coher||cocain||qeeg techniqu||control||acut||cognit||power||stimul||approach||alcohol||alpha-theta biofeedback||research||biofeedback||result||function connect||theta||qeeg||subject||neurotherapi||neurofeedback||genet factor||activ||heroin user||theta band||eeg characterist||heroin addict||report||group||clinic research||abus||drug||kulkoski||alpha-theta train||mental rehears||erp||alpha activ||techniqu,eeg||eeg biofeedback||biofeedback||alcohol eeg||neurofeedback||L. eeg biofeedback||T. eeg biofeedback||H. eeg biofeedback||eeg biofeedback treatment||eeg biofeedback protocol||addict||A. eeg||type-specif eeg biofeedback||eeg alpha||M. eeg,0.41||0.364||0.318||0.305||0.27||0.268||0.261||0.259||0.257||0.25||0.25||0.248||0.244||0.243||0.242,0.6,0.3,0.2
38,Diabetologia-3-1-1794135.txt,type 2 diabet||quantit trait||diabet||variant||data||studi||bmi||effect||risk||insulin sensit||receptor||sir cohort||genotyp||evid||adiponectin gene||associ studi||gene||cohort||control||result||analysi||polymorph||popul||associ||report||snp||UK popul||insulin resist||haplotyp||sequenc||adiponectin receptor,adipor1||adipor1 adipor2||adipor2||1 adipor1 adipor2 adipor1 adipor2||adipor1 adipor2 variant||interpret adipor1 adipor2||13 adipor1 adipor2||method adipor1 adipor2||result adipor1 adipor2||adipor1 rs6666089||tabl 3 adipor1 adipor2||tabl 1 adipor1 adipor2||adiponectin||adipor2 adipor2 14 15 13||0.3425 0.495 adipor2,0.596||0.591||0.585||0.473||0.404||0.395||0.394||0.394||0.394||0.306||0.296||0.296||0.264||0.235||0.204,0.0,0.0,0.0
39,J_Med_Internet_Res-7-5-1550689.txt,document||filter||time||system||data||technic perform||inform||total search time||meta-search filter||user||sourc||evid||meta-search engin||wrapper||approach||parallel process||evidence-bas medicin||pubm||small peak||paper||onlin evid retriev method||clinician||standard||unifi respons languag||capabl||search||intern compon||number||diseas||profil||design||search profil||result,queri||search||uql queri||sourc queri||wrapper||user queri||individu queri||queri time||queri languag uql||queri element||search speed||queri keyword||search capabl||1662 search||web search,0.374||0.322||0.268||0.261||0.235||0.234||0.202||0.201||0.198||0.195||0.188||0.187||0.187||0.184||0.182,0.4,0.2,0.13333333333333333
40,Eur_Radiol-2-2-1705542.txt,unclear shoulder pain||imag||arthrographi||superior||complex||coron obliqu||lesion||ighl||secondari imping||tear||shoulder disloc||common form||diagnost work-up||magnet reson||labro-ligament complex||acut||labrum||anterior instabl||bankart||diagnost arthroscopi||bicep||injuri||pain athlet shoulder||athlet||normal anatomi||therapeut decis,shoulder||arthrographi||glenohumer instabl||shoulder disloc shoulder||glenoid||shoulder disloc||anterior shoulder instabl||glenoid imping||shoulder ajr||anterior glenohumer instabl||glenohumer ligament||multidirect shoulder instabl||imping||glenoid labrum||sports-rel glenohumer instabl,0.395||0.354||0.296||0.292||0.262||0.24||0.24||0.239||0.235||0.229||0.219||0.219||0.216||0.215||0.212,0.2,0.2,0.13333333333333333
41,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2413120.txt,type||arthroscop view||time||time-disturb analysi||exact sig||disturb||qualiti||turbid||studi||comparison||knee joint||effect||view||arthroscop pump system||straightforward arthroscop knee surgeri||oper||frame||percentag||analysi||group||differ||presenc||arthroscopi||number||loos fibrou tissu||signific differ||result,shaver||autom pump||graviti pump||arthroscop pump system||pump system||pump perform||pump group||arthroscopi||knee arthroscopi||arthroscop knee oper||turbid||shaver durat||graviti pump cyst||disturb turbid||radiu shaver,0.297||0.283||0.251||0.227||0.214||0.214||0.211||0.206||0.203||0.192||0.19||0.185||0.173||0.17||0.168,0.2,0.2,0.2
42,Purinergic_Signal-4-1-2246000.txt,atp||microglia||propag||microgli cell||wave||work||lane||receptor||astrocyt||releas||site||calcium wave||transmiss||model||diffus substanc||valu||initi||cell||densiti||calcium,mbox||mu||document||documentclass||12pt||amsmath||amsfont||mathrsf||69pt||microglia||μ||end||microglia brain||rat microglia||activ microglia,0.152||0.076||0.066||0.049||0.049||0.049||0.049||0.049||0.049||0.038||0.025||0.023||0.022||0.021||0.02,0.0,0.1,0.06666666666666667
43,Neurochem_Res-4-1-2295255.txt,level||nos-2||patient||control mice||region||astrocyt||infect||brain||day||gfap||glial cell||hippocampu||mice||olfactori bulb||capillari blood vessel||model mous||report||infect mous brain||influenza viru||viru||blood vessel||result,influenza||influenza viru||nos-2||viru||influenza viru infect||nw viru||neurovirul influenza||neuroadapt influenza viru||avian influenza viru||influenza enceph||33 influenza viru||influenza viru replic||nw||influenza epidem||human influenza,0.443||0.372||0.348||0.3||0.295||0.268||0.261||0.256||0.254||0.253||0.253||0.251||0.236||0.229||0.223,0.6,0.3,0.2
44,Cancer_Causes_Control-2-2-1705538.txt,posit associ||birth||histori||data||studi||menopaus statu||bmi||densiti||continu form||multivari model||risk||effect||mammogram||clinic assess form||cutpoint||famili histori||patient intak form||analys||breast cancer risk factor||breast cancer risk||breast densiti||pariti||menarch||nhmn record||women||posit effect||age||previou studi||factor||hormon replac therapi||influenc||mammograph breast densiti||interact||larg popul||breast||current visit,breast||breast cancer||breast cancer breast cancer||breast densiti||mammograph breast densiti||breast cancer risk||breast cancer 0.09||histori breast cancer||denser breast||breast tissu||breast procedur||breast cancer Br||breast cancer prognosi||breast cancer prevent||high breast densiti,0.482||0.352||0.352||0.336||0.298||0.256||0.255||0.253||0.248||0.245||0.242||0.237||0.236||0.236||0.227,0.6,0.4,0.26666666666666666
45,J_Occup_Rehabil-3-1-2039785.txt,categori||low job satisfact||case||high effort||object instrument||measur||product loss||studi popul||pain intens||studi||dichotom variabl||musculoskelet symptom||select||mous usag||neck||worker||logist regress analys||sick leav||comput worker||presente||analys||psychosoci factor||product||pain||associ||product due||popul||subject||sick absenc||previou research||psychosoci load||respond||intens||factor||symptom||comput usag||descript statist||loss||mous posit||result,worker||symptom||sick||shoulder symptom||symptomat worker||comput worker||shoulder||full-tim worker||arm symptom||part-tim worker||arm symptom product loss||musculoskelet symptom||offic worker||hand symptom||loss,0.402||0.299||0.275||0.271||0.252||0.248||0.244||0.235||0.23||0.226||0.216||0.215||0.214||0.205||0.202,0.4,0.3,0.3333333333333333
46,Pediatr_Nephrol-4-1-2259256.txt,condit||time||infant||detrusor overact||lower extrem function||abnorm||intraves pressur||myelodysplasia||present||lower urinari tract||lower extrem||increas||spinal cord||lesion||pressur||newborn||bladder||urodynam studi||reflux||cerebr palsi||sphincter||urodynam||assess||dysfunct||renal function||low pressur||injuri||cic||cord||high||anticholinerg medic||sacral agenesi||incontin||complianc||children,bladder||neurogen bladder||spinal cord||urodynam||spinal dysraph||bladder dysfunct||cord||compliant bladder||underact bladder||spinal cord injuri||spinal cord malform||hyperact bladder||reflex bladder||myelodysplasia||bladder sphincter dyssynergi,0.313||0.222||0.219||0.216||0.196||0.182||0.18||0.177||0.173||0.173||0.172||0.17||0.17||0.168||0.168,0.6,0.4,0.3333333333333333
47,Virchows_Arch-3-1-2039779.txt,method||ileal mucosa||studi||comparison||patient||lower number||cell kinet||apoptot index||section||affer loop||famili adenomat polyposi||adenoma||investig||increas||tissu section||pouch||cell prolifer||restor proctocolectomi||apoptot rate||cell||prolifer||tissu area||apoptosi||semiquantit||rang||photograph||biopsi||differ||number||fap||signific differ||crypt||index,pouch||ileal pouch||pouch mucosa||pouch adenoma||ileal||ileoan pouch||pelvic ileal pouch||pouch adenocarcinoma||pouch content||polyposi||ileal mucosa||ileal prolifer||ileal pouch anal anastomosi||crypt||ileal loop,0.553||0.449||0.368||0.345||0.344||0.321||0.301||0.295||0.278||0.277||0.264||0.248||0.248||0.245||0.22,0.2,0.1,0.2
48,Diabetologia-4-1-2270365.txt,effect||risk||gene||power||case-control data||loci||joint effect||trio||type 1 diabet||interact||diseas||data||genotyp||hla||supplementari materi||result,ptpn22||ptpn22 ctla4 ptpn22 ctla4||ctla4 ptpn22||ptpn22 ctla4||ptpn22 ptpn22 df ptpn22||ptpn22 ctla4 jo27||ptpn22 ctla4 gene||ptpn22 df||interact ptpn22||ptpn22 1858t||conclus ptpn22||result ptpn22||ptpn22 4 5 ptpn22 df||ctla4 ptpn22 5 8||gene ctla4,0.546||0.458||0.458||0.458||0.431||0.338||0.325||0.316||0.291||0.281||0.274||0.273||0.236||0.229||0.215,0.0,0.0,0.0
49,Purinergic_Signal-4-2-2377325.txt,role||level||respons||releas||photoreceptor||adenosin||agonist||effect||space||transport||evid||signal||rpe||light-sensit signal||cell||stimuli||stimul||epinephrin||rpe cell||microenviron||membran||subretin space||rod||consist||ectoenzym activ||atp releas||glutam||cftr,retin pigment||pigment||retin pigment epithelium||subretin purin||subretin space||rpe||bovin retin pigment||human retin pigment||frog retin pigment epithelium||chick retin pigment epithelium||retin pigment epithelium 1998||subretin microenviron||subretin inject||adenosin||retin reattach,0.35||0.339||0.297||0.262||0.261||0.245||0.245||0.24||0.228||0.225||0.224||0.22||0.201||0.196||0.189,0.2,0.2,0.2
50,Eur_Radiol-3-1-1914269.txt,percentu width||measur||heart phantom||method||cardiac cycl||tempor resolut||longitudin plane||CT imag||imag||studi||stent||attenu profil||imag qualiti||plane||increas||coronari stent||heart rate||lumen visibl||averag spearman coeffici||highest score||CT attenu||64-slice mdct||coronari arteri||averag decreas||movement||attenu||heart||stent lumen||result,stent||coronari stent||stent lumen||stent imag||coronari stent lumen||coronari arteri stent||coronari stent restenosi||coronari stent patenc||drug-elut stent||stent increas||cypher stent||provision stent||stent diamet||coronari arteri stent patenc||coronari arteri stent assess,0.437||0.348||0.28||0.273||0.273||0.269||0.252||0.246||0.227||0.227||0.227||0.226||0.225||0.212||0.205,0.6,0.3,0.2
51,J_Gastrointest_Surg-3-1-1852377.txt,poor outcom||hepatocellular carcinoma||studi||patient||recurr||liver transplant||signific||microvi||df||present studi||multivari analysi||analysi||microvascular invas||vascular invas||hcc||liver||factor||tumor||surviv||histolog grade||number||liver explant||stage||outcom,hepatocellular||hepatocellular carcinoma||liver||liver transplant||transplant||microvi||macrovi||hepatocellular carcinoma valid||small hepatocellular carcinoma||hcc||orthotop liver transplant||LT||liver transplant versu liver resect||liver explant||d'amico DF liver transplant,0.451||0.337||0.273||0.267||0.262||0.259||0.259||0.227||0.227||0.194||0.193||0.185||0.175||0.169||0.153,0.6,0.5,0.4
52,Clin_Rheumatol-3-1-1820749.txt,mechan||chronic fatigu syndrom||physiolog mechan||cognit emot sensit||respons||central process||knowledg||pain complaint||studi||theoret background||patient||function brain activ||central nervou system||chronic widespread pain||sensit||investig||spinal cord||pain process||evid||similar||stimuli||brain abnorm||multipl spinal segment||tempor summat||cognit||electr stimul||chronic fatigu||catastroph thought||pain||musculoskelet pain||hyperalgesia||cf||central sensit||chronic pain||allodynia||wind-up||fibromyalgia||central mechan||inhibitori pathway||spatial summat||pathway||hypothesi||result,pain||cf||chronic pain||fibromyalgia||musculoskelet pain||chronic pain syndrom||fatigu||widespread pain||pain patient||pain complaint||pain disabl||pain modul||pain hypervigil||pain pathway||chronic musculoskelet pain,0.501||0.354||0.346||0.345||0.291||0.285||0.275||0.273||0.27||0.268||0.265||0.265||0.264||0.258||0.258,1.0,0.6,0.4
53,Environ_Manage-3-1-1914239.txt,legal entiti||skill||case||oper entiti||design oper entiti||cameroon||commun||project||capac||figur||cdm implement||studi||argument||develop||inform||carbon||sustain||project develop||impact||institut arrang||manag||resourc||cost||ngo||bimbia||rule||clean develop mechan project||commun forest||sustain develop||resourc tenur||clean develop mechan||environment impact||biodivers||cdm||reforest||materi||activ||implement||timber exploit||environment servic||impact assess||commun capac||emiss||tinto||requir||capac requir||forest||nation fund||current modal||commun manag||plan||addition||carbon sequestr,forest||cdm||cdm forestri||commun forest||forest carbon||bimbia||tinto commun forest||forest manag||bimbia tinto||manag tinto forest||forest inventori||forestri||forest countri||cdm forestri project||cdm project,0.511||0.413||0.342||0.342||0.329||0.321||0.307||0.299||0.279||0.279||0.276||0.272||0.272||0.269||0.267,0.6,0.4,0.26666666666666666
54,Eur_J_Pediatr-3-1-1914268.txt,domain read||find||case||system||children||perinat asphyxia||ambigu result||problem||mild NE||studi||normal rang||young age||school||behavior problem||heterogen group||moder NE||difficulti||criteria||review||abil||behavior consequ||neonat encephalopathi||sever NE||brain||neuropsycholog function||mild||inclus criteria||sarnat||cognit||research||futur research||long-term follow-up||age||educ achiev||gener||group||school age||asphyxia||intellig||healthi peer||area||read||averag rang||addit||score||function||outcom||result,NE||asphyxia||moder NE||mild NE||mild NE moder NE sever NE||neonat encephalopathi||neonat asphyxia||sever NE||attent NE||5 NE||perinat asphyxia||newborn encephalopathi||neonat||hypoxic-ischaem encephalopathi||rang mild NE,0.513||0.329||0.314||0.309||0.296||0.29||0.273||0.266||0.266||0.257||0.223||0.222||0.217||0.214||0.214,0.6,0.5,0.4
55,Sci_Eng_Ethics-4-1-2413106.txt,futur||fuel||time||main object||justic||line||cfc||fuel cycl||valu||reactor||risk||recycl||period||plutonium||nuclear reactor||ofc||trade-off||addit risk||moral discuss||sustain||countri||short-term||energi||long-term benefit||intergener justic||nea||iaea||prolifer||open||long-term radiolog risk||world||futur gener||product||secur concern||analysi||framework||materi||reprocess||present gener||reason||gener||option||order||wast||natur uranium||public||uranium||radiotox||benefit||nuclear wast||plant||safeti,fuel||wast||justic||fuel cycl||cfc||spent fuel||nuclear wast||nuclear fuel cycl||reprocess wast||spent nuclear fuel||intergener justic||fuel leak||reprocess||radioact wast||advanc nuclear fuel cycl,0.452||0.295||0.279||0.277||0.276||0.272||0.26||0.259||0.257||0.256||0.249||0.228||0.218||0.201||0.196,1.0,0.6,0.5333333333333333
56,Evid_Based_Complement_Alternat_Med-4-4-2176145.txt,type||program||health benefit||week||diabet||hypertens||glucos level||studi||session||cholesterol||yoga||overweight||effect||high cholesterol||review||intervent||adult||day||health condit||glucos||chronic diseas||subject||weight||bodi weight||cardiovascular diseas||benefit||systol BP||articl,yoga||hatha yoga||yoga asana||yoga train||yoga postur||yoga program||yoga intervent||yoga lifestyl||yoga exercis||yoga session||yoga practic||yoga review||yoga sequenc||yoga reduc||yoga lifestyl intervent,0.931||0.494||0.494||0.489||0.483||0.483||0.48||0.477||0.477||0.476||0.471||0.47||0.469||0.469||0.328,0.2,0.1,0.06666666666666667
57,Ann_Surg_Oncol-4-1-2277451.txt,cancer||adjuv therapi||surgic volum||hospit||volum||surgeon||studi||centr||servic||literatur||poor qualiti||patient||oper||manag||institut||outcom,volum||cancer||surgeon||cancer outcom||surgic volum||outcom||hospit volum||volum outcom relationship||surgeon procedur volum||keyword cancer volum outcom||colorect cancer outcom||unit volum||procedur volum||colorect cancer||volum low volum ref,0.319||0.223||0.217||0.212||0.202||0.2||0.197||0.197||0.19||0.186||0.182||0.18||0.177||0.172||0.17,0.8,0.5,0.3333333333333333
58,Pharm_World_Sci-3-1-2082655.txt,chronic ill experi||find||meta-synthesi||in-depth interview||individu||studi||patient||encount||effect||process||medic||health care practition||theme||interview transcript||medic experi||natur||control||understand||pharmaceut care||research||chronic condit||bodi||practic concept||pharmaceut care practic||practition||sens||ill||particip,medic||medic theme||medic experi||theme||chronic medic||patients’ medic experi||medic practic||experi||medic experi shoemak sarah||patients’ medic practic||pharmaci||neurolept medic||minnesota ramalho||bodili effect medic||patient ’s medic experi,0.243||0.218||0.195||0.192||0.164||0.163||0.162||0.147||0.144||0.141||0.136||0.135||0.135||0.134||0.133,0.6,0.3,0.2
59,Bioinformation-1-4-1891668.txt,record||number||diabet||medicin plant||databas||diseas||data||diamedbas||plant,diamedbas||plant||medicin plant||util diamedbas||plant part||plant speci||plant research||specif plant||bioinform bioinform bioinform||diabet||diamedbas alo vera figur 1||databas||visakhapatnam||diabet literatur databas||bioinform 1,0.49||0.461||0.282||0.262||0.247||0.24||0.234||0.234||0.162||0.16||0.152||0.126||0.118||0.105||0.081,0.6,0.4,0.3333333333333333
60,Biogerontology-3-1-2040177.txt,measur||major gene||individu||rate||sampl||chuvashia||herit||oss measur||effect||correl||biolog age||investig||residu varianc||sex||signific||parsimoni model||segreg analysi||present studi||BA index||livshit||age adjust||gene||women||age||analysi||popul||MG genotyp||genet factor||group||famili||skelet||oss||index||biomark,oss||kobylianski||oss varianc||log-transform oss||oss estim||oss score||oss valu||oss measur||oss data||age 45 oss||age||livshit||pavlovski||tel aviv||pavlovski OM kobylianski,0.353||0.251||0.211||0.202||0.186||0.185||0.181||0.18||0.18||0.174||0.166||0.16||0.16||0.154||0.152,0.2,0.2,0.26666666666666666
61,Behav_Genet-3-1-1914288.txt,measur invari||parent rate||boy||sex differ||behavior||adhd index||conner teacher rate scale||data||model||equal||correl||scale||teacher rate||MI criteria||sex||environment influenc||factor structur||item||preval differ||girl||varianc||estim||twin||odd||analysi||parent||genet||teacher||factor||differ||influenc||adhd||children,teacher||girl||boy||conner teacher||twin||adhd||teacher rate||teacher data||teacher report||AE girl||opposite-sex twin||ace||7-year-old twin||opposit sex twin||conner teacher rate scale,0.416||0.309||0.287||0.271||0.259||0.253||0.231||0.211||0.21||0.209||0.192||0.186||0.182||0.157||0.154,0.8,0.6,0.4666666666666667
62,Eur_J_Nucl_Med_Mol_Imaging-4-1-2275773.txt,normal tissu||tumour-specif apoptot respons||respons||protocol||radiat||roi||imag||baselin||studi||patient||earli apoptosi||effect||abil||dose||hnscc||tumour||apoptosi||lymph node||spect||primari tumour||parotid gland||differ||radiat dose||treatment-induc annexin uptak||salivari gland function||scintigraphi||submandibular gland||convent gamma camera||annexin,annexin||gland||tav||annexin uptak||parotid gland annexin uptak||parotid gland||imrt||parotid||oropharynx||radiotherapi annexin||tumour||neck cancer parotid gland||treatment-induc annexin uptak||neck||99m,0.299||0.236||0.23||0.227||0.222||0.217||0.204||0.199||0.197||0.182||0.177||0.173||0.163||0.163||0.162,0.2,0.2,0.26666666666666666
63,Naunyn_Schmiedebergs_Arch_Pharmacol-3-1-1915601.txt,mechan||antibodi||sphingosine-1-phosph receptor||membran||luminesc signal||time||fluoresc||BM chemiluminesc blot substrat||hisg-tag||protein||non-radioact method||receptor||fluoresc microscop||internalis||signal||detect method||cell||detect||cell membran||result,internalis||receptor internalis||receptor||alexafluor||adrenerg receptor||mous anti-hisg||anti-hisg 1:200||s1p-induc internalis||sphingosine-1-phosph receptor||receptor ligand||specif anti-hisg antibodi||n-termin hisg-tag receptor||hisg-tag||receptor hisg-tag quantif internalis cellular||antibodi,0.31||0.283||0.256||0.188||0.186||0.182||0.182||0.174||0.158||0.156||0.153||0.153||0.151||0.15||0.149,0.4,0.3,0.3333333333333333
64,Environ_Health_Perspect-114-2-1367850.txt,measur||method||neurolog examin||data||studi||specif aspect||year||seychel island||question||psycholog test||prenat exposur||develop||development effect||effect||inform||review||investig||mehg||consensu||test||development outcom||methylmercuri||mehg exposur||outcom||cognit process||exposur assess||neurobehavior test||research||futur research||assess||age||faro island||associ||subject||literatur||matern hair||report||import||exposur||field||current uncertainti||prenat mehg exposur||development rate scale||systemat review||outcom measur||children||result,methylmercuri||methylmercuri exposur||grandjean||prenat methylmercuri exposur||methylmercuri environ||methylmercuri poison||methylmercuri studi||2001 methylmercuri||fetal methylmercuri exposur||1999b grandjean||1983 methylmercuri exposur||postnat methylmercuri exposur||weih||shamlay||2003 prenat methylmercuri exposur,0.43||0.308||0.297||0.262||0.242||0.228||0.218||0.216||0.213||0.211||0.21||0.209||0.208||0.206||0.197,0.2,0.1,0.06666666666666667
65,Eur_Child_Adolesc_Psychiatry-2-2-1705530.txt,depress symptom||mother||birth||pre-nat smoke||studi||depress||effect||risk||famili risk||child||lbw||variabl||birth-weight||unit increas||analys||coeffici||genet risk||twin||age||social class||associ||standard||weight||birth weight||factor||regress analysi||parent report||gestat||report||influenc||symptom||interact||depress disord||children||result,birth-weight||psyc 157:190||psyc 163:369||psyc 152:833||psyc 155:172||psyc 160:625||psyc 184:446||psyc 179:230||psyc 156:133||psyc 179:116||psyc 179:450||psyc 175:380||psyc 178||depress||child psychol psyc 38:931,0.4||0.33||0.33||0.33||0.33||0.33||0.33||0.33||0.33||0.33||0.33||0.33||0.328||0.297||0.215,0.2,0.1,0.13333333333333333
66,Appl_Microbiol_Biotechnol-4-1-2266784.txt,jar fermentor||heterolog protein||cultur||signal peptid||product||secret||amino acid||kikuchi||industri product||industri scale protein product,corynebacterium glutamicum||corynebacterium||C. glutamicum corynebacterium||2005 corynebacterium glutamicum corynebacterium||C. glutamicum C.||C. glutamicum 2003||C. ammoniagen C. ammoniagen atcc6872||C. ammoniagen C.||2 C. glutamicum C.||C. ammoniagen atcc6872||2008 streptomyc mobaraensi corynebacterium glutamicum brevibacterium||corynebacterium taxonomi||18 C. ammoniagen||12 13 C. glutamicum||8 9 C. glutamicum,0.524||0.419||0.408||0.367||0.328||0.27||0.265||0.261||0.246||0.24||0.234||0.219||0.202||0.202||0.202,0.0,0.0,0.0
67,Fam_Cancer-4-1-2253650.txt,risk||potenti role||cancer||gene||syndrom||case||women||dgc||mutat carrier||studi||prophylact gastrectomi||lbc||lobular carcinoma||lobular breast cancer||loss||mutat||breast||predict genet test||famili,cdh1||cdh1 mutat||2007 cdh1 cdh1 mutat||cdh1 cdh1 mutat test||cdh1 gene||cdh1 promot||germlin cdh1 mutat||e-cadherin||recurr cdh1 mutat||method cdh1 mutat||cancer||cdh1 9 cdh1 42 43||cdh1 44 cdh1 45 46||breast cancer||gastric cancer,0.68||0.426||0.384||0.384||0.359||0.345||0.321||0.298||0.287||0.284||0.282||0.273||0.273||0.258||0.25,0.0,0.0,0.06666666666666667
68,Diabetologia-3-1-2100429.txt,type 2 diabet||mother||pregnanc||studi||offspr||matern nutrit variabl||newborn||adipos||bodi composit||women||thci||matern nutrit||indian||fat mass||size||folat||risk factor||insulin resist||nutrit measur||mma||children,folat||matern folat||insulin||pune||erythrocyt folat||yajnik CS||folat defici||nutrit||insulin resist||indian||pune matern nutrit studi yajnik||matern nutrit||india||homa-r||folat concentr,0.262||0.205||0.198||0.192||0.177||0.174||0.16||0.159||0.158||0.158||0.156||0.153||0.151||0.149||0.146,0.2,0.3,0.26666666666666666
69,Cancer_Immunol_Immunother-3-1-2082063.txt,antigen process machineri||independ predictor||prognost paramet||apm defect||case||patient||stromal cell||express||erap||df||tumour||human carcinoma||tap||erap1||intern posit control||signific associ||independ prognost paramet||defect express||apm compon||surviv||apm||normal express||cervic cancer||cervic carcinoma||cervic carcinoma patient||loss||clinicopatholog paramet||down-regul||score||compon,erap1||hla class||erap1 loss||erap1 down-regul||apm||class||partial hla class||ferron||hla express||antigen class||microglobulin hla class||alter hla class||antigen||3 hla class||machineri erap1 cervic carcinoma,0.322||0.262||0.235||0.214||0.213||0.212||0.201||0.2||0.199||0.195||0.186||0.184||0.179||0.175||0.175,0.4,0.2,0.13333333333333333
70,Apoptosis-4-1-2423419.txt,cancer||studi||icad||express level||region||promot||site||express||cell||myc||gene||dna fragment||function import||transcript||apoptosi||activ||human cancer||transcript regul||report||dff||ectop express||icad protein||construct||myc-bind site||result,icad||icad icad||2008 icad icad icad||icad myc icad||icad 5 icad||icad gene icad icad ecor||c-myc icad||myc icad 3 icad icad promot||icad promot||icad gene||icad express||icad protein||icad 39 icad gene regul||n-myc icad promot||icad promot activ,0.912||0.912||0.685||0.654||0.608||0.556||0.514||0.486||0.476||0.473||0.467||0.461||0.376||0.354||0.322,0.2,0.1,0.13333333333333333
71,Neuroradiology-4-1-2275774.txt,follow-up||imag||patient||stent||volum||contrast medium||intracrani stent||rotat acquisit||examin||volum dataset||invas techniqu||intraven administr||brain parenchyma||act||CT angiogram||cta||ica||vessel||cerebrovascular diseas||inject||stent lumen,stent||intracrani stent||stent lumen||nitinol stent||coronari stent||elect stent||stent placement||intracrani stent buhk jan-hendrik||iv-act||intracrani angioplasti||intracrani vessel||ia-dsa||intracrani aneurysm||intracrani arteri||tomographi flat-panel cerebrovascular diseas intracrani stent,0.459||0.391||0.272||0.252||0.245||0.241||0.239||0.229||0.225||0.209||0.192||0.19||0.187||0.185||0.182,0.6,0.3,0.2
72,Brain_Struct_Funct-4-1-2248604.txt,condit||function imag||respons||lexic statu||block||gyru||sensori compon||middl posit||roi||posit differenti bold||oddbal block||word deviant||motion||effect||oddbal||speech||posterior auditori cortex||test||sensori mechan||deh||stimuli||day||control||map||bonferroni||result||standard||subject||acoust factor||primari auditori cortex||activ||cognit mechan||anterior||speech stimulu interact||deviant||contrast||middl||standard-devi pair||sound||outlier,deviant||deh||non-word deviant||deviant map||deviant stimuli||deviant stimulu||stg||word deviant||deviant word||non-word||oddbal||deviant exemplar||deviant map deviant control map||deviant control||deviant respons,0.399||0.381||0.315||0.273||0.267||0.266||0.254||0.243||0.243||0.231||0.229||0.229||0.222||0.21||0.205,0.4,0.3,0.26666666666666666
73,Arch_Orthop_Trauma_Surg-4-1-2228384.txt,delay||signific pain reduct||studi||patient||durat||effect||adant||viscosupplement||infiltr||hh||hyaluronan||non-op treatment||treatment||hyaluron acid||product||hip||pain||prepar||hip osteoarthr||group||differ||signific differ||inject||tha||statist signific differ,hip||viscosupplement hip||viscosupplement||hip osteoarthr||hip infiltr||hyaluron||osteoarthr||hip pain||intra-articular hyaluron||symptomat hip osteoarthr||hip arthroplasti||hip OA||hip joint||hip patient||hip arthroscopi,0.428||0.398||0.368||0.354||0.317||0.297||0.279||0.267||0.254||0.247||0.242||0.24||0.239||0.232||0.222,0.6,0.3,0.2
74,Ann_Surg_Oncol-4-1-2234450.txt,superfici lymphat||system||first-tier lymph node||radiograph||intern thorac arteri||sentinel node biopsi||femal||anatom analysi||node||lymph vessel||cross-sect studi||dye||axilla||peritumor inject||thin adult cadav||tissu||neg sentinel node studi||lymph node||previou studi||anterior upper torso||subareolar inject||intern mammari lymphat||sentinel node||lymphat||specimen||germani||cadav||vessel||subareolar plexu||inject||sappey||branch||pathway||breast||sentinel lymph node biopsi||result,lymphat||breast lymphat||sentinel||sentinel node||sentinel lymph||sentinel lymph node||node||lymphat vessel||lymphat anatomi||breast||lymph node||lymph||superfici lymphat||lymphat collector||breast cancer sentinel lymph node,0.457||0.369||0.363||0.328||0.316||0.308||0.293||0.288||0.283||0.282||0.281||0.269||0.266||0.266||0.253,0.4,0.4,0.4
75,Antonie_Van_Leeuwenhoek-3-1-2140094.txt,conidiophor||uniqu||extrolit||ascospor||diam||aerial hypha||cultur||cya||coloni||mea||speci||promin equatori furrow,neosartorya||aspergillu||fumigati N.||neosartorya aspergillu N. indohii N.||N.||vel||diam||aspergillu fumigatu||aspergillu section fumigati||aspergillu panamensi||taxonomi neosartorya||penicillium fumigati 2004 aspergillu fumigati||genu neosartorya||aspergillu fumisynnematu||soil,0.337||0.308||0.225||0.221||0.216||0.211||0.211||0.204||0.182||0.18||0.18||0.179||0.176||0.173||0.171,0.0,0.1,0.06666666666666667
76,Dig_Dis_Sci-3-1-1914222.txt,bmp||morpholog||level||high-dos dox treatment||epitheli homeostasi||mucos||epitheli||increas||express||villi||dose||differenti||treatment||cell||damag||day||control||sever villu atrophi||prolifer||mice||medium dose||protein||group||decreas||dox||tcf4||length||pathway||crypt||stem cell||wnt pathway||mtx,dox||intestin||crypt||bmp4||tcf4||intestin crypt cell||dox treatment||tff3||intestin mucos||intestin damag||murin intestin crypt||intestin cell||high-dos dox induc||high-dos dox treatment||intestin mucosa,0.396||0.298||0.288||0.23||0.219||0.219||0.214||0.204||0.202||0.201||0.198||0.184||0.177||0.176||0.172,0.6,0.3,0.26666666666666666
77,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2367393.txt,posterior capsul||vitreou entrap||case||flare||optic edg||year||natur barrier effect||len epitheli cell||hyaloid||routin procedur||posterior capsul opacif||retin detach||anterior vitrectomi||optic buttonhol||eye||lec||primari posterior capsulorhexi||edg||potenti||intraocular lens||techniqu||after-cataract||pobh||surgeri||ppccc||central posterior capsul||peripher retina||iol||anterior||standard in-the-bag implant||capsular diaphragm||toric iol||optic centrat||after-cataract prevent||ovd||optic rim||optic||regeneratori lec prolifer||fibrosi||barrier,iol||iol optic||optic||capsul||lec||ppccc||posterior capsul||optic buttonhol||6-mm iol optic||posterior optic buttonhol||cataract||anterior capsul||bag-fix iol||iol diaphragm||posterior,0.37||0.353||0.335||0.275||0.266||0.247||0.24||0.239||0.237||0.227||0.212||0.21||0.209||0.207||0.205,0.6,0.6,0.4
78,Qual_Life_Res-3-1-1915604.txt,dutch huntington associ||consequ||qualiti||studi||patient||life||amount||durat||ill percept||percept||scale||qol||mental health||spous||analys||huntington||coupl||treatment||control||higher score||total motor score||research||gener health||futur research||social function||subscal||long durat||ill||belief||symptom||patient qol||partner||diseas||vital||result,ill||ill percept||percept||partners’ ill||patients’ ill percept||huntington||patients’ ill||ill psycholog||spousal ill percept||partners’ percept||partner||partners’ ill percept kaptein||ill percept questionnair||ill percept dimens||ill percept 1,0.357||0.324||0.291||0.275||0.272||0.269||0.262||0.26||0.25||0.242||0.235||0.227||0.227||0.218||0.216,0.6,0.4,0.3333333333333333
79,J_Abnorm_Child_Psychol-4-1-2277450.txt,cost diari||anxiou children||anxieti disord||method||inform care||children||preval||data||sever score||studi||year||annual societ cost-of-il||discrimin valid||school||physic problem||converg valid||mental health treatment||anxieti||disord||aim||treatment||childhood anxieti disord||resourc||cost||percentag||parent||psycholog problem||care||gener practition||clinic anxieti disord||reason||famili||group||differ||work||top-down data||cost-of-il||mental disord||diari||gener popul||result,cost||87.21 0.00||cost diari||bottom-up cost||societ cost||famili cost||out-of-pocket cost||annual cost||total cost||anxieti||prospect cost||indirect cost||cost dairi||social cost||childhood cost,0.412||0.355||0.285||0.283||0.238||0.238||0.23||0.22||0.219||0.216||0.214||0.214||0.212||0.211||0.211,0.4,0.3,0.2
80,Mol_Neurobiol-3-1-2039847.txt,AD brain||level||system||AD lesion||protein aggreg||data||apolipoprotein||strategi||hsp||aggreg||human||microgli cell||chaperon||amateur chaperon||profession chaperon||profession||transport||cell||brain||heat shock protein||tpa||gag||heparan sulfat proteoglycan||mice||protein||format||apo||hyperphosphoryl tau||activ||accumul||bind||shsp||earli develop||clearanc||toxic||neurodegen diseas||amyloid||addit||tau||amyloid beta-protein||vivo||result,Aβ||alzheim||Aβ apolipoprotein||alzheim amyloid||Aβ fibril||Aβ aggreg||Aβ clearanc||apolipoprotein||Aβ hspg||fibrillar Aβ||Aβ receptor||Aβ C3||Aβ serum amyloid||amyloid||alzheim ’s,0.489||0.393||0.375||0.315||0.287||0.28||0.273||0.26||0.259||0.253||0.251||0.249||0.245||0.238||0.225,0.0,0.1,0.13333333333333333
81,Purinergic_Signal-2-2-2254478.txt,ntpdase||nervou tissu||platelet||cd39||immunolog||ecto-atpas||vasculatur||ectonucleotidas||liver||apyras,cd39||diphosphohydrolas||atp diphosphohydrolas||ecto-atpas||triphosph diphosphohydrolas||ecto-nucleotidas cd39||atp||nucleosid triphosph diphosphohydrolas||sévigni||ecto-atpas ntpdase2||ecto-nucleosid triphosph diphosphohydrolas||ectonucleotidas||endotheli atp diphosphohydrolas||vascular atp diphosphohydrolas||endotheli cd39,0.314||0.287||0.247||0.241||0.233||0.212||0.208||0.207||0.197||0.195||0.185||0.184||0.179||0.178||0.177,0.4,0.2,0.2
82,Naunyn_Schmiedebergs_Arch_Pharmacol-4-1-2323035.txt,peptid YY||dpp-iv||cd26||diabet||dipeptidyl peptidas IV||glucagon-lik peptide-1,pyy3||dpp-iv||dipeptidyl peptidas IV||peripher pyy3||chronic pyy3||competit dipeptidyl||dpp-iv inhibitor||cd26||dipeptidyl peptidase-4 inhibitor||proteas dipeptidyl peptidas IV||dpp-iv inhibit||keyword dipeptidyl peptidas IV glucagon-lik||peptidas IV||dipeptidyl peptidase-4 inhibitor vildagliptin||glucagon-lik peptide-1,0.365||0.273||0.202||0.195||0.188||0.171||0.165||0.165||0.159||0.155||0.151||0.146||0.138||0.127||0.122,0.4,0.3,0.26666666666666666
83,J_Mol_Biol-1-5-1885970.txt,crystal||activ form||catalyt zinc||linker region||matrix metalloproteinas||contact||water molecul||catalyt domain||structur||form||pro-peptid domain||extracellular matrix||domain||region||asymmetr unit||activ enzym||triple-hel collagen||collagen||enzym||residu||hemopexin-lik domain||activ||peptid hydrolysi||hydrogen bond||crystal structur||activ site mutant||interact||water proton,mmp-1||mmp-1 structur||mmp-1 residu||activ mmp-1||mmp-1 interact||human mmp-1||porcin mmp-1||activ human mmp-1||metalloproteinas||monom||Å||collagenas||gln335||matrix metalloproteinas||e200a,0.512||0.301||0.292||0.275||0.274||0.268||0.266||0.191||0.174||0.173||0.168||0.167||0.158||0.146||0.138,0.0,0.0,0.06666666666666667
84,J_Med_Internet_Res-1-1-1761705.txt,grade||author||measur||method||system||internet user||sampl||qualiti||studi||correl||inform||articl||webometr||daili visit||content||updat||inbound link||journal||resourc||websit||evalu||medic websit||averag||citat||internet||rate system||medic matrix||citat analysi||visit||sens||number||world wide web||impact factor||qualiti indic||work||link||index||media||result,websit||websit editor||link websit||pediatr websit||websit evalu||medic websit||authorit websit||websit author||valuabl websit||websit characterist||extern websit||web||25 websit||institut websit||137 websit,0.533||0.312||0.305||0.292||0.29||0.286||0.285||0.277||0.272||0.271||0.271||0.271||0.269||0.269||0.268,0.2,0.2,0.13333333333333333
85,Diabetologia-3-1-1975734.txt,anim||lentivir deliveri||long-term transgen express||diabet||diabet mice||studi||gene therapi||lentivir vector||vitro||type 1 diabet||partial hepatectomi||deliveri||normal pancrea||insulin||express||cell||rat||gene||transduct effici||beta cell transcript factor||physiolog glucos control||intraven glucos toler test||ffo||liver||group||hepatocyt||pancreat beta cell||ins-fur||procedur||insulin storag||transduct||vivo,insulin||pdx1||hmd||lentivir vector||ins-fur||lentivir transduct||liver||insulin gene||ins-fur transduct||furin-cleav insulin||neurod1||pdx1 neurod1 neurog3||lentivir deliveri||hepatocyt||vector neurod1,0.289||0.262||0.249||0.228||0.228||0.223||0.214||0.211||0.19||0.176||0.176||0.174||0.172||0.17||0.169,0.6,0.4,0.4
86,Histochem_Cell_Biol-4-1-2323033.txt,mechan||cancer cell||cancer||alpha-hel bundl||form||syncytin||receptor||express||macrophag||placenta||cell||gene||membran microdomain||fusion||host cell||protein||regul||bind||fusogen||tumor||import||mous||cell fusion||molecul||membran,fusion||cell fusion fusion||syncytin||cell fusion||trophoblast fusion||fusogen||macrophag fusion||fusion protein||cancer cell fusion||spontan fusion||myoblast fusion||vitro fusion||gamet fusion||fusion event||host cell fusion,0.44||0.353||0.345||0.31||0.273||0.259||0.248||0.246||0.245||0.239||0.237||0.231||0.228||0.225||0.223,0.6,0.4,0.26666666666666666
87,J_Occup_Rehabil-3-1-1915618.txt,measur||capac||fce||pain intens||sampl||studi||patient||function capac||tampa scale||fear avoid belief questionnair||chronic low back pain||test||tsk||high intens perform level||variabl||analys||dynam||high intens lift||weak||rehabilit||relationship||effort||pain||regress equat||activ||intens||clbp||univers medic center groningen||avoid behavior||fabq||perform||fear||lift||hand||result,pain||back pain||pain disabl||chronic pain||pain variabl||pain intens||patient pain||musculoskelet pain||pain manag||pain symptom||pain β||pain expect||fear||lift||chronic pain behavior,0.497||0.321||0.315||0.289||0.279||0.278||0.266||0.259||0.257||0.253||0.253||0.252||0.242||0.214||0.212,0.2,0.2,0.26666666666666666
88,Bioinformation-1-10-1896055.txt,transcriptom||integr analysi||embryo||organ system||sampl||seri||microarray data||probe||express profil||dataset||biolog replic||file||gene||compar bioinformat analysi||annot||analysi||refer collect||mous||number||express data||birth defect||mous embryo,metachip||ciaeasi||metasampl metachip ciaeasi ciaeasi||metasampl metachip ciaeasi http://systemsanalysis.louisville.edu||432a-u74a metachip||figur 1 metasampl metachip ciaeasi||0.001||18 ciaeasi||10 ciaeasi||moe430av2||mg-u74av2||20 metasampl metachip tool||metasampl metachip continu button||17 18 ciaeasi||embryo,0.425||0.397||0.368||0.283||0.227||0.226||0.21||0.2||0.199||0.198||0.198||0.175||0.175||0.135||0.126,0.0,0.0,0.06666666666666667
89,Histochem_Cell_Biol-3-1-2137945.txt,mechan||target||retent||method||nuclear architectur||cajal bodi||distinct structur element||releas||rna motion||bind site||motion||transcript factor||chromatin||nucleu||intranuclear traffick||site||fundament question||key||dynam natur||sequestr||dynam||cell||nuclear bodi||gene||transcript||protein||bodi||nucleolu||rapid||nuclear compart||diffus||nuclear environ||interact||nuclear motion||molecul||dynam properti||rna,rna||rna dynam||mist||nuclear protein||nucleu||dynam||chromatin||nuclear motion||rna motion||protein dynam||dynam protein||nuclear compart||nuclear speckl||nuclear bodi||nuclear architectur,0.287||0.251||0.239||0.234||0.226||0.216||0.211||0.202||0.195||0.192||0.192||0.192||0.186||0.181||0.178,0.4,0.6,0.6
90,J_Gastrointest_Surg-3-1-1852389.txt,superior mesenter arteri||follow-up||left renal vein||smv||interposit graft||patient||involv||renal vein||pancreat cancer||creatinin level||superior mesenter vein||venou resect||left gonad||periop morbid||oper||superior border||portal vein||graft||pancreaticoduodenectomi||renal function||primari end-to-end anastomosi||eu||vein||resect||length||addit choic||reconstruct,vein||renal vein||renal vein graft||graft||portal vein||interposit graft||autolog vein interposit graft||autolog vein||splenic vein||left renal vein graft||portal vein reconstruct||femor vein||vein involv||adren vein||portal vein resect,0.551||0.372||0.368||0.359||0.348||0.334||0.325||0.316||0.314||0.3||0.288||0.286||0.285||0.282||0.281,0.8,0.5,0.3333333333333333
91,Med_Biol_Eng_Comput-4-1-2329731.txt,cross-correl||case||deform||matrix remodel||method||imag analysi||time||compact||imag||studi||local deform||standard deviat||matrix element||singl smooth muscl cell||specif cell||consecut imag||tool||cell||analysi||experi||algorithm||pixel||collagen deform||direct CC||coat||decomposit CC||nois||stage||techniqu,matrix||cross-correl||matrix remodel||collagen matrix deform||matrix compact||collagen deform||decomposit CC||local collagen matrix||decomposit cross-correl decomposit stage cross-correl window||local collagen matrix remodel||remodel||collagen matrix exp cell||matrix reorgan||decomposit stage||collagen matric,0.236||0.225||0.2||0.199||0.184||0.181||0.179||0.176||0.174||0.173||0.165||0.164||0.158||0.156||0.156,0.4,0.4,0.26666666666666666
92,Lipids-3-1-2039812.txt,ara||fatti acid composit||inflamm||fatti acid incorpor||concentr||data||patient||effect||section||human||proport||intervent||express||temperatur||cell||isotype-match control antibodi||protein||cytokin||fatti acid||activ||intestin inflamm||epa||fish oil||caco-2 cell||ibd||medium||vivo||result,ara||epa||caco-2||icam-1||ara versu epa||epa versu ara||fatti acid||fatti acid OA||n-3 fatti acid||epa cytokin||nf-κb||caco-2 enterocyt||OA||n-3 pufa epa||n-6 pufa ara,0.315||0.28||0.273||0.227||0.205||0.205||0.197||0.192||0.188||0.185||0.185||0.183||0.181||0.179||0.168,0.4,0.3,0.2
93,Mycorrhiza-4-1-2245993.txt,aggreg||effect||plug||chamber||1-octen-3-ol||signific inhibit||bodi||collembola||collembolan||speci||signific effect||methyl cinnam||sawahata,tricholoma matsutak||collembolan||mushroom||sawahata||collembola||tricholoma||proisotoma minuta||1-octen-3-ol tricholoma||2007 tricholoma matsutak proisotoma minuta T.||1-octen-3-ol||keyword collembola matsutak methyl||collembolan speci||1-octen-3-ol repel collembolan||fungivor collembolan||wild mushroom,0.323||0.282||0.25||0.222||0.219||0.202||0.2||0.192||0.184||0.182||0.172||0.171||0.164||0.161||0.152,0.6,0.4,0.26666666666666666
94,Reprod_Biol_Endocrinol-1-_-153492.txt,regress||structur luteolysi||term||process||progesteron||corpu luteum||luteolysi||speci||molecular mechan||luteal regress||function luteolysi||cell||function,luteolysi||luteolysi corpu luteum||corpu luteum||luteal regress luteolysi||luteal regress||luteal involut||rat corpu luteum||corpu luteum vari||structur luteal regress||function luteal regress||structur luteolysi||luteolysi frontier||function luteolysi||regress||telleria,0.361||0.351||0.347||0.33||0.315||0.267||0.248||0.233||0.221||0.213||0.198||0.194||0.185||0.148||0.144,0.6,0.3,0.4
95,Ann_Hematol-2-2-1705486.txt,bone marrow microenviron||patient||cytogenet respons||addit chromosom abnorm||clinic trial||treatment||therapi||cytotox effect||month||complet suppress||complex karyotyp||unexpect effect||normal||myelodysplast syndrom||cytogenet remiss||transfus independ||lenalidomid||metaphas||case studi||hemoglobin||md patient||erythroid respons,lenalidomid||5q||lenalidomid treatment||lenalidomid respons||lenalidomid therapi||del||md||keyword lenalidomid myelodysplast syndrom||lenalidomid clinic trial||springer-verlag 2006 lenalidomid||karyotyp||chromosom 5q delet||md patient||s00277-006-0217-i origin articl lenalidomid||transfusion-depend del,0.591||0.412||0.311||0.311||0.302||0.241||0.232||0.217||0.202||0.2||0.17||0.163||0.16||0.154||0.138,0.2,0.1,0.13333333333333333
96,Oecologia-3-1-1915602.txt,host||root tissu||qualiti||studi||harvey||effect||root biomass||develop||mortal||indol glucosinol||foliar herbivori||parasitoid||adult||natur enemi||control||herbivor||glucosinol||insect cultur||insect herbivor||interact||root||larva||plant||result,radicum||rapa||parasitoid||brassica||insect parasitoid||jersey trybliographa rapa delia radicum||trybliographa rapa||herbivor||T. rapa D. radicum adult||plant||brassica nigra||brassica P. brassica||T. rapa||insect herbivor||radicum 2005 2003,0.511||0.296||0.267||0.261||0.211||0.205||0.203||0.198||0.187||0.185||0.181||0.178||0.177||0.176||0.175,0.2,0.3,0.26666666666666666
97,Crit_Care-8-3-468887.txt,norepinephrin||flow||data||studi||patient||sepsi||splanchnic oxygen consumpt||gastric intramucos pH||effect||lower gastric phi||agent||increas||blood pressur||phi||shock||adrenerg drug||low-dos dopamin||splanchnic haemodynam||inflammatori respons||cardiac output||vasopressin||red blood cell transfus||splanchnic circul||epinephrin||iloprost||min||microcirculatori blood flow||dobutamin||cardiac index||group||fraction splanchnic blood flow||septic shock,septic shock||dobutamin||shock||norepinephrin||septic shock patient||sever septic shock||septic patient||splanchnic oxygen||norepinephrin hsbf||splanchnic haemodynam||splanchnic perfus||splanchnic hemodynam||splanchnic microcircul||epinephrin||dobutamin infus,0.35||0.296||0.278||0.272||0.25||0.236||0.235||0.208||0.206||0.186||0.181||0.179||0.172||0.171||0.168,0.8,0.5,0.4
98,Int_J_Biochem_Cell_Biol-1-5-1885942.txt,condit||kd||epiderm growth factor||liver phenotyp||sigma||western||ksfm||transcript factor||assay||de-differenti||GS||express||rt-pcr||dexamethason||day||urea product||liver function||pa||protein||ugt||differenti properti||dex||hepatocyt||keratinocyt serum-fre medium||cultur||rat hepatocyt||car||pituitari gland extract||medium||result,hepatocyt||al.||rat hepatocyt||differenti hepatocyt||hepatocyt differenti||cultur rat hepatocyt||hepatocyt isol||isol hepatocyt||hepatocyt ureagenesi||kds-cultur hepatocyt||human hepatocyt||hepatocyt prolifer||hepatocyt monolay||kd||primari hepatocyt cultur,0.44||0.293||0.272||0.243||0.243||0.235||0.233||0.233||0.227||0.227||0.224||0.224||0.224||0.215||0.209,0.4,0.2,0.2
99,Arch_Dermatol_Res-3-1-1839867.txt,igg||igg subclass||acantholysi||pathogen||blister-induc potenti||complement||studi||patient||type vii collagen||predomin||autoimmun bullou diseas||subepiderm blister||relev||intracellular||pemphigu||subclass||epidermolysi bullosa acquisita||mice||leukocyt||bullou pemphigoid patient||autoimmun||autoimmun respons||blister format||activ||skin||autoantibodi||bullou pemphigoid||diseas||bullou system lupu erythematosu,autoantibodi||subclass autoantibodi||bullou pemphigoid autoantibodi||subclass||pemphigu||bullou pemphigoid||pemphigoid||igg autoantibodi||igg4 autoantibodi||bullou pemphigoid igg subclass||pemphigu foliaceu autoantibodi||bullou pemphigoid igg||igg subclass||igg1 autoantibodi||complement-fix autoantibodi,0.419||0.378||0.352||0.337||0.325||0.318||0.304||0.3||0.297||0.289||0.277||0.272||0.259||0.251||0.231,0.6,0.4,0.3333333333333333
100,Breast_Cancer_Res_Treat-3-1-2001219.txt,orr||first-lin endocrin therapi||respons||postmenopaus||ttf||letrozol||endocrin therapi||breast cancer||studi||patient||tamoxifen||diseas progress||superior||effect||aromatas inhibitor||metastas||earliest date||advanc breast cancer||signific||treatment||advers event||therapi||metastat diseas||random||analysi||first-lin therapi||post-menopaus women||surviv||clinic benefit||trial||diseas||signific improv||progress,tamoxifen||letrozol||tamoxifen versu tamoxifen||first-lin tamoxifen||breast cancer||letrozol versu tamoxifen||subgroup letrozol tamoxifen||first-lin letrozol||first-lin letrozol versu tamoxifen||metastat breast cancer breast cancer||versu tamoxifen||metastat breast cancer||metastat breast cancer cancer||cancer||tamoxifen failur,0.464||0.367||0.33||0.329||0.298||0.297||0.282||0.28||0.272||0.267||0.263||0.246||0.245||0.241||0.234,0.6,0.3,0.2
101,Med_Biol_Eng_Comput-4-1-2329737.txt,find||respons||myocardi oxygen balanc||adenosine-medi vasodil||adenosin||channel||vasodil||coronari circul||hypertrophi||flow perturb||heart failur||coronari resist vessel||coronari vasoconstrict||receptor||endotheli dysfunct||coronari vasculatur||parasympathet control||LV dysfunct||product||coronari arteriol||dysfunct||exercis||activ||myocardi infarct||decreas||influenc||vasodil influenc||heart||swine||coronari blood flow||vivo,coronari||coronari vasodil||merku||heart||atp||coronari circul||vasodil||adenosine-medi coronari vasodil||heart failur||coronari reserv||swine||exercise-induc coronari vasodil||coronari arteriol||coronari vasomotor tone||coronari vasculatur,0.339||0.274||0.245||0.243||0.227||0.215||0.208||0.197||0.193||0.193||0.191||0.19||0.187||0.186||0.182,0.2,0.4,0.4666666666666667
102,Arch_Dermatol_Res-4-1-2254657.txt,chronic plaque-typ psoriasi||manifest||report||therapi||psoriasi||case||pustulosi||ppp||indic||treatment||psoriat arthriti||infliximab||patient||infliximab therapi||tnf||gpp||tnf-antagonist||pustular skin lesion||factor,psoriasi||infliximab||pustular psoriasi||ppp||plaque-typ psoriasi||plaqu psoriasi||psoriasi vulgari||psoriasi patient||recalcitr pustular psoriasi||new-onset psoriasi||moderate-to-sever psoriasi||psoriasi area||activ psoriasi||sever pustular psoriasi||infliximab therapi,0.542||0.406||0.404||0.346||0.342||0.305||0.296||0.286||0.281||0.279||0.279||0.272||0.272||0.271||0.233,0.6,0.3,0.26666666666666666
103,Eur_J_Clin_Pharmacol-4-1-2426926.txt,placebo||tablet||level||dacp||time||week||men||plasma||lipoprotein||concentr||baselin||studi||cholesterol||plant stanol||urinalysi||increas||hypercholesterolemia||higher dose||event||dose||treatment||advers event||blood sampl||singl dose||sitostanol||phase||pharmacokinet||subject||placebo group||stanol||phase 2||physic examin||activ||group||decreas||dasp||fm-vp4||plant sterol||stanol-contain product||low-dens lipoprotein cholesterol||dose group||ldl-c||safeti,fm-vp4||day fm-vp4||fm-vp4 tablet||fm-vp4 merit||fm-vp4 safeti pharmacokinet||dacp||dasp||placebo||sterol||subject||disodium ascorbyl phytostanol phosphat||disodium ascorbyl sitostanol phosphat||disodium ascorbyl campestanol phosphat||placebo tablet||disodium ascorbyl phytostanyl phosphat,0.546||0.322||0.318||0.276||0.233||0.177||0.164||0.162||0.143||0.131||0.127||0.127||0.127||0.126||0.117,0.2,0.5,0.3333333333333333
104,Eur_Arch_Otorhinolaryngol-4-1-2254469.txt,diagnost protocol||find||clinic sign||aspir||standard endoscopi protocol||ventil||ill patient||oral feed||endoscop assess||fee||studi||patient||oral diet||tracheotomi||risk||liquid bolu||naso-gastr tube||examin||swallow||evalu||deglutit||acut symptom||assess||popul||pharyng||fee find||silent aspir||rapid evalu||procedur||compensatori treatment procedur||decis||clinic studi||icu||percutan endoscop gastrostomi,aspir||tracheotomi||fee||silent aspir||aspir pneumonia||endoscopy-proven aspir||swallow||aspir event||aspir 115||aspir statu||aspir 129||bedsid fee||tracheotomi tube||post-extub fee||fee procedur,0.437||0.349||0.348||0.251||0.248||0.23||0.227||0.223||0.223||0.222||0.221||0.203||0.201||0.197||0.197,0.8,0.5,0.3333333333333333
105,Behav_Brain_Res-2-1-2424131.txt,delay||data||opfc||orbit prefront cortex||effect||lamp||lesion||inter-tempor choic||weber fraction||behaviour||rat||disconnect lesion||delay discount||sham-les group||phase||experi||curv||linear indiffer function||acbc||sucros solut||lever||light||callosotomi group||choic||group||size||callosotomi||signific differ||trial||reinforc||prefer function||result,callosotomi||acbc||disconnect||callosotomi lesion||core acbc callosotomi||szabadi||acbc lesion||callosotomi group||disconnect lesion||disconnect callosotomi sham lesion||fail callosotomi||opfc||reinforc||bradshaw c.m||2.2 surgeri disconnect callosotomi,0.347||0.26||0.24||0.235||0.218||0.195||0.191||0.184||0.181||0.18||0.176||0.176||0.169||0.15||0.15,0.4,0.4,0.4
106,J_Mol_Biol-1-5-2291451.txt,mechan||core||Ig||nativ state||pack||data||mutat||contact||nucleu||tnfn3||structur||fibronectin type iii||domain||fold||greek key topolog||residu||protein||cafn2||strand||loop||immunoglobulin||mutant||oblig||layer||interact||transit state||sheet||fniii,fold||fold nucleu||protein fold||φ-valu||domain fold||ig-lik fold||cafn2||obligatori fold nucleu||immunoglobulin fold||fold pathway||discuss cafn2 fold||fold mechan||ubiquitin fold||fold process||conserv fold nucleu,0.47||0.335||0.29||0.283||0.281||0.27||0.261||0.258||0.256||0.248||0.244||0.244||0.242||0.237||0.236,0.2,0.2,0.13333333333333333
107,Purinergic_Signal-3-4-2072918.txt,antibodi||entpd||transfect||purinoceptor||immunoprecipit analys||purinerg||genet immun||protein||immun||result||antipeptid antisera||ecto-enzym||antisera||express||western-blot analys||analys||cell||member||monoclon antibodi||famili,7619 rb 1:800 henpp2||5446 rb 1||purinoceptor||1:1600 mentpd1||ecto-enzym||entpd famili 5441 rb 1:1600 hentpd2||1:1600 mentpd2||koch-nolt||7620 rb 1:3200 renpp3||1:1600 metntpd2||p2x purinoceptor||116 rb 1:800 4 rg22||1:1600 7||1:1600 4||1:1600 1,0.171||0.171||0.169||0.16||0.152||0.151||0.148||0.148||0.141||0.135||0.132||0.129||0.124||0.123||0.123,0.4,0.2,0.13333333333333333
108,J_Headache_Pain-4-1-2245992.txt,horizont deviat||horizont plane||cerebellum||cerebellar||neuromuscular junction||studi||cerebellar function||movement||singl fiber emg||nmj||migrain||aura||neuromuscular transmiss||mcd||channel||patient||function||median valu,migrain||migrain headach||hemipleg migrain||aura||schoenen||migrain famili||migrain patient||migrain trust||headach||ambrosini||sfemg||aura ambrosini anna||headach pain||aura patient||typic aura,0.533||0.397||0.298||0.287||0.287||0.277||0.277||0.271||0.26||0.171||0.159||0.157||0.155||0.154||0.15,0.4,0.2,0.13333333333333333
109,Diabetologia-4-1-2270364.txt,type 2 diabet||level||diabet||studi||pgc-1α||non-diabet donor||insulin secret||oxid phosphoryl||human||insulin releas||dna methyl||express||sirna||human diabet islet||gene||beta cell function||pancreat islet||usa||human islet||GK rat||islet||insulin resist||gene express,ppargc1a||ppargc1a ppargc1a ppargc1a||ppargc1a ppargc1a||ppargc1a ppargc1a ppargc1a ppargc1a ppargc1a express||method ppargc1a ppargc1a ppargc1a ppargc1a||ppargc1a ppargc1a ppargc1a 2||ppargc1a ppargc1a 1 ppargc1a||ppargc1a ppargc1a express||hypothesi ppargc1a ppargc1a ppargc1a ppargc1a express||7 ppargc1a ppargc1a ppargc1a ppargc1a express||interpret ppargc1a ppargc1a||7 ppargc1a ppargc1a||1 ppargc1a ppargc1a||ppargc1a ppargc1a 19 ppargc1a gene||ppargc1a 5 ppargc1a ppargc1a express,0.965||0.965||0.965||0.807||0.772||0.724||0.724||0.649||0.647||0.646||0.644||0.643||0.643||0.583||0.583,0.0,0.0,0.0
110,Mol_Syst_Biol-4-_-2387231.txt,physic complex||set||measur||method||human protein||physic associ||microarray||data||comparison||likelihood||cold aceton||correl||human||tendenc||test||complex||ortholog||valid||ortholog gene||mass spectrometri||gene||control||cce||yeast||annot||protein||pair||analysi||accuraci||associ||nuclear export||distribut||co-express||posit||interact||score,al||cce||cce pair||pair||protein pair||cce associ||protein||cce set||cce partner||yeast protein||ortholog pair||cce case||yeast||figur 7D||human protein pair,0.379||0.308||0.256||0.204||0.191||0.188||0.178||0.175||0.17||0.166||0.165||0.155||0.154||0.153||0.146,0.4,0.3,0.26666666666666666
111,Dev_Genes_Evol-4-1-2265772.txt,annelid||worm||glutamin synthetas||myohara||amino acid ident||express||ejg||ovari||sequenc||regener,gs||japonensi||enchytraeu japonensi||gs E. japonensi 2006 E. japonensi||gs gene||gs right-hand||xenopu 1995 gs E. japonensi regener||enchytraeu japonensi 1999 E. japonensi 1999||glutamin||discuss E. japonensi glutamin synthetas||1991 gs C.||glutamin synthetas||E. japonensi 2006 1993||50 μm E. japonensi||glutamin metabol glutamin,0.614||0.602||0.372||0.336||0.321||0.317||0.248||0.242||0.236||0.222||0.208||0.206||0.178||0.178||0.163,0.0,0.0,0.06666666666666667
112,Matern_Child_Health_J-2-2-1592148.txt,chronic hypertens||import opportun||program||etiolog pathway||care coordin||week||infant||hypertens||birth||pregnanc||problem||locat||matern||weight problem||recurr||folic acid||risk assess||effect||internat care||internat visit||nutrit risk||postpartum care||health promot||intervent||content||addit support||psychosoci support||resourc||internat period||health||servic coordin||preconcept care||women||research||preterm birth||clinic intervent||servic||preterm deliveri||famili||import||visit||access||support||six-week postpartum visit||on-go care||oral health servic||children,internat care||internat visit||internat intervent||internat period||internat support||internat care.||internat psychosoci intervent||six-week internat visit||subsequ internat care||two-week internat visit||enhanc internat care||comprehens internat care||internat care model||internat care consist||univers internat care,0.432||0.424||0.406||0.367||0.363||0.363||0.307||0.303||0.298||0.293||0.293||0.292||0.291||0.29||0.289,0.6,0.3,0.2
113,Immunogenetics-3-1-1914236.txt,gene||snp||result||celiac diseas||appli biosystem||analysi||genet associ||sampl||express||studi||dutch popul||famili,"spink4||spink spink4 spink4 spink4 spink4||spink4 spink4 spink spink4||spink spink4 spink4||spink5||spink spink spink1 2 5 spink4||spink4 rs891671 33,222,271||spink4 sequenc analysi||2 spink tabl 2 spink4 snp||spink5 mutat||spink2||spink spink2 gusb error||asterisk 1 spink4 4 arrow point||1 spink haplotyp||fig. 2 spink",0.733||0.656||0.637||0.605||0.333||0.279||0.262||0.248||0.188||0.175||0.133||0.129||0.124||0.123||0.118,0.0,0.0,0.0
114,Diabetologia-3-1-1914278.txt,vascular vulner||diabet mellitu||diabet||arteri wall||patient||carotid arteri||cimt||type 1 diabet||sex||plasma hyaluronan||hyaluronan||present studi||endotheli glycocalyx||glycocalyx||control||age||subject||plasma hyaluronan level||hyaluronidas||intima-media thick||imag analyst,hyaluronan||hyaluronidas||cimt||diabet||plasma hyaluronan||hyaluronan metabol||serum hyaluronan||0.3 hyaluronan||urinari hyaluronidas||hyaluronidas activ||glycocalyx||18 hyaluronidas||diabet mellitu||1c||cimt measur,0.447||0.379||0.342||0.295||0.243||0.243||0.23||0.227||0.194||0.194||0.192||0.19||0.188||0.178||0.176,1.0,0.5,0.4666666666666667
115,Methods-1-5-1895922.txt,method||indic||concentr||fischer suppli||serial dilut||purifi compound||bacteri strain||microtitr plate||extract||assay||strain||compound||antibiot||resazurin||solut||minimum inhibitori concentr||test materi||mic||bacteri speci||crude extract||antibacteri assay||number||natur product||resazurin method||result,resazurin||mic||resazurin assay||resazurin solut||resazurin plant||resazurin method||steril resazurin tablet||modifi resazurin assay||modifi resazurin method||true’ mic||mic-2||mic-1||accur mic||steril||mic-2 mic-1 mic-2 mic-1 mic-2 staplyococcu,0.314||0.189||0.183||0.173||0.166||0.161||0.147||0.136||0.121||0.115||0.105||0.105||0.102||0.094||0.092,0.4,0.3,0.2
116,Planta-4-1-2270920.txt,cytosol||metabolit||sugar alcohol concentr||peach||non-aqu fraction||siev tube||subcellular distribut||studi||myo-inositol||sugar alcohol||leaf cell||phloem||compart||sourc||mannitol||common plantain||leav||ratio||sucros||leaf||subcellular compart||vacuol||sugar||mesophyl cell||sea plantain||distribut||sorbitol||celeri||apoplast||speci||fructos||activ transport||stroma||plant,phloem||plantain||sorbitol||celeri||plantain sea plantain peach celeri||phloem concentr||sea plantain||phloem sap||plantain sorbitol 133||plantain sorbitol 22||sucros||phloem load||plant||apoplast phloem load plant||apoplast phloem load,0.367||0.353||0.293||0.264||0.247||0.222||0.22||0.217||0.217||0.215||0.205||0.205||0.199||0.199||0.199,0.6,0.4,0.4
117,Purinergic_Signal-4-2-2377319.txt,atp||cyclic nucleotid||ideal||synaps||purinerg||nucleotid||tissu||atp releas||receptor||releas||introductori articl||receptor channel||adenosin||nucleosid||microenviron||cell,purinerg||purinerg signal purinerg||purinerg signal||autocrin purinerg||paracrin purinerg||microenviron||purinerg ligand||paracrin purinerg signal||extracellular purinerg signal||intralumin autocrin purinerg||atp||paracrin purinerg biolog||activ purinerg ligand||s11302-007-9091-x editori purinerg||ideal microenviron,0.529||0.409||0.35||0.331||0.32||0.291||0.287||0.27||0.257||0.235||0.222||0.22||0.193||0.192||0.174,0.2,0.2,0.2
118,Bioinformation-1-5-1891680.txt,pfm||sequenc motif||promot||user||web server||sequenc||server||motif||pmsearch||transcript factor,pfm||input pfm||similar pfm||507 pfm||pmsearch||server||conclus pmsearch||web server||predict bind site||site web server||tfbss||input||site||put bind site||transcript factor bind,0.73||0.425||0.377||0.373||0.329||0.195||0.166||0.13||0.126||0.126||0.123||0.119||0.118||0.113||0.107,0.4,0.4,0.26666666666666666
119,Dev_Biol-2-1-2098691.txt,anim||endoderm gene express||transgen||depend||sox site||element||tgf-β||effect||direct target||promot element||gfp fluoresc||region||promot||site||lane||veget||express||downstream||gene||endoderm||direct effect||transcript||endoderm differenti||gfp||bind||sox17||vegt||emsa||gastrula||endoderm element||construct||sequenc||network||result,xsox17||xsox17 xsox17||xsox17 clement||xsox17 sinner||endoderm network xsox17 xsox17 clement||1999 xsox17 xsox17 clement||endoderm||xsox17 hudson||xsox17 induct||2003 xsox17 xsox17 gurdon||xsox17 auto-induct||xsox17 zhang||xsox17 mech||endogen xsox17||bix xsox17,0.59||0.59||0.384||0.35||0.341||0.341||0.328||0.311||0.309||0.308||0.304||0.303||0.303||0.301||0.3,0.0,0.1,0.06666666666666667
120,Exp_Brain_Res-3-1-1914230.txt,variat||task constraint||role||trial block||kinemat paramet||heavi||target area||experiment condit||joint action||studi||interperson transfer||joint-act coordin||target region||high speed||effect||observ||action observ||mass||analys||interperson transfer effect||present studi||fitts’ law||experiment task||cylind||task||experi||dyad||repetit||weight||actor||transfer||data analys||size||trial||tabl||movement||particip||area||coordin||object||speed,"cylind||actor||fetching-actor||transfer cylind||fetching-s 1,13||cylind ’s||speed||thick cylind||heavi cylind||movement speed||size 1,13||movement||putting-actor lift||mass 1,13||putting-actor",0.348||0.294||0.217||0.213||0.188||0.185||0.184||0.183||0.182||0.18||0.178||0.177||0.168||0.162||0.158,0.4,0.3,0.26666666666666666
121,Angiogenesis-4-1-2268723.txt,blood suppli||endotheli cell||vasoprolif respons||host||folkman||effect||develop||neovascular||angiogenesi||evid||cell||growth||day||tissu||mice||judah folkman||activ||factor||tumor||vessel||cam||antiangiogen activ||blood vessel||molecul,folkman||angiogenesi angiogenesi||angiogenesi||tumor angiogenesi||judah folkman||joms.2002.36063 folkman||tumor||cotran RS folkman||angiogenesi inhibit||inhibit angiogenesi||prof. judah folkman||angiogenesi inhibitor||lane WS folkman||jandl JH folkman||474 9. folkman,0.588||0.362||0.362||0.326||0.319||0.302||0.289||0.235||0.217||0.217||0.215||0.212||0.208||0.202||0.201,0.6,0.4,0.26666666666666666
122,J_Biol_Inorg_Chem-3-1-2039866.txt,reaction||bi||attempt||structur||spectrum||sodium pyruv||precipit||solut||complex||chemic||differ fourier map||calc||zinc||signal||reaction mixtur,zn1||zn2||vahrenkamp||cl1||o1a||inorg chem 30:4098||inorg chem 34:2207||inorg chem 5158||inorg chem 1723||inorg chem 827||inorg chem 779||inorg chem 521||inorg chem 339||N4||N2,0.604||0.206||0.151||0.124||0.124||0.112||0.112||0.112||0.111||0.11||0.11||0.11||0.109||0.106||0.093,0.0,0.0,0.0
123,Health_Qual_Life_Outcomes-2-_-395842.txt,measur||instrument||commun||well-b||rate||qualiti||patient||year||contact||life||cognit rate scale||scale||nurs||dementia||behaviour||sever dementia||item||approach||daili live||assess||mobil||bcr||activ||old-old patient||factor||physician||barthel index||neg affect||life measur||global deterior scale,item||bcr||barthel||65 item||barthel item 9||barthel item 10||barthel item 7||barthel item 8||barthel item 5||barthel item 4||barthel item 3||barthel item 2||core item||item level||nurs barthel item 1,0.403||0.25||0.218||0.209||0.207||0.207||0.207||0.207||0.207||0.207||0.207||0.207||0.204||0.202||0.199,0.4,0.2,0.13333333333333333
124,Eur_Radiol-2-2-1705470.txt,prospect studi||case||gastric tumor||endolumin RF coil||mri||carcinoma||histopatholog stage||studi||gastric wall||gastric region||gastric wall layer||experiment studi||tumor volum||inform||sensit||cardia||lymphoma||lesion||magnet reson imag||coil concept||suffici imag||suffici detail||serosa||lymph node||opposed-phas sequenc||diffuse-typ gastric carcinoma||factor||tumor||layer||signal intens||imag techniqu||gastric carcinoma||gastric wall differenti||sequenc||intermedi||stage||vivo,gastric tumor||gastric carcinoma||gastric wall||gastric layer||gastric cancer||gastric adenocarcinoma||gastric malign||gastric region||gastric cardia||gastric lymphoma||oper gastric||gastric wall layer||resect gastric carcinoma||endolumin mri||gastric carcinoma specimen,0.343||0.323||0.308||0.308||0.285||0.279||0.272||0.27||0.268||0.268||0.261||0.241||0.232||0.231||0.23,0.6,0.4,0.3333333333333333
125,Pediatr_Nephrol-4-1-2335291.txt,cathet||dryness||capac||boy||indic||peni||birth||patient||year||risk||overact||pelvic floor||stoma||high detrusor pressur||upper urinari tract||pressur||bladder||approach||girl||age||abdomin approach||subject||surgeri||antimuscarin||renal function||high bladder pressur||cic||suspens||detrusorectomi||bladder neck||urinari contin||incontin||good result||spina bifida||children||result,bladder||stoma||sling||spina bifida||neuropath bladder||neurogen bladder||bladder autoaugment||bladder neck||overact neuropath bladder||detrusor||detrusor overact||overact detrusor||bladder capac||low-pressur bladder||overact,0.376||0.295||0.281||0.247||0.224||0.22||0.217||0.215||0.213||0.211||0.201||0.201||0.197||0.196||0.192,0.6,0.4,0.3333333333333333
126,Cancer_Causes_Control-2-2-1705485.txt,hair||incid rate||ear||melanoma||rate||data||hair cover||femal||neck||site||face||women||age||invas melanoma||incid||chang||australia||differ||younger women||scalp||sun exposur||solar UV exposur||solar ultraviolet radiat||hypothesi,melanoma||ear melanoma||ear||neck melanoma||hair||invas melanoma||cutan melanoma||facial melanoma||melanoma prevent||incid invas melanoma||hair cover||melanoma incid rate||cutan malign melanoma||bare ear||femal ear,0.534||0.45||0.366||0.348||0.331||0.309||0.296||0.284||0.271||0.239||0.226||0.226||0.204||0.203||0.199,0.6,0.4,0.3333333333333333
127,Eur_J_Appl_Physiol-3-1-1782100.txt,efl||control||blood||time||averag 52||debt||limit||recoveri||cardiac output||exercis||data||compon,hbox||efl||document||efl exercis||dot||documentclass||12pt||amsmath||amsfont||mathrsf||69pt||efl control exercis efl exercis||rm efl||exercis||efl exercis test,0.124||0.076||0.067||0.058||0.056||0.05||0.05||0.05||0.05||0.05||0.05||0.047||0.047||0.04||0.039,0.2,0.1,0.13333333333333333
128,Pediatr_Nephrol-4-1-2413095.txt,chronic kidney diseas||ra||ckd||CV abnorm||tissu ra||data||studi||renal diseas||patient||allel||risk||pediatr ckd popul||pediatr||increas||gene polymorph||renal||human genom||genotyp||natur||gene||cytokin||polymorph||popul||associ||whole-genom associ studi||genet||factor||snp||atherosclerot CV abnorm||potenti weak||CV diseas||function||error||diseas||haplotyp||preliminari evid||gene express||progress||kidney||cardiovascular diseas,ckd||polymorph||esrd||gene polymorph||kidney||ckd progress||genet polymorph||renal||diabet nephropathi ckd||delet polymorph||gene polymorph 4G||ckd popul||ace gene polymorph||renin-angiotensin gene polymorph||promot polymorph,0.332||0.314||0.249||0.214||0.213||0.204||0.201||0.197||0.196||0.195||0.184||0.18||0.177||0.169||0.167,0.8,0.5,0.3333333333333333
129,Eur_J_Pediatr-3-1-2151776.txt,pertussi control||case||infant||pertussi||strategi||childhood diseas||review||increas||adult||newborn||countri||infect||laboratori diagnosi||immun||vaccin strategi||incid||univers immun||cultur||ill||pcr||adolesc||diseas||diagnosi||laboratori techniqu,pertussi||acellular pertussi||pertussi infect||adult pertussi||prevent pertussi||pertussi incid||pertussi epidemiolog||classic pertussi||pertussi antibodi||pertussi control||pertussi problem||acellular pertussi vaccin||acelluar pertussi vaccin||vaccin strategi pertussi vaccin||bordetella pertussi infect,0.792||0.463||0.446||0.423||0.408||0.406||0.403||0.401||0.401||0.399||0.398||0.393||0.353||0.331||0.328,0.2,0.2,0.13333333333333333
130,Oecologia-4-1-2311384.txt,competit||concentr||studi||valu||hollow||competit abil||effect||water||bog||increas||cover chang||site||northern||mixtur||temperatur||signific interact||treatment||water level||growth||product||posit effect||biomass product||evapor||global warm||northern site||competit advantag||experi||greenhous||bulk densiti||differ||height||height increment||speci||water tabl,sphagnum balticum||sphagnum||sphagnum fuscum S. balticum||S. balticum||sphagnum S. balticum S.||sphagnum sphagnum sphagnum speci||sphagnum magellanicum S.||sphagnum cuspidatum||S. balticum S. magellanicum S. balticum||S. balticum S. fuscum||2008 sphagnum sphagnum sphagnum S.||S. balticum S. magellanicum||S. magellanicum S. balticum||S. balticum S.||S. fuscum S. balticum S. fuscum,0.511||0.501||0.414||0.395||0.39||0.388||0.375||0.369||0.367||0.356||0.355||0.353||0.353||0.352||0.343,0.0,0.0,0.0
131,Histochem_Cell_Biol-4-1-2248605.txt,type||transport vesicl||imag||endo-lysosom system||studi||endosom||lysosom||cargo||observ||lysosom membran protein||complex||direct pathway||receptor||gga||transport||cell||cd-mpr||enzym||protein||tgn||mannos 6-phosphat receptor||electron microscopi||literatur||escrt||factor||subdomain||specif compart||machineri||acid phosphatas||acid phosphatas activ||function||distinct stage||compon,endosom||lysosom||multivesicular endosom||endosom vacuol||endosom protein||lysosom protein||lysosom hydrolas||earli endosom||lysosom biogenesi||late endosom||endosom subdomain||lysosom enzym||endosom intermedi||lysosom traffick||sara endosom,0.489||0.47||0.288||0.285||0.274||0.265||0.264||0.261||0.257||0.255||0.254||0.251||0.25||0.249||0.248,0.4,0.2,0.13333333333333333
132,Eur_Child_Adolesc_Psychiatry-3-1-1914287.txt,attent||social commun||high level||level||boy||behavior||infant||sex differ||children||problem||princip compon analysi||sampl||data||studi||young age||develop||pearson correl||social commun problem||stabil||problem behavior||earli age||common||aim||analys||inhibit||item||age||parent||older children||dimens||factor||order||commun sampl||compet||work||total problem score||score||infant develop||result,behavior||behavior problem||problem behavior||uncommon problem behavior||child||opposit behavior||behavior dimens||problem||earli problem behavior||develop problem behavior||parent-report problem behavior||behavior scale||intern problem behavior||problem behavior evolv||unwant behavior,0.337||0.263||0.263||0.194||0.193||0.193||0.192||0.189||0.188||0.183||0.181||0.179||0.178||0.178||0.177,0.4,0.3,0.2
133,Eur_Radiol-2-2-1705545.txt,excel||coronari angiographi||low vessel opacif||protocol||diamet||bpm||high preval||imag||interv||studi||patient||data analysi||calcif||imag qualiti||diagnost accuraci||low signal-to-nois ratio||agatston score||extens coronari calcif||heart rate||motion artifact||heart rate control||high pre-test probabl||dsct||signific stenos||data acquisit||accuraci||popul||entir heart||nonenhanc dsct||cad||ica||dual-sourc CT||vessel||coronari arteri||coronari arteri stenosi||segment||score,coronari angiographi||dsct||coronari arteri||coronari stenos||angiographi||tomographi coronari angiographi coronari stenosi||coronari calcif||coronari angiographi scan||non-invas coronari angiographi||noninvas coronari angiographi||coronari arteri stenos||invas coronari angiographi||quantit coronari angiographi||coronari arteri segment||bpm,0.349||0.304||0.29||0.286||0.267||0.264||0.253||0.243||0.242||0.242||0.241||0.24||0.234||0.233||0.233,0.6,0.3,0.26666666666666666
134,Int_Arch_Occup_Environ_Health-3-1-1915645.txt,measur||level||time||higher level||passiv leisur||sampl||qualiti||studi||hypothesi||gener questionnair||home activ||worker||weekend||recoveri||variabl||activ leisur activ||hour||analys||sleep complaint||respect||diari studi||higher score||pleasur||effort||relationship||associ professor||high-effort group||experi||employe||job||activ||home||workday||group||differ||single-item report mark||particip||fatigu||support||partner||neg affect||daili basi||ancova||report mark||result,effort-group||weekend||workday||effort||overtim||work-rel effort||high-effort group||in-between workday||work-rel fatigu||overtim work||fatigu||workday hypothesi||weekend day||effort expenditur||weekend experi,0.281||0.273||0.254||0.251||0.219||0.217||0.205||0.184||0.18||0.178||0.176||0.165||0.157||0.151||0.15,0.6,0.4,0.3333333333333333
135,Pediatr_Radiol-4-1-2292499.txt,csf||find||flow||infant||complic||subarachnoid space||import role||extra-axi fluid collect||doppler||studi||patient||sonographi||brain sulci||mening||bacteri mening||ventricul||brain||evalu||earli abscess||fluid||ventricl||postinfecti hydrocephalu||neurolog find||subdur effus||central nervou system infect||diagnosi||children,mening||bacteri mening||neonat mening||citrobact mening||infantil mening||pyogen mening||mening edema||purul mening||streptococcu mening||neonat bacteri mening||suspect mening||mening thicken||infantil bacteri mening||complic bacteri mening||suspect bacteri mening,0.669||0.457||0.399||0.385||0.361||0.361||0.354||0.351||0.348||0.348||0.346||0.34||0.323||0.322||0.313,0.4,0.2,0.13333333333333333
136,J_Abnorm_Child_Psychol-3-1-1915605.txt,condit||neg evalu outcom||measur||find||pre-adolesc children||higher level||depress symptom||respons||mood||time||cdi||social||self-verif||studi||depress||subsequ||peer||effect||self-verif theori||prefer||failur||adult||control condit||evid||analys||state mood||success||real time||feedback||chang||highest score||contest||lowest total score||interact||particip||feedback prefer||peopl||score||children||neg feedback subsequ,feedback||peer feedback||feedback prefer||neg feedback||feedback valenc||feedback manipul||depress||peer feedback manipul||failur feedback||success feedback||subsequ feedback||C. feedback||feedback condit||peer||posit feedback,0.509||0.389||0.338||0.308||0.295||0.287||0.282||0.281||0.276||0.276||0.271||0.271||0.27||0.269||0.269,0.4,0.3,0.26666666666666666
137,Behav_Processes-2-1-2396234.txt,anim||measur||respons||neophilia||time||hole-board||valid measur||studi||central area||frequenc||explor||increas||hole||sex||rodent||head-dip||behaviour||male||rat||head-dip behaviour||research||mice||previou studi||environ||exposur||open field||presenc||trial||apparatu||area||avers condit||object||locomot||result,"head-dip||4,56||head-dip behaviour||hole-board||head-dip behavior||head-dip increas||hole-board apparatu||al.||hole-board file||head-dip male 9.3||hole-board behavior||apparatu||hole-board test||hole-board task||neophilia",0.494||0.389||0.299||0.284||0.278||0.249||0.224||0.22||0.182||0.179||0.173||0.164||0.151||0.147||0.135,0.6,0.3,0.3333333333333333
138,Eur_Radiol-3-1-2077908.txt,grade||find||time||OA||imag||studi||patient||multipl joint site||total||lesion||womac||cyst||bone marrow edema-lik||anatom locat||pain||associ||chang||bme||decreas||bone||size||knee||total size||diseas||progress,"bme||bme lesion||bme size||bme fluctuat||1,638 bme lesion||unchang bme lesion||327 bme lesion||knee||total bme score||knee osteoarthr||osteoarthr||keyword knee mri bme womac OA||lesion||knee OA||womac",0.713||0.459||0.377||0.369||0.331||0.31||0.309||0.291||0.271||0.257||0.224||0.216||0.205||0.187||0.184,0.2,0.2,0.26666666666666666
139,Eur_J_Epidemiol-4-1-2413078.txt,mortal||immigr||inform||earlier life condit||german pension scheme||germani||pension insur||foreign||death rate||popul||migrant mortal||host popul||data||death||studi||countri||pension||migrant||migrant background,migrant||migrant mortal||pension||foreign migrant||migrant popul||migrant health||migrant background||german pension||migrant mortal advantag||migrant group||mortal||2008 introduct migrant mortal||german pension scheme||healthi migrant effect’||german,0.498||0.367||0.345||0.339||0.295||0.27||0.266||0.264||0.257||0.251||0.237||0.188||0.187||0.184||0.184,0.6,0.4,0.4
140,Mol_Immunol-1-5-1995235.txt,role||primer||studi||perfus||specif role||blood contamin||blood cell||analys||spermatozoa||testi||cd59a||gene||absent||tissu||protein||motil||liver||mous||abund express||mac||cd59b||mrna||acrosom||amplif||result,cd59b||cd59a||cd59a cd59b cd59a cd59b primer||cd59b primer||cd59b mrna||cd59b express||cd59b protein||cd59b distribut||cd59b mamm||cd59b ratio||cd59a primer||cd59b testi 24.8||cd59a mrna||mous cd59a||cd59a holt,0.68||0.507||0.492||0.383||0.377||0.361||0.348||0.343||0.343||0.343||0.297||0.292||0.291||0.276||0.27,0.4,0.2,0.13333333333333333
141,J_Med_Internet_Res-8-4-1794003.txt,geriatr medicin||age-specif search term||databas||exp adult||combin||strategi||hand search||age-specif search strategi||mesh term||research assist||sensit||studi particip||three-term strategi||adult||journal||specif||term||clinician||obstetr||absolut decreas||clinic specialti||medlin||medicin||textword||combin term||precis||particip||neonat medicin||year 2000||articl,search||medlin search||sensit search||medlin||mp||medlin search strategi||search term||tw||age-specif search term||search strategi||age-specif search strategi||specif search||sensit||retriev medlin||hand search,0.299||0.269||0.244||0.239||0.232||0.215||0.208||0.206||0.204||0.202||0.201||0.195||0.19||0.171||0.161,0.2,0.2,0.3333333333333333
142,J_Gastrointest_Surg-3-1-1852385.txt,diverticul||author||case||complic||data||studi||patient||sigmoid diverticul||colon||elect surgeri||recurr episod||signific||diverticular diseas||oper||surgic manag||perfor diverticul||fistula||attack||surgeri||acut diverticul||high rate||surgeon||resect||perfor||procedur||diseas process||diseas||diagnosi,diverticul||sigmoid diverticul||perfor diverticul||complic diverticul||acut diverticul||sever diverticul||mild diverticul sever diverticul||diverticul II recurr||diverticul symptom frequenc||23 24 diverticul||diverticular periton||diverticular diseas||colon||complic diverticul surgic intervent||hinchey stage IV diverticul,0.724||0.432||0.398||0.388||0.382||0.366||0.365||0.25||0.248||0.242||0.241||0.227||0.217||0.205||0.201,0.8,0.4,0.4
143,Pediatr_Nephrol-4-1-2259257.txt,level||sdn||gfr||control group||studi||year||patient||steroid||rang 2||renal biopsi||treatment||biopsy-proven mcn||csa||studi group||glomerular filtrat rate||drop||remiss||month||renal function||mcn||csa toxic||chronic renal failur||minimal-chang nephrot syndrom||long-term treatment||nephrotox||latest follow-up||function,csa||gfr||nephrot syndrom csa||csa nephrotox||nephrot syndrom||nephrot children||csa therapi||csa 136.3||nephrotox csa therapi||cyclosporin||csa toxic||pediatr nephrot syndrom||3.4 gfr||196 gfr||normal gfr,0.457||0.419||0.34||0.315||0.282||0.27||0.268||0.24||0.236||0.235||0.233||0.219||0.214||0.214||0.214,0.4,0.2,0.2
144,Breast_Cancer_Res_Treat-3-1-2096638.txt,surviv||section||fancd2||prolifer||case||immunohistochemistri||hereditari invas breast cancer||percentag||sporad breast cancer||breast cancer||express||patient||brca1||brca||cell,fancd2||fancd2 inactiv||fancd2 neg||fancd2 protein||fancd2 express||fancd2 patient||fancd2 score||fancd2 intens||fanconi||neg fancd2 case||fanconi anemia||higher fancd2 express||low fancd2 level||fanconi anaemia||fanconi anemia protein,0.697||0.369||0.366||0.365||0.364||0.354||0.354||0.352||0.342||0.252||0.247||0.245||0.237||0.216||0.176,0.2,0.1,0.06666666666666667
145,Int_Urogynecol_J_Pelvic_Floor_Dysfunct-4-1-2335287.txt,uterovagin prolaps||follow-up period||effect size||complic||qualiti||studi||life||anatom outcom||prolaps||domain||bothersom symptom||standard questionnair||symptomat pelvic organ prolaps||urinari leakag||outcom||valid questionnair||urogenit symptom||women||posterior compart||pain||sacrospin ligament||surgeri||recurr cystocel||urinari incontin||sacrospin ligament fixat||sacrospin hysteropexi||symptom||function outcom||follow-up time||procedur||score||pelvic organ prolaps||result,sacrospin||prolaps||sacrospin hysteropexi||uterovagin prolaps||sacrospin colpopexi||sacrospin ligament||sacrospin fixat||hysteropexi||uterin prolaps||sacrospin cervicocolpopexi||sacrospin cervico||sacrospin hysteropexi show||vault prolaps||vagin sacrospin colpopexi||recurr prolaps,0.563||0.456||0.438||0.327||0.324||0.315||0.312||0.312||0.299||0.296||0.296||0.292||0.264||0.263||0.24,0.6,0.4,0.26666666666666666
146,J_Chem_Ecol-4-1-2373414.txt,lima bean||control||odor bind protein||efn secret||compound||lanolin past||signal||heil||plant||voc,plant||volatil||efn||heil||bean plant||arabidopsi plant||indirect plant defens||plant ecolog||attack plant||plant cultiv||A. volatil||M. 2006. herbivore-induc plant volatil||efn secret||lima bean efn||volatil emiss,0.295||0.253||0.224||0.216||0.199||0.187||0.186||0.183||0.173||0.162||0.158||0.152||0.144||0.14||0.138,0.4,0.2,0.2
147,Rev_Endocr_Metab_Disord-3-1-1894829.txt,type||diabet||children||patient||young age||clinic featur||gck||present||test||guidanc||insulin||sulfonylurea||featur||treatment||low dose||gene||glucos||age||young adult||kir6.2||neonat diabet||famili||resist||monogen diabet||lower part||pndm||diagnosi||modi||syndrom||result,diabet||monogen diabet||insulin||neonat diabet||diabet mellitu||maturity-onset diabet||famili diabet||diabet patient||diabet phenotyp||diagnos monogen diabet||early-onset diabet||very-early-onset diabet||diabet autoimmun||type-ii diabet||diabet rang,0.531||0.394||0.332||0.323||0.314||0.305||0.289||0.279||0.277||0.275||0.274||0.273||0.272||0.271||0.271,0.8,0.4,0.26666666666666666
148,Breast_Cancer_Res_Treat-3-1-2096637.txt,ilc||morpholog||author||calcul||find||case||mammographi||lesion size||convent imag||mri||data||studi||seri||valu||addit lesion||patient||dynam curv analysi||non-mass-lik lesion||small studi||correl||sensit||enhanc||lesion||magnet reson imag||mass||surgic manag||treatment||underestim||invas lobular carcinoma||meta-analysi||ultrasound||high variabl||foci||domin mass||addit find||chang||literatur||tumor||size||breast||irregular||detect||result,lobular||ilc||mri||breast mri||breast||lobular carcinoma||invas lobular||invas lobular breast carcinoma||lobular breast cancer||breast carcinoma||invas lobular carcinoma||invas lobular breast cancer||breast breast cancer||invas lobular carcinoma breast cancer||ilc imag,0.438||0.367||0.359||0.354||0.349||0.329||0.314||0.299||0.289||0.284||0.282||0.264||0.259||0.255||0.235,0.6,0.3,0.26666666666666666
149,Hernia-4-1-2231409.txt,ta||time||method||mesh fixat techniqu||complic||insert||studi||recurr||standard techniqu||crown||laparoscop repair||incision hernia||oper||straightforward repair||oper time||fixat techniqu||puh||studi group||tacker||group||hernia||differ||fixat||lrvih||techniqu,hernia hernia||hernia||ta||incision hernia||fixat||ta techniqu||hernia repair||tacker||laparoscop||ventral hernia||laparoscop hernia surgeri||tacker fixat techniqu||mesh fixat||ta site||fixat techniqu,0.466||0.466||0.435||0.305||0.297||0.296||0.292||0.278||0.27||0.268||0.261||0.244||0.235||0.228||0.227,0.8,0.5,0.4
150,Ann_Biomed_Eng-4-1-2239251.txt,shear load||muscl||joint||spinal load||sij stabil||sij||model||sij compress||pelvic floor||increas||slouch||pelvic region||gluteu mediu||present studi||simul model||pelvic floor muscl||sacroiliac joint||vertic sij shear||load||trunk||leg||biomechan analysi||pain||coxal bone||simul||direct||activ||pelvi||bone||pelvic muscl||ligament||postur||trunk load||sij compress forc||maximum muscl stress||sacrum||result,sij||muscl||muscl forc||biomech||forc||sij compress forc||sij compress||vertic sij||ligament forc||sij stabil||sij reaction forc||ligament||pelvic muscl||vertic sij shear forc||contralater sij,0.415||0.279||0.26||0.253||0.242||0.237||0.234||0.232||0.232||0.232||0.231||0.221||0.221||0.216||0.211,0.4,0.5,0.4666666666666667
151,Eur_Arch_Otorhinolaryngol-3-1-2099162.txt,tumour||adenocarcinoma||case||neck region||metastas||head||metastat tumour||palatin tonsil||rout||common origin||metastasi||primari adenocarcinoma||patient||oesophagu||tonsil||tumour cell,tonsil||palatin tonsil||adenocarcinoma||palatin||tonsillar metastasi||metastasi||keyword tonsil metastasi adenocarcinoma oesophagu head||gastric adenocarcinoma||esophag adenocarcinoma||primari adenocarcinoma||neck||oesophagu||metastat tumour||pescarmona||crupi,0.412||0.354||0.298||0.296||0.279||0.238||0.196||0.187||0.165||0.163||0.147||0.12||0.119||0.118||0.118,0.6,0.5,0.4666666666666667
152,Pediatr_Nephrol-3-1-1805049.txt,calcif||sodium thiosulf||hu||acut renal failur||week||soft tissu||calcif urem arteriolopathi||hemolyt urem syndrom||patient||calcium,calcif urem arteriolopathi||calcif||urem syndrom||hemolyt urem syndrom||recess hemolyt urem syndrom||sodium thiosulf||calciphylaxi||arteriolopathi||calcif ST sodium thiosulf||urem syndrom MC||syndrom calcif||metastat calcif||shalev||vascular calcif||moe SM urem,0.269||0.25||0.235||0.231||0.181||0.177||0.176||0.176||0.171||0.171||0.169||0.16||0.149||0.146||0.142,0.6,0.4,0.26666666666666666
153,Immunol_Lett-2-1-2430030.txt,murin||present||respons||antigen present||apc||cytokin product||rel pauciti||sampl||express||class II||neutrophil||macrophag||antigen||cell,neutrophil||polymorphonuclear neutrophil||murin neutrophil||human neutrophil||neutrophil gelatinas||neutrophil deplet||neutrophil prepar||neutrophil process||neutrophil sampl||3.3 neutrophil||periton polymorphonuclear neutrophil||human polymorphonuclear neutrophil||3.2 murin neutrophil||purifi murin neutrophil||neutrophil antigen present,0.612||0.402||0.396||0.318||0.317||0.312||0.311||0.311||0.311||0.31||0.28||0.276||0.27||0.267||0.254,0.2,0.1,0.06666666666666667
154,J_Gastrointest_Surg-3-1-1852374.txt,follow-up||perman fecal divers||case||surgic treatment||rate||patient||year||perian abscess||risk||rectal advanc flap||temporari stoma||stoma||perman stoma||fecal divers||fistula||multivari analysi||rectal resect||abscess format||surgeri||factor||abdomin procedur||temporari fecal divers||small bowel resect||fecal incontin,perian||perian fistula||perian crohn ’s||perian abscess||perian crohn ’s diseas||perian abscess fistula||crohn coliti||fistula||complex perian fistula||perian inspect||perian open||perian crohn ’s diseas surgeri||perian fistul crohn ’s diseas||complic perian crohn ’s diseas||perian crohn ’s diseas Br,0.525||0.399||0.381||0.316||0.304||0.302||0.278||0.273||0.271||0.265||0.264||0.253||0.253||0.249||0.246,0.2,0.2,0.13333333333333333
155,Cardiovasc_Intervent_Radiol-3-1-1914265.txt,endovascular treatment||occlus||abi||complic||procedur||sfa||occlud stent||option||endovascular stent||superfici femor arteri||angiograph result||pier||intervent radiolog||patient||side,stent||subintim stent||endovascular stent||occlud stent||double-barrel stent||self-expand stent||reocclud stent||stent segment||sfa||affect stent||addit stent||endovascular||subintim recan||recan||80.0 mm stent,0.539||0.403||0.387||0.384||0.315||0.298||0.286||0.285||0.285||0.276||0.272||0.235||0.233||0.198||0.198,0.4,0.3,0.2
156,Dig_Dis_Sci-4-1-2292501.txt,pathophysiolog mechan||rate||median age 40 year||studi||patient||maximum toler volum||effect||upper abdomin sensat||test||earli satieti||total||nutrient drink||gastric empti||gastric||daili life||relationship||upper abdomin symptom||upper abdomen||pathophysiolog disord||maximum satieti||age||proxim||stomach||drink test||symptom||nutrient drink test||sever||function dyspepsia,gastric||gastric empti||gastric barostat||gastric volum||gastric accommod||gastric function||relax gastric empti||delay gastric||dyspepsia||gastric motor||delay gastric empti||proxim gastric relax||proxim gastric volum||partial gastric volum||gastric function test,0.585||0.411||0.338||0.33||0.314||0.314||0.308||0.306||0.302||0.299||0.283||0.268||0.258||0.226||0.225,0.4,0.2,0.13333333333333333
157,Naunyn_Schmiedebergs_Arch_Pharmacol-2-2-1705472.txt,cardiac inotropi||low level||blockad||ang II||flow||mineralocorticoid receptor||aldosteron||effect||eplerenon||blood pressur||heart failur||glucocorticoid||chai||rat||aldosteron level||oxid stress||cardiac tissu||activ||synthesi||arrhythmia||inotropi||cardiac level||antagonist||cortisol,aldosteron||cardiac aldosteron||aldosteron synthas||aldosteron blockad||vascular aldosteron||aldosteron synthesi||plasma aldosteron||aldosteron product||blood-deriv aldosteron||aldosteron level||aldosteron potenti||cardiac aldosteron action||cardiac aldosteron product||nongenom aldosteron effect||aldosteron synthas gene,0.717||0.416||0.388||0.388||0.373||0.368||0.365||0.364||0.363||0.362||0.36||0.282||0.281||0.277||0.264,0.2,0.2,0.13333333333333333
158,Eur_J_Pediatr-4-1-2413082.txt,tubercul pericard||tuberculosi||pericardi fluid||diagnosi||pericard,tubercul pericard||pericard||tubercul pericardi effus||tuberculosi||constrict pericard||pericardi fluid||tuberculin||keyword tuberculosi pericard subxiphoid biopsi corticosteroid||pericardi effusion-mediastin lymph gland||larg pericardi effus bolt roel||15-year-old girl||effus M. tuberculosi dna||girl||pediatr||anti-tubercul drug,0.409||0.396||0.27||0.225||0.219||0.157||0.134||0.124||0.104||0.1||0.098||0.097||0.088||0.08||0.078,0.6,0.4,0.26666666666666666
159,Pediatr_Radiol-3-1-1805044.txt,find||pretext||siopel||patient||involv||pretext system||risk||pretext stage||criteria||metastas||high risk||current siopel studi||tumour||portal vein||risk stratif||ascit||extrahepat diseas||liver||origin pretext system||biopsi||major branch||hepatoblastoma||medial section||risk factor||hepat vein||revis||diseas||diagnosi||primari malign liver tumour||extrahepat abdomin diseas||children,pretext||hepatoblastoma||v3a pretext||pretext stage||pretext system||pediatr hepatoblastoma||pretext group||ruptur hepatoblastoma||pretext number||childhood hepatoblastoma||diffus pretext IV hepatoblastoma||pretext iii tumour||high-risk hepatoblastoma||siopel||hepatoblastoma eur,0.509||0.455||0.282||0.271||0.26||0.26||0.259||0.259||0.256||0.254||0.251||0.25||0.238||0.236||0.231,0.8,0.4,0.3333333333333333
160,Skeletal_Radiol-4-1-2424184.txt,chart review||follow-up||find||time||follow-up period||studi||patient||clinic outcom||bone marrow edema||age differ||review||total||edema||statist analysi||lesion||pattern||cartilag||tka||age||total knee arthroplasti||pain||subject||bandwidth rang||bme||group||function loss||bone||osteoarthrosi||knee||sever||cartilag loss,bme||bme bme||knee||global bme||bme pattern||tka||bme group||bme 23||bme result||knee osteoarthrosi||cartilag||knee OA||global bme 5||edema||bme 13.04 2.06,0.578||0.578||0.332||0.323||0.322||0.316||0.299||0.291||0.289||0.262||0.244||0.237||0.215||0.213||0.203,0.4,0.3,0.3333333333333333
161,Clin_Rev_Allergy_Immunol-4-1-2243253.txt,antibodi||RA patient||sensit||ccp2 test||test||studi||rheumatoid factor||arthriti||autoantibodi||data||diseas||patient||specif,arthriti||acpa||ccp2||rheumatoid arthriti||anti-ccp2 antibodi||autoantibodi||anti-ccp2 test||ccp2 peptid||ccp2 test||anti-ccp antibodi||peptid ccp2 test||so-cal acpa||anti-ccp autoantibodi system||anti-ccp test||earli rheumatoid arthriti van venrooij walther,0.307||0.217||0.217||0.2||0.176||0.172||0.156||0.155||0.135||0.132||0.121||0.119||0.117||0.113||0.105,0.2,0.3,0.2
162,Clin_Oral_Investig-4-1-2238785.txt,condit||level||system||indic||sextant||basic structur||studi||eros wear||level score||eros||develop||epidemiolog||bew score sum||tooth wear||manag||examin||basic eros wear examin||research||highest score||bew||surfac||gener dental practition||eros tooth wear||sever||gdp||diagnosi||index||score,eros||eros wear||dental eros||eros tooth wear||bew||sextant||wear||tooth wear||basic eros||eros loss||eros tooth wear 1||eros indic||eros anterior tooth||keyword eros tooth||physiolog eros,0.509||0.4||0.388||0.359||0.339||0.311||0.292||0.283||0.276||0.275||0.269||0.265||0.265||0.262||0.258,0.8,0.6,0.4
163,Placenta-1-5-1895600.txt,human pregnanc||gestat age||tunel-posit||sampl||apoptot index||individu cell||increas||express||immunoreact||signific increas||placenta||cell type||cell||stress||murin placenta||hne||oxid stress||gc||apoptosi||ihc||fetal endotheli cell||cyclooxygenas||dual-label||co-localis||mous||glycogen cell||primari antibodi||syncytiotrophoblast,placenta placenta||placenta||hne||cox-1||murin placenta||cox-2||human placenta||syncytiotrophoblast||rat placenta||immunoreact||hne co-localis stain||gestat||LZ||placent oxid stress||murin placenta burdon,0.352||0.352||0.314||0.232||0.217||0.215||0.187||0.186||0.184||0.177||0.176||0.169||0.167||0.15||0.15,0.6,0.5,0.3333333333333333
164,Diabetologia-3-1-1820754.txt,type 2 diabet||respir||muscl||studi||patient||parallel electron input||complex iii||oxid phosphoryl||healthi subject||increas||skelet muscl||insulin||content||evid||present studi||control||uncoupl state||oxid capac||electron transport capac||electron transport||mitochondria||subject||biopsi||citrat synthas activ||result,diabet muscl||muscl||skelet muscl||diabet complic||mitochondria skelet muscl||dela||mitochondri oxid phosphoryl||mitochondri respir||skelet muscl boushel||skelet muscl inhibitor||human skelet muscl||skelet muscl contribut||mitochondri content||rat skelet muscl||type 2 diabet,0.323||0.26||0.236||0.197||0.194||0.179||0.173||0.168||0.167||0.165||0.164||0.163||0.16||0.16||0.153,0.4,0.2,0.2
165,Biochem_Pharmacol-1-5-1920586.txt,blockad||protocol||concentr||long QT syndrom||data||studi||mutat||effect||current||herg channel||herg||inhibit||fit||control||potenti||short QT syndrom||inactiv||imipramin||extern solut||doxepin||channel pore||mutant||drug,herg||herg channel||herg blockad||herg inhibit||herg affin||herg herg fig. 4||mutant herg||herg β||herg measur||herg channel blockad||herg potassium channel||herg channel inactiv||herg channel block||mutant herg channel||close herg channel,0.964||0.509||0.501||0.487||0.485||0.485||0.485||0.483||0.482||0.352||0.35||0.345||0.342||0.341||0.34,0.4,0.2,0.13333333333333333
166,Int_J_Biochem_Cell_Biol-2-1-2267855.txt,pH depend||mutant||substrat transport||substrat||one-way anova||residu||oocyt||peptid||transport||proton||model||charg pair||substrat bind||wild-typ,meredith||pept1||al.||boyd||boyd c.a.r||cotransport pept1||1998 meredith||2004 meredith||meredith david||2000 meredith||2005 meredith||rabbit pept1||peptid transport pept1||co-transport pept1||oligopeptid transport pept1,0.445||0.402||0.271||0.263||0.241||0.237||0.231||0.227||0.226||0.226||0.224||0.222||0.22||0.217||0.212,0.0,0.0,0.0
167,Int_J_Colorectal_Dis-3-1-2077921.txt,dgp||anal manometri||follow-up||case||system||placement||result||artifici bowel sphincter||anal sphincter defect||problem||procedur||data||faecal incontin||studi||implant||treatment||patient||infect||institut,incontin||ab||anal sphincter||faecal incontin||fecal incontin||ruptur||feacal incontin||trauma||ab implant||ruptur anal repair||dgp||artifici sphincter||occasion incontin||artifici anal sphincter implant||anal repair,0.398||0.289||0.287||0.281||0.269||0.244||0.222||0.22||0.215||0.215||0.212||0.209||0.204||0.203||0.2,0.2,0.1,0.13333333333333333
168,Immunogenetics-2-2-1592254.txt,iplitr||detail sequenc analys||molecul||fcrl||domain||cyt||receptor||evid||content||polymorph differ||cell||gene||lrc||genom segment||chir||product||function signific||ident||analysi||catfish||common origin||member||famili||teleost||sequenc analysi||immun receptor||evolut||iplitr sequenc||uniqu composit||inhibitori||lrc-encod receptor||support||lilr||igsf receptor||zflitr||Ig domain||sequenc||membran||kir,iplitr||iplitr sequenc||iplitr gene||iplitr D1||uniqu iplitr||iplitr loci||individu iplitr||iplitr type||catfish||Ig||individu iplitr domain||iplitr1 Ig domain iplitr belong||iplitr1 Ig||iplitr famili member||variant iplitr sequenc,0.523||0.285||0.281||0.276||0.274||0.274||0.266||0.264||0.238||0.227||0.209||0.206||0.201||0.195||0.193,0.4,0.3,0.2
169,J_Med_Internet_Res-7-1-1550637.txt,gener theme||mesh||system||databas||patient||concept||consum||clinic||inform||major||broader literatur||servic manag||alli health literatur||scientif||definit||patient care||telemedicin||journal||medic informat||potenti||term||broad rang||applic||ehealth||research||research literatur||commun technolog||analysi||taxonomi||care||internet||medic informat literatur||literatur||clinic data||medic subject head||topic||medlin||order||scientif abstract||field||public||hand||organiz factor||articl,ehealth||e-health||e-health e-health||ehealth ehealth journal||ehealth internet telemedicin||search term ehealth ehealth||ehealth literatur||informat||term ehealth||ehealth research||ehealth system||ehealth scientif||ehealth tool||ehealth landscap||ehealth articl,0.518||0.455||0.455||0.356||0.306||0.279||0.279||0.276||0.271||0.269||0.267||0.266||0.265||0.265||0.264,0.2,0.1,0.06666666666666667
170,Dig_Dis_Sci-3-1-1914242.txt,chapter||central databas||endoscopi||system||code system||find||endobas iii system||complic||databas||descript||comput system||therapeut procedur||structur||investig||get-c||diagnos||text-block||classif||minim standard terminolog||code||intern classif||item||hospit inform system||terminolog||endoscop term||group||report||import||field||comprehens code system||procedur||diseas||endoscop find,gastric ulcer||gastric||icd-10||icd-10 code||code||get-c code||get-c||k25.1 gastric ulcer||k25.3 gastric ulcer||k25.5 gastric ulcer||k25.7 gastric ulcer||k25.9 gastric ulcer||k25.02 gastric ulcer||k25.22 gastric ulcer||k25.32 gastric ulcer,0.349||0.321||0.316||0.311||0.305||0.295||0.284||0.246||0.246||0.246||0.246||0.246||0.239||0.239||0.239,0.2,0.2,0.13333333333333333
171,Ann_Biomed_Eng-2-2-1705520.txt,condit||actin cytoskeleton||time||respons||mechan condit||load curv||studi||cell stiff||mechan properti||effect||hold period||frequenc||strain||baselin length||increas||amplitud||forc||cytod||matrix mechan||cell||day||load||collagen||tissu||drop||curv||bioartifici tissu||cell mechan||decreas||incub||matrix||step||larger rang,stretch||cyclic stretch||stretch amplitud||cyclic stretch amplitud||step stretch||mechan stretch||stretch magnitud||stretch length||singl stretch||term stretch||cyclic stretch frequenc||continu cyclic stretch||higher stretch amplitud||highest stretch amplitud||higher cyclic stretch amplitud,0.703||0.481||0.461||0.394||0.375||0.373||0.367||0.366||0.356||0.353||0.337||0.325||0.317||0.31||0.302,0.0,0.0,0.0
172,J_Fluoresc-3-1-1915606.txt,measur||time||experiment setup||protein aggreg||sec||dye fluoresc||sampl||irrevers denatur||focal volum||data analysi||aggreg||sensit||increas||temperatur||fluoresc correl spectroscopi||fluoresc intens||denatur protein aggreg||nile red||fluoresc spectroscopi||solut||experiment autocorrel function||protein||experi||normal||light||buffer||sensit detect||analyt detect||fluoresc||room temperatur||peak||heat||size exclus chromatographi,nile||β-galactosidas||nile red||aggreg β-galactosidas||β-galactosidas aggreg||bound nile||β-galactosidas solut||fluoresc||τ||_||nativ β-galactosidas||β-galactosidas molecul||tetramer β-galactosidas||tau _||β-galactosidas speci,0.262||0.217||0.175||0.152||0.152||0.134||0.131||0.126||0.125||0.119||0.114||0.112||0.111||0.111||0.109,0.2,0.2,0.13333333333333333
173,Matern_Child_Health_J-2-2-1592247.txt,nation map||program||measur||preconcept risk assess||preconcept||clinic practic strategi||unpublish data||indic||servic provid||public health||project||birth||jurisdict||pregnanc||matern||state||strategi||folic acid||patient||reproduct health||clinic||risk||unit state||perform measur||provid||intervent||preconcept care program||health||preconcept care||educ||health care||women||summit||effort||public polici||father||age||public health practition||popul||abstract||servic||prenat care||ppor||innov strategi||issu||state perform measur||famili plan||prioriti||preconcept health promot||nation summit,preconcept||preconcept health||preconcept care||preconcept counsel||preconcept intervent||preconcept health prioriti||preconcept focu||preconcept hepat||preconcept health care||preconcept health servic||keyword preconcept||preconcept care servic||preconcept health promot||preconcept care program||preconcept health indic,0.671||0.437||0.405||0.359||0.353||0.349||0.342||0.339||0.338||0.336||0.335||0.314||0.305||0.298||0.298,0.4,0.2,0.26666666666666666
174,Breast_Cancer_Res-5-6-314403.txt,upregul||role||emt||epitheli cell||insert||data||studi||cell cycl control||growth inhibit||total rna||express||treatment||cell||gene||cell growth||analysi||experi||regul||rhob||cdna microarray||hybrid||nmumg cell||data analys||signal intens||pathway||origin data file||time point||gene express||result,tgf-β||tgf-β regul||tgf-β signal||tgf-β play||tgf-β induc||tgf-β respons||ml tgf-β||tgf-β treatment||tgf-β action||tgf-β effect||tgf-β 1||tgf-β target gene||nmumg||gene||studi tgf-β respons,0.443||0.256||0.242||0.234||0.229||0.228||0.228||0.227||0.223||0.222||0.221||0.207||0.199||0.167||0.152,0.0,0.0,0.06666666666666667
175,Biochem_Pharmacol-2-1-2279149.txt,activ site||breast cancer||arylamin||studi||tamoxifen||model||inter-domain loop||assay||steroid||structur||recombin protein||compound||express||reaction||protein||nat||spectrum||activ||three-dimension structur||mous||substrat||peak||inhibitor,nat2||2.2 nat2 nat2||mous nat2||human nat2||nat2 activ||nat2 escherichia||4 discuss nat2 nat2||mous nat2 structur||mous nat2 inhibitor||unlabel mous nat2||mous nat2 spectrum||mous nat2 model||mous nat2 volum||mous nat2 solut||arylamin,0.702||0.469||0.427||0.365||0.36||0.353||0.351||0.296||0.293||0.293||0.291||0.288||0.287||0.287||0.281,0.0,0.0,0.06666666666666667
176,Cancer_Immunol_Immunother-3-1-2150627.txt,technolog||respons||protocol||panel||assay||frequenc||cimt||pbmc sampl||present||abil||clinic trial||reactiv||cell||elispot reader||percentag||pbmc||phase||analysi||standard||function assay||group||order||cmv||elispot||tetram||intracellular cytokin||posit||number||requir||donor,elispot||t-cell||elispot assay||t-cell tetram||antigen-specif t-cell||ifnγ elispot||elispot reader||t-cell assay||ifn-gamma elispot||elispot technolog||elispot analys||revers elispot||elispot panel phase||ifnγ elispot assay||tetram,0.431||0.32||0.279||0.263||0.258||0.253||0.234||0.224||0.22||0.219||0.218||0.217||0.215||0.211||0.206,0.2,0.2,0.2
177,Qual_Life_Res-3-1-2039846.txt,person||follow-up||measur||respons||questionnair||practic||util score||hear||studi||patient||standard deviat||dutch tariff||effect||distinct group||follow-up visit||test||life score||econom analys||qali||util||quality-adjust life year||icer||hui||cost||health||aid user||hear aid fit||popul||chang||aid fit||respond||dutch||group||differ||non-applic||visit||attribut||hear complaint||hear loss||score||hrqol||result,eq-5d||hear||hui3||tariff||hear aid||eq-5d dutch tariff||eq-5d UK tariff||hui2||euroqol eq-5d||eq-5d score||eq-5d qualiti||hui3 versu eq-5d dutch tariff||eq-5d UK||eq-5d UK tariff versu hui3||hui2 versu eq-5d dutch tariff,0.455||0.406||0.376||0.319||0.288||0.283||0.271||0.267||0.26||0.257||0.248||0.248||0.246||0.241||0.226,0.2,0.1,0.06666666666666667
178,Matern_Child_Health_J-2-2-1592143.txt,social market||time||behavior||pregnanc||patient||pcc||consum||healthi pregnanc||promot||provid||cost||health||preconcept care||product||women||research||health behavior theori||babi||servic||care||market||demand||benefit||outcom,preconcept||preconcept care||preconcept care servic||market preconcept care servic||preconcept counsel||pcc||preconcept health care||pcc servic||market||social market preconcept care servic||preconcept health promot||servic||preconcept care messag||preconcept health issu||social market,0.552||0.362||0.325||0.314||0.313||0.309||0.292||0.28||0.28||0.279||0.261||0.252||0.251||0.241||0.211,0.2,0.3,0.3333333333333333
179,Apoptosis-4-1-2311383.txt,role||protein kinas||respons||studi||transcript factor||increas||sirna||phosphoryl||cell||oxid stress||apoptosi||alveolar type II cell||protein||creb||activ||nuclear accumul||pka||import||exposur||creb activ||egfr||oxid||camp||result,creb||creb phosphoryl||phosphoryl creb||pka||creb activ||creb express||dominant-neg creb||creb inhibit||creb respons||pka-medi creb phosphoryl||a-medi creb phosphoryl||oxidant-induc creb respons||mossman||total creb band||300 creb 2,0.518||0.327||0.327||0.294||0.28||0.269||0.269||0.266||0.264||0.226||0.225||0.206||0.198||0.185||0.175,0.6,0.3,0.2
180,Surg_Endosc-3-1-2077356.txt,follow-up||enuresi||hospit stay||time||higher enterocol rate||laparoscop procedur||studi||patient||march 1994||adhes obstruct||duhamel procedur||rectum||end point||laparoscop duhamel||open||bowel||postop complic||cosmet result||group||differ||duhamel||adhes bowel obstruct||enuresi rate||signific differ||period||aganglionosi,duhamel||laparoscop duhamel||laparoscop||duhamel laparoscop duhamel gender||laparoscop duhamel procedur||duhamel procedur||open duhamel||laparoscop procedur||open duhamel procedur||bowel||rectum||enterocol||laparoscop seri||enuresi||laparoscop variant,0.434||0.374||0.314||0.298||0.274||0.255||0.252||0.195||0.193||0.187||0.176||0.175||0.173||0.169||0.169,0.4,0.5,0.4666666666666667
181,Mol_Genet_Genomics-3-1-2129107.txt,carbon sourc||gene||sucros||inulin||strain||bind||mutant||invertas||unpublish result||transcript||domain||protein||inulinolyt gene||inulinolyt enzym||data||express||extracellular enzym||inur||growth||result,inur||inur inur||pyrg inur inur||A. niger inur inur||inur amyr||inur inur amyr amyr||inur protein||inur 1989||inur materi||5 inur||niger||inur A. niger n402 inur materi||niger inur A. nidulan||inur sucb inur inu inua suca||fumigatu A. niger A. niger inur,0.788||0.788||0.554||0.518||0.46||0.46||0.403||0.398||0.397||0.394||0.384||0.35||0.347||0.311||0.307,0.2,0.1,0.06666666666666667
182,Appl_Microbiol_Biotechnol-3-1-1914294.txt,terpenoid||gene||emiss||iptg||strain||product||isopren||enzym||function||concentr||pathway||express||studi||methylerythritol phosphat pathway||biosynthesi||amount||cell||growth||isopren emiss,subtili||bacillu subtili||B. subtili||isopren||1996 bacillu subtili||2 B. subtili B.||keyword bacillu subtili isopren methylerythritol||bacillu subtili biochem biophi||molecular biotechnolog bacillu subtili||bacteri isopren emiss B. subtili strain||B. subtili 1999 2001||fig. 3 B. subtili||enzym E. coli B. subtili||2 bacillu subtili 600 nm||isopren emiss,0.655||0.422||0.406||0.307||0.282||0.242||0.237||0.215||0.215||0.213||0.205||0.203||0.2||0.193||0.184,0.2,0.1,0.13333333333333333
183,Cancer_Causes_Control-3-1-2039842.txt,type||subcohort||cancer||case||fat||mutat||studi||patient||colon||risk||total fat||epidemiolog||linol acid||intak||netherland cohort studi||express||polyunsatur fat||day||rectal tumor||lack||tumor||subcohort member||tabl||rectal cancer||addit||colon tumor||result,apc||apc apc||apc kra||apc apc apc gene||kra apc kra apc 25 apc||kra||2 apc apc||apc apc 1||apc kra kra kra gene||2 apc apc apc 2||mlh1 apc||kra apc gene||colorect cancer 1 apc apc apc||fat 3 apc apc||38 apc kra apc mutat,0.586||0.586||0.492||0.445||0.426||0.397||0.391||0.391||0.36||0.352||0.349||0.335||0.334||0.331||0.33,0.0,0.0,0.0
184,Matern_Child_Health_J-2-2-1592151.txt,respons||questionnair||practic||rate||pregnanc||studi||patient||folic acid||pcc||respons rate||carn||major||counsel||routin care||folic acid supplement||preconcept care||women||posit effect||care||routin exam||factor||group||topic||import||issu||survey||obstetrician-gynecologist||physician,pcc||preconcept care||preconcept counsel||pcc questionnair||pcc guidelin||pcc 5||pcc 3||pcc 2||preconcept care guidelin||preconcept care visit||routin exam||preconcept care morgan maria||posit aspect preconcept care||folic||physician,0.48||0.312||0.28||0.276||0.25||0.24||0.24||0.24||0.215||0.214||0.179||0.162||0.162||0.155||0.149,0.4,0.2,0.26666666666666666
185,J_Med_Internet_Res-7-3-1550662.txt,type||portal||cancer||categori||health-rel inform||onlin inform||redesign||patient||question||inform||form||search log||clinic trial||onlin||guidelin||cancer inform||health profession||page||websit||cancer patient||averag||result||onlin survey||free-text search||basic search form||feedback||abstract||nci||usabl test||summari||bet||user input||tabl||usabl||specif trial||survey||cancer inform product||internet,nci||nci websit||nci cancernet websit||redesign nci websit||websit||nci site||nci websit integr||current nci websit||nci websit avoid||2004 nci websit||conclus nci websit||nci websit 16||nci staff||nci program||nci press,0.576||0.457||0.373||0.363||0.339||0.328||0.307||0.307||0.306||0.306||0.305||0.305||0.3||0.292||0.29,0.4,0.2,0.13333333333333333
186,Exp_Brain_Res-4-1-2214825.txt,visual illus||illus||target||time||initi postur||grip select||model||studi||strategi||orient||effect||grip plan||end||percept||present||motor plan||grip type||target object||visual inform||grasp||sequenti object manipul task||frame||visual context||result||rod orient||task||experi||action||clockwis||start postur||rod||postur||end postur||trial||particip||movement||grip||object||plan||switch point,illus||rod||grip||orient illus||rod-and-fram illus||grasp||rod orient||grip plan||visual illus||ponzo illus||lyer illus||illus effect||ebbinghau illus||pictori illus||illus configur,0.408||0.34||0.32||0.284||0.272||0.26||0.25||0.246||0.246||0.219||0.218||0.211||0.211||0.209||0.207,0.6,0.7,0.4666666666666667
187,Int_J_Cardiovasc_Imaging-3-1-2048828.txt,tricuspid annulu||measur||RV function||tad||assess||analysi||mri||tad measur||magnet reson imag||taf||studi||patient||TA function||real-tim three-dimension echocardiographi,tricuspid||tricuspid annulu||rt3de||tricuspid regurgit||keyword tricuspid||mri||mri 2de rt3de mri||tricuspid annulu function||tricuspid annular motion||tricuspid annular veloc||tricuspid annular plane||tricuspid valv repair||tricuspid valv morpholog||function tricuspid regurgit||secondari tricuspid regurgit,0.572||0.381||0.355||0.327||0.286||0.27||0.269||0.264||0.263||0.254||0.253||0.241||0.238||0.228||0.224,0.2,0.2,0.13333333333333333
188,Eur_Biophys_J-3-1-2082062.txt,array||chromatin condens||alpha-satellit dna||measur||centromer||repeat number||liquid||gel||chromatin||nucleosom posit||site||internucleosom distanc||dna||nucleosom||afm||atom forc microscopi||nucleosom array||reconstitut||largest fragment||afm measur||distribut||histon||main phase||fraction||posit||agm||number||fragment||peak||kinetochor protein bind||sequenc||result,nucleosom||nucleosom array||nucleosom arrang||nucleosom core||localis nucleosom||phase nucleosom||nucleosom phase||nucleosom posit||nucleosom organis||nucleosom conform||telomer nucleosom||nucleosom height||nucleosom placement||nucleosom locat||discuss nucleosom,0.623||0.345||0.335||0.33||0.326||0.325||0.325||0.321||0.32||0.32||0.317||0.316||0.315||0.313||0.311,0.4,0.3,0.2
189,Ann_Surg_Oncol-4-1-2373867.txt,success nerve-preserv surgeri||time||ipss||pelvic autonom nerv||superior hypogastr plexu||studi||patient||preoper baselin data||preserv||femal||nerv||specif sexual problem||erectil function||point likert scale||oper||present studi||femal sexual dysfunct||evalu||inferior mesenter plexu||autonom nerv||intern prostat symptom score||surgeri||sigmoid colon cancer||surgic procedur||item score||rectal cancer||procedur||good||dissect||genitourinari function||function,iief||fsfi||nerve-preserv surgeri||autonom nerve-preserv surgeri||laparoscop autonom nerve-preserv surgeri||0||autonom nerv||autonom nerve-preserv oper||nerv||pelvic autonom nerv||ipss||sympathet nerve-preserv surgeri||rectal cancer||iief score||nerve-preserv procedur,0.273||0.248||0.223||0.216||0.201||0.2||0.194||0.193||0.187||0.183||0.18||0.179||0.177||0.176||0.172,0.0,0.3,0.3333333333333333
190,Arch_Dermatol_Res-3-1-1914293.txt,skin cell||plasmacytoid dendrit cell||studi||patient||relaps||lichen planu symptom||lesion biopsi||lichen planu lesion||reactiv||treatment||cell||lichen planu||lesion skin||protein||remiss||diseas activ||lymphocyt||skin diseas||biopsi||skin||number||diseas,hhv-7||lichen planu||planu||remiss hhv-7||lichen planu lesion||oral lichen planu||lichen planu symptom||lichen planu pathogenesi||lichen planu episod||discuss lichen planu||hhv-7 replic||hhv-7 reactiv||hhv-7 dna||hhv-7 antigen||patient hhv-7,0.54||0.456||0.456||0.329||0.315||0.308||0.308||0.307||0.306||0.304||0.287||0.287||0.284||0.281||0.279,0.4,0.3,0.2
191,Clin_Oral_Investig-2-2-1705496.txt,level||neurosensori dysfunct||oral implant||regard||questionnair||object evalu||trigemin nerv injuri||patient||studi||light touch sensat||placement||impress||nerv||complaint||region||sensat||psychophys test||orofaci region||lower jaw||load||age||month||popul||surgeri||test group||physic dysfunct||mental nerv||implant||group||symphysi||procedur||neurosensori disturb||oral caviti||object||area||age 56 year||lower lip,__||__ speak __||__ numb __||__ swallow __||__ temporari __ persist||side __ left __||hot __ itch __||drink __||__ burn __ tickl||__ eat __ whistl||__ frozen __ cut __ prurienc||implant||oral implant||tearer __ electr||neurosensori disturb,0.641||0.436||0.435||0.43||0.331||0.329||0.328||0.328||0.327||0.326||0.326||0.294||0.232||0.221||0.204,0.0,0.0,0.2
192,Neurosci_Lett-2-1-2271123.txt,habitu||increas||hippocampu||app||stress||brain||elev platform,app||solubl app||app process||alzheim amyloid precursor protein||amyloid precursor protein||app band ratio||stress||alpha-secretase-cleav amyloid precursor protein||amyloid beta precursor protein||alter app process||neurosci||total particul app level||total app protein express||breen k.c||hippocampu neurosci,0.383||0.22||0.205||0.176||0.174||0.15||0.145||0.14||0.139||0.139||0.133||0.13||0.126||0.12||0.115,0.2,0.2,0.13333333333333333
193,Mod_Rheumatol-4-1-2275302.txt,rheumatoid arthriti||vector||inflamm||transgen||joint||system deliveri||efficaci||anim model||patient||gene therapi||strategi||gene transfer||effect||angiogenesi||increas||system administr||deliveri||retrovir vector||express||plasmid dna||treatment||cell||therapi||gene transfer vector||success||mice||cytokin||destruct||adenoviru||pannu format||arthriti||inject||deliveri strategi||aav||fibroblast||vivo,arthriti||collagen-induc arthriti||experiment arthriti arthriti||rheumatoid arthriti||murin collagen-induc arthriti||collagen-induc arthriti prevent||collagen-induc arthriti reduc||arthriti synoviocyt||plasmid arthriti||adjuvant-induc arthriti||antigen-induc arthriti||collagen arthriti||inflammatori arthriti||experiment arthriti||arthrogen-induc arthriti,0.577||0.479||0.389||0.359||0.334||0.323||0.323||0.321||0.321||0.31||0.303||0.3||0.297||0.295||0.294,0.4,0.2,0.13333333333333333
194,Histochem_Cell_Biol-4-1-2386534.txt,squamou metaplasia||hair||langbein||diagnost applic||suprabas layer||moll||case||epitheli cell||simpl||mutat||hair follicl||adenocarcinoma||basal||express pattern||marker||pattern||express||schweizer||differenti||cell type||specif||diagnost marker||cell||type II||typic intermedi filament protein||tissu||protein||epitheli type||function signific||tumor||keratin||layer||diseas,keratin||hair keratin||epitheli keratin||keratin filament||keratin express||keratinocyt keratin||epiderm keratin||human keratin||keratin polypeptid||keratin antibodi||keratin gene||keratin pattern||corneal keratin||MB keratin||keratin k6hf,0.761||0.466||0.432||0.414||0.414||0.413||0.401||0.397||0.397||0.397||0.395||0.392||0.391||0.389||0.389,0.2,0.1,0.06666666666666667
195,Int_J_Colorectal_Dis-4-1-2386752.txt,tumour||post-op complic||fisi||score||studi||contin||function outcom||tem||procedur||qualiti||local excis||patient||seri||signific||life||rectal tumour||faecal contin||result,tem||transan endoscop microsurgeri||transan endoscop||transan endoscop microsurgeri Br||transan endoscop microsurgeri int||DW transan endoscop microsurgeri excis||tem procedur||rectum||tem techniqu||2008 introduct transan endoscop microsurgeri||fisi||tem local excis qualiti||rectal tumour||incontin||rectal adenoma,0.41||0.321||0.3||0.246||0.244||0.219||0.213||0.213||0.212||0.196||0.17||0.164||0.155||0.144||0.144,0.2,0.1,0.2
196,Virchows_Arch-3-1-2063564.txt,type||grade||intraduct papillari mucin neoplasm||tumor||pancrea||ipmn subtyp||case||intraduct tumor||recent year||ductal adenocarcinoma||prognosi||posit margin||invas||carcinoma||patient||intraduct papillary-mucin neoplasm||recurr||outcom||ipmn,intraduct||intraduct papillari neoplasm||intraduct papillari mucin neoplasm||intraduct papillary-mucin neoplasm||pancrea||intraduct oncocyt papillari neoplasm||intraduct tumor||intraduct papillari mucin tumor||intraduct papillari mucin tumour||papillari neoplasm||intraduct papillari mucin neoplasia||noninvas intraduct papillari mucin neoplasm||papillari mucin neoplasm||intraduct mucin-hypersecret neoplasm||intraduct recurr,0.535||0.367||0.342||0.315||0.315||0.299||0.287||0.286||0.285||0.283||0.282||0.279||0.278||0.276||0.275,0.6,0.4,0.26666666666666666
197,In_Vitro_Cell_Dev_Biol_Anim-4-1-2277440.txt,control group||doxorubicin concentr||hair follicl||effect||assay||signific||temperatur||viabil||cell||damag||human epiderm keratinocyt||doxorubicin exposur||hair loss||group||keratinocyt||scalp cool||differ||decreas||scalp||doxorubicin||signific differ||medium||drug uptak||result,"scalp||doxorubicin||scalp cool||cool||vitro doxorubicin||2,21||effect scalp||temperatur||doxorubicin exposur||doxorubicin uptak||keyword scalp||doxorubicin concentr||local scalp skin temperatur||optim doxorubicin exposur temperatur||strong cool",0.289||0.255||0.254||0.219||0.153||0.15||0.149||0.149||0.146||0.146||0.144||0.139||0.115||0.114||0.112,0.6,0.5,0.4
198,Bioprocess_Biosyst_Eng-2-2-1705532.txt,cool hex||steril inlet feed||pressur drop||flow||lower flowrat||rate||locat||valu||process side||spiral heat exchang||water||air||recycl||effect||process||continu heat treatment||volum||steril||abil||point||pressur||switch||util||temperatur||control||degre||steam||continu steril||ferment||hex||fluid||non-steril side||hot medium||heat treatment||media type||alkalin||acid||loop||resid time||min||fluid densiti||gap||outlet||valv||system outlet||pipe||inlet||steril medium||cooler||media compon||heat transfer||design||heat||media||side,steril||lpm||steril inlet||inlet||steam steril||steril temperatur||cooler||steril steril medium||steril inlet feed||steril feed||water steril||inlet temperatur||hex||steril side||cooler temperatur,0.288||0.266||0.255||0.223||0.215||0.212||0.205||0.199||0.199||0.187||0.185||0.179||0.175||0.171||0.17,0.4,0.4,0.3333333333333333
199,Biochim_Biophys_Acta-2-1-2396231.txt,upregul||respons||klf express||data||endothelin-1||studi||transcript factor||effect||multipl klf famili member||increas||total rna||gene promot||express||cell type||cell||signific role||cardiac myocyt||gene||krüppel-lik factor||klf||oxid stress||apoptosi||protein||famili||cardiac myocyt hypertrophi||polysom||mrna||pathway||gene express,klf||klf6||myocyt||klf4||sugden p.h||klf2||_||clerk A. sugden p.h||et-1||klf5||krüppel-lik famili||krüppel-lik factor||cardiac myocyt||klf express||clerk A.,0.268||0.236||0.23||0.221||0.2||0.199||0.186||0.176||0.173||0.171||0.167||0.166||0.164||0.164||0.151,0.2,0.1,0.26666666666666666
200,Matern_Child_Health_J-2-2-1592159.txt,infant||birth outcom||mother||birth||pregnanc||data||matern||state||cari||oral health||risk||case-control studi||deliveri||intervent||treatment||dental servic||infect||dental||matern oral health||health||potenti||women||preterm birth||age||care||matern periodont diseas||oral||factor||import||diseas||tooth||children,periodont||dental||periodont health||periodont diseas||periodont infect||pregnanc||oral||dental cari||periodont therapi||matern periodont diseas||dental care||dental servic||dental coverag||dental infect||periodont disease-associ preterm birth,0.515||0.371||0.332||0.288||0.284||0.271||0.269||0.267||0.26||0.227||0.224||0.22||0.218||0.212||0.21,0.2,0.4,0.3333333333333333
201,J_Gastrointest_Surg-3-1-1852382.txt,tetanu||case||gastrointestin procedur||complic||procedur||surgeri||diffus muscl spasm||patient||clinic present||vulner patient,tetanu||postop tetanu||tetanu bacilli||trismu||primari tetanu immun||tetanu case refer||stoddart JC tetanu||springer-verlag 2007 tetanu||quattlebaum J. postop tetanu||keyword tetanu hemorrhoid surgic procedur||12. murphi KJ tetanu||17. farrar JJ tetanu||dysphagia trismu||aliv||MJ murphi TV tetanu surveil,0.723||0.406||0.386||0.284||0.254||0.252||0.251||0.243||0.219||0.2||0.19||0.188||0.182||0.17||0.157,0.2,0.1,0.06666666666666667
202,Ann_Biomed_Eng-2-2-1705506.txt,scaffold||ecm||si||bioreactor||leaflet||anim model||studi||molecular imag||heart valv||remodel||heart valv tissu||mechan environ||human||polym||bone marrow||extracellular matrix||fibrin gel||decellular||adult||epc||evid||cell||growth factor||properti||applic||matrix protein||tissu||collagen||endotheli||mechan stimul||implant||myofibroblast||valv||field||biodegrad polym||heart||tissu engin||biomark||function||result,valv||heart valv||valv tissu||aortic valv||valv leaflet||bioprosthet valv||autolog valv||cardiac valv||pulmonari valv||valv replac||mitral valv||mechan valv||adult valv||nativ valv||natur valv,0.552||0.355||0.328||0.32||0.315||0.3||0.299||0.298||0.293||0.292||0.284||0.284||0.283||0.283||0.28,0.4,0.2,0.13333333333333333
203,Pediatr_Nephrol-3-1-1915616.txt,antibodi||hu||shiga-lik toxin||stx||hemolyt urem syndrom||effect||huvec||specif receptor||coincub||toxin||receptor||protein synthesi||temperatur||cell||cytotox effect||experi||temperatur shift||chang||supernat||renal endothelium||target cell||transfer||monocyt||vero cell,monocyt||toxin||stx||vero toxin||shiga toxin||shiga-lik toxin||stx-load monocyt||shiga||coincub stx2-load monocyt||human monocyt||load monocyt||blood monocyt||coincub||shiga toxin b-subunit||unload monocyt,0.385||0.321||0.29||0.279||0.277||0.263||0.251||0.232||0.216||0.214||0.213||0.205||0.204||0.204||0.202,0.6,0.4,0.3333333333333333
204,Ann_Biomed_Eng-2-2-1705509.txt,stereoscop movi||infrar rang||blood withdraw||blood vessel||imag||vi||nir||visual rang||inform||percept||depth||shadow||user||enhanc||shutter glass||depth percept||superfici artifact||tissu surfac||tissu||result||devic||wavelength rang||camera||surfac||pixel||crt||contrast||light sourc||mode||reflect||techniqu,nir||vi nir vi||nir imag||nir pixel||nir preview||vi||nir mask||nir view||nir transpar||1 nir||normal nir imag||nir imag size||vi imag||stereoscop||raw nir view,0.566||0.393||0.381||0.337||0.309||0.306||0.3||0.299||0.295||0.283||0.257||0.256||0.252||0.236||0.214,0.2,0.2,0.13333333333333333
205,Pediatr_Nephrol-4-1-2275772.txt,prevent||proteinuria||measur||antiproteinur||chronic kidney diseas||ra||hypertens||ckd||reduct||efficaci||renal failur||studi||normal rang||patient||effect||risk||therapeut strategi||increas||ckd patient||blood pressur||addit role||chronic inflamm||low-protein diet||adult||ace inhibitor||treatment||oxid stress||antihypertens agent||anemia||renal function||factor||renal replac therapi||kidney function||trial||renal diseas progress||progress||children,kidney||renal failur||renal diseas||proteinuria||renal outcom||renal dysfunct||renal function||renal injuri||chronic renal failur||renal tissu||renal diseas progress||progress renal diseas||chronic renal diseas||kidney diseas||pediatr renal diseas,0.332||0.265||0.249||0.235||0.222||0.221||0.221||0.219||0.217||0.214||0.208||0.208||0.207||0.202||0.2,0.4,0.3,0.26666666666666666
206,Ann_Surg_Oncol-4-1-2234448.txt,level||method||sln biopsi procedur||oper procedur||patholog assess||melanoma||sampl||fnb sampl||antimoni concentr||studi||true sln||antimoni||fine-needl biopsi||node||icp-m||fnb specimen||ppb||result||lymph node||ident||analysi||standard||sentinel lymph node||primari cutan melanoma||sln||hydrochlor acid||procedur||patholog||region lymph node||antimoni level||techniqu,sln||sentinel||melanoma||node||sentinel lymph node||sentinel lymph||antimoni||sentinel node biopsi||sentinel lymph node biopsi||lymph node||sln ident||true sln||excis sln||sln identif||sln assess,0.442||0.355||0.321||0.29||0.287||0.286||0.271||0.268||0.255||0.254||0.232||0.23||0.228||0.228||0.227,0.8,0.6,0.4666666666666667
207,Mod_Rheumatol-4-1-2279153.txt,rheumatoid arthriti||younger age||clinic respons||respons||retrospect studi||demograph factor||infliximab||low activ||studi||patient||notabl efficaci||diseas durat||secondari insuffici||discontinu||dose||treatment||advers event||therapi||advers reaction||RA manag group||retrospect clinic studi||diseas activ||remiss||age||respons criteria||factor||crp||japan||eular criteria||clinic efficaci||diseas||infliximab therapi||mtx,infliximab||infliximab therapi||concomit infliximab||infliximab treatment||das28-crp||infliximab therapi variabl||infliximab therapi 12||mtx||initi infliximab infus||infliximab continu rate||eular||infliximab therapi 3 4||coef||arthriti||rheumatoid arthriti,0.634||0.356||0.342||0.326||0.247||0.242||0.238||0.227||0.217||0.217||0.191||0.178||0.176||0.164||0.154,0.4,0.3,0.26666666666666666
208,Pediatr_Nephrol-3-1-2100430.txt,author||inflamm||chronic kidney diseas||import observ||hypertens||ckd||high preval||abnorm||data||renal failur||studi||transplant patient||hyperphosphatemia||patient||gener popul||calcif||cardiac risk factor||mortal||risk||process||diastol dysfunct||increas||ischem heart diseas||chronic inflamm||cardiac morbid||cardiac arrest||adult||treatment||esrd||renal transplant||lvh||young adult||coronari arteri diseas||anemia||valvular diseas||dyslipidemia||death||cvd||transplant||arteri||gener pediatr popul||high rate||doqi||dialysi||chronic hemodialysi||stiff||children||cardiovascular diseas,renal transplant||dialysi||pediatr dialysi||pediatr||transplant||pediatr ckd||kidney transplant||children||ckd||pediatr renal diseas||lvh||lvh lvh||pediatr nephrol pediatr nephrolog||renal failur||pediatr kidney transplant recipi,0.264||0.241||0.238||0.235||0.225||0.221||0.219||0.214||0.206||0.199||0.199||0.199||0.187||0.181||0.176,0.6,0.5,0.4666666666666667
209,Pediatr_Radiol-4-1-2292495.txt,cathet||peripher cannula||line||complic||contrast studi||tip posit||cathet tip||central venou cathet||studi||patient||tip||central venou access devic||thrombu||neck||lumen||contrast jet||contrast medium||site||oper||manag||subsequ manag||tunnel||central||clinic team||malfunct||fibrin sheath||access||initi examin||posit||cvc||inject||children||techniqu,cathet||cathet malfunct||tunnel cathet||cathet tip||central venou cathet||cathet lumen||hemodialysi cathet||haemodialysi cathet||infus cathet||cathet complic||double-lumen cathet||cathet salvag||infus cathet venou||cathet exchang||multilumen cathet,0.727||0.461||0.43||0.421||0.407||0.395||0.392||0.384||0.379||0.379||0.375||0.375||0.373||0.37||0.37,0.6,0.3,0.2
210,Med_Biol_Eng_Comput-3-1-2039845.txt,measur||cathet||respons||sampl rate||system||time||valu||tip||thermocoupl||vivo measur||air||frequenc||overshoot||leakag test||increas||transport||temperatur||calibr||signal||airway climat explor||sampl cathet||respons characterist||characterist||order||decreas||humid||sensor hous||central canal||intratrach climat||respons time||heat||step||total assembl||hme,humid||humid sensor||sensor||heat humid||capacit humid sensor||humid sensor polym||vaisala humid sensor||commerci humid sensor||test humid sensor||tracheal humid||humid step||intra-trach humid||humid measur||humid variat||humid assess,0.617||0.537||0.458||0.373||0.365||0.363||0.363||0.362||0.361||0.343||0.331||0.33||0.323||0.319||0.315,0.2,0.1,0.06666666666666667
211,Arch_Microbiol-4-1-2270922.txt,biolog||time||system||rel abund||bioreactor||steadi state||sampl||acet concentr||laboratori||comparison||flask||control cultiv||variabl||pattern||mass||electron donor||cell||growth||optic densiti||protein||proteom||analysi||chemostat cultur||cultiv||acid||shake flask||experi||shake flask cultur||cultur||system biolog||batch||peptid||organ acid||result,oneidensi||shewanella oneidensi||shewanella||shewanella oneidensi mr-1||oneidensi mr-1||flask||2007 shewanella oneidensi||flask cultur||proteom||grown shewanella||shake flask||mr-1||shake flask cultur||chemostat||shewanella oneidensi escherichia coli confer,0.381||0.364||0.347||0.304||0.283||0.271||0.244||0.209||0.189||0.186||0.186||0.185||0.173||0.164||0.162,0.0,0.2,0.26666666666666666
212,Pflugers_Arch-3-1-1915652.txt,ino||sampl||effect||increas||express||aminoguanidin||rat||renal proxim tubul||gene||product||renal drug transport||lp||proxim tubul||proxim tubular damag||supplementari materi||nephrotox||endotoxemia||tubul cell||renal abc transport||up-regul||gene express||kidney||import efflux pump,masereeuw||aminoguanidin||renal ino||ino||renal abc transport||bsep||renal efflux transport||russel FG masereeuw||renal proxim tubul||renal drug transport||renal express||abcc2||abc transport||renal injuri||tubul,0.187||0.172||0.166||0.153||0.133||0.127||0.121||0.12||0.117||0.117||0.111||0.111||0.11||0.106||0.102,0.6,0.5,0.3333333333333333
213,Matern_Child_Health_J-2-2-1592251.txt,incom||program||commun health center||preconcept||uninsur||center||public health||pregnanc||state||prevent care||medicaid||major||usual sourc||sourc||health||health coverag||preconcept care||approach||women||health clinic||servic||coverag||feder||fund||opportun||access||famili plan||profession guidelin||waiver||children,medicaid||medicaid waiver||medicaid coverag||preconcept||health||health coverag||waiver||coverag||medicaid servic||women health||health care coverag||preconcept care||health polici||health care||women health polici,0.406||0.335||0.329||0.307||0.299||0.276||0.264||0.253||0.243||0.243||0.243||0.241||0.239||0.237||0.222,0.6,0.6,0.4666666666666667
214,Arch_Orthop_Trauma_Surg-4-1-2324129.txt,upper ankl joint||follow-up||case||surgic techniqu||lower ankl joint||soft tissu||complic||wire||posterior facet||reduct||joint deviat||disturb||studi||patient||osteiti||clinic||view||lower leg||statist analysi||fractur||close reduct||treatment||intern fixat||calcaneu||intern fixat techniqu||averag||follow-up evalu||surgeri||normal shoe||disloc calcan fractur||good condit||rang||averag follow-up time||zwipp score||compar result||result,calcaneu||calcaneu fractur||fractur||calcan fractur||disloc calcaneu fractur||calcan fractur major fractur||intraarticular calcan fractur||disloc calcan fractur||calcaneu wire||92 calcan fractur||intraarticular fractur||100 calcan fractur||disloc calcaneu||intra-articular fractur||oper calcaneu,0.491||0.481||0.471||0.433||0.35||0.336||0.326||0.318||0.318||0.294||0.291||0.29||0.29||0.267||0.256,0.4,0.3,0.2
215,Sleep_Breath-4-1-2270921.txt,apnea||initi treatment option||linear regress||oral applianc||sleep medicin physician||level||sleep medicin||measur||time||reduct||success treatment outcom||data||model||studi||dental sleep medicin specialist||patient||rdi||upper airway||sleep disord breath||investig||recoveri||posttreat||valid||osa||titrat endpoint||clinic cut-off||sleep||mad||sleep apnea||dentist||obstruct sleep apnea||small sampl size||devic||algorithm||group||correl analysi||cpap therapi||mandibular advanc devic||outcom,sleep||sleep apnea||apnea||sleep breath sleep||keyword sleep apnea sleep||posttreat apnea||obstruct sleep apnea||sleep apnea syndrom||mad||sever sleep apnea||central sleep apnea||complex sleep apnea||snore||posttreat||sleep medicin,0.465||0.41||0.354||0.337||0.321||0.309||0.305||0.28||0.276||0.275||0.275||0.274||0.27||0.263||0.244,0.6,0.5,0.4666666666666667
216,Clin_Oral_Investig-4-1-2238780.txt,level||data||abras||eros||wear||teeth||smith||tooth wear||dentin||adult||evid||term||patholog tooth wear||research||age||popul||attrit||group||adolesc||clinic experi||small proport||hypothesi||progress||children,wear||tooth wear||tooth||palat tooth wear||patholog tooth wear||sever tooth wear||patholog eros tooth wear||eros||gradual wear||palat tooth||wear vari||wear indic||tooth surfac||patholog tooth||keyword eros tooth,0.6||0.579||0.557||0.404||0.397||0.388||0.381||0.33||0.308||0.305||0.302||0.302||0.297||0.296||0.296,0.6,0.4,0.26666666666666666
217,Appl_Microbiol_Biotechnol-3-1-1914249.txt,wastewat||ethanol||reactor||strain||srb||dna||electron donor||specif||cell||gram||oligonucleotid probe||electron acceptor||sulfat||acet||genet divers||singl energi sourc||micro-divers||presenc||substrat||full-scal sulfidogen bioreactor||sulfate-reduc bacteria,analysi desulfovibrio desulfovibrio||strain desulfovibrio||sulfate-reduc bacteria||bacteria||reactor||cell hybridis desulfovibrio giga desulfovibrio||desulfobacca||srb||eub338||sulfate-reduc bacterium||mesophil sulfate-reduc||similar sulfate-reduc bacteria||wastewat||desulfovibrio mexicanu sp. nov.||sulfate-reduc popul,0.254||0.227||0.219||0.173||0.168||0.168||0.157||0.156||0.156||0.148||0.147||0.147||0.145||0.141||0.139,0.4,0.3,0.26666666666666666
218,Skeletal_Radiol-3-1-2042033.txt,skelet system||diagnost sensit||muscl||case||system||system muscl diseas||fat||high resolut||scanner||mri||imag||muscl diseas||patient||malign diseas||bone marrow||pet-ct||sensit||diagnost accuraci||lesion||magnet reson imag||skelet metastas||multislic CT||muscl dystrophi||patient posit||bone scintigraphi||ms-ct||excel soft tissu contrast||examin||multipl cartilagin exostos||multipl||result||assess||spatial resolut||bodi||multipl myeloma||tumor||destruct||scintigraphi||radiographi||diseas||whole-bodi imag||introduct,whole-bodi mri||whole-bodi imag||bone||mri||whole-bodi mri ajr||multi-channel whole-bodi mri||bone imag||bone marrow||whole-bodi applic||bone metastas||high-resolut whole-bodi||bone marrow imag||state-of-the-art whole-bodi imag||ms-ct||bone marrow metastas,0.343||0.298||0.286||0.266||0.247||0.241||0.231||0.229||0.219||0.215||0.214||0.212||0.203||0.203||0.201,0.4,0.3,0.26666666666666666
219,Crit_Care-8-6-1065076.txt,metabol||effect||control||cardiac surgeri||intens care unit||hyperglycemia||studi||critic ill||hyperglycaemia||intens insulin therapi||ill patient||insulin||tight glucos control||patient,icu||insulin||icu mortal||icu stay||icu patient||critic ill||tight glucos control||abbrevi icu||blood glucos||tight blood||tight blood glucos control||glucos control||critic||intens care||tight control,0.336||0.234||0.219||0.212||0.198||0.195||0.193||0.174||0.168||0.164||0.163||0.161||0.159||0.157||0.157,0.2,0.3,0.2
220,J_Neurooncol-3-1-1915654.txt,von hippel-lindau diseas||hemangioblastoma,hemangioblastoma||radiotherapi||neuro-oncolog||progress hemangioblastoma||dissemin hemangioblastomatosi||von hippel-lindau diseas||von hippel-lindau diseas hans||piribau||radiotherapi field||high-dos total neuraxi radiotherapi||s11060-006-9321-z origin paper hemangioblastomatosi||myotom C4||PO box 5201||neurooncol journal||dieckmann,0.319||0.211||0.195||0.181||0.156||0.149||0.143||0.126||0.118||0.102||0.101||0.1||0.099||0.099||0.097,0.2,0.2,0.13333333333333333
221,Mol_Genet_Genomics-4-1-2413074.txt,cell wall||phylogenet analysi||studi||homologu||present||strain||fungi||express||aspergilli||similar||gene||glucoamylas||alpha-amylas||glucan||starch||enzym||protein||analysi||starch-bind domain||member||group||famili||amyr||maltos||presenc||transfer||agdb||sequenc||function||result,aspergillu niger||amyr||A. niger A. niger||A. niger||A. niger aspergillu A. niger||niger genom||amyr amyr amyr amyr strain||A. niger A.||A. niger 2007 aspergillu A. niger||2 A. niger aspergillu A. niger||21 barker aspergillu niger aspergillu niger||keyword aspergillu niger||aspergillu||A. niger amya||gh13,0.431||0.369||0.367||0.367||0.349||0.306||0.299||0.294||0.291||0.291||0.289||0.287||0.275||0.264||0.259,0.2,0.1,0.06666666666666667
222,Bioinformation-2-2-2174422.txt,teck databas||telomer||entri||inform||centromer||chromosom||protein||databas||data||sequenc||cell,teck||teck databas||centromer||telomer||databas||centromer sequenc||sastra||teck databas home page||centromer pattern||centromer chromosom kinetochor protein||kinetochor||telomeras||centromer bind protein||telomer pattern||protein databas,0.522||0.379||0.361||0.284||0.236||0.231||0.221||0.218||0.19||0.185||0.166||0.158||0.152||0.152||0.151,0.8,0.4,0.26666666666666666
223,Dev_Genes_Evol-4-1-2292473.txt,insight||insect||constraint||artifact||element||data||organ||breakpoint||region||complex||cluster||express||hox||gene||transcript||beeman||analysi||hox gene||homc||hox cluster||regulatori element||embryon develop||singl imag||sequenc||function||result,tribolium||ptl tc-antp||ptl d60||ptl d60 ptl d60||ptl kt76 ptl d60||tc-antp ptl d60||transcript tribolium tribolium||tribolium 2005 tribolium||ptl kt76||dch-3 ptl d60||tc-antp tribolium Cx tc-scr||tc-antp ptl kt76||tc-antp Cx tc-scr ptl d60||tribolium hox cluster||hox,0.468||0.388||0.356||0.356||0.327||0.323||0.323||0.313||0.298||0.294||0.289||0.285||0.28||0.272||0.266,0.0,0.0,0.06666666666666667
224,Naunyn_Schmiedebergs_Arch_Pharmacol-3-1-2020506.txt,phosphoinositid||actin cytoskeleton||ra||gtpase||isoform||actin remodel||direct interact||actin organ||receptor||arf||pld||schmidt||stimul||enzym||protein||regul||rho||activ||synthesi||small gtpase||phosphatid acid||plasma membran||membran,phospholipas||phospholipas D1||phospholipas D2||mammalian phospholipas||norepinephrine-induc phospholipas||adp-ribosylation-factor-stimul phospholipas||toxin-b-inhibit phospholipas||rho-control phospholipas||phosphatidylcholine-specif phospholipas||yeast phospholipas||distinct phospholipas||cardiomyocyt phospholipas||phospholipas A2||keyword phospholipas||phosphatidylinositol,0.56||0.33||0.309||0.294||0.285||0.285||0.285||0.285||0.285||0.285||0.283||0.283||0.283||0.28||0.247,0.0,0.0,0.0
225,Eur_J_Appl_Physiol-4-1-2374881.txt,person||muscl||mmc||ambulatori statu||non-domin side||joint||major muscl group||health-rel fit compon||studi||valu||ankl joint||relat||test||larg group||skin-fold||strength||result||mobil||young adult||joint mobil||physic fit||exercis||activ||maxim exercis test||hydrocephalu||differ||muscl strength||adolesc||particip||health-rel physic fit||aerob capac||spina bifida||compon,aerob fit||aerob capac||mmc||fit||buffart||rehabil||myelomeningocel||health-rel fit||physic fit||aerob train||aerob power||health-rel physic fit||capac||roebroeck||increas aerob capac,0.21||0.193||0.178||0.166||0.153||0.149||0.149||0.145||0.142||0.142||0.139||0.136||0.132||0.13||0.13,0.4,0.3,0.26666666666666666
226,Eur_Arch_Otorhinolaryngol-4-1-2254466.txt,type||follow-up||case||surgic complic||surgic treatment||facial nerv||studi||recurr||rpa||patient||clinic featur||risk||nerv||multinodular||total||lesion||intervent||signific||multipl lesion||postop radiotherapi||pleomorph adenoma||tumor recurr rate||surgeri||prognost factor||tumor||parotidectomi||malign||previou oper||period,pleomorph adenoma||recurr pleomorph adenoma||adenoma||parotid gland||recurr||rpa||residu pleomorph adenoma||parotidectomi||gland||parotid surgeri||parotid benign||recurr benign parotid tumour||recurr tumor||recurr lesion||uninodular recurr,0.348||0.328||0.314||0.308||0.286||0.253||0.234||0.224||0.22||0.213||0.21||0.178||0.167||0.167||0.162,0.4,0.4,0.26666666666666666
227,Arch_Sex_Behav-3-1-2042031.txt,sexual behavior||unprotect sex||men||previou std diagnos||past 3 month||studi||oral sex||patient||abus characterist||std||effect||risk||forc||sex||adult||sexual risk behavior||analys||outcom||coercion||demograph||research||penetr||gender||characterist||experi||sexual partner||group||sexual abus||episod||number||abus||limit||partner||addit||hiv||sexual act,sexual abus||abus||adolesc sexual abus sexual||penetr sexual abus||childhood sexual abus||child sexual abus||adolesc sexual abus||sexual abus characterist||non-penetr sexual abus||sexual abus sever||sever sexual abus||sexual abus experi||sexual abus influenc||sexual abus group||sexual abus statu,0.647||0.614||0.502||0.477||0.458||0.448||0.443||0.438||0.435||0.434||0.434||0.434||0.433||0.433||0.432,0.4,0.2,0.13333333333333333
228,Virchows_Arch-4-1-2329727.txt,normal colon||epitheli cell||sdf-1||normal mucosa||carcinoma||adenoma||express||cell||hypoxia||hypox cell||mammalian target||tissu||mtor||surfac epithelium||activ||cytoplasm||pimonidazol||surfac||hif-1||presenc||sdf1||area||colorect carcinogenesi||CA IX||antigen retriev||akt||normal colon tissu||colorect mucosa,hif-1α||sdf-1||hif-1||hif-1α stain||adenocarcinoma hif-1α||hif-1α express||adenoma||peri-necrot hif-1α||colorect adenoma||hif-1α presenc||colorect mucosa||hif-1α pattern||nuclear hif-1α||sdf-1 stain||mtor,0.405||0.297||0.258||0.256||0.25||0.234||0.225||0.223||0.222||0.215||0.21||0.208||0.207||0.202||0.201,0.4,0.3,0.3333333333333333
229,Osteoporos_Int-4-1-2277453.txt,placebo||vertebr fractur||data||studi||bone microarchitectur||osteopenia||patient||effect||risk||risk reduct||femor neck||fractur||postmenopaus women||treatment||advers event||bmd||women||nonvertebr fractur||low bone mass||analysi||popul||risedron||preval vertebr fractur||osteoporosi||fragil fractur||trial||trabecular architectur||fractur risk,fractur||risedron||vertebr fractur||nonvertebr fractur||fragil fractur||fragil fractur fragil fractur||fractur risk||osteoporot fractur||preval fractur||fractur efficaci||leg fractur||ankl fractur||subtrochanter fractur||fractur outcom||fractur type,0.576||0.441||0.373||0.371||0.369||0.369||0.319||0.315||0.311||0.303||0.303||0.297||0.295||0.292||0.289,1.0,0.6,0.4
230,Histochem_Cell_Biol-4-1-2413111.txt,mutant form||cancer||inflamm||endotheli cell||tj||ion select||role||TJ assembl||breast cancer develop||data||tight junction strand||patient||occludin||permeabl||observ||increas||toxin||diabet retinopathi||barrier||express||evid||cell||transmembran protein||integr membran protein||barrier dysfunct||tight junction||protein||brb||factor||paracellular pathway||diseas||claudin||molecular composit||cell polar||function||TJ strand,tight junction||junction||occludin||tight junction barrier||tight junction permeabl||tight junction strand||epitheli tight junction||tight junction protein||tight junction claudin-14||tight junction alter||tight junction dysfunct||osp-bas tight junction||freeze-cleav tight junction||cation-select tight junction||discontinu tight junction,0.418||0.383||0.345||0.329||0.315||0.308||0.305||0.297||0.286||0.284||0.283||0.282||0.282||0.282||0.28,0.4,0.3,0.2
231,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2292474.txt,measur||endogen insulin level||baselin||studi||somatostatin||healthi subject||ere||optic coher tomographi||hyperglycemia||peripher area||retina||glucos||blood retina barrier||maxim hyperglycemia||subject||chang||retin thick||blood glucos level||refract error||procedur||area||fovea||diabet retinopathi||result,hyperglycemia||refract||retin thick||thick||diabet||diabet retinopathi||normo-insulinaem hyperglycemia||ocular refract||coher tomographi||retin thick measur||optic coher tomographi||acut hyperglycemia||hypo-insulinaem hyperglycemia||macular thick||reproduc hyperglycemia,0.358||0.316||0.276||0.223||0.214||0.207||0.203||0.2||0.197||0.195||0.194||0.192||0.191||0.19||0.19,0.4,0.3,0.26666666666666666
232,Matern_Child_Health_J-2-2-1592139.txt,program||case||preconcept||diabet||birth||individu||pregnanc||data||studi||effect||birth defect||invest||investig||intervent||perspect||analys||cost||evalu||preconcept care||women||preconcept visit||servic||care||advers pregnanc outcom||prenat care||public health program||econom evalu||health care provid||case studi||econom burden||financi return||busi case||cost-benefit analysi||health outcom||benefit||health plan||outcom||result,preconcept||preconcept care||preconcept visit||cost||preconcept care visit||preconcept care servic||comprehens preconcept care||preconcept care intervent||preconcept care group||care||preconcept care prevent servic||actual preconcept care initi||health cost||financi cost||health care,0.579||0.413||0.311||0.294||0.29||0.289||0.287||0.285||0.279||0.248||0.225||0.215||0.213||0.209||0.19,0.8,0.5,0.3333333333333333
233,J_Chem_Ecol-4-1-2292484.txt,mechan damag||level||jasmon acid||terpenoid aldehyd||induct||total foliag||data||studi||comparison||young leav||effect||increas||gland number||higher concentr||signific||herbivori||leav||analys||individu leaf||treatment||damag||control||mechan injuri||leaf||cotton||simul herbivori||accumul||monoterpen||true leav||differ||total terpenoid||anova||number||gland||sesquiterpen||terpenoid||plant,terpenoid||cotton||cotton plant||plant||cotton gossypium hirsutum||cotton gossypium||spodoptera||gossypium hirsutum||cotton plant entomol||plant herbivor||H. terpenoid||minor cotton terpenoid||terpenoid aldehyd||spodoptera littorali||cotton leav,0.316||0.27||0.261||0.252||0.232||0.225||0.22||0.214||0.204||0.2||0.2||0.198||0.197||0.196||0.188,0.6,0.3,0.26666666666666666
234,Breast_Cancer_Res_Treat-3-1-2137942.txt,independ predictor||case||mast cell||surviv curv||core||breast cancer||studi||patient||ER score||statist analysi||MC infiltr||tma||invas breast cancer||cell||immun cell||train||prognosi||mc||total number||group||tumor||surviv||presenc||number||good prognosi||stroma||result,mast cell||mc||stromal mast cell||mast cell chymas||chymase-posit mast cell||stromal mc||mast cell secret||stromal mast cell correl||breast cancer||human mast cell chymas||her2||kosma VM mast cell||invas breast cancer||mast cell diseas leuk||kovanen PT mast cell chymas,0.286||0.254||0.236||0.224||0.199||0.195||0.193||0.184||0.181||0.169||0.159||0.151||0.149||0.148||0.148,0.4,0.3,0.26666666666666666
235,Matern_Child_Health_J-2-2-1592152.txt,prevent||condit||preconcept||dime birth defect foundat||profession practic guidelin||reproduct awar||health care profession||perinat period||medic condit||pregnanc||histori||patient||folic acid||perinat outcom||health statu||risk||organ||reproduct||specif type||preconcept assess||medic||nurs||unit state||profession||counsel||guidelin||health||health care||women||american colleg||effort||preconcept health||famili physician||standard||main perinat prevent strategi||servic||care||commit||poor pregnanc outcom||genet||committe||import||medicin||screen||preconcept health servic||decad||acog||diseas||nation organ||object||preconcept screen||current statu||fetal alcohol syndrom||outcom,preconcept||preconcept care||preconcept health||pregnanc||preconcept counsel||preconcept servic||preconcept screen||preconcept visit||preconcept carrier||preconcept curriculum||preconcept health care||preconcept period||annual preconcept||preconcept assess||preconcept movement,0.573||0.372||0.363||0.347||0.339||0.318||0.314||0.314||0.309||0.304||0.299||0.297||0.295||0.291||0.291,0.6,0.4,0.3333333333333333
236,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2292470.txt,condit||measur||line||asthenopia||fixat cross||prism||artifici view condit||comfort||interv||session||valu||fusion vergenc||observ||test||fixat dispar||heterophoria||stimuli||eye||fusion contour||paramet||natur view condit||phoria paramet||comfort prism||deviat||noniu line||differ||eso||phoria||feedback loop||trial,phoria||dissoci phoria||prism||phoria condit||phoria paramet||phoria valu||comfort prism||dissoci phoria condit||comfort||eso||comfort prism differ||comfort prism 2||prism power||rotari prism||prism dioptr,0.676||0.42||0.41||0.35||0.344||0.342||0.33||0.287||0.249||0.233||0.221||0.22||0.216||0.213||0.212,0.6,0.6,0.4
237,Doc_Ophthalmol-4-1-2235911.txt,array||measur||commerci system||time||iscev guidelin||artifact||element||data||patient||stimulu||mferg respons||reliabl mferg record||region||clinic electrophysiolog||signal||mferg trace||retina||frame||frame frequenc||display||normal||light||report||mferg||electr nois||trace||record||fixat||size||clinic multifoc electroretinographi||procedur||local amplitud||area||waveform||record time||result,mferg||mferg record||mferg amplitud||mferg trace||stimulu||mferg respons||mferg signal||clinic mferg||mferg result||mferg trace array||stimulu element||reliabl mferg record||stimulu hexagon||typic mferg display||stimulu array,0.531||0.344||0.325||0.322||0.303||0.296||0.291||0.275||0.266||0.253||0.236||0.233||0.225||0.212||0.209,0.6,0.4,0.3333333333333333
238,Ann_Surg_Oncol-3-1-1914276.txt,van nuy classif||mammographi||tissu microarray||PR express||biolog marker express||studi||patient||van nuy||interv group||PR neg||dci||immunohistochemistri||nonattend||neu express||express||two-year interv||suffici paraffin-embed tissu||screen-detect||multivari analysi||group||differ||woman||interv dci||screen round||screen||patholog||tma group||score||chi-squar analysi,dci||screen-detect dci||screen-detect||interv dci||high-grad dci||low-grad dci||pure dci||dci lesion||screen-detect versu interv dci||screen-detect patient||screen-detect 95||ductal carcinoma||situ||situ carcinoma||interv ductal carcinoma,0.653||0.512||0.371||0.369||0.341||0.339||0.332||0.33||0.278||0.204||0.195||0.189||0.163||0.154||0.154,0.6,0.3,0.2
239,Exp_Brain_Res-4-1-2335293.txt,condit||target||measur||color||time||respons||line||veloc||attribut color||latenc||visual process||lumin||orient||basi||finger||averag||shape||curv||subject||chang||systemat differ||differ||order||refer||posit||attribut||conspicu||particip||movement||hand movement||slope,latenc||target||veloc||respons latenc||target lumin||conspicu target||shorter latenc||movement||short latenc||averag respons latenc||target posit||jump||lumin||conspicu||veloc curv,0.401||0.273||0.271||0.25||0.225||0.223||0.219||0.214||0.211||0.195||0.192||0.18||0.178||0.173||0.171,0.6,0.4,0.4
240,Int_Arch_Occup_Environ_Health-4-1-2254471.txt,elderli employe||depress symptom||men||return||studi||depress||year||social legisl||median||occup health depart||durat||compani||depress episod||compani size||dutch situat||sector||absenc||day||educ||health care||psychiatr disord||sick-leav||age||popul||employe||group||differ||part-tim return||episod||industri sector||number||symptom||work||higher risk||period,"employe||depress employe||depress||employe sick absenc||absenc||employe return||depress men||depress episod||5,000 employe||depress symptom||depress women||dutch employe||sector||absent employe||sick absenc",0.416||0.394||0.373||0.289||0.269||0.267||0.262||0.246||0.245||0.24||0.236||0.234||0.23||0.23||0.226,0.6,0.5,0.4
241,Breast_Cancer_Res_Treat-3-1-2001220.txt,cancer||target||letrozol||ER overexpress||breast cancer||combin||studi||tamoxifen||patient||clinic||effect||microarray gene||agent||aromatas inhibitor||express||tool||treatment||cell||growth||therapi||growth factor||gene||adjuv therapi||tumor biolog||trastuzumab||recent advanc||breast tumor||combin therapi||estrogen||resist||tumor||trial||pathway||biomark,letrozol||letrozol breast cancer||her2 letrozol||inhibitor letrozol||breast cancer||breast cancer breast cancer||mtor letrozol||letrozol eur||long-term letrozol||bcr-abl letrozol||igfbp letrozol||vegf letrozol||letrozol 62||letrozol result||cancer,0.584||0.413||0.351||0.339||0.328||0.328||0.326||0.301||0.298||0.297||0.297||0.295||0.294||0.292||0.286,0.4,0.2,0.2
242,Exp_Appl_Acarol-3-1-2039815.txt,variat||dna sequenc||host plant associ||coi||host plant||tetranychid mite||base frequenc homogen||phylogenet analysi||sampl||studi||genu||parasit||dataset||mitochondri coi phylogeni||pattern||dna||gene||phylogeograph pattern||speci delin||analysi||barcod||tetranychida||identif||reproduct parasit||taxa||select sweep||access||spider mite||posit||evolutionari relationship||speci||paup||mite||sequenc||genbank||nuclear||result,tetranychu urtica||tetranychu||spider mite tetranychu urtica||tetranychida||tetranychu urtica koch||tetranychu kanzawai||1998 tetranychu tetranychu||tetranychu urtica complex||tetranychu cinnabarinu||mite||tetranychu speci||barcod||tetranychu kanzawai tetranychu truncatu T.||acari||tetranychu amphitetranychu,0.414||0.411||0.315||0.289||0.286||0.278||0.277||0.277||0.273||0.263||0.248||0.243||0.24||0.233||0.226,0.2,0.2,0.2
243,Calcif_Tissue_Int-3-1-2151961.txt,lifestyl||men||spine||studi popul||data||studi||genotyp||gene||bmd||bodi||analysi||age||associ||polymorph||subject||activ men||popul||low-dens lipoprotein receptor-rel protein 5||peak bone mass||differ||bone||fat mass||signific differ||particip||bodi height||bone miner densiti||bodi mass,lrp5||NS||bone||lrp5 polymorph||lrp5 genotyp||0.07 NS NS||bmd||val667met||bone miner||lrp5 gene||ala1330v||val667met polymorph||bone mass||bone densiti||polymorph,0.332||0.29||0.25||0.249||0.22||0.204||0.203||0.203||0.199||0.193||0.184||0.184||0.168||0.167||0.166,0.2,0.2,0.2
244,Matern_Child_Health_J-2-2-1592146.txt,public health concern||risk||obes||women||postpartum||birth outcom||age||prevent studi||activ||pregnanc||intervent||bmi||weight trend||nutrit||overweight,overweight||obes||matern overweight||postpartum||pregnanc||siega-riz||matern obes||matern||pregnanc weight gain||adolesc overweight||matern pre-pregn overweight||women||matern weight gain||keyword obes nutrit women pregnanc postpartum||obes epidem,0.297||0.267||0.243||0.238||0.238||0.235||0.228||0.189||0.182||0.179||0.176||0.169||0.166||0.164||0.158,0.8,0.4,0.3333333333333333
245,Pediatr_Nephrol-4-1-2413093.txt,podocyt||slit diaphragm||lmx1b,lmx1b||lmx1b lmx1b||lmx1b lox||lmx1b gene||johnson RL lmx1b lmx1b||lmx1b ldb1 e2a||podocyt||lmx1b cre nphs2 bar||lim-homeodomain transcript factor lmx1b||nphs2||knoer nvam gubler m-c lmx1b target||podocyt filtrat||podocyt differenti||glomerular slit||nephrin,0.753||0.753||0.409||0.391||0.386||0.266||0.248||0.239||0.205||0.178||0.151||0.13||0.128||0.111||0.089,0.2,0.2,0.13333333333333333
246,Ann_Surg_Oncol-3-1-2039827.txt,delay||dlt||week||maximum-toler dose||phase II studi||studi||patient||endopelv fascia||total||radiotherapi||dose||local recurr rate||day||chemoradi||surgeri||capecitabin||tumor||oxaliplatin||resect||pcr||rectal cancer||treatment cycl||result,oxaliplatin||rectal cancer||capecitabin||preoper oxaliplatin||rectal perfor||rectal cancer patient||advanc rectal cancer||T3||radiotherapi||poor-risk rectal cancer||irresect rectal cancer||rectal cancer int||rectal cancer Br||preoper radiotherapi||weekli oxaliplatin,0.324||0.275||0.259||0.245||0.203||0.201||0.198||0.195||0.193||0.188||0.188||0.187||0.184||0.18||0.179,0.6,0.4,0.26666666666666666
247,Ann_Surg_Oncol-4-1-2277454.txt,grade||fasciotomi||normal tissu||ilp||radiat||surgic resect||studi||patient||perfus||st||major therapeut intervent||medic intervent||treatment procedur||long-term morbid||manag||item||irrevers function damag||extrem||tissu||sever symptom||late effect||tumor||neg impact||limb||sever||ebrt||object||soft tissu sarcoma||daili activ,0 0||atrophi 0 0||object 0 0||extrem sarcoma||limb||tissu sarcoma||limb perfus||soft-tissu sarcoma||perfus||soft tissu sarcoma||multipl sarcoma||isol limb perfus||hypertherm isol limb perfus||melphalan||advanc soft tissu sarcoma,0.482||0.339||0.335||0.228||0.218||0.209||0.204||0.198||0.191||0.184||0.17||0.162||0.151||0.147||0.146,0.2,0.3,0.2
248,Anal_Bioanal_Chem-4-1-2287205.txt,FP detect||measur||gradient hplc system||system||affin||hr||concentr||optim||wavelength||assay||coumestrol||on-lin||phytoestrogen||compound||mixtur||meoh||hr system||experi||min||organ modifi||decreas||fia||fluoresc||competit bind curv||test compound||hplc||mode||fluoresc polar||result,erα||erα affin||erα bioaffin||erα lbd||e2-f||erα concentr||individu erα||erα FP rad||erα affin detect||fia||erα ligand E2||erα affin 6||erα affin 3||erα affin 2||individu erα bioaffin,0.583||0.35||0.341||0.329||0.316||0.311||0.296||0.279||0.241||0.24||0.235||0.233||0.233||0.233||0.231,0.0,0.1,0.06666666666666667
249,Photosynth_Res-4-1-2173912.txt,array||structur||red alga||width||phycobilisom||cyanobacteria||project||pbss||psii||pb||electron microscopi||membran,phycobilisom||cyanobacteri phycobilisom||phycobilisom diffus||phycobilisom size||phycobilisom model||phycobilisom method||photosystem||red algal phycobilisom||red alga porphyridium cruentum||discuss porphyridium cruentum||mullineaux CW phycobilisom mobil||red alga porphyridium||psii||thylakoid||photosystem II,0.554||0.317||0.284||0.282||0.278||0.278||0.27||0.222||0.205||0.192||0.18||0.163||0.156||0.156||0.151,0.2,0.1,0.13333333333333333
250,Int_J_Cardiovasc_Imaging-3-1-2121121.txt,heart failur,atrial function||atrial contribut||left atrial size||left atrial volum||left atrial perform||left atrial eject forc||atrial systol function||atrial function increas||left atrial function eur heart||left atrium||dernelli||toutouza||stefanadi||left ventricular function||heart,0.324||0.32||0.276||0.274||0.269||0.263||0.242||0.22||0.194||0.176||0.15||0.15||0.142||0.131||0.126,0.0,0.0,0.0
251,J_Magn_Reson-2-1-2323944.txt,equat||human brain||magnet transfer||duti cycl||optim||CW approxim||data||model||acquisit sequenc||excit puls||valu||standard deviat||two-pool model||effect||sensit||test||signal||similar||sled||paramet||solut||estim||experi||simul||flip angl||consist||ramani||CW variant||nois||excit flip angl||magnet||result,sled||rfb||τ sat||sat||RM||rfb RM 0||RM 0||0||0 0||ω cwpe||ramani||equat||vivo RM 0||1 τ sat||2.3 sled,0.301||0.251||0.237||0.235||0.225||0.222||0.208||0.191||0.191||0.189||0.184||0.184||0.17||0.158||0.158,0.2,0.1,0.2
252,J_Med_Internet_Res-4-2-1761933.txt,web site qualiti||time||url||search engin||qualiti||locat||studi||medic topic||internet archiv||specif health-rel topic||site locat||inform||temporari server problem||health claim||site||health inform||address field||content||page||web||web page||uncertain period||item||web content||previou studi||attrit||topic||access||refer||issu||world wide web||viewer||health-rel web site||medic knowledg||result,web||web site||url||web archiv||web page||health-rel web site||web site viewer||web site qualiti||web content||184 web site||access web site||web technolog||attrit||current web||origin web site,0.608||0.446||0.366||0.344||0.339||0.331||0.33||0.324||0.315||0.311||0.31||0.309||0.308||0.306||0.306,0.6,0.6,0.4666666666666667
253,Behav_Genet-4-1-2226020.txt,social interact effect||measur||find||phenotyp correl||attent problem||instrument||rate||problem||data||model||dsm||zygos||effect||correl||missing||test||variabl||cbcl||present paper||sex||environment influenc||present studi||specif||fit||item||varianc||twin||age||dsm-iv interview||cprs-r||age 12||genet||matern rate||clinic diagnos||factor||statist analys||influenc||statist power||adhd||score||children||result,cbcl||cprs-r||cbcl score||cbcl rate||cbcl question||cbcl measur adhd||twin||adhd||cbcl AP score||longitudin cbcl score||cbcl age 7||dsm cbcl age 7||twin zygos twin||dsm||dsm-iv adhd,0.59||0.338||0.316||0.31||0.298||0.285||0.279||0.251||0.217||0.215||0.214||0.208||0.196||0.191||0.182,0.4,0.4,0.3333333333333333
254,Eur_J_Pediatr-4-1-2292482.txt,epp||photosensit||girl||erythropoiet protoporphyria||symptom||nose||children||cutan manifest||age||porphyria||sever||sun exposur||liver enzym||diagnosi||patient||skin lesion||skin symptom||protoporphyrin,protoporphyria||erythropoiet protoporphyria||erythropoiet protoporphyria Br||domin erythropoiet protoporphyria||erythropoiet protoporphyria eur||epp||porphyria||erythropoiet protoporphyria-report||cutan porphyria||protoporphyria fech ferrochelatas ro||erytropoiet protoporphyria eur||young child-erythropoiet protoporphyria||protoporphyria current problem||erythropoiet protoprophyria-submicroscop event||hepat porphyria,0.549||0.513||0.348||0.346||0.346||0.283||0.275||0.249||0.197||0.194||0.194||0.191||0.187||0.167||0.145,0.2,0.3,0.2
255,J_Mol_Biol-2-1-2279256.txt,bind pocket||dtdp||activ site||case||wbmf||cofactor||studi||mutat||protein function||structur||site||gmer||wbmg||antigen||gene||reaction||potenti||triad||product||wbmh||catalyt site||residu||protein||side chain||sdr||blast||phosphat||2||pdb||bind||present time||mutant||posit||substrat||function||ump||deoxythymidin diphosph||lipopolysaccharid,wbmf||wbmf wbmg wbmh||wbmg wbmh wbmf wbmg||wbmh||wbmg wbmh||wbmg||wbmf wbmg wbmh B.||wbmf wbmg wbmh mutant||wbm wbm wbmf wbmg wbmh||bordetella bronchiseptica||wbmf structur||wbmf crystal||bordetella||incomplet wbmf||wbmf rel,0.483||0.397||0.383||0.365||0.353||0.342||0.316||0.303||0.299||0.293||0.265||0.249||0.246||0.244||0.243,0.4,0.3,0.2
256,Childs_Nerv_Syst-3-1-1849423.txt,capillari||intracrani complianc||puls pressur||csf||subarachnoid space||chronic hydrocephalu||ventriculostomi||theori||normal-pressur hydrocephalu||hydrodynam concept||view||etv||systol pressur||systol pressur transmiss||acut hydrocephalu||treatment||etiolog||dandi||cerebrospin fluid||csf pressur||pathophysiolog||hydrocephalu||brain parenchyma||narrow capacit vessel||patent aqueduct||complianc,hydrocephalu||hydrocephalu commun hydrocephalu||normal-pressur hydrocephalu||chronic hydrocephalu||acut hydrocephalu||hydrocephalu classif||intern hydrocephalu||hydrocephalu research||hydrocephalu greitz dan||normal pressur hydrocephalu||greitz||csf||minor pathway hydrocephalu||etv||normal pressur hydrocephalu Br,0.708||0.484||0.375||0.371||0.359||0.356||0.356||0.356||0.327||0.283||0.26||0.253||0.24||0.213||0.213,0.8,0.4,0.4
257,Eur_J_Pediatr-4-1-2254655.txt,mechan ventil||stay||week||case||respiratori distress syndrom||air leak||patient||cpap||air||pneumomediastinum||subcutan emphysema||infect||tissu||age||spontan PM||pneumopericardium||group||intens care unit||neonat||sever||diseas||lung||children,PM||neonat PM||neonat||spontan PM||pneumomediastinum||cpap||neonat air||icu PM||idiopath PM||spontan pneumomediastinum||neonat air leak||emphysema||4 PM||9 PM||5 PM,0.364||0.336||0.309||0.251||0.243||0.242||0.231||0.209||0.198||0.191||0.189||0.188||0.182||0.182||0.182,0.6,0.4,0.26666666666666666
258,Eur_J_Nucl_Med_Mol_Imaging-3-1-1914271.txt,effect||contrast agent||field||studi||imag||clinic arena||promis applic||specif inform||vessel wall||total plaqu burden||molecular imag||cardiovascular molecular imag||patient||therapi||cardiovascular diseas,imag||cardiovascular imag||molecular imag||molecular imag agent||cardiovascular molecular imag||cardiac imag||magnet reson imag||imag lamb||cardiovascular magnet reson imag||imag techniqu||fibrin-target contrast agent||contrast agent cardiovascular||reson imag predict||contrast-enhanc magnet reson imag||contrast agent,0.43||0.326||0.296||0.273||0.271||0.249||0.242||0.242||0.237||0.219||0.207||0.202||0.197||0.194||0.193,0.6,0.3,0.26666666666666666
259,J_Autism_Dev_Disord-4-1-2226079.txt,permeabl||autism||ratio||hyperserotonemia||blood sampl||platelet||serotonin||test||sat||studi||pdd||urin||intestin permeabl||patient||children,plt||curaçao||plt 5-ht||serotonin||autism||intestin permeabl||permeabl||kema||increas plt 5-ht||platelet serotonin||S. intestin permeabl||abnorm intestin permeabl||increas intestin permeabl||normal intestin permeabl||A. autism,0.258||0.254||0.236||0.211||0.21||0.201||0.194||0.172||0.163||0.152||0.15||0.144||0.141||0.136||0.136,0.4,0.4,0.26666666666666666
260,Skeletal_Radiol-3-1-2042032.txt,prospect studi||find||week||radiograph||incident find||abnorm||non-acut knee symptom||histori||studi||year||patient||bone marrow edema||articular surfac lesion||diagnos||radiologist||convent radiograph||magnet reson imag||non-acut knee problem||knee radiograph||loos bodi||young adult||group||osteoarthr||symptom||enchondroma||knee||signific differ,radiograph||mri||knee radiograph||mri 1 radiograph||patient radiograph||radiograph diagnos||convent radiograph||standard radiograph||unnecessari radiograph||conclus radiograph||recent radiograph||normal radiograph||knee||underw mri||mri evalu,0.519||0.409||0.387||0.309||0.291||0.278||0.274||0.269||0.265||0.262||0.261||0.261||0.254||0.211||0.21,0.4,0.3,0.26666666666666666
261,Breast_Cancer_Res_Treat-3-1-2137941.txt,tumour||age 50||cancer||breast tumour||cbc||missens variant||women||spectrum||studi||carrier||analysi||variant||age||atm||radiotherapi||ubc||breast cancer||mutat||treatment||patient,atm||atm 2 atm atm||llc 2007 atm atm atm atm||atm atm atm tabl 2 atm||atm atm missens variant||atm mutat||chek2 atm atm genotyp||atm heterozygot||atm haplotyp||atm function||atm atm missens mutat spectrum||atm missens mutat||atm missens variant||mutat analysi atm atm mutat||atm sequenc variant,0.873||0.655||0.584||0.582||0.524||0.498||0.445||0.442||0.44||0.439||0.425||0.411||0.408||0.399||0.334,0.2,0.1,0.06666666666666667
262,Pediatr_Radiol-3-1-1915603.txt,oper find||find||boy||children||viabl abdomin test||studi||patient||test||abdomen||re-examin||testi||npt||testicular posit||udt||laparoscopi||surgeri||surgic procedur||posit||physician||paediatr surgeon||result,npt||inguin testi||testi||152 npt||156 npt||true’ npt||118 npt||presum npt||49 npt||30 npt||nonpalp inguin testi||palpabl testi||undescend testi||impalp testi||inguin canal,0.589||0.322||0.312||0.306||0.303||0.303||0.299||0.299||0.298||0.297||0.276||0.236||0.23||0.211||0.206,0.4,0.2,0.13333333333333333
263,Virchows_Arch-3-1-1888715.txt,respons||partial cribriform prolifer||chi-squar test||reexcis||flat epitheli atypia||studi||patient||question||pathologist||interobserv variabl||criteria||atyp hyperplasia||lesion||adh||ductal intraepitheli neoplasia||signific||high proport||manag||resect margin||respond||number||invas carcinoma||duct||survey||diagnosi||breast||hyperplasia,dci||breast||pathologist||reexcis||ductal carcinoma||ductal lesion||breast lesion||ductal hyperplasia||ductal prolif breast lesion||duct||low-grad dci||invas ductal breast lesion||adh||expert breast pathologist||atyp ductal hyperplasia,0.362||0.287||0.27||0.252||0.238||0.232||0.225||0.225||0.212||0.206||0.205||0.203||0.203||0.197||0.195,0.6,0.4,0.3333333333333333
264,Soc_Sci_Med-2-1-2430159.txt,institut consult||find||depart||global economi||salari||practic||research consult||individu||problem||health-rel research||africa||govern depart||limit research capac||academ research||research programm||low univers salari||sub-saharan africa||northern||east africa||overhead||social scientist||research capac||global econom inequ||consult||institut||staff||health||ngo||research||social scienc capac||senior social scientist||contract||senior||report||uganda||agenc||local capac||interviewe||univers staff||donor,consult||zeleza||africa||capac||interviewe||research consult||consult research||uganda||nchinda||makerer||consult kwesiga||research capac||east africa||lansang||senior interviewe,0.242||0.214||0.201||0.201||0.181||0.179||0.179||0.173||0.172||0.172||0.164||0.159||0.157||0.155||0.153,0.6,0.5,0.4666666666666667
265,Int_J_Hematol-4-1-2330061.txt,cdna||cocultur||gene||cfc assay||defect||increas||stromal cell||mice||microarray||analysi||express||anim experi||hematopoiet stem cell||cell||hsc,pa6||pa6 cell||pa6 s-2 cell||pa6 subclon cell||pa6 cocultur microarray||pa6 cell line||pa6 s-12 3.2||chimer pa6 10.8||19.9 pa6 s-2 0.60||pa6 subclon cell 3||23.0 pa6 s-2 4||hsc||myeloid b-lymphoid t-lymphoid pa6 9||stromal cell||1110007f12rik forward,0.645||0.383||0.329||0.292||0.266||0.265||0.248||0.23||0.223||0.219||0.219||0.187||0.15||0.144||0.144,0.0,0.0,0.13333333333333333
266,Clin_Auton_Res-3-1-1858602.txt,attent||deficit||sampl||duschek||recent research||studi||hypotens individu||blood pressur||test||memori||clinic practic||hypotens||brain||cortic activ||cognit||brain perfus||relationship||eeg studi||lower limit||group||perform||limit||cognit test||cognit deficit||tonic brain perfus||cerebr blood flow||cognit perform||strong evid||addit,hypotens||schandri||chronic hypotens||duschek||orthostat hypotens||moder hypotens||40 hypotens||essenti hypotens||hypotens 26||hypotens 32||hypotens 25||hypotens 37||hypotens group||hypotens individu||hypotens int,0.481||0.333||0.256||0.249||0.247||0.247||0.244||0.244||0.243||0.243||0.242||0.242||0.242||0.242||0.242,0.4,0.2,0.2
267,Immunogenetics-3-1-1914291.txt,gene||rhesu macaqu||indian rhesu macaqu||clone||macaqu||evolut||loci||cynomolgu macaqu||vertebr speci||chines origin||polymorph||region configur||haplotyp||sequenc||allel,A1||A2||8822 A1||8765 A1||4053 A1||81 A1||77 A1||80 A1||88 A1||83 A1||mamu-a||mhc||0515 3 A1||0513 3 A1||3001 2 A1,0.526||0.275||0.272||0.268||0.268||0.266||0.265||0.264||0.264||0.264||0.249||0.206||0.191||0.188||0.187,0.0,0.0,0.0
268,Eur_J_Pediatr-4-1-2292480.txt,colchicin||fmf||amyloidosi||attack||famili mediterranean fever||month||patient||treatment||chest pain||anakinra,colchicin||anakinra||fever||colchicin resist anakinra||famili mediterranean fever||fever attack||fmf||famili mediterranean fever protein||famili mediterranean fever patient||period fever||recurr fever attack||springer-verlag 2007 colchicin||ozdogan||triest||fmf resist,0.446||0.346||0.328||0.28||0.221||0.22||0.192||0.17||0.169||0.167||0.155||0.155||0.144||0.122||0.12,0.6,0.4,0.26666666666666666
269,Intensive_Care_Med-3-1-2092441.txt,mechan||mortal||control||acut respiratori distress syndrom||criteria||ali||children||studi||ard||acut lung injuri||incid||diseas||cd||patient||unit||admiss||high morbid||syndrom||result,cd||ventil cd||ard||ali||24 cd||conclus cd||syndrom||respiratori||ard criteria||acut respiratori distress syndrom||ventil patient||ventil set||acut lung injuri||ident ventil||acut respiratori failur,0.469||0.345||0.294||0.267||0.238||0.237||0.191||0.19||0.159||0.153||0.127||0.119||0.116||0.116||0.115,0.6,0.5,0.4
270,Diabetologia-4-1-2292423.txt,paee||type 2 diabet||follow-up||measur||level||triacylglycerol||diabet||reduct||individu||bodi size||total bodi movement||baselin||data||year||bmi||risk||hdl-cholesterol||increas||systol blood pressur||metabol subcompon||metabol syndrom||variabl||analys||fit||zm||glucos||accelerometri||metabol risk||associ||chang||activ||aerob fit||differ||score||height||physic activ||waist circumfer||particip||statist signific,paee||metabol||ekelund||proactiv β||mathop||text||proactiv trial||proactiv cohort||proactiv UK||proactiv particip||proactiv 18||1 proactiv||fit||metabol syndrom||waist circumfer,0.125||0.116||0.113||0.103||0.095||0.095||0.094||0.089||0.089||0.087||0.084||0.084||0.081||0.081||0.078,0.2,0.1,0.26666666666666666
271,Breast_Cancer_Res_Treat-4-1-2217623.txt,effect||risk||gene||entri||differ||case||age||variant||polymorph||popul||meta-analys||data||breast cancer||studi||estrogen receptor||result,pvuii||xbai||2 pvuii xbai pvuii||meta-analysi pvuii xbai||xbai pvuii 13||result pvuii xbai||method pvuii xbai polymorph||eralpha pvuii||pvuii rflp||pvuii restrict||0.05 pvuii||xbai 1||eralpha xbai polymorph||tabl 2 pvuii xbai genotyp||llc 2007 background pvuii xbai polymorph,0.558||0.533||0.412||0.377||0.364||0.364||0.325||0.301||0.288||0.282||0.281||0.266||0.261||0.23||0.22,0.0,0.0,0.0
272,Cancer_Immunol_Immunother-4-1-2253649.txt,cancer||clinic impact||studi||patient||hla||colon||stromal cell||immunohistochemistri||low||analys||impact||prognosi||local recurr||group||tumor||surviv||differ||low express||number||total absenc||rectal cancer||irradi||msi||hla express||result,hla||hla class||hla express||hla allel||down-regul hla class||total hla class||non-class hla class||hc10 antibodi hca2 hc10 hla class||hca2||hc10||class||affect total hla class||keyword immunolog hla class||tumor||rectal tumor,0.636||0.453||0.366||0.324||0.317||0.308||0.307||0.295||0.279||0.279||0.27||0.232||0.229||0.222||0.195,0.4,0.2,0.2
273,Virchows_Arch-3-1-1888720.txt,cancer||case||icc||data||studi||seri||valu||clinic outcom||patient||neg control||high homogen||immunohistochemistri||express||cell||multivari analysi||liver cirrhosi||immunohistochem||apoptosi||surviv||antibodi demonstr||cholangiocarcinoma||liver fluke infest||tumour cell,cox-2||cox-2 express||cox-2 overexpress||cox-2 antibodi||R2 cox-2||cholangiocarcinoma||cox-2 moder||cox-2 inhibitor||0.095 cox-2||cox-2 counteract||cox-2 gene||cox-2 protein express||cox-2 express 18.7||specif cox-2 immunostain||icc,0.604||0.33||0.326||0.323||0.319||0.318||0.317||0.311||0.31||0.309||0.308||0.224||0.224||0.222||0.2,0.0,0.1,0.13333333333333333
274,Matern_Child_Health_J-2-2-1592246.txt,infant||behavior||birth||pregnanc||matern||state||perinat outcom||effect||risk||medicaid||primari care provid||profession organ||matern mortal||unit state||deliveri||intervent||evid||primari care||health||preconcept care||women||age||matern complic||servic||prenat care||american academi||pregnanc outcom,preconcept||preconcept servic||preconcept health||preconcept care||obstetrician||gynecologist||pregnanc||preconcept intervent||servic||preconcept risk||prevent servic||rubella||women||women health||health,0.304||0.243||0.226||0.212||0.207||0.207||0.197||0.187||0.182||0.164||0.164||0.16||0.158||0.153||0.147,0.2,0.3,0.3333333333333333
275,J_Mol_Med-4-1-2374880.txt,effect||renin level||tissu angiotensin gener||bind||blockad||prorenin||activ site||renin receptor||renin inhibitor||renin inhibit||enzymat activ||tissu||receptor||site||function||renin||low pH||vitro studi||activ||gener,prorenin||renin||prorenin receptor||prorenin bind||danser ahj prorenin||prorenin activ||high-affin prorenin||plasma prorenin||prorenin disappear||prorenin molecul||releas prorenin||prorenin concentr||renin receptor||renin receptor renin renin angiotensin system||danser ahj prorenin induc,0.686||0.48||0.38||0.361||0.36||0.356||0.354||0.347||0.347||0.345||0.345||0.344||0.277||0.273||0.272,0.4,0.2,0.2
276,Graefes_Arch_Clin_Exp_Ophthalmol-3-1-2082068.txt,eog channel||glaucoma||preval||ocular blood flow||high preval||visual field defect||studi||patient||nerv fiber layer thick||polysomnographi||ahi||apnea-hypopnea index||posit correl||optic nerv perfus defect||control||systol blood veloc||iop||obstruct sleep apnea syndrom||RI increas||factor||group||intracrani pressur increas||ophthalm arteri||sever osa group||oari||risk factor||sever||crari||result,glaucoma||apnea||sleep apnea||sleep||osa||normal-tens glaucoma||glaucoma patient||normotens glaucoma||glaucoma preval||open-angl glaucoma||sleep apnea syndrom||obstruct sleep apnea||s00417-007-0656-8 glaucoma||secondari glaucoma||pre-exist sleep apnea,0.49||0.36||0.348||0.336||0.31||0.287||0.278||0.265||0.265||0.263||0.261||0.259||0.255||0.249||0.236,0.2,0.1,0.06666666666666667
277,Crit_Care-6-3-137445.txt,cathet||case||complic||femor arteri||pseudoaneurysm||rate||studi||haemodynam monitor||patient||radial arteri||arteri cathet||sepsi||risk||site||radial||infect||axillari arteri||ischaem damag||paper||dorsal pedi||incid||present review||brachial||arteri||temporari occlus||report||arteri cannul||factor||patient popul||risk factor,cannul||arteri cannul||radial arteri cannul||arteri||radial arteri||radial||radial arteri cathet||percutan radial arteri cannul||long-term radial arteri cannul||arteri cathet||arteri cannul site||radial arteri monitor||radial arteri pseudoaneurysm||radial arteri infect||arteri catheter,0.494||0.468||0.453||0.442||0.433||0.423||0.364||0.346||0.341||0.334||0.32||0.31||0.309||0.306||0.285,0.6,0.5,0.3333333333333333
278,Cancer_Causes_Control-2-2-1764594.txt,program||method||feder poverti level||mammographi screen||grante||breast cancer||data||state||breast cancer screen||year||screen rate||mammogram||provid||cervic cancer earli detect program||health insur||ethnic background||percentag||women||estim||poverti level||hispan origin||popul||poverti||servic||famili incom||prevent servic task forc||uninsur women||nation level||number||nation breast||race||elig||ethnic,women||elig women||nbccedp||elig||poverti||u.s. women||uninsur women||underinsur elig women||program elig||underserv women||low-incom women||incom elig||race nbccedp mammographi||hispan women||mammographi screen,0.29||0.266||0.242||0.242||0.222||0.2||0.193||0.19||0.179||0.176||0.174||0.168||0.166||0.164||0.161,0.6,0.4,0.3333333333333333
279,Matern_Child_Health_J-2-2-1592147.txt,pregnanc||smoke,quitlin||tobacco||smoke||telephon quitlin||state quitlin||nicotin||cigarett smoke||treat tobacco||nicotin tob||prevent cigarett smoke||morb mortal wkli rep 2004||morb mortal wkli rep 2005||pregnanc||tobacco user||annual smoke,0.313||0.273||0.246||0.229||0.199||0.196||0.187||0.171||0.168||0.156||0.15||0.149||0.148||0.144||0.142,0.2,0.1,0.13333333333333333
280,Histochem_Cell_Biol-3-1-2137940.txt,antibodi||morpholog||method||dna break||sentinel||apoptot cascad||staurosporin||probe||marker||cytochem techniqu||apoptot cell||tissu section||tunel assay result||light microscopi||necrosi||specif||cell||ssdna antibodi||wide varieti||transmiss electron microscopi||apoptosi||tunel assay||cell death||tissu||protein||electron microscopi||activ||import||caspas||mode||varieti||detect,apoptosi||taatj||apoptot cell||apoptosi assay||cardiomyocyt apoptosi||apoptosi detect||apoptosi taatj dougla||nuclear apoptosi||apoptosi reagent||scanti apoptosi||apoptosi occur||apoptosi 1998||term apoptosi||apoptot cell death||apoptosi exp cell,0.423||0.252||0.249||0.243||0.237||0.233||0.228||0.228||0.226||0.22||0.218||0.217||0.213||0.204||0.203,0.4,0.2,0.13333333333333333
281,Diabetologia-3-1-1781097.txt,pten||key regul||studi||insulin sensit||glucos toler test||primari myocyt||insulin signal||pancreat area||insulin||cell||insulin hypersensit||blood sampl||blood||glucos||insulin inject||mice||protein||activ||blood glucos level||glucos uptak||incub||haploinsuffici||inject||vivo,pten||interpret pten pten||method pten pten||2 pten pten||pten haploinsuffici||pten phosphatas||uptak pten||pten gene||triangl pten||pten activ||WT pten||18 pten||pten level||hypothesi pten||anim pten,0.829||0.554||0.554||0.553||0.444||0.431||0.43||0.422||0.421||0.42||0.419||0.418||0.417||0.417||0.417,0.2,0.1,0.06666666666666667
282,Environ_Health_Perspect-115-3-1849945.txt,author||level||lead||measur||occup||higher level||effect||current||worker||review||relat||stronger predictor||increas||acut effect||test||cognit function||health effect||adult||blood lead||dose||evid||sourc||blood||cognit||analysi||age||associ||current exposur||psychiatr symptom||cumul exposur||report||bone||exposur||consist||symptom||manual dexter||past||chronic effect||neurobehavior test score||cumul lead dose||function||outcom,lead||lead lead||lead exposur||tibia lead||al||lead dose||cumul lead exposur||cognit||patella lead||blood lead||occup lead exposur||cumul lead dose||bone lead||lead smelter||lead worker,0.375||0.375||0.294||0.28||0.264||0.259||0.258||0.255||0.251||0.25||0.25||0.235||0.235||0.227||0.223,0.2,0.3,0.26666666666666666
283,Appl_Microbiol_Biotechnol-4-1-2266783.txt,metabolit||biodegrad||monooxygenas||final volum||hydroxymucon semialdehyd||strain||organ||carbon||degrad||hydroquinon||batch cultur||energi||solid MM||cell||reaction||enzym||hydroxyquinol||sole sourc||growth substrat||reaction mixtur||activ||high-perform liquid chromatographi||fluorid||cultur||phenol||catechol||benzoquinon||substrat||pathway||tree||peak||cell-fre extract||intermedi||result,4-fp||4-fp monooxygenas||4-fp degrad||4-fp pathway||4-fp metabol||4-fp enrich||4-fp util||4-fp start||hydroquinon||4-fp monooxygenas reaction||4-fp monooxygenas activ||0.1 mM 4-fp||hydroxyquinol||2008 arthrobact arthrobact strain if1||4-fp liquid medium,0.567||0.334||0.325||0.298||0.295||0.294||0.287||0.285||0.263||0.234||0.225||0.221||0.218||0.208||0.203,0.0,0.1,0.13333333333333333
284,Plant_Mol_Biol-4-1-2238787.txt,type||seed||stress toler||level||atipk2β||transgen||relat||increas||test||inositol polyphosph kinas||continu white light||express||treatment||stress||gene||tobacco||transcript level||higher plant||alpha level||wild type||activ||abiot stress||toler||replic||western blot analys||salt||medium||plant||result,atipk2β||ipk2 atipk2β atipk2β||1 atipk2β arabidopsi atipk2β atipk2β||arabidopsi atipk2β||atipk2β arg82 arg82 arg82 atipk2β||atipk2β arg82 arg82||ipk2 atipk2β||protein atipk2β||atipk2β protein||method atipk2β||atipk2β 2||1999 2000 2000 atipk2β atipk2β||atipk2β 6 6 atipk2β 6||atipk2β atipk2β arabidopsi 2 fig. 2||plant,0.787||0.548||0.514||0.499||0.467||0.432||0.428||0.405||0.405||0.394||0.393||0.317||0.315||0.298||0.286,0.2,0.1,0.13333333333333333
285,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2190783.txt,condit||contour articular prosthet||osteochondr defect||data||studi||contact pressur||experiment studi||test||cartilag||articular compon||flush implant||implant result||sensor||medial femor condyl||ground||devic||implant||test condit||specimen||peak contact pressur||posit||full extens||stanc posit||knee||trial||articular cartilag defect||prosthesi||result,knee||cartilag||articular cartilag||knee joint||articular cartilag defect||articular||osteochondr defect||knee simul||femor articular cartilag||human knee||method knee||cartilag contact stress||defect||contact pressur||implant,0.352||0.274||0.246||0.242||0.222||0.217||0.212||0.194||0.191||0.181||0.177||0.176||0.174||0.174||0.172,0.6,0.4,0.4
286,J_Interv_Card_Electrophysiol-4-1-2262917.txt,cathet||time||system||sheath||accessori pathway||cathet tip||data||studi||patient||tip||artisan control cathet||ablat||human||magnet navig||forc||ablat cathet||cathet ablat||outer sheath||left femor vein||artisan||oper||robot ablat||steerabl guid cathet||map||cardiac arrhythmia||left atrium||radiat exposur||posit||remot cathet ablat||robot navig||procedur||effect remot navig||result twenti patient||laboratori,cathet||cathet ablat||ablat cathet||ablat||remot cathet ablat||robot cathet ablat||artisan cathet||robot remot cathet ablat||robot cathet||cathet ablat procedur||cathet ablat journal||cathet navig||robot ablat||cathet map||remot cathet ablat system,0.491||0.479||0.479||0.466||0.393||0.381||0.345||0.341||0.338||0.338||0.327||0.327||0.326||0.301||0.301,1.0,0.5,0.4
287,Microbes_Infect-2-1-2426737.txt,gene||sequenc||rab||express profil||parasit||apicomplexa||transcript||protein||rab gtpase||function||analysi||intracellular parasit||cluster||upstream region||motif||specif||vesicular traffic||famili,rab||P. falciparum rab rab||theileria plasmodia rab T. parva rab||theileria||rab T. parva P. falciparum rab||T. parva rab rab1a rab2 rab||rab gtpase||T. annulata T. parva rab T.||rab famili||abstract rab||essenti rab||9 rab||T. parva T. parva||T. parva||theileria parva mol,0.486||0.33||0.326||0.306||0.301||0.271||0.253||0.252||0.247||0.244||0.244||0.243||0.242||0.242||0.218,0.2,0.2,0.13333333333333333
288,Clin_Rheumatol-3-1-1847465.txt,rheumatoid arthriti||disabl||fibromyalgia,arthriti||rheumatoid arthriti||arthriti disabl||arthriti australia||life rheumatoid arthriti||arthriti care||fibromyalgia||disabl||II arthriti care||FM||sf-36||keyword disabl fibromyalgia qualiti||icf||australia||fibromyalgia syndrom,0.416||0.312||0.311||0.267||0.245||0.218||0.212||0.205||0.15||0.143||0.134||0.132||0.123||0.119||0.116,0.2,0.3,0.2
289,Pflugers_Arch-4-1-2226063.txt,level||integrin stimul||integrin function||ldh||releas||studi||intact ctni||viabl cardiomyocyt||integrin||assay||necrosi||cell||day||ldh activ||control||activ||ctni||incub||cultur||control cardiomyocyt||propidium iodid||chemiluminesc||cardiomyocyt||medium,grgd||ctni||grgd sdgrg grgd||grgd sdgrg||ctni 1 2 grgd grgd||ctni releas||ctni degrad||ctni assay||intact ctni||purifi ctni||discuss grgd||3 2 grgd grgd||fragment ctni||nanogram ctni||32 grgd grgd 25 sdgrg,0.548||0.533||0.452||0.404||0.326||0.309||0.298||0.283||0.28||0.275||0.274||0.274||0.274||0.273||0.272,0.2,0.2,0.13333333333333333
290,J_Muscle_Res_Cell_Motil-3-1-2045119.txt,iso-osmot ringer||find||increas||nerv fibr||diamet||conduct||osmolar||waveform||skelet muscl||local circuit current||earli surfac||membran potenti||conduct veloc||valu||constant||extracellular osmolar,osm||rm||frac||osmolar||document||theta||osm _ 2||extracellular osmolar||rm i2||rm sp||documentclass||12pt||amsmath||amsfont||mathrsf,0.123||0.076||0.073||0.067||0.062||0.059||0.049||0.048||0.047||0.046||0.046||0.046||0.046||0.046||0.046,0.2,0.2,0.13333333333333333
291,Pediatr_Nephrol-3-1-1805045.txt,plasmapheresi||allograft surviv rate||nativ kidney nephrectomi||rate||patient||LD graft||recurr||induct therapi||regimen||risk||subsequ report||cyclosporin||recurr rate||pre-op PP||esrd||remiss||nativ kidney||graft||incid||transplant||factor||report||recipi||fsg||graft surviv||clinic recurr||diseas||pediatr renal allograft recipi,fsg||recurr||post-transpl fsg||glomerulosclerosi||fsg keyword recurr||transplant||fsg spectrum||fsg impact||recipi||recurr focal segment glomerulosclerosi||focal glomerulosclerosi||segment glomerulosclerosi||focal segment glomerulosclerosi||post-transpl focal segment glomerulosclerosi||pediatr recipi,0.484||0.345||0.328||0.279||0.277||0.249||0.247||0.246||0.238||0.234||0.228||0.207||0.198||0.191||0.186,0.4,0.4,0.26666666666666666
292,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2292476.txt,prism||vergenc adapt,vergenc||vergenc adapt||tonic vergenc||vergenc system||vergenc adapt vergenc eye movement||prism||keyword prism binocular vergenc adapt||binocular vision||vergenc eye movement||adapt vergenc control||binocular dysfunct vergenc eye movement||heterophoria||binocular vision disord vergenc eye movement||fusion vergenc reserv||binocular dysfunct,0.51||0.303||0.264||0.256||0.249||0.248||0.231||0.219||0.213||0.203||0.196||0.19||0.183||0.179||0.17,0.2,0.2,0.13333333333333333
293,Eur_J_Appl_Physiol-3-1-2039775.txt,muscl||level||time||veloc||rate||upper arm-forearm||prolong test||standard deviat||ipl method||lower||effect||mup||lowest forc level||posit task||increas||forc||variabl||motor unit||within-subject standard deviat||dynam||MU activ||present studi||pv||mvc||sd-pv||motor unit potenti||load||dynam contract||paramet||declin||task||higher valu||experi||subject||skew||activ||mup frequenc||lower valu||initi phase||order||prolong dynam test||motor unit discharg||muscl fibr conduct veloc||posit||peak||peak frequenc||shift||load torqu,mup||mup veloc||veloc||mup propag veloc||peak veloc||lower mup veloc||within-subject mup||mup frequenc||conduct veloc||fast mup||mup activ||muscl conduct veloc||mvc||mvc mvc||propag veloc,0.425||0.406||0.387||0.287||0.279||0.276||0.259||0.24||0.234||0.228||0.224||0.223||0.221||0.221||0.218,0.4,0.3,0.26666666666666666
294,Int_Arch_Occup_Environ_Health-4-1-2413126.txt,level||case||atherosclerosi||chd||individu||studi||offic worker||carotid arteri||global stress level||correl||risk||scale||imt||stress||smoke||neg correl||work-rel stress||earli atherosclerosi||ldl||employe||healthi lifestyl||factor||sera||low decis latitud||presenc||work||plaqu||result,work-rel stress||stress||atherosclerosi||atherosclerosi atherosclerosi||job stress||imt||polish||perceiv stress||cope||psychosoci stress||stress work||work stress||consciou stress||stress manag||stress situat,0.319||0.319||0.237||0.237||0.23||0.215||0.2||0.198||0.196||0.188||0.185||0.185||0.172||0.166||0.165,0.6,0.4,0.26666666666666666
295,BMC_Genomics-5-_-375527.txt,match||set||measur||concentr||human promot||bind site||refseq||transcript factor||tfb||gene express||correl||human||threshold||z-transform||promot sequenc||regulatori region||promot||statist analysi||chromosom||cluster||signific||gene||cgi||approach||analysi||list||pwm||score||statist signific||matrix||sequenc||result,tfb||pwm||tfb cluster||cluster tfb||ap2 _ Q6||predict tfb||tfb predict||start _||genuin tfb||tfb concentr||tfb densiti||pwm match||matrix ap2 _ Q6||cgi-rel pwm||cgi-independ pwm,0.432||0.367||0.302||0.302||0.262||0.238||0.238||0.226||0.223||0.221||0.219||0.204||0.201||0.199||0.194,0.4,0.2,0.13333333333333333
296,Bioprocess_Biosyst_Eng-2-2-1705473.txt,condit||lower level||lactat overflow||level||case||lactat product||maxim glutam concentr||ldh||final stoppag||gdh||strategi||step chang||constant control||ferment process||metabol balanc||glutam product||metabol flux||enzym||ferment||glutam ferment||metabol flux analysi||activ||tca metabol flux||lactat||bmc||agit rate||tca cycl||glutam||balanc metabol control||oxygen concentr||result,glutam||glutam ferment||corynebacterium glutamicum||glutam metabol||ferment||hbox||corynebacterium||flux||glutam product||ldh||metabol flux||glutam ferment perform||glutam synthesi||glutam concentr||corynebacterium glutamicum 9114,0.31||0.265||0.242||0.237||0.22||0.22||0.204||0.2||0.186||0.186||0.183||0.178||0.173||0.173||0.172,0.6,0.5,0.4
297,Ann_Gen_Hosp_Psychiatry-2-_-162166.txt,attent deficit disord||auditori cortex||respons||auditori deficit||psychoacoust||electrophysiolog test||patient||dyslexia||speech stimulu||test||capd||disord||central auditori deficit||evalu||mental retard||paper||great varieti||central auditori process disord||disabl||mental disord||central auditori system,auditori||central auditori||auditori deficit||auditori deficits'||midlat auditori||auditori test||auditori cortex||auditori dysfunct||auditori hallucin||auditori abnorm||auditori pattern||auditori inform||central auditori disord||auditori process disord||central auditori deficit,0.667||0.394||0.366||0.356||0.356||0.353||0.351||0.346||0.342||0.341||0.338||0.334||0.316||0.291||0.285,0.2,0.2,0.2
298,Int_J_Colorectal_Dis-3-1-2039795.txt,sln procedur||sln||case||number||colon carcinoma||multi-centr studi||studi||ihc||lymph node||aberr lymphat drainag||micrometastas||procedur||result||sentinel lymph node||posit node||patient||multi-centr set||lymph node metastas||tumour cell||group,sln||node||lymph node||sentinel lymph node||lymph node micrometastas||sentinel||sln procedur||tumour-neg sln||colon||sentinel lymph node map||micrometastas||nonsentinel lymph node||lymph node metastas||sentinel node map||pericol lymph node,0.444||0.325||0.286||0.273||0.26||0.249||0.246||0.237||0.231||0.217||0.208||0.208||0.208||0.207||0.2,0.6,0.4,0.4
299,Obes_Surg-4-1-2226018.txt,person||vertic||follow-up||time||questionnair||neurotic||self-esteem||studi||year||patient||psychopatholog||psycholog variabl||follow-up assess point||bodi imag||norm group||relev norm group||respect||psychosoci function||psychosoci||gastroplasti||surgeri||weight||social anxieti||bariatr surgeri||morbid obes||extrem obes||signific differ||mix result||addit||score||signific improv||gener popul,gastroplasti||bariatr surgeri obe||psychosoci||bariatr surgeri||obes||obe surg obes surgeri||obes surgeri||laparoscop bariatr surgeri||obe 2003||bariatr surgeri behav||scl-90||obe surg 1997||vertic||psychosoci improv||keyword morbid obes bariatr surgeri vertic,0.31||0.223||0.21||0.198||0.184||0.17||0.149||0.143||0.137||0.135||0.129||0.127||0.126||0.126||0.125,0.6,0.3,0.26666666666666666
300,Invest_New_Drugs-3-1-2039853.txt,cancer||administr||studi||patient||mtd||atp||effect||infus||nurs||disord||side effect||dose||pre-termin cancer||chest discomfort||dyspnea||pre-termin cancer patient||medic supervis||cardiac ischemia||maximum dose||reason||home||presenc||lower mtd||day care center||cardiac disord||lung cancer||deep breath,infus||atp infus||atp||subsequ atp infus||atp infus rate||infus extravas||infus complaint||subsequ infus||previou atp infus||infus rate||concern atp infus||atp infus 21||infus arm||hospit infus||51 infus,0.629||0.482||0.335||0.328||0.328||0.327||0.326||0.324||0.324||0.324||0.323||0.322||0.321||0.321||0.319,0.4,0.2,0.13333333333333333
301,Osteoporos_Int-3-1-1820757.txt,vertebr fractur||independ correl||apo polymorph||spine||vertebr bodi||lipid profil||studi||multipl regress model||wrist fractur||risk||observ||fractur||postmenopaus women||acut cardiovascular event||serum triglycerid||lipid||osteoporot fractur||total cholesterol||bmd||bodi composit||women||observ studi||hip||aorta calcif||associ||factor||independ contributor||differ||bone||serum lipid||osteoporosi||signific differ||sever||cardiovascular event||triglycerid||bone loss||apob||bone miner densiti||cardiovascular diseas,fractur||hip fractur||bmd||vertebr fractur||hip bmd||wrist fractur||hip||osteoporot fractur||p-valu hip fractur||bone||non-vertebr fractur||fractur risk||humer fractur||lipid||fractur 16.4,0.371||0.298||0.25||0.249||0.237||0.233||0.224||0.214||0.209||0.207||0.206||0.203||0.192||0.191||0.19,0.6,0.7,0.5333333333333333
302,Diabetologia-4-1-2170456.txt,follow-up||case||diabet||birth||baselin||studi||year||middle-ag women||bmi||baselin recruit||durat||risk||whr||type 2 diabet mellitu||analys||glucos||trend||dietari intak||age||month||associ||breast-feed||weight||parou women||number||physic activ||particip||diabet mellitu||children||in-person interview,breast-feed||breast-feed women||breast-feed durat||trend breast-feed||lifetim breast-feed||breast-feed histori||interpret breast-feed||shanghai||diabet||diabet mellitu||women||whr||shanghai diabet studi||breast-feed durat assess inform||breast-feed month 0 18.40 128,0.472||0.322||0.278||0.251||0.246||0.242||0.238||0.233||0.214||0.203||0.171||0.153||0.151||0.143||0.137,0.2,0.3,0.26666666666666666
303,Infect_Genet_Evol-1-5-2080692.txt,malaria||south asia||egg||hookworm infect||human hookworm infect||locu||analysi||individu||popul||associ||chitin||data||chitotriosidas||studi||evid||infect||tropic diseas||allel,chit1||al.||chit1 chit1 genotyp||abstract chit1 chit1||st chit1||1997 chit1 chit1 chit1 locu||chit1 brooker||2001 chit1||chit1 chit1 tabl 2||1998 chit1 boot||chitotriosidas||malaguarnera||popul genotyp chit1||wuchereria bancrofti chit1 hise||chit1 meso choi,0.529||0.389||0.371||0.354||0.352||0.323||0.287||0.267||0.265||0.236||0.23||0.215||0.206||0.203||0.197,0.0,0.0,0.06666666666666667
304,Ann_Biomed_Eng-2-2-1705544.txt,mpa||breakdown||level||system||stress level||bioreactor||sampl||studi||densiti||linear bear||PG breakdown||mechanotransduct||compress||displac||strain||test||abil||tissu engin bioreactor||menisc tissu||pressur||cycl||stress||mechan stimuli||load||physiolog load||meniscu||gag||greater PG breakdown||cell death||standard||pressur film||deep zone||displac control||usa||differ||explant||dynam compress||incub||load cell||larg load||actuat||film||meniscectomi||media||result,compress||explant||compress strain||compress rod||menisc explant||mpa||load||bioreactor compress rod||explant compress system||dynam compress||strain||compress test||cartilag explant||unconfin compress||bioreactor,0.333||0.27||0.266||0.247||0.245||0.23||0.228||0.226||0.211||0.201||0.2||0.197||0.194||0.192||0.186,0.4,0.5,0.4666666666666667
305,Purinergic_Signal-3-4-2072912.txt,adenin receptor,xylosoxidan||achromobact xylosoxidan||achromobact||adenin||A. xylosoxidan||achromobact 50 A. xylosoxidan||kirbi BD achromobact xylosoxidan||achromobact spp||4 3 achromobact xylosoxidan||text||result A. xylosoxidan||2 A. xylosoxidan||3 achromobact acinetobact 17 A. xylosoxidan||adenin receptor||radioligand bind studi compound achromobact xylosoxidan,0.222||0.199||0.176||0.135||0.131||0.112||0.101||0.1||0.1||0.088||0.087||0.087||0.086||0.085||0.083,0.0,0.0,0.06666666666666667
306,Environ_Health_Perspect-114-9-1570082.txt,particul air pollut||measur||method||spe||cross-valid||concentr||kriging-bas estim approach||locat||data||studi||valu||model||geocod address||geograph inform system||spatial correl||se||population-bas studi||unit state||site||krige||daili ambient PM||semivariogram paramet||day||averag PE||approach||estim||rmss||rang||location-specif PM||cross-valid paramet||weight least-squar method||address||PM estim||semivariogram||result,krige||ordinari krige||lognorm krige||krige estim||lognorm ordinari krige||national-scal krige||log-norm krige||krige model||univers krige||krige procedur||krige method||regular ordinari krige||log-norm ordinari krige||nation ordinari krige||region ordinari krige,0.663||0.441||0.431||0.366||0.361||0.354||0.348||0.343||0.337||0.333||0.333||0.312||0.305||0.301||0.299,0.2,0.1,0.06666666666666667
307,Histochem_Cell_Biol-4-1-2413109.txt,actin cytoskeleton||patj||membran asymmetri||junction format||molecul||recent evid||apico-bas polar||par3||complex||jam||aj||signal||adheren junction||specif||cell||protein complex||afadin||local||tight junction||protein||associ||lgl||format||bind||small gtpase||par protein||apkc||interact||major multiprotein complex||claudin||cell polar||membran||function,junction||tight junction||cell junction||epitheli junction||epitheli tight junction||junction adhes||tight junction protein||cell||cell adheren junction||adheren junction||cell polar||tight junction format||polar||epitheli tight junction format||epitheli cell polar,0.358||0.319||0.299||0.281||0.281||0.261||0.255||0.24||0.238||0.237||0.234||0.234||0.229||0.226||0.224,0.2,0.3,0.26666666666666666
308,Exp_Appl_Acarol-3-1-2039800.txt,eriophyida||dgt||slt||infest||phytoseiida||data||predatori mite||densiti||space||coconut||perianth||bulb||coconut palm||adult femal||cultivar||surfac||gap||coconut fruit||size||coconut mite||mite||sri lanka||narrow space,coconut||coconut mite||coconut fruit||infest coconut||coconut predatori||coconut cultivar||coconut mite aceria guerreroni||mite||coconut mite experi||coconut palm||matur coconut||uninfest coconut fruit||guerreroni||perianth||coconut fruit sourc,0.636||0.493||0.376||0.369||0.368||0.365||0.354||0.349||0.329||0.329||0.322||0.269||0.264||0.252||0.252,0.6,0.5,0.4
309,Eur_Radiol-3-1-2039780.txt,case||fat||renal arteri stenosi||mri||imag||higher sensit||studi||patient||renal cell carcinoma||adc||enhanc||lesion||magnet reson imag||renal arteri||renal imag||potenti kidney donor||pseudocapsul||angiomyolipoma||tumor||renal lesion||signal intens||oncocytoma||malign lesion||opposed-phas imag||function||kidney,renal imag||renal angiomyolipoma||mri||renal tumor||renal lesion||renal donor||renal angiomyolipoma ajr||renal neoplasm||renal cell||renal vein||renal arteri||renal pyramid||renal infect||renal diseas||renal cell carcinoma,0.283||0.275||0.241||0.235||0.234||0.232||0.219||0.217||0.213||0.211||0.206||0.205||0.199||0.197||0.187,0.6,0.3,0.3333333333333333
310,Diabetologia-4-1-2170455.txt,retin haemodynam||blood flow||level||measur||diabet particip||paramet||good glycaem control||diabet||retin vessel||retinopathi||type 1 diabet||blood glucos||diabet retinopathi||individu||abnorm||retin circul||studi||year||patient||haemodynam measur,diabet||retin haemodynam||diabet retinopathi||retinopathi||result 1 1c 1c 1c 1c||retin microangiopathi||retin haemodynam abnorm||retin hemodynam||retin vessel||nonprolif diabet retinopathi||retin circul||retin haemodynam studi||normal retin haemodynam||haemodynam||insulin-depend diabet,0.362||0.348||0.334||0.306||0.263||0.261||0.253||0.251||0.247||0.245||0.244||0.233||0.233||0.229||0.205,0.8,0.5,0.4
311,J_Headache_Pain-4-1-2386850.txt,european countri||tth||chronic headach||interest||burden||preval||direct cost||data||studi||year||europ||life||patient||neurolog disord||qol||countri||impact||cost||day||headach||estim||public health perspect||social function||popul||methodolog||differ||headach patient||work||migrain||disabl||partner||children,headach||headach headach||migrain headach||migrain||headach impact||tension-typ headach||non-migrain headach||headach disord||headach pain||headach suffer||headach preval||headach patient||nonmigrain headach||headach worldwid||self-report headach,0.631||0.631||0.595||0.559||0.358||0.336||0.336||0.333||0.332||0.33||0.327||0.324||0.322||0.322||0.321,0.4,0.2,0.2
312,Exp_Neurol-2-1-2288636.txt,effect||variat||frequenc||tap||stimul||anova||excess synchron||db||perform||side||synchron||variabl||movement||rate||precis frequenc||normal limit||patient||stn||parkinsonian patient||updr motor score,al.||60 μs||130 Hz||130 Hz fog||140 Hz||185 Hz||180 Hz||145 Hz||130 Hz lid||20 Hz||10 Hz||12 Hz||130 Hz tremor||parkinson||fog,0.391||0.27||0.215||0.195||0.17||0.167||0.167||0.164||0.164||0.163||0.163||0.163||0.161||0.156||0.155,0.0,0.0,0.0
313,Eur_J_Epidemiol-3-1-2071962.txt,hypertens||data||model||stroke||potassium||mortal||risk||volum||blood pressur||potassium intak||intak||event||posit relationship||creatinin||cohort||all-caus mortal||relationship||sodium||analysi||associ||subject||lower quartil||cvd||dietari data||myocardi infarct||dietari potassium||urinari sodium||salt||cardiovascular event||standard deviat increas||cardiovascular diseas,potassium||potassium intak||urinari potassium||intak||dietari potassium intak||dietari potassium||cvd||sodium intak||sodium||dietari sodium intak||dietari intak||urinari sodium||potassium excret||cvd mortal||dietari sodium,0.35||0.318||0.294||0.286||0.285||0.284||0.282||0.275||0.264||0.256||0.252||0.251||0.245||0.244||0.241,0.6,0.6,0.4666666666666667
314,Int_J_Cardiovasc_Imaging-4-1-2373860.txt,volum score||method||cms-index||bpm||scanner||artifici arteri||dual sourc CT||suscept||motion curv||motion||densiti||calcif||effect||electron beam CT||ca-scor||equival mass||agatston score||phantom||heart rate||calcium||slice thick||cardiac motion||mdct||dsct||smaller slice thick||calcium score||triangl||ebt||arteri||physic mass||differ||decreas||circl||64-slice mdct||calcif densiti||score||equival mass score||result,ca-scor||dsct||64-slice mdct||mdct||ebt||slice||absolut ca-scor||ca-scor method||64-slice multi-detector||slice thick||calcif||thick||calcium||calcif densiti||densiti calcif,0.376||0.349||0.312||0.294||0.245||0.207||0.203||0.191||0.189||0.183||0.174||0.159||0.147||0.145||0.145,1.0,0.6,0.6
315,Diabetologia-3-1-2063563.txt,type 2 diabet||insulin secret||insulin sensit||risk||hyperglycaem clamp||gene||glucos||pancreat beta cell||beta cell||glp-1||result||carrier||variant||polymorph||particip||insulin||data||plasma glucos||ogtt||clamp,tcf7l2||tcf7l2 tcf7l2 variant||tcf7l2 tcf7l2 15||tcf7l2 tcf7l2 14||result tcf7l2 tcf7l2||tcf7l2 polymorph||tcf7l2 gene||hypothesi tcf7l2 tcf7l2 polymorph||interpret tcf7l2||method tcf7l2||25 tcf7l2 9 tcf7l2 gene||glp-1||tcf7l2 gene variant||s00125-007-0753-6 articl tcf7l2||transcript factor tcf7l2,0.703||0.485||0.47||0.47||0.469||0.384||0.371||0.368||0.353||0.352||0.29||0.288||0.264||0.25||0.248,0.0,0.0,0.06666666666666667
316,Eur_J_Epidemiol-4-1-2226058.txt,effect||mortal||risk||chd mortal||hdl-cholesterol||lower risk||hr||relat||analys||rotterdam studi||normal weight individu||age||individu||particip||genotyp||studi||year||normal weight||overweight,apo||apo apo||apo apo apo||apo apo apo genotyp||20 apo apo||1 apo apo||apo genotyp||obes apo||overweight apo||apo polymorph||apo epsilon4||apo statu||trend apo||2008 apo||35 apo apo 36,0.913||0.913||0.913||0.697||0.609||0.609||0.48||0.475||0.474||0.471||0.465||0.46||0.458||0.458||0.458,0.0,0.0,0.0
317,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-2082652.txt,vascular repair||literatur review||embolectomi||occlus||case||arteri embol||aclr||complic||knee||anterior cruciat ligament reconstruct||pseudoaneurysm||graft||poplit arteri occlus||reconstruct||sensori loss||foot||poplit arteri||vascular complic,poplit arteri||cruciat ligament reconstruct||aclr||anterior cruciat ligament||arteri||anterior cruciat ligament reconstruct||anterior cruciat||poplit arteri occlus||anterior cruciat ligament repair||proxim poplit arteri||anterior cruciat ligament reconstruct ann||gore-tex ligament||reconstruct||ligament repair||middl genicular arteri,0.323||0.299||0.298||0.291||0.268||0.267||0.263||0.231||0.228||0.223||0.215||0.207||0.197||0.193||0.18,0.4,0.4,0.3333333333333333
318,Pediatr_Nephrol-2-2-1764601.txt,proteinuria||case||preval||patient||year||seri||risk||epidemiolog||increas||nephrot syndrom||naprtc||focal segment glomerulosclerosi||renal biopsi||adult||esrd||age||popul||incid||fsg||diagnosi||children,fsg||idiopath fsg||fsg histolog||fsg progress||fsg account||nephrot syndrom||glomerulosclerosi nephrot syndrom||fsg caus gene||steroid-resist nephrot syndrom||idopath nephrot syndrom||famili nephrot syndrom||primari nephrot syndrom||nephrot syndrom predict||nephrot rang proteinuria||sporad steroid-resist nephrot syndrom,0.588||0.34||0.307||0.302||0.301||0.276||0.245||0.202||0.2||0.195||0.187||0.187||0.186||0.162||0.154,0.2,0.2,0.13333333333333333
319,Osteoporos_Int-3-1-1766476.txt,prevent||comprehens geriatr assess||convent care||control group||studi||individu care plan||intervent||fractur||treatment||day||fall||multifactori intervent||activ prevent||control||rehabilit||hospit||fall risk factor||multifactori intervent program||surgeri||intervent group||injuri||delirium||group||differ||number||fewer injuri||orthoped||systemat assess||intervent ward||hip fractur||intervent program,fall||fall prevent||fractur||fall risk||inpati fall||in-pati fall||fall calcium||recurr fall||geriatr rehabilit||geriatr ward||hip fractur||fall prevent trial||fall prevent studi||fall prevent measur||geriatr patient,0.508||0.293||0.29||0.282||0.275||0.269||0.26||0.257||0.252||0.245||0.212||0.206||0.197||0.196||0.194,0.4,0.2,0.2
320,Arch_Orthop_Trauma_Surg-3-1-2092411.txt,anim||drill time||time||daili practic||rabbit||studi||long time||hind limb||osteocyt||vivo studi||drill||aim||signific||absenc||posit correl||insert forc||tibia||distanc||experi||femur||surgeri||insert time||bone||base plate||kirschner wire||result,drill||osteocyt||implant drill||drill hole||drill speed||drill time||drill tract||osteocyt lacuna||disappear osteocyt||k-wire||osteocyt apoptosi||osteocyt death||osteocyt turn||osteocyt function||osteocyt result,0.572||0.465||0.33||0.328||0.303||0.294||0.289||0.282||0.269||0.268||0.249||0.239||0.236||0.233||0.233,0.4,0.3,0.2
321,Eur_J_Clin_Pharmacol-3-1-1914266.txt,measur||time||co-trimoxazol||data||studi||patient||pdr||risk||clinic||coumarin||user||antibiot||signific||anticoagul clinic||inr||day||dose adjust||sever overanticoagul||consent||acenocoumarol||overanticoagul||differ||dose reduct||interact||follow-up time||therapeut rang||initi||phenprocoumon||result,pdr||co-trimoxazol pdr||co-trimoxazol||antibiot pdr||overanticoagul pdr||inr||antibiot||percentag pdr||0.16 pdr||0.55 pdr||pdr approach||0.24 pdr||0.87 pdr||conclus pdr||co-trimoxazol user,0.568||0.514||0.46||0.429||0.388||0.381||0.29||0.289||0.289||0.288||0.287||0.286||0.286||0.284||0.282,0.4,0.4,0.26666666666666666
322,J_Med_Internet_Res-7-2-1550646.txt,mass media||mesh||author||notic||ihca||press releas||lexisnexi academ databas||databas||studi||patient||clinic outcom||cochran retract||review||articl||al paper||medic||scientist||page||web||princip conclus||health||retract||citat||pubm||conclus||internet||press report||search||cochran collabor||refer||case studi||public||systemat review||media||queri||result,ihca||retract||cochran retract||ihca review||retract public||ihca result||retract 2005||cochran retract 18||ihca review author||ihca review conclus||ihca review situat||ihca review result||retract systemat review||separ retract notic||retract articl relat,0.579||0.525||0.361||0.343||0.313||0.291||0.268||0.242||0.235||0.232||0.23||0.229||0.222||0.185||0.185,0.6,0.3,0.2
323,Biochim_Biophys_Acta-2-1-2258316.txt,tau||tyrosin phosphoryl||tauopathi||syk,tau||syk||tau phosphoryl||blot tau||tau 0n3r||0n3r tau||IP tau||tau y18f||tau y197f||tau y394f||tau pervanad||tau protein||tau splice||fetal tau||human tau,0.673||0.446||0.416||0.384||0.376||0.376||0.36||0.356||0.356||0.356||0.354||0.349||0.341||0.34||0.34,0.4,0.2,0.13333333333333333
324,Clin_Oral_Investig-3-1-1797073.txt,applianc||volunt||sampl||studi||seri||varnish||site||saliva||acquisit||present studi||detect limit||day||applic||enamel sampl||deminer enamel||duraphat||uptak||fluorid||specimen||opposit buccal aspect||transfer||oral caviti||enamel||tooth||respect tooth,fluorid||fluorid varnish||koh-solubl fluorid||fluorid dentifric||fluorid uptak||fluorid sampl||salivari fluorid||bound fluorid||fluorid specimen||fluorid site||fluorid applic||fluorid retent||fluorid rins||fluorid content||topic fluorid,0.828||0.5||0.471||0.458||0.448||0.438||0.433||0.431||0.431||0.43||0.428||0.426||0.426||0.426||0.425,0.2,0.1,0.06666666666666667
325,J_Biol_Inorg_Chem-3-1-1915625.txt,activ site||sampl||model||spectroscop data||wild-typ||water||water molecul||structur||t309v||cytochrom p450 2d6||dft calcul||enzym||experiment observ||heme moieti||supplementari materi||experiment structur||heme||substrat||spin equilibrium||experiment data||rel destabil||result,t309v||t309v mutant||t309v spin equilibrium||cyp2d6||t309v mutat||t309||ν Fe||cyp2d6 spin equilibrium||heme||heme spin equilibrium||spin equilibrium||5ch heme||1 ν Fe||spin state||5ch,0.395||0.25||0.235||0.221||0.206||0.197||0.186||0.177||0.16||0.156||0.155||0.139||0.124||0.121||0.119,0.2,0.2,0.2
326,Clin_Rheumatol-3-1-2071969.txt,large-vessel vascul||test||patholog uptak||pet||wall||cogan||hear loss||involv||white cell||ear pain||syndrom,cogan||cogan ’s||keyword cogan||cogan ’s syndrom||cogan DG syndrom||cogan le maladi||atyp cogan ’s syndrom||kita GD cogan||cogan ’s syndrom balink||large-vessel vascul||rheumatolog||hear||stanson AW ilstrup DM cogan||syndrom||CT hear loss large-vessel vascul,0.577||0.31||0.289||0.251||0.244||0.227||0.207||0.207||0.198||0.187||0.183||0.135||0.134||0.133||0.132,0.2,0.2,0.2
327,Behav_Genet-4-1-2226021.txt,quantit genet analysi||behavior||linkag analysi||golden retriev||control group||anim model||aggress||studi||allel||effect||frequenc||non-aggress golden retriev||microsatellit marker||loci||dog||genotyp||dna||gene||power||serotonin||dna sampl||estim||analysi||associ||behavior inform||aggress dog||molecular genet studi||strong effect||snp||candid gene||major role||haplotyp||aggress behavior||owner impress,htr1b||htr1a htr1b htr2a||htr1b htr2a slc6a4||htr1a htr1b htr2a slc6a4||htr1a htr2a htr1b slc6a4||htr1a||htr2a||slc6a4||1 htr1b htr2a slc6a4 htr1b htr2a||aggress||4 htr1a htr1b||aggress dog||aggress dog-direct aggress htr1a||htr1b _{||0.30 htr1b,0.405||0.374||0.373||0.369||0.369||0.358||0.358||0.355||0.313||0.255||0.254||0.232||0.226||0.223||0.213,0.0,0.1,0.13333333333333333
328,J_Comput_Aided_Mol_Des-4-1-2270916.txt,metric||measur||target||enrich||comput||data||model||studi||comparison||properti bia||ligand-bas tool||atom posit||structur||virtual screen||resolut||dataset||compound||purpos||nomin resolut||decoy||simpl molecular properti||properti||applic||paper||crystallograph||atom||decoy set||dpi||predict||rmsd||number||perform||coordin error||robust comparison||area||error||conform reproduct||ligand||engin||pose predict||result,decoy||dpi||pose||metric||metric error||virtual screen||text||pose predict||decoy set||enrich||error||calcul dpi||decoy select||decoy lie||presumpt decoy,0.192||0.186||0.186||0.181||0.145||0.131||0.12||0.119||0.118||0.111||0.108||0.107||0.106||0.105||0.104,0.6,0.7,0.5333333333333333
329,Diabetologia-3-1-2039833.txt,muscl||triacylglycerol||diabet||releas||haart||thiazolidinedion||rate||adipocyt||studi||patient||beta cell damag||atp||insulin secret||develop||risk||organ||adipos tissu||metabol syndrom||lipotox||type 2 diabet mellitu||cell||circul||mitochondria||fatti acid||genet factor||pancreat beta cell||ectop triacylglycerol deposit||insulin resist||result,adipocyt||fatti acid||fatti acid-induc uncoupl||mitochondri diabet||mitochondri uncoupl||debat fatti||fatti acid-induc uncoupl mitochondri β-oxid||diabet||uncoupl||fatti acid releas||fatti acid-induc insulin resist||fatti acid remov||fatti acid esterif||fatti acid re-esterif||fatti acid concentr,0.324||0.309||0.268||0.248||0.245||0.245||0.235||0.233||0.228||0.226||0.222||0.218||0.214||0.213||0.21,0.4,0.3,0.2
330,Histochem_Cell_Biol-3-1-1779629.txt,vector||high level||system||homolog recombin||embryo||primer||element||lacz activ||transgen mice||probe||hypertroph zone||bac||enhanc||offspr||founder||event||newborn||express||transgen copi||cartilag||dna||report gene mous||downstream||specif||cell||chondrocyt||growth factor||gene||bac dna||hypertroph chondrocyt||hypertroph cartilag||activ||long bone||genom context||growth plate||integr site||fvb mice||construct,lacz||bac||chondrocyt||bac transgen||lacz 2004 lacz transgen||hypertroph chondrocyt||col10a1||lacz activ||bac transgen E.||bac transgen line||bac col10a1 environ||bac clone||chondrocyt express||non-hypertroph chondrocyt||bac dna,0.378||0.313||0.291||0.265||0.244||0.229||0.226||0.199||0.188||0.182||0.181||0.178||0.176||0.174||0.174,0.4,0.4,0.3333333333333333
331,Eur_J_Appl_Physiol-3-1-2039810.txt,blood flow||condit||time trial perform||valu||perform decrement||effect||increas||muscl temperatur||bodi temperatur||energi flow model||temperatur||present studi||ambient temperatur||power output||higher cardiac output||climat||exercis||differ||decreas||skin||perform||trial||extra blood||hot condit||heat||time trial exercis,2max||sk||text||document||_{||exercis||GE||heat||sk 2000||documentclass||12pt||amsmath||amsfont||mathrsf||69pt,0.146||0.094||0.078||0.065||0.064||0.062||0.051||0.05||0.048||0.048||0.048||0.048||0.048||0.048||0.048,0.0,0.2,0.13333333333333333
332,Exp_Brain_Res-3-1-2039806.txt,condit||cue||prior||surfac slant||combin||stimulu||orient||head||textur||textur cue||conflict||slant||inform||probe||binocular dispar||motion parallax||cue conflict||weight||surfac||binocular||monocular||posit||trial||rotat screen||particip||movement,cue||binocular cue||textur cue||_{||binocular||motion cue||slant||cue conflict||textur cue vision||motion parallax||dispar cue||textur||cue weight||visual cue||reliability-bas cue,0.236||0.202||0.186||0.181||0.167||0.161||0.154||0.143||0.142||0.138||0.136||0.135||0.129||0.126||0.122,0.6,0.6,0.4666666666666667
333,Diabetologia-4-1-2235909.txt,type 2 diabet||hypoglycaemia||target||week||fast plasma glucos||insulin detemir||studi||patient||insulin||event||glycaem control||dose||fpg||analys||present studi||treatment||advers event||basal insulin analogu||ten-point PG profil||glargin||oral glucose-low drug||meal-tim insulin||bodi weight||detemir||oral glucose-low agent||oral agent||insulin glargin||trial||particip||weight gain,detemir||insulin detemir||insulin||insulin glargin||glargin||insulin glargin detemir glargin differ||daili insulin detemir||once-daili insulin detemir||twice-daili insulin detemir||insulin detemir result||once-daili detemir||1c 1c||1c||1c 1c 1c 1c 1c 1c||insulin glargin event,0.58||0.492||0.405||0.398||0.391||0.354||0.346||0.338||0.335||0.328||0.304||0.277||0.277||0.277||0.276,1.0,0.5,0.3333333333333333
334,J_Chem_Ecol-3-1-2039843.txt,time||endogen glucosinol||leaf tissu||sampl||amount||gener linear model||extract||growth rate||instar||infloresc||genotyp||herbivori||natur enemi||glucosinol concentr||leaf||mechan homogen||result||caterpillar||glucosinol||access||flower||lepidoptera||intern standard||pierida||plant||myrosinas,brassica||pieri brassica||plant||P. brassica||brassica napu||brassica oleracea||M. brassica||brassica juncea||P. brassica pieri rapa||brassica campestri||pieri||llc 2007 pieri pieri brassica brassica||plant ecol||insect pieri brassica B.||4 P. brassica P. rapa brassica,0.466||0.353||0.292||0.286||0.276||0.269||0.266||0.247||0.246||0.242||0.24||0.237||0.223||0.221||0.22,0.2,0.1,0.06666666666666667
335,Histochem_Cell_Biol-3-1-2137947.txt,cancer cell||pnb||cancer||author||mitot phosphoryl||ribosom biogenesi||depend||nucleolar protein||nuclear receptor||norc||studi||process||complex||rdna transcript machineri||nucleolar compon||rdna||dynam||biogenesi||cell||nuclear bodi||nucleolar structur||ribosom||dfc||local||transcript||protein||ribosom protein||nucleolu||upstream bind factor||nuclear export||nucleolar assembl||cell cycl||activ||rrna||bind||factor||nuclear function compartment||compon||nucleolar machineri||assembl||viru||molecul||sequenc||rdna transcript,nucleolu||nucleolar transcript||segreg nucleolu||nucleolu disrupt||nucleolu biochem||nucleolu play||nucleolu differ||nucleolar protein||nucleolar assembl||nucleolar machineri||nucleolar local||nucleolar factor||nucleolar retent||nucleolar traffick||nucleolar organ,0.588||0.31||0.299||0.297||0.297||0.295||0.294||0.277||0.269||0.261||0.25||0.249||0.248||0.248||0.248,0.2,0.4,0.26666666666666666
336,Eur_Arch_Otorhinolaryngol-4-1-2358940.txt,posterior part||ventromediocaud part||arytenoid cartilag||level||unilater vocal fold paralysi||arytenoid||cricoarytenoid joint||healthi side||posit||paralysi||movement||procedur||surgeri||patient||phonat||three-dimension comput tomographi||techniqu,vocal fold||arytenoid||paralyz vocal fold||paralyz vocal process||vocal cord||vocal process||healthi vocal fold||3dct||arytenoid cartilag||unilater vocal fold paralysi||vocal fold level||vocal fold relax||vocal cord paralysi||phonat||tomographi unilater vocal,0.357||0.352||0.339||0.274||0.273||0.26||0.256||0.252||0.248||0.243||0.242||0.241||0.237||0.227||0.213,0.2,0.3,0.26666666666666666
337,Neurosurg_Rev-2-2-1705527.txt,dural arterioven fistula||pulsatil tinnitu||complet obliter||transcondylar approach||patholog vessel||posterior condylar emissari vein||patient||occipit condyl||region||treatment||fistula||pulsatil bruit||occipit arteri||approach||surgeri||hypogloss canal||foramen magnum||intraoss davf||obliter||jugular bulb||transoss arteri feeder||extens boni drill||davf||arteri feeder,dural||dural arterioven fistula||arterioven fistula||dural arterioven malform||intracrani dural arterioven fistula||dural arteri||tentori dural arterioven fistula||complex dural arterioven fistula||dural avf||dural malform||fistula||intraoss dural arterioven malform||arterioven malform||extens dural arterioven malform||spinal dural arterioven malform,0.474||0.394||0.354||0.336||0.308||0.3||0.299||0.297||0.292||0.292||0.285||0.277||0.267||0.255||0.253,0.2,0.1,0.13333333333333333
338,Neurochem_Res-4-1-2270371.txt,antibodi||anim||level||stain||gdnf protein||transect injuri||western blot||spinal cord||rostral stump||dpo||caudal stump||gdnf||present studi||cell||rat||hindlimb||injuri site||neuron||adult rat||rostral||white matter||cord||ventral horn||incub,gdnf||gdnf antibodi||gdnf mrna||intrins gdnf||gdnf express||gdnf immunoreactivti||inflammation-induc gdnf||gdnf protein||gdnf famili||exogen gdnf||endogen gdnf||gdnf deliveri||gdnf antibodi neutral||tabl 2 gdnf||rat gdnf gene sequenc,0.725||0.387||0.373||0.371||0.37||0.37||0.368||0.368||0.366||0.366||0.365||0.365||0.26||0.242||0.207,0.2,0.2,0.13333333333333333
339,Pathol_Oncol_Res-4-1-2413131.txt,oscc||egfr inhibitor||concentr||cisplatin sensit||combin||studi||effect||sensit||oral cancer||cell line||inhibit||treatment||cell||growth||higher express||oscc cell growth||protein||cisplatin resist||cisplatin||egfr||pathway||addit||cancer therapi||oral squamou cell carcinoma,cisplatin||egfr||oscc||cisplatin resist||cisplatin sensit||egfr inhibitor||1 cisplatin||p-egfr||egfr downstream||cisplatin-resist oscc cell line cisplatin sensit||ag1478||egfr blockad||differenti egfr||oscc cell||egfr inhibitor oral,0.454||0.383||0.277||0.262||0.248||0.228||0.227||0.223||0.204||0.204||0.202||0.198||0.194||0.193||0.173,1.0,0.6,0.4
340,Arthritis_Res_Ther-5-3-165040.txt,mechan||type||connect tissu||nutrient||vertebr bodi||studi||disc||patient||nucleu||human||nerv||articular cartilag||back pain||low||cell||therapi||growth||gene||disc degener||spinal canal||tissu||collagen||pain||intervertebr disc||exercis||cartilag end-plat||factor||nutrient suppli||major role||proteoglycan||matrix||loss||annulu||degener,disc||intervertebr disc||intervertebr disc degener||lumbar intervertebr disc||intervertebr disc herniat||disc degener||degener disc||scoliot intervertebr disc||canin intervertebr disc||human intervertebr disc||intervertebr disc cell||intervertebr disc degrad||lumbar disc||bovin intervertebr disc||normal intervertebr disc,0.613||0.587||0.459||0.449||0.419||0.409||0.409||0.4||0.397||0.397||0.396||0.394||0.394||0.393||0.393,0.4,0.3,0.2
341,J_Mol_Med-3-1-1820751.txt,noonan syndrom||gene||costello syndrom||clinic phenotyp||ra||result||protein||ns-like featur||k-ra||ra pathway||disord||jmml||pathway||short statur||mutat||gtp||human cancer||patient||syndrom||germlin,ptpn11||ptpn11 mutat||nf1||noonan||ptpn11 braf hra||ptpn11 gene||noonan syndrom||somat ptpn11 mutat||leukemia-associ ptpn11 mutat||32 ptpn11 mutat||neel BG ptpn11||ra||noonan syndrom NS noonan syndrom||germlin kra||kra germlin mutat,0.44||0.3||0.295||0.276||0.248||0.239||0.219||0.213||0.205||0.2||0.193||0.184||0.18||0.179||0.173,0.0,0.1,0.13333333333333333
342,J_Mol_Model-3-1-2039870.txt,dft||classic electrostat attract||data||combin||lda||densiti||homo-bas stack||refer data||interact energi||base||ccsd||larg basi set||densiti function||π-π stack interact||dna||energi||term||vertic separ||twist angl||hydrogen bond||densiti function theori||function||result,stack||π-π stack||phi chem||π-π||π-π stack interact||mp2||stack benzen||π-π stack system||stack base||delta||hobza||sponer||bickelhaupt FM||homo-bas stack||hetero-bas stack,0.227||0.19||0.164||0.153||0.144||0.139||0.133||0.128||0.124||0.123||0.121||0.121||0.12||0.119||0.119,0.2,0.1,0.13333333333333333
343,Cardiovasc_Eng-3-1-2137944.txt,myocardi energet output||cardiovascular system||system||myocardi oxygen consumpt||data||patient||valu||stroke||ventricl dysfunct||blood pressur||heart failur||numer simul||myocardi energet||numer model||paramet||cardiac rhythm pace||pulmonari pressur||echocardiographi examin||work||ventricular pace||heart||mode||vvi||aai,pace||ventricular pace||aai pace||dual-chamb pace||cardiac pace||physiolog pace||text||pace left ventricl||cardiac rhythm pace||perman cardiac pace||aai||pacemak||myocardi energet||aai mode||ventricular myocardi fibr,0.271||0.194||0.185||0.172||0.164||0.142||0.13||0.126||0.12||0.114||0.1||0.094||0.084||0.077||0.076,0.2,0.2,0.26666666666666666
344,Plant_Mol_Biol-3-1-1805041.txt,seed||line||databas||insert||rice gene||import gene||gene function||correl||function analysi||phenotyp data||insert line||gene||mutant panel databas||natur condit||field||mutant||number||phenotyp||experiment data||long leaf||retrotransposon||sequenc||nipponbar||function,tos17||2 tos17 tos17 tos17 tos17 insert||tos17 tos17 1998||tos17 retrotransposon||tos17 http://www.rgrc.dna.affrc.go.jp/||2 tos17 tos17 insert point||tos17 insert mutant popul||leaf||dwarf||discuss 2 tos17 retrotransposit||rice||phenotyp||panicl||2006 2006 2005 tos17 insert||dwarf mutant,0.704||0.484||0.47||0.372||0.359||0.3||0.234||0.191||0.187||0.183||0.181||0.166||0.165||0.161||0.159,0.0,0.0,0.06666666666666667
345,Biochim_Biophys_Acta-2-1-2225445.txt,antibodi||thymu||phd||panel||mutat||nuclear extract||chromatin||kinas||air||domain||Ku 80||site||phd finger||express||phosphoryl||cell||thymic epitheli cell||gene||protein||activ||posit control||whole-cel extract||apec||immunoprecipit||dna-pk,air||dna-pk||dna-pk phosphoryl air||air phosphoryl||air protein||co-immunoprecipit air||air dimer||air phosphoryl site||phosphoryl||air interact||air gene||air phosphoryl http://scansite.mit.edu/cgi-bin/motifscan_seq||air phosphoryl level||air phosphoryl effici||dna-pk phosphoryl site,0.435||0.411||0.359||0.333||0.269||0.261||0.233||0.232||0.231||0.23||0.229||0.228||0.227||0.225||0.224,0.4,0.3,0.2
346,Ann_Biomed_Eng-2-2-1705476.txt,antibodi||level||pathogen||time||simpl bar code system||reaction chamber||strain||pathogen detect||test||region||filament||classif||specif||fara||solut||captur||fluoresc||chamber||posit||captur antibodi||laser||peak||viru||decis tree||detect,reoviru||filament||reoviru t3d||reoviru t3sa||filament fluoresc||reoviru strain||reoviru attach||antibodi||reoviru infect||plaque-purifi reoviru||reoviru t1l classif||viru||t3d||reoviru strain classif||wash filament,0.449||0.402||0.334||0.294||0.276||0.272||0.246||0.237||0.236||0.235||0.224||0.221||0.219||0.216||0.216,0.2,0.2,0.2
347,Ann_Biomed_Eng-2-2-1705503.txt,type||cell cycl analysi||silicon sheet||concentr||studi||effect||pdgf-ab||increas||cultur substrat||cell prolifer||collagen synthesi||express||cell||gelatin||growth factor||two-dimension substrat||prolifer||collagen||ligament tissu engin||tissu regener||synthesi||cultur||substrat||franc||fibroblast||result,ligament||ligament fibroblast||cruciat ligament fibroblast||collagen||anterior cruciat ligament||collater ligament||tgf-β1||fibroblast||anterior cruciat ligament cell||ligament tissu engin||ligament tissu eng||reconstruct anterior cruciat ligament||anterior cruciat ligament reconstruct||collagen synthesi||fibroblast prolifer,0.352||0.272||0.241||0.209||0.205||0.198||0.196||0.192||0.183||0.173||0.171||0.163||0.163||0.163||0.156,0.2,0.3,0.26666666666666666
348,J_Gastrointest_Surg-3-1-1852383.txt,case||arteri thrombosi||group||abo-incompat blood group||result||risk factor||chi-squar test||biliari||graft||incid||bc||biliari complic||studi||BC risk factor||neg liver graft||patient||liver transplant||Rh nonident||donor,Rh||Rh nonident||Rh graft||transplant||Rh donor||nonident Rh group||liver transplant||biliari transplant||liver||abo||graft||biliari||conclus liver transplant||nonident 0.01||rh-nonident liver graft,0.392||0.329||0.281||0.25||0.234||0.227||0.22||0.204||0.191||0.186||0.171||0.159||0.148||0.148||0.147,0.2,0.2,0.26666666666666666
349,Bioinformation-1-3-1891659.txt,program||time||posit||repeat||microsatellit||ssrscanner||motif||ssr||genom||perl,ssrscanner||ssr||softwar ssrscanner||comput program ssrscanner||repeat||bioinform bioinform bioinform||futur develop ssrscanner||huzzi99@hotmail.com scanner ssr||ssr identif||anwar||aligarh||perl||simpl sequenc repeat||program||motif,0.57||0.321||0.293||0.239||0.217||0.206||0.197||0.176||0.167||0.151||0.142||0.132||0.123||0.119||0.118,0.6,0.3,0.4
350,J_Mol_Med-4-1-2374882.txt,proteinuria||level||nephropathi||glomerulosclerosi||renal angiotensin level||renin receptor||nonproteolyt activ||hypertens||import role||anim model||develop||increas||region||recent||receptor||express||renin receptor express||rat||mitogen-activ protein kinas||intracellular||angiotensin||activ||part||bind||podocyt||prorenin||mrna express||angiotensin II||hypertens condit||addit||kidney||result,prorenin||renin||receptor-bound prorenin||prorenin receptor||receptor-bound renin||rat prorenin||renin receptor||prorenin bind||prorenin proseg||activ prorenin||prorenin contribut||prorenin level||human prorenin||prorenin induc||prorenin bound,0.614||0.529||0.385||0.366||0.343||0.334||0.324||0.323||0.321||0.316||0.312||0.312||0.311||0.31||0.309,0.2,0.2,0.13333333333333333
351,Anal_Bioanal_Chem-4-1-2359830.txt,biota||calcul||methylmercuri biothiol||figur||mehgci||cy||detect condit||extract||direct inject||plant extract||inform||form||organ molecul||electrospray mass spectrometri||complex||methylmercuri||compound||icp-m||mass||signal||ion trap||molecular ion||ammonia group||electrospray mass spectromet||biothiol||solut||es-m paramet||in-sourc fragment||standard||group||analyt method||order||hplc eluent||es-m||fragment||mercuri||fragment pattern||nitrogen atom||proton||molecul||plant,mercuri||mercuri compound||mehgci||es-m||mercuri complex||mercuri speciat||mercuri intens||mercuri speci||mercuri bound||mercuri biomolecul cy||mercuri biothiol complex||select mercuri||Hg||cy||distinguish mercuri biothiol compound,0.365||0.238||0.208||0.208||0.202||0.201||0.197||0.196||0.196||0.188||0.186||0.184||0.176||0.167||0.159,0.6,0.3,0.26666666666666666
352,Urol_Res-3-1-2082064.txt,eswl||va||effect||air||inhal entonox||extracorpor shock wave lithotripsi||pethidin||va score||group||stone||statist analysi||pain||signific differ||procedur||pain relief||entonox||studi||patient||analgesia,entonox||entonox pethidin||air entonox||inhal entonox||eswl||lithotripsi||entonox ga||entonox group||conclus entonox||pethidin||shockwav lithotripsi||eswl patient||analgesia||isfahan||outpati eswl,0.61||0.415||0.343||0.341||0.327||0.327||0.318||0.314||0.305||0.221||0.185||0.178||0.177||0.174||0.171,0.6,0.4,0.3333333333333333
353,J_Abnorm_Child_Psychol-3-1-1915632.txt,find||social maladjust||boy||behavior||problem||aggress||school||peer||problemat social behavior||depend variabl||behavior pattern||social adjust||stabil||bulli||class||pattern||featur||similar||analys||girl||item||social function||gender||nomin||victim||group||report||adjust||dislik||transient||adolesc||score,bulli||victim||childhood bulli||olweu bulli||school bulli||stabl bulli||K. bulli||transient bulli||femal bulli||peer victim||childhood victim||non-involv children bulli||aggress victim||children victim||stabl victim,0.703||0.425||0.418||0.391||0.374||0.373||0.371||0.356||0.352||0.31||0.278||0.276||0.261||0.249||0.234,0.4,0.2,0.13333333333333333
354,Pharm_World_Sci-3-1-1915627.txt,atyp||combin||data||studi||patient||europ||frequenc||medic||clinic practic||polypharmaci||countri||anticholinerg||antipsychot polypharmaci||common practic||belgium||antipsychot agent||number||antipsychot||hospit pharmacist||larg number||daili clinic practic||result,antipsychot||antipsychot polypharmaci||atyp antipsychot||low-pot antipsychot||convent antipsychot||antipsychot properti||antipsychot agent||antipsychot medic||antipsychot polypharmaci 31.7||atyp antipsychot 42.1||individu atyp antipsychot||low-pot convent antipsychot||polypharmaci||atyp polypharmaci||anticholinerg,0.763||0.537||0.51||0.459||0.395||0.385||0.385||0.385||0.36||0.349||0.341||0.315||0.311||0.284||0.28,0.4,0.3,0.3333333333333333
355,Qual_Life_Res-4-1-2248606.txt,nurs home||qualiti||depress complaint||life||question||alpha||correl||pgcm||scale||oqol||resid||cognit impair||gip-||pilot studi||self-report||gd||valid||na||cognit||item||pa||research||intern consist||group||depress list||posit||neg||cognit test||cognit group||neg affect,scale||cognit||oqol scale||oqol||self-report oqol scale||resid||life scale||self-report scale||self-report oqol||voor||pgcm||mmse||neg scale||geriatr depress scale||resid ’s cognit,0.244||0.241||0.239||0.235||0.195||0.191||0.187||0.175||0.17||0.159||0.152||0.15||0.149||0.148||0.148,0.6,0.4,0.3333333333333333
356,J_Digit_Imaging-3-1-2039858.txt,method||system||scp emul||net librari||command line version||project||storag||core||imag||session||definit file||valu||dicom||scu||view||dicom file viewer||exampl||test||servic class user||detail||dataset||tool||valid||dicom file||file||class definit file||applic||scp||script||modal||associ||standard||framework||pac||stand-alon tool||import||sut||attribut||sop class||emul||addit||philip||send||messag||dvt||result,dicom||dvt||dicom file||dicom messag||dicom valid||dvtk||dicom sniffer||dvt script||dicom interfac||dicom object||dicom standard||dicom editor||dicom element||dicom compar||dicom environ,0.6||0.434||0.406||0.335||0.334||0.325||0.319||0.314||0.313||0.31||0.308||0.307||0.304||0.302||0.302,0.6,0.3,0.2
357,J_Mol_Med-4-1-2359832.txt,human tumorigenesi||level||variant||sampl||data||studi||mdm4 variant||comparison||ptc||correl||form||western blot||express||signific||tumor properti||thyroid carcinoma||ratio||protein||analysi||p53||papillari thyroid carcinoma||human cancer||group||tumor||method tissu sampl||presenc||histopatholog featur||mdm2||mdm4||mrna||ctrl||addit,mdm4||n.d||mdm4 variant||mdm4 mrna||mdm4 cancer||full-length mdm4||mdm4 alter||mdm4 level||human mdm4||mdm4 express||0.58 mdm4||mdm4 loss||18 mdm4||mdm2||n.d. n.d,0.506||0.332||0.288||0.279||0.278||0.263||0.259||0.259||0.258||0.257||0.255||0.254||0.254||0.239||0.225,0.4,0.2,0.2
358,Eur_J_Epidemiol-3-1-2071967.txt,glaucoma||measur||anxieti disord||method||endocrin diseas||protocol||atherosclerosi||imag||determin||macular degener||studi||depress||stroke||risk||optic disc||heart failur||high risk||disord||updat||dementia||examin||parkinson diseas||gene||amd||blood sampl||blood||research||grief||assess||age||associ||subject||genet factor||myocardi infarct||factor||alzheim diseas||rotterdam studi||osteoporosi||elderli||candid gene||drug||import inform||risk factor||particip||area||urin||diseas||object||larg number,hofman||rotterdam||bretel mmb||JR hofman||bretel mmb witteman jcm||witteman jcm bretel mmb||AK hofman||stricker bhch||bretel mmb harskamp||witteman jcm||JR bretel MM hofman||duijn CM bretel mmb||swieten JC hofman||tuijl HR hofman||bot ML hofman,0.444||0.292||0.266||0.233||0.227||0.227||0.224||0.204||0.19||0.187||0.187||0.175||0.173||0.168||0.165,0.0,0.0,0.0
359,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2413123.txt,hartmann-shack aberrometri||measur||endogen insulin level||studi||ocular paramet||increas||equival refract index||hyperglycemia||hyperop shift||refract properti||higher order aberr||eye||glucos||shape||blood glucos||len||subject||chang||ogtt||order||refract error||ocular refract||procedur||precis||healthi human eye||refract index,refract||ocular refract||refract chang||refract index||refract error||refract properti||object refract||refract indic||len||refract acta ophthalmol||hyperglycemia||transient hyperop refract||ocular refract error||equival refract index||hartmann-shack aberrometri refract error len,0.669||0.37||0.359||0.35||0.348||0.346||0.337||0.336||0.328||0.286||0.286||0.256||0.255||0.243||0.23,0.6,0.5,0.4666666666666667
360,Ann_Biomed_Eng-2-2-1705519.txt,respons||center||cat type IV unit||paramet estim||rate||model||sensit analysi||frequenc||gerbil||rm||notch nois respons||spectral notch detector||inhibit||notch||unit||cell||NN stimuli||connect paramet||type iii||physiolog data||paramet||princip cell||sound pressur level||good fit||simul||type IV unit||cat||inhibitori||center frequenc||spontan rate||nois stimuli||experiment data||dcn||nois||sound local,rm||rm nsa||rm BW||model rm||document||documentclass||12pt||amsmath||amsfont||mathrsf||69pt||dcn||gerbil dcn||notch||gerbil,0.207||0.111||0.11||0.108||0.066||0.049||0.049||0.049||0.049||0.049||0.049||0.04||0.034||0.031||0.029,0.2,0.1,0.26666666666666666
361,Eur_J_Nutr-2-2-1705483.txt,cereal fraction||author||diet supplement||week||microbicid activ||protect effect||studi||effect||immun function||healthi subject||health promot||cereal||periton leukocyt||gssg||macrophag||leukocyt function||healthi mice||immun cell||health||control||antioxid||chronic diseas||oxid stress||mice||total polyphenol||diet||activ||import||redox state||natur product||immun respons||catechin||diseas||supplement||lipid oxid damag||function||polyphenol||result,antioxid||polyphenol antioxid||polyphenol||phenol antioxid||cereal||antioxid vitamin||dietari antioxid||antioxid nutrient||antioxid statu||antioxid signal||antioxid enzym||antioxid protect||antioxid activ||antioxid effect||antioxid defenc,0.356||0.322||0.288||0.235||0.229||0.218||0.217||0.188||0.187||0.186||0.186||0.185||0.184||0.184||0.184,0.6,0.3,0.2
362,Behav_Genet-3-1-1914301.txt,measur||sum||attent problem||respons||varianc decomposit||handl||individu||sum score||data||model||ceil effect||herit||effect||irt||correl||trait||mcmc||underestim||non-shar environment varianc||varianc compon||paramet||item||estim||approach||varianc||twin||latent variabl||analysi||simul||framework||distribut||genet||item respons theori||classic test theori||number||normal distribut||measur error||score||result,irt||item||irt estim||irt model||irt approach||irt framework||sum||item score||twin||sum score||sum latent score||irt model paramet||1pl irt model||multidimension irt model||latent,0.389||0.246||0.238||0.238||0.212||0.21||0.201||0.2||0.194||0.177||0.174||0.173||0.172||0.168||0.168,0.4,0.5,0.3333333333333333
363,Sci_Eng_Ethics-4-1-2413105.txt,engin ethic||system||implicit contract||problem||feel||model||self-esteem||pride||view||notion||special oblig||countri||high moral standard||code||virtu||profession integr||approach||social statu||societi||membership-requir view||implicit social contract||contract||occup capac||profess||ethic||sens||high incom||japan||student||social-contract view||posit feel||engin,pride||profession pride||engin||profession engin||profession||real-world profession pride||engin profess||motiv engin||profession motiv||engin ethic||ethic profession integr japan pride||profession ethic||japanes engin||profession oblig||engin societi,0.529||0.429||0.343||0.337||0.33||0.29||0.266||0.25||0.244||0.243||0.237||0.236||0.225||0.21||0.206,0.4,0.3,0.2
364,Eur_J_Pediatr-3-1-2042511.txt,metabol diseas||studi||mutat||patient||platelet||defect||platelet-bas bleed disord||dmd||disord||adhes||adp||gene||gray platelet syndrom||protein||broader clinic phenotyp||platelet function||secret||epstein syndrom||human patholog||pathway||diseas||platelet research||function||result,platelet||platelet defect||platelet adhes||platelet secret||platelet 5-ht||morpholog platelet||platelet aggreg||platelet format||giant platelet||platelet petechia||platelet function||blood platelet||platelet activ||platelet research||patients' platelet,0.71||0.422||0.393||0.377||0.37||0.368||0.366||0.366||0.365||0.364||0.363||0.363||0.363||0.362||0.361,0.2,0.1,0.2
365,Crit_Care-9-3-1175868.txt,cardiac surgeri||author||dopexamin group||enoximon||tachycardia||amrinon||vital organ perfus||signific reduct||data||pulmonari hypertens||studi||patient||clinic outcom||effect||agent||investig||cardiovascular drug||increas||cpb||cowork||dose||signific||levosimendan||signific increas||cabg||low dose||low cardiac output syndrom||map||advers cardiac event||paper||cardiac output||catecholamin||epinephrin||cardiac surgeri patient||min||dobutamin||group||milrinon||clinic research||low cardiac output||literatur search||report||pdi||lco||signific differ||trial||pulmonari arteri pressur||function,milrinon||milrinon milrinon||dobutamin||haemodynam||enoximon||enoximon enoximon||amrinon||dopexamin||intraven milrinon||prophylact milrinon||low-dos milrinon||milrinon increas||milrinon administr||milrinon ref.||preemptiv milrinon,0.363||0.363||0.298||0.266||0.262||0.262||0.254||0.233||0.19||0.19||0.19||0.189||0.188||0.188||0.185,0.6,0.4,0.26666666666666666
366,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998889.txt,locoregion rit||surviv time||resect caviti||mri||high radiat dose||baselin||studi||valu||recurr||patient||tumour-fre statu||fet||fet uptak||effect||sensit tool||intracavitari radioimmunotherapi||clinic deterior||threshold||highest uptak||blood-brain barrier||criterion||normal brain tissu||present studi||treatment||malign glioma||tumour recurr||tumour||ratio||post-therapeut phase||analysi||reliabl indic||residu tumour||initi surgeri||uptak||radiat therapi||pet||peak||contrast||addit||serial fet pet||rit||result,fet||fet pet||rit||fet uptak||pet||04||fet pet monitor||serial fet pet||conclus fet pet||patient fet uptak||glioma||highest fet uptak||serial fet pet scan||serial fet pet monitor||max,0.437||0.364||0.327||0.309||0.291||0.262||0.26||0.259||0.243||0.223||0.215||0.211||0.21||0.208||0.198,0.8,0.5,0.3333333333333333
367,Bioinformation-1-6-1891690.txt,databas,dod2006||databas||web databas dod2006||dod2006 newli||append databas||databas categori||databas entri||databas suit||bioinform bioinform bioinform||visakhapatnam||molecular biolog databas||12. organel databas||5. genom databas||gene express databas||4. structur databas,0.51||0.428||0.322||0.269||0.269||0.261||0.249||0.228||0.211||0.185||0.181||0.158||0.157||0.153||0.15,0.2,0.1,0.06666666666666667
368,Skeletal_Radiol-4-1-2257990.txt,high intens||advanc imag||case||radiograph||entir marrow space||mri||imag||vertebr bodi||patient||lumbar vertebra||chordoma||bnct||lesion||adipocyte-lik vacuol chordoid cell||metastat diseas||soft tissu mass||pain||benign notochord cell tumor||progress diseas||bone scintigram||tumor||biopsi||surgic procedur||notochord vestig||bone||low signal intens||diagnosi||giant notochord rest,chordoma||classic chordoma||intra-oss chordoma||incipi chordoma||curettag chordoma aliv||notochord vestig||biopsi chordoma aliv||bnct||marten F. chordoma||L5 chordoma die||benign notochord cell tumor||vertebr notochord rest||vertebr chordoma yamaguchi takehiko||giant notochord rest||notochord cell origin,0.567||0.296||0.294||0.292||0.243||0.235||0.234||0.224||0.21||0.205||0.191||0.187||0.185||0.175||0.161,0.2,0.3,0.3333333333333333
369,Histochem_Cell_Biol-4-1-2323029.txt,subsequ studi||type||mechan||organel||viral transmiss||thin||tnt||data||intercellular transfer||tunnel nanotub||membran continu||cell||direct transfer||tissu||virus||similar structur||mitochondria||format||tnt-like structur||nanotub||transfer||bridg||connect||plasma membran,nanotub||tunnel nanotub||membran nanotub||f-actin||tnt-like connect||drosophila||tnt-like structur||cell||distinct membran nanotub||cell protrus||connect cell||nanotub facilit commun||cell protrus drosophila 2007||intercellular bridg||davi DM membran nanotub,0.333||0.217||0.217||0.203||0.201||0.197||0.19||0.175||0.146||0.141||0.128||0.125||0.124||0.123||0.121,0.4,0.4,0.26666666666666666
370,Eur_Arch_Otorhinolaryngol-3-1-2042030.txt,imdd||biopsi||midlin facial structur||complaint||case||local||progress ulcer||lesion||palat||radiotherapi||diseas||radiat ulcer||patient||year||rare diseas||physic examin||treatment||re-irradi||total dose,re-irradi||midlin||idiopath midlin||radiat||radiat ulcer||destruct||lethal midlin granuloma||recurr midlin||ulcer||destruct diseas radiotherapi midlin granuloma||imdd||reirradi||irradi area re-irradi||neck||radiat oncolog,0.384||0.338||0.244||0.211||0.197||0.192||0.187||0.184||0.182||0.168||0.165||0.165||0.162||0.155||0.15,0.4,0.2,0.2
371,Purinergic_Signal-3-1-2096766.txt,role||respons||cd39||vascular inflammatori||cellular immun respons||data||adenosin||effect||treg||atp||platelet||major defect||dendrit cell||receptor||express||cell||immunoregulatori function||lymphocyt||ecto-enzym||ecto-nucleotidas||function||ecto-atpas||vasculatur||immun respons,cd39||cd39 cd39||cd39 cd39 3 cd39 3||panel cd39||cd39 express||cd39 function||cd39 28 cd39 28||2007 cd39||robson SC cd39||cd39 famili modul||robson SC palmitoyl target cd39||human cd39 transgen mice||s11302-006-9050-i origin paper cd39||robson||cd39 lymphoid cell activ antigen,0.775||0.775||0.465||0.398||0.397||0.393||0.389||0.388||0.345||0.272||0.211||0.206||0.199||0.183||0.181,0.2,0.1,0.06666666666666667
372,J_Med_Internet_Res-5-4-1550572.txt,person||attempt||time||behavior||studi||adolesc searcher||question||school||observ||inform||correct||site||qualit data||adult||content||similar||health educ||page||web||success||result||factor||topic||issu||comput literaci||adolesc||survey||link||answer||internet,search||student||search engin||search question||search string||unsuccess search||success search||search tactic||search behavior||search phrase||search simul||search topic search topic||adolesc search behavior||search strategi||search term,0.546||0.383||0.352||0.335||0.324||0.321||0.318||0.303||0.303||0.303||0.296||0.293||0.29||0.283||0.28,0.0,0.0,0.0
373,Support_Care_Cancer-3-1-2092408.txt,sr||cancer||measur||level||time||measur time||distress||studi||year||patient||physic function||chemotherapi||refer group||start||qol||testicular cancer||mental health||spous||coupl||treatment||relationship||social function||stress respons symptom||correspond||differ||partner||diagnosi||function||children,sr||partner||testicular cancer||testicular cancer survivor||cancer||testicular cancer patient||qol||testicular germ-cel cancer||partners’ sr||dissemin testicular cancer||testicular cancer treatment||testicular cancer-review||testicular cancer-pati||cancer patient cancer||sever sr,0.364||0.323||0.314||0.242||0.239||0.237||0.236||0.221||0.219||0.219||0.216||0.204||0.204||0.187||0.185,0.8,0.5,0.3333333333333333
374,J_Mol_Med-3-1-2121656.txt,hypoxia||hif||therapeut||brain||stroke,hif||stroke||prolyl||hif phd1||hif phd||hypoxia||divert hif||hif prolyl 4 hydroxylas||hypoxia-induc stroke toler||hif phd3 inhibit||hif phd isoform||stroke therapeut||hypoxia-induc factor-1||stroke pathophysiolog||acut stroke,0.352||0.261||0.22||0.21||0.205||0.203||0.185||0.185||0.163||0.148||0.148||0.147||0.145||0.139||0.139,0.4,0.3,0.2
375,J_Gastrointest_Surg-3-1-1915638.txt,follow-up||center||complic||data||studi||year||eea||long-term result||leakag||stent||patient||stent therapi||stenosi||endoscop||treatment||present studi||addit therapi||reconstruct surgeri||bdi||strictur||end-to-end anastomosi||surgeri||injuri||cholecystectomi||bile duct injuri||bile duct||surviv||long-term stricture-fre surviv||data analys||percutan transhepat catheter||duct||procedur||present seri||referr||outcom,eea||duct||bile duct||perop eea||complic eea||eea patient||eea procedur||primari eea||previou eea||eea popul||bile duct injuri||cholecystectomi||eea endoscop treatment||postop bile duct||intrahepat bile duct,0.536||0.326||0.325||0.317||0.316||0.3||0.286||0.28||0.272||0.269||0.254||0.245||0.238||0.237||0.228,0.6,0.3,0.3333333333333333
376,Soc_Psychiatry_Psychiatr_Epidemiol-2-2-1764204.txt,popul center||servic util||alcohol abus||rate||tarapaca||data||socio-demograph differ||studi||substanc abus disord||bio bio||region||mental health||disord||countri||interview||chile||drug abus||psychiatr disord||major depress disord||conclus region differ||analysi||lifetim||popul||servic||major depress||region differ||differ||drug||household||mental health servic||span wide geograph area||district,disord||psychiatr disord||mental disord||panic disord||anxieti disord||dsm-iii-r disord||region disord||substanc abus disord||disord rate||schizophreniform disord||delusion disord||affect disord||schizoaffect disord||psychot disord||cognit disord,0.322||0.237||0.231||0.224||0.22||0.199||0.199||0.184||0.174||0.174||0.174||0.173||0.173||0.166||0.166,0.4,0.3,0.2
377,Arch_Orthop_Trauma_Surg-4-1-2225998.txt,measur||reproduc||tradit measur techniqu||radiu fractur||studi||patient||radial length||distal radiu fractur||x-ray||direct measur||observ||AO fractur type||improv||classif||reduct result||techniqu||volar angul||radiu||normal valu||radial inclin||templat||distal radiu||distal radial fractur||side||result,fractur||distal radial fractur||radiu fractur||unilater distal radial fractur||distal radiu fractur||radial inclin||radial styloid||fractur side||radial axi||unilater disloc distal radial fractur||distal radial oper||distal radial fractur van eerten||colles’ fractur||radial length||templat,0.435||0.394||0.31||0.307||0.299||0.291||0.265||0.26||0.256||0.253||0.251||0.245||0.245||0.245||0.24,0.6,0.4,0.4
378,Eur_J_Appl_Physiol-3-1-1914221.txt,level||deficit||studi||patient||year||life||liver transplant||complaint||test||neuromuscular fit||liver transplant recipi||cross-sect studi||norm valu||present studi||fit||ltx||relationship||bodi composit||percentag||rehabilit program||sedentari person||sever||fatigu||isokinet strength||gener popul,2peak||2peak ffm||2peak recr||fit||liver transplant||fatigu||transplant||cardiorespiratori fit||liver transplant recipi||physic fit||transplant liver patient||orthotop liver transplant||neuromuscular fit||6mwd||liver transplant databas,0.505||0.329||0.312||0.233||0.218||0.216||0.214||0.191||0.187||0.177||0.154||0.153||0.151||0.148||0.147,0.4,0.4,0.3333333333333333
379,Diabetologia-3-1-1914285.txt,upregul||lipid content||level||matur adipocyt||thiazolidinedion||adipokin||adipocyt||tzd||prostaglandin metabol||secret protein||lipolysi||rosiglitazon||rosi||adipos tissu||increas||low insulin||insulin||adipos||cell type||treatment||cell||gene||protein||lipid accumul||analysi||fatti acid||chang||metabol||decreas||secret||pathway||result,rosiglitazon||adipocyt||insulin rosiig rosiglitazon||rosiglitazon treatment||result rosiglitazon||3t3-l1 adipocyt||matur adipocyt||pcr rosi rosiglitazon||insulin||matur 3t3-l1 adipocyt||adipocyt differenti||rosiglitazon stimul adipogenesi||adipocyt 11beta||1.52 0.000||1.63 0.000,0.45||0.307||0.251||0.228||0.226||0.219||0.197||0.192||0.184||0.175||0.169||0.166||0.161||0.161||0.158,0.4,0.4,0.26666666666666666
380,Ann_Hematol-4-1-2413090.txt,md||case||ipss||studi||patient||cytogenet find||clinic manag||therapeut strategi||complex abnorm||cell||gene||delet||result||prognosi||month||cytogenet||multicentr studi||group||genet materi||profound||median surviv||prognost relev||monosomi 7||karyotyp||deleteri cytogenet alter||anomali||monosomi,cytogenet||md||5q||imraw cytogenet md||keyword md cytogenet||7q||cytogenet subgroup||cancer cytogenet||poor-risk cytogenet||myelodysplast syndrom||poor cytogenet||cytogenet profil||cytogenet follow-up||cytogenet featur||cytogenet respons,0.379||0.281||0.25||0.229||0.22||0.212||0.203||0.203||0.201||0.198||0.198||0.198||0.195||0.193||0.192,0.4,0.2,0.13333333333333333
381,Mol_Genet_Genomics-4-1-2329726.txt,condit||gene||human||strain||absent||gene pool||abu||genom||number||transcript||microarray||hypothet protein||urinari tract infect||urinari tract||environment condit||analysi||upec||up-regul||gene express||asymptomat bacteriuria,83972||strain 83972||strain 83972 E. coli||escherichia coli||escherichia coli E. coli||escherichia coli strain||abu strain 83972||83972 grown||strain 83972 island||cft073||strain 83972 descript||strain||escherichia coli bacteriuria||2008 escherichia coli strain||escherichia coli isol,0.561||0.402||0.351||0.319||0.31||0.294||0.292||0.285||0.28||0.275||0.269||0.243||0.24||0.224||0.222,0.0,0.0,0.06666666666666667
382,Int_Urogynecol_J_Pelvic_Floor_Dysfunct-4-1-2259253.txt,measur||pregnanc||data||studi||pad test||stress urinari incontin||test||women||self-report symptom||curv||diagnost strength||urinari incontin||group||symptom||clinic relev||sever||childbirth||incontin||weight gain||pad||result,incontin||pad||urinari incontin||incontin women||self-report incontin||pad test||stress incontin||patient-report incontin||sever incontin||femal incontin||transient incontin||incontin research||self-report urinari incontin||stress urinari incontin||pregnanc,0.567||0.549||0.384||0.353||0.317||0.316||0.301||0.292||0.291||0.288||0.287||0.286||0.278||0.267||0.255,0.6,0.4,0.4
383,Health_Care_Anal-4-1-2362137.txt,polici develop process||target group||interact polici develop||databas||problem||pam||data||theori||patient||effect||neurologist||develop||criteria||central pre-utilis approv||central committe||nation databas||clinic practic||variabl||clinic trial||guidelin||medic advisor||intervent||hcib||treatment||argument polici analysi||cost||health||workshop||polici||nation registri||clear protocol||interferon-beta||actor||specif recommend||target popul||order||reimburs||long-term effect||multipl sclerosi||drug||interact process||ministri||reimburs request||particip||drug interferon-beta,ifnβ||ifnβ reimburs||reimburs ifnβ||ifnβ prescript||save ifnβ||ifnβ show||polici||ifnβ user actor||ifnβ ’s effect||ifnβ ’s abil||ifnβ ’s introduct||neurologist||polici implement||polici problem||effect ifnβ effici pam staff,0.708||0.417||0.417||0.371||0.357||0.355||0.318||0.286||0.243||0.241||0.24||0.201||0.192||0.187||0.185,0.0,0.1,0.13333333333333333
384,Eur_J_Clin_Pharmacol-4-1-2254473.txt,find||beta-lactam antibiot||outpati antimicrobi treatment||model||studi||patient||admiss||cap||mortal||pneumonia||antibiot||caus pathogen||treatment||antimicrobi therapi||atyp pathogen||hospit||microbi aetiolog||diagnost workup||antimicrobi drug||predictor||co-morbid||potenti predictor||initi treatment||aetiolog||hospit admiss||diagnosi||bacteria,pneumonia||community-acquir pneumonia||streptococcu pneumonia||viral pneumonia||mycoplasma pneumonia||pneumonia sever||suspect pneumonia||community-acquir pneumonia neth||atyp mycoplasma pneumonia||bt pneumonia guidelin||commun acquir pneumonia||S. pneumonia H.||S. pneumonia 19||pneumonia sever index||danc DA streptococcu pneumonia,0.689||0.461||0.382||0.373||0.371||0.351||0.349||0.312||0.282||0.263||0.248||0.247||0.244||0.239||0.196,0.2,0.1,0.06666666666666667
385,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2413121.txt,placebo||inflamm||nsaid||cartilag lesion||anterior cruciat ligament||intern knee document committe||studi||patient||joint preserv||function recoveri||effect||chondroprotect||follow-up visit||form||increas||recoveri||articular cartilag||knee pain||cartilag||treatment||i-on||day||control||joint reaction||studi design||sport activ||pemf||arthroscop reconstruct||pain||placebo group||activ||group||ikdc knee examin form||biophys stimul||recoveri time||signific differ||procedur||score||puls electromagnet field||result,i-on||ikdc||knee||knee cartilag||cartilag||acl||articular cartilag||i-on group||i-on treatment||setti||acl reconstruct||knee pain||cadossi||articular cartilag protect||ikdc form,0.307||0.256||0.255||0.253||0.251||0.212||0.208||0.172||0.166||0.162||0.156||0.155||0.153||0.141||0.14,0.4,0.3,0.26666666666666666
386,Neurogenetics-4-1-2238789.txt,gene||SI _ figur _||probe||link||biolog associ||lewi bodi||number||drug||interact||microarray||iter analysi||substantia nigra||data||express||studi||neurodegener||complet list||diseas||cell,parkinson||SI _ figur _||SI _ figur||SI _ figur _ 2||SI _ figur _ 1||SI _ tabl||parkinson diseas||parkinson ’s||1b http://www.morphonom.net/ng/esm/f/si_figure_1b.png SI _ figur||1c http://www.morphonom.net/ng/esm/f/si_figure_1c.png SI _ figur||5 http://www.morphonom.net/ng/esm/f/si_figure_5.png SI _ figur||3 http://www.morphonom.net/ng/esm/t/si_table_3.xl SI _ figur||1b http://www.morphonom.net/ng/esm/t/si_table_1b.txt SI _ tabl||1c http://www.morphonom.net/ng/esm/t/si_table_1c.xl SI _ tabl||1a http://www.morphonom.net/ng/esm/t/si_table_1a.xl SI _ tabl,0.337||0.328||0.292||0.263||0.263||0.256||0.201||0.193||0.185||0.185||0.18||0.18||0.164||0.163||0.163,0.2,0.1,0.06666666666666667
387,Eur_J_Health_Econ-3-1-1913175.txt,copd||cost effect||data||model||patient||valu||year||effect||tiotropium||ipratropium group||ipratropium||spain||qali||util||clinic trial||prefer option||analys||perspect||treatment||cost||diseas state||spanish nation health system||similar declin||month||life year||salmeterol||scenario||gener practition||econom evalu||chronic obstruct pulmonari diseas||differ||scenario analys||trial||sever||probabl||bronchodil||spanish healthcar utilis||ce-plan,tiotropium||copd||salmeterol||ipratropium||exacerb||exacerb cost||inhal tiotropium||tiotropium pulm||tiotropium trial||tiotropium 1.80||tiotropium group||daili tiotropium||tiotropium eur||tiotropium salmeterol ipratropium moder sever||cost,0.446||0.307||0.304||0.273||0.261||0.241||0.24||0.235||0.234||0.228||0.227||0.225||0.225||0.222||0.221,0.8,0.4,0.3333333333333333
388,Ann_Surg_Oncol-4-1-2244700.txt,cancer||studi||prolif activ||prognost signific||correl||section||apoptot cell||perimembran||postop surviv||poor prognosi||overexpress||present studi||nsclc||neg control slide||signific factor||prognosi||surgeri||tumor||cell mitosi||aurora-a||lung cancer||non-small-cel lung cancer||clinic studi||result,aurora-a||aurora-a express||aurora-a statu||aurora-a contribut||perimembran aurora-a express||stk15||aurora-a express statu||immunohistochemistri aurora-a express||aurora-a protein express||conclus perimembran aurora-a statu||aurora-a 22 22||2007 purpos aurora-a||aurora||perimembran||kinas stk15,0.666||0.369||0.36||0.334||0.318||0.276||0.264||0.249||0.248||0.235||0.226||0.224||0.221||0.217||0.172,0.2,0.1,0.13333333333333333
389,J_Med_Internet_Res-7-3-1550657.txt,cancer||method||interest||search activ||internet user||common cancer||search engin||onlin inform||studi||media coverag||cancer search activ||test||user||health inform||news||buzz index||news media||health||term||month||popul||incid||neoplasm||yahoo||specif cancer type||time period||news coverag||breast||score||internet,yahoo||cancer cancer yahoo||daili yahoo||search engin yahoo||search||2003 yahoo||identifi yahoo||prostat cancer yahoo||cancer search||internet search||cancer||cancer cancer||internet||news||cancer search activ,0.624||0.359||0.34||0.33||0.327||0.315||0.314||0.301||0.277||0.269||0.226||0.226||0.21||0.206||0.201,0.2,0.1,0.3333333333333333
390,Exp_Brain_Res-3-1-2080346.txt,musculoskelet factor||maxim flexion||target||find||present experi||visuo-motor track||extens excurs||flexion||effect||feedback signal||organ||form||region||variabl||point||coordin dynam||harmon||maxim extens||cycl||dynam||present studi||wrist postur||phase space||phase||analysi||direct||musculoskelet underpin||execut||veloc profil||trial||global kinemat||shorter||particip||wrist||stroke patient||experiment trial||movement trajectori||endpoint variabl||global track behavior||anchor||extens||full track trajectori||peak veloc,gaze||anchor||wrist||wrist postur||wrist movement||wrist postur gaze direct postur||spatial anchor||tempor anchor||gaze direct||flexion||anchor endpoint||wrist postur block||neutral wrist postur||anchor point||gaze fixat,0.32||0.308||0.299||0.259||0.228||0.223||0.204||0.193||0.188||0.182||0.18||0.178||0.178||0.174||0.17,0.6,0.4,0.26666666666666666
391,Bioprocess_Biosyst_Eng-2-2-1705497.txt,optim valu||set||individu||problem||design variabl||amount||bit||multi-object experiment optim||process||mop||multi-object optim||variabl||softwar tool||experiment effort||small popul size||experi||popul||algorithm||experiment design||genet algorithm||gener||object||result,game.opt||mathbf||_{||game.opt perform||algorithm||method game.opt||multi-object optim||text||multi-object experiment optim||experiment multi-object optim||0||_{ 6||_{ 5||_{ 1||incr,0.203||0.183||0.157||0.104||0.103||0.102||0.099||0.087||0.087||0.087||0.08||0.079||0.079||0.079||0.074,0.2,0.3,0.2
392,Apoptosis-4-1-2423418.txt,st||effect||control||hicc||process||electron cell||regulatori volum increas||apoptosi||hela cell||experi||shrunken cell||rvi||avd||hyperton stress||cation channel||cell shrinkag||activ||channel||cell||hypertonicity-induc cation channel,hicc||avd||wehner||apoptosi apoptosi||apoptosi||hicc activ||hypertonicity-induc cation channel||hicc activ inhibit avd||rvi||cation channel||apoptosi pfluger||osmot hicc activ||j.1748-1716.2006.01561.x wehner||avd process||minu minu,0.361||0.278||0.27||0.247||0.247||0.197||0.172||0.172||0.167||0.161||0.159||0.153||0.149||0.147||0.145,0.6,0.6,0.4
393,Transgenic_Res-3-1-1829418.txt,tumor latenc||mammari tumor phenotyp||latenc||breast cancer||model||studi||data||fvb||effect||strain||increas||background||metastasi||mice||ino defici||analysi||mammari tumorigenesi||tumor||differ||mous||pymt||phenotyp||molecular pathway||gland||ino||result,mammari gland||mammari tumor||mammari tumorigenesi||pymt||gland||pymt B6||mammari epithelium||inguin mammari gland||mammari gland hyperplasia||mammari gland develop||mammari gland initi||mammari develop||transgen mammari tumor||mammari line||B6,0.282||0.252||0.225||0.217||0.202||0.198||0.197||0.194||0.192||0.19||0.189||0.184||0.183||0.183||0.179,0.6,0.3,0.2
394,Eur_J_Pediatr-3-1-2039787.txt,neuro-cognit sequela||aspect||intens care treatment||measur tool||psycholog sequela||qualiti||studi||patient||life||effect||health statu||review||qol||outcom||treatment||sequela||health||paediatr intens care unit||lung function||parent||origin ill||post-traumat stress disord||famili||survivor||follow-up research||support||function||children,"picu||picu survivor||survivor||mother picu||ward picu survivor||3,444 picu survivor||picu admiss||diseas picu||picu discharg||52 picu||picu 10.5||picu 50||picu 1||pediatr survivor||paediatr survivor",0.492||0.39||0.289||0.276||0.273||0.268||0.26||0.259||0.251||0.25||0.249||0.248||0.246||0.203||0.196,0.2,0.1,0.06666666666666667
395,J_Gastrointest_Surg-3-1-1915599.txt,anim||reproduc||immun system||laboratori anim||treatment strategi||organ sampl||mucos barrier function||rout||pancreat||model||studi||anim model||biliopancreat duct||effect||experiment studi||human||intestin flora||anim speci||treatment||duoden content||rat||infect||sever acut pancreat||bacteri transloc||fals posit result||earli mortal||sever||acut pancreat||diseas||intestin motil||bacteria||bacteriolog result||immun respons||result,pancreat||acut pancreat||pancreat duct||pancreat sepsi||bacteri pancreat infect||pancreat necrosi||pancreat secretagogu||hemorrhagic-necrot pancreat||pancreat morpholog||experiment acut pancreat||acut experiment pancreat||bacteri transloc||bile-induc acut pancreat||sever acut pancreat||acut pancreat Br,0.595||0.408||0.35||0.324||0.317||0.315||0.311||0.306||0.304||0.288||0.288||0.285||0.278||0.278||0.276,0.4,0.2,0.26666666666666666
396,Cardiovasc_Intervent_Radiol-3-1-2062488.txt,esophag varic||cathet||transjugular intrahepat portosystem shunt||patient||tip||intervent radiolog||placement||varic||collater vein||portal vein||avp||varic bleed||devic||liver||closur||portal vein collater||avp devic||amplatz vascular plug||procedur||embol||large-diamet vessel||creation||emerg procedur,avp||avp embol||avp placement||embol||tip||avp devic||varic||16-mm-diamet avp||avp deliveri||avp ’s||transhepat avp placement||vein embol||tip placement||avp devic proper||bleed varic,0.53||0.418||0.333||0.306||0.306||0.303||0.298||0.279||0.27||0.266||0.262||0.261||0.221||0.209||0.205,0.6,0.5,0.3333333333333333
397,Cancer_Causes_Control-4-1-2323031.txt,program||cancer||categori||mammographi||gp||women||repres sampl||screen||fear||result||rate||subject||nationwid opinion poll||franc||evid||gener practition||reason||crc||gener popul||cancer screen,screen||franc||cancer screen||crc screen||gp||cancer||cancer screen test||screen test||screen program||PC screen||edific||screen rate||oncogenet screen||screen status||cancer screen procedur,0.429||0.341||0.335||0.307||0.249||0.242||0.241||0.241||0.238||0.236||0.235||0.234||0.234||0.232||0.226,0.8,0.5,0.3333333333333333
398,Naturwissenschaften-4-1-2270361.txt,condit||anim||hair||infant||mother||bodi angl||problem||primat||gorilla||valu||cling||densiti||mechan properti||bodi hair||human||forc||friction||african ape||infant carri||load||gibbon||human hair||orangutan||result||bodi||curv||biped||adult bodi||scenario||chang||weight||young modulu||skin||ape||posit||limit||area||safeti,hair||ape hair||hair friction||hominoid hair||ape||bodi hair||mother hair||hair keratin||human hair||hair densiti||hair structur||hair thick||curl hair||hair pull-out||singl hair,0.558||0.438||0.368||0.322||0.318||0.298||0.297||0.295||0.293||0.291||0.289||0.288||0.288||0.285||0.285,0.4,0.4,0.26666666666666666
399,Breast_Cancer_Res_Treat-3-1-2092407.txt,shape factor form _ AR||case||nuclear morphometr featur||benign tissu||nuclear size||histori||breast cancer||patient||bbd||multivari analys||risk||breast tumor tissu||case-control studi||nuclear area||famili histori||featur||analys||control||women||form _ AR||associ||longest axi||subject||perimet||nuclear perimet||risk factor||subsequ develop||shape factor||area||benign breast diseas||form _ nci||longest nuclear axi||diagnosi||hyperplasia||morphometri,breast||breast cancer||bbd||nuclear morphometri||nuclear axi||nuclear perimet||breast cancer risk||morphometri||subsequ breast cancer||breast carcinogenesi||invas breast cancer||shortest nuclear axi||breast int||breast cancer patient||breast cancer case,0.464||0.335||0.323||0.299||0.273||0.255||0.24||0.239||0.238||0.238||0.236||0.235||0.235||0.228||0.228,0.4,0.4,0.26666666666666666
400,Int_J_Cardiovasc_Imaging-3-1-2121119.txt,LA contractil||ventricular||measur||lav||eject fraction||studi||left atrial volum||patient||aei||la-k||wall thick||aa-sv||mass||lad||control||hypertroph cardiomyopathi||LA size||group||differ||LA conduit||hcm||atrial volum||function,hcm||non-obstruct hcm||hypertroph cardiomyopathi||obstruct hcm||hcm patient||conclus hcm||atrial fibril||non-obstruct hcm patient||atrial volum||atrial wall||left atrial volum||obstruct hcm patient||apic hypertroph cardiomyopathi||left atrial enlarg||symptomat hypertroph cardiomyopathi,0.439||0.279||0.259||0.258||0.239||0.221||0.201||0.199||0.198||0.193||0.186||0.185||0.183||0.182||0.182,0.4,0.3,0.26666666666666666
401,Support_Care_Cancer-4-1-2206248.txt,type||cancer||time||total problem||problem||studi||patient||recurr||physic problem||health statu||qol||spous||aim||treatment||cancer patient||relationship||signific relationship||male partner||psychosoci||age||parent||parent cancer||report||group||ill||adolesc||treatment intens||diagnosi||norm||score||function||children,qol||spous||cancer||spouses’ qol||spouses’||patients’ qol||parent qol||spous ’s qol||cancer patients’||parent cancer||cancer patient cancer||parents’ qol||male spouses’ qol||femal spous||cancer patients’ qol 1,0.305||0.305||0.286||0.267||0.228||0.228||0.228||0.221||0.219||0.219||0.216||0.201||0.198||0.187||0.186,0.6,0.4,0.26666666666666666
402,Intensive_Care_Med-3-1-2039828.txt,serum||GM assay||combin||patient||diagnost process||high tropism||breakthrough infect||ipa||relat||human studi||sign||clinic trial||antifung therapi||treatment||invas diseas||voriconazol||fungal infect||non-invas diagnost test||combin therapi||chronic obstruct pulmonari diseas||invas pulmonari aspergillosi||drug||pcr||risk factor||oral administr||diagnosi,aspergillosi||aspergillu||invas aspergillosi||pulmonari aspergillosi||aspergillosi non-neutropen||multiple-triazole-resist aspergillosi||invas pulmonari aspergillosi||aspergillu aspergillu pcr||aspergillu niger aspergillu||conclus aspergillu aspergillu aspergillu pcr||lethal pulmonari aspergillosi||acut invas pulmonari aspergillosi||aspergillu antigen||scedosporium aspergillu||aspergillu speci,0.607||0.435||0.392||0.372||0.337||0.309||0.307||0.305||0.292||0.27||0.25||0.234||0.229||0.227||0.225,0.0,0.1,0.06666666666666667
403,Bioinformation-1-7-1891696.txt,web databas||inform||enzym||protein interact||cell signal||databas||dcse||hyperlink||tool||blast||biolog commun||sequenc||cell,dcse||databas||web databas databas||blast||sastra||web databas||coiled-coil structur||coiled-coil region||bioinform bioinform bioinform||databas pblast||abovement databas||multicoil||enzym||databas interfac||coiled-coil predict tool,0.405||0.274||0.225||0.21||0.205||0.2||0.196||0.188||0.188||0.178||0.166||0.162||0.159||0.152||0.142,0.6,0.4,0.3333333333333333
404,Behav_Genet-4-1-2257998.txt,case||suffici statist||exact simul||time||effect size||method||mont carlo||data||model||studi||genet design||transform||effect||fals hypothesi||raw data||power||paramet||summari statist||varianc||analysi||qtl||simul||power studi||power calcul||distribut||genotyp valu||group||DZ twin||number||sampl size||probabl||suffici summari statist||design,Σ||power||Σ μ Σ μ Σ μ||Σ μ||upbeta||simul||Σ μ Σ μ 1996 Σ||bmod||qtl||upbeta _{||varvec||exact simul||_{||mathbf||power calcul,0.155||0.131||0.129||0.129||0.125||0.116||0.113||0.113||0.111||0.107||0.094||0.09||0.09||0.087||0.085,0.2,0.3,0.3333333333333333
405,Breast_Cancer_Res_Treat-4-1-2244694.txt,irregular categori||testosteron||menstrual cycl||cancer||level||find||breast cancer||studi||year||lifetim exposur||risk||menopaus||cycl||breast cancer risk||androgen||androstenedion||menarch||fftp||cumul number||dhea||women||trend||age||characterist||lifetim||sex hormon level||number||physic activ||risk factor||particip||shbg||reproduct characterist||hormon||children||sex hormon,shbg||menstrual cycl||hormon||shbg level hormon||shbg level||shbg μg||dsl-4100 shbg||fftp||cancer||breast cancer cancer||breast cancer||breast cancer breast cancer||breast||menstrual characterist||menstrual factor,0.322||0.201||0.197||0.181||0.173||0.17||0.167||0.161||0.158||0.158||0.158||0.158||0.157||0.151||0.144,0.6,0.5,0.4
406,J_Neurol-3-1-1915650.txt,follow-up||method||db||reduct||studi||intent tremor||patient||effect||advers effect||tremor amplitud||scale||ataxia||intent||tremor reduct||treatment||function improv||case report||thalamotomi||tremor||isoniazid||limb||multipl sclerosi||trial||placement site||movement||disabl||superior cerebellar peduncl||articl,tremor||intent tremor||cerebellar tremor||bilater tremor||postur tremor||arm tremor||tremor patient||clinic tremor||limb tremor||tremor sever||sever tremor||improv tremor||action tremor||tremor assess||tremor reduct,0.904||0.505||0.485||0.484||0.478||0.469||0.464||0.46||0.46||0.46||0.46||0.457||0.457||0.457||0.456,0.4,0.2,0.2
407,J_Struct_Funct_Genomics-3-1-2140095.txt,crystal||dehydrogenas||target||protein kinas||case||method||structur determin||wide scientif audienc||drug develop||target area||scientif commun||determin||data||sgc||pdz||develop||inform||human||structur||domain||class||reductas||compound||specif||protein structur||inhibitor||approach||enzym||protein||success||metabol enzym||data collect||ligand screen||nmr||oxford||wide structur rang||protein character||gener||famili member||import||number||diseas||purifi protein sampl||ligand,sgc||crystal||crystal structur||sgc target||sgc oper||protein||crystal screen||protein structur||structur||margin crystal||crystal optim||crystal character||crystal imag||nanolitr crystal||crystal condit,0.407||0.328||0.256||0.246||0.214||0.2||0.193||0.192||0.184||0.178||0.177||0.177||0.175||0.174||0.171,0.4,0.5,0.3333333333333333
408,Skeletal_Radiol-4-1-2335296.txt,find||mri||calcan edema||logist regress||studi||patient||pearson chi-squar analys||calcan spur format||nerv||marker||inferior calcan nerv||achil tendinosi||plantar enthesophyt||abductor digiti minimi atrophi||plantar fasciiti||ptt dysfunct||initi report||analysi||age||calcan spur||format||posterior tibial tendinosi||atrophi||adma||foot||order||presenc,adma||plantar calcan||calcan spur||plantar||plantar fasciiti||calcan edema||calcan spur format||plantar nerv||abductor digiti||abductor digiti minimi||inferior calcan nerv||abductor digiti minimi atrophi||plantar nerv entrap||atrophi||calcan edema 0.005,0.435||0.389||0.33||0.325||0.283||0.257||0.225||0.22||0.212||0.207||0.206||0.199||0.177||0.174||0.174,0.6,0.5,0.5333333333333333
409,Eur_J_Appl_Physiol-4-1-2267484.txt,muscl||find||modul||data||studi||motor cortex||walk||healthi subject||test||central fatigu||contractil properti||muscl damag||spinal modul||signific recoveri||evok potenti||day||dom||voluntari contract||subject||exercis||intens||mvt||decreas||maxim voluntari torqu||muscl sore||plantar flexor muscl||result,"max||exercis||dom||muscl||muscl sore||muscl fatigu||fatigu||soleu||eccentr exercis||walk exercis||max soleu gastrocnemiu mediali||max intens||exercis intens||voluntari muscl drive||1,9",0.303||0.274||0.223||0.213||0.206||0.2||0.186||0.18||0.178||0.176||0.175||0.164||0.15||0.148||0.147,0.8,0.4,0.26666666666666666
410,Eur_Radiol-3-1-1779628.txt,cancer||neoadjuv therapi||mri||imag||studi||patient||coil system||crm||mesorect fascia||rectal carcinoma||local excis||local stage||fov||import anatom landmark||rectal tumor||import criterion||recent year||accuraci||imag modal||power gradient system||local recurr||mesorect fatti tissu||tumor||eu||rectal cancer||sequenc||stage,rectal cancer||rectal tumor||rectal carcinoma||rectal adenocarcinoma||rectal wall||rectal tumour||rectal cancer stage||rectal distens||resect rectal cancer||mri rectal carcinoma||T4 rectal cancer||rectal cancer Br||advanc rectal cancer||rectal cancer eur||rectal cancer surgeri,0.419||0.371||0.366||0.339||0.335||0.334||0.331||0.326||0.305||0.294||0.291||0.286||0.284||0.284||0.284,0.6,0.3,0.2
411,Pediatr_Nephrol-3-1-1915619.txt,gene||role||marker||vur||result||linkag||locu||sampl||linkag studi||children||famili,gdnf||gdnf ret||vesicoureter reflux||reflux||vur||ret||upk3a||agtr2||nonsyndrom vesicoureter reflux||primari vesicoureter reflux||upk1a upk3a||gdnf eya1||slit2||linkag||refer gdnf,0.275||0.241||0.241||0.232||0.213||0.207||0.195||0.176||0.169||0.163||0.163||0.152||0.147||0.14||0.138,0.2,0.1,0.13333333333333333
412,Pharm_World_Sci-3-1-2039831.txt,week||questionnair||melatonin||qualiti||patient||year||effect||medic||user||pdd||intervent||discontinu||low dose||daili dose||discontinu rate||gp||bd||gener practic||group||hypnot||differ||trial||particip||placebo control group||primari care||benzodiazepin||period,melatonin||benzodiazepin||benzodiazepin discontinu||melatonin group||melatonin primari||melatonin facilit discontinu||benzodiazepin hypnot||long-term benzodiazepin||anxiolyt benzodiazepin||benzodiazepin depend||chronic benzodiazepin||benzodiazepin investig||benzodiazepin 1993||random discontinu trial melatonin||discontinu,0.581||0.456||0.33||0.297||0.293||0.268||0.253||0.248||0.244||0.235||0.234||0.234||0.23||0.215||0.204,0.4,0.2,0.2
413,Clin_Oral_Investig-4-1-2238781.txt,case||indic||problem||studi||eros||wear||teeth||forc||depth||tooth wear||dentin||lesion||dental cari||relev||paramet||tissu||primari||acid||factor||exposur||sever||area||enamel||loss||diagnosi||dentit||score,dentin||eros||eros tooth wear||dentin eros 2||dental eros||tooth||tooth wear||wear||expos dentin||keyword tooth eros tooth||dentin exposur||palat eros||dentin loss||dentin hypersensitivity-ar||remineralis dentin,0.521||0.515||0.378||0.345||0.331||0.318||0.31||0.302||0.293||0.288||0.279||0.276||0.269||0.267||0.267,0.4,0.4,0.26666666666666666
414,Appl_Microbiol_Biotechnol-3-1-2043089.txt,biorefineri||calcul||n-function||advantag||econom||year||agricultur wast stream||arginin||plant compon||polym||amino acid||protamylass||bulk chemic||technic process||cost||raw materi||cyanophycin product||potenti||applic||ton||product||cyanobacteria||protein||ferment||paper||import group||cyanophycin||materi||larg scale||fossil raw materi||amino acid arginin||chemic||biomass||potato||large-scal ferment||organ acid||plant,cyanophycin||cyanophycin polym||cyanophycin product||cyanophycin biopolym||cyanophycin biosynthesi||cyanophycin synthetas||cyanophycin deriv||cyanophycin properti||cyanophycin modif||cyanophycin metabol||cyanophycin extract||cyanophycin accumul||gram-posit cyanophycin||cyanophycin molecul||cyanophycin elong,0.787||0.461||0.448||0.419||0.415||0.407||0.4||0.4||0.399||0.399||0.398||0.397||0.397||0.396||0.396,0.4,0.2,0.13333333333333333
415,Ann_Surg_Oncol-4-1-2266786.txt,biolog||deceas donor liver graft||liver graft||studi||patient||year||dropout rate||patient surviv||liver transplant||ldlt||criteria||morphology-bas stage system||select bia||favor preliminari surviv result||graft||hcc||olt||past 10 year||transplant||tumor||milan criteria||size||tumor morpholog||ucsf group||ddlt||outcom||result,hcc||liver transplant||transplant||ldlt||donor liver transplant||hcc patient||living-donor liver transplant||live donor liver transplant||liver graft||liver transplant recipi||hepatocellular carcinoma||conclus liver transplant||advanc hcc||1. hcc||pancreat tumor liver transplant,0.413||0.328||0.323||0.286||0.283||0.234||0.231||0.23||0.228||0.227||0.225||0.219||0.21||0.21||0.195,0.8,0.5,0.3333333333333333
416,Int_Arch_Occup_Environ_Health-4-1-2413125.txt,measur||regard||determin||studi||year||life||lower regress coeffici||life style||stress life event||multivari model||older age||increas||abil||variabl||mental health||work-rel factor||event||white-collar worker||health||studi popul health promot||higher score||psychosoci factor||lack||age||stress handl||associ||dimens||factor||wai||influenc||work abil||physic activ||work||demand||score||oldest age group||self-develop||result,abil||teamwork||self-develop||work abil||work teamwork||worker||work||work abil score||0.02 n.||white-collar worker||versu teamwork||work abil scand||0.54 n.||stress-handl||work abil index,0.268||0.242||0.237||0.229||0.216||0.194||0.19||0.176||0.176||0.173||0.168||0.165||0.162||0.16||0.159,0.6,0.5,0.3333333333333333
417,Cogn_Process-4-1-2254470.txt,mechan||attent||role||level||retent||find||time||behavior||modul||represent||pfc||episod buffer||inform||process||sensit||abil||complex||memori||integr||pattern||cognit control||evid||unit||stimuli||cell||neural model||brain||posterior part||control||posterior cortex||task||simul||neuron||neural pattern||recurr loop||mainten||coher||cell assembl||instanc||activ||recurr connect||order||cortex||activ state||relev inform||synchron||input||interact||interdepend function||prefront cortex||area||assembl||automat process||function,pfc||memori||prefront||prefront cortex||cortex||pfc represent||pfc modul||memori represent||pfc feedback||pfc area||pfc sourc||pfc involv||anterior prefront cortex||prefront assembl||human prefront cortex,0.452||0.381||0.335||0.314||0.293||0.279||0.252||0.244||0.239||0.239||0.229||0.228||0.218||0.215||0.214,0.8,0.4,0.26666666666666666
418,Neurochem_Res-4-1-2413118.txt,vector||level||DA level||data||studi||α-synuclein||gene express||ds oligo||express||cell||normal function||specif primer||DA biosynthesi||protein||activ||specif monoclon antibodi||dopamin||min||rna interfer||pcr||PD patholog,alpha-synuclein||α-synuclein||mn9d||alpha-synuclein gene||alpha-synuclein mutat||alpha-synuclein regul||alpha-synuclein function||alpha-synuclein share||alpha-synuclein display||alpha-synuclein increas||α-synuclein express||function α-synuclein||present α-synuclein||dopamin||mn9d cell,0.454||0.41||0.313||0.243||0.24||0.239||0.233||0.231||0.231||0.229||0.225||0.211||0.206||0.197||0.196,0.2,0.1,0.13333333333333333
419,Diabetologia-3-1-2039867.txt,genet varianc||type 2 diabet||variat||principl||total variat||lipid metabol||metabol characterist||model||studi||chorion||herit||effect||correl||hdl-cholesterol||environment factor||leptin level||east flander prospect twin survey||sex||trait||insulin||random intercept model||young healthi twin popul||varianc compon||total cholesterol||hdl-cholesterol ratio||varianc||twin||high rang||pair||metabol risk factor||genet factor||genet||MZ MC||quantit sex differ||fat mass||covari||MZ DC pair||insulin resist||twin studi,twin||twin twin||MZ twin||DZ twin||women twin||twin model||twin correl||vzw twin||twin int||adult twin||countri twin||femal twin||twin sampl||twin popul||danish twin,0.543||0.543||0.346||0.305||0.293||0.284||0.282||0.28||0.277||0.277||0.276||0.276||0.276||0.276||0.275,0.2,0.1,0.06666666666666667
420,J_Med_Internet_Res-5-4-1550579.txt,pharmaceut compani||method||common convers||studi||consum||difficulti||inform||criteria||process||site||consum search||web site||sourc||variabl qualiti||standard||internet||group||search||medicin||health public||issu||drug||particip||apprais skill||focu group||result,search||particip||internet||consum search||medicin particip||search engin||consum||internet-bas inform||inform||medicin search engin||search skill||medicin drug inform internet consum||health search||sourc particip||medicin,0.365||0.361||0.327||0.315||0.279||0.265||0.264||0.249||0.246||0.242||0.226||0.212||0.209||0.196||0.196,0.8,0.6,0.4666666666666667
421,Calcif_Tissue_Int-3-1-1914224.txt,vertebr fractur||follow-up||baselin||studi||year||allel||risk||promot||fractur||bmd||women||analysi||associ||independ effect||chang||osteoporosi||colia1||pcr cycl||femor neck bmd||haplotyp||bone miner densiti||result,colia1||colia1 colia1||llc 2007 colia1 colia1 colia1 colia1||colia1 polymorph||densiti fractur colia1||15 colia1||0.03 colia1 genotyp colia1 3||fractur||colia1 sp1 polymorph influenc bmd||2 colia1 genotyp||baselin colia1 genotyp 2 colia1 2||3 tabl 3 colia1 genotyp colia1||26 colia1 gene||s00223-007-9033-1 articl colia1||sp1,0.613||0.613||0.411||0.408||0.312||0.308||0.265||0.253||0.247||0.236||0.234||0.221||0.211||0.211||0.21,0.2,0.2,0.13333333333333333
422,Photosynth_Res-3-1-1769344.txt,aps-ito||OG micel||effici energi transfer||photosynthesi||electrod||IR spectra,palustri||R. rubrum||palustri R. rubrum rp||palustri rp||R. rubrum R.||2004 R. rubrum R. rubrum rp||1 R. rubrum R. rubrum rp||palustri bacterium R. rubrum rp||palustri 2003 R. rubrum rp||R. rubrum R. rubrum 1991 λ||2002 R. rubrum rp||method R. rubrum rp||4 R. rubrum rp||rp||2006 rhodospirillum rubrum rhodopseudomona palustri,0.375||0.371||0.341||0.31||0.299||0.29||0.288||0.275||0.273||0.253||0.247||0.247||0.247||0.245||0.219,0.0,0.0,0.0
423,Eur_Radiol-4-1-2373858.txt,follow-up||high tempor resolut imag||time||method||case||tempor resolut||mri||imag||studi||valu||morpholog characterist||clinic inform||malign group||benign||diagnost accuraci||total||reader||lesion||magnet reson imag||breast||imag protocol||initi enhanc||multivari analysi||local imag||evalu||analysi||min||order||auc||divers histolog distribut||perform||pharmacokinet paramet||signific differ||wash-out||lesion size 14 mm||malign lesion||diagnost perform||result,breast||breast lesion||breast mri||dynam breast mri||lesion||malign breast lesion||mri||benign lesion||smaller breast lesion||imag||suspici breast lesion||breast cancer||small breast lesion||acr breast||breast carcinoma,0.368||0.312||0.297||0.273||0.256||0.251||0.227||0.226||0.215||0.215||0.213||0.211||0.211||0.201||0.198,0.4,0.4,0.26666666666666666
424,Ann_Surg_Oncol-4-1-2190337.txt,cancer||center||data||studi||patient||hospit volum||mortal||high-volum center||risk adjust||volum||comorbid||treatment||in-hospit mortal||multivari analysi||hospit||case-mix||import determin||lvh||ptnm stage||clinic data||hvh||group||surviv||origin patient file||differ||esophag resect||adjust||resect||tumor stage||procedur||neoadjuv treatment||diseas||high-volum hospit||stage||outcom||result,lvh||outcom lvh hvh||hvh||adm||characterist lvh hvh||esophag resect||mortal||resect||in-hospit mortal||volum||resect esophag cancer||surgic mortal||surgic resect||hospit mortal||high-volum hospit,0.398||0.254||0.247||0.222||0.218||0.19||0.186||0.179||0.175||0.163||0.161||0.161||0.157||0.156||0.156,0.4,0.7,0.5333333333333333
425,Eur_J_Appl_Physiol-4-1-2225999.txt,food intak||measur||full||respons||cortisol level||level||session||lf-to-hf ratio||sensori rate||human||relat||increas||blood pressur||desir||heart rate||eat||food intak regul||amylas||food||subject||satieti||min||hunger||orosensori stimul||waist-to-hip ratio||hip circumfer||cortisol||oral activ,satieti||α α||α||food||appetit||food intak||perceiv satieti||satieti quotient||satieti cascad||orosensori||food stimul||food intak regul||food consumpt||data analys α α||comfort food,0.309||0.225||0.225||0.217||0.179||0.178||0.171||0.165||0.161||0.155||0.134||0.125||0.12||0.117||0.116,0.4,0.3,0.26666666666666666
426,Glycoconj_J-4-1-2234449.txt,antibodi||lmwh||gag||biolog characterist||nadroparin||anticoagul||enzymat digest||danaparoid||domain||chemic||sulodexid||enoxaparin||reactiv||heparinas||immunoprofil||sulfat||heparinoid||specif immunoprofil||heparin-induc thrombocytopenia,heparinoid||therapeut heparinoid heparinoid||anticoagul heparinoid||sulfat||heparinoid batch||complex heparinoid||heparin||heparan sulfat||sulfat c5-epimer||method heparinoid 1||sulodexid||sulfat mpb49||heparin heparin 5.0||chondroitin sulfat||glycosaminoglycan sulodexid,0.534||0.358||0.286||0.286||0.276||0.268||0.238||0.195||0.187||0.178||0.178||0.17||0.161||0.154||0.154,0.4,0.2,0.2
427,J_Med_Internet_Res-9-2-1913941.txt,medic research||nlm||interest||inform manag||session||studi||inform||open access||domain||altern medicin practition||user||profession||clinic practic||tool||chiropractor||specif||health||degre||research||pubm||inform retriev||full text||profession develop||abstract||servic||literatur||practition||medicin||access||full-text articl||limit||public||cam||particip||life scienc||articl,pubm||pubm search||bookshelf pubm||pubm tool||pubm session||pubm ’s||pubm resourc||pubm afterward||pubm central||pubm interact||chiropractor||search histori pubm||pubm search result||research access pubm||10 pubm tool,0.461||0.322||0.304||0.289||0.272||0.257||0.249||0.238||0.234||0.233||0.225||0.221||0.215||0.205||0.193,0.2,0.1,0.13333333333333333
428,Ann_Surg_Oncol-3-1-1914247.txt,follow-up||level||complic||ilp||object measur||patient||amput||year||median follow-up||perfus||st||femor PI||treatment||limb salvag treatment strategi||vascular complic||lower limb||ultrasonographi||month||arteri occlus diseas||critic leg ischemia||late vascular morbid||rang||limb||arteri occlus||vascular reconstruct||resect||poplit PI||ebrt||sarcoma||long-term vascular side effect,ebrt||sarcoma||ilp||limb||poplit PI||limb perfus||poplit arteri||amput||perfus||adjuv ebrt||primari poplit||iliac perfus||postop ebrt||upper leg amput||recurr poplit,0.312||0.275||0.24||0.236||0.216||0.212||0.21||0.193||0.188||0.178||0.175||0.171||0.165||0.164||0.163,1.0,0.7,0.4666666666666667
429,Osteoporos_Int-2-2-1705543.txt,method||bisphosphon||data||model||patient||conclus patient||effect||clinic practic||fractur||therapi||cohort||alendron||hip||nonvertebr fractur||month||incid||risedron||differ||osteoporosi||primari analysi||date||risk factor||trial||baselin characterist||hip fractur||health plan||result,fractur||nonvertebr fractur||risedron||alendron||osteoporosi fractur||nonvertebr fractur osteoporosi||hip fractur||nonvertebr fractur incid||fractur incid||nonvertebr fractur risk||vertebr fractur||fractur risk||traumat fractur||fractur rate||fractur outcom,0.528||0.426||0.396||0.384||0.359||0.348||0.339||0.307||0.298||0.295||0.283||0.28||0.272||0.27||0.27,0.8,0.5,0.3333333333333333
430,Clin_Oral_Investig-3-1-2099161.txt,rate||perman molar||studi||year||cari||effect||oral health||altern treatment strategi||teeth||perman dentit||failur||caviti||art||primari dentit||treatment||gross margin defect||oper effect||evalu||restor||dentist||result||primari||high-cari popul||analysi||cox regress analysi||three-year surviv||materi||secondari cari||dental treatment||two-surfac restor||dutch dentist||signific differ||basic oral health care||children||restor treatment,restor||art restor||art||two-surfac art restor||single-surfac art restor||two-surfac restor||glass-ionom restor||one-surfac art restor||multi-surfac art restor||seventy-f art restor||restor treatment||one-surfac restor||twenty-six restor||amalgam restor||restor present,0.548||0.479||0.41||0.369||0.352||0.348||0.34||0.33||0.325||0.324||0.293||0.29||0.28||0.28||0.279,0.4,0.3,0.26666666666666666
431,Childs_Nerv_Syst-3-1-2092440.txt,level||case||mmc||protocol||modern palli care||groningen protocol||prospect||ethic debat||qualiti||studi||deliber termin||life||sever form||decis||criteria||lesion||newborn||palli care||countri||hopeless||treatment||sever physic disabl||intern medic recommend||end-of-lif decis||dutch associ||medic care||pain||babi||experi||parent||care||termin||hydrocephalu||intern legisl||ethic||sever||meningomyelocel||physician||suffer||spina bifida||result,bifida||spina bifida||spina||newborn||mmc||spina bifida aperta||untreat spina bifida||open spina bifida||spina bifida int||newborn child||spina bifida gothenburg 27||isol open spina bifida||open spina bifida Br||hydrocephalu||handicap newborn,0.403||0.395||0.386||0.284||0.283||0.275||0.274||0.266||0.264||0.202||0.2||0.2||0.2||0.194||0.184,0.6,0.3,0.26666666666666666
432,Childs_Nerv_Syst-4-1-2413122.txt,tumour||meningioma||marker||analysi||mutat||dna||loh||patient||year||radiat therapi||myoepithelioma,ini1||ini1 mutat||conclus ini1||meningioma||method ini1 mutat||tumour genet predisposit ini1||radiation-induc meningioma||s00381-007-0578-0 case report ini1 mutat||teratoid||radiation-induc tumour||tumour||myoepithelioma||atyp teratoid||hulsebo tjm||rhabdoid tumor,0.698||0.383||0.35||0.294||0.256||0.231||0.215||0.163||0.147||0.126||0.116||0.11||0.107||0.105||0.094,0.2,0.1,0.2
433,Neuropsychologia-2-1-2265793.txt,condit||categori||level||effect size||recognit||individu||data||environment support||studi||comparison||asd||difficulti||process||inform||abil||recal||memori||pattern||evid||relat inform||item||hippocampu||task||list||asd particip||group||word||autism spectrum disord||asd group||perform||relat memori||particip||support,asd||bowler||asd categori||recal||asd individu||asd particip||memori||asd group||bowler d.m||asd experi||3 asd||2000a bowler||item-specif memori process||1991 bowler||1989 bowler,0.352||0.312||0.246||0.236||0.2||0.194||0.19||0.183||0.181||0.18||0.176||0.166||0.16||0.159||0.158,0.4,0.5,0.3333333333333333
434,J_Comp_Physiol_A_Neuroethol_Sens_Neural_Behav_Physiol-4-1-2248214.txt,case||diagram||reflect spectra||wavelength||angular reflect||pattern||butterfli||kinoshita||transmiss electron microscopi||scatter||singl scale||singl butterfli scale||butterfli speci||light||structur colour||angular distribut||colour||wing||multilay structur||backscatt light||reflect,butterfli||morpho butterfli||morpho||pierid butterfli||morpho butterfli proc||pierid butterfli wing||singl morpho butterfli scale||butterfli speci||pierid butterfli proc||butterfli scale giraldo||male butterfli||singl butterfli scale||scatter||scale scatter||butterfli ancyluri meliboeu,0.438||0.407||0.376||0.313||0.285||0.261||0.249||0.224||0.222||0.221||0.221||0.207||0.203||0.178||0.174,0.2,0.2,0.26666666666666666
435,Eur_J_Pediatr-3-1-1820762.txt,condit||antibodi||hu||method||plasma||vwf||sampl||mutat||studi||ttp||patient||assay||immunoblot||heterozyg carrier||congenit||thrombot thrombocytopen purpura||polyclon antibodi||normal phenotyp||proteas||normal plasma||von willebrand factor||parent||activ||sds-page||adamts13||normal individu||result,adamts13||adamts13 mutat||adamts13 antigen||adamts13 phenotyp||adamts13 activ||adamts13 autoantibodi||adamts13 band||adamts13 bioactiv||adamts13 present||adamts13 express||adamts13 method||willebrand||purifi plasma adamts13||adamts13 gene mutat||ttp,0.654||0.356||0.349||0.337||0.336||0.336||0.334||0.333||0.33||0.329||0.329||0.267||0.261||0.239||0.237,0.2,0.1,0.13333333333333333
436,Int_J_Colorectal_Dis-3-1-2134973.txt,abdomin cramp||questionnair||irrig||dynam graciloplasti||defec disord||qualiti||studi||patient||life||amount||water||colon irrig||treatment||addit therapi||dgp||success rate||defec||colostomi||contin||constip||appendico-cecostomi||fecal incontin||result,irrig||colon irrig||colostomi irrig||antegrad irrig||retrograd irrig||rectal irrig||irrig bag||irrig pump||irrig 21.39||irrig fluid||irrig method||fecal incontin||conclus colon irrig||dgp||colostomi irrig Br,0.638||0.426||0.369||0.365||0.338||0.336||0.329||0.328||0.325||0.321||0.32||0.302||0.285||0.26||0.253,0.4,0.2,0.26666666666666666
437,J_Gastrointest_Surg-3-1-1852386.txt,linear regress||author||respons||week||time||signific growth inhibit||rate||interv||studi||valu||patient||brdurd-label cell||schedul II||treatment time||clinic down-stag||clinic assess||radiotherapi||spf||signific||treatment||cell||prolifer rate||schedul||earli tumor respons||ratio||brdurdli||prolifer||complet respons||cell death||surgeri||local recurr||tumor||preoper radiotherapi||regress||resect||rectal cancer||cancer cell prolifer,brdurd||rectal tumor||tumor||RT tumor||brdurdli||RT brdurdli||rectal cancer||prolifer tumor||brdurd LI||RT brdurd LI||RT||preoper RT||rectal carcinoma||preoper radiotherapi||radiotherapi,0.341||0.34||0.321||0.279||0.279||0.258||0.255||0.255||0.25||0.246||0.238||0.22||0.206||0.202||0.201,0.4,0.3,0.3333333333333333
438,J_Comp_Physiol_A_Neuroethol_Sens_Neural_Behav_Physiol-4-1-2323032.txt,mechan||ear||caudal region||tonotop axi||tympan membran||frequenc||spontan otoacoust emiss||organ||anuran||similar||tonotop organ||narin||round window||tectori curtain||auditori system||s-shape extens||characterist||amphibian||contact membran||mammalian cochlea||nerv fiber||frog||basilar papilla||sacculu||emiss||frequenc select||amphibian auditori system||otoacoust emiss||vertebr||endolymphat space||amphibian papilla||hair cell||speci||spontan emiss||hair bundl||membran||function||singl auditori filter,papilla||amphibian papilla||basilar papilla||amphibian||amphibian papilla caudal||amphibian papilla exhibit||amphibian ear||papilla tectorium||papilla recess||respect papilla||small papilla||anuran amphibian||basilar papilla ’s||basilar papilla impli||basilar papilla function,0.467||0.396||0.337||0.326||0.281||0.268||0.247||0.242||0.238||0.234||0.234||0.233||0.231||0.228||0.228,0.6,0.3,0.2
439,J_Headache_Pain-4-1-2276243.txt,autosom domin||mechan||chronic headach||epigenet||model||studi||mutat||genet repertoir||cluster headach||clinic featur||risk||genet variat||chromosom||typic migrain||headach pathogenesi||disord||featur||behaviour||primari||attack||suscept loci||primari headach||fhm||genet||famili||infanc||migrain||diseas||epigenet mechan,migrain||migrain headach||hemipleg migrain||migrain gene||headach||famili migrain||typic migrain||migrain attack||syndrom migrain||episod migrain||matern migrain||migrain vertigo||primari migrain||migrain featur||mendelian migrain,0.688||0.534||0.413||0.385||0.381||0.373||0.359||0.357||0.356||0.355||0.354||0.353||0.351||0.35||0.349,0.2,0.2,0.13333333333333333
440,Ann_Surg_Oncol-3-1-2039838.txt,anim||mmc||cytoreduct surgeri||model||studi||physic condit||perfus||heat intraperiton chemotherapi||clinic trial||dose||temperatur||treatment||rat||day||adjuv therapi||periton carcinomatosi||result||macroscop tumor||surgeri||group||surviv||surgic procedur||median surviv||rit administr||hipec||procedur||toxic||preclin studi||radioimmunotherapi,hipec||rit||hipec CS||adjuv hipec||carcinomatosi||intraperiton||hipec procedur||hipec group||hipec model||intraperiton radioimmunotherapi||periton carcinomatosi||adjuv rit||rit adjuv||radioimmunotherapi||intraperiton chemotherapi,0.531||0.364||0.352||0.316||0.293||0.29||0.276||0.273||0.271||0.244||0.236||0.232||0.232||0.199||0.192,0.2,0.1,0.2
441,Eur_Radiol-4-1-2220024.txt,data||patient||solid residu||regimen||effect||diagnost accuraci||colonoscopi||total||barium||dose||magnesium citrat||ctc||polyp||residu||fluid||bowel prepar||reason||group||proxim colon||differ||score||statu||patient accept||addit||prone||prepar||diagnost perform,polyp||tag||colon polyp||polyp correl polyp||regimen||colonoscopi||ctc||6-mm polyp||tag fluid||fluid tag||ctc-detect polyp||diminut polyp||5-mm polyp||polyp detect||72 polyp,0.372||0.293||0.255||0.25||0.247||0.24||0.22||0.201||0.196||0.196||0.196||0.194||0.193||0.192||0.19,0.4,0.4,0.26666666666666666
442,Behav_Genet-4-1-2292426.txt,questionnair||homophobia score||homophobia||individu||sampl||data||model||studi||herit||effect||femal||twin pair correl||threshold||hlq||total||sex||environment influenc||signific||gay men||homosexu||item||estim||varianc||twin||non-heterosexu||pair||genet||differ||contribut||homophobia categori||attitud||influenc||item score||twin studi||score||result,homophobia||homosexu||attitud||twin||homophobia score||homophobia categori||homophobia scale||femal homosexu||homosexu men||homosexu person||homophobia data||homosexu questionnair||miss homosexu||homosexu individu||homosexu scale,0.429||0.389||0.293||0.266||0.246||0.223||0.221||0.221||0.22||0.22||0.217||0.215||0.214||0.208||0.201,1.0,0.6,0.4
443,Mol_Imaging_Biol-3-1-1915656.txt,elig studi||imag||data||studi||patient||rel lesion detect||review||sensit||articl||lesion||positron emiss tomographi||attenu correct||AC imag||fdg||specif||nac imag||meta-analysi||fr-pet||index test||oncolog patient||dual-head coincid pet||methodolog qualiti||test accuraci||transmiss||elig||lesion detect||systemat review||tomographi||refer test||result,tw||pet||nac||fdg pet||pet imag||nac fr-pet||nac imag||pet emiss imag||fr-pet||nac FR fdg pet||whole-bodi pet||pet scanner||dual-mod pet||f-fdg pet||fluorine-18-fluorodeoxyglucos pet,0.531||0.344||0.28||0.25||0.25||0.246||0.218||0.211||0.211||0.201||0.193||0.186||0.185||0.179||0.178,0.0,0.2,0.13333333333333333
444,Mol_Biochem_Parasitol-1-5-1885993.txt,rdgc||myristoyl||data||motif||phosphatas||ef-hand domain||parasit||amino acid||ef-hand||ppef||specif||gene||conserv||protein phosphatas||protein||analysi||high confid||tbppef||s-gfp||lmppef||result,trypanosoma brucei||T. brucei||phosphatas||T. brucei ppef||T. brucei L.||T. brucei T.||myristoyl||ppef phosphatas||trypanosoma brucei trypanosoma cruzi||T. brucei T. cruzi||T. brucei T. brucei rna||tbppef T. brucei||T. brucei T. cruzi T. cruzi||protein phosphatas||T. brucei http://www.genedb.org/,0.271||0.27||0.265||0.244||0.232||0.23||0.228||0.228||0.227||0.226||0.217||0.212||0.211||0.209||0.191,0.2,0.2,0.2
445,Osteoporos_Int-4-1-2277446.txt,placebo||level||administr||calcium intak||nurs home||baselin||studi||serum 25||effect||secondari hyperparathyroid||increas||bone turnov marker||serum pth||dose||calcium||day||calcium supplement||month||phosphat||pth||nurs staff||home||group||decreas||monthli administr||random clinic trial||particip||daili administr||result,vitamin||Dd||Dw||weekli vitamin||vitamin D3||Dm||daili vitamin||calcium supplement vitamin||oral vitamin||dietari vitamin||defici vitamin||total vitamin||vitamin D2||optim vitamin||sever vitamin,0.433||0.298||0.298||0.287||0.273||0.269||0.258||0.243||0.233||0.225||0.225||0.221||0.22||0.219||0.217,0.0,0.0,0.0
446,Histochem_Cell_Biol-4-1-2228381.txt,patholog gain-of-funct mechan||edem1||earli secretori pathway||ER stress||gl II||golgi apparatu||pathogenesi||nuclear envelop||exampl||complex||edem||chaperon||degrad||oligosaccharid||cell||copii coat||erad||glucosidas II||protein qualiti control||protein||qualiti control||endomannosidas||zuber||chemic chaperon||myocilin-caus open-angl glaucoma||synthet chaperon||protein fold diseas||work||mammalian cell||diseas||result,endoplasm||endoplasm reticulum||reticulum||endoplasm reticulum protein||misfold protein||protein misfold||misfold glycoprotein||rough endoplasm reticulum||misfold myocilin||endoplasm reticulum stress||endoplasm reticulum degrad pathway||endoplasm reticulum subdomain||endoplasm reticulum hydrolas||chaperon||endoplasm reticulum-associ degrad,0.295||0.27||0.245||0.234||0.216||0.216||0.213||0.188||0.187||0.186||0.185||0.183||0.183||0.177||0.175,0.0,0.0,0.06666666666666667
447,Neurosci_Lett-1-5-1885995.txt,notch||sub-nuclear bodi||cbf-1,icd||icd icd||icd icd icd||abstract icd icd icd||fig. 2 icd icd icd||fig. 3 icd icd||notch||drosophila notch||receptor notch||sub-nuclear bodi||kopan R. notch||notch intracellular domain||kadesch T. notch signal||keyword notch cbf-1 transcript luciferas||notch receptor nat. genet,0.912||0.912||0.912||0.685||0.55||0.46||0.17||0.092||0.09||0.075||0.072||0.072||0.066||0.06||0.053,0.0,0.2,0.13333333333333333
448,J_Chem_Ecol-4-1-2239250.txt,insect||level||time||induct||concentr||individu||studi||GS concentr||dri mass determin||effect||femal||parasit||pieri rapa||parasitoid||sex||compound||natur enemi||defens||generalist||caterpillar||mithen||popul||oviposit||glucobrassicin||herbivor||direct defens||surviv||glucosinol||artifici select||speci||total GS concentr||specialist||plant,brassica||brassica oleracea||oleracea||plant||B. brassica oleracea||brassica rapa||brassica B.||J. brassica||brassica diadegma||brassica D.||D. brassica||P. xylostella||H. brassica brassica oleracea B. rapa||brassica popul||brassica coenospeci,0.413||0.354||0.294||0.293||0.275||0.273||0.266||0.254||0.253||0.252||0.252||0.234||0.233||0.228||0.225,0.2,0.1,0.06666666666666667
449,Eur_J_Pediatr-3-1-2151775.txt,breastf infant||netherland paediatr surveil unit||case||week||administr||infant||birth||data||current dutch guidelin||studi||effect||cholestat liver diseas||netherland||surveil||newborn||dose||late vkdb||age||prophylaxi||incid||current incid||oral||paediatr||report||order||secondari case||vkdb,vitamin||vkdb||prophylaxi vitamin||bleed||late vitamin||oral vitamin||micellar vitamin||neonat vitamin||intramuscular vitamin||prophylact vitamin||nutrit vitamin||TJ vitamin||keyword vitamin||defici bleed||late vkdb,0.491||0.371||0.36||0.331||0.295||0.277||0.273||0.263||0.259||0.256||0.252||0.25||0.246||0.242||0.235,0.2,0.1,0.13333333333333333
450,Ann_Surg_Oncol-3-1-1914273.txt,follow-up||adjuv radiotherapi||respons||ilp||radiat||patient||year||amput||distant metastas||perfus||radiotherapi||necrosi||patholog examin||treatment||tumor necrosi factor alpha||late morbid||recurr diseas||month||critic leg ischemia||resect margin||isol limb perfus||limb salvag||tumor||surviv||melphalan||limb||skin||time period||resect||diseas||sarcoma||patholog fractur||result,limb||melphalan||ilp||sarcoma||limb perfus||limb salvag||perfus||tnf-α ilp||isol limb perfus||R0||advanc limb||soft-tissu sarcoma||ilp patient||tissu sarcoma||limb perfusion.,0.345||0.328||0.327||0.326||0.284||0.256||0.223||0.222||0.214||0.193||0.191||0.188||0.188||0.187||0.181,0.8,0.7,0.4666666666666667
451,J_Biol_Inorg_Chem-4-1-2359831.txt,condit||polyacrylamid gel electrophoresi||odn||gel||sampl||copper complex||platinum||copper||close proxim||dna||dna cleavag||odn II||adduct||major groov||sequence-select cleavag||solut||clear sequenc select||band||cleavag||fragment||strand cleavag||nucleobas||smear||result,odn||odn II||free odn||odn II adduct||odn II strand||platinum||pitié||cleavag||complementari strand odn II||odn II arrowhead materi||dna cleavag||heterodinuclear platinum||strand cleavag||adduct||dna adduct,0.535||0.284||0.273||0.234||0.222||0.201||0.19||0.172||0.169||0.15||0.147||0.136||0.135||0.134||0.128,0.4,0.4,0.4666666666666667
452,Diabetologia-3-1-2039826.txt,type 2 diabet||insulin level||vascular event||chronic hyperglycaemia||white matter lesion||diabet||mri||histori||data||vascular risk factor||patient||multivari model||cerebr complic||pwml||brain infarct||test||infarct||insulin||type 2 diabet mellitu||macrovascular diseas||present studi||brain||vascular factor||control||regress analys||cognit||sever wml||retinopathi||sever mri abnorm||associ||atrophi||brain mri||group||factor||perform||neuropathi||risk factor||cognit domain||neuropsycholog examin||cognit perform||larg number||score,diabet||diabet mellitu||diabet encephalopathy’||diabet patient||diabet characterist||2 diabet||cognit||mri||type 2 diabet||type 1 diabet||non-insulin-depend diabet patient||2 diabet mellitu||diabet care 21||elderli diabet subject||6.1 diabet treatment,0.438||0.244||0.24||0.238||0.23||0.219||0.199||0.175||0.17||0.17||0.168||0.163||0.156||0.154||0.149,0.2,0.4,0.26666666666666666
453,J_Mol_Model-4-1-2386531.txt,crystal||type||method||solid||eid||unit cell||higher accuraci||bond length||bond||pm6||artifact||optim||model||valu||distort||ion||densiti||strong bond||partial charg||form||forc||silic||compound||period boundari condit||paramet optim||dabco||fault||unit||energi||net charg||geometri||distanc||train||good accuraci||organ compound||unpair electron||atom||polymorph||gradient||sulfur||ice||turn||charg||hydrogen bond||inter-r distanc||carbon group||solid state||electrostat potenti||miner||survey||speci||error||weak interact||proton||good approxim||organ solid||acet group||molecul||result,pm6||pm6 structur||pm6 sodium||optim pm6||pm6 calcul||nitrat pm6||pm6 valu||degre pm6||pm6 method||pm6 differ||distanc x-ray pm6||optim pm6 geometri||optim pm6 structur||degre pm6 x-ray||pm6 structur 2,0.116||0.064||0.063||0.062||0.061||0.061||0.059||0.058||0.058||0.058||0.05||0.047||0.046||0.045||0.043,0.2,0.1,0.06666666666666667
454,Neurosurg_Rev-3-1-2077911.txt,occipit bone||case||dura||rate||fmm||import vascular structur||studi||patient||craniocerv junction||head||difficulti||nerv||occipit condyl||surgic strategi||spinal cord||drill||lesion||point||FM area||skull base surgeon||lower cranial nerv||anatomi||VA damag||surgic approach||nerv root||approach||atla||complet resect||VA transposit||literatur||foramen magnum||FM meningioma||tumor||arteri||exposur||meningioma||resect||lower part||branch||vertebr arteri||bone resect,meningioma||foramen magnum meningioma||foramen||foramen magnum||VA meningioma||anterior meningioma||extradur meningioma||posterior foramen||FM meningioma||anterior foramen||meningioma displac||anterolater meningioma||meningioma case||intraextradur meningioma||recurr meningioma,0.458||0.415||0.394||0.394||0.32||0.279||0.274||0.248||0.247||0.247||0.244||0.243||0.243||0.238||0.234,0.4,0.3,0.2
455,Neuroimage-2-1-2225446.txt,method||scanner||imag||data||studi||grey matter||effect||medial tempor lobe||upgrad||test||region volum||multi-scann data-set||signific||calibr||brain||control||varianc||analysi||subject||qualiti control||group||differ||interact||error||diseas||imag intens||thalamu||result,scanner||scanner effect||scanner differ||multipl scanner||oldest scanner||scanner group||singl scanner||6 scanner||5 scanner||scanner 5||scanner 4||scanner 3||scanner 2||scanner 1||greatest scanner effect,0.683||0.354||0.35||0.349||0.349||0.346||0.343||0.342||0.342||0.342||0.342||0.342||0.342||0.342||0.246,0.2,0.1,0.06666666666666667
456,Intensive_Care_Med-3-1-1915613.txt,case||respons||medic condit||disturb||studi||clinic observ||patient||effect||present||criteria||anxieti||hypoact||antipsychot medic||disord||patient descript studi||adult||treatment||picu||diagnost||acut||ill children||approach||pediatr intensivist||haloperidol||parent||routin clinic practic||incid||psychiatr consult||delirium||explan||clinic present||risperidon||intens care unit||design||treatment respons||dsm-iv criteria||pediatr intens care unit||children,delirium||delirium delirium||hyperact delirium||pediatr delirium||delirium catatonia||icu delirium||richtlijn delirium||delirium incid||subsyndrom delirium||childhood delirium||delirium criteria||delirium 2002||haloperidol||keyword delirium critic||yudofski SC delirium textbook,0.753||0.753||0.439||0.431||0.401||0.395||0.388||0.386||0.383||0.382||0.381||0.379||0.344||0.264||0.213,0.2,0.1,0.13333333333333333
457,Cell_Calcium-1-5-1885971.txt,steady-st level||tip||extrus||effect||casm||depth||recoveri||larg snail neuron||diffus coeffici||sequestr||cell||calcium||intracellular calcium||solut||experi||mobil||neuron||cell membran||buffer||time constant||depolaris||appar paramet||diffus||respons time||transient||size||influx||peak||membran||microelectrod||result,Ca||app||casm||Ca τ casm||Ca κ||Ca transient||Ca level||Ca data||Ca 2||seq app||Ca transient height||app 2||app 1||casm movement||casm step,0.509||0.388||0.353||0.341||0.331||0.303||0.256||0.256||0.255||0.253||0.204||0.194||0.194||0.187||0.185,0.2,0.1,0.06666666666666667
458,Matern_Child_Health_J-2-2-1592158.txt,embryo||assist reproduct technolog||birth||fertil||pregnanc||patient||risk||art||cycl||ivf||treatment||lower birth weight||embryo cultur condit||multipl gestat||women||multipl||twin||infertil||factor||addit counsel||singleton||fertil problem,fertil||humrep||infertil||male fertil||vitro fertil||ivf||fertil problem||art||wichita||birth||infertil patient||vitro fertil assist reproduct technolog||s0015-0282||infertil diagnos||icsi,0.362||0.28||0.247||0.203||0.202||0.196||0.191||0.159||0.155||0.139||0.137||0.137||0.131||0.129||0.125,0.4,0.6,0.4
459,Behav_Genet-4-1-2226023.txt,time||week||gestat age||birth||insert||studi||chorion||herit||effect||environment factor||covari matrix||increas||placenta||growth||cord insert||matern factor||varianc||twin||qtl||umbil cord||weight||birth weight||gestat||regress||order||separ placenta||influenc||covari||placent factor||unadjust model||chanc,twin||twin data twin||twin analysi twin||first-born twin||covari||born twin||monozygot twin||live born twin twin||liveborn twin||twin pregnanc||pregnanc twin||8464 twin||body-height twin||twin pair||adult twin,0.3||0.201||0.201||0.195||0.19||0.172||0.162||0.162||0.157||0.155||0.155||0.154||0.154||0.154||0.153,0.4,0.2,0.13333333333333333
460,Clin_Oral_Investig-4-1-2238777.txt,condit||consumpt||dental eros||time||soft tissu||protect effect||salivari flow||studi||eros||effect||wear||sport||miner content||clinic examin||increas||dentin||saliva||calcium||enamel surfac||acid drink||eros potenti||eros agent||fluorid||surfac||factor||chemic factor||behaviour factor||phosphat content||import||drink||chemic||enamel||tooth||tooth surfac||progress,eros||enamel eros||dental eros||eros tooth||enamel eros cari||dental eros cari||dental eros monograph||vitro eros||facial eros||eros potenti||eros lesion||eros condit||eros agent||eros effect||induc eros,0.62||0.462||0.447||0.404||0.358||0.347||0.321||0.321||0.318||0.315||0.315||0.315||0.314||0.313||0.311,0.4,0.3,0.26666666666666666
461,J_Med_Internet_Res-4-3-1761945.txt,nation||system||parti||commun||conduct||user guid||relev profession associ||european council||state||criteria||inform||specif tool||medic||user||unit state||provid||guidelin||label||tool||content||avid consum||websit||code||health||eeurop||hon||site provid||bodi||standard||action||rate system||site develop||european||possibl||high qualiti servic||privaci||qualiti initi||order||core set||european union||specif aim||organis||member state||eeurop 2002 action||qualiti criteria||initi||sixti||internet,websit||internet||organis||qualiti||qualiti criteria||internet user||code||public websit||criteria||health||health relat websit||internet site||eeurop||good health websit||hon code,0.299||0.214||0.204||0.192||0.185||0.182||0.18||0.18||0.178||0.177||0.172||0.171||0.17||0.165||0.162,0.8,0.7,0.5333333333333333
462,Eur_J_Epidemiol-4-1-2249618.txt,indic drug||discharg||full multivari model||studi||patient||year||admiss||prescript||non-acut care hospit||medic||intervent||ace inhibitor||day||arb||hospit||health care system||statin||odd||popul||secondari prevent||care||myocardi infarct||acut MI||MI admiss||copay||aspirin||beta-block||sick fund||absolut contraind,copay||infarct||myocardi infarct||waiv copay||acut myocardi infarct||drug copay||nonfat myocardi infarct||0.79 copay||myocardi infarct 2||myocardi infarct 1||0.65 copay||0.84 copay||acut myocardi infarct care||acut myocardi infarct trial||myocardi revascularis,0.27||0.253||0.252||0.199||0.191||0.178||0.173||0.172||0.168||0.168||0.168||0.158||0.152||0.146||0.144,0.4,0.2,0.13333333333333333
463,Chiropr_Osteopat-13-_-1151650.txt,method||search engin||problem||data||studi||year||patient||question||overweight||bmi||risk||obes||review||bodi mass index||evid||evidence-bas practic||research||causal factor||paper||pain||associ||definit answer||literatur||osteoarthr||search||date||risk factor||link,back pain||pain||obes||pain symptomolog||musculoskelet pain||low-back pain||pain syndrom||bmi||sciatic pain||knee pain||obes patient||background obes||osteoarthr||acut low back problem||chronic low-back pain,0.402||0.357||0.348||0.205||0.204||0.197||0.195||0.191||0.19||0.185||0.178||0.177||0.156||0.149||0.138,0.4,0.3,0.26666666666666666
464,Appl_Microbiol_Biotechnol-4-1-2243254.txt,petrochem process||metabol pathway||immobil||studi||yield||process||ferment process||organ||agent||fungi||cell||fumar acid||glucos||product||ferment||acid||maleic anhydrid||carboxyl acid||fumar||product recoveri||organ acid,fumar||rhizopu||rhizopu arrhizu||fumar acid||rhizopu oryza||calcium fumar||rhizopu nigrican||rhizopu arrhizu ital||rhizopu arrhizu cell||fumar acid product||immobil rhizopu||genu rhizopu||rhizopu 1995||fumar acid deriv||fumar acid properti,0.549||0.489||0.406||0.343||0.317||0.278||0.277||0.274||0.273||0.262||0.261||0.248||0.246||0.233||0.232,0.4,0.2,0.13333333333333333
465,Pflugers_Arch-3-1-2082651.txt,condit||quinidin||data||studi||bcl||arrhythmogenesi||arrhythm activ||flecainid||effect||parallel||point||treatment||heart rate||solut||analysi||ventricl||restitut curv||full agreement||critic DI||br||repolar||drug||pharmacolog condit||extrasystol stimul||heart||arrhythmogen||murin heart,scn5a||Δ scn5a||anim scn5a||42 scn5a||scn5a gene||singl scn5a||13 scn5a||result scn5a||2 scn5a||arrhythmogen 90 scn5a||8.9 11.8 scn5a||44.2 9.3 scn5a||9.0 10.3 scn5a||6.7 35.0 scn5a||15.9 113.3 scn5a,0.633||0.408||0.318||0.318||0.318||0.317||0.317||0.317||0.317||0.262||0.217||0.216||0.216||0.216||0.216,0.0,0.0,0.0
466,Dig_Dis_Sci-4-1-2413116.txt,questionnair||sexual offenc||histori||studi||depress||total score||GI symptom||ssf||childhood||anxieti||definit||signific||valid||non-consult||odd ratio||rape||function gastrointestin disord||kind||ib||adulthood||women||sweden||popul||subject||assault||group||hrql||fgid||dyspepsia||abus||signific differ||irrit bowel syndrom||function dyspepsia||gener popul,abus||fgid||sexual abus||emot abus||childhood abus||adulthood abus||abus histori||physic abus||abus questionnair||abus 3.95||abus child||previou abus||past abus||abus 8.86||abus 7.59,0.598||0.48||0.391||0.368||0.351||0.333||0.332||0.329||0.311||0.309||0.308||0.308||0.305||0.305||0.305,0.4,0.2,0.13333333333333333
467,Environ_Manage-2-2-1705511.txt,forag||anim||studi area||meadow||conflict||region||kiang||pastor||war||livestock||nomad||product||changthang||estim||eastern ladakh||kiang densiti||ladakh||hanl valley||livestock popul||survey||herder||area||import habitat||habitat,ladakh||kiang||equu kiang kiang||gujrat equu kiang kiang||kiang habitat||kiang conflict||ladakh himalaya||ladakh trans-himalaya||eastern ladakh||kiang densiti||2003. ladakh||kiang popul||kiang count||ladakh environ||ladakh 1999,0.566||0.561||0.4||0.313||0.31||0.31||0.307||0.303||0.299||0.297||0.291||0.29||0.286||0.286||0.285,0.4,0.4,0.26666666666666666
468,Int_J_Cardiovasc_Imaging-3-1-2121118.txt,blood pressur data||control||systol||studi||aortic distens||aortic stiff||nccm patient||gender-match control||conclus||noncompact||aortic diamet||wall||diastol heart failur||patient||aortic elast||nccm||result,nccm||nccm noncompact cardiomyopathi||noncompact||nccm patient||nccm 3||nccm patient nccm patient age||aortic stiff||aortic distens||aortic diamet||ventricular noncompact||nccm noncompact cardiomyopathi fig. 4||aortic stiff β||noncompact cardiomyopathi neme||aortic elast||aortic complianc,0.498||0.323||0.305||0.274||0.249||0.222||0.218||0.202||0.196||0.195||0.195||0.189||0.185||0.182||0.181,0.6,0.6,0.4666666666666667
469,Bioinformation-1-1-1891626.txt,gene||est||inform||eukaryot||mrna sequenc||databas||mrna||avatar||gene locat||altern splice||genom,"avatar||avatar avatar||est||avatar develop||est sequenc||est align||5,469,433 est||est score||cluster est||web databas avatar||avatar web site||est align inform||biolog commun avatar||mrna||larg scale est",0.608||0.608||0.487||0.31||0.304||0.302||0.288||0.252||0.25||0.248||0.23||0.218||0.209||0.182||0.167,0.4,0.2,0.2
470,Photosynth_Res-3-1-1779625.txt,metabolit||time||rate||valu||extract||water||present||incorpor||carbon||mixtur||chloroplast||oxygen electrod||label||dephosphoryl step||glucos||solut||sugar||cylind||analysi||experi||mox-tm deriv||filter membran||intern standard||work-up||apparatu||octulos||photosynthesi||dri nitrogen||membran||sugar phosphat,sugar||chloroplast||derivat sugar||mox-tm sugar||sugar phosphat||octulos||dri sugar||photosynthesi||spinach chloroplast||chloroplast extract||chloroplast intact||free sugar||chloroplast isol||chloroplast prepar||octulos phosphat,0.338||0.322||0.233||0.228||0.228||0.213||0.205||0.199||0.193||0.19||0.185||0.174||0.17||0.17||0.165,0.6,0.5,0.3333333333333333
471,Eur_J_Pediatr-3-1-1829442.txt,case||flow||hilar portion||lrv||gross hematuria||data||studi||patient||renal vein||PV ratio||screen examin||renal doppler ultrasound||doppler ultrasound||nutcrack group||asymptomat microscop hematuria||adult||nutcrack syndrom||examin||ratio||doppler angl||hematuria||hypercalciuria||detect||children,hematuria||nutcrack||lrv||hematuria renal doppler||nutcrack syndrom||gross hematuria||microscop hematuria||lrv nutcrack group||isol hematuria||nutcrack syndrom nutcrack group||hematuria persist||doppler||total hematuria||nutcrack group||keyword nutcrack,0.505||0.474||0.332||0.304||0.281||0.275||0.271||0.271||0.265||0.261||0.257||0.255||0.253||0.24||0.237,0.6,0.4,0.3333333333333333
472,Ann_Surg_Oncol-3-1-1914261.txt,primari melanoma site||type||melanoma||re-excis specimen||diagnost biopsi type||import confound||re-excis||studi||patient||incis biopsi||primari melanoma||SN statu||site||posit margin||df||wide excis biopsi group||age||tumor cell||narrow excis biopsi||group||surviv||unknown||influenc||melanoma patient surviv||lymphat invas||breslow thick||invas,melanoma||biopsi||excis biopsi||incision biopsi||melanoma patient||cutan melanoma||excision biopsi||malign melanoma||melanoma prognosi||diagnost biopsi||primari melanoma||nodular melanoma||narrow excis biopsi||incis biopsi||metastat melanoma,0.478||0.447||0.337||0.307||0.288||0.283||0.27||0.268||0.261||0.261||0.252||0.251||0.248||0.248||0.247,0.2,0.1,0.26666666666666666
473,Eur_J_Nucl_Med_Mol_Imaging-4-1-2100432.txt,condit||femal group||men||sex differ||auditori||baselin||data||studi||rcbf||region||sex||spm||contrast||male||stimuli||brain||prefront region||auditori process||analysi||gender||subject||auditori stimul||primari auditori cortex||activ||pac||differ||pet||prefront cortex||attent result||music||nois||white nois||result,auditori||auditori cortex||pac||pac music||music||auditori stimuli||primari auditori cortex||prefront cortex||human auditori||secondari auditori cortex||auditori affer||auditori process||auditori task||auditori stimul||auditori condit,0.441||0.354||0.274||0.271||0.267||0.257||0.247||0.246||0.238||0.237||0.231||0.231||0.229||0.229||0.225,0.6,0.5,0.4666666666666667
474,Purinergic_Signal-2-3-2096647.txt,atp||fura-2 microfluorometri||ach||concentr,ach||atp||ach 8D||ach compon||combin ach||keyword atp ach 2||atp neuron||atp 6C||atp 1B||extracellular atp||atp analogu||atp compon||atp 2||ach fig. 4||ach receptor channel biophi,0.749||0.544||0.384||0.376||0.376||0.323||0.316||0.285||0.277||0.276||0.274||0.274||0.272||0.251||0.209,0.4,0.2,0.13333333333333333
475,Pediatr_Cardiol-4-1-2267487.txt,subgroup||hla-b locu||ethnic group||taq dna polymeras||studi||comparison||hla||patient||allel||frequenc||increas||dna||signific increas||gene||healthi control group||hla-b||kawasaki diseas||polymorph||associ||korean children||healthi korean adult||diseas||amplif||intern control primer||children,kawasaki diseas||kawasaki syndrom||kawasaki diseas patient||hla||two-gener kawasaki diseas||recurr kawasaki diseas||kawasaki diseas eur||0.0||hla allel||allel||epidem kawasaki syndrom||kawasaki diseas genom dna||2007 background kawasaki diseas||keyword gene hla kawasaki diseas polymorph||hla-drb1 allel,0.371||0.34||0.257||0.256||0.254||0.253||0.248||0.248||0.245||0.235||0.233||0.2||0.187||0.184||0.177,0.4,0.3,0.2
476,BMC_Med_Educ-4-_-328087.txt,inform explos||educ activ||knowledg||core||problem||knowledg base||inform manag||medic school||doctor||develop||graduat||learn||knowledg manag||pbl||today||train||trend||factual||web-bas resourc||teach||teacher||challeng||faculti time||opportun cost||student||medic educ,pbl||teach||problem-bas learn||educ||pbl teach philosophi||learn||didact teach||lecture-bas teach||pbl veer||abbrevi pbl||medic educ||problem-bas learn epstein richard||curricula||qualiti teach||teach medium,0.364||0.311||0.309||0.276||0.241||0.236||0.209||0.191||0.19||0.185||0.183||0.165||0.164||0.161||0.157,0.4,0.3,0.26666666666666666
477,Clin_Rheumatol-3-1-2092406.txt,follow-up||situat||studi||profession guidanc||year||patient||durat||sick leav||proport||guidanc||eac||vocat guidanc||aim||tool||chronic arthriti||health profession||workplac adapt||earli arthriti||work disabl||job||gener practition||symptom durat||group||adapt||number||symptom||statu||arthriti||work||studi entri||disabl||diagnosi||diseas||period||gener popul,arthriti||sick||sick leav||disabl||rheumatoid arthriti||disabl pension||arthritis-rel sick leav||earli arthriti||work disabl||rheumatoid arthriti patient||arthriti symptom||work disabl pension||partial sick||incomplet sick leav||psoriat arthriti,0.413||0.401||0.332||0.33||0.295||0.273||0.242||0.234||0.231||0.229||0.229||0.226||0.224||0.223||0.222,0.6,0.5,0.3333333333333333
478,Diabetologia-3-1-1794136.txt,type 2 diabet||independ predictor||follow-up||baselin||patient||year||incomplet covari adjust||risk||end||annual assess||variabl||independ contribut||macrovascular diseas||cardiac death||present studi||all-caus mortal||western australian data linkag system||smbg||community-bas cohort||rosso||full adjust||outcom||result,smbg||smbg smbg number||time-depend smbg||baselin smbg||smbg statu||interpret smbg||baselin time-depend smbg||fremantl||diabet||fd||self-monitor||type 2 diabetes’ smbg self-monitor||unadjust analysi||retinopathi||fremantl diabet studi davi,0.637||0.427||0.356||0.333||0.327||0.321||0.247||0.245||0.206||0.196||0.178||0.174||0.136||0.131||0.128,0.2,0.1,0.06666666666666667
479,Mar_Drugs-5-4-2365694.txt,person||system||center||educ materi||studi||marin||inform||major||organ||toxin||public health personnel||pilot studi||caller||blue green alga||health profession||evalu||coastal manag||interview||red tide||cyanobacteria||educ outreach materi||futur hab outreach||hotlin||hab||florida red tide||florida||ciguatera fish poison||brevetoxin||outreach||particip||poison inform specialist||ciguatoxin||healthcar provid,hotlin||florida||caller||poison||florida aquat toxin hotlin||aquat toxin hotlin caller||hab||aquat toxin hotlin||tide||florida marin||florida red tide||toxin||hotlin easi||aquat toxin hotlin servic||aquat toxin hotlin evalu,0.402||0.351||0.311||0.284||0.281||0.271||0.264||0.257||0.233||0.225||0.219||0.213||0.205||0.2||0.197,0.6,0.4,0.4
480,Surg_Radiol_Anat-3-1-1820760.txt,scapula visibl||muscl||deform||intern||patient||contralater side||superior trunk outlet||view||scapula||rotat||ratio||clavicl||paramet||shoulder||width||sublux||obstetr brachial plexu palsi||brachial plexu||extern rotat||height||acromion||area||angl||children,scapular deform||brachial plexu||scapula||scapular hypoplasia||scapular posterior||scapular angl||scapular elev||scapular plane||scapular area||scapular line||obstetr brachial plexu palsi||scapular spine||conclus scapular deform||deform||obstetr brachial plexu paralysi,0.34||0.3||0.29||0.269||0.263||0.262||0.252||0.252||0.25||0.248||0.24||0.24||0.227||0.208||0.207,0.4,0.2,0.26666666666666666
481,Dig_Dis_Sci-3-1-1914298.txt,superior mesenter arteri||optim diagnost accuraci||measur||target||exercis intens||low level||low cost||studi||patient||consecut period||test||anaerob threshold||optim exercis test||exercis level||exercis tonometri||paramet||roch diagnost||chronic gastrointestin ischemia||tonometri||exercis||rapid serial lactat||lactat||false-neg test||decreas||target HR||exercis test||gastric exercis tonometri||gastric ischemia||diagnosi||period,exercis||exercis tonometri||tonometri exercis||RQ||tonometri||gastric exercis tonometri||submaxim exercis||exercis test||exercis intens||exercis episod||exercis level||clinic exercis||exercis int||lactat||RQ monitor,0.534||0.453||0.453||0.409||0.373||0.339||0.311||0.309||0.298||0.286||0.282||0.272||0.268||0.251||0.244,0.6,0.6,0.5333333333333333
482,Neurogenetics-2-2-1513515.txt,caucasian dataset||ethnic group||autism patient||sampl||data||studi||seizur||allel||autism||subunit||dataset||disord||caucasian popul||autism risk||gene||gaba receptor subunit||analysi||associ||popul||signific associ||candid||gaba||group||snp||differ||potenti regulatori region||largest differ||interact||addit||result,gabra4||gabra4 gabra4 gabra4||gabra4 gabrb1||gabra4 gabrb1 gabra4 gabrb1 gabrb1 gabra4||autism||gabrb1||gabrb1 gabra4 4 gabra4 gabrb1 gabrb1||signific valu gabra4 gabrb1 gabra4 gabrb1||gabra4 23 gabrb1||gabra4 gabrb1 gabrb1 utr variat||23 gabra4||44 gabra4||result gabra4||gabrb1 tabl 1 gabra4 gabrb1||5 0.047 discuss gabra4 gabra4 gabrb1,0.577||0.577||0.503||0.503||0.444||0.43||0.407||0.339||0.337||0.293||0.29||0.289||0.289||0.288||0.265,0.2,0.1,0.06666666666666667
483,Plant_Mol_Biol-4-1-2295252.txt,line||rosett||plastochron||juvenil||singl mutant||apic domin||abaxi trichom||day||gene||phase chang||leaf||veget phase chang||averag||arabidopsi||success||leaf initi||light||order||flower||mutant||number||t-dna||signific differ||shoot develop||plant,spl15 spl15 spl15 spl15 spl15||spl15||spl15 spl9 spl15||spl15 spl15 spl9||spl9 spl15||spl15 spl9 spl15 spl9 spl15 spl9||spl15 spl9||spl9||spl9 spl15 spl9 spl15 mir156b||spl9 spl15 spl9 spl15 spl2 spl9||spl9 spl15 spl9 spl15 2003||spl15 1 spl15 spl15||spl9 spl15 pp2a spl9||2008 spl9 spl15 mir156b spl9 spl15||spl9 spl15 mutant,0.667||0.667||0.658||0.658||0.654||0.654||0.654||0.64||0.583||0.546||0.523||0.501||0.49||0.486||0.44,0.0,0.0,0.0
484,Purinergic_Signal-4-2-2377324.txt,atp||membran||jnk||Na||nkcc||usa||cotransport||Cl||intercal cell||purinerg receptor||inhibit||activ||cell||medium||stress-activ protein kinas||kinas,cotransport||na-k-cl cotransport||atp||sodium-potassium-chlorid cotransport||cotransport intercal cell||gekl||chlorid cotransport||orlov SN||grygorczyk||secretori na-k-cl cotransport||kinas||nkcc||bourcier||extracellular atp||c11-mdck cell,0.296||0.185||0.184||0.17||0.168||0.155||0.153||0.15||0.133||0.131||0.127||0.123||0.123||0.12||0.119,0.4,0.2,0.26666666666666666
485,Int_J_Hematol-4-1-2276242.txt,c-kit gene||find||case||nasal lymphoma||mutat||studi||patient||malign lymphoma||frequenc||develop||korea||epidemiolog||lymphoma||epidemiolog studi||lmp1||pesticid||cell||gene||nktcl||tumor suppressor gene||china||p53 gene||gene mutat||japan||risk factor||ebv||diseas||latin american countri||western countri,lymphoma||nasal lymphoma||t-cell lymphoma||nasal t-cell lymphoma||sinonas lymphoma||nasopharyng lymphoma||malign lymphoma||nk-cell lymphoma||peripher t-cell lymphoma||t-cell lymphoma int||cell lymphoma||’s lymphoma||t-cell||t-cell lymphoma number||convent lymphoma,0.457||0.347||0.346||0.31||0.309||0.25||0.248||0.242||0.239||0.238||0.238||0.238||0.236||0.232||0.23,0.4,0.3,0.2
486,Intensive_Care_Med-3-1-2040486.txt,condit||muscl||scherer||lactic acid||patient||demonstr||patholog condit||observ||autopsi||articl||shock||puerper fever||blood||research||johann joseph scherer||carl folwarczni||death||lactat||human blood||leukaemia||result,milchsäur||ueber milchsäur||ueber||die milchsäur||milchsäur bei sauerstoffmangel||ueber milchsäur im blut||ueber die bildung von milchsäur||scherer||milchsäur im blut und harn||milchsäur im thierischen organismu||ueber bildung von glycos||lactic acid||vorkommen der milchsäur||und harnanalys bei leukämi||glycos im organismu bei sauerstoffmangel,0.358||0.316||0.274||0.249||0.229||0.226||0.206||0.191||0.178||0.178||0.167||0.166||0.162||0.16||0.16,0.0,0.1,0.13333333333333333
487,Ann_Surg_Oncol-4-1-2190340.txt,follow-up||case||aspir||false-neg result||melanoma||sampl||locat||studi||patient||cytolog||clinic||difficulti||histopatholog evalu||sensit||diseas statu||needl||test||diagnost accuraci||failur||site||lesion||cell||verif||cytopathologist||fnb||axillari node||lymph node||accuraci||clinic follow-up||malign cell||materi||metastat melanoma||factor||posit||number||primari lesion||fine needl biopsi||clinic materi||procedur||needl pass||patholog||diagnosi||larg number||result,fnb||melanoma||suspici fnb||false-neg fnb||subcuti fnb||confirm fnb||fnb procedur||fnb stage||fnb case||739 fnb||fnb attempt||multipl fnb||603 fnb||conclus fnb||result fnb,0.624||0.384||0.373||0.333||0.331||0.326||0.324||0.321||0.321||0.317||0.315||0.315||0.314||0.313||0.313,0.4,0.2,0.13333333333333333
488,Pain-2-1-2258319.txt,method||respons||questionnair||line||practic||return||studi||vignett||patient||clinic practic||recommend||health care practition||pt||UK gp||behaviour||guidelin recommend||treatment||hcp||advic||gp||clinic behaviour||clinic guidelin||pain||associ||subscal||activ||practition||attitud||lbp||belief||work||random sampl||survey||practic behaviour||score,pain pain||pain||back pain||back pain belief||hcp||pain guidelin||lbp||hcp attitud||belief||pain spine||pain manag||pabs.pt||bedrest||pain disappear||gp,0.334||0.334||0.29||0.264||0.254||0.241||0.236||0.215||0.212||0.204||0.194||0.19||0.19||0.183||0.18,0.4,0.4,0.3333333333333333
489,Exp_Brain_Res-3-1-1914235.txt,condit||muscl||measur||afference-bas interact||time||error correct||peak flexion||bilater muscl activ||kinemat||method||bimanu coordin||left||depend||electromyographi||rel phase||valu||flexion||effect||neural control signal||correct||rhythmic bimanu coordin||pattern||cycl||emg activ||signal||effer signal||control||tempor relat||coordin pattern||instruct||half-cycl||ecr||phase||analysi||emg||phase entrain||activ||coher||rhythmic movement||differ||kinesthet track||limb||time error||antiphas coordin||time correct||emg amplitud||trial||movement||extens||coordin||cycl durat||hand||success half-cycl||result,"yy||xy||FC||bimanu coordin||rhythmic bimanu movement||rm FC||FC Φ||rhythmic bimanu coordin||motor-driven movement||yy A2||x,i||movement||HC||HC HC||coordin",0.222||0.144||0.144||0.136||0.122||0.122||0.121||0.12||0.114||0.113||0.112||0.109||0.106||0.106||0.104,0.2,0.2,0.26666666666666666
490,J_Med_Internet_Res-6-2-1550592.txt,health servic research||technolog||qualiti expert||project||accur||rate instrument||conduct||search engin||qualiti||studi||patient||common reason||consum||inform||criteria||organ||review||abil||eysenbach||user||site||consum search||health inform||web site||recommend||onlin search||content||tool||code||health||educ||ehealth||research||result||popul||algorithm||stakehold meet||search engin expert||pew||factor||search||access||import variabl||human mediat||particip||health-rel web site||engin||internet,search||consum search||consum||web search||web||health search||consum health||search engin||internet||onlin consum search||search mediat search||consum search strategi||health web||consum search terminolog||web site,0.427||0.422||0.418||0.4||0.374||0.313||0.308||0.304||0.301||0.296||0.291||0.289||0.286||0.284||0.265,0.6,0.5,0.4
491,Plant_Cell_Rep-4-1-2413081.txt,ornament||transgen||line||ornament plant||root induct||somat embryo||transform||millenium||current studi||poinsettia||pnmv-deriv hprna construct||infect||genet engin||non-fe plant||pnmv||pcp||co-cultiv||somat embryogenesi||resist||explant||poinsettia genom||t-dna||transgen line||area||poinsettia plant||medium||rna,poinsettia||poinsettia plant||plant||plant plant||transgen poinsettia plant||transform poinsettia plant||transgen poinsettia||eck poinsettia||poinsettia cv||poinsettia genom||poinsettia industri||poinsettia product||poinsettia stem||ornament plant||poinsettia mosaic viru,0.588||0.48||0.372||0.372||0.365||0.361||0.361||0.322||0.314||0.304||0.303||0.3||0.298||0.29||0.259,0.4,0.3,0.26666666666666666
492,BMC_Bioinformatics-4-_-166134.txt,mesh||method||figur||introduct||data||text mine||keyword content||question||section||full text articl||inform||mesh term||articl||context||content||cell||biolog inform||gene||term||relev||inform extract||analysi||subject||abstract||natur text||word||order||number||keyword||biolog concept||scientif articl||result,word||section||text||articl section||text mine||non-inform word||full text||singl word||multipl word||mine||noun||method section||full text articl||abstract||discuss section,0.328||0.284||0.211||0.191||0.187||0.179||0.172||0.166||0.166||0.163||0.157||0.149||0.148||0.145||0.144,0.6,0.3,0.3333333333333333
493,Biotechnol_Lett-3-1-1914260.txt,dextran||gene||starch||result||class||starch granul||kd-ut||foreign polym||asr||alternan||express||tuber juic||potato||starch content||tuber||transform||plant||glucansucras,asr||starch||potato||starch polym||potato plant||transgen starch||freeze-thaw-st potato starch||starch granul||plant||potato tuber starch granul||alternan||2007 asr leuconostoc||transgen potato plant||starch biosynthesi||starch gelatin,0.404||0.298||0.23||0.205||0.202||0.196||0.183||0.182||0.174||0.174||0.172||0.17||0.166||0.166||0.162,0.6,0.5,0.4
494,Cell_Tissue_Res-4-1-2386754.txt,medium||alp activ||studi||surface-mark express profil||assay||frequenc||chondrogen differenti potenti||human||adipos tissu||abdomen||rel target gene express||variabl||fat depot||cell||svf||day||gene||asc||protein||chondrogen differenti||differenti capac||osteogen differenti||differ||order||osteogen lineag||chondrogen||cultur||signific differ||tissue-harvest site||homogen popul||stem cell||gene express||donor,asc||t-l||cultur asc||asc frequenc||chondrogen||asc nodul||asc prolifer||asc 5||homogen asc cultur||adipos tissu||procedur asc yield||adipos differenti||homogen asc popul||adipos tissue-harvest site||chondrogen differenti,0.443||0.277||0.248||0.237||0.236||0.23||0.23||0.222||0.176||0.167||0.165||0.162||0.162||0.159||0.156,0.4,0.3,0.26666666666666666
495,World_J_Urol-3-1-1913171.txt,inflamm||bladder tumour||mmc||studi thermo-chemotherapi||transit cell carcinoma||sampl||studi||patient||local microwav||human||chemotherapi||high-grad urotheli cell carcinoma||increas||prolifer activ||temperatur||bladder||treatment||cell||haemorrhag||day||tumour||thermo-chemotherapi||tumour sampl||p53||activ||superfici bladder cancer||group||decreas||hyperthermia||posit||bladder cancer||cystectomi||result,cystectomi||hyperthermia||intraves hyperthermia||cystectomi sampl||mmc||thermo-chemotherapi||microwave-induc hyperthermia||studi hyperthermia||hyperthermia 2||bladder||combin intraves hyperthermia||intraves mmc||local microwav hyperthermia||p53||combin local bladder hyperthermia,0.502||0.441||0.294||0.259||0.255||0.247||0.231||0.222||0.221||0.209||0.201||0.2||0.186||0.182||0.171,0.6,0.5,0.4
496,Nutr_J-2-_-293472.txt,low densiti lipoprotein cholesterol||tablet||isoflavon||studi||cholesterol||effect||form||daidzein||serum TC||phytoestrogen||intervent||mixtur||treatment||lipid||soy protein||meta-analysi||subject||diet||serum cholesterol||serum lipid||genistein||soy||trial||isp,soy||soy isoflavon||isoflavon||purifi soy isoflavon||soy phytoestrogen||isoflavon tablet||soy protein||soy capsul||soy diet||soy biscuit||soy phyto-estrogen||soy compon||soy polysaccharid||soy food||soy product,0.598||0.577||0.556||0.386||0.361||0.335||0.321||0.32||0.318||0.316||0.309||0.305||0.302||0.302||0.301,0.4,0.3,0.2
497,Int_J_Colorectal_Dis-4-1-2386753.txt,follow-up||perian fistula||previou fistula surgeri||seri||recurr||patient||anal fistula plug||rectal advanc flap||cryptoglandular origin||high transsphincter fistula||high success rate||recurr rate||treatment||fistula||sphincter||advanc||anal canal||sphincter complex||surgeri||fibrin glue||group||high transsphincter perian fistula||intern open||consecut seri||altern treatment||closur||advanc flap||procedur||outcom||result,fistula||perian fistula||cryptoglandular fistula||anal fistula||fistula recurr||recurr fistula||fistula tract||fistula surgeri||flap||high fistula||glue||rectovagin fistula||fibrin glue||fibrin||recurr perian fistula,0.655||0.428||0.383||0.376||0.36||0.36||0.359||0.349||0.343||0.339||0.336||0.334||0.327||0.319||0.307,0.4,0.2,0.2
498,Cancer_Causes_Control-2-2-1764867.txt,alcohol consumpt||consumpt||cancer||drink pattern||time||wine intak||ovarian cancer||baselin||breast cancer||year||risk||rel||california||daili glass||alcohol beverag||intak||analys||median famili incom||day||cohort||women||cohort studi||alcohol||decil||age||associ||estrogen||report||liquor||drink||non-drink||wine||censu block group||beer||california teacher studi cohort||daili intak,wine||alcohol||1.00||ovarian cancer alcohol||wine intak||cancer alcohol||wine consumpt||ovarian cancer||wine drink||alcohol intak||cancer||alcohol consumpt||alcohol drink||baselin wine intak||alcohol women,0.41||0.331||0.318||0.295||0.294||0.288||0.28||0.278||0.275||0.255||0.245||0.241||0.235||0.232||0.221,0.6,0.4,0.4
499,Histochem_Cell_Biol-4-1-2228382.txt,type||morpholog||cargo||fission||post-golgi transport||process||structur||cisterna||complex||domain||golgi||transport||tubular subdomain||molecular motor||protein||carrier||clem||golgi complex||tgn||format||motor||precursor||tubular network||cell surfac||apic surfac||post-golgi carrier||plasma membran||pgc||target membran||membran||molecular machineri,golgi||pgc||golgi cisterna||tgn||golgi network||golgi stack||golgi complex||golgi apparatu||tran golgi network||yeast golgi||golgi enzym||golgi organ||golgi interfac||golgi area||golgi region,0.488||0.41||0.316||0.303||0.279||0.269||0.268||0.26||0.257||0.252||0.248||0.248||0.247||0.247||0.245,0.6,0.4,0.26666666666666666
500,Pediatr_Radiol-3-1-1950216.txt,dwi||time||protocol||spine||mri||imag||abnorm||patient||year||diffusion-weight imag||plane||fat satur||addit sequenc||manufactur||imag protocol||brain||tumour||slice thick||signal-to-nois||age||injuri||contrast||axial||sequenc||children,t1-w||t1-w spin-echo||coron t1-w spin-echo||axial t1-w spin-echo||spin-echo axial t1-w||sagitt t1-w spin-echo||t2-w spin-echo||axial t1-w||sagitt t1-w||t2-w||sagitt t1-w spin-echo dwi||axial t1-w imag||sagitt t1-w imag||contrast-enhanc t1-w||axial t1-w spin-echo orbit,0.43||0.389||0.336||0.322||0.322||0.315||0.313||0.309||0.298||0.277||0.275||0.272||0.265||0.265||0.256,0.0,0.0,0.0
501,J_Membr_Biol-2-2-1764598.txt,mechan||vesicl||synapt bodi||find||system||ribbon||releas||rate||studi||channel||immumoact||exocytosi||synapt transmiss||molecular dissect||increas||evid||auditori nerv fiber||activ zone||cell||calcium||hair cell synaps||protein||synapt ribbon||ribbon synaps||pool||synaps||mous||number||synapt relev||hair cell exocytosi||hair cell||function pool||neurotransmitt||capacit measur||larg number||sound||compon,al.||ribbon||synapt ribbon||ribbon synaps||synaps||hair cell ribbon synaps||hair cell ribbon||hair cell synaps||synapt vesicl||hair cell||auditori hair||khimich||hair cell affer synaps||synapt exocytosi||hair cell synaps safieddin,0.357||0.298||0.29||0.281||0.264||0.257||0.254||0.243||0.24||0.233||0.232||0.229||0.211||0.209||0.202,0.8,0.6,0.4
502,Plant_Cell_Rep-4-1-2413084.txt,respons||anthocyanin accumul||red color||metabol pathway||studi||red pigment||transcript factor||lettuc plant||leaf color||anthocyanin||anthocyanin biosynthesi||express||rt-pcr||repressor||gene||structur protein||myb transcript factor||analysi||regul||atmyb||accumul||factor||lettuc||secondari metabol||plant||result,atmyb60||4 atmyb60 atmyb60 atmyb60 atmyb60 1994||atmyb60 protein||WT atmyb60||plant||atmyb60 2005 atmyb60 2005 atmyb60 result||anthocyanin product atmyb60||lettuc plant||lettuc||atmyb||anthocyanin||atmyb60 atmyb60-atmyb60 atmyb60 transcript factor||arabidopsi plant||atmyb60 transcript factor||lettuc plant atmyb agrobacterium,0.59||0.394||0.304||0.303||0.296||0.296||0.287||0.285||0.273||0.265||0.261||0.252||0.234||0.219||0.215,0.2,0.4,0.3333333333333333
503,Pediatr_Nephrol-3-1-1805050.txt,standard method||case||hypertens||kidney||serum creatinin level||diastol BP||studi||patient||blood pressur||daytim||uak||control||renal mass||renal size sd||renal function||compensatori hypertrophi||abpm||report||ufsk||renal size||group||unp||patient group||solitari kidney||creatinin concentr||size||ura||BP profil||urin microalbumin||renal agenesi||children,av.||Av||24-h sbp||24-h sbp sd||24-h dbp sd||24-h systol||24-h sbp load||sbp||24-h HR||24-h sbp load sd||24-h map||0.001 av.||24-h map sd||24-h dbp load sd||kidney,0.288||0.263||0.225||0.199||0.19||0.175||0.17||0.168||0.164||0.164||0.163||0.16||0.158||0.157||0.154,0.0,0.0,0.06666666666666667
504,J_Mol_Med-4-1-2262918.txt,hsf1||transfect||yfp||protect effect||studi||hsp||aggreg||effect||western blot||polyglutamin toxic||therapeut agent||treatment||cell||protect||protein||hsp70||hsp gene||experi||polyglutamin||polyglutamin aggreg||number||celastrol||drug||diseas||toxic||result,celastrol||polyglutamin||polyglutamin aggreg||hsf1||celastrol treatment||result celastrol||polyglutamin toxic||polyglutamin diseas||polyglutamin repeat||polyglutamin express||polyglutamin protein aggreg||polyglutamin aggreg format||celastrol concentr treatment||aggreg||beal MF celastrol,0.538||0.436||0.311||0.283||0.276||0.27||0.256||0.233||0.228||0.228||0.226||0.217||0.189||0.186||0.186,0.8,0.5,0.4
505,Biogerontology-4-1-2367389.txt,calor restrict||anim||phd||hif-1α||data||diet protocol||restrict||prolyl-4-hydroxylas domain||diet-specif||skelet muscl||express||rat||hypoxia||gene||hif||tissu||protein||age||chang||liver||mif||mous||calor intak||heart,calor restrict||phd3||calor intak||mif||calor restrict regimen||phd3 mrna||phd3 express||restrict||phd3 level||prolyl-4-hydroxylas||mif mrna||phd1||phd3 mrna express||phd2||phd3 express level,0.339||0.317||0.249||0.237||0.23||0.199||0.194||0.19||0.163||0.161||0.159||0.158||0.157||0.136||0.133,0.6,0.4,0.26666666666666666
506,Arch_Orthop_Trauma_Surg-3-1-1914284.txt,antevers||inaccuraci||safe zone||data||patient||placement||freehand placement||acetabular cup posit||resid||total hip arthroplasti||present studi||free hand||acetabular compon||surgic approach||approach||estim||hip||accuraci||abduct||perop||factor||differ||cup||posit||surgeon||posterolater approach||signific differ||result,antevers||cup antevers||abduct antevers||acetabular cup antevers||cup||acetabular cup||abduct||acetabular abduct||cup placement||planar antevers||acetabular cup posit||calcul antevers||acetabular cup impactor-position||addit antevers||freehand cup,0.518||0.471||0.439||0.427||0.424||0.381||0.36||0.349||0.292||0.269||0.268||0.26||0.26||0.259||0.251,0.4,0.3,0.26666666666666666
507,Osteoporos_Int-3-1-1820756.txt,follow-up||measur||men||elderli men||spine||roi||larg cohort||rate||baselin||age-rel appar net||studi||periost apposit||periost expans||individu slope||abmd||increas||bone miner content||morpholog basi||femor neck||site||signific||mass||prospect follow-up||hip||bodi||age||chang||areal bone miner densiti||distal forearm||bmc||decreas||bone||periost expans rate||osteoporosi||cross-sect data||distal radiu||area||distal ulna||loss||bone loss,bone||bone loss||endost bone loss||bone miner||bone width||age bone||age-rel bone loss||net bone loss||bone mass||deposit bone||trabecular bone loss||bone strength||0.001 bone||bone size||bone microstructur,0.492||0.336||0.312||0.305||0.277||0.269||0.267||0.265||0.261||0.259||0.258||0.256||0.256||0.255||0.252,0.4,0.2,0.13333333333333333
508,Purinergic_Signal-4-1-2245997.txt,ligand-bas homolog model||molecular model studi||ligand bind||affin||molecular model||structure-act relationship||receptor||side chain||adenosin receptor||deriv||antagonist||ligand||select,adenosin||spalluto||adenosin receptor||moro||cacciari||receptor||adenosin receptor antagonist||adenosin receptor subtyp||adenosin A3 receptor||A3 adenosin receptor||neuron adenosin receptor||a2b adenosin receptor||uniqu adenosin receptor||human adenosin receptor||3 adenosin receptor,0.32||0.314||0.271||0.246||0.244||0.222||0.218||0.199||0.194||0.194||0.187||0.186||0.182||0.182||0.181,0.2,0.2,0.13333333333333333
509,Exp_Cell_Res-1-5-2131725.txt,centromer||polo||polo kinas||anaphas||phosphatas treatment||chromatin||histon modif||kinas||aurora||region||nhk-1||mitosi||phosphoryl||chromosom arm||cell cycl||cyclin||chromosom segreg||histon||loss||centromer region||function,h2a||nhk-1||h2a phosphoryl||centromer h2a phosphoryl||h2a t119||h2a t119 phosphoryl||phosphoryl||centromer h2a t119 phosphoryl||centromer phosphoryl||centromer||polo nhk-1||nhk-1 nhk-1 e107||nhk-1 kinas||down-regul h2a phosphoryl||down-regul h2a t119 phosphoryl,0.415||0.392||0.369||0.341||0.331||0.329||0.323||0.318||0.304||0.285||0.285||0.275||0.267||0.258||0.256,0.2,0.3,0.2
510,Intensive_Care_Med-2-2-1315314.txt,hospit stay||icu admiss||sap II||system||project||origin counterpart||northern europ||data||model||studi||patient||europ||sap 3 databas||admiss||sap II paramet||risk adjust||region||variabl||sap 3 studi||intens care||countri||cohort||hospit||chronic condit||intens care unit||vital statu||esm||perform||risk adjust system||icu||outcom,icu||icu admiss||icu coordin||icu patient||icu outcom||307 icu||icu lo||icu stay||303 icu||icu level||26 icu||icu structur||6 icu discharg||icu mortal rate||current icu case-mix,0.64||0.417||0.353||0.352||0.346||0.333||0.33||0.329||0.326||0.322||0.322||0.321||0.236||0.228||0.228,0.4,0.2,0.13333333333333333
511,Antonie_Van_Leeuwenhoek-3-1-2140096.txt,array||complet genom sequenc||studi||present||strain||chromosom||region||dataset||dna||signal||gene||conserv||protein||termin region||analysi||core region||group||linear genom||secondari metabol||speci||sco||sequenc||result,streptomyc||S. coelicolor streptomyc||S. avermitili streptomyc maritimu streptomyc||microarray streptomyc||S. coelicolor streptomyc streptomyc cattleya kitasatospora||2 streptomyc coelicolor||S. avermitili streptomyc S. coelicolor||murx streptomyc||streptomyc ambofacien||streptomyc S. coelicolor streptomyc kitasatospora saccharomonospora||2007 streptomyc||streptomyc maritimu kitasatospora||S. maritimu streptomyc S.||put septum||array streptomyc coelicolor 2004,0.488||0.304||0.295||0.282||0.265||0.258||0.255||0.254||0.254||0.246||0.244||0.231||0.226||0.208||0.206,0.0,0.0,0.0
512,Abdom_Imaging-4-1-2386533.txt,follow-up||regard||fat||accur||cross-sect imag||inflammatori bowel diseas||patient prepar||colon||bowel wall enhanc||CD patient||contrast medium||CT enterographi||magnet reson imag||termin ileum||bowel wall||vce||ultrasonographi||accuraci||bowel||contrast administr||specif valu||activ||small bowel||diseas||optim bowel prepar||ibd||sequenc||detect||diagnost perform||techniqu,bowel||diseas bowel||bowel ultrasonographi||bowel sonographi||small bowel||bowel wall||bowel prepar||bowel ultrasound||bowel lumen||bowel assess||bowel purgat||bowel spasm||bowel segment||larg bowel||small bowel crohn diseas,0.584||0.341||0.336||0.324||0.323||0.317||0.311||0.31||0.308||0.301||0.299||0.299||0.297||0.295||0.274,0.4,0.3,0.2
513,Anal_Bioanal_Chem-3-1-1802726.txt,vibrat band||current experi||dmso||corneocyt||molecular structur inform||secondari structur||imag||sampl||solvent||studi||current work||spectra||structur||spectral data||treatment||cell||protein structur||lipid||human SC||relationship||strong band||tissu||factor analysi||II band intens||patholog state||factor||singl cell||band||keratin||skin||epidermi||raman||imag plane||intact tissu||compon,corneocyt||corneocyt spectra||raman||isol corneocyt||individu corneocyt||50 corneocyt||15 corneocyt||raman spectra||corneocyt epidermi protein||raman spectroscopi||isol human corneocyt||corneocyt 4 2||raman intens||confoc raman spectroscopi||dmso,0.544||0.353||0.332||0.292||0.274||0.274||0.273||0.247||0.218||0.21||0.196||0.182||0.181||0.167||0.163,0.4,0.2,0.2
514,Behav_Brain_Res-1-5-2148464.txt,muscimol||cannula||dorsal||place||guid cannula||ap5||studi||ventral hippocampu||effect||infus||food reward||altern||correct||ventral hpc||lesion||dose||present studi||rat||spatial memori||goal arm||hippocampu||result||task||experi||arm||perform||drug||trial||side,hippocampu||dorsal hippocampu||ventral hippocampu||muscimol||muscimol infus||dorsal||ventral infus||ventral hippocampu contribut||infus||spatial memori||memori||dorsal hippocampu tempor inactiv||dorsal hpc infus||ventral hippocamp lesion||ventral hpc,0.42||0.336||0.334||0.302||0.255||0.253||0.228||0.227||0.207||0.188||0.186||0.182||0.176||0.161||0.158,0.6,0.6,0.4666666666666667
515,J_Neurol-3-1-1915612.txt,va||placebo||botulinum toxin||muscl||whiplash||week||baselin||studi||total pain||patient||central nervou system||effect||neck||btx||total||improv||cervic rang||treatment||day||whiplash syndrom||va intens||pain||placebo group||intens||chronic pain||differ||number||central mechan||trial||signific differ||chronic whiplash syndrom||neck pain||placebo-control clinic trial,whiplash||botulinum toxin||pain||botulinum toxin-a||chronic whiplash syndrom botulinum toxin||whiplash syndrom||botulinum group||neck pain||whiplash injuri||botulinum toxin group||conclus botulinum toxin||acut whiplash||neck||12 week botulinum toxin||chronic whiplash syndrom,0.482||0.378||0.293||0.289||0.277||0.275||0.263||0.262||0.26||0.26||0.252||0.249||0.232||0.224||0.21,0.6,0.5,0.4666666666666667
516,Plant_Cell_Rep-3-1-1824786.txt,seed||level||transgen||respons||line||signific reduct||studi||fhb||fusarium head blight||parent materi||inocul||transgen plant||analys||rt-pcr||fhb sever||percent fhb sever||field condit||greenhous||wheat||chitinas||resist||field||screen||transgen wheat||sever||diseas||transgen wheat line||plant||result,wheat||fusarium||wheat fusarium graminearum||fusarium graminearum||wheat plant||transgen wheat||transgen wheat plant||wheat α-1-purothionin||wheat scab||fusarium graminearum infect||fusarium graminearum infect fusarium graminearum 2000||979 fusarium graminearum||plant||fusarium head||wheat spike,0.41||0.407||0.377||0.36||0.325||0.303||0.282||0.281||0.265||0.251||0.246||0.243||0.24||0.239||0.236,0.2,0.2,0.2
517,FEBS_Lett-1-5-1942071.txt,s6k1||cell develop||embryon stem cell||pkc||mice||pkd||phosphoryl||pdk1||lymphocyt||depend||pathway||agc kinas||loss||activ||present studi||cell||p90rsk||kinas,pdk1||pdk1-null||kinas||S6 kinas pdk1||pdk1 loss||pdk1 express||pdk1 requir||pdk1 result||flδneo||pkc||phosphoinositide-depend kinas||pkd||pdk1-null cell||protein kinas||serin kinas protein kinas,0.46||0.293||0.281||0.256||0.244||0.235||0.235||0.231||0.209||0.199||0.197||0.194||0.19||0.188||0.177,0.4,0.3,0.26666666666666666
518,Int_Ophthalmol-4-1-2359829.txt,donor cornea||method||time||storag||endothelium||studi||risk||hypotherm storag||inspect||antibiot||evalu||corneoscler button||tissu||solut||storag time||donor||cornea||eye bank||mandatori||microbiolog safeti||preserv techniqu||addit||organ cultur||bank||medium||techniqu,cornea||corneal||corneal storag||donor cornea||storag||hypotherm storag||hypotherm||store cornea||donor cornea preserv||corneal endothelium||cornea tran||cornea 3:219||cornea 4:80||cornea 3:231||human cornea,0.491||0.374||0.353||0.347||0.332||0.312||0.292||0.263||0.259||0.256||0.255||0.253||0.253||0.253||0.252,0.6,0.4,0.26666666666666666
519,Ann_Hematol-3-1-1914243.txt,CR rate||surviv||secondari aml||level||elderli aml patient||aml||studi||wbc count||drug resist||age||mrna||major vault protein||breast cancer resist protein||express||patient||cell||event-fre surviv||ef||result,bcrp||mdr1 bcrp bcrp bcrp mdr1||mdr1 bcrp||mdr1 bcrp mdr1 bcrp||mdr1 mdr1 bcrp mdr1||mdr1||po mdr1 bcrp||0.001 mdr1 bcrp||analysi mdr1 bcrp||1 bcrp mdr1||mdr1 mrp1 lrp bcrp||mrp1 lrp bcrp 1 mdr1 mdr1||1 bcrp mrp1 bcrp lrp||mdr1 mrp1 lrp bcrp 1||2 mdr1 bcrp coexpress,0.694||0.652||0.641||0.641||0.614||0.588||0.43||0.429||0.428||0.427||0.418||0.376||0.356||0.334||0.325,0.0,0.0,0.0
520,J_Mol_Med-3-1-2121654.txt,effect||tat cpp||actin||cpp||protein||primari cell||terminu||concentr||peptid||tat||phase-contrast imag||myosin motor domain||cardiomyocyt||cell||primari adult cardiomyocyt,peptid||cardiomyocyt||vlc-1-tat peptid||tat||morano||trojan peptid||membrane-perm peptid||cell-penetr peptid||arginine-rich peptid||tat cpp||human vlc-1 peptid||transduc peptid||ingo morano||rat cardiomyocyt||vlc-1,0.267||0.234||0.203||0.203||0.189||0.165||0.151||0.151||0.149||0.143||0.143||0.142||0.142||0.14||0.139,0.6,0.4,0.26666666666666666
521,Virchows_Arch-3-1-1888719.txt,grade||ki-67 index||clinic behavior||system||stage iiib||confer||prognost assess||session||patient||digest tumor||foregut||propos||consensu||guidelin||classif||net||neuroendocrin tumor||consensu confer||tumor||tnm||mitot index||particip||pancrea||endocrin||stage||enet guidelin,tumor||M0||endocrin tumor||neuroendocrin tumor||N0||enet||endocrin||foregut tumor||digest endocrin tumor||digest tumor||carcinoid tumor||digest neuroendocrin tumor||net||gastroenteropancreat net||T2 tumor,0.27||0.245||0.235||0.219||0.202||0.201||0.199||0.199||0.194||0.191||0.19||0.183||0.178||0.17||0.166,0.4,0.4,0.3333333333333333
522,Theory_Biosci-4-1-2254468.txt,attent||biolog||find||essenti||graduat student||earlier paradigm||evolutionari tree||singl student||question||phylogenet||cladogram||phylogenet relationship||region univers colleg||relationship||remaind||evolutionari biolog||popul||respond||taxon||group||order||import||taxa||text book||stem group||correct answer||linnean categori||speci||tree||systemat||modern evolutionari biolog||draw,tree||student||evolutionari tree||biolog student||cladogram||student draw||evolutionari tree draw||2008 tree||anthropocentr tree||tree tip||graduat student||unbias evolutionari tree||univers student||ten student||singl student,0.325||0.314||0.237||0.198||0.195||0.192||0.181||0.178||0.175||0.168||0.167||0.163||0.162||0.161||0.159,0.6,0.3,0.3333333333333333
523,Diabetologia-4-1-2170457.txt,adipos vein||abdomin subcutan adipos tissu||time||sat||vivo whole-bodi||releas||lipolysi||lipolyt respons||obes||infus||adipos tissu||net uptak||tag||unit||present studi||blood||isotop enrich||insulin concentr||glycerol||glycerol uptak||mainten||abdomin sat||min||obes particip||import||obes individu||beta-adrenerg stimul||particip||neg net flux||result,adipos||obes||sat||sat lipolysi||adipos tissu||adipos vein||lipolysi||abdomin sat lipolysi||glycerol||abdomin sat||abdomin subcutan adipos tissu lipolysi||subcutan adipos tissu||adipos vein enrich||abdomin subcutan adipos tissu||subcutan abdomin adipos tissu,0.33||0.253||0.229||0.208||0.201||0.197||0.188||0.183||0.18||0.18||0.159||0.158||0.156||0.152||0.152,0.6,0.7,0.5333333333333333
524,Diabetologia-3-1-1914282.txt,insulin sensit||high molecular weight||adiponectin||men||alcohol||concentr||oxid capac||moder alcohol consumpt||studi||activ||hmw||hmw adiponectin||result,adiponectin||hmw adiponectin||lmw adiponectin||mmw adiponectin||adiponectin oligom||adiponectin concentr||hmw adiponectin concentr||hmw||whiski||plasma adiponectin oligom||9.4 0.61 adiponectin||fat-deriv hormon adiponectin||41.0 0.21 adiponectin||consumpt||keyword adiponectin high,0.42||0.315||0.272||0.266||0.241||0.222||0.218||0.21||0.186||0.168||0.161||0.152||0.15||0.146||0.142,0.4,0.3,0.2
525,Clin_Oral_Investig-2-2-1544376.txt,titanium||anim||mandibl||week||osseointegr||experiment studi||direct bone||bone format||pilot studi||dog||histolog data||bmp-a||tibia||present studi||rhbmp-2||distanc||BD valu||implant||surfac||differ||germani||biocoat||titanium implant||respect site,implant||rhbmp-2||titanium implant||jennissen HP||implant surfac||dental implant||rhbmp-2-biocoat titanium implant||surgic implant||implant placement||implant brush||implant instal||control implant||titanium||bone||dental implant clin oral implant,0.396||0.316||0.295||0.245||0.241||0.214||0.213||0.21||0.209||0.203||0.203||0.199||0.194||0.182||0.179,0.6,0.3,0.26666666666666666
526,J_Neurooncol-4-1-2174520.txt,effect||report||agent||dna fragment||apoptosi||non-chemotherapeut agent||lovastatin||trail||dna-depend protein kinas||glioblastoma||combin||synergist effect||studi||strategi||activ||medium||cell||flow cytometri,lovastatin||lovastatin glioblastoma||glioblastoma||trail||glioblastoma cell||lovastatin lead||apoptosi||glioblastoma multiform||human glioblastoma cell||glioblastoma cell line||cell||glioblastoma treatment||trail enhanc apoptosi||trail receptor||anim tissu lovastatin,0.429||0.396||0.364||0.329||0.278||0.22||0.212||0.21||0.192||0.192||0.192||0.188||0.185||0.175||0.146,0.6,0.4,0.3333333333333333
527,Histochem_Cell_Biol-4-1-2413112.txt,morpholog||day 1||uuo||data||control group||studi||Le hir||interstiti space||uranyl acet||cortic interstitium||fibrosi||fibrot kidney||s100a4||cell||rat||day||control||proxim tubul||uret||tubul||resid fibroblast||rer||mitot activ||tubular cell||distal tubul||fsp1||myofibroblast||cortex||interstitium||ligatur||larg popul||uret obstruct||fibroblast||kidney,myofibroblast||fibroblast||renal myofibroblast||interstiti fibroblast||interstiti fibrosi||renal fibrosi||kidney||interstiti fibroblast cell||fibrosi||renal tubul||uret||renal interstiti myofibroblast popul||resid fibroblast||resid peritubular fibroblast||renal cortic peritubular fibroblast,0.293||0.27||0.253||0.25||0.212||0.204||0.202||0.198||0.193||0.19||0.187||0.185||0.184||0.183||0.182,0.4,0.4,0.4
528,Eur_Arch_Psychiatry_Clin_Neurosci-2-2-1705499.txt,current knowledg||pyromania||behavior||preval||rate||intermitt explos disord||posit result||efficaci||studi||psychiatr||patient||impuls||effect||internet addict||comorbid||evid||icd||treatment||pharmacolog option||specif subtyp||internet||impuls control disord||report||kleptomania||double-blind||skin||double-blind trial||impuls disord||compuls buy||addit||patholog gambl||result,compuls||gambl||psychiatri||compuls disord||impuls gambl||trichotillomania||gambl fluvoxamin||obsess compuls disord||compuls shop||compuls buy||patholog gambl||kleptomania||compuls shop disord||compuls sexual behavior||compuls comput,0.359||0.333||0.275||0.259||0.252||0.251||0.239||0.214||0.21||0.209||0.199||0.198||0.193||0.187||0.183,0.0,0.1,0.2
529,J_Gastrointest_Surg-3-1-1852372.txt,measur||time||biliari reflux||esophagu||upper gastrointestin diseas||studi||valu||refer valu||data||patient||acid reflux||bilirubin absorb||ambulatori pH||bile||age 51 year||reflux||simultan bile||lower esophag sphincter||age||gender-match control||acid||barrett||stomach||meal||group||bile reflux||healthi volunt||intragastr pH||healthi control||esophag manometri||period||result,reflux||esophagu||bile reflux||bile||esophag bile||esophag||barrett esophagu||bile reflux monitor||duodenogastr reflux||bile acid reflux||esophag biliari reflux||24-hour bile reflux||patholog bile reflux||biliari reflux||acid reflux,0.431||0.388||0.374||0.317||0.316||0.316||0.31||0.28||0.273||0.262||0.262||0.259||0.257||0.235||0.235,0.8,0.4,0.4
530,J_Gastrointest_Surg-3-1-1852384.txt,pulmonari embol||complic||logist regress||leak||data||patient||year||bmi||roux-en-i gastric bypass||mortal||risk||obes||morbid||comorbid||msof||signific||male||oper||women||age||obstruct sleep apnea||coronari arteri diseas||incid||surgeri||death||cad||bariatr surgeri||report||periop risk||major complic||morbid obes||surgeon||rygb||procedur||postop small bowel obstruct||syndrom,rygb||bariatr surgeri||rygb complic||bariatr procedur||open rygb||primari rygb||cad||conclus rygb||bariatr surgeri program||leak||bmi||mortal||surgeri||0.01 cad||fail bariatr procedur,0.382||0.262||0.235||0.206||0.203||0.198||0.197||0.193||0.18||0.162||0.161||0.154||0.15||0.142||0.14,0.4,0.4,0.4666666666666667
531,Virchows_Arch-3-1-1888721.txt,cutan melanoma||morpholog spectrum||case||male breast||carcinoma||data||studi||seri||larg tertiari center||patient||frequenc||femal counterpart||metastas||site||slide||male||lobular||histolog subtyp||distribut||invas carcinoma||breast||period,breast||breast carcinoma||carcinoma||male breast carcinoma||male breast||breast cancer||male breast cancer breast cancer||male breast cancer||femal breast||breast patholog||male breast histolog||invas carcinoma||lobular carcinoma||femal breast cancer||femal breast carcinoma eur,0.538||0.493||0.449||0.411||0.392||0.376||0.35||0.333||0.305||0.303||0.301||0.29||0.275||0.275||0.267,0.6,0.3,0.26666666666666666
532,Biogerontology-4-1-2174522.txt,glycolysi||condit||level||nad avail||dietari restrict||nadh level||mitochondri||increas||sirtuin activ||cell||sirtuin||control||product||protein||nad||age||format||accumul||activ||dhap||genet||gener||metabol||AL condit||alter protein||lifespan||nadh||pathway||methylglyox||oxid||benefici effect||function,methylglyox||nad||nadh||methylglyox induc||methylglyox modif||methylglyox impair||plasma methylglyox||methylglyox feb||nad regener||nad metabol||glycolysi byproduct methylglyox||intracellular nad||nad level||nad unavail||nad avail,0.408||0.35||0.233||0.215||0.214||0.21||0.209||0.207||0.203||0.197||0.193||0.187||0.181||0.181||0.179,0.6,0.3,0.26666666666666666
533,Crit_Care-8-1-420054.txt,measur||capac||cardiopulmonari resuscit||earlier applic||suboptim care||patient||admiss||risk||develop||team||process||chain||increas||medic||clinic practic||cardiac arrest||acut pain team||intervent||evid||treatment limit decis||treatment||advers event||staff||ward||medic emerg team||hospit||approach||outreach care||earlier recognit||care||servic||literatur||group||report||import||opportun||emerg||outreach||critic ill||error||critic care||icu,care||outreach care||critic care||critic care outreach||intens care||outreach||crit care critic care||ill||hospit care||health care||multidisciplinari outreach care||suboptim care||collabor care||critic care servic||critic care servic critic care servic,0.362||0.303||0.263||0.256||0.248||0.243||0.239||0.229||0.224||0.215||0.213||0.211||0.204||0.201||0.201,0.6,0.4,0.3333333333333333
534,Med_Biol_Eng_Comput-3-1-1820753.txt,random nois||period signal||modul||sampl||thorax||electrocardiogram||ecg||inform||scale||amplitud||sourc||scale transform||signal||potenti||term||sft||random||multi-modul sourc||phase||spectral analysi||standard||algorithm||heart rate variabl||waveform||compon,τ||kj τ||ε kj τ||x′ τ||ε||ij τ||ε kj||min ε kj τ||4 τ||3 τ||1 τ||kj||2 4 τ||1 2 τ||signal ε,0.463||0.343||0.312||0.281||0.252||0.249||0.237||0.235||0.231||0.231||0.231||0.223||0.154||0.154||0.14,0.0,0.0,0.0
535,Ann_Hematol-4-1-2324127.txt,multipot adult progenitor cell||multi-lineag differenti||protocol||germ layer||differenti capabl||differenti potenti||circumst||marker||isol||mapc||adult||express||msc||differenti||present studi||cell||gene||adult stem cell||basal medium||cultur||passag||stem cell||pluripot||medium,mapc||mapc differenti||differenti mapc||P4 mapc||mapc isol||singl cell-deriv mapc||mapc 4 2||singl cell-deriv mapc transcrib oct4||mapc 6 2 2||oct4||stem cell||pluripot stem cell||pluripot||mesenchym stem cell||cell,0.744||0.423||0.423||0.388||0.386||0.329||0.248||0.235||0.186||0.149||0.142||0.141||0.137||0.125||0.117,0.2,0.1,0.26666666666666666
536,J_Gastrointest_Surg-4-1-2231408.txt,biopsi||correl||strain||specif type||pud||lavag fluid||result||studi||analysi||strip||popul||determin||sampl||genotyp||allel type||patient||ppu||perop lavag fluid,vaca||vaca vaca vaca caga||vaca caga vaca||helicobact pylori||caga vaca||H. pylori H. pylori H. pylori||H. pylori H. pylori||H. pylori||conclus vaca caga vaca||caga H. pylori||vaca genotyp||caga||vaca statu||18 caga vaca||vaca effect,0.534||0.471||0.45||0.409||0.408||0.359||0.359||0.359||0.338||0.334||0.309||0.282||0.28||0.273||0.268,0.0,0.0,0.0
537,Mar_Biotechnol_(NY)-3-1-2100433.txt,adhes test||anim||find||studi||marin||tyrosinas||marin mussel||recombin protein||domain||similar||marin mussel adhes||freshwat mussel||plant||cell||adhes||strength||dopa||product||quinon||research||collagen||protein||repetit motif||larg quantiti||byssu||surfac||specif identif||spider silk||natur adhes||adhes research||substrat||repeat||plaqu||marin polychaet||foot organ||attach||mussel||varieti||durabl||thread,mussel||eduli||mussel adhes||mytilu eduli||mussel byssal||sea mussel mytilu eduli||mytilu||mussel byssu||mussel protein||mussel mytilu galloprovinciali||marin mussel||mussel adhes protein||marin mussel adhes||recombin mussel||zebra mussel,0.542||0.439||0.417||0.386||0.355||0.332||0.332||0.327||0.325||0.319||0.315||0.314||0.307||0.301||0.296,0.2,0.1,0.2
538,Cardiovasc_Intervent_Radiol-4-1-2367387.txt,measur||person dosimet||data||studi||lead apron||special holder||intervent procedur||relat||dosimet||radiologist||protect apron||statist analysi||dose||william||present studi||occup exposur||effect dose||singl year||holder||addit dosimet||linear relat||differ||exposur||transmiss||addit inform||procedur||physician||result,apron||lead apron||wrap-around apron||protect apron||msv||dosimet||wrap-around lead apron||lead equival apron||dose||radiologist||0.25 msv||0.11 msv||16.78 msv||0.12 msv||0.01 msv,0.757||0.431||0.395||0.385||0.349||0.307||0.299||0.292||0.281||0.212||0.19||0.188||0.188||0.187||0.185,0.4,0.5,0.3333333333333333
539,Sleep_Breath-4-1-2194800.txt,placebo||armodafinil||hypertens||episod secondari memori||residu ES||baselin||clinic global impress||studi||patient||effect||long-term memori||test||cognit function||sleepi||adjunct treatment||treatment||advers event||therapi||day||obstruct sleep apnea syndrom||daili live||wake test||analysi||placebo group||ncpap||wake||visit||fatigu||final visit||signific amount||score||ncpap-adher patient,armodafinil||sleep||adjunct armodafinil||sleep breath sleep||armodafinil group||role armodafinil||obstruct sleep apnea||keyword armodafinil fatigu obstruct sleep apnea||nighttim sleep||sleep apnea syndrom||apnea||adjunct armodafinil treatment||sleep apnoea||ncpap||sleep latenc,0.527||0.383||0.302||0.273||0.269||0.265||0.236||0.232||0.221||0.216||0.216||0.21||0.209||0.208||0.205,0.2,0.1,0.13333333333333333
540,Pediatr_Radiol-3-1-1891641.txt,vesicoureter junction||uti||veloc||doppler||studi||durat||observ||sphincter muscl||function sphincter||ureter jet||pattern||bladder||physiolog||pregnant women||vur||dual compon||uret||age||action||subject||gener anaesthesia||chang||healthi uret||vuj||neural compon||activ sphincter||group||physiolog condit||signific differ||jet||initi slope||normal subject||children,jet||ureter jet||ureter jet pattern||monophas jet||ureter jet multispik||jet waveform||ureter jet direct||ureter jet proper||ureter jet characterist||ureter jet chang||ureter jet length||ureter jet effect||ureter jet 18||ureter jet 11||jet pattern,0.717||0.594||0.417||0.416||0.411||0.408||0.398||0.397||0.397||0.397||0.397||0.397||0.397||0.396||0.39,0.4,0.2,0.13333333333333333
541,Eur_J_Appl_Physiol-4-1-2226001.txt,measur||obstacl||capac||account||risk||correl||push-off||jump height||abil||high risk||grip strength||lower limb strength||classif||leg press apparatu||strength||daili life||leg||age||subject||faller||muscl strength measur||fall risk||leg extens strength||non-fal||healthi older adult||muscl strength||knee||trial||particip||hand grip strength||result,trip||fall||faller||legpress max||legpress max legpress rfd||legpress max jump||legpress rfd||induc trip||trip trial||simul trip||trip initi||jump||older faller||max jump||elderli faller,0.445||0.278||0.273||0.263||0.25||0.25||0.237||0.232||0.231||0.229||0.226||0.223||0.209||0.196||0.176,0.2,0.1,0.06666666666666667
542,Calcif_Tissue_Int-4-1-2268729.txt,anim||measur||time||ovx||bisphosphon||structur paramet||studi||valu||standard deviat||mechan properti||ultim displac||effect||bone structur||test||late zol||singl inject||cortic thick profil||rat||mechan adapt||control||zol||age||late treatment||group||percentag chang||differ||bone||anova||osteoporosi||earli||time point||cortic thick||absolut valu||result,zol||ovx||bone||late zol||zol treatment||zol group||earli zol||zol inject||0.673 0.999||0.265 0.999||3 0.999 0.999 0.579||3 0.999 0.999 0.353||trabecular bone||ovx group||late zol treatment,0.472||0.351||0.281||0.263||0.259||0.254||0.251||0.242||0.236||0.234||0.232||0.232||0.224||0.193||0.19,0.8,0.4,0.26666666666666666
543,Virchows_Arch-3-1-1888718.txt,case||tcrbcl||infiltr pattern||studi||hepat lymphoma involv||malign lymphoma||frequenc||diagnost algorithm||immunohistochemistri||liver biopsi||infiltr||lymphoma||site||pattern||classif||extranod lymphoma||margin zone lymphoma||lymphoma cell||anaplast larg cell lymphoma||entiti||liver||extranod site||biopsi||differenti diagnosi||pcr||molecular analys||diagnosi||dlbcl||addit biopsi,lymphoma||t-cell lymphoma||b-cell lymphoma||lymphoma infiltr||hepat lymphoma||extranod lymphoma||lymphoma entiti||lymphoma diagnosi||malign lymphoma||high-grad lymphoma||follicular lymphoma||low-grad lymphoma||burkitt lymphoma||splenic lymphoma||hodgkin lymphoma,0.687||0.438||0.434||0.415||0.411||0.388||0.366||0.364||0.36||0.359||0.359||0.358||0.357||0.354||0.353,0.2,0.3,0.2
544,Auton_Neurosci-2-1-2428072.txt,antibodi||import role||somat motoneuron||studi||chat-ir cytoplasm||chat||sympathet preganglion||electroton transmiss||lower cell surfac||spinal cord||rhythmic||slice||express||gap junction||lamina viii||coupl||cell||motoneuron||adult anim||dendrit process||cell bodi||neuron||adult rat||cytoplasm||import||connexin||optic section||room temperatur||vitro studi||close apposit||electr synaps,al.||cx36||cx36 puncta||motoneuron||cx36 immunostain||spinal motoneuron||cytoplasm cx36||sympathet preganglion motoneuron||sympathet preganglion||cx36 protein||sympathet preganglion motoneuron logan||preganglion neuron||sympathet preganglion neuron||cx36 punctat immunostain||somat motoneuron,0.405||0.404||0.289||0.272||0.233||0.232||0.229||0.228||0.205||0.203||0.189||0.187||0.184||0.184||0.175,0.2,0.2,0.2
545,Pediatr_Nephrol-3-1-1794138.txt,podocyt||nephrin||podocin||nephrot syndrom||anim model||tubulointerstiti||injuri||pathophysiolog,fsg||glomerulosclerosi||alpha-actinin-4-medi fsg||fsg prolifer||segment glomerulosclerosi||question fsg||primari fsg||fsg podocyt loss||focal segment glomerulosclerosi||podocyt||idiopath focal segment glomerulosclerosi||podocyt injuri||tubulointerstiti||nephrot syndrom||podocyt lead,0.482||0.332||0.275||0.251||0.245||0.244||0.243||0.233||0.226||0.199||0.185||0.125||0.118||0.113||0.109,0.0,0.1,0.2
546,Calcif_Tissue_Int-3-1-1914289.txt,endocort osteocyt||shaft||periosteum||studi||rat tibia||endost surfac||section||probe||bone format||increas||express||singl period||tibia||cell||rat||brain||control||bone marrow cell||load||igfbp-2 mrna express||endost side||sham-load tibia||sham||group||hybrid||bone||four-point bend system||mechan load||lamella,igfbp-2||igfbp-2 mrna||osteocyt||igfbp-2 mrna-express osteocyt||igfbp-2 mrna express||endogen igfbp-2 mrna||igfbp-2 mrna product||tibia||endocort osteocyt||load tibia||bone||igfbp-2 mrna express level||mous igfbp-2 cdna||situ hybrid igfbp-2 mrna express||total igfbp-2 mrna-posit osteocyt number,0.581||0.372||0.324||0.308||0.272||0.252||0.249||0.242||0.225||0.212||0.209||0.206||0.201||0.199||0.195,0.2,0.3,0.26666666666666666
547,Sex_Abuse-2-2-1764595.txt,affin self-report rate||categori||affin||VT approach||interest||ppg||femal children||sexual arous||rate||individu||data||offend||studi||devianc index||sexual attract||self-report sexual arous||correl||femal toddler||self-report||adult||view time||male||letourneau||research||assess||age||prepubesc children||intern consist||adult femal||experi||male child victim||victim||group||photograph||auc||sexual interest||intern consist estim||sexual offend||adolesc||procedur||particip||children,sexual offend||sexual arous||self-report sexual arous||sexual abus||adolesc sexual offend arous sexual abus||adolesc sexual offend arous||offend||juvenil sexual offend||sexual offend journal||sexual offens||sexual assault||sexual recidiv||sexual interest||sexual thing||sexual histori,0.452||0.413||0.345||0.344||0.342||0.341||0.333||0.314||0.313||0.313||0.311||0.307||0.307||0.304||0.293,0.6,0.4,0.3333333333333333
548,Bioinformation-1-10-1896059.txt,array||aspect||import aspect||level||method||copi number alter||data||valu||effect||boundari||gene express analysi||region||chromosom||gene||term||copi number||analysi||alter||cgh array||group||hybridis||diseas||profil||step||gene express||detect||function,copi number||copi number alter||alter copi number||amplicon||chromosom copi number alter||copi number estim||copi number variat||copi number gain||similar copi number||copi number measur||amplicon region||copi number alter 14||isowindow||copi number chang detect||copi number estim problem,0.314||0.26||0.26||0.253||0.235||0.219||0.215||0.213||0.213||0.21||0.198||0.196||0.179||0.169||0.166,0.4,0.2,0.13333333333333333
549,Theor_Appl_Genet-2-2-1544375.txt,seed||match||set||coffe||databas||pericarp||librari||gene famili||similar chromosom architectur||est||annot||tissu||solanacea||protein||blast||famili||cdna||uniqu||tomato||number||speci||stage||unigen set||highli||unigen||sequenc||seed develop||function||result,arabidopsi||arabidopsi arabidopsi arabidopsi||4 arabidopsi arabidopsi arabidopsi arabidopsi||unigen||springer-verlag 2005 arabidopsi arabidopsi arabidopsi arabidopsi||arabidopsi arabidopsi 3||coffe unigen||coffe||tomato coffe||coffe arabidopsi materi||arabidopsi thaliana||method arabidopsi||8 arabidopsi||coffe seed||6 arabidopsi,0.53||0.53||0.424||0.379||0.354||0.353||0.352||0.326||0.289||0.288||0.275||0.266||0.265||0.265||0.265,0.2,0.2,0.13333333333333333
550,Apoptosis-3-1-1914234.txt,antibodi||concentr||nuclear ro product||sampl||studi||effect||atp||heart failur||express||cell||apoptosi||experi||usa||decreas||incub||nuclear nitrotyrosin residu||cardiomyocyt||sah||pb||hci||result,hci||homocystein||hci concentr||mM hci||Ψ||s-adenosyl homocystein||homocystein thiolacton||incub mM hci||homocystein enhanc||homocystein trial||lower hci concentr||elev hci concentr||high hci concentr||cardiomyocyt||nox2,0.458||0.344||0.253||0.251||0.221||0.191||0.191||0.187||0.181||0.175||0.172||0.17||0.169||0.153||0.143,0.2,0.1,0.13333333333333333
551,Eur_J_Epidemiol-3-1-1914270.txt,level||measur||find||method||reproduc||cac||studi||cholesterol||technic variabl||epidemiolog||relat||coronari calcium measur||volum||agatston||measur protocol||mass||ebct||calcium||slice thick||mdct||absolut||calcium score||coronari arteri calcif||subject||scan||differ||cardiovascular risk factor||random select||coronari arteri||risk factor||particip||error||score||result,coronari calcium||agatston||calcium||agatston score||coronari calcif||inter-scan reproduc||calcium score||coronari arteri calcium||coronari calcium quantif||coronari calcium measur||inter-scan absolut||coronari arteri||mdct||low coronari calcium score||tomograph coronari calcium scan,0.303||0.3||0.28||0.239||0.233||0.231||0.229||0.227||0.216||0.216||0.201||0.2||0.2||0.198||0.186,0.4,0.4,0.4
552,Breast_Cancer_Res_Treat-3-1-2001224.txt,placebo||posit immunohistochem analysi||letrozol||efficaci||breast cancer||data||patient||tamoxifen||median follow-up||year||recurr||post-unblind analysi||risk||placebo-control trial||HR statu||nation cancer institut||tamoxifen therapi||aromatas inhibitor||df||treatment||therapi||adjuv therapi||women||result||analysi||tumor||continu hormon treatment||hormon therapi||clinic benefit||adjuv tamoxifen therapi||trial||ma.17||benefit||hazard ratio||outcom||safeti,letrozol||adjuv letrozol||tamoxifen||letrozol therapi||letrozol versu tamoxifen||letrozol treatment||ma.17||letrozol improv||letrozol suppress||adjuv tamoxifen||aromatas inhibitor letrozol||breast cancer||letrozol versu placebo||letrozol protect therapi||tamoxifen therapi,0.546||0.369||0.344||0.306||0.301||0.285||0.283||0.277||0.277||0.268||0.228||0.213||0.213||0.206||0.205,0.4,0.3,0.3333333333333333
553,Sleep_Breath-3-1-1794626.txt,apnea||daytim function||follow-up||oral applianc||measur||author||airway||applianc||reduct||overbit||rate||efficaci||data||studi||patient||benefici respons||upper airway||ess||respons rate||cpap||effect||clinic||abnorm anatomi||polysomnographi||sleep studi||inform||present||investig||common featur||bed partner||continu posit airway pressur||clinic trial||treatment||upper airway resist syndrom||sleep||random||sleep apnea||success||assess||mandibular advanc||group||loud||symptom||subject percept||signific differ||success rate||signific improv||outcom||result,applianc||snore||apnea||sleep apnea||sleep||oral applianc||maa||herbst applianc||advanc applianc||dental applianc||mandibular protrus applianc||applianc therapi||obstruct sleep apnea||mandibular advanc applianc||snorex applianc,0.532||0.374||0.37||0.357||0.344||0.33||0.303||0.292||0.289||0.287||0.279||0.274||0.274||0.271||0.268,0.8,0.5,0.3333333333333333
554,Eur_Arch_Otorhinolaryngol-4-1-2279159.txt,subglott||time||peakflow||dilat tracheoscopi||patient||upper airway||femal||present||progress complaint||refer group||tracheal stenosi||stenosi||intervent||treatment||institut||age||number||subglott stenosi||sg||diagnosi||local diseas||tracheoscop,subglott||subglott stenosi||sg||stenosi||tracheal stenosi||WG||stenosi tracheal stenosi dilat tracheoscopi constrict||posttraumat tracheal stenosi||thermal tracheal stenosi||DT||TS||congenit stenosi||postintub stenosi||post-intub stenosi||laryngotrach stenosi,0.402||0.376||0.359||0.349||0.319||0.229||0.225||0.217||0.216||0.194||0.19||0.19||0.185||0.185||0.185,1.0,0.5,0.3333333333333333
555,J_Biomol_NMR-4-1-2268728.txt,structur restraint||residu||nmr structur||nmr data||protein data bank,nmr||wwpdb||bmrb||wwpdb nmr TF||nmr structur||nmr restraint||bmrb deposit||nmr TF||nmr structur deposit||biomolecular nmr||nmr data||nmr spectroscopi||wwpdb nmr TF meet||wwpdb nmr task forc||wwpdb leadership,0.476||0.382||0.358||0.312||0.305||0.297||0.28||0.277||0.27||0.265||0.253||0.245||0.243||0.219||0.213,0.2,0.1,0.13333333333333333
556,Breast_Cancer_Res_Treat-3-1-2001222.txt,cardioprotect effect||placebo||exemestan||joint symptom||signific decreas||letrozol||breast cancer||studi||year||tamoxifen||patient||endometri cancer||effect||risk||vagin dryness||disadvantag||increas||aromatas inhibitor||ai||life-threaten event||event||fractur||postmenopaus women||treatment||advers event||adjuv therapi||women||result||incid||co-morbid||heart diseas||anastrozol||bone||earli breast cancer||lower incid||trial||signific differ||nation surgic adjuv breast||hot flash||bone loss||safeti,tamoxifen||tamoxifen breast cancer||adjuv tamoxifen||tamoxifen versu tamoxifen||breast cancer||tamoxifen therapi||cancer||adjuv tamoxifen therapi||arimidex tamoxifen||postmenopaus breast cancer women||tamoxifen versu||tamoxifen treatment||exemestan versu tamoxifen||adjuv anastrozol||tamoxifen resist,0.45||0.348||0.345||0.308||0.298||0.252||0.249||0.248||0.247||0.242||0.237||0.236||0.227||0.227||0.226,0.4,0.2,0.13333333333333333
557,J_Med_Internet_Res-8-2-1550696.txt,electron health inform||document||level||skill||journal articl||case||measur||behavior||understand plagiar||data||studi||question||research librari||higher educ||consum||procedur knowledg||inform||health inform compet||studi particip||articl||actual perform||health inform||consum health inform||idea||sourc||rrsa||one-keyword search||health profession||health educ||secondari sourc||websit||multipl choic||health||nutrit supplement||item||research skill||librarian||assess||health topic||import marker||plagiar||respond||search||compet||particip||area||self-report skill level||score||inform age student||internet,rrsa||student||rrsa item||rrsa score||rrsa particip||rrsa instrument||rrsa assess||rrsa complet||rrsa find||rrsa studi||websit||undergradu student||health||56 rrsa item||skill,0.499||0.324||0.291||0.278||0.271||0.264||0.264||0.259||0.256||0.252||0.25||0.214||0.209||0.198||0.192,0.2,0.1,0.26666666666666666
558,Diabetologia-3-1-1871609.txt,prevent||type 2 diabet||follow-up||level||diabet||weight loss||signific reduct||individu||control group||studi||effect||risk||impair glucos toler||review||cardiovascular fit||multi-compon lifestyl intervent||exercis intervent||moder increas||glucos||analysi||independ effect||physic fit||incid||exercis||igt||plasma glucos||chang||group||physic activ||trial||particip||ifg||relev clinic measur||prediabet||outcom measur,diabet||igt||exercis||prediabet||glucos||diabet mellitu||physic exercis||exercis intervent||glucos igt impair||impair glucos toler diabet||0.1||glucos toler||strenuou exercis||non-insulin-depend diabet mellitu||diabet mellitu report,0.334||0.285||0.273||0.266||0.226||0.217||0.215||0.194||0.193||0.18||0.162||0.159||0.155||0.153||0.152,1.0,0.6,0.4
559,Anal_Bioanal_Chem-4-1-2324126.txt,peptid vpp||method||hydrophil fraction||amino acid||compound||complex mixtur||hilic||analys||at-lin assay||separ||column||identif||activ||min||formic acid||fraction||peptid||ace-inhibit||milk hydrolys||larg number||total activ||total run time,n.r||hilic||peptid||hydrophil peptid||n.m||hilic column||hydrophil fraction||n.r. n.m||fraction||hydrophil ace-inhibit peptid||reversed-phas hilic||column||unretain hydrophil fraction||ods3 column||dimens hilic column fraction,0.441||0.27||0.26||0.249||0.241||0.228||0.227||0.222||0.216||0.212||0.197||0.186||0.182||0.173||0.17,0.4,0.4,0.3333333333333333
560,Pediatr_Radiol-3-1-2077923.txt,week||project tract||gestat age||infant||anisotropi||roi||imag||refer valu||studi||valu||patient||fraction anisotropi||adc||correl||diffus tensor||brain||white-matt tract||age||standard||direct||white matter||scan||diffus||signific correl||pyramid tract||dti||diffus tensor imag,white-matt tract||adc||roi||tract||diffus tensor||infant||white-matt injuri||FA||preterm infant||diffus||white-matt develop||white-matt abnorm||diffus anisotropi||preterm||diffus tensor imag,0.27||0.227||0.217||0.212||0.192||0.191||0.189||0.183||0.18||0.177||0.173||0.173||0.172||0.169||0.168,0.8,0.6,0.4666666666666667
561,Surg_Endosc-4-1-2292804.txt,path length||motion analysi||expert||studi||resid||plane||point||normal path length||object assess||shortest path||method particip||goal-ori movement||train||retract||cylind||mi perform||assess||phase||analysi||experi||task||group||differ||import||basic mi skill||mi||perform||import measur||signific differ||movement||novic||result,mi||novic||retract||mi skill||retract phase||abp||mi instrument||mi perform||path length||basic mi skill||phase||abp AB abp||shortest path||experts’ path length||goal-ori movement,0.408||0.327||0.306||0.28||0.25||0.238||0.221||0.217||0.208||0.199||0.195||0.187||0.185||0.179||0.179,0.6,0.6,0.6
562,Ann_Biomed_Eng-2-2-1705493.txt,outflow decreas||coronari bed||limit number||flow||low ventricular volum||model||isobar beat||strain||cardiac wall||coronari inflow||volum||increas||pressur||radial wall stress||ventricular wall||cycl||stress||bottom||paramet||fiber||nfa||experiment observ||primari interact||chang||resist||ventricular pressur||intramyocardi pump||decreas||normal physiolog condit||minimum||vessel||intramyocardi pressur||primari relat||paramet sensit analysi,"rm||rm m,r||rm lv||rm r0||rm art,c||rm ven,c||rm im||rm s,a0||rm art,c,min||rm m,f||rm f0||rm ar||rm max||rm lv0||rm art,c,max",0.212||0.139||0.131||0.121||0.121||0.12||0.12||0.115||0.115||0.113||0.11||0.11||0.109||0.109||0.109,0.0,0.0,0.0
563,Environ_Health_Perspect-115-3-1849909.txt,mechan||anim||document||set||similar inhal exposur||case||occup||respons||asthma||subsequ inhal challeng||protect cloth||potenti risk||dermal exposur||studi||polyurethan product||clinic||develop||worker||human||sensit||skin absorpt||childhood||import chemic||health administr||workplac||person protect equip||isocyan||health||potenti||respiratori exposur||product||research||host factor||mdi-ig||isocyan asthma||factor||absorpt||import||exposur||skin||mdi||subsequ develop||occup safeti||immun respons||result,isocyan||isocyan exposur||isocyan asthma||isocyan sensit||isocyan absorpt||isocyan vapor||airborn isocyan||aliphat isocyan||less-volatil isocyan||isocyan product||isocyan skin exposur||isocyan antibodi||isocyan reactiv||isocyan research||isocyan public,0.757||0.482||0.469||0.406||0.394||0.394||0.392||0.386||0.386||0.385||0.384||0.384||0.382||0.381||0.381,0.4,0.2,0.13333333333333333
564,Pediatr_Nephrol-3-1-1994209.txt,anatom defect||ureter bud||children||structur variat||urinari tract||linkag analysi||kidney||studi||mutat||larg multicentr collabor group||clinic classif||develop||human||defect||form||renal||trait||disord||malform||classif||clinic diagnosi||gene||approach||gene map||clinician||congenit anomali||dysplasia||development disord||diseas||renal agenesi||discoveri||signific discoveri||renal parenchyma||syndrom,agenesi hypoplasia||renal agenesi||hypoplasia||kidney agenesi||renal hypoplasia||kidney hypoplasia||dysplasia||renal dysplasia||renal||kidney dysplasia||kidney||syndrom renal agenesi||syndrom renal dysplasia||nonsyndrom renal agenesi||primari renal agenesi,0.33||0.32||0.319||0.315||0.309||0.303||0.3||0.299||0.298||0.294||0.288||0.257||0.244||0.224||0.22,0.2,0.3,0.26666666666666666
565,Pediatr_Nephrol-3-1-2064942.txt,mechan||proteinuria||angiotensin type 1 receptor||glomerulosclerosi||ckd||kidney||low nephron number||mutat||renal diseas||patient||glomerulu||aldosteron||effect||human||increas||spironolacton||abil||receptor||macrophag||key role||cell||therapi||growth factor||mice||result||angiotensin||tubulointerstiti fibrosi||action||low birth weight||interstiti fibrosi||angiotensin receptor blocker||injuri||activ||genet factor||experiment model||sclerosi||podocyt||regress||initi injuri||fsg||function||glomerular hypertens||diseas||acei||progress||fibrosi||cardiovascular diseas,kidney||fogo||angiotensin||kidney fibrosi||fogo AB angiotensin||podocyt||diabet kidney||kidney diseas||keyword angiotensin angiotensin||fogo AB||glomerular hypertens||end-stag kidney||kidney model||kidney function||renal fibrosi,0.32||0.264||0.263||0.212||0.204||0.202||0.195||0.187||0.175||0.175||0.172||0.164||0.163||0.163||0.162,0.4,0.3,0.26666666666666666
566,Purinergic_Signal-2-2-2096640.txt,oxid stress||cd39||e-ntpdas||bacteri clearanc,airway||picher||airway clearanc||airway e-ntpdas||boucher||cystic fibrosi airway||cystic fibrosi||human airway||fibrosi||airway epithelium||lung||airway calib||airway homeostasi||airway inflamm||mucociliari clearanc,0.322||0.255||0.233||0.233||0.229||0.228||0.181||0.179||0.175||0.174||0.17||0.169||0.165||0.164||0.162,0.0,0.0,0.0
567,Clin_Rev_Allergy_Immunol-3-1-2071970.txt,antibodi||infliximab||patient||rituximab||effect||salivari flow rate||infus||va score||improv||biolog agent||clinic trial||treatment||cell||therapi||autoimmun diseas||promis result||baff||pss patient||pss||II studi||trial||score||result,rituximab||sjogren ’s||sjogren ’s syndrom||pss||primari sjogren ’s||n.r.||primari sjogren ’s syndrom||rituximab treatment||sjogren ’s syndrom scand||ifn-α||rheumatoid arthriti||pss patient||salivari baff||malt||ifn-α oromucos,0.298||0.254||0.218||0.193||0.184||0.184||0.175||0.17||0.165||0.16||0.126||0.122||0.118||0.116||0.114,0.4,0.2,0.2
568,Oecologia-4-1-2270366.txt,anim||seed||author||bodi size||model||studi||adult size||intercept||correl||mammal||present||reproduct||egg||scale||empir evid||cold-blood vertebr||variabl||fecund||offspr||present paper||mass||reproduct event||averag||annual cycl||heterotherm||reproduct paramet||weight||terrestri habitat||regress||number||allometr scale||speci||expon||plant||slope,0.0001||rp||cdot||τ||allometri||rl τ||text||ecol||0.0001 1978||rl||seed||0.0001 0||offspr||0.0001 1979||0.0001 1953,0.166||0.151||0.145||0.131||0.128||0.121||0.114||0.113||0.112||0.111||0.11||0.109||0.105||0.096||0.095,0.0,0.0,0.13333333333333333
569,Ann_Surg_Oncol-4-1-2190341.txt,case||center||neoadjuv therapi||re-explor||studi||patient||pancreat cancer||unresect||initi find||oper||day||analysi||surgeri||reoper||group||tumor||resect||initi oper||distal pancreatectomi||diseas||pancreat surgeri||result,unresect||resect||pancreat resect||re-explor||unresect tumor||unresect patient||reoper||initi unresect||resect patient||initi resect||reoper pancreaticoduodenectomi||surgic resect||unresect pancreat ductal adenocarcinoma||resect group||resect rate,0.435||0.38||0.321||0.289||0.265||0.264||0.256||0.253||0.236||0.225||0.223||0.215||0.21||0.194||0.194,0.6,0.4,0.26666666666666666
570,Neuroradiology-2-2-1592467.txt,respons||intraobserv variabl||astrocyt glioma||mri||glioma||oligodendroglioma||data||studi||seri||patient||oligodendrogli tumour||prognost signific||chemotherapi||volum||grade II oligoastrocytoma||genotyp||tumour||rcbv||pcv chemosensit||pcv||pf||primari tumour||factor||chemosensit||loss||outcom,rcbv||tumour rcbv||19q||high rcbv||low rcbv||rcbv measur||elev rcbv||rcbv data||1 rcbv||1p||oligodendroglioma||nr||oligodendrogli tumour||high rcbv valu||19q genotyp,0.6||0.39||0.329||0.311||0.304||0.302||0.302||0.302||0.3||0.29||0.219||0.218||0.211||0.209||0.209,0.2,0.1,0.2
571,Matern_Child_Health_J-4-1-2335294.txt,lead||occup||commun||pregnanc||reproduct toxic||patient||water||worker||reproduct risk||wast site||exampl||site||workplac||health||women||fish||clinician||food||diet||home||hobbi||medicin||exposur||chemic||toxic||environment exposur,environment exposur||occup||occup exposur||exposur||environment hazard||environment health||environment contamin||environment exposur histori||workplac exposur||environment medicin||environment histori||environment risk||environment agent||environment clinic||environment exposur mcdiarmid melissa,0.262||0.254||0.241||0.228||0.216||0.195||0.191||0.19||0.188||0.174||0.171||0.166||0.156||0.153||0.152,0.6,0.3,0.2
572,Pflugers_Arch-3-1-1839769.txt,condit||action potenti||hypokalemia correl||critic interv||membran potenti||clinic observ||stimulu||hypokalem heart||neg shift||effect||criteria||refractori||experiment result||tdr||hypokalemia||conduct time||map||arrhythmia||repolar||refractori period||verp||heart||arrhythmogen,lidocain||repolar||arrhythmogen||QT||heart||verp||normokalem heart||normokalem heart 90||refractori||hypokalem heart||torsad||90||90 90||90 90 90||QT dispers,0.223||0.223||0.194||0.186||0.177||0.176||0.165||0.157||0.155||0.154||0.148||0.142||0.142||0.142||0.139,0.6,0.6,0.4
573,Purinergic_Signal-4-1-2245999.txt,adenylyl cyclas||level||terminu||intern||studi||adenosin||effect||human||amino acid||receptor||arrestin||adenosin receptor||grk||specif||phosphoryl||cell||gpcr||desensit||stimul||protein||lipid raft||agonist exposur||caveola||addit||function||result,2A||2A 2B 2A 2A||2B||2A receptor||2A 2B adenosin receptor||70 2A 2A||adenosin||2B receptor||2B 2B 2B 2B 86||2B 2B 2B 2B 83||2B 2B 2B 81||adenosin receptor||intern 2A 2A 4||2A receptor antagonist||2A 69,0.333||0.314||0.256||0.245||0.239||0.223||0.21||0.206||0.205||0.205||0.192||0.183||0.17||0.169||0.168,0.0,0.1,0.13333333333333333
574,J_Chem_Ecol-4-1-2266969.txt,multi-speci herbivori||volatil||predatori mite||effect||test||plant speci||compound||gc-m||herbivori||natur enemi||treatment||feed||cucumb||volatil blend||min||lima bean||emiss||cold trap||spider mite||speci||thermodesorpt cold trap setup,plant||S. exigua||S. exigua T. urtica S. exigua||spodoptera exigua||T. urtica||plant volatil||tetranychu urtica||S. exigua T.||S. exigua S.||spodoptera exigua S.||volatil||T. urtica S.||T. plant||herbivor||herbivore-induc plant volatil,0.287||0.285||0.278||0.277||0.265||0.255||0.241||0.236||0.232||0.227||0.224||0.219||0.212||0.21||0.19,0.0,0.0,0.06666666666666667
575,Mol_Biochem_Parasitol-1-5-1906845.txt,polv,var var var||var||var var var var||var P. falciparum var||var gene||fig. 2 var var||plasmodium falciparum var gene||plasmodium falciparum plasmodium falciparum||plasmodium falciparum||plasmodium||plasmodium falciparum 3d7 var gene||plasmodium falciparum var gene transcript||var gene divers||var gene transcript||fig. 1 var supplementari inform var,0.717||0.717||0.717||0.447||0.39||0.364||0.355||0.319||0.319||0.298||0.292||0.288||0.269||0.267||0.252,0.0,0.0,0.0
576,Pflugers_Arch-3-1-2040175.txt,fiaf||inflamm||level||vegf||adipokin||adipocyt||effect||glut||obes||adipos tissu||normox condit||hypox condit||white adipos tissu||express||differenti||present studi||cell||hypoxia||gene||product||protein||inflammatori respons||mif||leptin||mrna||adiponectin||result,hypoxia||adipocyt||hif-1α||adipokin||adipos factor hif-1α hypoxia||trayhurn||placent hypoxia||hypoxia induc||mild hypoxia||adipocyt differenti||inflammation-rel adipokin||human adipocyt||hypoxia stimul hif-1α gene express||fiaf||adipokin secret,0.338||0.308||0.262||0.217||0.194||0.184||0.183||0.18||0.173||0.17||0.17||0.169||0.15||0.145||0.14,0.6,0.3,0.26666666666666666
577,Doc_Ophthalmol-3-1-1784540.txt,time||grey hexagon||studi||valu||xlr||patient||femal||situ inversu||amplitud||test||retin dysfunct||eye||control||stimulu array||carrier||subject||averag control subject||mferg||hexagon||x-link retinoschisi||implicit time||segment||area,x-link retinoschisi||xlr||xlr carrier||hexagon||carrier||x-link retinoschisi carrier carrier age||x-link retinoschisi Br||juvenil retinoschisi||OU||x-link retinoschisi kim linda||sex-link juvenil retinoschisi||situ inversu||grey hexagon||multifoc erg||oblig carrier,0.364||0.282||0.272||0.267||0.262||0.251||0.247||0.239||0.226||0.187||0.176||0.17||0.166||0.164||0.147,0.8,0.4,0.4
578,J_Comput_Aided_Mol_Des-4-1-2311385.txt,report||evalu||inform||set||goal||method||binding-mod predict||field||test||paper||requir||practic applic||result||recommend||area||special issu||data||prepar||statist evalu||statist report,ligand||affin||predict ligand||decoy||ligand inform||test ligand||activ ligand||predict||ligand complex||specif ligand||doi||affin predict test||pose predict||affin estim||virtual screen,0.326||0.252||0.248||0.235||0.188||0.185||0.181||0.169||0.167||0.165||0.161||0.155||0.151||0.151||0.147,0.0,0.0,0.0
579,Curr_Genet-4-1-2413079.txt,report||luciferas imag||cultur||bioluminesc||luminesc imag||vivo||express||signal||activ||cell||luminesc||arginin||assay sensit,g-luc chlamydomona||chlamydomona||chlamydomona chlamydomona||g-luc g-luc chlamydomona 5 g-luc||g-luc chlamydomona gaussia chlamydomona chlamydomona chlamydomona||hsp70a g-luc hsp70a g-luc||g-luc chlamydomona strain||chlamydomona reinhardtii||chlamydomona gaussia||g-luc WT hsp70a r-luc hsp70a g-luc||chlamydomona g-luc gaussia C.||g-luc C.||g-luc r-luc g-luc dark grey||hse g-luc g-luc hsp70a 2007||r-luc,0.559||0.491||0.491||0.474||0.468||0.44||0.377||0.371||0.355||0.345||0.34||0.325||0.314||0.306||0.303,0.0,0.0,0.0
580,Pharm_World_Sci-3-1-2082656.txt,treatment regimen||attempt||psycholog reactanc||respons||intervent strategi||freedom||studi||physician behaviour||patient||reactanc theori||reactanc||decis support system||recommend||intervent||evid||behaviour||treatment||clinic care recommend||pharmacist||care||action||factor||sens||medic regimen||medic review||medic practition||physician||decis,reactanc||psycholog reactanc||reactanc theori||reactanc potenti||psycholog reactanc theori||fenton M. reactanc||keyword pharmacist physician psycholog reactanc medic||reactanc 20 20 21||hong ’s psycholog reactanc scale||pharmacist||physician||14. fogarti J. reactanc theori||recommend||physician-ori intervent||physician non-compli,0.81||0.475||0.428||0.41||0.332||0.283||0.229||0.203||0.201||0.198||0.183||0.183||0.132||0.122||0.119,0.6,0.4,0.4
581,Ann_Surg_Oncol-4-1-2277449.txt,retrograd outflow||ihhp||respons||time||isol hepat perfus||hepat toxic||concentr||perfus circuit||hepat arteri||retrograd||studi||simpl procedur||median||leakag||patient||perfus||tumor respons||treatment||oper time||partial respons||portal vein||pharmacokinet||heart-lung machin||progress diseas||month||liver||system melphalan concentr||blood loss||surviv||melphalan||hepat metastas||bile duct necrosi||present seri||stabl diseas||circuit||progress||ihpp procedur,melphalan||perfus||hepat perfus||ihhp||liver perfus||infus melphalan||isol hepat perfus||hypox hepat perfus||perfus retrograd||hepat metastas||high-dos melphalan||kg melphalan||perfus circuit||crc||perfus circuit perfus set,0.393||0.342||0.312||0.264||0.258||0.245||0.242||0.238||0.237||0.221||0.211||0.209||0.203||0.201||0.189,0.6,0.5,0.4
582,Virchows_Arch-3-1-1888717.txt,colorect carcinoma||case||tissu microarray||reactiv cell||core||metastat site||studi||patient||correl||concord egfr statu||section||metastas||tissu section||site||egfr-posit cell||slide||express||tma||epiderm growth factor receptor||egfr statu||crc||tumor||number||primari crc||egfr||result,egfr||egfr pharmdx||egfr express||egfr immunohistochemistri||egfr statu||egfr immunostain||egfr egfr immunohistochemistri 1||egfr immunoreact||tma||metastas||crc||result egfr express||concord egfr statu||tissu section egfr reactiv||synchron metastas,0.532||0.32||0.296||0.292||0.285||0.281||0.279||0.277||0.234||0.226||0.203||0.198||0.198||0.18||0.152,0.4,0.4,0.4
583,J_Chem_Ecol-4-1-2239252.txt,specialist herbivor||insect||plant defens||bar-typ plant||effect||amino acid level||egg||amino acid||bar-typ||leav||glucosinol concentr||leaf||sugar||generalist||chemotyp||experi||oviposit||herbivor||glucosinol||perform||prefer||larva||plant,brassica||pieri brassica||M. brassica||J. brassica||mamestra brassica||brassica oleracea||rapa||oviposit P. rapa M. brassica brassica||plasmodiophora brassica||brassica napu||brassica crop||brassica juncea||glucosinol||glucosinol glucosinol||M. pieri brassica,0.58||0.361||0.36||0.357||0.354||0.331||0.315||0.306||0.305||0.301||0.3||0.298||0.295||0.295||0.288,0.0,0.0,0.06666666666666667
584,Photosynth_Res-3-1-1779624.txt,method||enzym prepar||reduct PP||rate||octulos phosphat||assay||carbon||phosphotransferas reaction||photosynthet carbon reduct cycl||chloroplast||label||leav||calvin cycl||reaction||reaction sequenc||pga||enzym||PT enzym||phosphat||activ||intact||sep||spinach chloroplast||mg chl||octulos||spinach||sugar phosphat||non-oxid segment||result,hbox||chloroplast||sc||spinach chloroplast||ara 5-p||spinach||octulos||intact spinach chloroplast||octulos phosphat||spinach chloroplast prepar||glc 6-p||intact chloroplast||chloroplast phosphofructokinas||phosphat||chloroplast prepar,0.386||0.157||0.147||0.141||0.132||0.124||0.115||0.104||0.103||0.101||0.101||0.094||0.092||0.091||0.09,0.4,0.5,0.4
585,Pediatr_Nephrol-3-1-1989764.txt,attent||chronic kidney diseas||group deficit||infant||deficit||ckd||mri||data||studi||norm popul||effect||develop||frequenc||cognit function||nervou system||kidney diseas||esrd||kidney transplant||control||cognit||age||popul||literatur||transplant||cognit deficit||dialysi||diseas||function||children,ckd||children||ckd modal||dialysi||mild-to-moder ckd||IQ||children cognit||cognit IQ||transplant||kidney transplant||esrd||cognit||neurodevelopment outcom ckd||gener pediatr ckd popul||transplant-depend children,0.414||0.253||0.245||0.239||0.229||0.222||0.216||0.2||0.196||0.194||0.186||0.179||0.172||0.165||0.157,0.6,0.5,0.4666666666666667
586,Osteoporos_Int-3-1-1915640.txt,femor neck width||placebo||synergist effect||studi||year||fractur risk||total||femor neck||clinic trial||dxa-bmd||intak||dose||postmenopaus women||treatment||osteocalcin||non-osteoporot women||day||strength||clinic endpoint||women||age||fnw||menaquinon||bmc||group||bone||osteoporosi||bone loss||vitamin||result,mk-4||bone||dxa-bmd||bone vitamin||fnw||vitamin||hip bone||bone strength||bone miner||mk-4 group||mk-4 treatment||differ mk-4||hip fractur||bone geometri||femor neck dxa-bmd,0.329||0.245||0.239||0.227||0.209||0.209||0.206||0.18||0.177||0.174||0.171||0.167||0.155||0.154||0.151,0.6,0.4,0.26666666666666666
587,Transgenic_Res-4-1-2268725.txt,gene||skin||mice||periton lavag||bac||mast cell||eyfp||transgen mice||cre||cell,mcpt5-cre||mast cell||cre||cre mcpt5 cre||mcpt5 cre||mcpt5||cre cre 2007 mcpt5-cre||mcpt5 mcpt5-cre mice||skin mast cell||periton mast cell||mast cell lineag||mucos mast cell||mast cell gate||mast cell biolog||mast cell develop,0.376||0.34||0.319||0.31||0.306||0.292||0.255||0.246||0.242||0.24||0.233||0.23||0.23||0.23||0.228,0.4,0.2,0.13333333333333333
588,Arch_Dermatol_Res-3-1-2064945.txt,role||find||eosinophil||pathogen effect||mast cell degranul||model||neutrophil||develop||human||neutrophil infiltr||cell||autoimmun diseas||hemidesmosom||mice||lesion skin||extracellular matrix protein||blister fluid||experiment BP||human BP||autoantibodi||diseas||pathogen epitop||inflammatori cell,pemphigoid||bullou pemphigoid||bullou pemphigoid autoantibodi||autoimmun bullou pemphigoid||bullou pemphigoid antigen||human bullou pemphigoid||bullou pemphigoid autoantigen||experiment bullou pemphigoid||bullou pemphigoid cdna||bullou pemphigoid 180||bullou pemphigoid patient||bullou pemphigoid Br||bullou pemphigoid arch dermatol||pemphigoid antigen||pemphigoid antibodi,0.577||0.573||0.428||0.397||0.394||0.393||0.392||0.389||0.387||0.385||0.384||0.384||0.327||0.307||0.304,0.0,0.0,0.0
589,J_Biol_Inorg_Chem-3-1-2099461.txt,formaldehyd oxidoreductas||reaction||high concentr||pre-steady-st data||substrat||ferredoxin||benzyl viologen||visibl spectrum||enzym||concentr||singl broad line||substituted-enzym mechan||data||electron acceptor||valu||wavelength||formaldehyd||pre-steady-st kinet,text||rightleftharpoon||formaldehyd||formaldehyd oxidoreductas||max formaldehyd||prime||P. furiosu formaldehyd oxidoreductas||total formaldehyd||free formaldehyd||formaldehyd inhibit||ferredoxin||oxidoreductas||P. furiosu formaldehyd oxidoreductas R.||keyword tungsten formaldehyd oxidoreductas pyrococcu furiosu||formaldehyd oxidoreductas tri tri,0.251||0.23||0.229||0.166||0.147||0.143||0.126||0.116||0.116||0.116||0.104||0.102||0.101||0.093||0.089,0.4,0.2,0.2
590,Eur_J_Nucl_Med_Mol_Imaging-3-1-2121116.txt,phase histogram||cardiac cycl||substanti LV dyssynchroni||studi||patient||histogram bandwidth||interventricular dyssynchroni||LV dyssynchroni||correl||inform||heart failur||gmp||tdi||gate spect||phase analysi||assess||gate myocardi perfus spect||analysi||higher valu||LV segment||tri-plan tissu doppler imag||crt implant||kurtosi||crt||good correl,dyssynchroni||LV dyssynchroni||interventricular dyssynchroni||intraventricular dyssynchroni||dyssynchroni assess||substanti LV dyssynchroni||LV dyssynchroni assess||baselin LV dyssynchroni||LV dyssynchroni paramet||studi LV dyssynchroni||tri-plan tdi||gmp versu LV dyssynchroni||tdi||LV||left ventricular dyssynchroni,0.652||0.466||0.344||0.344||0.341||0.327||0.321||0.314||0.313||0.311||0.303||0.285||0.28||0.28||0.255,0.4,0.3,0.26666666666666666
591,J_Affect_Disord-1-5-1894757.txt,prospect studi||children||infant||mother||birth||pregnanc||studi||depress||year||earli identif||rural sub-district||life event||difficulti||persist||debt||prolong depress||preval rate||event||countri||psycholog symptom||social support||postnat period||item||women||trimest||persist depress||maximum score||month||subject||depress women||factor||famili||pakistan||infant growth||ladi health worker||depress disord||postnat depress||postnat year||outcom,depress||postnat depress||depress mother||postpartum depress||persist depress||depress women||al.||prenat depress||matern depress||persist postnat depress||depress disord||antenat depress||depress symptom||prolong depress||clinic depress,0.496||0.352||0.346||0.346||0.309||0.295||0.291||0.291||0.29||0.275||0.274||0.269||0.268||0.255||0.25,0.6,0.4,0.4
592,Oecologia-3-1-2039789.txt,total biomass product||main stolon||main effect||defens induct||respons||time||measur anova||induct||competit||petiol||competit tray||leaf tissu||studi||effect||leaf area||rel biomass alloc||stolon||adapt plastic hypothesi||dri mass||trait||express||leav||clonal plant||cost||damag||defens||leaf||asymmetr competit||experi||resist||herbivor||leaf area loss||tray||perform||phenotyp||area||leaf dri mass||petiol dri mass||benefit||ramet||plant||result,ramet||plant||stolon||clonal plant||uninduc ramet||induc ramet||uninduc plant||herbivor||plant genotyp||benefit plant||induc plant||petiol||induc plant defens||youngest ramet||interconnect ramet,0.352||0.329||0.319||0.242||0.223||0.213||0.212||0.209||0.208||0.207||0.202||0.201||0.191||0.19||0.185,0.8,0.5,0.4
593,J_Med_Internet_Res-5-4-1550575.txt,search rank||search engin||search term||studi||correl||search effici||user||site||health inform||web site||page||web||smoke cessat||direct relev||result||link densiti||characterist||internet||teen||search||presenc||posit||number||web-sit characterist checklist||popular search site||googl||posit rank||link||simpl web search||teenag,search||web search||web||search site||web site||site||web page||web site search term||simpl web search||typic web search||popular search site||smoke cessat||search rank||search site url||teenag smoke cessat,0.359||0.344||0.33||0.306||0.291||0.253||0.248||0.244||0.236||0.233||0.23||0.227||0.222||0.214||0.213,0.6,0.5,0.5333333333333333
594,Int_J_Colorectal_Dis-4-1-2386750.txt,colon cancer||oscc||time||case||radial margin||bloc resect||studi||patient||hemicolectomi||colon||laparoscop surgeri||middl colic vessel||altern||convers||transvers colon||laparoscop resect||middl colic arteri||statist differ||anterior resect||local||lymph node||oncolog qualiti||laparoscopi||proxim resect margin||surgeri||group||tumor||differ||long-term analysi||number||laparoscop approach||splenic flexur||patholog outcom||tcc,laparoscop||colon cancer laparoscop||colon||laparoscop resect||laparoscop surgeri||transvers colon||laparoscop lymph||laparoscop transvers colon cancer resect||laparoscop colorect resect||laparoscop transvers colon cancer surgeri||transvers colon cancer||laparoscop versu||laparoscop colecotomi||laparoscop re-oper||colon cancer,0.557||0.377||0.376||0.375||0.344||0.338||0.329||0.324||0.312||0.312||0.291||0.29||0.29||0.287||0.286,0.6,0.4,0.3333333333333333
595,Plant_Foods_Hum_Nutr-4-1-2413119.txt,ast activ||placebo||anim||liver damag||noni||placebo pretreat||noni juic||alt||protect effect||experi||liver||rat||group,noni||noni juic||tahitian noni||noni fruit||noni compon||noni control||noni juic pretreat||noni fruit juic||juic||morinda citrifolia||swollen hepatocyt noni juic suppress alt||anion radic tnj tahitian noni||morinda hold||carbon tetrachlorid hepatotox||morinda hold inc.,0.707||0.5||0.383||0.382||0.356||0.356||0.352||0.352||0.293||0.236||0.195||0.176||0.168||0.136||0.119,0.4,0.2,0.13333333333333333
596,J_Med_Internet_Res-4-2-1761932.txt,type||survey research||questionnair||commun||inform consent||databas||studi||patient||site visitor||qualit research||inform||electron public||electron one-to-on interview||exampl||clinic trial||technic issu||web||select bia||research||result||confidenti||data collect||materi||type 2 public||due emphasi||ethic||issu||trial databas||public||survey||particip||peopl||newsgroup||e-mail||internet,internet||internet survey||web||internet survey research||web survey||internet commun||internet search||internet address||internet technolog||med internet||pew internet||internet popul||internet women||internet studi||survey,0.487||0.365||0.293||0.273||0.268||0.259||0.257||0.253||0.253||0.252||0.251||0.246||0.246||0.246||0.243,0.4,0.2,0.2
597,Eur_J_Nucl_Med_Mol_Imaging-3-1-1914225.txt,non-invas detect||target||case||imag||model||patient||strategi||molecular imag||annexin A5||process||vulner plaqu||necrot cell||lesion||apoptot program||apoptot macrophag||cell||apoptosi||environ||death||cell suicid||atherosclerot lesion||cardiovascular diseas||caspas cascad||non-invas imag||pet||caspas||plaqu||clinic studi||detect||vivo||result,99m||apoptosi||apoptosi imag||99m 99m 48 99m tc-c2a-gst||molecular imag apoptosi||imag||arrow 99m||99m arrow||macrophag apoptosi||cardiomyocyt apoptosi||99m 75||apoptosi synaptotagmin||cvd apoptosi||apoptosi detect||annexin,0.425||0.376||0.302||0.26||0.227||0.227||0.225||0.225||0.222||0.222||0.217||0.216||0.213||0.211||0.208,0.2,0.2,0.13333333333333333
598,Skeletal_Radiol-3-1-1934928.txt,mechan||fat signal||radiograph||spine||CT imag||low signal||imag||mri||vertebr bodi||patient||disc||neural dysfunct||periost apposit||epidur fat||increas||osteoclast activ||signal||cord compress||pain||intervertebr disc||signal characterist||facet||activ||clinic symptom||spinal stenosi||bone||neural||spinal involv||diseas||vertebra,paget||paget diseas||paget facet||paget complic||paget arthriti||paget enlarg||paget t11||paget L3 vertebra||paget spinal stenosi||paget ’s diseas||paget vertebr ankylosi||paget neural arch||paget ’s diseas periost||monostot paget ’s diseas||lytic paget ’s diseas,0.859||0.46||0.45||0.441||0.439||0.439||0.434||0.342||0.338||0.329||0.325||0.301||0.258||0.255||0.253,0.0,0.0,0.0
599,Environ_Manage-3-1-2094719.txt,swc||project withdraw||soil manag practic||project||knowledg||practic||farmer-bas extens||bolivia||strategi||solid foundat||develop||farmer contest||wide-scal impact||rural develop||rural poverti||sustain||tool||farmer||impact||cl||widespread sustain result||local institut||swc practic||rural villag||approach||train||sustain develop||paper||zimbabw||conserv leader||villag||stone line||mainten||activ||natur resourc manag||famili||group||bolivian mountain valley||contest||ex-post evalu||order||train activ||particip rate||particip||extens||experiment||institut level||farmer group||farmer-to-farm train,swc||swc contest||contest||swc practic||swc extens||swc contest mainten||success swc contest||swc activ||contest farmer||farmer contest||swc activ swc activ experiment||replic swc practic||villag||execut swc practic||improv swc practic,0.709||0.566||0.423||0.401||0.396||0.388||0.379||0.362||0.315||0.315||0.292||0.281||0.279||0.276||0.271,0.6,0.4,0.3333333333333333
600,J_Plant_Res-3-1-2039807.txt,consequ||cell wall||carbohydrate-bind modul||modul||sampl||wall||cellulos||high express||cell wall modif||acid hydrolysi||express||plant develop||cell type||plant||tobacco||control||tobacco cell wall||tissu||cell wall structur||primari||prolong juvenil||polysaccharid||wall loosen||singl cbm||xylem cell||layer||stem||membran||cbm||result,plant||cbm||transgen plant||plant cell||cellulos||plant cell wall||transform plant||plant growth||plant breed||plant height||cbm transgen||promiscu cbm||matur plant||control plant||plant morpholog,0.434||0.353||0.266||0.264||0.243||0.238||0.237||0.235||0.234||0.23||0.226||0.225||0.224||0.223||0.222,0.6,0.3,0.2
601,Exp_Eye_Res-2-1-2394572.txt,anim||onl||intravitr inject||administr||find||time||outer||retin transplant||greater number||studi||photoreceptor||disrupt||effect||section||olm||integr||dose||signific increas||eye||cell||retina||control||adult mous||mice||normal||transplant||subretin space||aaa administr||mous||recipi||number||segment layer||layer||subretin inject||müller cell||cell integr||photoreceptor cell,al.||aaa||olm||photoreceptor||olm karlsen||olm disrupt||aaa inject||olm integr||photoreceptor transplant||transplant photoreceptor||aaa administr||retin transplant||retina||aaa treatment||retin layer,0.376||0.349||0.347||0.268||0.255||0.23||0.209||0.207||0.201||0.201||0.199||0.191||0.185||0.175||0.173,0.4,0.2,0.3333333333333333
602,Int_J_Hematol-4-1-2276240.txt,multi-centr survey||case||indic||efficaci||favor respons||patient||criteria||investig||clinic evid||clinic trial||treatment||advers event||invas fungal infect||malign hematolog diseas||voriconazol||fungal infect||prophylaxi||activ||diseas||toxic||ifi||antifung,voriconazol||triazol voriconazol||oral voriconazol||voriconazol vehreschild jörg||ifi||averag initi voriconazol dose||oestmann j-w voriconazol versu amphotericin||averag initi voriconazol mg||amphotericin||antifung||fungal infect||4 tabl 4 voriconazol dose||liposom amphotericin||invas fungal infect||ifi 57,0.642||0.364||0.335||0.227||0.216||0.175||0.171||0.168||0.167||0.157||0.156||0.137||0.133||0.131||0.129,0.4,0.3,0.3333333333333333
603,J_Abnorm_Child_Psychol-3-1-1915590.txt,co-occurr||hostil reactiv parent||parent psychopatholog||high level||children||behavior||mother||problem||sampl||physic aggress||model||studi||prenat smoke||impuls||scale||comorbid||matern depress||signific||low||analys||smoke||hyperact||item||age||trajectori||associ||parent||earli childhood||group||famili||tremblay||high||neg parent||adhd||contrast||control variabl,smoke||chi||prenat smoke||matern smoke||matern prenat smoke||matern prenat||E. prenat smoke||hyperact||child||J. matern smoke||L. matern smoke||A. prenat smoke||document||matern prenat smoke matter||2 matern prenat smoke,0.099||0.094||0.093||0.09||0.089||0.083||0.077||0.075||0.074||0.07||0.07||0.068||0.068||0.067||0.067,0.4,0.3,0.2
604,Matern_Child_Health_J-2-2-1592150.txt,pregnanc||preconcept care||hiv,hiv||perinat hiv||perinat hiv transmiss||zidovudin||hiv infect||perinat transmiss||hiv screen||hiv test||routin hiv||hiv treatment||transmiss||immunodefici virus-1||human immunodefici viru||perinat care||perinat human immunodefici viru test,0.434||0.368||0.315||0.285||0.275||0.256||0.236||0.233||0.223||0.221||0.211||0.194||0.19||0.19||0.181,0.2,0.1,0.06666666666666667
605,Histochem_Cell_Biol-4-1-2248607.txt,vesicl||role||earli biochem approach||granul||isoform||neuroendocrin tissu||data||hypothesi||msg||molecular tool||isg||prohormon convertas||assay||observ||chromogranin||process||constitutive-lik secret||matur||import issu||secretori granul||cell type||cell||zymogen granul||biochem||neuroendocrin cell||homotyp fusion||protein||mice||golgi complex||experi||tgn||secretori pathway||biochem approach||ph||pc||immatur secretori granul||secret||size||phenotyp||special cell||pathway||addit||hormon process||membran||physiolog pH,secretori||secretori granul||granul||neuroendocrin secretori granul||secretori granul biogenesi||secretori granul matur||pituitari secretori granul||immatur secretori granul||secretori granul protein||endocrin secretori granul||secretori granul format||acth-contain secretori granul||secretori granul malform||isg||secretori cell,0.497||0.464||0.431||0.352||0.344||0.343||0.334||0.332||0.327||0.319||0.317||0.314||0.311||0.311||0.299,0.4,0.3,0.26666666666666666
606,Bioinformation-1-2-1891631.txt,medicin||aromat plant||india||databas||folklor||plant,kashmir||plant||jammu||aromat plant jammu||aromat plant||kashmir india||medicin plant||databas||folklor||plant speci||india||folklor background medicin plant||plant materi||medicin plant speci||bioinform bioinform bioinform,0.399||0.364||0.333||0.325||0.321||0.304||0.251||0.25||0.249||0.212||0.209||0.191||0.189||0.187||0.171,0.4,0.4,0.3333333333333333
607,Int_J_Legal_Med-3-1-2039830.txt,age interv||socioeconom statu||method||complet fusion||CT scan||individu||data||model||studi||hdi||medial epiphysi||year||effect||femal||variabl||sex||signific||examin||clavicl||slice thick||fusion||age||dri bone specimen||fusion statu||differ||probabl||ethnic||result,clavicl||text||matur clavicl||clavicl fusion||fuse clavicl||clavicl ossif||medial clavicl||clavicl indian||clavicl examin||radiolog clavicl examin||matur clavicl model independ||hdi||operatornam||epiphysi||clavicular epiphys,0.342||0.283||0.207||0.197||0.194||0.192||0.192||0.179||0.179||0.12||0.108||0.102||0.081||0.078||0.077,0.2,0.1,0.13333333333333333
608,Biochim_Biophys_Acta-1-5-2212780.txt,mechan||cx43||IP||glycogen synthas kinas 3||pten||measur||role||diazoxid||connexin43||data||ischaemia||mediat||reactiv oxygen speci||mitochondri permeabl transit pore||kinas||effect||atp||ro format||sensit||mct1||increas||volum||pkc||complex||reperfus||recoveri||abil||gsk3||evid||channel open||phosphoryl||pharmacolog agent||calcium||csa||ro level||cardiac myocyt||cyp||respiratori chain||open||pkg||mitochondri atp-depend potassium channel||apoptosi||product||pore||oxid stress||protein||techniqu||adenin nucleotid||surviv kinas cascad||vdac||cyclophilin||sfa||ant||experi||mitochondria||calcium overload||activ||light||respiratori chain inhibitor||ro product||membran||ampk||decreas||mitok||note||adenin nucleotid translocas||sur||ro||pathway||pharmacolog||heart||mitochondri protein||mptp||ischaem precondit||monocarboxyl transport 1||protect,mitochondri||precondit||mitochondri k-atp||mitochondri permeabl||halestrap||mitochondri k-atp channel||mitochondria||mitochondri ca2||reperfus||mitochondri cyclophilin||mitochondri uncoupl||mitochondri matrix||mitochondri oxid||mitochondri permeabl transit||mitochondri potassium channel,0.35||0.29||0.246||0.24||0.239||0.216||0.205||0.199||0.196||0.194||0.194||0.192||0.191||0.19||0.189,0.0,0.2,0.13333333333333333
609,Anal_Bioanal_Chem-4-1-2413088.txt,flow cell||flow||concentr||solut composit||bife||electrochem detect||electrod||increas||maximum respons||signal||adsorpt||potenti||solut||flow system||sensor||analysi||injection-mould electrochem micro-flow cell||cadsv||height||carbon fibr||dimethylglyoxim||film||peak||mercuri film||sampl solut||in-lin,electroanalysi||ogorevc||bife||hočevar SB ogorevc||electroanalysi 15:392||electroanalysi 14:1707||electroanalysi 14:112||electroanalysi 16:1745||electroanalysi 16:1616||electroanalysi 15:1859||electroanalysi 14:1359||electroanalysi 14:192||electroanalysi 13:13||electroanalysi 18:823||electroanalysi 18:223,0.394||0.316||0.225||0.217||0.205||0.205||0.205||0.205||0.205||0.205||0.205||0.205||0.205||0.205||0.205,0.2,0.1,0.06666666666666667
610,Mol_Immunol-1-5-1994210.txt,role||thymu||real-tim pcr||mtec||epitheli cell||air protein||data||studi||thymocyt||microarray data||air||effect||develop||express||signal||antigen||tra||cell||thymic epitheli cell||gene||normal develop||lymph node||autoimmun regul||autoimmun||mous||central toler||result,tra||air||thymic||al.||tra express||tra anderson||air express||air induc tra express||thymic express||tra level||tra local||3.2 tra||air KO||air over-express||air gene,0.479||0.401||0.377||0.359||0.299||0.262||0.26||0.252||0.248||0.243||0.242||0.242||0.229||0.224||0.217,0.4,0.2,0.13333333333333333
611,Plant_Mol_Biol-3-1-1805039.txt,respons||flag||microarray||high-salin stress||cold||studi||rice||motif||full-length cdna sequenc||flag leaf||express pattern||organ||express profil||high-salin||promot||express||leav||rehydr||stress||promot region||gene||salin||genom express||analysi||experi||shoot||panicl||group||regulatori element||drought||bind protein||plant||result,drought||high-salin||drought stress||plant drought||high-salin stress||high-salin stress gene||drought toler||drought treatment||drought stress 2||high-salin toler||stress||high-salin treatment||high-salin condit||high-salin stress vari||high-salin stress 2,0.502||0.413||0.357||0.344||0.312||0.265||0.262||0.255||0.238||0.217||0.211||0.21||0.209||0.209||0.208,0.6,0.3,0.26666666666666666
612,Matern_Child_Health_J-2-2-1592157.txt,alcohol consumpt||major health risk||preconcept||behavior||indic||infant health||birth||pregnanc||data||state||folic acid||effect||preconcept period||risk||hiv test||inform||hiv transmiss||brfss||unit state||intervent||health||preconcept care||percentag||women||alcohol||insur||advers pregnanc outcom||factor||opportun||risk factor||current smoke||birth defect||hiv||outcom,preconcept||preconcept women||pregnant women||women||2004 brfss preconcept women||preconcept intervent||preconcept period||preconcept care||pregnanc||preconcept stage||non-prengn women||brfss||million women||2004 women||individu women,0.476||0.426||0.378||0.376||0.265||0.262||0.256||0.246||0.245||0.241||0.202||0.197||0.194||0.193||0.19,0.4,0.5,0.4
613,Exp_Brain_Res-3-1-1914290.txt,attent||visual depriv||postur sway||cop||valu||local stabil||amount||effect||sagitt plane||depend variabl||largest lyapunov expon||increas||correl dimens||plane||variabl||surrog data||sampl entropi||analys||dimension||regular cop trajectori||eye||postur control||control||center-of-pressur||cognit dual task||task||dual task||task difficulti||postur stabil||cognit invest||order||decreas||regular||postur||sway-path length||particip||intern focu||expon||dynam structur||result,postur||postur sway||postur task||postur variabl||postur stabil||postur control||upright postur||postur sway regular||human postur||postur recoveri||cop||human postur sway||postur task difficulti||gait postur 1:225||dual-task postur control,0.604||0.407||0.386||0.325||0.322||0.32||0.316||0.308||0.307||0.306||0.293||0.274||0.267||0.238||0.234,0.6,0.4,0.3333333333333333
614,Virchows_Arch-3-1-1888722.txt,cancer||case||microsatellit analysi||residu cancer||figur||block||rp||atyp foci||prostat tissu||biopsi core||core||posit biopsi||studi||patient||section||RP specimen||slide||paraffin block||dna||dna specimen analysi||ident||incid||deeper section||specimen||biopsi||vanish cancer||residu prostat cancer||prostatectomi||dna analysi||number||prostat cancer||radic prostatectomi||addit||step,prostatectomi||prostatectomi specimen||radic prostatectomi||pt0 radic prostatectomi||pt0||radic prostatectomi specimen||prostat||prostatectomi tissu||prostatectomi sampl||prostatectomi area||total prostatectomi||prostat cancer||radic retropub prostatectomi||biopsi||pt0 rp,0.509||0.359||0.351||0.342||0.324||0.303||0.303||0.278||0.266||0.259||0.258||0.252||0.239||0.236||0.224,0.4,0.2,0.26666666666666666
615,Neuroradiology-3-1-2082067.txt,avm||onyx||embol agent||flow||pial fistula||detach coil||venou side||shunt||liquid embol agent||high flow||AV shunt,shunt||high-flow shunt onyx||high-flow AV shunt||AV shunt||fistula||larg high-flow shunt||high-flow intracrani arterioven shunt||larg high-flow AV shunt||pial fistula||larg AV shunt||high-flow arterioven fistula ajnr||pial fistula avm||onyx||avm||side-wal pial fistula,0.522||0.358||0.34||0.334||0.311||0.298||0.285||0.26||0.245||0.229||0.228||0.226||0.201||0.188||0.182,0.4,0.3,0.3333333333333333
616,J_Comput_Aided_Mol_Des-3-1-2039848.txt,aldosteron synthesi||backbon atom||method||cyp11b1||activ site||isoform||model||cyp11b2||aldosteron||select||substrat bind||helix||hydroxyl||steroid||natur substrat||structur||amino acid||region||similar||protein-inhibitor interact||cell||templat structur||hydroxyl group||protein||inhibitor potenc||molecular dynam||metyrapon||steric fit||carbon atom||fadrazol||crystal structur||substrat||interact||molecular dock||hydroxyl distanc||inhibitor||result,hcyp11b2||cyp11b2||alpha-helix||cyp11b1||hcyp11b1||fadrazol||cyp101||cyp11b2 isoform||helix||cyp11b1 isoform||isoform cyp11b1||alpha-helix B′||hcyp11b2 model||bernhardt||hcyp11b2 possess,0.217||0.211||0.211||0.196||0.184||0.167||0.166||0.151||0.15||0.144||0.144||0.143||0.141||0.135||0.127,0.4,0.4,0.26666666666666666
617,Virchows_Arch-4-1-2335297.txt,type||cancer||follow-up||case||contralater breast||flat epitheli atypia||carcinoma||studi||atypia||patient||dci||epitheli atypia||descript criteria||lesion||tubular carcinoma||adh||subsequ cancer||classif||fea||ductal carcinoma||median follow-up 160 month||lobular neoplasia||atyp ductal hyperplasia||biopsi||initi diagnosi||high slide rate||microcalcif||diagnosi||malign||breast,atypia||breast||atypia adh||breast biopsi||epitheli atypia||breast cancer||cancer breast||biopsi epitheli atypia||cytolog atypia cytolog atypia||keyword breast epitheli atypia lobular||lobular hyperplasia||breast core||biopsi||lobular carcinoma||atyp lobular hyperplasia,0.421||0.366||0.298||0.293||0.28||0.262||0.262||0.26||0.253||0.242||0.234||0.229||0.22||0.219||0.215,0.6,0.3,0.26666666666666666
618,Eur_Arch_Otorhinolaryngol-4-1-2279158.txt,vocal emiss||qualiti||voic||studi||perceptu analysi||patient||life||laser surgeri||inform||radiotherapi||dysphonia||signific||treatment||maximum phonat time||vocal||grab||spectrogram||voic qualiti||fundament frequenc||surgeri||group||laser cordectomi||voic handicap index||differ||laser||score,voic||voic qualiti||voic outcom||hypofunct voic||voic disord||voic paramet||voic 1981||voic characterist||accept voic||voic impair||voic signal||voic result||voic handicap index||vocal||post-treat voic qualiti,0.578||0.337||0.301||0.298||0.296||0.294||0.294||0.293||0.291||0.291||0.291||0.29||0.246||0.236||0.229,0.4,0.2,0.26666666666666666
619,Environ_Health_Perspect-113-12-1314901.txt,document||case||ethylen bisdithiocarbam||meet||compani||human||phosphin||review||mrl||commod industri coalit||pesticid regul||pesticid||methopren||ebdc||coalit||world health organ||tobacco pesticid||public interest||regul||standard||member||note||agenc||epa||industri||case studi||public||philip morri||vettorazzi||regulatori agenc||tobacco industri,seckar||epa||pesticid||coresta||tobacco pesticid||u.s. epa||tobacco||tobacco industri||phosphin||industri||seckar 1999i seckar 1999i seckar 1999i||access||ebdc pesticid||seckar 1999f||tobacco pesticid regul,0.321||0.246||0.245||0.237||0.23||0.219||0.216||0.201||0.195||0.186||0.181||0.18||0.171||0.167||0.167,0.6,0.6,0.4
620,Extremophiles-4-1-2175526.txt,major peak||coval bond||glycerol dibiphytanyl glycerol tetraeth||core lipid||fraction||dcm layer||group||analysi||compound||intact polar lipid analysi||cell||thermoacidophil||gdgt,aciduliprofundum boonei||A. boonei||gdgt||analysi A. boonei||hydrotherm vent||deep-sea vent||deep-sea||lipid||keyword aciduliprofundum boonei dhve2 cluster glycerol||deep-sea hydrotherm vent biofilm||schouten||sinningh damsté JS||archaea||thermoacidophil||itoh,0.352||0.259||0.204||0.175||0.174||0.168||0.162||0.155||0.136||0.136||0.133||0.132||0.128||0.126||0.125,0.2,0.1,0.13333333333333333
621,Diabetologia-4-1-2292422.txt,atp||type 2 diabet||current||function effect||insulin secret||effect||subunit||beta cell||diabet||neurolog examin||block||sulfonylurea therapi||sur||kir6.2||mutat||channel||patient||mgatp||neonat diabet||atp sensit,atp||kcnj11 atp||atp channel||l164p atp||kir6.2||atp sensit||channel atp sensit||atp inhibit||atp current||atp 50||atp conduct||atp channel inhibit||atp 1||discuss kcnj11 atp||result atp channel,0.48||0.359||0.358||0.309||0.286||0.257||0.25||0.248||0.247||0.246||0.246||0.244||0.24||0.24||0.239,0.4,0.3,0.2
622,J_Med_Internet_Res-5-4-1550578.txt,type||cancer||internet user||search engin||cancer type||individu||sampl||cancer queri||data||studi||question||difficulti||inform||nation cancer institut||exampl||natur languag process||user||site||health inform||web site||cancer inform||gener public||treatment||specif||web||term||user question||internet||subcategori||topic||methodolog||search||issu||vocabulari||symptom||specif type||breast||queri||gener inform,queri||cancer queri||categori queri||user queri||breast queri||internet cancer queri||59619 queri||76077 queri||1852 queri||treatment queri||8959 queri||bone cancer queri||organ-typ queri||cancer type queri||queri cancer type,0.721||0.541||0.424||0.411||0.407||0.4||0.384||0.38||0.379||0.379||0.378||0.378||0.376||0.376||0.376,0.4,0.2,0.13333333333333333
623,Clin_Auton_Res-3-1-1914255.txt,blood flow||measur||method||reproduc||vop||venou occlus pressur||head-up tilt||studi||venou occlus||increas||doppler ultrasound||DU measur||supin posit||leg||superfici femor blood flow||subject||hut||cbf||agreement||posit||strain gaug plethysmographi||superfici femor arteri||venou occlus plethysmographi||angl||blood flow measur||tilt angl||techniqu,hut||vop||hut agreement vop||hut posit||hut 45||hut start||plethysmographi||head-up tilt||vop measur||vop correl||cbf||venou occlus plethysmographi||flow||passiv head-up tilt||strain-gaug plethysmographi,0.606||0.365||0.328||0.31||0.309||0.307||0.26||0.207||0.206||0.185||0.182||0.162||0.157||0.147||0.14,0.4,0.3,0.3333333333333333
624,Pediatr_Nephrol-3-1-2064946.txt,ccd||Na||capillari||endotheli cell||proteinuria||sodium retent||nephrot patient||renal retent||hydrostat pressur||patient||aldosteron||high blood pressur||effect||increas||nephrot syndrom||edema||glucocorticoid||fluid leakag||cortic collect duct||rat||oncot pressur||pan||sodium||edema format||chang||alter||distal nephron||factor||interstitium||trans-capillari gradient,nephrot syndrom||nephrot rat||sodium||nephrot patient||sodium retent||retent||experiment nephrot syndrom||nephrot syndrom scand||nephrot syndrom site||nephrot syndrom 34||renal sodium retent||nephrot children pediatr||renal sodium||sodium reabsorpt||sodium retent preced,0.328||0.289||0.269||0.261||0.251||0.233||0.226||0.223||0.221||0.22||0.197||0.181||0.179||0.177||0.17,0.8,0.4,0.26666666666666666
625,Skeletal_Radiol-3-1-2141652.txt,blood flow||rheumatoid arthriti||connect tissu||author||measur||ray||small quantiti||flow||joint||mri||imag||studi||patient||eros||disadvantag||space||view||sensit||increas||synov||finger||proxim phalanx||small joint||contrast agent||small field||tendon||ultrasound||proxim recess||fluid||normal||neovascularis||bone||subcutan tissu||dorsal aspect||hand||detect||tendon insert,ultrasound||arthriti||joint||synov||doppler ultrasound||rheumatoid arthriti||rheumatoid synov||rheumatoid||keyword ultrasound joint rheumatoid arthriti synov||doppler||rheumatoid hand joint synov||ultrasound imag||ultrasound detect synov||power doppler ultrasound||earli rheumatoid arthriti,0.316||0.297||0.28||0.272||0.271||0.269||0.256||0.24||0.234||0.226||0.21||0.209||0.207||0.202||0.188,0.6,0.4,0.26666666666666666
626,Cell_Tissue_Res-3-1-2071963.txt,antibodi||cone||outer plexiform layer||goldfish||electron micrograph||cone triad||rod triad||section||process||spinul||pkc||structur||receptor||arrow||cell||retina||rod-driven hc||horizont cell||similar posit||result||dendrit||protein||metabotrop glutam receptor||BC marker||bc||synapt ribbon||electron microscopi||light||rod||posit||mglur||BC dendrit||mglur antibodi||bipolar cell,retina||goldfish retina||metabotrop glutam||glutam||zebrafish retina||metabotrop glutam receptor||carp retina||metabotrop glutam receptor mglur7||goldfish||fish retina||bipolar||metabotrop receptor||mglur||mudpuppi retina||salamand retina,0.313||0.252||0.246||0.225||0.221||0.198||0.196||0.192||0.191||0.189||0.187||0.185||0.179||0.176||0.173,0.2,0.3,0.26666666666666666
627,Dev_Genes_Evol-4-1-2292471.txt,cuticl||gene circuit||class iii||gene||conserv||short germ insect||embryo||normal number||segment polar gene||segment||rnai||express||segment groov||cell,tc-hh||tribolium||tc-hh tc-smo||tc-ci||tc-ci tc-smo tribolium||tc-ci tc-hh tc-smo tc-ci tc-ptc tribolium||tc-smo tc-ci||tribolium drosophila drosophila tribolium||wg tribolium||tc-smo tc-ci tc-ptc||tc-hh tc-smo tribolium 2 drosophila tribolium||drosophila tribolium drosophila||tc-smo||tc-ptc tc-ptc tc-ptc tribolium||tribolium wg ptc tribolium,0.454||0.42||0.379||0.37||0.364||0.363||0.336||0.334||0.328||0.311||0.307||0.305||0.303||0.301||0.298,0.0,0.0,0.0
628,Intensive_Care_Med-4-1-2244699.txt,effect||sepsi intervent strategi||level||lp inject||increas||pct||ct-proavp||intervent||prednisolon||human endotoxemia||dose||mr-proanp||studi||patient stratif method||biomark||mr-proadm||corticosteroid||sepsi,struck||sepsi||morgenthal NG struck||morgenthal NG||ct-proavp||midregion||joachim struck||endotoxemia||biomark||biomark mr-proadm||stabl sepsi biomark||mr-proadm||mr-proanp||christ-crain||combinatorx,0.316||0.249||0.246||0.211||0.187||0.187||0.185||0.174||0.173||0.161||0.154||0.15||0.15||0.15||0.15,0.4,0.3,0.3333333333333333
629,Eur_Radiol-4-1-2270358.txt,invas angiographi||find||pulmonari embol||protocol||imag||dose length product||studi||patient||chest pain||simultan evalu||recent CT technolog||respect valu||diagnost accuraci||aortic diseas||neg predict valu||contrast materi||coronari cta||coronari find||diagnost evalu||examin||heart rate||acut chest pain||analysi||diagnost workup||chest pain assess||coronari arteri diseas||coronari arteri segment||cta find||stenos||cta||cardiologist||dual-sourc CT||coronari atherosclerosi||equival dose||heart||insuffici contrast opacif,coronari angiographi||angiographi||coronari CT angiographi||coronari stenos||coronari arteri||coronari cta||noninvas coronari angiographi||coronari angiographi databas||coronari angiographi laboratori||invas angiographi||chest||addit invas coronari angiographi||coronari angiogram||coronari atherosclerosi||coronari assess,0.389||0.369||0.329||0.29||0.277||0.267||0.263||0.263||0.261||0.244||0.228||0.226||0.223||0.222||0.222,0.0,0.2,0.2
630,Histochem_Cell_Biol-4-1-2228376.txt,plc||bax||smooth domain||data||studi||reticulon||subcompart||transit endoplasm reticulum||smooth ER||marker||ER fraction||domain||chaperon||protein complex||cell||lipid||rough||enzym||protein||proteom||analysi||associ||molecular machin||metabol||fraction||ER subcompart||microtubul||membran traffic||rough endoplasm reticulum||pathway||smooth endoplasm reticulum||ER protein||plasma membran||ser||membran||function,endoplasm reticulum||endoplasm reticulum membran||rough endoplasm reticulum||ER||smooth endoplasm reticulum||transit endoplasm reticulum||eukaryot endoplasm reticulum||endoplasm reticulum subdomain||granular endoplasm reticulum||endoplasm reticulum network||endoplasm reticulum ca2||ER protein||rough endoplasm reticulum membran||protein||ER subcompart,0.379||0.287||0.28||0.277||0.268||0.261||0.257||0.257||0.256||0.255||0.255||0.246||0.236||0.214||0.208,0.4,0.3,0.4
631,Virchows_Arch-3-1-2151131.txt,cancer||author||target||mirna express||normal tissu||dna sequenc||case||human protein||role||oligonucleotid||pathogenesi||develop||malign transform||cell prolifer||express||human genom||differenti||cell||gene||human diseas||approach||apoptosi||protein||group||mirna||antisens therapi||microrna||function,microrna||mirna||let-7 microrna||microrna target||microrna express||silenc microrna||microrna polycistron||microrna precursor||microrna sequenc||microrna compon||perspect microrna||mirna express||disease-caus mirna||mirna molecul||mirna therapi,0.628||0.504||0.442||0.339||0.339||0.329||0.319||0.319||0.319||0.316||0.315||0.277||0.262||0.258||0.257,0.4,0.2,0.2
632,Purinergic_Signal-3-4-2072928.txt,mechan||atp||bbg||immunofluoresc||process||posit cell||microglia||gfap||microgli cell||receptor||activ||nac||data||studi||injuri||pakt||agonist||cell||rat||P2 receptor,microglia||rat microglia||microglia brain||microgli cell||microgli chemotaxi||microgli activ||receptor||activ microglia||microglia activ||microglia pflüger||cultur microglia||primari microglia||microglia accumul||microglia respons||purinerg receptor,0.344||0.213||0.21||0.21||0.197||0.195||0.192||0.192||0.192||0.181||0.179||0.178||0.175||0.175||0.163,0.4,0.3,0.2
633,J_Neurol-2-2-1705488.txt,correct descript||medic emerg||measur||questionnair||knowledg||St john ambul||heart attack||session||studi||stroke awar||stroke||brain attack||inform||sign||acut stroke||brain||educ||train||action||lesson||hands-on measur||teach||topic||healtheduc||symptom||number||aid train||particip||cours||peopl,stroke||stroke lesson||stroke symptom||stroke knowledg||stroke awar||stroke 78.7||acut stroke||stroke care||stroke progress||stroke manag||stroke patient||stroke initi||stroke awar campaign||stroke knowledg emerg||stroke inform campaign,0.769||0.465||0.424||0.408||0.406||0.403||0.401||0.39||0.387||0.387||0.387||0.386||0.301||0.298||0.295,0.4,0.3,0.2
634,Pflugers_Arch-3-1-1915642.txt,find||fat||plasma||glycogen||studi||fat oxid||carbohydr ingest||effect||infus||fiber type||muscl glycogen||lipid-droplet densiti||total||con trial||insulin||imtg||con||plasma ffa oxid||carbohydr||muscl biopsi||glucos||averag||skelet muscl glycogen||insulin concentr||subject||exercis||oxid rate||carbohydr supplement||cho||adipos tissu lipolysi||oxid||cho trial||rest,glycogen||text||carbohydr||exercis||muscl glycogen||glycogen spare||ox||muscl glycogen spare||muscl glycogen oxid||glycogen util||glycogen metabol||skelet muscl glycogen||glycogen content||muscl glycogen util||ingest carbohydr,0.205||0.181||0.16||0.155||0.154||0.128||0.125||0.12||0.119||0.117||0.115||0.115||0.113||0.113||0.112,0.8,0.4,0.3333333333333333
635,Int_J_Cardiovasc_Imaging-3-1-2048829.txt,measur||method||aortic stenosi||studi||patient||left ventricl||tte||aortic regurgit||ava||signific||axial view||avc||contrast allergi||mild||non-invas method||result||moder||tte measur||cardiac catheter||ebt||valv||aortic valv area||aortic valv||sever||area||signific correl||contrast||aortic valv stenosi||function||techniqu,ava||aortic valv||ebt||anatom ava||ava overestim||larger ava||smallest ava||valv||function ava||aortic valv stenosi||aortic stenosi||aortic valv calcif||aortic valv sclerosi||aortic valv area||aortic valv diseas,0.614||0.364||0.349||0.322||0.318||0.316||0.316||0.315||0.311||0.302||0.295||0.262||0.251||0.25||0.245,0.6,0.5,0.4666666666666667
636,Diabetologia-3-1-1998885.txt,type 2 diabet||level||gfr||plasma||diabet||hyperglycaemia||concentr||microvascular complic||studi||patient||urinari albumin excret||metabol control||renal dysfunct||marker||type 1 diabet||metabol dysfunct||thiamin||microalbuminuria||adhes molecul||plasma thiamin concentr||erythrocyt||urinari excret||link||diabet complic||vascular dysfunct,thiamin||thiamin thiamin||thiamin thiamin thiamin||thiamin plasma thiamin||plasma thiamin||thiamin transport||thiamin mnl||thiamin clearanc||thiamin effect’||thiamin metabolit||thiamin defici||thiamin transporter-1||thiamin statu||thiamin uptak||thiamin deliveri,0.847||0.847||0.847||0.587||0.457||0.446||0.445||0.439||0.436||0.433||0.432||0.431||0.43||0.428||0.426,0.2,0.1,0.06666666666666667
637,Neuroradiology-3-1-1786189.txt,mechan||anim||find||secondari deterior||complement||cerebr ischemia||mri||studi||strategi||clinic outcom||rat model||brain damag||patient||disrupt||stroke||effect||temporari mcao||reperfus||platelet||increas||vasogen edema||magnet reson imag||ischem stroke||rat||blood||tissu||reperfus injuri||hypothermia||leukocyt||brain cool||leukocyt infiltr||infarct volum||ischemia||injuri||hyperperfus||bbb||group||blood reperfus||result,reperfus||cerebr reperfus||reperfus injuri||cerebr reperfus injuri||stroke||postischem reperfus||blood reperfus||coronari reperfus||reperfus group||reperfus phase||reperfus area||postischem reperfus injuri||global reperfus injuri||WC reperfus injuri||hypothermia,0.563||0.404||0.38||0.335||0.321||0.313||0.31||0.287||0.286||0.286||0.284||0.274||0.257||0.256||0.238,0.6,0.4,0.3333333333333333
638,J_Mol_Biol-1-5-1950483.txt,atom forc microscopi||mechan stabil||tnfn3||fibronectin type iii||simul||fnfn10||afm,fibronectin||fnfn10||unfold forc||afm||mechan unfold||simul||forc||fnfn10 domain||unfold pathway||fibronectin type iii fnfn10||unfold event||single-molecul afm||mechan unfold intermedi||mechan forc||human fibronectin tnfn3,0.295||0.279||0.245||0.214||0.202||0.187||0.184||0.181||0.167||0.164||0.157||0.154||0.147||0.14||0.133,0.4,0.3,0.2
639,Histochem_Cell_Biol-4-1-2386530.txt,mechan||flow||ciliari membran||studi||mutat||cilia||ciliopathi||cell biologist||structur||defect||signal||basal bodi||human diseas||tissu||primari cilia||protein||motil||mous||electron microscop studi||diseas||function||ciliogenesi,cilia||primari cilia||sensori cilia||mammalian cilia||cilia biolog||rudimentari cilia||renal cilia||cilia function||satir||cilium||adult tissu primari cilia||ciliari motil||15889083 wheatley DN cilia||FL wheatley DN cilia||ciliari signal,0.609||0.343||0.334||0.322||0.318||0.316||0.311||0.311||0.248||0.191||0.185||0.181||0.179||0.176||0.139,0.4,0.2,0.13333333333333333
640,Neuroimage-2-1-2330063.txt,left||studi||patient||seizur||tle||white matter tract||correl||medial tempor lobe||volum||test||memori||tractographi analysi||signific interact||memori function||epilepsi||control||voxel||tractographi||parahippocamp gyru||age||hippocamp atrophi||visual cue||hippocamp volum||connect||signific correl||structur connect||side,tle||al.||left tle||tle patient||unilater tle||refractori tle||tle group||tle 3||epilepsi||left tle patient||tempor lobe epilepsi epilepsi||tempor lobe epilepsi||tempor lobe epilepsi eichenbaum||cp||medial tempor lobe epilepsi,0.525||0.388||0.315||0.275||0.271||0.271||0.265||0.262||0.227||0.218||0.197||0.187||0.153||0.152||0.15,0.2,0.2,0.13333333333333333
641,Appl_Microbiol_Biotechnol-3-1-1914237.txt,transcriptom||gene||high-dens oligonucleotid microarray||absent||strain||fragment dna||relationship||discrimin phylogenet relationship||genomotyp||solvent-toler bacteria||microarray||pseudomonad||orf||cog||studi||aflp||absenc||function categori||function||intergen region,pseudomona putida||P. putida||pseudomona putida kt2440||pseudomona monteilii putida P. putida P.||P. putida pseudomona pseudomona||pseudomona putida s12||discuss P. putida P. putida P.||P. putida s12||P. putida pseudomona strain||700801 P. putida||P. putida 1977||pseudomona P. monteilii P. putida||P. putida 2002||proteom pseudomona putida P.||pseudomona putida kt2440 cell,0.522||0.467||0.396||0.386||0.381||0.372||0.343||0.335||0.32||0.315||0.314||0.313||0.313||0.311||0.298,0.0,0.0,0.0
642,Purinergic_Signal-4-2-2377318.txt,mechan||filter||flow||epitheli cell||releas||perfus||atp||assay||signal||cell||stimuli||hypoton challeng||volum addit control||ionomycin||mechan stimul||fluid||atp secret||pool||purinerg||apic surfac||atp releas||transient||monocilium||medium||monolay,atp||monolay||atp releas||releas atp||rescu monolay||cell monolay||mutant monolay||atp signal||atp secret||extracellular atp||atp receptor||atp mediat||atp left||rescu cell monolay||atp proce,0.398||0.38||0.279||0.279||0.252||0.25||0.24||0.237||0.227||0.225||0.224||0.209||0.208||0.208||0.204,0.6,0.4,0.26666666666666666
643,J_Gastrointest_Surg-3-1-1852380.txt,cha||hepat inflow||major surgeri||major hepatectomi||gastroduoden arteri||hemostasi||case||complet hemostasi||hepat failur||pseudoaneurysm||hepat arteri||patient||pha||tae proxim||angiographi||success outcom||superselect tae distal||rha||hemorrhag||ligat||re-laparotomi||tae||massiv arteri hemorrhag||subphren arteri||surgeri||spa||vascular reconstruct||sma||pancreat head||gda||hilar bile duct cancer||outcom,tae||pseudoaneurysm||rha||arteri pseudoaneurysm||hepat arteri pseudoaneurysm||tae re-laparotomi||ruptur pseudoaneurysm||splenic arteri pseudoaneurysm||pseudoaneurysm distal||gda||arteri||tae proxim||success tae||viscer arteri pseudoaneurysm||viscer pseudoaneurysm,0.394||0.389||0.305||0.302||0.258||0.242||0.221||0.22||0.216||0.215||0.215||0.214||0.212||0.208||0.205,0.6,0.4,0.3333333333333333
644,Support_Care_Cancer-3-1-2092409.txt,attent||cancer||pleasur intens||preval||tempera dimens||problem||studi||analys factor analys||year||question||concept||eatq-r||pearson correl analys||effect||life event||variabl||frustrat||adolesc children||control||relationship||tempera||recurr diseas||age||parent||educ level||dutch||factor||parent cancer||group||report||inter-item correl||socio-demograph||number||daughter||adolesc||illness-rel variabl||children,tempera||tempera dimens||children ’s tempera||internalis||children||parent||import tempera dimens||externalis problem||internalis problem||cohen DJ tempera||earli adolesc tempera questionnair||problem adolesc tempera life event||adolesc children||earli adolesc tempera measur||earli adolesc tempera questionnair minneapoli,0.566||0.308||0.279||0.268||0.237||0.213||0.208||0.198||0.195||0.194||0.193||0.185||0.183||0.183||0.157,0.6,0.4,0.3333333333333333
645,Pharm_World_Sci-3-1-1805038.txt,pharmaci||health care centr||case||system||questionnair||databas||determin||studi||patient||risk||correl||validation-set||netherland||dutch commun pharmaci||drug interact||ratio||analysi||medic surveil system||advers patient outcom||medic surveil||dispens||import||number||drug||euron system||drug combin,dispens||pharmaci||dispens drug||commun pharmaci||pharmaci prepar||dutch pharmaci||sixty-eight pharmaci||256 pharmaci||swedish pharmaci||pharmaci part||62 pharmaci||74 pharmaci||12 pharmaci||drug||dutch commun pharmaci,0.483||0.47||0.333||0.25||0.249||0.247||0.244||0.241||0.24||0.24||0.238||0.237||0.236||0.183||0.175,0.4,0.2,0.26666666666666666
646,J_Chem_Ecol-3-1-1915630.txt,plant defens||van loon||leaf tissu||effect||gl||egg||van poeck||test||total||leaf surfac||leav||natur enemi||butterfli||treatment||pupal weight||cabbag||sixth leav||control||paper||experi||butterfli speci||oviposit||surfac||herbivor||glucosinol||number||perform||leaf surfac extract||plant,plant||oviposit||pieri rapa||pieri brassica||pieri||glucosinol||glucosinol glucosinol||oviposit entomol||P. brassica P. rapa||P. brassica||pieri butterfli||insect brassica||G. pieri rapa||A. pieri||brassica oleracea,0.301||0.298||0.285||0.268||0.254||0.254||0.254||0.223||0.215||0.207||0.202||0.201||0.196||0.193||0.193,0.4,0.3,0.2
647,Int_Arch_Occup_Environ_Health-3-1-1915587.txt,pharmaci||level||method||concentr||cytotox drug||hospit pharmaci||sampl||locat||solvent||data||analyt run||effect||variabl physic characterist||threshold||sensit||wipe||platinum||compound||initi amount||icp-m||valid||laf hood||hcl||hospit||dutch hospit pharmaci||clean room||materi||facil||surfac||import||contamin||intern standard||cytotox agent||drug||desorpt solvent||nebulis||procedur||surfac contamin||complianc||result,platinum||wipe||platinum contamin||platinum wipe sampl||platinum content platinum||contamin||platinum surfac contamin||platinum recoveri||platinum drug||low platinum contamin||platinum agent||5 platinum contamin||wipe sampl||platinum concentr||platinum compound,0.525||0.484||0.422||0.362||0.352||0.32||0.316||0.296||0.291||0.283||0.283||0.282||0.281||0.276||0.275,0.4,0.3,0.2
648,Mol_Genet_Genomics-4-1-2270915.txt,tobacco||defens||fourth leav||level||respons||jasmon acid||pathogen||transcript||acc||express||studi||valu||rice||plant||infect,ospr1||ospr1 ospr1 8 ospr1||ospr1 ospr1 2 ospr1||051 ospr1 ospr1||ospr1 gene ospr1||074 ospr1||071 ospr1||073 ospr1||072 ospr1||011 ospr1||gu ospr1||012 ospr1||022 ospr1||ospr1 gene||052 ospr1,0.77||0.578||0.578||0.532||0.524||0.501||0.441||0.432||0.426||0.426||0.421||0.419||0.403||0.4||0.397,0.0,0.0,0.0
649,Diabetologia-3-1-2039861.txt,contractil dysfunct||basal phosphoryl||triacylglycerol||fat||lcfa uptak||data||substrat uptak||diabetes-rel heart diseas||cd36||basal||high-fat feed||cardiac dysfunct||increas||insulin||hfd||phosphoryl||rat||high-fat diet||vivo cardiac function||diabet cardiomyopathi||diet||lcfa||group||glucos uptak||myocardi triacylglycerol accumul||utilis||sso||lfd||insulin-resist rat||insulin resist||heart||cardiomyocyt,cd36||hfd||cd36 lfd hfd||hfd heart cd36||lfd||sarcolemm cd36||lfd start lfd hfd||hfd heart||hfd cardiomyocyt||hfd rat||hfd feed||cd36 transloc||cd36 redistribut||hfd induc||shorten hfd,0.411||0.405||0.368||0.302||0.289||0.261||0.248||0.247||0.244||0.238||0.225||0.223||0.216||0.211||0.21,0.6,0.3,0.2
650,Pediatr_Nephrol-4-1-2335295.txt,appar diseas onset||follow-up||proteinuria||time||children||studi||year||end-stag renal diseas||patient||corticosteroid||mesangi prolifer degre||late group||signific||focal mesangi prolifer||outcom||treatment||long-term outcom||present studi||multivari analysi||iga-n||studi period||signific factor||sever mesangi cell prolifer||renal surviv||mild iga-n||analysi||japanes children||sever iga-n||group||differ||mesangi prolifer||time period||initi renal biopsi||diseas||diagnosi||baselin characterist||rct||result,iga-n||mild iga-n||iga-n patient||iga||sever iga-n||mesangi prolifer||iga nephropathi||nephropathi||focal mesangi prolifer||childhood iga nephropathi||mesangi prolifer 329||mesangi prolifer degre||focal mesangi prolifer 1976||idiopath iga nephropathi||kobe,0.506||0.274||0.266||0.263||0.261||0.257||0.252||0.242||0.203||0.181||0.174||0.173||0.173||0.172||0.166,0.6,0.5,0.4
651,Qual_Life_Res-4-1-2358934.txt,level||method||global qualiti||index score||individu||qualiti||patient||life||correl||conjoint analysi||aca||domain||util||valid||iqol||altern method||cancer patient||averag||feasibl||worst option||task||pair||social judgment theori||seiqol||scenario||direct weight||weight||respond||import||largest benefit||agreement||number||individu qualiti||life domain||score||global individu qualiti,aca||aca weight aca||aca weight||iqol||aca task||iqol domain||correl aca||aca survey||aca method||univers aca||iqol weight||domain||aca weight 4||life DW index aca index||global iqol,0.563||0.438||0.375||0.344||0.302||0.299||0.294||0.286||0.285||0.283||0.266||0.255||0.25||0.196||0.195,0.4,0.2,0.2
652,Neuropsychol_Rev-3-1-2039835.txt,block||practic motor skill||practic||studi||patient||amount||procedur learn||effect||review||abil||motor-skil learn||cognit function||clinic practic||recommend||dick||train program||control||schmidt||rehabilit||train||research||task||non-pharmacolog intervent||feedback||motor||compon||implicit motor-skil learn||implicit learn||implicit||AD patient||perform||movement||result,learn||AD||implicit learn||motor learn||dementia learn||skill learn||motor-skil learn||learn motor skill||implicit motor-skil learn||learn task||implicit||implicit motor||explicit learn||A. motor learn||motor,0.409||0.364||0.332||0.325||0.301||0.301||0.291||0.282||0.279||0.256||0.254||0.248||0.245||0.244||0.242,0.2,0.3,0.3333333333333333
653,J_Behav_Med-4-1-2346512.txt,psycholog treatment||condit||time||therapist time||problem||control group||studi||patient||effect||review||disord||intervent||adult||treatment||headach||health condit||chronic diseas||research||cognit behavior therapi||pain||health problem||popul||internet||trial||therapist||systemat review||tradit form||cbt||result,cbt||internet-bas cbt||internet||cbt intervent||internet-bas cbt intervent||internet intervent||internet-deliv cbt||face-to-fac cbt||internet-bas intervent||internet-administ cbt||headach||intervent||cbt modul||waiting-list||psychoeduc,0.363||0.298||0.288||0.287||0.269||0.249||0.226||0.223||0.221||0.214||0.213||0.21||0.183||0.179||0.179,0.4,0.2,0.26666666666666666
654,Clin_Oral_Investig-3-1-2134843.txt,surgic periodont therapi||statist unit||ral-v gain||baselin||studi||patient||greater bone loss||effect||clinic||teeth||aggress periodont||site||baselin ppd||therapi||smoke||single-root teeth||baselin data||paramet||ppd reduct||recent statist method||analysi||nonsurg||ral-v||pli||oral||interproxim groov||srp||factor||influenc||clinic paramet||periodont therapi||doubl contour||bone loss||treatment result||ppd,periodont||ppd||periodont therapi||baselin ppd||aggress periodont||ral-v||periodont re-evalu||smoking-attribut periodont||advanc periodont||chronic periodont||periodont measur||periodont diseas||srp||surgic periodont therapi||ppd reduct,0.361||0.313||0.229||0.205||0.2||0.197||0.19||0.189||0.185||0.184||0.183||0.183||0.181||0.169||0.166,0.8,0.5,0.5333333333333333
655,Eur_J_Epidemiol-3-1-2039783.txt,effect intervent||theori||studi||disadvantag||risk||epidemiolog||child||intervent||earli disabl pension||administr databas||evid||countri||health||educ||norway||polici||low parent educ||death||gener||disabl||parent disabl||social polici||low educ,disabl pension||disabl||parent disabl||earli disabl pension||expuls||parent||gravseth||pension decis||bioethic||earli disabl||educ||polici gravseth||irrevers disabl||parent disadvantag||earli expuls,0.304||0.272||0.229||0.223||0.214||0.186||0.178||0.176||0.173||0.168||0.167||0.152||0.152||0.142||0.139,0.6,0.3,0.26666666666666666
656,Pediatr_Radiol-3-1-1891645.txt,tracheobronchi tree||airway||case||time||protocol||high-resolut imag||imag||mpr||compress||low-dos protocol||inform||CT protocol||congenit||dose||anatom relationship||tracheal||scan||radiat dose||clinic case||lung||children||techniqu,tracheobronchi anomali||airway||bronchoscopi||scan||tracheobronchi strictur||tracheobronchi tree||0.75 0.75 0.75 0.75 0.75||mdct||CT||tracheobronchi patholog||combi||mdct imag||mdct scanner||virtual tracheobronchi endoscopi||0.75 mm,0.21||0.206||0.199||0.191||0.19||0.187||0.184||0.18||0.18||0.171||0.166||0.149||0.147||0.145||0.143,0.4,0.3,0.2
657,Arch_Dermatol_Res-3-1-1950585.txt,pre-analyt sampl prepar||background intens level||ratio||intens||amplif||array cgh studi||genom dna||fresh tissu||skin dna||tissu||clinic practic||sampl||qualiti||signal||agaros gel||fix||molecular fix||result,dna||genom dna||formalin||array cgh||male genom dna||skin dna||digest dna||fresh sampl||amplifi dna||hmw dna||dna yield||fresh tissu||formalin sampl||dna puriti||genom amplif,0.298||0.259||0.226||0.203||0.177||0.175||0.175||0.17||0.169||0.163||0.163||0.162||0.16||0.158||0.155,0.2,0.2,0.2
658,Surg_Endosc-4-1-2262145.txt,curriculum||level||endoscop surgeri||skill||mandatori part||time||competit element||studi||traine||resid||pgi||train program||train time||surgic resid||train||paramet||task||opinion||virtual realiti||month||simul||endoscop procedur||possibl||perform||particip||virtual realiti simul||surgic curriculum||virtual realiti train||score||result,train||simul train||resid||VR train||VR simul train||simul||realiti train||skill||pgi||endoscop skill||resid train program||surgic resid||basic skill train||voluntari train||surgic train curriculum,0.417||0.354||0.352||0.294||0.293||0.292||0.29||0.284||0.28||0.277||0.263||0.254||0.252||0.251||0.249,0.4,0.5,0.4
659,Cancer_Immunol_Immunother-3-1-2150634.txt,respons||figur||serum||protocol||immun monitor||panel||valid practic||cell recoveri||studi||strategi||low background||panel particip||assay||dri ice shipment||criteria||intern site||immun assay||abil||plate||recoveri||harmon||common sourc||guidelin||valid||antigen||cell||intern locat||elispot assay||result||pbmc||immun||central lab||protocol choic||spot||donor||assay outcom||choic||group||report||cmv||elispot||profici panel||perform||repeat||survey||particip||weak respond||laboratori,elispot||panel||elispot assay||elispot profici panel||elispot plate||elispot particip||panel assay||elispot perform||elispot test||elispot usag||elispot techniqu||elispot result||elispot profici panel program||intern elispot profici panel||cvc elispot profici panel member,0.53||0.368||0.358||0.338||0.307||0.3||0.277||0.276||0.273||0.268||0.267||0.266||0.258||0.257||0.251,0.6,0.3,0.2
660,Arch_Sex_Behav-3-1-1914258.txt,person||self-efficaci||person norm||measur||find||hiv-posit statu||men||casual sex encount||behavior||subject norm||consequ||import role||msm||determin||neg influenc||unprotect anal intercours||theori||effect||antivir therapi||prosoci behavior||intent||context||sex||variabl||plan behavior||signific||sexual risk behavior||signific increas||present studi||condom||norm-activ theori||moral concern||person characterist||riski sexual behavior||item||varianc||prosoci tendenc||predictor||steadi||predict||neg impact||particip||partner||sexual motiv||peopl||addit||step||emot,condom||casual partner||casual sex||casual sex partner||partner||sex partner||intend condom||sexual||sex||steadi sex partner||steadi partner||norm||casual sex partner variabl||heterosexu condom||steadi,0.398||0.296||0.287||0.276||0.254||0.245||0.244||0.239||0.236||0.233||0.232||0.216||0.212||0.211||0.211,0.4,0.3,0.26666666666666666
661,Eur_J_Pediatr-3-1-2151778.txt,antibodi||follow-up period||data||studi||year||patient||liver biopsi||fibrosi||low rate||natur histori||adult||hematolog diseas||infect||minim necrosi||nosa||hcv||liver||hgv||group||biopsi||diseas||children,hcv||hepat||hcv infect||viru hcv hepat||antibodi hepat||hcv patient||hepat fibrosi||hcv genotyp||inno-lipa hcv||hepat biopsi||viral hepat||chronic hepat||hcv infect 23||autoimmun hepat||hepat failur,0.462||0.387||0.33||0.326||0.28||0.277||0.265||0.254||0.242||0.24||0.229||0.226||0.221||0.213||0.206,0.2,0.1,0.06666666666666667
662,Rev_Endocr_Metab_Disord-3-1-1894828.txt,syndrom||respons||children||cfc||birth||growth hormon||mutat||year||normal rang||patient||short neck||costello syndrom||adult||cardio-facio-cutan syndrom||high incid||treatment||growth||gene||age||hypertroph cardiomyopathi||cytokin||similar cardiac defect||noonan syndrom||height||factor XI||function||leopard syndrom||clinic studi||hormon||short statur,noonan||noonan syndrom||noonan JA noonan||syndrom||ptpn11||noonan ’s syndrom||keyword noonan||cardio-facio-cutan syndrom||costello syndrom||ptpn11 mutat||cfc syndrom||s11154-006-9021-1 articl noonan syndrom||puberti noonan jacquelin||leopard syndrom||ajmg.a.20502 noonan JA,0.515||0.397||0.348||0.279||0.276||0.266||0.258||0.237||0.221||0.209||0.209||0.205||0.197||0.191||0.185,0.4,0.4,0.3333333333333333
663,Anal_Bioanal_Chem-4-1-2287204.txt,anim||gross||concentr||model||studi||sexual differenti||water||develop||effect||femal||observ||neg control||increas||test||exampl||gonad||metamorphosi||tank||treatment||acclim||complet||daili||dilut water||analysi||experi||treatment group||terminolog||biolog variabl||light||water qualiti||frog||group||statist analys||order||exposur||mix sex||procedur||dpf||environment chamber||tadpol||flow-through system||result,gonad||tank||gross gonad||narrow gonad||gonad morpholog||aplasia gonad||gonad tissu||complet gonad||gonad femin||gonad area||gonad abnorm||gonad 14. transluc gonad||thin gonad||gonad 9-c||sinuat gonad,0.649||0.366||0.353||0.341||0.34||0.34||0.338||0.334||0.333||0.333||0.332||0.332||0.331||0.33||0.33,0.4,0.2,0.13333333333333333
664,Biodegradation-3-1-2151777.txt,oxygen consumpt||long-chain alkylamin||nitrogen||depend||micro-organ||octylamin||ammonium||strain||carbon||silica gel||substrat specif||growth||enzym assay||dodecylamin||enzym||strain bert||fatti acid||activ||cell suspens||cultur||substrat||oxid||cell-fre extract||biodegrad pathway||prepar||alkylamin,alkylamin||pseudomona||alkylamin dehydrogenas||biodegrad biodegrad||biodegrad||long-chain alkylamin||alkylamin degrad||chain alkylamin||anthropogen alkylamin||octylamin||long-chain alkylamin dehydrogenas||growth pseudomona pseudomona pseudomona strain bert||short-chain alkylamin dehydrogenas||pseudomona sp||ratledg biodegrad,0.49||0.382||0.317||0.301||0.301||0.293||0.29||0.257||0.253||0.245||0.244||0.226||0.217||0.216||0.206,0.2,0.3,0.2
665,Plant_Mol_Biol-4-1-2268730.txt,rice||Zn defici||zn-defici shoot||barley||nicotianamin||transport||iron||ma secret||dma||dma synthesi||analysi||experi||zn-defici rice||shoot||absorpt||Fe defici||secret||zinc||root||dma secret||ma||plant,phytosiderophor||plant||Zn||zn-defici plant||nishizawa||nishizawa NK osnas1 osnas2 osnas3||62 Zn||rice plant||mori||zn-defici rice plant||dma||iron plant||graminac plant||phytosiderophor releas||osdmas1,0.304||0.273||0.257||0.23||0.217||0.198||0.197||0.196||0.193||0.192||0.191||0.188||0.17||0.17||0.169,0.2,0.1,0.13333333333333333
666,J_Behav_Health_Serv_Res-4-1-2214828.txt,case||subclassif||individu||data||studi||state||idb||state agenc||IP SA||medicaid||inform||medicaid enrol||washington state||unit state||opiat||co-occur||mh-onli||day||coeffici||analysi||popul||MH servic||servic||care||group||mental health servic administr||residenti SA servic||window||record||client||addit||diagnosi,medicaid||medicaid servic||servic||medicaid servic agenc servic||medicaid agenc servic||medicaid agenc||agenc servic||medicaid servic 2 agenc servic||medicaid enrol agenc servic||MH servic agenc servic||medicaid servic group||medicaid servic 2||SA servic||medicaid MH||medicaid enrol,0.459||0.456||0.453||0.396||0.377||0.339||0.335||0.316||0.316||0.315||0.304||0.304||0.3||0.297||0.296,0.4,0.2,0.2
667,Bioprocess_Biosyst_Eng-2-2-1705514.txt,total biomass||batch-to-batch reproduc||concentr||valu||distort||growth rate||process||recombin protein||pat||manufactur||rel deviat||biomass concentr||cell||control||product||predefin profil||result||ferment||experi||deviat||feedback control||cultur||procedur||biomass||profil||reproduc,μ||μ μ||μ μ profil||lübbert||biomass||ferment||simuti||cultiv||7 μ||μ 12||μ 4||text||fed-batch cultiv process||batch-to-batch reproduc||ferment process,0.216||0.216||0.157||0.125||0.123||0.122||0.121||0.109||0.108||0.108||0.108||0.104||0.104||0.095||0.093,0.2,0.2,0.2
668,Biochim_Biophys_Acta-2-1-2323027.txt,oocyt||nano||element||data||translat activ||deadenyl||meiotic matur||translat repress||complex||symplekin||parn||signal||tail||phosphoryl||polyadenyl||cpsf||regul||associ||translat control||activ||cytoplasm||cpeb||bind||factor||synthesi||maskin||polymeras||mrna||gld2||addit||cytoplasm polyadenyl||function,polyadenyl||cytoplasm polyadenyl||polyadenyl mrna||cytoplasm polyadenyl xenopu||mrna cytoplasm polyadenyl||polyadenyl element||cpeb||cpe-medi polyadenyl||polyadenyl complex||maturation-specif polyadenyl||earli polyadenyl||polyadenyl factor||polyadenyl substrat||cpeb-depend polyadenyl||polyadenyl statu,0.578||0.382||0.376||0.342||0.313||0.312||0.309||0.307||0.305||0.296||0.296||0.294||0.293||0.293||0.29,0.4,0.3,0.2
669,Anal_Bioanal_Chem-4-1-2324128.txt,stationari phase||larg rang||post-transl modif||proteom level||hydrophil interact liquid chromatographi||retent||scx||separ||chromatographi||proteom||analysi||column||enrich||hydrophil compound||sampl||hilic||neg charg,hilic||hilic applic||categori hilic||common hilic||hilic method||chromatogr||proteom||hilic separ mechan keyword hilic proteom||hilic stationari phase||hellig||sarg||chromatogr 635:19||chromatogr 473:189||peptid||proteom applic,0.535||0.281||0.27||0.27||0.269||0.257||0.242||0.23||0.202||0.169||0.143||0.139||0.139||0.136||0.134,0.2,0.2,0.13333333333333333
670,Evid_Based_Complement_Alternat_Med-4-2-1876616.txt,condit||non-malign pain||robust support||headach pain||find||week||tension-typ headach||discret pain condit||futur work||patient||depress||rigor studi design||chronic||acupunctur||chronic pain condit||effect||craniosacr therapi||neck||superior||review||colleagu||waitlist control||broad overview||improv||evid||moyer||massag||treatment||therapi||headach||spinal manipul||meta-analysi||broad array||relax||futur studi||pain||follow-up assess||assess||conclus||posit group||chronic pain||group||cochran collabor||fibromyalgia||massag therapi||relev studi||limit||trial||date||preliminari support||support||usual care||migrain||futur clinic trial||outcom||result,massag||acupunctur massag||massag therapi||massag treatment||massag techniqu||massag group||swedish massag||therapeut massag||swedish-typ massag||cranioscar massag||convent massag||friction massag||pain||find massag therapi||massag therapi effect,0.756||0.44||0.413||0.395||0.384||0.384||0.383||0.383||0.382||0.382||0.381||0.381||0.36||0.281||0.28,0.4,0.2,0.2
671,Ann_Biomed_Eng-2-2-1705516.txt,bioreactor||mechan forc||leaflet||valv leaflet||cyclic stretch||cell morpholog||imag||elastin||studi||valv failur||effect||section||nativ structur||forc||tissu section||current studi||express||stretch||contractil phenotyp||valv interstiti cell||circumferenti stretch||fiber||dmem||tissu||collagen||cell phenotyp||elastin content||analysi||circumferenti cyclic stretch||sgag||sgag content||aortic valv leaflet||valv||rel motion||aortic valv||stretch bioreactor||avl,leaflet||stretch leaflet||valv leaflet||aortic leaflet||aortic valv leaflet||stretch||fresh leaflet||static leaflet||valv||heart valv leaflet||valv leaflet ann||valv leaflet sampl||leaflet morpholog||leaflet section||leaflet wall,0.652||0.52||0.512||0.446||0.422||0.388||0.384||0.377||0.373||0.352||0.347||0.343||0.342||0.338||0.329,0.6,0.5,0.3333333333333333
672,Anal_Bioanal_Chem-4-1-2262919.txt,antibodi||target||recognit||nanoscal sensor||fet||sensit||high sensit||nacl solut||signal||small size||electrochem aptam sensor||detect limit||carbon nanotub||recognit element||deby screen length||protein||sensor||electr signal||bind||electr doubl layer||aptam,aptam||aptam sensor||thrombin aptam||electrochem aptam sensor||aptam handbook||engin aptam||biotin-label aptam||polym aptam||small aptam||aptam configur||stabl aptam||secondari aptam||sensor||mb-tag thrombin aptam||s00216-007-1643-i review aptam,0.668||0.472||0.368||0.358||0.358||0.343||0.342||0.339||0.339||0.338||0.337||0.336||0.276||0.259||0.232,0.4,0.2,0.2
673,Arch_Dermatol_Res-3-1-1950346.txt,placebo||chronic plaqu psoriasi||psoriasi||ccr5||baselin||data||patient||pasi||pathogenesi||receptor||lesion||express||treatment||cell||day||pasi 50 respond||analysi||psoriasi patient||placebo group||total number||non-lesion skin||skin||single-stain section||result,psoriasi||ccr5||chemokin||psoriasi patient||chemokin receptor ccr5||psoriasi area||psoriasi Br||activ psoriasi||keyword psoriasi ccr5 chemokin inhibitor||ccr5 express||ccr5 inhibitor||ccr5 mrna||ccr5 proport||i.e. ccr5||psoriasi skin Br,0.527||0.472||0.283||0.281||0.28||0.271||0.27||0.269||0.266||0.262||0.259||0.244||0.238||0.238||0.231,0.6,0.3,0.2
674,Sleep_Breath-3-1-1794625.txt,satisfact||night||studi||patient||c-flex||cpap||effect||va score||pressur||ahi||treatment||therapi||patient prefer||apap||potenti||standard cpap||sleep||expir||airflow||technician||subject||devic||convent cpap||score||central apnea||central event||prefer||complianc,c-flex||cpap||rsa c-flex||c-flex cpap pressur||cpap night||standard cpap rsa c-flex cpap||rsa c-flex night||sleep||cpap pressur||cpap complianc||rsa||cpap therapi||nasal cpap||rsa c-flex arm||convent cpap,0.513||0.5||0.395||0.377||0.369||0.362||0.342||0.327||0.309||0.286||0.277||0.276||0.271||0.267||0.266,0.4,0.3,0.26666666666666666
675,Mol_Cell_Biochem-4-1-2226060.txt,growth medium||level||vascular calcif||atherosclerosi||concentr||amlodipin||combin||studi||atorvastatin||calcif||effect||vitro||ascorb acid||ca||vascular smooth muscl cell||vsmc||dexamethason||cell||calcium||day||calcium deposit||calcif medium||prolifer||apoptosi||statin||immunofluoresc imag||incub||cultur||highest concentr||plaqu||vsmc cultur||calcium antagonist||medium||result,vsmc||vsmc calcif||calcif||aortic vsmc calcif||atorvastatin||aortic vsmc||vsmc cultur||vascular calcif||vsmc prolifer||vsmc apoptosi||amlodipin||bovin vsmc||vitro calcif||atherosclerot calcif||vitro vsmc calcif 4,0.488||0.468||0.449||0.355||0.339||0.308||0.271||0.271||0.265||0.264||0.261||0.256||0.256||0.252||0.25,0.6,0.5,0.4
676,Naunyn_Schmiedebergs_Arch_Pharmacol-3-1-1915621.txt,respons||kcl||olcegep||interest||vehicl||concentr||model||studi||channel||capsaicin||distal coronari arteri||cgrp||relax||concentr respons curv||arteri||bath fluid||porcin||segment||antagonist||human coronari arteri||relax respons,cgrp||capsaicin||capsaicin-induc relax||cgrp receptor||arteri||capsaicin receptor||cgrp releas||olcegep||cgrp concentr||endogen cgrp||coronari arteri||porcin arteri||0.1 μM||keyword capsaicin cgrp human||cgrp level,0.291||0.277||0.172||0.165||0.16||0.158||0.156||0.155||0.155||0.151||0.15||0.149||0.149||0.148||0.146,0.6,0.4,0.26666666666666666
677,Int_J_Biochem_Cell_Biol-1-5-1906734.txt,cytosol||hsj1||bind surfac||system||vivo assay||substitut||western analysi||data||mutat||conserv qkraa motif||structur||abil||region||domain||loop region||similar||conserv||helix IV||leu||protein||residu||dnaj||bind||bip||iii||interact||basic residu||prj-b vector||function||result,j-domain||al.||dnaj||hennessi||coli genevaux||genevaux||erj1 j-domain||E. coli E. coli genevaux||tcj3 j-domain||ER j-domain||bip-interact j-domain||escherichia coli dnaj||j-domain repres||2005a E. coli hennessi||1997 E. coli E. coli hennessi,0.407||0.393||0.28||0.276||0.27||0.239||0.235||0.228||0.212||0.21||0.208||0.208||0.204||0.2||0.198,0.2,0.1,0.06666666666666667
678,Community_Ment_Health_J-2-2-1705498.txt,level||measur||commun||tradit servic||formal servic||model||substanc abus servic prefer||reserv||effect||SU problem||american indian||mental health||adult||substanc abus||social support||health||higher score||current medic model||research||statement||servic||care||respond||import||cultur||novin||prefer,servic||reserv servic||tradit servic||mental health servic||indian health servic||health servic||reserv||formal servic||mental health||american indian reserv||mental health servic whitbeck||servic prefer||american indian||mental health servic util||J. mental health servic,0.381||0.329||0.297||0.293||0.29||0.282||0.277||0.267||0.25||0.247||0.244||0.234||0.232||0.229||0.229,0.4,0.5,0.4
679,Breast_Cancer_Res_Treat-3-1-2001216.txt,treatment strategi||letrozol||breast cancer||model||studi||tamoxifen||patient||effect||human||peripher tissu||ai||aminoglutethimid||aromatas||complet inhibit||postmenopaus women||select inhibit||vivo model||estrogen||anastrozol||tumor||random clinic trial||trial||breast||clinic signific||vivo,aromatas||letrozol||breast||aromatas inhibitor letrozol||aromatas inhibitor||breast cancer||breast cancer breast cancer||aromatas inhibit||postmenopaus breast cancer||human aromatas||aromatas activ||aromatas overexpress||intracellular aromatas||aromatas express||keyword aromatas breast cancer estrogen postmenopaus,0.485||0.427||0.351||0.346||0.306||0.288||0.288||0.254||0.252||0.25||0.249||0.246||0.246||0.244||0.24,0.6,0.4,0.26666666666666666
680,Eur_J_Pediatr-4-1-2190787.txt,prematur children||school outcom||problem||data||studi||year||school||norm score||test||development outcom||neurolog||special assist||follow-up programm||motor skill||development domain||standard test||mild||perinat data||problemat follow-up outcom||school perform||development disturb||development follow-up||age||follow-up assess||assess||parent||low birth weight||group||differ||school outcom group||score||children||result,children||problemat development outcom||problemat school outcom||problemat follow-up outcom||problemat school outcom follow-up||development outcom||school||school outcom normal problemat||development problem||development follow-up||mild problemat score||children nicu||prematur children||school outcom||school outcom school outcom,0.27||0.259||0.234||0.2||0.199||0.198||0.195||0.194||0.186||0.183||0.176||0.173||0.166||0.16||0.16,0.4,0.5,0.4666666666666667
681,Diabetologia-3-1-1914300.txt,type 2 diabet||csf||hypercholesterolaemia||white matter lesion||diabet||wml volum||studi||patient||grey matter||effect||leukoaraiosi||volum||total csf volum||sex||smaller volum||magnet reson imag||control particip||intracrani volum||analys||brain||wml||control||women||cerebrospin fluid||age||associ||cerebr tissu||atrophi||white matter||larger wml volum||segment||particip||white matter volum,wml||diabet||wml volum||matter hyperintens||ventricl||csf||periventricular wml||ventricl volum||white matter||white matter hyperintens||white matter volum||white matter hyperintens volum||grey matter||larger wml volum||volum,0.355||0.277||0.269||0.242||0.235||0.22||0.21||0.209||0.207||0.203||0.199||0.198||0.191||0.189||0.183,0.6,0.5,0.6
682,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2206250.txt,suicid bomb||senior surgeon||type||ophthalmologist||ED stay||patient||urgent primari closur||head||lacer||primari repair||eye||open globe||ocular trauma||hospit||terror||attack||ocular injuri||surgeri||emerg facil||medic treatment||injuri||ocular procedur||victim||bomb||primari closur||special attent||surgic procedur||intra-lenticular foreign bodi||mass casualti||surgeon||trauma||vitrectomi,bomb||suicid bomb||suicid bomb injuri||terrorist bomb||globe||suicid bomb attack||terrorist bomb attack||globe injuri||suicid||trauma||ocular trauma||ocular injuri||injuri||ophthalmologist||car bomb,0.401||0.322||0.289||0.288||0.273||0.271||0.248||0.247||0.243||0.242||0.234||0.224||0.222||0.216||0.207,0.4,0.3,0.4666666666666667
683,Invest_New_Drugs-3-1-1915607.txt,mass balanc studi||pseudopharmacokinet paramet||faecal excret||administr||plasma||sampl||studi||patient||radioact||termin elimin phase||typic radio-trac studi||recoveri||long half-lif||dose||tra||epothilon||pharmacokinet||ixabepilon||bile duct||metabol||high concentr||auc||acceler mass spectrometri||total volum||drug||mobil phase||total radioact||urin,ixabepilon||ixabepilon half-lif||ixabepilon Nr ixabepilon radioact||ixabepilon metabolit||unchang ixabepilon||ixabepilon metabol||ixabepilon equiv.||epothilon analog ixabepilon||long ixabepilon half-lif||total urinari ixabepilon||ixabepilon parent drug||anticanc agent ixabepilon||unchang ixabepilon plasma pharmacokinet||normal ixabepilon plasma concentr||epothilon,0.76||0.421||0.414||0.403||0.399||0.391||0.389||0.327||0.286||0.278||0.27||0.267||0.249||0.219||0.207,0.2,0.1,0.13333333333333333
684,Pediatr_Radiol-4-1-2292494.txt,nephrogen system fibrosi||previou gadolinium exposur||time||chronic kidney diseas||nsf||ckd||gadolinium||patient||year||develop||renal dysfunct||proinflammatori condit||dose||day||renal impair||contrast agent||renal transplant||end-stag renal failur||bodi||age||gadolinium-bas contrast agent||kidney failur||gadodiamid exposur||group||report||contrast-enhanc mri||gadodiamid||risk factor||diseas||children,nephrogen fibros||nephrogen fibros dermopathi||dermopathi||fibros dermopathi||gadodiamid||nsf||keyword nephrogen||gadolinium||nephrogen system fibrosi||nephrogen fibros dermopathi research updat inform||gadodiamid dose||mra||gadodiamid administr||gadodiamid exposur||gadodiamid inject,0.405||0.394||0.372||0.349||0.312||0.286||0.242||0.221||0.208||0.201||0.181||0.18||0.17||0.167||0.164,0.2,0.4,0.3333333333333333
685,Arch_Orthop_Trauma_Surg-3-1-2111040.txt,time||proxim femor nail||arthroplasti||complic||revis rate||hip screw||multipl regress analysi||total hip replac||studi||year||patient||full weight bear||mortal||risk||comorbid||fractur||primari arthroplasti||outcom||treatment||intern fixat||rel risk||hip||primari||age||treatment group||mortal risk||complic rate||trochanter femor fractur||group||minimum age||influenc||dh||dynam hip screw,fractur||hip fractur||intertrochanter fractur||intertrochanter hip fractur||trochanter fractur||hip||dh||hip arthroplasti||arthroplasti||pfn||pertrochanter hip fractur||unstabl fractur||pertrochanter fractur||unstabl intertrochanter hip fractur||extracapsular hip fractur,0.461||0.386||0.331||0.324||0.323||0.311||0.309||0.306||0.301||0.292||0.286||0.279||0.273||0.268||0.262,0.2,0.4,0.26666666666666666
686,Ann_Hematol-4-1-2324130.txt,gammopathi||follow-up||level||ert||clinic respons||studi||normal rang||patient||mgu||risk||increas||prednison||free light chain||cell||flc||growth factor||gaucher diseas||cohort||protein||age||cytokin||parc||multipl myeloma||rang||decreas||immunoglobulin||serum level||diseas sever||monoclon gammopathi||risk factor||diseas||result,gaucher||gammopathi||mgu||ert||flc||monoclon gammopathi||gaucher diseas||gaucher ’s||gaucher cell||gaucher type||polyclon gammopathi||triclon gammopathi||55 ert mgu||46 ert mgu||monoclon flc,0.513||0.438||0.331||0.31||0.296||0.284||0.283||0.27||0.264||0.263||0.244||0.225||0.216||0.216||0.212,0.8,0.6,0.4
687,J_Gastrointest_Surg-3-1-1852388.txt,case||middl pancreatectomi||patient||mortal||neck||risk||exocrin function||benign||exocrin pancreat function||oper||main pancreat duct||long-term endocrin||tumor||distal transect||surgeon||middl segment pancreatectomi||procedur||low-grad malign tumor||segment||gland||median pancreatectomi,pancreatectomi||segment pancreatectomi||middl pancreatectomi||central pancreatectomi||distal pancreatectomi||conserv pancreatectomi||medial pancreatectomi||median pancreatectomi||pancreatectomi ann||multipl pancreatectomi||middl segment pancreatectomi||central segment pancreatectomi||pancreat fistula||pancreat neck||pancreat stump,0.65||0.373||0.364||0.35||0.35||0.335||0.335||0.334||0.332||0.327||0.275||0.266||0.24||0.24||0.239,0.2,0.2,0.2
688,Purinergic_Signal-3-4-2072915.txt,adenin deriv||affin||adenosin receptor subtyp||adenosin receptor antagonist||adenosin receptor||deriv||result,2B||2B receptor||klotz k-n 2B||conclus 2B||volpini||cristal||adenosin receptor||2A 3 2B||6 2B adenosin receptor subtyp||18 22 2B 2B 21||vittori||2A||6 2A 2B subtyp||jacobson KA 2B||adenosin receptor antagonist,0.526||0.355||0.268||0.264||0.262||0.249||0.242||0.241||0.213||0.212||0.21||0.196||0.194||0.192||0.185,0.0,0.1,0.13333333333333333
689,Mol_Neurobiol-3-1-2039784.txt,neurotox||cell interact||role||cn injuri||releas||model||studi||patholog condit||central nervou system||effect||vitro||synapt transmiss||abil||cn||electrophysiolog properti||receptor||astrocyt||express||cell||brain||microglia||protein||neuron||death||neuroprotect activ||injuri||activ||report||cell function||cultur||interact||cn cell||pathway||chemokin||chemokin express,chemokin||neuron chemokin||cxcr4 chemokin||chemokin fractalkin||chemokin cx3cl1||chemokin receptor||chemokin express||monocultur||chemokin ccl2||chemokin sdf-1||cxc chemokin||chemokin mcp-1||chemokin monocyt||neuron chemokin express||chemokin cxcl10,0.596||0.436||0.379||0.374||0.348||0.348||0.336||0.331||0.326||0.323||0.322||0.321||0.321||0.315||0.315,0.2,0.2,0.13333333333333333
690,J_Struct_Funct_Genomics-3-1-1769342.txt,interfac||genom sequenc||time||figur||databas||year||structur||region||domain||domain interfac||structur genom||amino acid sequenc||famsbas||hydrophob||orf||homolog model||genom||surfac||famili||sequenc ident||solubl protein||templat||number||p-loop||eukaryot protein||function,"orf||3D||3D structur||rm||protein 3D structur||structur||734,193 orf||model 3D structur||protein structur||structur genom||templat structur||orf product||singl orf||protein||structur domain",0.177||0.141||0.123||0.116||0.111||0.106||0.101||0.097||0.096||0.095||0.094||0.09||0.09||0.086||0.086,0.2,0.3,0.2
691,Diabetologia-3-1-1914292.txt,ccn famili member||diabet retina||diabet||connect tissu growth factor||protein level||studi||advanc glycat end product||increas||streptozotocin-induc diabet||extracellular matrix||aminoguanidin treatment||express||aminoguanidin||rat||retina||ctgf||ace inhibit||gene express regul||mice||protein||diabet milieu||age||cystein-rich protein 61||microvascular basement membran||famili||differ||extracellular matrix compon||ccn famili||mrna||diabet retinopathi||mrna level,ctgf||result cyr61 ctgf cyr61 ctgf||cyr61||retin ctgf||lysin ctgf||interpret ctgf||ctgf 19||diabet||discuss cyr61 ctgf express||ctgf cyr61 48 49||ctgf 28 ctgf 28 50||ccn||diabet retina||cyr61 ctgf mrna level summari||ctgf 10 10,0.575||0.378||0.368||0.333||0.304||0.289||0.288||0.252||0.247||0.238||0.232||0.22||0.215||0.202||0.192,0.2,0.2,0.2
692,Histochem_Cell_Biol-4-1-2323030.txt,mechan||antibodi||cancer||role||target||ligand bind||concentr||intern||studi||endosom||year||erbb||cbl||review||complex||receptor||degrad||evid||epiderm growth factor receptor||cell||endosom sort||lysosom degrad||protein||activ||bind||import||ubiquitin||caveola||egfr||pathway||anti-canc therapi||plasma membran||ligand||erbb2||endocytosi,egfr||erbb||erbb receptor||egfr endocytosi||erbb endocytosi||erbb receptor endocytosi||egfr ubiquitin||ubiquitin egfr||receptor||egfr downregul||endocytosi||receptor ubiquitin||egf receptor endocytosi||receptor downregul||erbb2 endocytosi,0.338||0.334||0.295||0.294||0.292||0.28||0.27||0.27||0.257||0.252||0.25||0.229||0.216||0.211||0.209,0.4,0.3,0.26666666666666666
693,Eur_J_Epidemiol-3-1-2071965.txt,discharg||doubl count||hospit mortal||time||case||men||data||studi||patient||admiss||recurr case||mortal||epidemiolog||linkag||acut myocardi infarct||hospit regist||recurr event||event||regist||cohort||ratio||hospit||hospit morbid data||trend||declin||postal code||gender||incid||differ||date||hospit admiss||nation hospit discharg regist||ami||result,regist||regist hospit regist||hospit regist||link regist||regist men||nation regist||popul regist||regist person||nation ami regist||hospit discharg regist||ami||hospit regist 7||link regist trend||link regist 1995 2000 hospit regist||nation hospit discharg regist,0.428||0.333||0.285||0.252||0.233||0.231||0.229||0.228||0.219||0.212||0.194||0.19||0.185||0.183||0.167,0.4,0.2,0.26666666666666666
694,Eur_Child_Adolesc_Psychiatry-2-2-1705537.txt,attent||fwit||tmt||indic||schizophren patient||interfer task||patient||studi||cognit flexibl||young person||select||first-degre rel||effect||risk||correl||rel||test||correct||cognit function||cognit impair||variabl||control||execut function||cognit adjust||genet risk||task||analysi||correct trial||genet vulner||subject||genet influenc||group||differ||proband||sibl||perform||impair||wcst||speed||schizophrenia||score||gener alert||children||result,tmt||fwit||schizophrenia||schizophrenia schizophr||schizophren||tmt test||fwit error||wcst||tmt subtest||fwit subtest||tmt part||schizophrenia patient||cognit||d2||schizophrenia epidemiolog,0.369||0.365||0.36||0.264||0.223||0.206||0.201||0.198||0.196||0.194||0.192||0.191||0.189||0.185||0.183,0.6,0.4,0.26666666666666666
695,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2206251.txt,delay||time||case||tertiari care eye hospit||studi||endophthalm||patient||visual loss||remov||nlp||risk||clinic evid||antibiot||treatment||repair||eye||foreign bodi||vision||visual outcom||ocular trauma||iofb||age||associ||final VA||ocular injuri||king khale eye specialist hospit||injuri||factor||eye trauma||risk factor||visual acuiti||decad||trauma||vitrectomi,iofb||endophthalm||retain iofb||iofb remov||eye||iofb studi eye||iofb forcep||iofb extract||underw iofb remov||eye trauma||infecti endophthalm||clinic endophthalm||endophthalm develop||keyword endophthalm trauma foreign||eye injuri,0.614||0.422||0.359||0.333||0.329||0.315||0.313||0.309||0.226||0.222||0.218||0.214||0.214||0.199||0.19,0.6,0.4,0.26666666666666666
696,J_Biol_Inorg_Chem-3-1-1915633.txt,crystal||ecftna||data||channel||outer entranc||chain ferritin||structur||electron-dens map||Fe atom||site||fourfold channel||side-chain atom||huhf||iron||similar||main-chain||glu||high number||protein||residu||bfr||phase||side chain||ferroxidas center||FC epr signal||monom||refin||afftn||hyperthermophil microorgan||ferritin||hydrogen bond||crystal structur||factor||pfftn||symmetri||result,pfftn||ferritin||pfftn 24-mer||pfftn monom||as-isol pfftn||as-crystal pfftn||pfftn resembl||fe-load pfftn crystal||function pfftn 24-mer||thermost ferritin||nonsoak pfftn crystal||afftn||1vlg ferritin||hyperthermophil ferritin||archaeal ferritin,0.551||0.372||0.351||0.322||0.319||0.307||0.278||0.243||0.234||0.226||0.226||0.213||0.211||0.21||0.209,0.4,0.2,0.2
697,Osteoporos_Int-4-1-2267483.txt,follow-up||poorer complianc||categori||bisphosphon therapi||bisphosphon||data||interv||patient||year||mpr||risk||treatment benefit||medic||user||fractur||low complianc||osteoporot fractur||studi period||women||treatment complianc||analysi||pharmo-rl||osteoporosi||hormon replac therapi||drug||maxim treatment benefit||femal user||complianc||result,bisphosphon||fractur||bisphosphon dispens||osteoporot fractur||complianc||complianc complianc||mpr||non-compli bisphosphon||bisphosphon user||osteoporosi||fractur risk||bisphosphon therapi||bisphosphon treatment||femur fractur||introduct bisphosphon,0.47||0.446||0.313||0.31||0.31||0.31||0.291||0.278||0.261||0.258||0.256||0.254||0.252||0.245||0.235,0.8,0.6,0.4666666666666667
698,J_Gastrointest_Surg-3-1-1852373.txt,cohort||surviv||tumor||node||nodal involv||number||dismal prognosi||studi||lymph node||analysi||patient||impact||lymphadenectomi||patholog stage||stage||outcom,node||esophagu||0 0 0 0 0 0||0 0 0||0||0 0||solitari node||lymph node||0 0 0 0 2||solitari lymph node||sentinel node||involv node||thorac node||0 0 74||0 0 14,0.392||0.342||0.319||0.319||0.319||0.319||0.287||0.283||0.255||0.249||0.24||0.221||0.219||0.216||0.215,0.2,0.2,0.13333333333333333
699,Planta-4-1-2270913.txt,report||SA treatment||author||defens||final extens||induct||pathogen||salicyl acid||promot||element||luc||region iii||ethephon||rice||salicyl acid induct||activ||gfp||plant,ospr10a||ospr10a promot ospr10a ospr10a||ospr10a ospr10a promot||ospr10a ci ospr10a promot||ospr10a promot||ospr10a osactin||ospr10a http://www.dna.affrc.go.jp/cdna/plac||ospr10a cis-bold||result ospr10a||ospr10a Os materi||rt-pcr analysi 16 ospr10a ospr10a||promoter-luc construct ospr10a ospr10a pr10a Os||site ospr10a promot||method bar ospr10a ospr10a promot construct||element ospr10a promot salicyl,0.93||0.703||0.628||0.495||0.477||0.472||0.472||0.469||0.465||0.382||0.373||0.351||0.319||0.316||0.253,0.0,0.0,0.0
700,World_J_Urol-4-1-2413091.txt,independ predictor||follow-up||diamet||median||studi||patient||median follow-up||mtd||patholog stage||risk||tumor volum||total TV||correl||independ prognost factor||short follow-up||high risk||total||largest diamet||index TV||largest tumor||signific||maximum tumor diamet||month||bcr||prostat||prognost factor||tumor||gleason score||psa failur||high-risk group,mtd||bcr||conclus mtd||prostat||bcr irrespect||radic prostatectomi||psa||prostat cancer||radic prostatectomi specimen||gleason||median bcr rate||tumor||prostat carcinoma||prostat tumor size||tumor diamet,0.497||0.366||0.25||0.248||0.202||0.201||0.198||0.16||0.159||0.151||0.147||0.14||0.14||0.131||0.123,0.6,0.3,0.26666666666666666
701,Ann_Hematol-4-1-2275303.txt,md||risk||order||myelodysplast syndrom||lenalidomid||respons||time||drug||recommend||panel||abnorm||clinic trial||vte||nhae||diseas||patient||neutropenia||treatment||advers event||therapi,lenalidomid||lenalidomid therapi||lenalidomid treatment||polycythemia lenalidomid||lenalidomid dose||2008 lenalidomid||interrupt lenalidomid treatment||5q||md||lenalidomid treatment digoxin digoxin||myelodysplast syndrom||vte||partial respons continu lenalidomid therapi||lenalidomid treatment gonad function testosteron||complet hematolog respons continu lenalidomid therapi,0.7||0.379||0.374||0.37||0.368||0.357||0.277||0.223||0.218||0.214||0.186||0.18||0.164||0.157||0.155,0.2,0.2,0.26666666666666666
702,Mol_Immunol-1-5-2080686.txt,igg||level||Tg||sle||increas||light chain||endogen light chain||mice||genet background||activ||FO||ab||model||autoab||MZ||cell||margin zone,al.||c1qa||1998 c1qa||2002 c1qa||2000 c1qa||mandik-nayak||weigert||lpr lpr||lpr||botto||method 2.1 mice c1qa||c1q||immunol||lpr mice||erikson,0.506||0.449||0.228||0.227||0.227||0.15||0.148||0.147||0.147||0.142||0.135||0.132||0.13||0.116||0.115,0.0,0.0,0.0
703,Appl_Microbiol_Biotechnol-4-1-2279157.txt,imag analysi||method||time||larg number||imag||gel||sampl||data||valu||larg amount||express level||quantiti||express profil||test||background||statist||proteom map||pattern||label||calibr||approach||techniqu||protein||analysi||experi||biolog system||biolog interpret||spot||intens||imag process method||differ||show||express analysi||statist method||softwar||statist test||step||detect||vivo||result,spot||gel spot||gel||protein spot||two-dimension gel||spot quantit||proteom||spot match||spot quantiti||two-dimension electrophoresi gel||two-dimension gel electrophoresi||spot pattern||spot detect||consensu spot||spot label,0.543||0.457||0.371||0.318||0.305||0.3||0.297||0.297||0.295||0.294||0.294||0.291||0.289||0.287||0.281,0.4,0.2,0.13333333333333333
704,Doc_Ophthalmol-3-1-1896293.txt,clinic perg record||measur||frame rate||respons||amplitud measur||time||amplif system||baselin||patient||lumin||stimulu||electrod||frequenc||pattern electroretinogram||amplitud||clinic electrophysiolog||macula||surfac electrod||perg||perg record||ground||peak time||standard||steady-st perg||compon||transient perg||tempor frequenc||field||refer||checkerboard||implicit time||small signal||waveform||equip||peak||activ electrod||techniqu,perg||perg amplitud||perg record||steady-st perg||standard perg||field perg||transient perg||perg measur||normal perg||perg examin||perg result||monocular perg record||lower amplitud perg||reproduc perg record||clinic perg record,0.84||0.476||0.475||0.455||0.447||0.437||0.434||0.427||0.424||0.422||0.42||0.334||0.324||0.324||0.323,0.6,0.4,0.3333333333333333
705,J_Autism_Dev_Disord-4-1-2268726.txt,wai iii factor scale||asperg syndrom||wais-iii||level||piq||process speed||problem||studi||hfa group||inform||intellig profil||adult||comprehens||subtest||subtest level||group||differ||hfa||wais-iii profil||perform||diagnost group||speed||peopl||factor scale,asperg||autism asperg||autism||hfa||asperg syndrom||subtest||asperg group||asperg syndrom group subtest||high-funct autism||autism handbook||autism journal||autism learn||infantil autism||asperg syndrom group||autism 1995,0.459||0.424||0.389||0.342||0.287||0.279||0.241||0.219||0.218||0.216||0.211||0.202||0.2||0.199||0.196,0.4,0.3,0.2
706,Pediatr_Nephrol-3-1-1766479.txt,administr||sever side effect||noncompli||concentr||studi||adult patient||increas||guidelin||pediatr periton dialysi patient||iron||adult||erythropoietin||treatment||carnitin supplement||dosag||anemia||iron prepar||carnitin||report||periton dialysi||drug||children,erythropoietin||iron||periton dialysi||pediatr||erythropoietin alpha||pediatr nephrol pediatr nephrolog||erythropoietin therapi||pediatr periton dialysi patient||erythropoietin beta||perit dial int 21||nephrol dial transplant 14||opinion||chronic periton dialysi||periton dialysi patient||pediatr periton dialysi patient guidelin,0.315||0.242||0.22||0.198||0.172||0.168||0.167||0.164||0.163||0.159||0.158||0.158||0.157||0.153||0.148,0.6,0.4,0.26666666666666666
707,Plant_Mol_Biol-4-1-2295253.txt,seed||role||aba insensit||stratif||arrest||germin||studi||seed germin||develop||glucose-arrest seedl||treatment||day||gene||control||sugar||result||analysi||experi||compon||import||abscis acid||mutant||similar time window||phenotyp||seedl develop||media||aba,abi3||abi3 abi5||abi4 abi5 rab18 abi3 abi3||abi4||er abi3||gin abi4||abi3 mutant||abi3 gene||PC abi3||abi3 mutat||abi3 locu||abi4 abi5||3 abi3||abi4 aba2-1 abi4 abi4||abi4 abi4 abi4 abi4 agrobacterium,0.637||0.446||0.399||0.387||0.364||0.343||0.334||0.333||0.329||0.322||0.321||0.321||0.319||0.319||0.31,0.0,0.0,0.0
708,Matern_Child_Health_J-2-2-1592249.txt,time||knowledg||pregnanc||data||studi||patient||risk||inform||deliveri||famili medicin practic||annual exam||preconcept care||vast major||women||annual well-woman exam||preconcept health||popul||import||primari care practic||risk factor||survey||preconcept healthcar||physician||primari care,preconcept health||preconcept care||preconcept healthcar||preconcept folic acid||preconcept inform||preconcept health educ||pregnanc||women||preconcept prevent practic||comprehens preconcept health care||preconcept health promot program||pregnant women||periconcept||pregnanc intended||folic acid,0.292||0.277||0.249||0.239||0.237||0.216||0.178||0.178||0.175||0.174||0.155||0.15||0.149||0.133||0.131,0.6,0.5,0.3333333333333333
709,Anal_Bioanal_Chem-3-1-1839866.txt,signal enhanc||method||seira||immobil||gold||function studi||studi||metal||electrod||enhanc||potenti||properti||approach||protein||acid||surfac||metal electrod||substrat||interact||self-assembl monolay||film||enhanc factor||membran||techniqu,seira||osawa||ataka||seira spectroscopi||seira substrat||quantit seira||seira result||heberl||bcsj.70.2861 osawa||0003702934067478 osawa||metal||la971110v ataka||metal surfac||nishikawa||adsorb,0.449||0.311||0.28||0.271||0.265||0.227||0.225||0.171||0.167||0.167||0.153||0.152||0.125||0.121||0.12,0.2,0.1,0.13333333333333333
710,Biotechnol_Lett-4-1-2248218.txt,bioactiv||recombin protein||exendin-4||protein determin protein||express||purif||min||vivo||result,exendin-4||recombin exendin-4||synthet exendin-4||exendin-4 glucagon||exendin-4 reduc||exendin-4 dimer||exendin-4 antibodi||exendin-4 facilit||P. pastori||exendin-4 purif purif step total protein||analogu pichia pastori||summari P. pastori P. pastori||glp-1||exenatid||j.pep.2004.10.014 15866711 pichia pastori,0.774||0.441||0.399||0.397||0.394||0.394||0.393||0.391||0.187||0.175||0.163||0.153||0.135||0.134||0.133,0.2,0.1,0.06666666666666667
711,Arch_Orthop_Trauma_Surg-4-1-2413128.txt,calcaneu||report||conserv treatment||subtalar arthrodesi||case||subtalar joint||bone graft||complic||pain||nonunion||month||calcan nonunion||fractur||patient||pseudarthrosi||trauma,subtalar||subtalar arthrodesi||arthrodesi||nonunion||calcan nonunion||calcan||subtalar joint arthrodesi||subtalar arthrodesi 6||subtalar arthrodesi 3||calcaneu||subtalar joint||calcaneu fractur||subtalar fusion||fractur||intra-articular calcan fractur,0.46||0.434||0.408||0.337||0.327||0.316||0.309||0.29||0.289||0.263||0.26||0.251||0.244||0.239||0.231,0.6,0.4,0.4
712,Curr_Eye_Res-1-1-2430176.txt,visual prognosi||venou thrombosi||laser treatment||case||follow-up period||macular thick||studi||patient||effect||pathogenesi||neovascular||brvo||improv||sheathotomi||signific||ilm||macula||treatment||eye||abnorm hematolog factor||blood||branch retin vein occlus||occlus||hemodilut||month||final VA||small sampl size||group||grid laser photocoagul||random clinic trial||laser photocoagul||risk factor||inject||visual acuiti||short follow-up period||initi VA||hematolog disord||diseas||initi,retin occlus||retin vein occlus||occlus||vein occlus||vein||branch retin vein occlus||branch retin vein||retin branch||central retin vein occlus||retin vein occlus Br||retin vein occlus kaohsiung||hemicentr retin vein occlus||retin vein occlus result||sheathotomi||retin venou occlus,0.374||0.355||0.344||0.331||0.317||0.316||0.306||0.301||0.271||0.269||0.268||0.268||0.267||0.258||0.257,0.2,0.2,0.2
713,Photosynth_Res-3-1-1769343.txt,absorpt spectra||band||structur||chl||reconstitut||fluoresc excit||complex||protein||pcp||nativ pcp||room temperatur||peridinin||molecular detail||energi transfer||high effici||energi transfer effici||spectroscop studi||chlorophyl||spectra||fluoresc excit spectra,peridinin||carotenoid peridinin||light-harvest||carotenoid||hiller RG||light-harvest complex||ic2||pcp||peridinin molecul||chl pcp||amphidinium cartera||hiller RG polívka||photosynthet light-harvest||chl||hiller RG grondel,0.288||0.241||0.232||0.194||0.161||0.16||0.159||0.157||0.15||0.146||0.144||0.141||0.139||0.136||0.135,0.2,0.2,0.2
714,Ann_Hematol-3-1-2040174.txt,follow-up||refractori itp||time||week||respons||long-term complic||studi||patient||rituximab||chronic||rituximab therapi||platelet||immun thrombocytopen purpura||dose||itp||treatment||cell||median time||month||chronic itp||rang||splenectomi||diseas||result,rituximab||thrombocytopen purpura||itp||purpura||Az||rituximab hematol||rituximab therapi||rituximab infus||idiopath thrombocytopen purpura||refractori itp||immun thrombocytopen purpura||refractori idiopath thrombocytopen purpura||thrombot thrombocytopen purpura||chronic idiopath thrombocytopen purpura||chronic itp,0.517||0.336||0.331||0.312||0.312||0.293||0.277||0.272||0.264||0.264||0.255||0.247||0.229||0.215||0.201,0.4,0.4,0.4
715,Eur_J_Clin_Pharmacol-3-1-1779627.txt,categori||system antibiot||respons||questionnair||alspac||databas||data||studi||medicin product||medic||avon longitudin studi||antibiot||cohort||health||product||age||babi||parent||tick box respons option||paracetamol||medicin||number||drug||children,alspac||children||product||alspac team||ointment||alspac studi children||medic alspac||alspac law||medicin product||paracetamol||homeopath product||herbal product||questionnair||dermatolog product||pre-school children,0.299||0.222||0.187||0.181||0.181||0.177||0.166||0.16||0.156||0.155||0.154||0.151||0.138||0.138||0.133,0.6,0.5,0.4
716,Qual_Life_Res-4-1-2238779.txt,follow-up||measur||respons||time||gener health statu measur||clinic condit||studi||patient||similar symptom||health statu||kccq score||empir evid||heart failur||nyha||clinic trial||valid||analys||similar clinic manifest||assess||intern consist||anemia||kccq||clinic chang||symptom||psychometr properti||statu||reliabl||disease-specif measur||baselin assess||diseas||follow-up interview,kccq||anemia||heart||heart failur||kccq score||kccq chang||anemia statu||M. anemia||anemia patient||heart failur journal||heart failur questionnair||W. anemia||A. spertu||congest heart failur||B. anemia,0.446||0.306||0.267||0.241||0.237||0.229||0.197||0.195||0.186||0.183||0.177||0.176||0.173||0.168||0.167,0.8,0.4,0.26666666666666666
717,Cancer_Metastasis_Rev-4-1-2362138.txt,mef||dna damag||cancer||role||target||level||respons||oncogen||depend||target protein||wip1||intrins activ||phosphatas||effect||dna damag respons||tumor suppressor||increas||dephosphoryl||compound||overexpress||cell||phosphoryl||major compon||apoptosi||mice||ppm1d||atm||p53||activ||human cancer||tumor||import||homeostat regul||cancer cell line||amplif||function||result,wip1||49 wip1 wip1 wip1 wip1 wip1||wip1 wip1 wip1 71 wip1||wip1 phosphatas||wip1 dephosphoryl||overexpress wip1||wip1 overexpress||E. wip1||wip1 pathway||wip1 gene||wip1 journal||wild-typ wip1||human wip1||wip1 target||wip1 sirna,0.914||0.763||0.732||0.502||0.474||0.473||0.473||0.467||0.465||0.464||0.464||0.464||0.463||0.461||0.461,0.2,0.1,0.06666666666666667
718,Skeletal_Radiol-4-1-2226078.txt,cancer||nsaid||method||week||complic||spinal metastas||ideal treatment||tumour ablat||combin||studi||patient||electrod||CT guidanc||effect||ablat||opioid||metastas||lesion||pain relief||treatment||cancer patient||net ablat time||pain interfer||local anaesthesia||bpi score||pain||deploy||radiopharmaceut therapi||radiat therapi||radiofrequ ablat||bone metastas||procedur||osseou metastas,ablat||radiofrequ ablat||radiofrequ||radiofrequ ablat session||image-guid radiofrequ ablat||radiofrequ session||RF ablat||ct-guid radiofrequ||pain||saline-infus bipolar radiofrequ ablat||keyword radiofrequ ablat osseou||tumor ablat||imaging-guid radiofrequ||tumour ablat||pain metastas,0.481||0.48||0.48||0.348||0.346||0.281||0.277||0.264||0.263||0.262||0.26||0.256||0.253||0.249||0.214,0.4,0.3,0.26666666666666666
719,Mol_Genet_Metab-2-1-2279742.txt,find||dmso||nativ gel||data||mutat||state||chemic chaperon rescu||amount||rescu||effect||catalyt domain||increas||amino acid||chaperon||compound||osmolyt||mixtur||tmao||growth||yeast||homocystinuria||enzym||protein||enzym activ||mutant cb protein||glycerol||activ||chemic chaperon||tetram||mutant||diseas||addit||missens mutat||cb||media||result,cb||chaperon||i278t cb||i278t||fold i278t cb||i278t cb protein||chemic chaperon||mutant cb||wild-typ cb||cb protein||WT cb||cb activ||chaperon mixtur||chemic chaperon rescu||i278t mutant,0.424||0.421||0.387||0.35||0.286||0.275||0.266||0.26||0.238||0.237||0.229||0.228||0.226||0.224||0.223,0.4,0.3,0.26666666666666666
720,J_Med_Internet_Res-2-2-1761853.txt,health||ethic||product||health inform||care||servic||peopl||internet,servic||internet||health servic||site||internet health site||health internet||e-health site||health||servic share||onlin profession servic||user health||user||users' privaci||onlin health care||health care,0.301||0.288||0.252||0.25||0.246||0.245||0.23||0.202||0.202||0.201||0.197||0.193||0.167||0.161||0.16,0.4,0.3,0.2
721,Anal_Bioanal_Chem-3-1-1764596.txt,author||molecular fragment||method||instrument||injector||higher bromin congen||hrm||studi||review||sensit||on-column inject||pbde||octabd congen||increas||compound||degrad||detector||polybromin diphenyl ether||temperatur||analyt||environment sampl||human sampl||bromin flame retard||HR instrument||instrument method||analyt techniqu||ptv injector||paper||higher bromin compound||analysi||column||standard||mass resolut||min||isobutan||congen||work||molecular weight||inject||inject techniqu||commerci standard||multipl inject||result,pbde||pbde congen||pbde degrad||bde congen||pbde measur||pbde content||pbde level||pbde research||bromin||congen||major bde congen||1 pbde 25||bde 209||environ||higher bromin congen,0.461||0.337||0.241||0.24||0.235||0.234||0.231||0.231||0.214||0.213||0.161||0.155||0.153||0.148||0.146,0.2,0.2,0.2
722,Purinergic_Signal-3-4-2072917.txt,time||concentr||protect effect||experiment condit||effect||caspase-3||guanosin||treatment||cell||mpp||dna fragment||apoptosi||cell death||protein||dopaminerg neuron||activ||bind||cell surviv||molecular mechan||addit||result,co-treat||co-treat post-treat||post-treat||pre-treat||guanosin||post-treat 1||pre-treat co-treat 35 37||parkinson||guanosin receptor||inhibitori guanosin||sh-sy5i||post-treat 1 materi||post-treat 38 38||post-treat fig. 4||post-treat 5 5,0.43||0.419||0.409||0.305||0.285||0.204||0.186||0.163||0.15||0.146||0.142||0.14||0.139||0.138||0.137,0.2,0.1,0.06666666666666667
723,Clin_Rheumatol-4-1-2367388.txt,rheumatoid arthriti||non-signific increas||studi||patient||clinic characterist||open pilot studi||effect||da||marker||intervent||benefici effect||antioxid intervent||treatment||blood||antioxid||oxid stress||stabl non-steroid anti-inflammatori drug||diseas activ score||clinic symptom||number||clinic paramet||step||period,antioxid||antioxid intervent||antioxid statu||antioxid intak||antioxid capac||antioxid supplement||plasma antioxid||antioxid therapi||rheumatoid||rheumatoid arthriti||blood antioxid statu||bioavail natur antioxid||rheumatoid arthriti nutr||rheumatoid arthriti scand||vitamin,0.667||0.371||0.357||0.35||0.347||0.346||0.345||0.343||0.31||0.281||0.248||0.233||0.193||0.192||0.167,0.4,0.3,0.2
724,Ann_Surg_Oncol-3-1-1914254.txt,cancer||univers hospit||expertis||oper procedur||center||studi||year||patient||univers||hospit volum||effect||mortal||esophag cancer||select referr||outcom||treatment||oper mortal||hospit||data collect||surgeri||death||surviv||tumor||esophag carcinoma||esophag resect||surgeon||diagnosi||referr||stage||region cancer registri,esophag cancer||nonunivers||nonteach hospit||esophag resect||esophag surgeri||esophag carcinoma||esophag cancer surgeri||esophag cancer patient||hospit||teach nonunivers hospit||esophag cancer treatment||esophag cancer patient surviv||100.0||local esophag cancer||cancer,0.312||0.275||0.275||0.253||0.253||0.249||0.239||0.234||0.232||0.217||0.217||0.215||0.213||0.212||0.211,0.4,0.4,0.3333333333333333
725,Eur_J_Clin_Pharmacol-4-1-2235908.txt,curriculum||medic student||skill||knowledg||practic||core||patient||valid inform||inform||process||nierenberg||clinic practic||lectur||analyt reason||context-learn||undergradu medic curriculum||treatment||consult||essenti skill||educ||term||approach||effect approach||diagnost reason||script||experi||clinic clerkship||therapeut||teach||reason||current theori||clinic pharmacolog||import||undergradu student||pharmacotherapi||compet||student||drug||diseas||futur doctor||object||undergradu teach,student||curriculum||undergradu student||context-learn curriculum||medic student||teach||undergradu medic student||undergradu teach||core curriculum||medic curriculum||undergradu medic curriculum||therapeut teach||CP||context-learn||medic student educ,0.431||0.346||0.318||0.274||0.252||0.247||0.236||0.226||0.218||0.21||0.208||0.205||0.201||0.201||0.195,0.8,0.6,0.5333333333333333
726,Behav_Genet-3-1-2039802.txt,variat||origin||complex phenotyp||epigenet background||rat model||apo-su||epigenet factor||apomorphin suscept||low gnaw score||ap-pcr product||complex disord||topoisomeras II bind site||dna||unsu rat genom||rat||product||hippocampu||genet||wistar rat||unsu genom||genom||differ||high gnaw score||locu||epigenet variat||ap-pcr analysi||thalamu,aph-1b aph-1b aph-1b aph-1b gene||aph-1b aph-1b gene||aph-1b aph-1b copi||apo-su||aph-1b mrna||aph-1b express||aph-1b aph-1b 2005 2002||wistar rat aph-1b||apo-su rat||rat model aph-1b||gamma-secretas compon aph-1b||aph-1b 2006b 2006a||apo-su sequenc||rsa hpa||discuss 2002 aph-1b,0.505||0.424||0.42||0.397||0.317||0.315||0.315||0.28||0.266||0.258||0.228||0.216||0.214||0.21||0.21,0.2,0.1,0.06666666666666667
727,Neuroradiology-3-1-2151779.txt,aneurysm||intracrani aneurysm||hour||time||logist regress analysi||diagnost angiograph run||procedur time||vessel||support devic||logist||anterior cerebr arteri||procedur||predictor||angiograph run||devic||patient||occurr||coil||min,aneurysm||coil||coil intracrani aneurysm||intracrani aneurysm||642 aneurysm||unruptur aneurysm||giant aneurysm||aneurysm locat||aneurysm size||817 aneurysm||ruptur intracrani aneurysm||coil procedur||intracrani aneurysm ajnr||aneurysm procedur time||keyword intracrani aneurysm,0.648||0.45||0.429||0.418||0.355||0.346||0.338||0.336||0.333||0.33||0.323||0.313||0.3||0.293||0.279,0.6,0.3,0.2
728,Appl_Microbiol_Biotechnol-4-1-2271084.txt,rel abund||concentr||methanogen popul||acetogen bacteria||studi||sulfat ratio||reactor||srb||probe||dgge||anaerob commun||methanogen||propion||divers||ratio||fish||oligonucleotid probe||complet oxid||sulfat||acet||activ||methanogen archaea||lactat||effluent||total bacteria||mix anaerob commun||acetogen||domin microbi commun||sulfate-reduc bacteria||percentag abund||bacteria||microbi commun||result,text||sulfat||methanogen||anaerob bacteria||bacteria||cdot||sulfate-reduc bacteria||sulfat ratio||acetogen bacteria||sulfat reduc||sulfat reduct||methanogen archaea||sulfat concentr||similar sulfat||muyzer,0.233||0.145||0.114||0.105||0.102||0.101||0.098||0.082||0.081||0.079||0.078||0.075||0.075||0.073||0.073,0.6,0.6,0.4666666666666667
729,Matern_Child_Health_J-2-2-1592142.txt,consumpt||awar||knowledg||birth||pregnanc||year||folic acid||vitamin supplement||increas||folic acid daili||fortif||recommend||dietari supplement||educ||ntd||women||age||folic acid consumpt||health care provid||number||survey||supplement||birth defect,folic||folic acid||folic acid daili||folic acid awar||folic acid supplement||folic acid messag||folic acid recommend||folic acid consumpt||folic acid mandat||suffici folic acid||genet folic acid||women||meaning folic acid messag||folic acid consumpt childbear age women||lower folic acid knowledg,0.716||0.46||0.342||0.339||0.327||0.324||0.318||0.316||0.315||0.308||0.308||0.247||0.245||0.243||0.241,0.4,0.3,0.26666666666666666
730,Exp_Brain_Res-3-1-2048826.txt,condit||surfac orient||author||cue||surfac slant||slant trapezoid||data||studi||stimulu||orient||depth cue||percept||slant||altern||depth||depth percept||vergenc||perspect||slant rectangl||signal||present studi||eye||saccad||monocular arrow||slant rivalri stimulu||dispar||ambigu||conclus||display||direct||onset||surfac||ambigu stimulu||influenc||perceptu condit||trial||hypothesi||show||result,vergenc||eye vergenc||vergenc veloc||vergenc data||ocular vergenc||vergenc step||vergenc respons||vergenc chang||vergenc system||vergenc differ||depth influenc vergenc||depth govern vergenc||slant||preprogram vergenc offset||slant cue,0.729||0.397||0.377||0.368||0.368||0.367||0.367||0.367||0.367||0.367||0.328||0.326||0.297||0.265||0.257,0.2,0.1,0.13333333333333333
731,Int_J_Biol_Sci-3-3-1802012.txt,transcriptom||broad-coverag array||author||respons||method||microarray||databas||data||gene express||inform||review||serial analysi||increas||filament conceptu||abil||express||porcin sequenc||cell type||cell||infect||gene||pig gene express||est||annot||pig||porcin tissu||transcript||paper||tissu||protein||immun||analysi||qpcr||bioinformat||group||report||differ||snp||number||porcin||pathway||unpublish project||sequenc||librari||result,porcin||pig||porcin affymetrix||pig microarray||est||porcin sequenc||pig gene express||gene||porcin transcriptom analysi porcin||microarray||pig genom||porcin embryo||porcin differenti gene express||porcin parthenot||porcin fetal,0.394||0.315||0.29||0.265||0.258||0.254||0.235||0.226||0.224||0.216||0.215||0.213||0.213||0.212||0.208,0.6,0.7,0.4666666666666667
732,Mech_Dev-2-1-2428104.txt,embryo||shh||breakpoint||region||human disord||site||pattern||express||dna||gene||delet||mice||ihh||limb||mous chromosom 1||anterior||mutant||polydactyli||limb bud||sequenc||posterior||result,dbf||dbf dbf||ihh dbf||shh dbf||2.6 dbf ihh dbf ihh dbf||3.3 dbf mutat dbf dbf||gli3 dbf||2.4 dbf shh dbf||ihh ihh dbf||shh ihh dbf||hand2 dbf||dbf hay||3.2 dbf polydactyli dbf||hoxd13 dbf||dbf hpi dbf delet,0.851||0.851||0.576||0.56||0.526||0.512||0.51||0.493||0.485||0.474||0.472||0.438||0.438||0.437||0.431,0.0,0.0,0.0
733,Qual_Life_Res-4-1-2238788.txt,futur||questionnair||satisfact||control group||experiment condit||data||studi||patient||liver transplant||effect||inform||chronic liver diseas||clinic practic||mental hrqol||cld||consult||univari analys||control||chronic diseas||hepatolog||age||gener practic||experiment group||implement||group||hrqol measur||differ||checklist||computer measur||physician||diseas||experiment||score||hrqol||gener popul||result,hrqol||patient hrqol||disease-specif hrqol||patients’ hrqol||hrqol inform||hrqol measur||mental hrqol||hrqol issu||hrqol data||hrqol topic||hrqol 24||disease-specif hrqol questionnair||computer hrqol questionnair||gener hrqol mc||patients’ gener hrqol,0.699||0.414||0.407||0.391||0.367||0.366||0.363||0.355||0.354||0.352||0.35||0.297||0.279||0.271||0.266,0.2,0.3,0.2
734,Eur_J_Epidemiol-3-1-2071968.txt,signific risk factor||case||socioeconom statu||independ variabl||data||model||studi||year||patient||water||inform||variabl||proport||sourc||signific||impact||agricultur||cryptosporidiosi||analysi||popul||associ||water suppli||postcod||water treatment||ill||speci||result,cryptosporidium||cryptosporidium parvum||C. parvum cryptosporidium cryptosporidium C. parvum||cryptosporidium C. homini C. parvum||cryptosporidium C. homini C. parvum C.||cryptosporidium oocyst||0.001 cryptosporidium||C. homini C. parvum||C. parvum C. homini||cryptosporidium speci||cryptosporidium spp.||cryptosporidium int||cryptosporidium strain||cryptosporidium applic||method cryptosporidium cryptosporidium 15,0.623||0.558||0.432||0.38||0.347||0.329||0.329||0.319||0.319||0.317||0.316||0.315||0.314||0.312||0.312,0.0,0.0,0.0
735,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2413124.txt,case||ppv||complic||studi||endophthalm||patient||pdr||anti-glaucoma eye drop||retin detach||event||prolif vitreoretinopathi||eye||advers event||final examin||hospit||intra-op complic||analysi||incid||convent ppv group||surgeri||intravitr TA inject||group||factor||differ||order||retin break||sampl size||signific differ||visual acuiti||diseas||diagnosi||addit surgeri,ppv||ta-assist ppv||pdr||convent ppv||triamcinolon||ppv specialist||triamcinolon acetonid||vitrectomi||acetonid||pdr eye||intravitr triamcinolon||ta-assist par||convent ppv group||success ppv outcom||complic pdr,0.459||0.338||0.29||0.251||0.239||0.233||0.232||0.232||0.225||0.196||0.178||0.177||0.173||0.16||0.156,0.4,0.2,0.2
736,J_Fluoresc-3-1-2064943.txt,short-liv unwrap state||data||time resolut||valu||blink||process||bulk experi||excit||total||acceptor||event||dna||label||intact nucleosom||dynam||fret pair||nucleosom||fluoresc intens||fret||immobil nucleosom||fret effici||lifetim||experi||fluorophor||spfret measur||trace||fluoresc||subpopul||nois||averag fret effici||donor,nucleosom||fret||blink||immobil nucleosom||nucleosom dna||nucleosom dynam||dissoci nucleosom||keyword fret nucleosom single-molecul blink||intact nucleosom||nucleosom core||nucleosom construct||nucleosom structur||singl nucleosom||unlabel nucleosom||condit nucleosom,0.338||0.279||0.218||0.208||0.207||0.193||0.187||0.186||0.182||0.181||0.174||0.173||0.173||0.173||0.172,0.8,0.5,0.3333333333333333
737,Pediatr_Radiol-4-1-2292492.txt,delay||tumor||neuroendocrin tumor||present||function imag||carcinoid||pancrea||carcinoid crisi||children||anatom||imag||diseas||diagnosi||patient||imag find||detect||gep-net,carcinoid||carcinoid tumor||net||neuroendocrin||neuroendocrin tumor||tumor||carcinoid tumour||carcinoid crisi||pediatr gastroenteropancreat neuroendocrin tumor||pulmonari net tumor||nonfunct net||metastat gastroenteropancreat neuroendocrin tumor||nonfunct tumor||neuroendocrin tumour||gep-net,0.42||0.348||0.296||0.281||0.278||0.275||0.254||0.221||0.209||0.206||0.199||0.195||0.189||0.185||0.175,0.4,0.4,0.3333333333333333
738,J_Gastrointest_Surg-3-1-1852387.txt,anim||inflammatori tissu infiltr||method||veloc||endothelium interact||model||studi||platelet||intravit microscopi||mild||sever AP||mild AP||microcircul||inflammatori respons||leukocyt||activ||perfus failur||platelet function||thromboxan||platelet activ||sever||acut pancreat||pancrea||tissu damag||inflammatori cell||function||result,platelet||pancreat||intravit||platelet veloc||platelet adhes||platelet p-selectin||acut pancreat||platelet reinject||thromboxan||intravit microscopi||pancreat microcircul||rhodamine-stain platelet||platelet activ||leukocyt||temporari platelet,0.41||0.357||0.324||0.246||0.243||0.235||0.232||0.229||0.227||0.226||0.221||0.218||0.214||0.212||0.211,0.2,0.4,0.4
739,J_Mol_Biol-1-5-2291452.txt,role||parent protein||depend||core||side-chain dynam||mutat||tnfn3||stabil||region||domain||exchang||dynam||fold||properti||protein||residu||chimer protein||parent||strand||backbon||loop||surfac||rate constant||fnfn10||fnotnc||fniii||intermedi,fnotnc||tnfn3||fnfn10||fnotnc protein||tnfn3 core||unfold fnotnc||tnfn3 domain||wild-typ tnfn3||tnfn3 gdmcl||fold||Φ||human tenascin fnotnc||human fibronectin tnfn3||fnotnc display curvatur||protein fold,0.523||0.43||0.331||0.33||0.293||0.285||0.256||0.233||0.229||0.223||0.219||0.193||0.187||0.181||0.181,0.6,0.4,0.26666666666666666
740,Intensive_Care_Med-2-2-1315315.txt,equat||icu admiss||hospit mortal||time||refer databas||prognost model||databas||logist regress||comput||sampl||data||model||patient||icu level||circumst||sap 3 score||mortal||develop||hospit discharg||variabl||sap 3 system||maximum valu||physiolog data||approach||hospit||region differ||goodness-of-fit||predict||intens care unit||score||refer||ill||check||icu||final estim||outcom||result,icu||icu admiss||admiss||unplan icu admiss||icu admiss data||icu admiss date||icu admiss 13||icu admiss 8||icu characterist||icu popul||icu level||icu 6||admiss score||icu admiss moreno rui||icu admiss emerg room,0.464||0.422||0.379||0.296||0.286||0.284||0.282||0.282||0.24||0.237||0.234||0.233||0.227||0.226||0.215,0.4,0.2,0.2
741,Liver_Int-1-_-2156150.txt,respons||rate||combin||studi||patient||lamivudin||hbeag clearanc||quantit meta-analys||intent||hbeag-posit patient||treatment||meta-analysi||biochem respons||heterogen||analysi||nonadult popul||treatment safeti||primari efficaci measur||group||monotherapi||interferon||trial||addit,lamivudin||interferon||lamivudin combin||lamivudin therapi||hepat||lamivudin addit||lamivudin reduc||pegyl interferon||lamivudin combin therapi||hbeag||lamivudin combin treatment||interferon monotherapi||interferon alfa-2a||chronic hepat||convent interferon,0.623||0.359||0.344||0.338||0.315||0.314||0.313||0.251||0.247||0.241||0.24||0.236||0.209||0.207||0.205,0.4,0.2,0.13333333333333333
742,J_Neurooncol-4-1-2295256.txt,meg||low-grad glioma||lgg||studi||state||patient||hemispher||correl||higher cognit function||special brain area||increas||rel||region||state brain activ||lower alpha||rel power||neurocognit deficit||delta||gamma band||brain||bilater frontocentr meg region||control||power||frequenc band||neurocognit function||analysi||theta||left pariet region||brain tumor patient||group||differ||tumor||diffus||healthi control||lower alpha band||diseas||left hemispher||result,meg||lgg||brain||lgg patient||brain tumor||band||meg record||meg registr||meg region||neurocognit dysfunct||neurocognit function||neurocognit deficit||tumor||brain tumor patient||meg measur,0.348||0.306||0.24||0.214||0.211||0.192||0.19||0.188||0.188||0.186||0.185||0.185||0.183||0.182||0.179,0.6,0.3,0.4666666666666667
743,Bioprocess_Biosyst_Eng-4-1-2214824.txt,envirocam||condit||measur||imag analysi softwar||imag analysi||shroud||system||broth||diamet||liquid||imag||larger number||ferment broth||scale||increas||abil||resolut||frame||modular camera system||bubbl size||ferment||situ measur devic||standard||agit||ccd camera||led light sourc||distribut||sauter||light||rang||camera||pixel||photograph||number||limit||size||bubbl||agit rate||result,"bubbl||bubbl size||bubbl imag||bubbl diamet||bubbl measur||bubbl break-up||500 bubbl||2,000 bubbl||bubbl edg||bubbl distribut||smaller bubbl||overlap bubbl||circular bubbl||bubbl contrast||65,000 bubbl",0.757||0.417||0.413||0.404||0.403||0.397||0.396||0.396||0.393||0.391||0.389||0.387||0.387||0.384||0.384,0.4,0.2,0.13333333333333333
744,Neuropsychologia-2-1-2394569.txt,addit activ||condit||non-sign||skill||BA 37||superior tempor cortex||hear adult||nativ signer||hear||gyru||individu differ||BA 21||experiment condit||model||studi||deaf nativ signer||perisylvian region||hemispher||deaf||languag||fmri||correl||speech||posterior portion||region||cluster||posit correl||sign languag||stimuli||brain||voxel||hear non-sign||BA 46||frontal cortex||analysi||task||associ||speechread||identif||activ||deaf children||group||deaf peopl||word||score||particip||experiment||middl||deaf particip,speechread||deaf||gyru||al.||deaf speechread proceed||speechread skill||hear||silent speechread||speechread word||speechread condit||speechread block||individuals’ speechread||speechread materi||tempor gyru||deaf particip,0.45||0.372||0.305||0.283||0.275||0.267||0.267||0.266||0.239||0.237||0.236||0.229||0.226||0.218||0.217,0.6,0.4,0.3333333333333333
745,Neuropharmacology-2-1-2194164.txt,effect||glutamaterg transmiss||excitatori postsynapt current||applic||endocannabinoid||solut||hippocampu||glutamaterg synaps||high dose||cannabinoid||concentr||transmitt releas||experi||slice||data||glutam||channel,al.||cannabinoid||hájo||cannabinoid receptor||cannabinoid inhibit||cannabinoid modul||endogen cannabinoid||cannabinoid ligand||cannabinoid compound||cannabinoid effect||cb1 cannabinoid receptor||hájo norbert||2001 hájo||2005 hájo||freund,0.441||0.438||0.377||0.25||0.24||0.227||0.227||0.222||0.221||0.22||0.207||0.195||0.193||0.192||0.189,0.2,0.1,0.06666666666666667
746,Intensive_Care_Med-4-1-2271085.txt,bioimped||measur||svi||stroke volumeindex||studi||bioimped svi||cardiac output||coronari arteri bypass graft||error||data||algorithm||patient||tpco||transpulmonari thermodilut,bioimped||bioimped svi||svi||bioimped algorithm||thermodilut||bioimped devic||bioimped versu thermodilut||thorac bioimped devic||thorac electr bioimped||thorac bioimped cardiographi devic||7 svi||transpulmonari thermodilut||second-gener bioimped devic||13 svi SB 14 svi||1 loa svi TD,0.479||0.44||0.401||0.303||0.299||0.272||0.261||0.213||0.212||0.21||0.201||0.199||0.189||0.174||0.172,0.6,0.3,0.26666666666666666
747,Bioinformation-2-4-2255066.txt,gene||neurolog disord||entri||dnd||drug||databas||disord||diseas||neurodegen disord||sequenc,dnd||neurodegen disord||neurodegen disord databas||databas||neurodegen diseas||relat neurodegen diseas||major neurodegen diseas||neurodegen diseas mechan||relat databas||compil databas||sourc databas||comprehens databas||neurodegen disord gowthaman ragul 1||kegg id||kegg,0.388||0.311||0.309||0.306||0.268||0.191||0.181||0.181||0.171||0.17||0.166||0.162||0.157||0.153||0.145,0.6,0.3,0.2
748,BMC_Struct_Biol-4-_-331416.txt,program||method||figur||mlv||murin leukaemia viru||model||structur||probe||eia||region||domain||quest||loop region||sequenc similar||helic||gene||paramet||multipl||protein||molecular model||ident||residu||sequenc align||loop||agreement||signific sequenc similar||viru||sequenc||fv1||result,fv1||fv1 sequenc||fv1 align||fv1 model||fv1 sub-famili||mous fv1||fv1 NB||abbrevi fv1||fv1 action||fv1 29||fv1 n-termin domain||mlv||capsid||mlv sequenc||sequenc,0.561||0.39||0.371||0.317||0.316||0.288||0.285||0.283||0.282||0.282||0.248||0.239||0.229||0.229||0.219,0.2,0.1,0.2
749,Arch_Dermatol_Res-3-1-1800369.txt,prognost classif||cancer||tumour entiti||serum||melanoma||skin cancer pathogenesi||patient||skin cancer||primari melanoma||immunohistochemistri||malign melanoma||express||classif||metastasi||cell||squamou cell carcinoma||molecular marker||prognosi||vascular invas||prognost factor||cancer entiti||primari tumour||cutan malign||tumour size||classif system||invas||diseas||molecul||biomark||gene express,melanoma||melanoma melanoma||metastat melanoma melanoma||melanoma marker melanoma||melanoma progress melanoma||cutan melanoma||malign melanoma||metastat malign melanoma melanoma||metastat melanoma||malign melanoma cutan||cutan malign melanoma||melanoma patient||melanoma cell||melanoma Br||melanoma correl,0.686||0.686||0.492||0.483||0.468||0.445||0.445||0.42||0.395||0.365||0.365||0.362||0.36||0.358||0.356,0.2,0.2,0.13333333333333333
750,Angiogenesis-4-1-2268731.txt,cancer||role||endotheli cell||nf-κb||mediat||effect||agent||angiogenesi||express||inhibit||treatment||cell||growth||growth factor||direct effect||apoptosi||angiogenesi inhibitor||activ||report||pathway||addit||inhibitor,nf-κb||angiogenesi angiogenesi||angiogenesi||nf-κb activ||nf-kappab||tumor cell nf-κb||keyword angiostat nf-κb||tumor angiogenesi||mechan nf-κb activ||system nf-κb inhibit||transcript factor nf-κb||angiogenesi inhibit||endotheli cell||angiogenesi inhibitor||2008 angiogenesi,0.526||0.311||0.311||0.293||0.25||0.246||0.236||0.21||0.201||0.199||0.191||0.189||0.176||0.173||0.164,0.4,0.2,0.26666666666666666
751,BMC_Fam_Pract-4-_-169167.txt,elect appoint||measur||time||method||questionnair||compat system||practic||appoint data||data||patient||numer data||primari care organis||develop||appoint||day||routin||term||approach||clinician||survey techniqu||care||literatur||definit problem||search||access||number||organis||broad approach||primari care||demand||mind||articl,appoint||care appoint||urgent appoint||routin appoint||elect appoint||surgeri appoint||same-day appoint||GP appoint||appoint data||appoint system||free appoint||appoint 21||care measur appoint||routin appoint avail||routin appoint 9,0.738||0.433||0.433||0.406||0.401||0.398||0.391||0.39||0.383||0.382||0.372||0.371||0.304||0.282||0.271,0.4,0.3,0.2
752,J_Chem_Ecol-4-1-2373416.txt,hydrocarbon||type||ppg||individu||strohm||extract||femal||postpharyng gland||sphecida||compound||proport||chemic composit||alken||unsatur||hymenoptera||gc-ftir||femal european beewolv||group||european beewolf||keton||secret||herzner||crabronida||function||polar fraction,strohm||philanthu triangulum||philanthu||E. philanthu triangulum||strohm E. philanthu triangulum fabriciu||strohm E. linsenmair||hefetz||hymenoptera||s002650050652 strohm||j.1365-2311.2001.00300.x strohm||13.1.52 strohm||s004420100702 strohm||j.asd.2006.08.007 strohm||2008 philanthu triangulum||E. philanthu triangulum F.,0.397||0.289||0.277||0.233||0.223||0.217||0.217||0.207||0.205||0.205||0.205||0.205||0.205||0.196||0.182,0.2,0.2,0.13333333333333333
753,Environ_Manage-4-1-2242854.txt,total nitrogen||watersh manag||downstream reach||spatial scale||stream size||nutrient||concentr||sampl||data||studi||effect||correl||ecoregion||total phosphoru||scale||land||total||site||watersh||downstream water qualiti||land cover||analys||relationship||riparian zone||varianc||previou studi||water chemistri||first-ord||high flow||water qualiti||differ||signific predictor||riparian||influenc||stream||annual water volum||surfac water chemistri||entir watersh||result,watersh||riparian||watersh land||riparian land||land||watersh land cover||riparian land cover||riparian cover||stream||agricultur watersh||watersh geomorpholog||riparian forest||land cover||watersh manag||watersh size,0.483||0.423||0.421||0.391||0.359||0.329||0.309||0.283||0.271||0.27||0.262||0.254||0.251||0.251||0.249,0.6,0.4,0.4
754,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-1779626.txt,membran||type II collagen||method||number||tissu||phenotyp express||cell viabil||articular cartilag||sampl||maci procedur||matrix||tissu engin||implant||distribut||chondrocyt||cell||ultrastructur analys||maci,chondrocyt||autolog chondrocyt||autolog chondrocyt implant||chondrocyt phenotyp||chondrocyt transplant||human chondrocyt||sheep chondrocyt||chondrocyt expans||autolog chondrocyt transplant||knee||autolog chondrocyt implant int||human articular chondrocyt||implant||matrix-support autolog chondrocyt transplant||autolog chondrocyt implant versu mosaicplasti,0.583||0.407||0.346||0.346||0.309||0.304||0.3||0.297||0.283||0.275||0.261||0.248||0.225||0.22||0.219,0.2,0.1,0.13333333333333333
755,Pituitary-3-1-2045692.txt,larg bronchial carcinoid||pancreat polypeptid||ectop ghrh-syndrom||glucos load||case||approxim entropi||ghrh concentr||ghrh||mri||concentr||studi||valu||patient||serum ghrh concentr||remov||increas||test||octreotid||pituitari gland||repeat CT||GH secret||treatment||secretori regular||examin||primari tumor||igf-i||acromegali||normal valu||long-term follow-up||medic therapi||surgeri||normal||report||tumor||decreas||carcinoid||secret||primari pituitari somatotropinoma||clinic find,ghrh||ghrh secret||acromegali||patient ghrh||ghrh concentr||concentr ghrh||ectop ghrh tumor||ectop acromegali||dissemin ghrh||ghrh sourc||ghrh test||ghrh receptor||ectop ghrh syndrom||ectop ghrh sourc||carcinoid,0.517||0.336||0.328||0.289||0.278||0.278||0.276||0.271||0.264||0.262||0.262||0.261||0.253||0.246||0.222,0.6,0.3,0.26666666666666666
756,Virus_Res-2-1-2194287.txt,bcl-2||vector||replicon vector||alphavirus||protect effect||releas||data||studi||effect||semliki forest viru||high-level express||similar result||vlp||express||cell||infect||egfp||apoptosi||cell death||protein||death||sfv||ire||replicon||viru replic||viru||construct||rna||result,bcl-2||al.||liljestrom||semliki||bcl-2 tsujimoto||sfv||bcl-2 express||bcl-2 ash||bcl-2 embo||posit bcl-2||bcl-2 regul||bcl-2 faseb||sfv replicon||bcl-2 overexpress||bcl-2 famili,0.379||0.366||0.262||0.231||0.221||0.215||0.213||0.204||0.195||0.195||0.194||0.193||0.192||0.192||0.192,0.2,0.2,0.13333333333333333
757,Med_Oncol-4-1-2386844.txt,cancer cell||cancer||level||low level||tumor growth||patient||basal express level||hsp||effect||sirna||express||present studi||cell||growth||fir||gene||reaction||heat shock protein||prolifer||protein||brdu incorpor||medic treatment||incub||result,fir||fir radiat||fir incub||fir irradi||hsp70||hsp70 hsp70||hsp70a||fir incub 2||result fir irradi||hsp70 sirna||hsp70 protein||hsp70a hsp70a hsp70a hsp70a xba bam||hsc3||endogen hsp70||2007 hsp70,0.669||0.364||0.363||0.356||0.336||0.336||0.278||0.242||0.238||0.208||0.189||0.189||0.181||0.171||0.169,0.2,0.1,0.06666666666666667
758,Biochim_Biophys_Acta-2-1-2428106.txt,Na||drug transport||studi||small intestin||effect||amino acid||nhe3||caffein||electrochem gradient||exchang||inhibit||cell||phosphodiesteras||uptak||activ||brush-bord membran||pde||incub||small intestin epithelium||function||monolay,phosphodiesteras||dipeptid||thwait d.t||intestin dipeptid transport||dipeptid uptak||caffein||nhe3||intestin hpept1||caco-2||dipeptid absorpt||ganapathi V. thwait d.t||uptak||intestin imino||transport||phosphodiesteras inhibitor,0.241||0.24||0.238||0.207||0.193||0.187||0.183||0.182||0.15||0.15||0.15||0.147||0.143||0.143||0.139,0.2,0.3,0.26666666666666666
759,J_Occup_Rehabil-3-1-1915628.txt,follow-up||femal comput worker||week||muscl activ||myofeedback train||pain intens||baselin||model||studi||myofeedback||muscl relax||effect||work-rel neck-should complaint||complaint||EC group||va score||netherland||improv||intervent||signific||odd ratio||neck-should region||shoulder||pain||analysi||mfb||subject||factor||group||work-rel musculoskelet complaint||work||cinderella-bas myofeedback train||disabl||result,myofeedback||mfb||pain||myofeedback train||shoulder pain||ergonom intervent||myofeedback int||myofeedback devic||disabl||myofeedback system||occup pain||mfb group||ambul myofeedback train||cinderella-bas myofeedback train||pain intens,0.377||0.328||0.274||0.243||0.214||0.213||0.197||0.196||0.196||0.191||0.185||0.184||0.18||0.179||0.174,0.8,0.5,0.4666666666666667
760,Osteoporos_Int-4-1-2358936.txt,grade||measur||low-norm bmd||method||deform||follow-up period||bone resorpt||baselin||data||vertebr deform||studi||year||patient||lumbar spine||risk||increas||sarcoidosi||fractur||suggest||bone turnov||bmd||GC therapi||gc||progress vertebr deform||women||hip||age||popul||subject||multivari logist regress analysi||group||preval deform||bone||ictp||progress deform||diseas||bone miner densiti,sarcoidosi||deform||fractur||vertebr deform||vertebr fractur||densiti sarcoidosi vertebr deform||bmd||bone||progress vertebr deform||morphometr vertebr deform||incid vertebr deform||preval vertebr deform||hip fractur||incid vertebr fractur||ns,0.365||0.354||0.33||0.324||0.312||0.268||0.262||0.26||0.232||0.23||0.228||0.226||0.224||0.22||0.22,0.8,0.7,0.4666666666666667
761,J_Gastrointest_Surg-3-1-1852378.txt,follow-up||case||imag||hepat aml||hepatocellular carcinoma||surgic resect||studi||year||seri||recurr||patient||hepat angiomyolipoma||conserv treatment||oper||treatment||month||angiomyolipoma||report||tumor||fine needl aspir biopsi||conserv manag||diagnosi,angiomyolipoma||hepat angiomyolipoma||malign angiomyolipoma||renal angiomyolipoma||solitari angiomyolipoma||small angiomyolipoma||keyword angiomyolipoma hepat angiomyolipoma liver tumor||hepat angiomyolipoma exhibit||hepat angiomyolipoma yang||hepat angiomyolipoma eur||hepat||recurr malign hepat angiomyolipoma||hepat angiomyolipoma case sex||tumor||hepat aml,0.643||0.465||0.332||0.329||0.329||0.324||0.317||0.312||0.312||0.311||0.286||0.25||0.242||0.22||0.211,0.4,0.2,0.26666666666666666
762,J_Abnorm_Child_Psychol-4-1-1915634.txt,type||self-report questionnair||homotyp||rcad data||sad||futur soph||gener anxieti disord||sampl||studi||correl||continu||scale||anxieti||disord||ocd||anxieti dimens||soph||girl||varianc||previou studi||taxonomi||social phobia||anxieti construct||gad||obsess compuls disord||commun sampl||symptom||previou work||item score||adolesc||panic disord||young adolesc,000||anxieti||soph||rcad||anxieti disord||000 boy||000 sex||anxieti symptom||child anxieti||000 note||gad||anxieti problem||anxieti dimens||rcad scale||early-adulthood anxieti,0.306||0.274||0.231||0.218||0.183||0.168||0.166||0.163||0.162||0.156||0.156||0.146||0.144||0.143||0.142,0.4,0.2,0.26666666666666666
763,Ann_Biomed_Eng-3-1-2040176.txt,atd||rollov||measur||acceler||time||crash mode||vehicl||roof deform||roof crush||data||studi||contact||head||far-sid||driver||test||rollov crash||dynam||present studi||human spine||atd neck||probabl column injuri||hybrid iii dummi||load||passeng||spinal injuri||local peak neck forc||dynam rollov test||seat belt||sensor||residu forc magnitud||injuri||camera||onboard clock||lap belt||cervic spine||cadav||load cell||suv||passeng atd||neck load||peak||passeng car||result,roof||rollov||passeng||roof rail||passeng atd||atd||rail||rollov crash||sae||roof rail acceler||roof rail acceleromet||driver rail||atd neck||passeng atd head||roof crush,0.365||0.351||0.317||0.316||0.311||0.306||0.268||0.239||0.239||0.225||0.222||0.22||0.22||0.217||0.216,0.6,0.5,0.4666666666666667
764,Ann_Hematol-4-1-2226003.txt,risk||thrombosi||studi||atherosclerosi||genet marker||serum ferritin concentr||carrier||associ||anemia||coronari heart diseas||coronari arteri diseas||iron||cardiovascular event||patient||thrombocytosi||cardiovascular diseas,iron||c282i||iron defici||iron store||iron overload||iron defici anemia||bodi iron||iron hypothesi||iron deplet||iron statu||iron paradigm||iron level||iron defici anaemia||c282i mutat||mutat c282i,0.547||0.341||0.339||0.306||0.296||0.289||0.288||0.285||0.283||0.282||0.277||0.275||0.243||0.222||0.222,0.2,0.1,0.06666666666666667
765,Ann_Surg_Oncol-4-1-2234441.txt,condit||cancer cell||cancer||level||case||line||import role||hypoxia-resist hcc line||studi||patient||differenti hcc||immunohistochemistri||tumor differenti||hypox condit||statist analysi||express||differenti||liver cirrhosi||result||analysi||immunoblot analysi||hcc||tumor||import||rage||hepat||normal liver||noncancer tissu,rage||hcc||rage express||rage mrna||rage transfect||rage ligand||rage level||result rage||tumor rage express||0.456 rage express||differentiation-associ rage express||enhanc rage express||hypoxia-induc rage express||3. rage express||increas rage express,0.741||0.43||0.406||0.387||0.385||0.382||0.376||0.371||0.292||0.275||0.275||0.274||0.274||0.271||0.271,0.4,0.2,0.13333333333333333
766,Ann_Surg_Oncol-3-1-2077910.txt,follow-up||risk carrier||cancer||prophylact surgeri||find||complic||ovarian cancer||histori||microscop examin||breast cancer||hereditari BC||studi||year||mutat||pbso||data||risk||care histolog examin||fnac||relev data||pm||institut||examin||metastat diseas||standard procedur||women||mastectomi specimen||age||addit investig||prophylact mastectomi||group||famili||hereditari breast cancer||number||malign find||signific differ||primari BC||reconstruct||decis||breast||mastectomi,mastectomi||breast||prophylact mastectomi||brca1||breast cancer||breast reconstruct||hereditari breast||hereditari breast cancer||prophylact bilater mastectomi||bilater prophylact mastectomi||mastectomi specimen||breast cancer risk||pbso||breast cancer famili||cancer,0.357||0.352||0.299||0.293||0.275||0.248||0.225||0.216||0.215||0.215||0.208||0.206||0.206||0.201||0.198,0.8,0.5,0.5333333333333333
767,Eur_Radiol-3-1-2077918.txt,peripher vascular diseas||level||time||scanner||contrast arriv||imag||data||patient||peripher arteri||review||extens calcif||imag qualiti||enhanc||resolut||peripher CT angiographi||contrast media||acquisit||vessel wall calcif||CT angiographi||bolu||import||diagnost cost||tabl||tomographi||pad||techniqu,angiographi||CT angiographi||tomographi angiographi||mdct angiographi||subtract CT angiographi||peripher CT angiographi||abrams’ angiographi||tomograph angiographi||spiral-ct angiographi||multislice-ct angiographi||multidetector CT angiographi||multi-detector row CT angiographi||3D CT angiographi||helic CT angiographi||dual-energi CT angiographi,0.581||0.405||0.325||0.317||0.313||0.311||0.304||0.298||0.297||0.297||0.293||0.292||0.28||0.277||0.273,0.2,0.2,0.13333333333333333
768,Diabetologia-4-1-2270360.txt,diabet||children||hyperglycaemia||mutat||patient||test||site||guidelin||featur||molecular genet diagnosi||treatment||genet diagnosi||molecular genet||gene||maturity-onset diabet||blood glucos||analysi||report||monogen diabet||diagnosi||modi||interpret||syndrom||result,hnf1a||hnf4a||gck||gck hnf1a hnf4a mutat||hnf1a mutat hnf1a hnf1a young-onset diabet||hnf4a mutat||practic gck hnf1a hnf4a maturity-onset diabet||gck hnf1a tcf1||result gck hnf1a hnf4a mutat||diabet||issu gck hnf1a||hnf1a gene||maturity-onset diabet||hnf1a mutat hnf4a mutat screen||interpret gck hnf1a hnf4a gene,0.456||0.371||0.36||0.351||0.316||0.294||0.285||0.282||0.281||0.278||0.273||0.259||0.256||0.253||0.253,0.0,0.1,0.13333333333333333
769,Childs_Nerv_Syst-2-2-1705512.txt,mirna express||method||array result||microarray||sampl||oma||oligonucleotid microarray||human||probe||express profil||organ||human chromosom 13||nervou system develop||express||cluster||signal||nervou system||specif||analysi||cdna||hybrid||mirna||northern blot||microrna||profil,mirna||microrna||mirna oligo||mirna oma||mirna probe||mirna express||mirna biogenesi||intron mirna||neighbor mirna||mirna famili||mirna research||67 mirna||result mirna||mirna express profil||human mirna express,0.661||0.413||0.376||0.372||0.362||0.36||0.343||0.337||0.336||0.336||0.333||0.332||0.331||0.262||0.251,0.4,0.3,0.2
770,Int_J_Med_Sci-4-2-1796947.txt,larg||dna damag||cancer||function effect||method||individu||studi||nucleotid excis repair pathway||allel||effect||risk||drc||human||abil||dna repair||multipl gene||dna repair gene||dna||genotyp||epidemiolog studi||dna repair capac||damag||gene||meta-analysi||heterogen||polymorph||popul||associ||ner pathway||genet polymorph||nucleotid excis repair||lung cancer risk||lung cancer||pathway||statist signific||function,xpd||xpd ercc2||xpd polymorph||ercc2||ercc2 polymorph||polymorph||xpa polymorph||xpa||dna repair polymorph||xpd gene polymorph||dna repair gene xpd polymorph||xpd lys751gln polymorph||xpd ercc2 49||dna repair||dna repair gene xpd,0.363||0.336||0.321||0.308||0.293||0.278||0.271||0.264||0.237||0.235||0.227||0.226||0.225||0.216||0.214,0.0,0.1,0.13333333333333333
771,Fam_Cancer-3-1-1914241.txt,cancer||method||multipl tumour||fifti year||carcinoma||data||patient||young age||lynch syndrom||criteria||inform||bethesda-guidelin||colorect cancer||famili histori||guidelin||tumour||hospit||clinic genet centr||age||microsatellit instabl||crc||msi-analysi||famili||group||medic specialist||physician||diagnosi||hnpcc,msi-analysi||colorect||colorect cancer||hereditari colorect cancer||hnpcc||hereditari nonpolyposi colorect cancer||hereditari nonpolyposi||hereditari colorect cancer syndrom||cancer||colorect carcinoma||hereditari nonpolyposi colorect cancer syndrom||hereditari tumour||invas colorect tumour||suspect hereditari nonpolyposi||hnpcc predisposition.,0.388||0.38||0.306||0.298||0.286||0.271||0.237||0.234||0.233||0.227||0.226||0.217||0.181||0.166||0.159,0.6,0.4,0.26666666666666666
772,Eur_J_Appl_Physiol-4-1-2358938.txt,muscl||time||exercis countermeasur||individu||rate||torqu develop||studi||resist exercis||inact control group||bed rest||frequenc||effect||increas||forc||abil||intrins contractil properti||knee extensor||maxim||vibrat train||day||mvc||stimul||foa||torqu||resist vibrat exercis||characterist||subject||exercis||contract||group||rve||isometr knee extens||isometr contract||train session||rest,torqu||bed||muscl||bed rest||rest||countermeasur||assess muscl torqu||voluntari steady-st torqu||skelet muscl||exercis countermeasur||voluntari torqu develop||bed rest eur||voluntari contract||peak torqu||vibrat muscl exercis,0.276||0.258||0.243||0.23||0.201||0.194||0.174||0.167||0.166||0.163||0.163||0.163||0.161||0.16||0.159,0.8,0.5,0.3333333333333333
773,J_Biomol_NMR-3-1-1892527.txt,tensor||case||order paramet||system||dipolar coupl||constraint||bond||sampl||data||deriv||valu||princip axi||cholesterol||molecular re-orient||nmr interact||orient||inform||similar result||exampl||site||high degre||experiment error||dynam behaviour||pseudo-forc||quadrupolar interact||averag||molecular properti||nmr investig||nmr interact tensor||analysi||simul||molecular dynam||molecular align||solid state nmr||pgla||segment orient||pyren||membran||order||MD approach||peptid||heat||nmr data||molecul||molecular dynam simul||axi||time averag||compon,vec||nu||nmr||nu }_||}_||rm||deuterium nmr||nmr constraint||tensor||document||simul tensor||_{||orient||nmr interact tensor||simul,0.142||0.103||0.096||0.088||0.073||0.071||0.068||0.064||0.062||0.058||0.058||0.056||0.055||0.054||0.054,0.0,0.1,0.26666666666666666
774,J_Abnorm_Child_Psychol-3-1-1915644.txt,longitudin model||lower level||high level||questionnair||children||behavior||infant||parent-child attach||problem||qualiti||model||studi||year||caregiv||mediat||complet longitudin model||life||strang situat||extern behavior||stress life event||develop||low se||risk||test||se||domain||variabl||signific||cognit abil||present studi||earlier find||tempera||primari caregiv||research||contextu characterist||toddlerhood||assess||high-risk sampl||characterist||parent||path analysi||predictor||effect guidanc||teacher||factor||famili||predict||influenc||interact||earli predictor||ego-resili||score||parent-child interact||attach||result,parent-child attach||child||parent-child interact||child psycholog||child tempera||extern behavior||attach||parent-child attach 1975||child behavior problem||behavior||psycholog||neg parent-child interact||earli parent-child interact||ego-resili||attach disorgan,0.257||0.239||0.211||0.197||0.184||0.183||0.18||0.176||0.17||0.162||0.156||0.153||0.153||0.151||0.146,0.4,0.5,0.4
775,BMC_Bioinformatics-4-_-521197.txt,model paramet||linear regress||cumul normal distribut||set||method||real gene||random sequenc||hidden markov model||emiss probabl||model||state||glimmer||hmm||fals posit||organ||test||start||signific||similar||gene||stop||train||protein||orf||rb||put gene||distribut||raw genom||challeng||order||score||number||perform||markov model||tabl||codon||length||probabl||statist signific||order markov chain||background state||sequenc,codon||easygen||orf||start codon||gene finder||gene||orf score||stop codon||orf length||rb||codon model||random orf||genemark||hmm||easygen glim,0.332||0.318||0.315||0.214||0.209||0.206||0.203||0.201||0.2||0.199||0.194||0.191||0.179||0.174||0.173,0.4,0.4,0.3333333333333333
776,Calcif_Tissue_Int-3-1-2039811.txt,placebo||follow-up||method||raloxifen||baselin||studi||year||postmenopaus osteoporosi||total trabecular bone area||osteocyt||effect||correl||section||immunohistochemistri||test||follow-up biopsi||osteocyt apoptosi||cell||bone remodel||empti lacuna||percentag||women||apoptosi||apoptot osteocyt||placebo group||chang||group||biopsi||differ||number||raloxifen treatment||signific differ||posit osteocyt||averag standard deviat,osteocyt||osteocyt apoptosi||raloxifen||apoptot osteocyt||viabl osteocyt||osteocyt densiti||dead osteocyt||osteocyt death||osteocyt number||osteocyt surviv||posit osteocyt||total osteocyt||osteocyt turn||osteocyt integr||bone,0.64||0.392||0.382||0.357||0.331||0.328||0.328||0.325||0.325||0.325||0.324||0.324||0.323||0.322||0.275,0.8,0.4,0.3333333333333333
777,FEBS_Lett-1-5-1964784.txt,thymu||thymocyt||transcript factor||develop||egr||express||notch||cell||rhoa||transcript||mice||protein||enzym||pre-tcr||ap-1||wild type||cell develop||affymetrix gene||divers biolog function||loss||function,thymocyt||dn3 thymocyt||dn3||C3 dn3 thymocyt||rhoa||C3 dn3||dn3 cell||thymocyt develop||pre-tcr||thymocyt differenti||3 dn3||C3 dn3 cell||gtpase rhoa||thymocyt factor satb1||high dn3 cell,0.385||0.377||0.369||0.281||0.249||0.229||0.225||0.203||0.203||0.197||0.184||0.18||0.157||0.156||0.152,0.4,0.3,0.2
778,Oecologia-3-1-1915600.txt,pot||top-down control||studi||soil microorgan||microarthropod||effect||inocul||steril||soil biota||hodgkin||microorgan||growth||control||multipl||multitroph interact||plant perform||cook||factor||natur ecosystem||plant commun composit||influenc||biomass||rooij van der||root||nematod||microbi enemi||soil||result,T. ventrali||T. ventrali T. ventrali T.||nematod||T. ventrali T. ventrali A.||T. ventrali T.||T. ventrali A. arenaria T. ventrali||experi T. ventrali||2 T. ventrali||1 T. ventrali||tylenchorhynchu ventrali telotylenchu ventrali 1993 T.||T. ventrali tabl 1 tylenchorhynchu ventrali||2 tylenchorhynchu ventrali||ammophila arenaria T. ventrali 1995||soil T. ventrali 1998 T.||pasteuria paenibacillu T. ventrali,0.443||0.387||0.386||0.359||0.349||0.346||0.298||0.296||0.296||0.289||0.286||0.277||0.267||0.243||0.236,0.2,0.1,0.06666666666666667
779,J_Interv_Card_Electrophysiol-4-1-2292475.txt,time||line||block||conduct||radiofrequ||pain score||isthmu length||studi||recurr||patient||atrial fibril||ecg||ablat||cathet ablat||atrial flutter||flutter||signific||cryo group||lower requir||bidirect block||recurr rate||cryothermi||applic||cathet curv||success||pain||similar rate||bidirect isthmu block||group||recurr flutter||arrhythmia||isthmu||cryotherapi||procedur||isthmu line||fibril||acut success||isthmu conduct,flutter||atrial flutter||atrial flutter ablat||ablat||atrial isthmu||J. atrial flutter||previou flutter ablat||isthmus-depend atrial flutter||atrial flutter journal||radiofrequ ablat||cathet ablat||isthmu||typic atrial flutter||NS flutter||lone atrial flutter,0.53||0.445||0.429||0.399||0.332||0.315||0.311||0.307||0.307||0.306||0.305||0.304||0.303||0.301||0.299,0.6,0.3,0.3333333333333333
780,Eur_Arch_Otorhinolaryngol-4-1-2217621.txt,adult form||year||cidofovir||rrp||form||vaccin||papilloma||lesion||treatment||hpv||infect||laryng papilloma||infect host cell||suffici clinic follow-up data||recurr respiratori papillomatosi||prophylact hpv vaccin||low incid||larg multi-centr collabor clinic trial||adequ airway||risk factor||diseas||juvenil onset form,papillomatosi||recurr respiratori papillomatosi||papilloma||glottal papillomatosi||pulmonari papillomatosi||human papillomaviru||juvenil recurr respiratori papillomatosi||juvenile-onset recurr respiratori papillomatosi||laryng papilloma||recurr respiratori papillomatosi lesion||recurr respiratori papillomatosi int||human papillomaviru E6||hpv||rrp||recurr respiratori papilloma,0.462||0.247||0.245||0.243||0.235||0.228||0.21||0.206||0.19||0.189||0.187||0.184||0.182||0.176||0.174,0.4,0.3,0.3333333333333333
781,Clin_Oral_Investig-4-1-2238784.txt,measur||dental eros||method||system||indic||data||age group||amount||eros||wear||criteria||epidemiolog||teeth||tooth wear||dentin||epidemiolog studi||occlus||partial record system||hard tissu loss||literatur||surfac||aetiolog||sever||loss||score,tooth||tooth wear||wear||dentin||eros||multifactori tooth wear||enamel eros||dental eros||dent||dentin 1 dentin||multifactori tooth||keyword tooth||dentin exposur||tooth surfac occlus||wear terminolog,0.434||0.419||0.404||0.378||0.337||0.288||0.268||0.263||0.255||0.252||0.229||0.217||0.216||0.212||0.212,0.8,0.5,0.3333333333333333
782,J_Biol_Inorg_Chem-4-1-2359827.txt,reson||zero-field paramet||iii||electron supplementari materi||line||quadrupol split||citrat||site||fe-protein||superreduc||pattern||cluster||state||epr||activ,buckel||münck||0||0 0||superreduc||W. buckel||0 δ||0 0 cluster||pierik AJ buckel||δ||β||spectra 0||0 cluster||0 0 31||0 51 0,0.328||0.193||0.188||0.188||0.172||0.167||0.163||0.152||0.144||0.138||0.137||0.134||0.134||0.13||0.126,0.2,0.1,0.06666666666666667
783,Ann_Biomed_Eng-2-2-1705490.txt,clinic situat||respons||hypertens||model||anim studi||averag error||increas||heart failur||adapt control||hemodynam||anim experi||dbt||drug interact||acut heart failur||acut||cardiac output||acut disturb||physiolog variat||part||snp-map loop||snp||snp infus||drug||input||setpoint||hemodynam variabl||actual hemodynam,NN||NN mod NN||mod NN||NN mod mod NN||NN mod||NN mod mod||NN mod mod mod mod||mod||1 NN NN NN||NN 4 mod NN||2 NN NN||mod mod NN 6||2 mod mod mod mod||1 mod mod mod mod||llc 2006 NN NN NN,0.477||0.44||0.422||0.422||0.422||0.404||0.389||0.367||0.358||0.33||0.318||0.303||0.294||0.294||0.287,0.0,0.0,0.0
784,Ann_Biomed_Eng-2-2-1705524.txt,capillari||consumpt||hepatocyt layer||case||simul result||model||strategi||mat||intern oxygen||hepatocyt distribut||inform||increas||doubl number||mmhg||intern geometri||cell||oxygen||flow field||shear stress||percentag||zone||flow rate||micro model||extern oxygen||flow veloc||cell distribut||shear stress distribut||hepatocyt||maxim shear stress||fraction||fluid flow||outflow zone||ga capillari||effect hepatocyt util ratio||amc-bal||clinic set||medium||result,hepatocyt||mat||amc-bal||oxygen||hepatocyt distribut||inlin||hepatocyt layer||hepatocyt cultur||oxygen ga||oxygen capillari||hepatocyt spheroid||amc-bal micro model||rat hepatocyt||activ hepatocyt||hepatocyt util ratio,0.334||0.246||0.239||0.216||0.194||0.194||0.192||0.191||0.182||0.178||0.175||0.173||0.168||0.168||0.162,1.0,0.6,0.4
785,J_Gastrointest_Surg-3-1-1852394.txt,greater omentum||tumor||hemangiopericytoma||case||resect||patient||english literatur||literatur,hemangiopericytoma||omentum||greater omentum||malign hemangiopericytoma||omentum present||keyword hemangiopericytoma greater||greater omentum eur||s11605-007-0099-x articl hemangiopericytoma||schein CJ hemangiopericytoma||greater omentum shiba hiroaki||tumor||resect tumor||haemangiopericytoma||peduncul tumor||solitari tumor,0.643||0.561||0.354||0.347||0.282||0.263||0.239||0.23||0.228||0.194||0.131||0.097||0.086||0.083||0.078,0.4,0.2,0.2
786,Behav_Genet-3-1-1824713.txt,model test||time||marijuana||problem||abnorm||model||year||normal rang||risk||frequenc||inform||present||environment influenc||analys||present studi||twin||age||liabil||parent||longitudin studi||conduct problem||genet||factor||presenc||influenc||substanc||england twin||risk factor||adolesc||initi||progress||environment risk factor||result,marijuana||adolesc marijuana||twin||self-report marijuana||experiment marijuana||marijuana involv||increas marijuana||2 marijuana||adolesc||barn GE adolesc marijuana||twin psychiatri||keyword conduct problem marijuana||adolesc alcohol||adolesc twin sampl||adolesc substanc,0.565||0.409||0.295||0.29||0.285||0.283||0.283||0.283||0.254||0.212||0.207||0.199||0.193||0.192||0.182,0.4,0.3,0.2
787,J_Mol_Evol-3-1-1894752.txt,mechan||translat system||nuclear genom||case||origin trna-il||reassign||modif||cau||stramenopil||mutat||argument||aaa||present||base||cun||abil||amino acid||fungi||ambigu translat||mitochondri genom||uag||trna||code||ucu||gene||aua||delet||met||absent||stop||estim||wobbl posit||gau||pair||codon reassign||ambigu||simul||chang||releas factor||asn||trna gene||small number||uga||fact||posit||disappear||codon||ambigu intermedi mechan||speci||mitochondri genet code||base frequenc||length||origin posit||show,reassign||codon reassign||reassign codon||codon||aua codon reassign||codon disappear reassign||stop codon reassign||mitochondri codon reassign||codon reassign knight||sens codon reassign||codon reassign event||sense-to-sens codon reassign||UC reassign||trna||uag reassign,0.527||0.497||0.497||0.467||0.37||0.36||0.359||0.355||0.34||0.339||0.338||0.334||0.311||0.311||0.309,0.6,0.3,0.26666666666666666
788,DNA_Repair_(Amst)-1-5-2077361.txt,telomer||yeast||role||non-permiss temperatur||strain||defect||checkpoint activ||mrc1||telomer dna||dna repair||protein||experi||depend||nucleas||checkpoint pathway||temperatur||accumul||ssdna||activ||dna replic,cdc13-1 cdc13-1 mrc1δ||cdc13-1 mrc1δ||cdc13-1 cdc13-1 rad9δ||cdc13-1 cdc13-1 mrc1δ yku70δ mrc1δ||rad9δ cdc13-1 cdc13-1 mrc1δ||cdc13-1 yku70δ||cdc13-1 mrc1δ yku70δ||mrc1δ||mrc1δ mrc1δ||cdc13-1 mrc1δ exo1||cdc13-1 rad9δ||cdc13-1 mutant||uncap cdc13-1 cdc13-1 cdc13-1 fig. 5||cdc13-1 mrc1δ yku70δ mrc1δ mrc1δ rad9δ||cdc13-1 mre11δ,0.625||0.574||0.502||0.493||0.482||0.446||0.438||0.422||0.422||0.407||0.39||0.376||0.374||0.369||0.366,0.0,0.0,0.0
789,Cell_Tissue_Res-4-1-2295254.txt,ecm||fibronectin||studi||ami phase 2||section||border-zon||adipos tissu||increas||infarct||cell||adhes||asc||prolifer||posit effect||stem cell therapi||ami||myocardi infarct||incub||posit||number||infarct area||area||stem cell||heart||cardiomyocyt||attach,fibronectin||fibronectin deposit||fibronectin stain||fibronectin accumul||human fibronectin||fibronectin express||fibronectin isoform||fibronectin penetr||fibronectin intens||fibronectin occur||fibronectin concentr||fibronectin serv||infarct||fibronectin 1||asc,0.617||0.36||0.327||0.325||0.319||0.318||0.316||0.313||0.313||0.313||0.312||0.311||0.309||0.309||0.291,0.2,0.1,0.2
790,J_Behav_Med-4-1-2413087.txt,alcohol consumpt||level||find||higher level||time||wave||regard||mother||problem||parent problem drink||effect||genet suscept||environment factor||test||present studi||control||van der vorst||item||alcohol||father||parent||parent alcohol||longitudin studi||problem drink||famili||factor||drink||behavior control||adolesc||support||addit||children||result,alcohol||alcohol parent||parent alcohol||parent||adolesc alcohol||parent YA T2||parent OA T2||T2||parent YA T3||YA T2||U. parent alcohol||alcohol OA T3||parent OA T3||OA T2||adolesc,0.376||0.373||0.373||0.369||0.302||0.296||0.276||0.275||0.262||0.259||0.25||0.245||0.242||0.229||0.228,0.6,0.3,0.26666666666666666
791,Dev_Genes_Evol-4-1-2292478.txt,insect||genom sequenc||embryo||head||develop||observ||region||paralog||tiptop||teashirt||express||gene||conserv||trunk||leg||protein||ident||rnai||hox gene||member||famili member||dsrna||milkwe bug||pcr||segment||ectop express||addit||larval rnai||function||tsh||result,tc-tiotsh||tc-tiotsh tc-tiotsh tc-tiotsh||tc-tiotsh tc-tiotsh||tsh||tc-tiotsh tc-tiotsh tc-tiotsh tc-tiotsh prothoraxless||tc-tiotsh tsh tio tsh||tc-tiotsh tsh tio||tc-tiotsh 2000 tc-tiotsh||tribolium tc-tiotsh tribolium tc-tiotsh tsh drosophila||tsh tsh tsh trichoplax||tsh drosophila||drosophila tsh 2005 tsh tsh||tc-tiotsh tio tio tc-tiotsh drosophila||tc-tiotsh drosophila tio||tc-tiotsh express,0.657||0.657||0.657||0.559||0.527||0.489||0.466||0.438||0.432||0.421||0.378||0.376||0.375||0.345||0.338,0.2,0.1,0.06666666666666667
792,Mol_Syst_Biol-3-_-1800356.txt,set||method||enrich||modul||data||bind site||motif||top||inform||human||test||promot sequenc||background||signific conserv||promot||site||sourc||proxim promot||express||tcat||catalog||cis-regulatori modul||random||tissu||transcript||analysi||liver||balanced-error rate||order||mous||tissue-specif regul||vote||genbank||result,motif||tissue-specif motif||tissue-specif||testi motif||tissue-specif transcript||high-confid tissue-specif motif||well-known tissue-specif motif||regulatori motif||tissue-specif modul||t-rich motif||rfx motif||NM||binding-sit motif||g-rich motif||nuclear-receptor motif,0.36||0.349||0.337||0.251||0.251||0.244||0.236||0.229||0.225||0.216||0.21||0.2||0.2||0.2||0.19,0.2,0.1,0.06666666666666667
793,Behav_Genet-4-1-2226022.txt,uniqu environment factor||sex differ||phobia||twin correl||individu||sampl||data||model||studi||herit||effect||femal||blood-injuri||sex||spous||women||estim||varianc||twin||herit estim||age||genet||ade model||famili member||famili||factor||differ||domin||sibl||influenc||fear||assort mate||broad-sens herit estim||particip||non-addit genet effect||oldest age group||result,fear||twin||blood-injuri fear||agoraphob fear||phobic fear||social fear||australian twin twin||blood-injuri||fear score||fear subtyp||sibl twin||twin sibl||irrat fear||self-report fear||DZ twin,0.527||0.448||0.403||0.378||0.345||0.305||0.302||0.279||0.277||0.277||0.275||0.275||0.274||0.273||0.272,0.4,0.3,0.2
794,Breast_Cancer_Res_Treat-3-1-2001218.txt,time||letrozol||signific benefit||hormone-sensit breast cancer||breast cancer||patient||tamoxifen||year||recurr||clinic||risk||prior cancer event||event||df||treatment||upfront therapi||distant site||system df||adjuv therapi||big 1-98||women||primari||analysi||monotherapi||trial||addit||primari core analysi||result,tamoxifen||tamoxifen versu tamoxifen||adjuv tamoxifen||letrozol||breast cancer||letrozol versu tamoxifen||tamoxifen therapi||tamoxifen group||tamoxifen treatment||1-98||concurr tamoxifen||ospedal||cancer||postmenopaus breast cancer patient breast cancer||hospit,0.393||0.27||0.259||0.242||0.23||0.22||0.218||0.21||0.203||0.202||0.2||0.19||0.184||0.181||0.177,0.6,0.3,0.2
795,J_Insect_Sci-1-_-355886.txt,lepidopteran||condit||immunodiffus||cecropia||concentr||v-mth||m-mth||sampl||fat bodi||extract||reserv||femal||present||egg||femal pupa||pupa||metamorphosi||yolk format||hemolymph||day||arh||short day condit||protein||whole-bodi extract||long day condit||hexamerin||monarch||mth||support||adult develop||post-eclos egg format,cecropia||telfer||cecropia v-mth||insect||cecropia femal||1980 telfer||1983 telfer||1988 telfer||1990 telfer||hyalophora cecropia tojo||experiment insect hyalophora cecropia||1978 hyalophora cecropia||hexamerin||monarch||1991 hyalophora cecropia,0.455||0.45||0.286||0.272||0.25||0.238||0.237||0.237||0.236||0.233||0.219||0.216||0.205||0.205||0.204,0.2,0.1,0.2
796,Domest_Anim_Endocrinol-2-1-2428105.txt,mechan||de||caruncular stroma||involut||caruncular tissu||studi||uterin involut||uteru||uterin horn||uterin igf system||myometrium||deep endometri stroma||se||region||dairi cow||express||similar||postpartum uteru||tissu||igf-ii||sub-epitheli stroma||horn||igf-i mrna||postpartum||mrna||bovin||igf,insulin-lik growth||igf||uterin involut||insulin-lik growth factor-i||uteru||insulin-lik growth factor||endometri igf||cow||insulin-lik growth factor-l||postpartum uteru||uterin horn||postpartum cow||uterin igf system||postpartum||caruncular stroma,0.235||0.218||0.182||0.18||0.171||0.167||0.165||0.163||0.162||0.16||0.158||0.156||0.155||0.15||0.149,0.6,0.4,0.5333333333333333
797,Breast_Cancer_Res_Treat-4-1-2217620.txt,grade||follow-up||role||cancer||socioeconom statu||time||statist probabl valu||breast cancer||adjuv treatment||studi||year||excess mortal||brca||patient||risk||mortal||node||breast cancer patient||obes||larger tumour||classif||treatment||tumour||women||clinic behaviour||nodal statu||lymph node||age||prognosi||prognost factor||factor||surviv||tumour size||probabl||diagnosi||BC diagnosi||BC patient,breast||breast cancer||breast cancer breast cancer||breast cancer surviv||cancer||primari breast cancer breast cancer||age breast cancer||breast cancer diagnosi||surviv||breast cancer recurr||breast cancer patient||patient breast cancer||breast cancer mortal||node-neg breast cancer||breast cancer death,0.501||0.42||0.42||0.381||0.34||0.339||0.306||0.304||0.304||0.303||0.301||0.301||0.298||0.298||0.293,0.4,0.3,0.26666666666666666
798,Health_Care_Anal-4-1-2226192.txt,level||bioethic principl||principl||bioethic||commun||univers principl||intern||social||univers||african countri||social respons||context||guidelin||ethic committe||countri||health||interview||relev||research||paper||polici||south africa||declar||research project||nation level||kenya||ethic||biomed research ethic||nation law||unesco,bioethic||unesco||unesco bioethic declar||bioethic declar||unesco declar||bioethic principl||kenya||bioethic polici||unesco endeavour||bioethic regul||unesco guidanc||bioethic tradit||unesco ’s||bioethic educ||17. unesco,0.521||0.514||0.421||0.375||0.372||0.315||0.285||0.279||0.273||0.267||0.266||0.264||0.264||0.263||0.258,0.4,0.4,0.26666666666666666
799,Appl_Microbiol_Biotechnol-4-1-2270352.txt,lime-tr wheat straw||lactic acid||amount||lime||process||ssf||total||ltw||hydrolysi||wheat straw||monomer sugar||product||glucan||enzym||ferment||phase||supernat||polysaccharid||pretreat||lactic acid product||fed-batch phase||pH control||hydrochlor acid||biomass||addit||mol||medium||calcium hydroxid||organ acid||result,lactic||coagulan||lactic acid||ferment||lactic acid puriti||lactic acid product||lactic acid concentr||lactic acid deriv||B. coagulan||ferment product||decreas lactic acid product||acid||microbi ferment||ferment process||ferment broth,0.455||0.31||0.308||0.296||0.222||0.22||0.209||0.208||0.186||0.17||0.167||0.161||0.158||0.157||0.156,0.4,0.3,0.2
800,Int_J_Legal_Med-4-1-2226061.txt,stabl mrna marker||time||method||genom express analysi||rna marker||sampl||stain||vagin secret||test||forens||saliva||express||rna degrad||tissue-specif mrna marker||gene||blood||tissu||analysi||experi||cotton swab||candid||identif||saliva stain||signal intens||mrna||gene express||candid marker,forens||saliva||saliva identif||forens casework||saliva stain||forens medicin||swab||forens scienc||human saliva||saliva dataset||saliva detect||rna||rna marker||saliva stain sampl||forens molecular biolog,0.437||0.379||0.233||0.231||0.228||0.225||0.224||0.219||0.203||0.2||0.196||0.194||0.167||0.164||0.159,0.6,0.3,0.26666666666666666
801,Apoptosis-4-1-2217618.txt,therapeut protein||rgdpeg-avidin||integrin||huvec||subunit||tumor tissu||complex||angiogen endothelium||cell||tumor vasculatur||jurkat cell||approach||product||apoptosi||proapoptot effect||protein||antitumor activ||rgdpeg group||experi||promega||tumor cell||activ||primari amino group||bind||incub||trail||ligand||result,trail||biotinyl trail||rgdpeg-avidin||trail complex||trail bind||trail activ||trail variant||unmodifi trail||rgd-target trail||trimer trail||trail molecul||trail deriv||trail ’s||trail eur||clinic trail,0.597||0.401||0.371||0.324||0.323||0.321||0.311||0.31||0.308||0.305||0.303||0.302||0.301||0.3||0.299,0.4,0.2,0.13333333333333333
802,Bioinformation-2-2-2174421.txt,year 2005||entri||categori||molecular biolog||javascript||access||global search||molecular biolog databas||number||categori list||user||databas||keyword||data||link||list||page,dod2007||dod2007 dod2007||databas||util dod2007||conclus dod2007||databas link||databas entri||1082 databas||inaccess databas||genom databas||209 databas||patent databas||databas segreg||databas scan||databas home page,0.637||0.637||0.503||0.328||0.32||0.291||0.284||0.282||0.28||0.272||0.263||0.262||0.262||0.256||0.232,0.2,0.1,0.06666666666666667
803,Breast_Cancer_Res_Treat-4-1-2190785.txt,cancer||time||se indic||breast cancer||studi||patient||year||se||socio-econom strata||proport||high particip rate||women||eindhoven cancer registri||social class||socio-econom statu||distribut||group||surviv||vital statu||differ||adequ treatment||multivari rate||screen||diseas||screen programm||period||stage||introduct,breast||se||breast cancer||op||cancer||breast cancer surviv||breast cancer screen||cancer surviv||breast cancer diagnosi||breast cancer mortal||netherland breast cancer||invas breast cancer||breast cancer patient||breast cancer treatment||socio-econom strata,0.274||0.266||0.26||0.255||0.247||0.227||0.22||0.204||0.194||0.192||0.187||0.183||0.183||0.18||0.169,0.6,0.3,0.26666666666666666
804,Clin_Rheumatol-4-1-2367392.txt,amyloidosi||tracheobronchomalacia||kidney||patient,amyloidosi||tracheobronchomalacia||AA amyloidosi||keyword amyloidosi kidney rheumatoid arthriti tracheobronchomalacia||amyloidosi chin med||amyloid||system AA amyloidosi||rheumatolog||amsterdam||amyloid deposit||s10067-008-0836-x case report tracheobronchomalacia||perivascular amyloid deposit||trachea||rheumatoid arthriti turkstra franktien||kidney,0.501||0.419||0.271||0.21||0.185||0.184||0.182||0.165||0.151||0.14||0.135||0.131||0.113||0.101||0.1,0.4,0.2,0.2
805,Clin_Auton_Res-3-1-1797060.txt,hrr||coronari arteri calcium||relationship||presenc||atherosclerosi||slow hrr||cac||young adult||particip||exercis||middl age||heart rate recoveri||year||cac score||heart rate||gxt,hrr||hrr tertil||slow hrr||2-minut hrr||hrr tertil 1||prior hrr studi||conclus slower hrr||exercis||sidney||cac||cardia||tertil||treadmil exercis||kizilbash||men 392 391 402 NA hrr,0.627||0.387||0.358||0.356||0.258||0.215||0.215||0.179||0.171||0.161||0.156||0.147||0.134||0.126||0.126,0.4,0.4,0.26666666666666666
806,Purinergic_Signal-1-3-2096543.txt,atp||respons||corneal epithelium||imag||migrat||wound repair||cell,egf||wound||receptor||nucleotid receptor||migrat||p2i receptor||nucleotid||cell migrat||trinkaus-randal||egf receptor transactiv||purinerg receptor||p2i||g-protein-coupl receptor||tri-nucleotid receptor||wound heal,0.225||0.211||0.209||0.192||0.187||0.176||0.175||0.158||0.158||0.157||0.152||0.144||0.142||0.134||0.131,0.2,0.1,0.06666666666666667
807,J_Autism_Dev_Disord-4-1-2175022.txt,diagnost protocol||social domain||aq-d||studi||patient||mild asd||asd||diagnos||domain||comorbid||atn||adult||II disord||present studi||high function autism||item||gener outpati clinic||dutch||group||differ||autism spectrum disord||symptom||pddno||clinic experi||score||autism spectrum quotient||result,asd||autism||asd patient||adult asd||asd group||asd symptom||mild asd||asd expertise-centr||asd diagnosi||sever asd||asd statu||autism spectrum disord||non-asd patient||high-funct autism||autism journal,0.505||0.42||0.289||0.278||0.27||0.268||0.267||0.264||0.261||0.256||0.254||0.234||0.233||0.231||0.223,0.2,0.2,0.2
808,J_Mol_Biol-2-1-2267215.txt,fn3||previou peptid studi||Ig||neural cell adhes molecul||bind site||spr||fibroblast growth factor receptor||tris-buff salin||fgfr||structur||tb||domain||fibronectin type 3||cell||conform||protein||ncam||acid box||dissoci constant||immunoglobulin||cell surfac||interact||cam||peptid||weak interact||mammalian cell||pb,ncam||ncam fn3||fn3||ncam fn3 domain||ncam fn3 tandem||ncam tandem||ncam protein||ncam ig1||ncam region||ncam cdna||recombin ncam||ncam fn3 domain tandem||nativ ncam||fgfr1||fn3 domain,0.581||0.501||0.422||0.369||0.36||0.328||0.315||0.299||0.298||0.297||0.296||0.296||0.293||0.268||0.263,0.4,0.2,0.13333333333333333
809,Diabetologia-4-1-2292425.txt,type 2 diabet||variat||insulin secret||gene||snp||childhood||genet variat||region||type 1 diabet||age||birth||variant||associ||popul||genotyp||studi||materi||growth||children,igf1 igf1||igf1 igf1 igf1 igf1||result igf1 igf1 igf1||hypothesi igf1 igf1||igf1 8 igf1||method igf1 igf1||igf1 variant||0.425 igf1||interpret igf1||9 igf1 10 igf1||igf-1 concentr igf1||sex discuss igf1 9 igf1||2 igf1 igf1 6 7||1 diabet igf1||1 igf1 tag-snp,0.827||0.827||0.62||0.553||0.552||0.552||0.442||0.423||0.416||0.414||0.352||0.332||0.331||0.324||0.315,0.0,0.0,0.0
810,Intensive_Care_Med-4-1-2271079.txt,bdi-ii||posttraumat stress disord||follow-up||younger age||ies-r||stay||final model||questionnair||instrument||abdomin sepsi||secondari periton||model||studi||depress||patient||sepsi||multivari model||major comorbid||develop||risk||memori||intens care||event||ptss-10||traumat event||initi emerg laparotomi||previou 3 year||hospit||age||hospit ward||median apache-ii score||factor||predict||nomogram||symptom||ptsd||diseas||icu||periton,ptsd||ptsd symptom||ptsd symptomatolog||ptsd categori||ptsd posttraumat stress disord||moderate’ ptsd symptom||posttraumat stress||prevent ptsd symptom||ptsd symptom 1||high-risk ptsd patient||self-administ ptsd questionnair||posttraumat stress disord||posttraumat stress symptom||stress||icu,0.532||0.326||0.285||0.279||0.273||0.223||0.22||0.219||0.217||0.204||0.192||0.187||0.186||0.179||0.174,0.2,0.1,0.2
811,Sleep_Breath-4-1-2211364.txt,srbd||oral applianc||sleep-rel breath disord||posit||dgz||posit paper||snore||mandibular advanc devic||obstruct sleep apnea||effect treatment option||treatment||dental sleep medicin||upper airway resist syndrom,sleep||sleep breath sleep||sleep apnea||sleep medicin||obstruct sleep apnea||sleep physician||sleep research||dental sleep medicin||obstruct sleep apnoea||oral applianc||sleep disord dentist||dgz||sleep medicin report||intern sleep societi||dd,0.483||0.352||0.322||0.267||0.25||0.247||0.244||0.227||0.224||0.209||0.206||0.193||0.179||0.177||0.163,0.2,0.3,0.26666666666666666
812,Neurochem_Int-2-1-2194163.txt,effect||control||synapt transmiss||applic||amplitud||capsazepin||drug||glutam releas||data||glutam||studi||wild type||spontan epsc||capsaicin||epsc,al.||vanilloid||capsaicin||caterina||vanilloid receptor||capsaicin receptor||hájo||vanilloid receptor trpv1||kofalvi||vanilloid receptor-1||marinelli||capsaicin research||trpv1||knockout||function trpv1 vanilloid receptor,0.472||0.306||0.291||0.197||0.195||0.187||0.187||0.176||0.167||0.163||0.16||0.147||0.14||0.138||0.133,0.2,0.1,0.06666666666666667
813,Purinergic_Signal-3-4-2072924.txt,singl channel||model||kinet,channel||p2x||p2x receptor||cation channel||surpren||ion channel||p2x atp receptor||atp-activ channel||singl channel||4 receptor channel||atp-gat cation channel||p2x receptor kinet||atp||purinoceptor-oper cation channel||ligand-g ion channel,0.353||0.274||0.258||0.257||0.247||0.244||0.233||0.23||0.201||0.199||0.196||0.192||0.183||0.182||0.18,0.0,0.1,0.06666666666666667
814,Eur_Arch_Otorhinolaryngol-3-1-1914238.txt,cancer||troubl||qlq-h||qualiti||studi||patient||tongu||neck cancer||speech||teeth||comorbid||classif||tumor site||function deficit||impact||present studi||treatment||tongu mobil||pain||wors score||function statu||ill||major impact||singl item||oral caviti||oral tumor||score||hrqol||function||gener popul||result,comorbid||comorbid comorbid||hrqol||speech||neck||neck cancer||pretreat hrqol||head||neck qualiti||n35||tongu||qlq-c30||qlq-h||speech intellig||hrqol deficit,0.307||0.307||0.304||0.283||0.264||0.2||0.19||0.188||0.184||0.184||0.183||0.182||0.181||0.175||0.168,0.6,0.4,0.4
815,Eur_J_Pediatr-3-1-1802727.txt,placebo||respons||infant||efficaci||baselin||good clinic practic||studi||data||patient||bodi temperatur||gener state||probiot||trial medic||ecn||treatment||day||health||stool||treatment group||placebo group||nissl 1917||group||present trial||differ||acut diarrhoea||bodi weight||diarrhoea||number||trial||toddler||acut gastroenter||children,ecn||treatment ecn||ecn treatment||ecn group||investig ecn placebo ecn placebo||ecn suspens||nissl 1917||coli nissl 1917||probiot||diarrhoea||nissl 1917 infant probiot toddler||probiot E. coli nissl 1917||coli||coli-stamm nissl 1917||keyword acut diarrhoea ecn escherichia,0.534||0.285||0.285||0.28||0.278||0.277||0.273||0.246||0.221||0.217||0.206||0.202||0.193||0.19||0.186,0.2,0.4,0.26666666666666666
816,Purinergic_Signal-3-4-2072925.txt,mechan||subtyp||role||neural stem cell||releas||patholog condit||central nervou system||atp||biolog function||develop||process||synapt transmiss||embryogenesi||cn||astrocyt||cell prolifer||express||calcium wave||differenti||cell||rat||physiolog||prolifer||approach||antisens oligonucleotid||glial cell||hippocampu||neuron||specif agonist||activ||rat hippocampu||earli stage||import||purinerg||knockout anim||purinerg receptor express||pathway||glutam||antagonist||purinerg receptor||result,purinerg||purinerg receptor||receptor||atp receptor||atp||purinerg signal purinerg||P2 receptor||p2y1 purinerg receptor||purinerg receptor subtyp||purinerg receptor express||purinerg receptor activ||purinerg signal||purinerg receptor function||purinerg receptor cell membran receptor||astrocyt,0.312||0.295||0.279||0.265||0.25||0.242||0.226||0.216||0.214||0.214||0.208||0.208||0.203||0.202||0.198,0.6,0.4,0.3333333333333333
817,Exp_Brain_Res-4-1-2257995.txt,measur||lowest intens||studi||motor cortex||effect||correl||mep||variabl||interhemispher inhibit||activ condit||motor hotspot||tm||inhibit||transcrani magnet stimul||sici||motor system||corticospin output||age||corticospin excit||subject||chang||fdi||activ||intens||older individu||function imag studi||ihi||pathway||hand,ihi||rest ihi||motor||chang ihi||stronger ihi||long-lat ihi||ihi measur||mep||amt||motor cortex||activ chang ihi||interhemispher inhibit||corticospin excit||activ ihi 0.54||ipsilater motor cortex,0.429||0.258||0.249||0.24||0.228||0.225||0.223||0.222||0.199||0.196||0.172||0.169||0.163||0.157||0.147,0.2,0.3,0.3333333333333333
818,Dig_Dis_Sci-3-1-1914226.txt,tumor||rectal examin||signific medic histori||rectal gist||constip||calculu||gastrointestin stromal tumor||gist||abdomin pain||rectal tumor,gist||rectal gist||gastrointestin stromal tumor||gastrointestin||calculu||rectal calculu||gastrointestin tumor||tumor calculu||rectal tumor||rectal gist present||calcifi gist||tumor||malign gastrointestin stromal tumor||gist present||submucos calculu,0.418||0.334||0.283||0.275||0.262||0.256||0.249||0.243||0.236||0.226||0.223||0.223||0.216||0.215||0.199,0.8,0.5,0.4
819,Crit_Care-9-1-1065098.txt,attent||oper manag||role||regard||protocol||icu director||icu physician||ethic challeng||nurs manag||ethic topic||decis||review||articl||nurs||profession||intens care||manag||paper||polici||clinician||literatur||director||intens care unit||search||ethic||issu||difficult decis||physician||resourc alloc||dilemma||ethic dilemma||critic care||icu||clinic issu,icu||icu ethic||ethic||icu care||icu director||ethic issu||icu physician||manag ethic||organiz ethic||ethic dilemma||icu environ||abbrevi icu||ethic topic||ethic challeng||ethic role,0.556||0.527||0.497||0.349||0.341||0.321||0.313||0.306||0.296||0.295||0.291||0.281||0.273||0.267||0.262,0.6,0.5,0.4666666666666667
820,Crit_Care-9-1-1065088.txt,administr||case||eh||core temperatur||rate||studi||patient||dantrolen||effect||convent cool||sever case||heat stroke||bodi temperatur||dose||temperatur||treatment||cool||group||hyperthermia||relev studi||exert heat stroke||heat||convent method||result,dantrolen||dantrolen sodium||intraven dantrolen||dantrolen pretreat||dantrolen dose||dantrolen treatment||dantrolen action||dantrolen group||dantrolen exert heat||dantrolen sodium eur||dantrolen 3 mg||dantrolen 23 25||dantrolen inhibit muscl contract||cool||chaffman MO sorkin EM dantrolen,0.895||0.468||0.465||0.461||0.459||0.457||0.451||0.451||0.365||0.313||0.31||0.299||0.238||0.19||0.184,0.2,0.1,0.13333333333333333
821,J_Mol_Evol-3-1-1915622.txt,method||immun system||hypervari domain||secondari structur||select pressur||model||slr method||select||structur||vaccin||amino acid||region||domain||site||phylogenet relationship||analys||stretch||nonsynonym substitut||potenti||local||protein||recombin||outer membran protein||immun studi||posit||codon||sequenc||immun respons||align,influenza||omp-p1||H. influenza||codon||H. influenza H. influenza bolduc||al||omp-p1 H.||H. influenza bolduc||omp-p1 H. influenza thompson||heamophilu influenza||haemophilu influenza type||H. influenza H. influenza meat||omp-p1 protein||omp-p1 sequenc||haemophilu,0.407||0.359||0.247||0.239||0.231||0.228||0.223||0.221||0.217||0.211||0.207||0.205||0.204||0.203||0.199,0.2,0.1,0.06666666666666667
822,Eur_J_Epidemiol-4-1-2270357.txt,signific level||set||method||case||scientif find||microarray||problem||data||model||studi||valu||variabl||confound||statist||signific||marit statu||smoke||independ data set||data split||research||analysi||pain||predictor||part||hypothesi fish||independ parti||two-stag analysi||number||epidemiolog hypothes||epidemiolog survey||case studi||hypothes||procedur||statist signific||population-bas survey,hypothes||split||hypothes fish||pain||mushroom||epidemiolog hypothes||multipl hypothes||pain site||hypothesi fish||hypothes effect||hypothesi||primari hypothes||data split||split regim||bonferroni,0.355||0.304||0.27||0.262||0.222||0.217||0.198||0.186||0.183||0.18||0.18||0.179||0.178||0.161||0.158,0.4,0.4,0.3333333333333333
823,Pediatr_Radiol-3-1-1950215.txt,cowperian duct||mullerian duct cyst||embryolog||urethr strictur||patient||intern sphincter||male urethra||present||vcug||congenit||bladder||diverticulum||male||urethra||urogenit diaphragm||anterior urethr diverticula||valv||anterior||dorsal aspect||urorect septum||anomali,urethra||urethr obstruct||urethr strictur||urethra posterior||posterior urethra||urethr duplic||male urethra||prostat urethra||bulbou urethra||posterior urethr valv||dilat urethra||congenit urethr strictur||ventral urethra||membran urethra||anterior urethr diverticula,0.502||0.312||0.306||0.304||0.304||0.304||0.289||0.273||0.269||0.266||0.264||0.264||0.262||0.255||0.237,0.4,0.3,0.26666666666666666
824,Cancer_Immunol_Immunother-4-1-2335290.txt,anim||cancer||case||immun system||respons||complic||carcinoma||studi||high altitud||patient||human patient||effect||massiv liber||section||sensit||system immun||metastas||necrot materi||human cancer patient||local edema||dose||therapeut effect||bladder||local treatment||immunotherapi||cell||therapi||treatment||boscc||day||applic||complet regress||sarcoid||local||mice||immun||month||conclus||nasopharyng carcinoma||interleukin-2||tumor||regress||order||cure||function||inject||sarcoma||immun reaction||median surviv time||result,il-2||intratumor il-2||local il-2||il-2 therapi||il-2 immunotherapi||intralesion il-2||intraves il-2||recombin il-2||il-2 instil||il-2 applic||il-2 treatment||inhal il-2||il-2 induc||free il-2||intraperiton il-2,0.836||0.478||0.458||0.446||0.443||0.442||0.436||0.435||0.434||0.434||0.432||0.431||0.429||0.427||0.424,0.0,0.0,0.0
825,Childs_Nerv_Syst-4-1-2367395.txt,small ventricl||case||tv||small supraorbit craniotomi||patient||altern||etv||routin procedur||shunt||treatment||slit ventricl||headach||mtv||ventricl||supraorbit craniotomi||hydrocephalu||lamina terminali||report||multipl shunt revis||procedur||supraorbit approach,hydrocephalu||ventriculostomi||shunt||sylviu||obstruct hydrocephalu||occlus hydrocephalu||etv||tv||aquaduct||shunt-depend hydrocephalu||hydrocephalu therapi||lamina terminali||microsurg tv||shunt malfunct||ventricl,0.37||0.28||0.273||0.233||0.221||0.212||0.21||0.207||0.207||0.198||0.187||0.183||0.175||0.164||0.159,0.4,0.4,0.4
826,Protein_Expr_Purif-1-5-1885977.txt,gene||vector||tap||yellow fluoresc protein||yfp||tandem affin purif||protein||site||gfp||mc||tag||purif||cell,dictyostelium||abstract dictyostelium dictyostelium dictyostelium arp2||dictyostelium arp2||exp5||dictyostelium arp||protein complex dictyostelium discoideum dictyostelium||dictyostelium discodeum||dictyostelium gene dev||yfp||late dictyostelium develop||ef028663 exp5||tap-tag p34-arc dictyostelium D. discoideum||c-term||tap||bait,0.473||0.305||0.287||0.286||0.253||0.253||0.248||0.168||0.161||0.16||0.155||0.154||0.151||0.146||0.141,0.0,0.1,0.13333333333333333
827,Biotechnol_Lett-3-1-2045120.txt,crystal||cross-link protein crystal||ara||time||transport phenomena||studi||channel||motion||water||pore wall||amino acid||diffus coeffici||transport||lysozym||protein crystal||solut||protein||residu||analysi||orthorhomb lysozym crystal||simul||molecular dynam||order||diffus||free lysozym||molecul||result,crystal||lysozym crystal||lysozym||orthorhomb lysozym crystal||lysozym crystal channel||lysozym tetragon crystal||lysozym crystal matric||protein crystal||cross-link crystal||crystallin lysozym||crystal channel||enzym crystal||β-lactoglobulin crystal||hen lysozym||lysozym molecul,0.42||0.399||0.378||0.309||0.28||0.279||0.274||0.257||0.243||0.239||0.231||0.23||0.228||0.227||0.223,0.6,0.4,0.26666666666666666
828,Pediatr_Radiol-4-1-2292498.txt,grade||administr||urinari tract||imag||kidney||studi||uca||durat||fundament imag||vcug||increas||fundament mode||harmon||vu||cycl||bladder||urethra||advers event||examin||reflux||intraves administr||evalu||contrast agent||vur||renal pelvi||normal salin||levovist||modal||microbubbl||posterior urethr valv||ultrasound contrast agent||grade II||low diagnost accuraci||reflux diagnosi||procedur||vesicoureter reflux||precontrast||children||result,vu||reflux||void||vesicoureter reflux||urosonographi||microbubbl||contrast-enhanc vu||uca||reflux diagnosi||cyclic vu||vesicoureteroren reflux||reflux detect||reflux sonographi||levovist-enhanc vu||urosonographi ultrasound contrast agent vesicoureter reflux,0.36||0.353||0.35||0.328||0.248||0.234||0.23||0.224||0.208||0.204||0.188||0.187||0.187||0.186||0.185,0.6,0.6,0.4
829,Bioinformation-2-1-2139994.txt,gene||approach||polar side chain||protein||hypothet protein||databas||sequenc||amino acid residu||function||network,hypothet protein||protein||human hypothet protein||un-annot protein||india||hypo||protein famili||annot||order protein||disord protein||potenti protein||bioclues.org||b3bp||438169||human protein suravajhala prashanth,0.382||0.272||0.261||0.169||0.156||0.153||0.151||0.147||0.146||0.142||0.139||0.132||0.132||0.132||0.123,0.4,0.2,0.13333333333333333
830,Diabetologia-4-1-2292424.txt,follow-up||diabet foot diseas||diabet||heal||individu||rate||data||model||studi||end-stag renal diseas||year||patient||older age||prospect data||variabl||analys||sensat||eurodial studi||treatment||outcom||infect||esrd||foot ulcer||ulcer||diabet foot ulcer||predict model||characterist||popul||predictor||co-morbid||major amput||peripher arteri diseas||foot||non-heal||presenc||neuropathi||pad||daili clinic practic||result,foot||foot ulcer||ulcer||diabet foot ulcer||diabet foot||diabet||diabet foot ulcer patient||pad||foot ulcer patient||recurr diabet foot ulcer||diabet foot ulcer 11||diabet foot infect||neuropath foot ulcer||diabet foot diabet metab||diabet foot wound,0.455||0.426||0.397||0.394||0.393||0.332||0.312||0.312||0.306||0.297||0.296||0.293||0.288||0.282||0.277,0.8,0.6,0.4
831,Ann_Surg_Oncol-3-1-2077912.txt,time||seer||preval||data||locat||studi||year||patient||distant metastas||head||durat||seer 17 registri||pancreat cancer||epidemiolog||duoden gastrinoma||seer databas||tumor site||small insulinoma||multivari analysi||uncertain malign potenti||seer stage||age||pancreat endocrin tumor||prognost factor||group||islet cell||surviv||seer 9 registri||tumor||neoplasm||registri||islet cell carcinoma||seer program||diseas||diagnosi||pancrea||malign,seer||islet||seer registri||islet cell||seer stage||seer stage seer stage||islet cell tumor||seer program||seer databas||seer 13||seer 17||seer 9||islet cell carcinoma||islet cell neoplasm||pancreat islet cell carcinoma,0.334||0.334||0.227||0.192||0.184||0.184||0.18||0.176||0.174||0.169||0.169||0.168||0.167||0.161||0.159,0.6,0.5,0.4
832,Eur_Radiol-3-1-1914219.txt,filter||measur||coronari angiographi||msct||imag||studi||valu||standard deviat||lumen||increas||vivo studi||cnr||contrast media||contrast materi||smooth||evalu||tissu compon||coronari plaqu||result||vivo model||oil||intracoronari attenu||specimen||snr||attenu valu||germani||coronari arteri||noncalcifi plaqu||plaqu||attenu||convolut||vivo||plaqu attenu valu,plaqu||noncalcifi plaqu||coronari plaqu||noncalcifi plaqu attenu||calcifi plaqu||calcifi plaqu attenu||atherosclerot coronari plaqu||coronari atherosclerot plaqu||convolut||noncalcifi coronari atherosclerot plaqu||noncalcifi plaqu valu||noncalcifi plaqu compon||coronari plaqu attenu valu||plaqu attenu valu||plaqu compon,0.472||0.366||0.365||0.323||0.317||0.29||0.273||0.273||0.271||0.27||0.256||0.252||0.251||0.249||0.247,0.6,0.4,0.3333333333333333
833,Addiction-1-_-2253702.txt,target||measur||effect size||subject norm||tpb||determin||model||studi||expect||ecstasi||review||intent||test||variabl||behaviour||evidence-bas intervent||ancestri approach||control||neg expect||research||associ||theoret framework||attitud||belief||social facilit||drug||posit outcom||public||compound construct,ecstasi||ecstasi user||ecstasi 29||actual ecstasi||ecstasi 11||ecstasi users’ approv||ecstasi 1 0.40||ecstasi 4 7||ecstasi 3 8 perceiv||ecstasi 3 7 perceiv||e.g. ecstasi enhanc sex||psycholog effect 1 4 ecstasi||1980 public year 4 ecstasi||perceiv||ecstasi 4 8 intent 5 8,0.755||0.395||0.382||0.381||0.378||0.262||0.256||0.252||0.226||0.226||0.198||0.163||0.158||0.146||0.142,0.2,0.1,0.06666666666666667
834,Ann_Hematol-4-1-2174523.txt,long travel||author||case||anteced||data||studi||patient||travel||venou thromboembol||vted||relat||plane||variabl||transport||potenti bias||control||meta-analysi||heterogen||associ||bia||factor||episod||methodolog qualiti||hospit patient||systemat review||dvt||result,travel||vted||vted dvt||dvt||travel meta-analysi||air travel||long travel||prolong travel||lengthi travel||intern travel||travel Br||vted episod||confirm dvt dvt||thrombophilia vted||subsequ vted,0.502||0.409||0.387||0.364||0.287||0.276||0.276||0.265||0.259||0.257||0.254||0.246||0.245||0.231||0.208,0.6,0.4,0.26666666666666666
835,Arch_Dermatol_Res-3-1-1910890.txt,therapeut option||evidence-bas guidelin||unsystemat literatur search||evalu||aspect||psoriasi||psoriasi vulgari||expert||drug||recommend||guidelin||evid||patient||literatur||treatment||therapi||induct therapi||drug interact,psoriasi||psoriasi vulgari||plaqu psoriasi||psoriasi plaqu||psoriasi therapi||plaque-typ psoriasi||psoriasi Br||psoriasi patient||nonscalp psoriasi||moderate-to-sever psoriasi||sever psoriasi||psoriasi lesion||ordinari psoriasi||psoriasi vulgari Br||psoriasi vulgari patient,0.728||0.452||0.404||0.404||0.398||0.384||0.376||0.374||0.373||0.373||0.371||0.367||0.366||0.309||0.308,0.4,0.2,0.13333333333333333
836,Neuroimage-1-5-1971136.txt,quantit histopatholog||measur||visual inspect||protocol||mri||imag||roi||data||studi||valu||patient||volumetr mri data||correl||mtr||patholog block||region||neun||signal||resect tempor lobe||epilepsi||focal epilepsi||paramet||anterior tempor lobe resect||tissu||neuron loss||gray matter||vivo mri||quantit mri||field fraction||analysi||middl tempor gyru||subject||normal||quantit neuropatholog||white matter||neuron tissu||field||neuron densiti||mtr valu||patholog||histopatholog measur,mtr||T2||al.||roi1||mri||roi2||epilepsi||quantit mtr||mtr imag||histopatholog||mtr space||T2 imag||T2 correl||mtr p.u||neun,0.315||0.281||0.243||0.233||0.226||0.217||0.217||0.215||0.195||0.185||0.182||0.178||0.175||0.173||0.171,0.4,0.3,0.26666666666666666
837,Biochim_Biophys_Acta-2-1-2258317.txt,cytosol||calmodulin||neuron calcium sensor||sampl||CN||data||studi||assay||dephosphoryl||nfat||analys||specif||cell||CN activ||calcium||nfat-gfp||control||pierc||gst||bovin brain cytosol||protein||nc||vitro evid||calcineurin activ||activ||bind||sd dissoci buffer||interact||cam||sd||calcineurin||bind buffer||detect||result,nfat||ncs-1||calcineurin||calcium nfat||nfat protein||nc||nfat dephosphoryl||nfat signal||nfat activ||nfat gene||nfat pathway||ncs-1 protein||nfat inhibitor||nc protein||ncs-1 signal,0.416||0.31||0.298||0.271||0.267||0.262||0.255||0.238||0.224||0.216||0.216||0.214||0.212||0.19||0.185,0.4,0.3,0.2
838,Ann_Biomed_Eng-2-2-1705526.txt,tempor variat||variat||straight tube model||dynam model||time||oxygen transport||flow||veloc||import role||outer||wall||coronari arteri motion||studi||model||gradual increas||wss||motion||dynam curvatur effect||effect||pulsatil flow effect||region||ldl transport||lad||oxygen||pulsatil||ldl||flux||futur studi||factor||speci transport||medial region||arteri||mass transport pattern||curvatur||wall motion||instantan variat||coronari arteri||mass transport||wss pattern||speci||distal region||result,pulsatil||wall||wss||wall motion||arteri wall||motion||arteri||ldl||coronari arteri motion||flow pulsatil||pulsatil flow||pulsatil coronari arteri flow||coronari arteri||ldl wall flux||coronari arteri curvatur,0.25||0.24||0.234||0.223||0.22||0.206||0.201||0.198||0.196||0.195||0.195||0.193||0.192||0.188||0.173,0.8,0.8,0.6
839,Ann_Biomed_Eng-2-2-1705491.txt,flow condit||system||method||flow||studi||ldv||averag number||view||leukocyt adhes||specif||cell||shear stress||averag||hydrogel||leukocyt||surfac||firm adhes||field||number||interact||molecul,hydrogel||A. hydrogel||hydrogel scaffold||B. hydrogel||hydrogel substrat||nonadhes hydrogel||hydrogel system||polyethylen glycol hydrogel||hydrogel leukocyt adhes flow chamber||L. photopolymeriz hydrogel||A. 1986 hydrogel||leukocyt adhes||peg hydrogel 1||cell adhes||adhes ligand,0.447||0.282||0.253||0.251||0.243||0.237||0.227||0.212||0.197||0.195||0.193||0.19||0.189||0.187||0.183,0.2,0.1,0.13333333333333333
840,Eur_Radiol-2-2-1766021.txt,level||case||spatial compound||mammography-dens breast||CM enhanc||mri||imag||combin||studi||patient||harmon imag||calcif||tumour vascularis||breast tumour||speckl reduct imag||fundament mode||lesion||focal breast lesion||breast ultrasound||vascularis||thi||tumour||tissu||small tumour||vacuum biopsi||sri||bolu inject||biopsi||chi||digit imag||malign tumour||malign||contrast||breast||detect||tissu harmon imag,breast||breast ultrasound||ultrasound||breast imag||breast lesion||doppler ultrasound||breast tumour||harmon imag||breast tissu||doppler||sri||malign breast lesion||power doppler ultrasound||imag||tissu harmon imag,0.352||0.326||0.301||0.273||0.262||0.257||0.249||0.248||0.218||0.213||0.21||0.199||0.196||0.194||0.193,0.4,0.4,0.4666666666666667
841,Eur_J_Appl_Physiol-3-1-1914240.txt,surfac emg signal||muscl||high level||knee angl||experiment day||data||studi||voluntari activ||neural drive||muscl length||maxim VA||increas||forc||high contract intens||present studi||twitch interpol||mvc||minor influenc||relationship||voluntari torqu||torqu||contract intens||conclus||subject||emg||herzog||contract||differ||triplet||rsemg||subject popul||angl||rest,torqu||voluntari torqu||triplet torqu||superimpos torqu||knee||torqu relationship||interpol twitch torqu||extens torqu||torqu increas||torqu capac||torqu level||absolut torqu||rel voluntari torqu||isometr knee extens torqu||knee angl,0.522||0.383||0.329||0.3||0.299||0.277||0.275||0.272||0.266||0.266||0.264||0.263||0.258||0.243||0.234,0.4,0.2,0.2
842,Biochim_Biophys_Acta-1-5-1906864.txt,cmr||find||particl||lrp||atherosclerosi||studi||cholesterol||effect||increas||receptor||oxid state||top fraction||macrophag||foam cell||lipid||cell||crlp||lactoferrin||ldl||lipid accumul||uptak||apo||accumul||excess ldl||import||decreas||incub||chylomicron remnant||pathway||oxid||phagocytosi||foam cell format||result,chylomicron||crlp||chylomicron remnant||chylomicron biochim||crlp paramet crlp||chylomicron metabol||artifici chylomicron||macrophag||chylomicron remnant biochim||fluorescent-label chylomicron remnant||chylomicron remnant-lik particl||chylomicron remnant model||remnant||bravo E. chylomicron||crlp lower,0.46||0.361||0.327||0.246||0.242||0.241||0.237||0.232||0.229||0.223||0.221||0.22||0.194||0.185||0.183,0.4,0.3,0.2
843,Matern_Child_Health_J-2-2-1592145.txt,pregnanc||disabl,disabl||disabl issu||physic disabl||disabl statu||pregnanc||disabl woman guid||disabl thierri joann||women||women women||carlson D. disabl||disabl statist report||2006 keyword disabl pregnanc women health||pregnanc welner guid||welner guid||women health,0.65||0.363||0.343||0.329||0.27||0.256||0.252||0.25||0.25||0.234||0.225||0.211||0.207||0.176||0.172,0.4,0.2,0.13333333333333333
844,Invert_Neurosci-4-1-2413115.txt,crystal||insect||import role||bind site||achbp||subunit||structur||backbon carbonyl||molecular basi||ion channel||neonicotinoid||ctd||vertebr nachr||protein||residu||nitro group||ligand-bind site||hydrogen bond||crystal structur||interact||nicotin acetylcholin receptor||imi||insect nachr,Ls||neonicotinoid Ls||neonicotinoid||neonicotinoid insecticid||0 Ls||Ls 4||3 Ls||1 Ls||neonicotinoid Ls 1 2002||lymnaea stagnali Ls||sattel DB neonicotinoid||neonicotinoid action||commerci neonicotinoid||neonicotinoid sensit||elus neonicotinoid,0.537||0.474||0.412||0.279||0.271||0.268||0.268||0.268||0.238||0.236||0.223||0.221||0.212||0.211||0.21,0.2,0.1,0.06666666666666667
845,Pediatr_Nephrol-3-1-1784542.txt,long-term cohort studi||proteinuria||respons||children||rate||studi||renal diseas||cholesterol||patient||lower respons rate||corticosteroid||effect||risk||agent||medic||nephrot syndrom||adult||dose||treatment||therapi||sirolimu||esrd||resist||report||urinari protein excret||kidney function||fsg||diseas||kidney||cardiovascular diseas,fsg||glomerulosclerosi||nephrot syndrom||steroid-resist nephrot syndrom||focal glomerulosclerosi||nephrot patient||fsg therapi||segment glomerulosclerosi||steroid-resist idiopath nephrot syndrom||idiopath nephrot syndrom||steroid-resist focal segment glomerulosclerosi||kidney||focal segment glomerulosclerosi||nephrot syndrom treatment||nongenet fsg,0.318||0.263||0.239||0.219||0.207||0.197||0.192||0.186||0.178||0.177||0.175||0.174||0.174||0.172||0.168,0.4,0.2,0.2
846,Dysphagia-3-1-1914227.txt,pharyng residu||volunt||data||studi||amount||head||water||viscos||increas||marker||temperatur||percentag||solut||data collect||analysi||bolu||xanthan||deglutit disord||pharyng||differ||refer||substanc||healthi volunt||oral caviti,pharyng||swallow||xanthan||pharyng residu||viscos||pharyng mucosa||pharyng paramet||pharyng pressur||postdeglutit pharyng residu||xanthan solut||pharyng bolu transit||volunt||residu||bolu||increas bolu viscos,0.471||0.424||0.393||0.329||0.307||0.246||0.243||0.238||0.233||0.229||0.222||0.191||0.186||0.176||0.164,0.8,0.4,0.4
847,Eur_J_Pediatr-4-1-2234440.txt,hypogonadotrop hypogonad||hypogonad||moebiu syndrom||patient,hypogonad||hypogonadotrop hypogonad||moebiu syndrom||moebiu sequenc||moebiu spectrum||hypogonadotroph hypogonad||hypogonadotrop hypogonad lópez||suspect hypogonadotrop hypogonad||poland syndrom hypogonadotrop hypogonad||baraits||0.7 mU||moebius-poland syndrom||3.5 mU||0.2 mU||0.1 mU,0.359||0.312||0.299||0.253||0.245||0.238||0.222||0.216||0.196||0.177||0.154||0.152||0.145||0.144||0.144,0.6,0.3,0.2
848,FEBS_Lett-1-5-1942070.txt,class II histon deacetylas||cell surviv||surviv||role||prolifer||respons||pkc||oxid stress||pkd||regul||pathway||data||express||bcr||present report||activ||cell antigen receptor||cell||essenti role||stress stimuli,pkd||pkd kinas||kinas||dt40||protein kinas||pkd enzym||dt40 cell||pkd famili||threonin kinas||famili kinas||abbrevi pkd||cantrel||protein kinas D2||pkd-null dt40||dt40 b-cell,0.342||0.337||0.332||0.276||0.23||0.187||0.182||0.181||0.177||0.176||0.173||0.171||0.171||0.166||0.163,0.2,0.1,0.06666666666666667
849,Pediatr_Nephrol-3-1-1805047.txt,crystal||calcium ion||risk||kidney stone||bri||healthi subject||kidney stone diseas||healthi children||statist analysi||age||adolesc||urin||adult||subject||studi||valu||ammonium oxal||bonn risk index||children||result,bri||oxal||bri valu||normal bri||calcium oxal||calcium oxal crystal||ammonium oxal||bialystok||stone||laub||calcium||caox||calcium oxal urolithiasi world||urinari calcium oxal satur||children,0.58||0.373||0.302||0.297||0.271||0.221||0.211||0.194||0.18||0.171||0.169||0.166||0.165||0.164||0.157,0.2,0.2,0.2
850,Pediatr_Nephrol-4-1-2335288.txt,gfr||chronic kidney diseas||case||hypertens||ckd||studi||end-stag renal diseas||year||patient||renal diseas||liver transplant||renal insuffici||risk||develop||epidemiolog||cyclosporin||lung transplant||esrd||serum creatinin||hematopoiet stem cell transplant||renal function||liver||transplant||hsct||calcineurin inhibitor||risk factor||diseas||cardiac||cardiac transplant||children,transplant||renal transplant||marrow transplant||lung transplant||heart transplant||liver transplant||transplant pretranspl||cardiac transplant||bone marrow transplant||transplant type||transplant physician||age transplant||transplant vari||renal transplant patient||marrow transplant recipi,0.673||0.483||0.45||0.397||0.396||0.389||0.373||0.366||0.344||0.339||0.338||0.338||0.338||0.328||0.322,0.4,0.4,0.26666666666666666
851,Eur_Radiol-2-2-1766022.txt,earli post-op period||time||case||complic||joint||high resolut||mri||aci||imag||high signal-to-nois ratio||cartilage-cartilag interfac||cartilag defect||smooth contour||studi||patient||autolog chondrocyt implant||cartilag repair surgeri||structur||defect||cartilag repair tissu||complet fill||synov||variabl||articular cartilag||delamin||cartilag||signal||defect fill||repair||evalu||paramet||tissu||cylind||graft||adjac cartilag||joint effus||normal||surfac||earli stage||bone||cartilag repair||osteochondr autograft||signal intens||biomechan statu||sequenc||nativ cartilag||techniqu,cartilag||cartilag repair||articular cartilag||graft cartilag||implant cartilag||cartilag implant||cartilag transplant||cartilag defect||articular cartilag repair||adjac cartilag||cartilag surfac||hyalin cartilag||cartilag integr||cartilag T2||cartilag signal,0.669||0.442||0.44||0.412||0.397||0.397||0.37||0.37||0.365||0.364||0.356||0.353||0.351||0.351||0.347,0.6,0.5,0.3333333333333333
852,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2358931.txt,measur||intact joint surfac||tekscan sensor||cartilag defect||contact||motion||effect||defect||forc||pressur||cartilag||stress||bottom||plug||surfac measur||osteochondr transplant||earli osteoarthr||flush level||sensor||weight bear motion||stress elev||weight||condyl||transplant||group||mosaicplasti||bone||border contact pressur||surfac congruenc||full-thick cartilag defect||knee||signific differ||articular cartilag defect,mosaicplasti||unbottom mosaicplasti||knee||cartilag||osteochondr cartilag defect||three-plug mosaicplasti||knee cartilag defect||osteochondr defect||osteochondr plug||unbottom||mosaicplasti techniqu||mosaicplasti area||subsequ mosaicplasti||16 mosaicplasti||cartilag defect,0.497||0.378||0.302||0.299||0.277||0.268||0.267||0.266||0.265||0.259||0.257||0.256||0.255||0.249||0.249,0.6,0.3,0.26666666666666666
853,J_Mol_Biol-1-5-2098880.txt,muscl||fast||muscl contract||concentr||isoform||rate||releas||S1||data||studi||rabbit||amount||equilibrium||muscl fibr||actin bind||actin||amplitud||elc||adp||fast phase||essenti light chain||reaction||tca||pig||phase||lifetim||actomyosin complex||mhc||regulatori light chain||light chain||fluoresc||presenc||myosin heavi chain||constant||rlc||myosin||bovin,myosin||ob||S1 myosin||myosin subfrag||myosin isoform||adp||non-muscl myosin||myosin motor||αD||αD BM||myosin biochem||BM||BM BM||slow muscl myosin||myosin tail,0.454||0.412||0.289||0.277||0.276||0.269||0.263||0.252||0.238||0.236||0.236||0.234||0.234||0.234||0.233,0.2,0.2,0.13333333333333333
854,J_Neurol-2-2-1705504.txt,genet studi||csf||molecular etiolog||anim model||model||studi||multifactori disord||pathogenesi||human||major||form||congenit||cellular signal pathway||brain||growth factor||molecular genet||gene||molecular||htx rat||genet diseas||cerebrospin fluid||genet loci||cytokin||genet factor||development mechan||hydrocephalu||locu||aqueduct||diseas||cellular prolifer||function,hydrocephalu||congenit hydrocephalu||hereditari hydrocephalu||x-link hydrocephalu||hydrocephalu gene||human hydrocephalu||inherit hydrocephalu||prenat hydrocephalu||infantil hydrocephalu||normal-pressur hydrocephalu||early-onset hydrocephalu||famili hydrocephalu||obstruct hydrocephalu||murin hydrocephalu||fgf-2-induc hydrocephalu,0.884||0.5||0.465||0.464||0.456||0.454||0.454||0.453||0.451||0.45||0.45||0.449||0.448||0.447||0.447,0.2,0.1,0.06666666666666667
855,Plant_Mol_Biol-3-1-1805040.txt,respons||microarray||data||comparison||valu||rice||floral transit||jasmon||express||genotyp||main shoot||present studi||stress||gene||control||salin||tissu||transcript||protein||growth stage||shoot||salt stress||report||toler||salt||agami||root||auxin||stage||plant,rice||rice plant||indica||salin||rice genotyp||japonica||plant||skc1 skc1 skc1 japonica japonica m103||_||skc1 2005 indica skc1 skc1||rice gene||4 skc1 indica skc1||skc1 2005 skc1 skc1||salin stress||rice growth,0.331||0.277||0.257||0.245||0.244||0.232||0.224||0.221||0.205||0.202||0.191||0.189||0.189||0.186||0.184,0.4,0.3,0.2
856,Immunogenetics-3-1-1914303.txt,host||data||studi||host respons||express profil||express||signific||cell||pmn||infect||gene||mice||transcript||immun||analysi||group||rna qualiti||number||locu||pathway||lung||immun respons,pertussi||B. pertussi||B. pertussi B. pertussi||bordetella pertussi||3 B. pertussi B. pertussi||pertussi 3||B. pertussi infect||B. pertussi inocul||2004 bps-3 B. pertussi B. pertussi||B. pertussi 1949||2 B. pertussi||3 B. pertussi infect||3 B. pertussi inocul||B. pertussi grey bar||3 B. pertussi 6,0.807||0.52||0.52||0.496||0.416||0.404||0.366||0.363||0.355||0.351||0.346||0.275||0.272||0.263||0.26,0.0,0.0,0.0
857,Matern_Child_Health_J-2-2-1592140.txt,condit||embryo||asthma||mother||individu||pregnanc||studi||folic acid||concept||effect||risk||advers effect||inform||medic||dose||treatment||therapi||health||preconcept care||women||chronic condit||medic supervis||exposur||health care provid||isotretinoin||drug||drug administr||addit inform||fetu||plan,pregnanc||pregnanc registri||pregnanc regist||human pregnanc||pregnanc talk||isotretinoin||teratogen||effect pregnanc manag||postmarket pregnanc registri||neg pregnanc test||pregnanc matern effect 6||teratogen exposur||isotretinoin treatment||fetu||normal human pregnanc Br,0.574||0.301||0.295||0.293||0.293||0.28||0.231||0.209||0.208||0.196||0.184||0.17||0.162||0.155||0.15,0.2,0.2,0.2
858,J_Gastrointest_Surg-3-1-1852390.txt,time||stay||complic||persist dysphagia||studi||dysphagia||seri||patient||convers rate||convers||postop dilat rate||short gastric vessel divis||oper||oper time||cohort||fundopl||short gastric vessel||hospit||dilat||wrap||month||curv||reoper||decreas||laparoscop||seventh cohort||number||surgeon||learn curv||open fundopl||procedur||length||lnf||singl surgeon||laparoscop nissen fundopl||result,fundopl||laparoscop fundopl||laparoscop||laparoscop nissen fundopl||nissen fundopl||underw laparoscop fundopl||laparoscop reoper||redo fundopl||laparoscop nissen fundopl Br||toupet fundopl||watson fundopl||open fundopl||redo nissen fundopl||dehn tcbd laparoscop fundopl||convent nissen fundopl,0.564||0.506||0.448||0.414||0.397||0.362||0.329||0.327||0.315||0.307||0.304||0.295||0.295||0.274||0.268,0.6,0.3,0.26666666666666666
859,Exp_Brain_Res-4-1-2315690.txt,sensorimotor impair||target||obstacl||visual monitor||hemiparet CP||individu||begin||lah||data||studi||prospect control||hypothesi||intermedi fixat||effect||end||visual inform||statist analysi||visuomotor control||respect||control||cerebr palsi||saccad||hemiparesi||task||action||affect hand||experiment group||saccad initi||group||grasp time||number||hand||healthi control||trial||signific differ||particip||movement||object||landmark region||experiment||peak veloc,moa||moa moa mta||saccad||hand||moa mta moa mta moa mta||moa mta||hand movement||hemiparet CP||mta||hand coordin||target-reach saccad||CP||steenbergen||task hand||gaze,0.357||0.308||0.307||0.295||0.283||0.283||0.227||0.215||0.209||0.204||0.198||0.197||0.193||0.186||0.185,0.4,0.3,0.2
860,Evid_Based_Complement_Alternat_Med-5-1-2249747.txt,mechan||condit||chronic smoker||method||emphysema patient||potenti applic||gsh inhal||studi||patient||sulfit||effect||respiratori diseas||review||potenti concern||antioxid protect||minor side effect||side effect||respiratory-rel condit||dose||inhal gsh||treatment||defens||antioxid||gsh||oxid stress||clinic effect||sulfit sensit||report||optim dose||glutathion||inhal||upper||urin||diseas||lung||lower respiratori tract||pulmonari diseas||articl,gsh||inhal gsh||gsh inhal||glutathion||gsh defici||gsh replenish||gsh metabol||gsh concentr||gsh mechan||gsh level||gsh transferas||inhal glutathion||glutathion inhal||inhal gsh effect||regular gsh inhal,0.68||0.504||0.504||0.358||0.354||0.351||0.35||0.347||0.346||0.344||0.344||0.343||0.343||0.34||0.338,0.8,0.4,0.26666666666666666
861,Eur_J_Clin_Pharmacol-3-1-2039832.txt,regress analysi||limit sampl strategi||auc||time||satisfactori predict||ape||lss||popul||tacrolimu||renal transplant recipi||studi||strategi||pharmacokinet profil||literatur||patient||tacrolimu concentr,tacrolimu||text||0||transplant||tacrolimu pharmacokinet||tacrolimu monitor||tacrolimu concentr||tacrolimu dose||tacrolimu Op||tacrolimu exposur||tacrolimu prevent||tacrolimu metabol||keyword tacrolimu||document||long-term tacrolimu pharmacokinet,0.123||0.116||0.083||0.082||0.081||0.066||0.065||0.064||0.064||0.063||0.062||0.062||0.061||0.055||0.054,0.2,0.2,0.13333333333333333
862,Pflugers_Arch-3-1-2137943.txt,respir||anim||cathet||time||trans-diaphragm approach||trans-thorac approach||studi||increas||small amount||netherland||recoveri||mmhg||diaphragm||pressur||mct-induc PH||echocardiographi||rat||control||studi period||pulmonari arteri||cardiac output||ventricl||surgeri||pulmonari circul||respiratori rate||procedur||small burst||heart,trans-diaphragm||pressur||anim||RV pressur||pressur cathet||pulmonari arteri pressur||trans-diaphragm approach||trans-thorac approach||RV||diaphragm||pulmonari arteri||cathet||trans-thorac group||trans-diaphragm group||RV catheteris,0.293||0.22||0.201||0.197||0.188||0.18||0.177||0.177||0.173||0.165||0.16||0.156||0.151||0.151||0.149,0.4,0.5,0.4666666666666667
863,Qual_Life_Res-3-1-2039864.txt,program||group differ||measur||rate||baselin||session||studi||attend||effect||vitamin supplement||mci||cognit declin||qol||intervent||community-dwel adult||signific interact||analys||outcom||day||percentag||item||random||daili live||age||subject||exercis||pap||physic health||possibl||activ||intens||group||differ||mild cognit impair||random control trial||trial||particip||supplement||moder intens||vitamin||result,vitamin||d-qol||vitamin b12||vitamin B6||b12||qol||B6||vitamin B6 supplement||vitamin B6 mci||vitamin supplement||b12 supplement||vitamin pill||B6 placebo||walk||vitamin b-12,0.283||0.283||0.272||0.267||0.26||0.255||0.251||0.222||0.216||0.208||0.196||0.18||0.18||0.175||0.166,0.2,0.3,0.2
864,Environ_Manage-2-2-1705480.txt,variat||lake||spatial scale||boreal lake||deposit variabl||independ variabl||studi||amount||water movement||effect||stepwis rda||water chemic variabl||total phosphoru||water resid time||process||region||variabl||site||alpin||veget||analys||alpin treeless area||largest amount||variat partit||rda||varianc||treeless land cover||toc||arabl land||natur variabl||water chemistri||stream chemistri||local-scal variabl||partial redund analysi||ecosystem||factor||differ||import||geograph posit||uniqu varianc||stream||anc||aquat ecosystem||interact||landscap posit||lake chemistri||total organ carbon||catchment,stream||lake||stream catchment||stream lake geograph||stream chemistri||stream ecolog||lake chemistri||boreal stream||stream water-qu||lake ecosystem||stream width||stream manag||boreal lake||stream hydrolog||midwestern stream,0.48||0.423||0.358||0.348||0.307||0.287||0.278||0.277||0.269||0.253||0.252||0.248||0.248||0.248||0.248,0.6,0.4,0.3333333333333333
865,J_Gastrointest_Surg-3-1-1852376.txt,origin imag find||metastat site||patient||recurr||patholog find||chemotherapi||sensit||metastas||high risk||extens extrahepat diseas||lesion||nonresect diseas||treatment||neoadjuv chemotherapi||bevacizumab||hepat resect||extrahepat diseas||liver||longer follow-up||tumor||colorect liver metastas||resect||neoadjuv treatment||abdomin CT||fdg-pet||detect||result,fdg-pet||fdg-pet neoadjuv chemotherapi||metastas||neoadjuv chemotherapi||resect||fdg-pet scan||colorect metastas||hepat metastas||contrast-enhanc fdg-pet||baselin fdg-pet||follow-up fdg-pet||CT||conclus fdg-pet||hepat colorect metastas||colorect hepat metastas,0.462||0.339||0.314||0.278||0.273||0.258||0.252||0.249||0.246||0.241||0.238||0.235||0.232||0.23||0.23,0.8,0.4,0.26666666666666666
866,Neuroradiology-3-1-2039855.txt,follow-up||superior cerebellar arteri||sca||cranial nerv||complic||clinic condit||patient||aneurysm||nerv||treatment||institut||circul||basilar arteri||endovascular treatment||initi angiograph result||complet||occlus||incid||good angiograph||addit||coil||outcom||result,"aneurysm||sca aneurysm||ruptur aneurysm||ruptur sca aneurysm||distal aneurysm||peripher aneurysm||intracrani aneurysm||2,112 aneurysm||wide-neck aneurysm||treat aneurysm||distal sca aneurysm||36 aneurysm||28 aneurysm||multipl aneurysm||27 aneurysm",0.74||0.546||0.411||0.391||0.388||0.385||0.38||0.38||0.38||0.378||0.376||0.372||0.371||0.371||0.371,0.2,0.1,0.06666666666666667
867,Oecologia-4-1-2270359.txt,forag||tarangir||low nutrient||constraint||nutrient||larg tree||sampl||qualiti||domin grass speci||studi||savanna tree||savanna||gener linear model||effect||grass||high fibr content||canopi||veget||lower fibr concentr||ludwig||open grassland||energi||bush||dom||protein concentr||percentag||season||posit effect||nutrient requir||protein||veget zone||wildebeest||herbivor||open field||forag qualiti||requir||linear program model||african savanna||canopi edg||speci||tree||eleph||larg herbivor||maximum fibr intak||result,savanna||savanna tree||tree||larg savanna tree||neotrop savanna tree||tree canopi||grass||african savanna||forag||tropic savanna||savanna ecosystem||semi-arid savanna||dead tree||acacia tortili tree||larg tree,0.352||0.347||0.342||0.241||0.236||0.231||0.219||0.219||0.214||0.202||0.202||0.2||0.196||0.187||0.186,0.6,0.6,0.4666666666666667
868,Naturwissenschaften-3-1-2039849.txt,time||pratt||social carri||model||emigr||strategi||recruit||frank||paramet||late recruit||paper||experi||ant||nest||scout||activ||mallon||rang||revers tandem||fraction||number||tandem||coloni||tandem run,ant||tandem||ant leptothorax albipenni||emigr||ant temnothorax albipenni||tandem run||house-hunt ant||passiv ant||nest emigr||naïv ant||activ ant||ant move||knowledg ant||leptothorax albipenni||revers tandem,0.257||0.199||0.172||0.164||0.154||0.15||0.145||0.14||0.135||0.132||0.132||0.13||0.13||0.129||0.128,0.6,0.4,0.3333333333333333
869,Eur_J_Pediatr-3-1-1876255.txt,middl ear||acut otiti media||studi||patient||year||aom||effect||tympanostomi tube insert||poor long-term prognosi||vaccin||tympanostomi tube||eustachian tube||antibiot||treatment||infect||day||acut inflamm||recent prospect studi||virus||result||age||month||dysfunct||viral infect||amoxicillin||tube||antibiot treatment||ome||episod||nasopharyng aspir cultur||viral test||bacteria||eustachian tube dysfunct,otiti media||acut otiti||acut otiti media||aom||keyword acut otiti media otiti media||infant otiti media||otiti media eur||persist otiti media||chronic otiti media||recurr acut otiti media||acut otiti media eur||acut otiti media int||acut otiti media pathogen||janoski JE otiti media||chronic suppur otiti media,0.394||0.39||0.3||0.299||0.281||0.279||0.268||0.268||0.264||0.241||0.228||0.227||0.226||0.208||0.203,0.4,0.2,0.13333333333333333
870,Virchows_Arch-3-1-2039817.txt,tumor||mix inflammatori cell||pancrea||cystic mass||case||mural nodul||primari retroperiton||borderlin malign||foci||mucin cystadenoma||mass||cyst||retroperitoneum,cystadenoma||mucin cystadenoma||retroperiton cystadenoma||retroperiton||primari retroperiton cystadenoma||ovarian mucin cystadenoma||discuss mucin cystadenoma||mucin cystadenocarcinoma||cystadenoma present||mucin tumor||primari retroperiton||retroperiton cyst NR mcabor||springer-verlag 2007 introduct mucin cystadenoma||mucin cystic tumor||keyword retroperitoneum mucin,0.502||0.476||0.463||0.424||0.327||0.324||0.318||0.283||0.253||0.249||0.239||0.193||0.193||0.191||0.189,0.2,0.1,0.13333333333333333
871,Eur_Radiol-3-1-2077913.txt,time||thorac aorta||bpm||artifact||roi||imag||studi||patient||chest||acut coronari syndrom||ecg-gating-rel artifact||imag qualiti||ecg-gat chest examin||heart rate||excel inter-observ agreement||evalu||contrast media protocol||slice thick||acut chest pain||data acquisit||ventricl||pulmonari trunk||contrast attenu||attenu valu||dual-sourc CT||coronari arteri||independ reader||attenu||heart||nois||lung||aorta||score,chest||coronari arteri||aorta||chest pain||artifact||pulmonari arteri||imag||ecg-gat artifact||rca||acut chest pain||arteri||thorac aorta||ecg-gat||angiographi||pulmonari trunk,0.267||0.228||0.216||0.21||0.199||0.192||0.189||0.186||0.185||0.181||0.179||0.174||0.173||0.171||0.167,0.8,0.6,0.5333333333333333
872,Purinergic_Signal-3-4-2072910.txt,gene||yeast||pseudogen||posit||evolut||nucleotid||orphan gpcr||receptor||intron||key residu||express||ortholog||specif||analys||agonist||adp||group,receptor||7.3 kbp||9.5 kbp||8.2 kbp||5.2 kbp||47 kbp||1.2 kbp||2.3 kbp||66 kbp||2.5 kbp||4 kbp||5 kbp||2 kbp||1 kbp||p2y12 receptor,0.324||0.292||0.292||0.292||0.292||0.291||0.291||0.291||0.29||0.29||0.288||0.288||0.288||0.288||0.251,0.2,0.1,0.06666666666666667
873,Eur_Radiol-4-1-2270369.txt,signific cad||coronari angiographi||three-dimension imag||origin||variant||intermedi branch||preval||data||studi||patient||anomali||visual||cca||msct-ca||coronari anomali||complex anatomi||popul||anatom variant||diagon branch||number||coronari arteri||variabl number||segment||conu branch arteri,coronari anomali||coronari arteri||coronari angiographi||coronari arteri anomali||anomali||intrins coronari anomali||coronari arteri variant||anomal coronari arteri||coronari segment||congenit coronari arteri||coronari domin||coronari diseas||coronari arteri tree||coronari arteri diseas||arteri,0.408||0.367||0.355||0.352||0.323||0.277||0.271||0.271||0.266||0.258||0.253||0.252||0.251||0.248||0.242,0.8,0.4,0.26666666666666666
874,Virchows_Arch-3-1-1888716.txt,common variant||role||find||microarray||variant||sampl||data||studi||ptc||potenti biomark||lesion||express||cluster||gene||tumour||benign thyroid tissu||metallothionein||transcript||molecular patholog||papillari thyroid carcinoma||express microarray studi||group||follicular variant||rna qualiti||function||biomark||classic morpholog||result,ptc||metallothionein||thyroid carcinoma||fvptc||papillari thyroid carcinoma||thyroid cancer||thyroid tumour||thyroid lesion||thyroid tumor||papillari thyroid cancer||human thyroid||thyroid neoplasia||thyroid carcinogenesi||classic ptc||malign thyroid carcinoma,0.332||0.301||0.248||0.247||0.227||0.218||0.213||0.212||0.21||0.207||0.204||0.201||0.201||0.192||0.185,0.6,0.3,0.2
875,Matern_Child_Health_J-2-2-1592248.txt,ecolog model||program||strateg plan||level||commun||behavior||children||knowledg||panel||pregnanc||individu||focu||model||preconcept period||high risk||action step||clinic practic||recommend||provid||intervent||purpos||sector||health||preconcept care||goal||preconcept intervent||women||research||public polici||preconcept health||action||care||member||famili||lifespan||partner||select panel||step||outcom,preconcept||preconcept health||preconcept care||preconcept intervent||preconcept servic||preconcept risk||preconcept health care||includ preconcept||preconcept period||preconcept measur||keyword preconcept||preconcept health promot||preconcept health program||preconcept care intervent||preconcept health knowledg,0.636||0.43||0.404||0.367||0.347||0.346||0.344||0.327||0.322||0.322||0.318||0.315||0.309||0.302||0.297,0.6,0.4,0.26666666666666666
876,Mol_Biochem_Parasitol-1-5-1964783.txt,effect||dextran||rna interfer||parasit||defect||pcf||major defect||protein||degrad||rnai||express||arf||lysosom||knockdown||endocytosi,trypanosoma brucei||trypanosoma brucei arf1||T. brucei T. brucei||trypanosoma||trypanosoma brucei embo||tbarf1||arf1||T. brucei lifecycl||lysosom||p67||T. brucei procycl cell||tbarf1 rtf1||tbarf1 rtr1||fig. 1 T. brucei||abstract trypanosoma,0.433||0.372||0.321||0.303||0.292||0.278||0.251||0.23||0.228||0.195||0.192||0.167||0.167||0.165||0.155,0.0,0.1,0.06666666666666667
877,Eur_J_Clin_Pharmacol-3-1-2071959.txt,level||method||time||haart||histori||data||studi||patient||bottl||antiretrovir medic||regimen||period||form||failur||mem cap||thirti patient||self-report||hiv patient||treatment||therapi||feasibl||viral replic||low resourc||pilot-studi||reason||pill intak||monitor||botswana||adher||electron monitor||pill,adher||antiretrovir adher||poor adher adher||electron adher monitor||medic adher||treatment adher||adher failur||antiretrovir drug adher||adher measur||adher partner||strict adher||adher level||low adher||lamivudin||medic regimen adher,0.444||0.331||0.3||0.249||0.249||0.242||0.235||0.232||0.232||0.231||0.228||0.227||0.227||0.208||0.205,0.2,0.1,0.06666666666666667
878,Histochem_Cell_Biol-4-1-2386529.txt,type||denk||steatohepat||apoptot protein||unpublish data||variant||zatlouk||cytoplasm inclus||omari||mallory-denk bodi||mdb format||studi||patient||aggreg||human||inclus||mdb||degrad||p62||phosphoryl||type II||oxid stress||alcohol||mice||protein||format||liver||hepatocyt||import||ubiquitin||keratin||major constitu||diseas||toxic memori||function,keratin||omari||omari MB keratin||keratin filament||mallori||MB keratin||omari MB||omari MB keratin variant||p62||keratin cytoskeleton||keratin variant||keratin transgen||keratin refold||keratin modif||keratin fragment,0.389||0.366||0.285||0.268||0.266||0.244||0.233||0.224||0.221||0.216||0.214||0.211||0.202||0.202||0.199,0.4,0.3,0.2
879,Pflugers_Arch-3-1-1915585.txt,role||endotheli cell||glycosaminoglycan chain||endothelium||dermatan sulfat||delic layer||permeabl||mechanotransduct||glycoprotein||plasma-deriv protein||two-photon microscopi||chondroitin sulfat||hyaluronan||vascular diseas||specif||heparan sulfat||endotheli surfac layer||cell||endotheli glycocalyx||glycocalyx||blood||shear stress||vascular endothelium||specif protein bind||part||number||layer||interact||proteoglycan||patholog||molecul||membran||function||compon,glycocalyx||endotheli glycocalyx||glycocalyx composit||venular glycocalyx||glycocalyx structur||glycocalyx thick||endotheli cell glycocalyx||glycocalyx perturb||glycocalyx degrad||intact glycocalyx||cardiac endotheli glycocalyx||endotheli glycocalyx protect||endotheli glycocalyx determin||lumin endotheli cell glycocalyx||lumin capillari glycocalyx,0.687||0.489||0.357||0.353||0.351||0.351||0.35||0.349||0.349||0.348||0.328||0.328||0.327||0.269||0.259,0.4,0.2,0.13333333333333333
880,Mol_Syst_Biol-3-_-2174632.txt,biolog||set||ra||block||databas||data||quantit analysi||mutat||motif||oncogene-sign block||mutat frequenc||node||oncogene-sign collabor||tumorigenesi||event||pattern||regulatori relat||downstream||cell||gene||map||protein||analysi||regulatori loop||neutral hub||alter||cancer signal||tumor||oncogene-sign rout||surviv||gene mutat||number||oncogen stimuli||sequenc||function||network||result,mutat||gene mutat||mutat gene||gene||signal gene mutat||gene methyl||oncogene-sign block||methyl||network gene||cancer gene||gene mutat frequenc||oncogene-sign map||oncogene-sign collabor||network||cancer gene mutat frequenc,0.342||0.31||0.31||0.278||0.271||0.265||0.265||0.253||0.243||0.225||0.218||0.216||0.212||0.209||0.207,0.6,0.4,0.4
881,Obes_Surg-4-1-2367390.txt,band||case||morbid obes||gastric band||paraesophag hernia||perfor||complic||sever complic||patient||stomach||gastric perfor,intrathorac||intrathorac perfor||perfor||gastric perfor||intrathorac stomach||complic gastric perfor||gastric band||ischem gastric perfor||stomach||nissen fundopl||gastric content||underw gastric band||laparoscop nissen fundopl||gastric band procedur||paraesophag hernia,0.422||0.387||0.352||0.341||0.327||0.261||0.238||0.235||0.233||0.202||0.172||0.172||0.166||0.164||0.163,0.4,0.4,0.3333333333333333
882,Mol_Biochem_Parasitol-1-5-1906846.txt,sdx||low level||higher level||intern pH||nutrient||depend||pH gradient||exogen folat transport||effect||pyr||assay||parasit||proton gradient||transport||cell||glucos||2′||npp||uptak||2||folin acid||erythrocyt||buffer||paba||drug||folat||stage||profil||plasma membran||pb||membran||dnp,folat||parasit||plasmodium falciparum||parasit erythrocyt||malaria parasit||plasmodium||P. falciparum||folat uptak||human malaria parasit plasmodium falciparum||folat transport||abstract plasmodium falciparum||plasmodium falciparum induc||parasit membran||folat salvag||nake parasit,0.381||0.377||0.355||0.278||0.273||0.267||0.266||0.265||0.254||0.241||0.238||0.238||0.217||0.213||0.205,0.4,0.2,0.13333333333333333
883,Purinergic_Signal-3-1-2096771.txt,inflamm||human neutrophil||dc||eosinophil||import role||releas||cell damag||studi||neutrophil||atp||receptor||dendrit cell||migrat||recruit||evid||cell||immun cell||intracellular calcium||nucleotid||chemotact activ||lymphocyt||human immun cell||earli recruit||activ||monocyt||function||immatur||chemotaxin||chemokin||immun respons||purinerg receptor,receptor||nucleotid receptor||P2 receptor||nucleotid||P2||p2i receptor||nucleotid atp||eosinophil||purinerg receptor||extracellular nucleotid||p2x receptor||lymphocyt||p2y14 receptor||neutrophil||chemokin receptor,0.29||0.269||0.259||0.248||0.228||0.223||0.21||0.207||0.206||0.198||0.193||0.192||0.184||0.182||0.179,0.4,0.4,0.4
884,Eur_J_Nutr-2-2-1705489.txt,digest residu||method||sampl||dsc||experiment condit||studi||model||digest||amount||x-ray||small intestin||experiment paramet||digest product||dynam||lower crystallin||glucos||starch||experi||mechan stress||ham||fraction||substrat||batch||crystallin||lower amount||prepar||vivo,starch||starch digest||indigest starch||digest||rtmd||resist starch||enzyme-resist starch||starch polym||low-amylopectin starch||starch gelatinis||total starch||starch swell||indigest starch fraction||batch digest||rtmd batch,0.58||0.462||0.357||0.345||0.335||0.33||0.322||0.306||0.306||0.306||0.294||0.294||0.26||0.245||0.24,0.4,0.2,0.13333333333333333
885,springeropen-4-1-2200676.txt,mechan||biolog||upregul||find||respons||unigen number||studi||hypertrophi||express level||section||increas||hypox condit||differenti||independ experi||oxygen||cardiac myocyt||hypoxia||gene||zebrafish||normox||oxygen level||chronic hypoxia||group||molecular function||decreas||import||adapt||cch||heart||hyperplasia||gene express||chronic constant hypoxia,hypoxia||zebrafish||zebrafish heart||heart||normoxia hypoxia normoxia hypoxia||hypoxia physiol||chronic hypoxia||hypox heart||constant hypoxia||high-altitud hypoxia||tissu hypoxia||hypoxia increas||fish heart||hypoxia treatment||cch,0.303||0.237||0.226||0.214||0.181||0.179||0.167||0.166||0.163||0.159||0.156||0.155||0.154||0.154||0.146,0.6,0.4,0.3333333333333333
886,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-1950586.txt,follow-up||time||week||return||studi||labral tear||patient||hockey player||fai||joint motion||sport||femor neck||open surgic approach||treatment||adhes||arthroscop approach||structur abnorm||revis arthroscopi||techniqu||hip||microfractur||averag time||profession athlet||imping||femoroacetabular imping||activ||soft tissu patholog||osseou abnorm||order||acetabular rim||arthroscopi||extens OA||atraumat hip injuri||athlet||cam||hip arthroscopi||pincer||patholog||procedur||debrid procedur||proxim femor neck||acetabular retrovers,athlet||fai||profession athlet||hip||hip arthroscopi||athlet hip injuri||high-level athlet||arthroscopi||thirty-f athlet||twenty-on athlet||twenty-two athlet||45 athlet||addit athlet||femoroacetabular imping||imping,0.452||0.322||0.29||0.284||0.263||0.25||0.243||0.243||0.237||0.236||0.231||0.23||0.228||0.225||0.222,1.0,0.6,0.5333333333333333
887,J_Mol_Biol-2-1-2279226.txt,nativ page||bromodomain||rsc complex||modif||rsc||depend||rate||mutat||studi||atp-depend chromatin||chromatin||effect||increas||lysin acetyl||complex||amino acid||octam transfer||dna||result gener||tail||nucleosom||hydrolysi||histon acetyl||reaction||control||full-length||acetyl||enzym||protein||activ||octam||snf2||histon||transfer||histon tail||effici||atp hydrolysi||addit||purif,nucleosom||histon||nucleosom acetyl||nucleosom histon modif||histon acetyl||histon H4||nucleosom reposit||nucleosom mobil||mobil nucleosom||nucleosom dna||acetyl histon H4||nucleosom modif||histon H3||promot nucleosom||unmodifi nucleosom,0.567||0.452||0.409||0.354||0.352||0.336||0.328||0.311||0.311||0.309||0.308||0.305||0.299||0.297||0.294,0.6,0.3,0.2
888,Int_Urol_Nephrol-4-1-2268719.txt,phosphat control||level||valu||phosphate-bind||serum phosphat level||serum||sever hypermagnesemia||end-stag renal diseas||rang||serum magnesium level||serum phosphat||studi||magnesium||magnesium carbon||patient||hemodialysi||calcium||group,magnesium||serum magnesium||dialys magnesium||magnesium carbon||magnesium hydroxid||renal magnesium||magnesium salt||NS magnesium||magnesium metabol||low magnesium||serum magnesium level||ns||hemodialysi||low magnesium dialys||dialys magnesium solut,0.541||0.355||0.321||0.301||0.3||0.298||0.293||0.291||0.288||0.278||0.241||0.231||0.223||0.219||0.216,0.4,0.2,0.26666666666666666
889,Eur_J_Pediatr-4-1-2413080.txt,syndrom||closur defect||wh||boy||dutch||delet size||age||birth||growth chart||data||studi||weight||sever growth||patient||growth||children,wh||wh growth growth chart||growth chart||growth||wolf-hirschhorn syndrom||wh support group||standard growth chart||specif growth chart||bf00395654 5868696 abbrevi wh wolf-hirschhorn syndrom||develop specif growth chart||growth retard||wolf-hirschhorn syndrom materi||boy fig. 6 growth chart||catch-up growth||girl fig. 5 growth chart,0.623||0.362||0.296||0.234||0.212||0.211||0.202||0.2||0.191||0.15||0.148||0.142||0.136||0.135||0.133,0.6,0.3,0.2
890,Eur_J_Pediatr-3-1-1829443.txt,age 3 year||episod||symptom||insulinoma||confusion state||month||gtc||diagnosi||state||seizur||patient,insulinoma||seizur||insulinoma present||epilepsi||tonic-clon seizur||epilept seizur||nguyen DK insulinoma||niedermey||hypoglycem seizur||epilepsi myoclonu||myoclon jerk||intract epilepsi||yerevan||jme||armenia,0.468||0.286||0.238||0.226||0.191||0.176||0.168||0.164||0.159||0.156||0.15||0.146||0.145||0.145||0.145,0.4,0.2,0.13333333333333333
891,Qual_Life_Res-3-1-2039822.txt,fsq specif||follow-up||life questionnair||respons||method||questionnair||regard||acut otiti media||poor sensit||paediatr condit||caregiv||year||gener questionnair||mcid||aom||effect||clinic||correl||sensit||nr||valid||function health statu||health||estim||om6||function limit||assess||moder||disease-specif||popul||fh||subscal||chang||sem||gener||nr caregiv||taiqol||fsq||otiti media||episod||inter-item correl||clinic relev||reliabl||frequent episod||chang score||sever diseas||hand||construct||score||hrqol||children,aom||fsq||taiqol||questionnair||fh questionnair||disease-specif questionnair||nr||fh||taiqol subscal||aom episod||hrqol questionnair||rand fsq||life questionnair||disease-specif||otiti media,0.3||0.28||0.28||0.242||0.218||0.208||0.203||0.194||0.194||0.191||0.189||0.184||0.18||0.175||0.171,0.8,0.6,0.6
892,Neurochem_Res-4-1-2226019.txt,effect||rat cerebr cortex||vesicular glutam transport||vglut||normal morpholog||incub||cultur||cell cultur||amino acid||peptid||transport||quantit analysi||neuron||glutam||cell||rat,Aβ||sat1||neuron sat1||neuron||neuron sat1 contribut||neuron cultur||Aβ 3||glutamin transport sat1||neuron glutamin transport||neuron cell||cortic neuron||sat1 immunoreact||map2||gabaerg neuron||neuron marker map2,0.453||0.367||0.362||0.358||0.242||0.241||0.226||0.218||0.215||0.212||0.21||0.207||0.207||0.196||0.195,0.2,0.1,0.06666666666666667
893,Histochem_Cell_Biol-4-1-2413110.txt,mechan||desmosom||stratifi epithelia||PV pathogenesi||acantholysi||pathogen||desmoglein||specif epiderm layer||desmoglein compens||dsc||cadherin||cell biologist||present||human||desmosom format||rho gtpase||desmoplakin||receptor||dsg||event||adheren junction||cell||junction||intercellular adhes||adhes||gene||pemphigu||plakoglobin||mice||protein||steric hindranc||experi||PV patient||extracellular||tyrosin kinas||bind||keratinocyt||skin||epidermi||PV serum||epiderm split||plakophilin||egfr||desmosom compon||junction complex||autoantibodi||pv-igg||intermedi filament||molecul||compon,desmosom||pemphigu||desmosom cadherin desmosom||desmosom compon desmosom||pemphigu vulgari||desmosom cadherin||pemphigu acantholysi||keratinocyt desmosom||desmosom cell||desmosom adhes||pemphigu foliaceu||desmosom junction||pemphigu autoantibodi||desmosom plaqu||pemphigu igg,0.528||0.52||0.393||0.357||0.329||0.326||0.316||0.316||0.304||0.3||0.299||0.299||0.298||0.281||0.279,0.4,0.2,0.13333333333333333
894,Eur_J_Pediatr-3-1-1914296.txt,robot surgeri||convent laparoscopi||robot||case||techniqu||vur||children||surgic treatment||complic||laparoscopi||experi||treatment||laparoscop techniqu||vesicoureter reflux||patient||open surgeri||submucos tunnel||patient laparoscopist||reflux||group,reflux||laparoscop||vesicoureter reflux||reimplant||robot||postpubert vesicoureter reflux||vesicoureter reflux manag||primari vesicoureter reflux||vesicoureter reflux 32||ureter reimplant||laparoscop ureteroneocystostomi||laparoscop techniqu||laparoscop transves ureter reimplant||keyword vesicoureter reflux laparoscopi||vesico-ureter reflux,0.338||0.332||0.327||0.246||0.241||0.226||0.224||0.22||0.219||0.218||0.207||0.204||0.199||0.189||0.189,0.6,0.3,0.26666666666666666
895,Pediatr_Nephrol-3-1-1766475.txt,renal osteodystrophi||level||sever lesion||growth hormon||patient||normal rang||parathyroidectomi||recommend||hypercalcemia||intak||normal level||dose||growth||calcium||parathyroid hormon||pth level||phosphat||pth||chronic renal failur||group||pediatr patient||dialysi||upper limit||children,dialysi||nephrol dial transpl||pediatr||phosphat||pediatr nephrol pediatr nephrolog||nephrol dial transplant 15||hyperparathyroid||pth||kidney int||phosphat binder||pediatr dialysi patient||fischbach||perit dial int 21:323||kidney di||chronic renal failur pediatr nephrol 18:1242,0.216||0.193||0.185||0.18||0.172||0.165||0.161||0.156||0.155||0.15||0.143||0.138||0.134||0.129||0.125,0.4,0.3,0.2
896,Matern_Child_Health_J-2-2-1592243.txt,prevent||prepregn plan||preconcept||practic pattern||knowledg||practic||nation recommend||pregnanc||key word||studi||patient||folic acid||risk||behavior pattern||medic||counsel||recommend||provid||intervent||preconcept survey||guidelin||specif preconcept recommend||preconcept care||ntd||effort||women||approach||age||preconcept counsel||prepregn survey||famili||health care provid||survey||physician||pregnanc outcom||nation summit,preconcept||preconcept care||preconcept counsel||keyword preconcept care preconcept||preconcept survey||preconcept risk||enhanc preconcept||preconcept behavior||preconcept factor||preconcept care practic||preconcept care knowledg||preconcept care innov||preconcept care trial||comprehens preconcept care||preconcept health teach,0.722||0.438||0.414||0.399||0.395||0.375||0.366||0.366||0.362||0.338||0.315||0.301||0.294||0.294||0.281,0.8,0.4,0.26666666666666666
897,Pharm_World_Sci-4-1-2253652.txt,cancer||complementari treatment option||system||support medic||health care profession||consequ||medic error||system cancer therapi||problem||care process||patient||risk||cancer chemotherapi||oncolog||drug-rel problem||chemotherapi||advers effect||process||specif contribut||prescript||medic||drug regimen||clinic trial||treatment||cancer patient||pharmaceut care||drp||research||analysi||pharmacist||oncolog pharmaci||order||pharmaceut care concept||drug||adr||interact||physician||adher||error||cochran librari,pharm||pharmaceut care||drug||chemotherapi pharm||cancer||cancer patient pharm||pharmaceut care issu||pharmaceut care process||pharmacist||oncolog||pharmaceut care concept||commun pharm||cancer chemotherapi||drug interact||pharmaceut valid,0.298||0.234||0.211||0.207||0.197||0.191||0.164||0.164||0.163||0.161||0.16||0.158||0.157||0.149||0.147,0.6,0.5,0.4666666666666667
898,Eur_Arch_Otorhinolaryngol-2-2-1705529.txt,flap||periosteum||volum||mastoidectomi caviti||studi||caviti||open caviti problem||cmof||small meatoplasti||eac||eac volum||neo-osteogenesi||fascioperiost flap||patient||year||meatoplasti||radic mastoidectomi||mastoid obliter,eac||mastoidectomi caviti||radic mastoidectomi||radic mastoidectomi caviti||meatoplasti||mastoid||mastoidectomi elimin||simpl mastoidectomi||open caviti mastoidectomi||mastoid caviti||caviti||cmof||eac reconstruct||eac volum||radic mastoidectomi indic,0.366||0.344||0.288||0.265||0.252||0.244||0.24||0.239||0.234||0.232||0.219||0.216||0.215||0.207||0.193,0.8,0.4,0.4666666666666667
899,Matern_Child_Health_J-2-2-1592250.txt,report||risk||health||alcohol consumpt||level||women||high rate||alcohol||screen||assess||alcohol-expos pregnanc||age||individu||pregnanc||intervent||fa||effect contracept||fetal alcohol syndrom||bing drink,alcohol-expos pregnanc||pregnanc||alcohol||cdc alcohol||pregnanc postpon||alcohol-expos pregnanc 7 8 www.preventiveservices.ahrq.gov||alcohol syndrom||pregnanc occur||summari alcohol||alcohol misus||alcohol exposur||prenat alcohol||alcohol consumpt||fetal alcohol syndrom||rlf,0.466||0.376||0.333||0.208||0.205||0.197||0.194||0.192||0.185||0.183||0.179||0.178||0.176||0.168||0.154,0.6,0.3,0.3333333333333333
900,Int_J_Hematol-4-1-2330060.txt,gene||respons||express||activ||cell type||cell,hox||hox gene||keyword hox||hox hox hoxd10 hoxd11 hoxd12||rel express hox hoxa2 hox||hox gene express||humphri RK hox regul||s12185-008-0057-8 origin articl hox gene||largman||homeobox gene||homeobox gene hoxa9||gene||hoxb gene||hematopoiesi||hoxa5,0.864||0.466||0.432||0.368||0.366||0.324||0.234||0.193||0.087||0.075||0.069||0.068||0.063||0.062||0.058,0.0,0.0,0.06666666666666667
901,Gene-2-1-2270349.txt,respir||rate||oligomycin||bioenerget capac||effect||haplogroup||oxid phosphoryl||human popul||cybrid||cell||ident nuclear dna||bioenerget differ||nuclear gene||analysi||mitochondria||differ||intact cybrid||proton leak||atp synthesi||triphenylmethylphosphonium||result,haplogroup||ψ||mitochondri haplogroup||mtdna haplogroup||al.||2007 ψ ψ ψ ψ brand||1 ψ ψ ψ brand||mitochondri dna haplogroup||1990 ψ ψ||ineffici mitochondri haplogroup||mitochondri haplogroup oper||haplogroup associ||cybrid||human mtdna haplogroup||brand,0.512||0.4||0.388||0.331||0.314||0.305||0.285||0.277||0.27||0.262||0.261||0.26||0.249||0.229||0.223,0.2,0.1,0.13333333333333333
902,Pediatr_Radiol-4-1-2292491.txt,pituitari siderosi||method||mri||place||studi||patient||correl||liver biopsi||myocardium||pituitari gland||iron||time domain||signal intens ratio||relax||iron elimin||age||relaxometri||iron overload||organ dysfunct||liver||relaxometri method||ferritin||order||thalassaemia||tissu iron||chelat therapi||multipl echo||liver siderosi,iron||iron overload||liver iron||iron chelat||myocardi iron||pituitari iron overload||liver iron overload||iron deposit||iron content||iron store||tissu iron||transferrin-receptor-independ iron||cellular iron||iron load||myocardi iron overload,0.591||0.414||0.352||0.351||0.331||0.315||0.314||0.31||0.307||0.306||0.306||0.303||0.3||0.3||0.299,0.4,0.2,0.2
903,Int_J_Cardiovasc_Imaging-3-1-2048827.txt,TV leaflet shape||measur||TV anatomi||cross-sect view||TV leaflet||leaflet||imag||studi||patient||normal TV||TV annulu diamet||commissur width||assess||analysi||agreement||commissur||tricuspid annulu shape||qualit assess||area||standard two-dimension echocardiographi||suffici||inadequ,tricuspid||tricuspid valv||valv tricuspid||TV||tricuspid valv leaflet||TV leaflet||tricuspid valv annulu||leaflet||rt3de imag tricuspid||tricuspid regurgit||TV annulu||anterior tricuspid valv leaflet||tricuspid valv area||tricuspid valv repair||tricuspid valv morpholog,0.544||0.404||0.404||0.388||0.375||0.351||0.338||0.315||0.302||0.297||0.297||0.286||0.283||0.274||0.273,0.0,0.2,0.13333333333333333
904,Evid_Based_Complement_Alternat_Med-4-1-1810371.txt,dna damag||anim||consumpt||high level||tobacco smoke||year||regular intak||effect||risk||period||latent period||epidemiolog studi||dose||evid||non-smok||cell||tea||smoke||day||tobacco||carcinogen||mice||long durat||human trial||exposur||cup||smoker||lung cancer||trial||chemoprevent effect||green tea,tea||green tea||tea polyphenol||tea consumpt||tea antioxid||black tea||tea 2||green tea polyphenol||green tea consumpt||green tea intak||green tea exposur||green tea mutat||green tea extract||green tea reduc||green tea eur,0.8||0.501||0.486||0.441||0.425||0.409||0.4||0.391||0.361||0.347||0.347||0.338||0.338||0.337||0.335,0.4,0.2,0.13333333333333333
905,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2226194.txt,studi||patient||flexion||postop knee kinemat||rotat||stair ascent||signific||dynam stair activ||knee arthroplasti||posterior cruciat||control||stair activ||activ||tibial rotat||group||differ||ligament||knee||knee kinemat||previou report||condylar contact||static knee flexion||averag center||spreader||posterior||anterior femor translat||techniqu,knee||knee arthroplasti||knee kinemat||knee arthroplasti kinemat||arthroplasti||mobile-bear knee arthroplasti||cruciate-retain knee arthroplasti||total knee arthroplasti||knee motion||valgu knee||varu knee||knee kinemat tka||knee joint||total knee||s00167-007-0447-0 knee,0.579||0.485||0.433||0.419||0.391||0.339||0.339||0.332||0.328||0.324||0.314||0.309||0.305||0.303||0.298,0.6,0.3,0.2
906,Trans_R_Soc_Trop_Med_Hyg-1-5-1950430.txt,unpublish data||preval||pregnanc||aor||sampl||studi||effect||malaria||stool sampl||hiv infect||infect||hookworm infect intens||hookworm||women||estim||analysi||anaemia||associ||moder||intens||import||uganda||epg||helminth||trial||hiv||result,helminth||anaemia||pregnanc helminth||al.||helminth infect||malaria||anaemia Hb||soil-transmit helminth||hookworm||anaemia strongyloid mansonella mansonella||mild-to-moder anaemia||uganda||3.6 anaemia||sever anaemia||soil-transmit helminth infect,0.353||0.338||0.252||0.235||0.233||0.217||0.204||0.191||0.186||0.18||0.179||0.178||0.171||0.171||0.165,0.4,0.4,0.3333333333333333
907,J_Gastrointest_Surg-3-1-1852375.txt,gastrointestin symptom||case||genit ulcer||ileocec resect||surgic resect||patient||year||seri||intestin perfor||lesion||reperfor||ocular lesion||ulcer||intestin ulcer||age||intestin involv||oral ulcer||symptom||resect||diseas||diagnosi,behçet||intestin behçet||behçet ’s||ileocec resect||behçet ’s diseas||behçet ’s syndrom||ileum||keyword behçet ’s||intestin behçet ’s diseas||perfor intestin behçet ’s diseas||resect||ileocec region||behçet ’s diseas criteria||ileocec resect group||ileocec resect 18,0.697||0.423||0.38||0.302||0.266||0.264||0.258||0.253||0.237||0.218||0.215||0.205||0.203||0.202||0.202,0.2,0.1,0.13333333333333333
908,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998890.txt,gep tumour||tumour||follow-up||administr||fsh concentr||chi-squar test||side-effect||progress diseas||final dose||dose||uptak||patient||treatment||therapi||octreot,177||177 177 177||tumour||1. 177 lu-octreot||octreot||gep tumour||octreot kwekkeboom||dose||lutetium-177 gep tumour||sandostatin||neuroendocrin tumour||tumour deposit||tumour progress||small tumour||tumour growth,0.339||0.339||0.23||0.22||0.203||0.186||0.147||0.144||0.141||0.136||0.131||0.126||0.124||0.121||0.12,0.4,0.4,0.26666666666666666
909,Int_J_Colorectal_Dis-4-1-2225995.txt,placebo||certolizumab pegol 400 mg||placebo respons rate||infliximab||efficaci||baselin||studi||patient||life||inflammatori bowel diseas||effect||domain||improv||analys||treatment||certolizumab pegol||offici||crp||symptom||clinic benefit||clinic efficaci||phase iii studi||diseas||hrqol||ibdq||cdai score,certolizumab pegol||certolizumab||subcutan certolizumab pegol||certolizumab pegol treatment||certolizumab pegol 400 mg||subcutan certolizumab||crohn diseas||ibdq||certolizumab pegol 400 mg improv hrqol||certolizumab pegol 100 mg group||s00384-007-0395-7 origin articl certolizumab pegol||pegol 400 mg||crohn ’s diseas||certolizumab pegol 100 mg treatment group||feagan,0.472||0.472||0.33||0.322||0.261||0.26||0.24||0.221||0.204||0.204||0.192||0.191||0.178||0.173||0.173,0.4,0.3,0.2
910,Naturwissenschaften-3-1-1829419.txt,behavior||ii||studi||ci||serotonin receptor||bee||marker||region||defens respons||receptor||trait||express||ortholog||pollen||analys||defens behavior||gene||clone||map||qtl||ovariol number||cdna||natur variat||influenc||number||candid gene||coloni||behavior genet||step||sequenc,honeybe||bee||honeybe forag||qtl||api mellifera||drosophila||honeybe ecotyp||honeybe divis||behavior||guard bee||honeybe social behavior||african honeybe||honey bee||forag||high-defens bee,0.352||0.282||0.265||0.216||0.205||0.198||0.191||0.186||0.186||0.185||0.185||0.183||0.183||0.178||0.164,0.4,0.3,0.2
911,Neuroradiology-3-1-2082066.txt,axial imag||find||rate||studi||patient||aneurysm||middl cerebr arteri||angiographi||risk||inconclus find||unenhanc CT||treatment||rebleed||intern carotid arteri||endovascular treatment||raw date imag||subarachnoid haemorrhag||surgeri||distribut||ia-dsa||cta||diagnost modal||neg||neuroradiologist||sah||vessel loop||posterior||result,aneurysm||cta||intracrani aneurysm||ruptur aneurysm||ia-dsa||cerebr aneurysm||asymptomat aneurysm||symptomat aneurysm||vertebrobasilar aneurysm||aneurysm true||proven aneurysm||aneurysm surgeri||aneurysm detect||addit aneurysm||29 aneurysm,0.612||0.484||0.389||0.377||0.352||0.331||0.32||0.319||0.316||0.315||0.314||0.312||0.312||0.308||0.307,0.6,0.3,0.2
912,Purinergic_Signal-3-4-2072913.txt,atp||ntpdase||swelling-inhibitori effect||A1 receptor||extracellular degrad||enzym||retina||receptor||rat retina||releas||neuron||retin parenchyma||ectonucleotidas||nuclear layer||retin slice||glutam||activ||agonist||cell||extracellular metabol,retin||müller||retin glial müller cell||retina||retin müller cell||retin glial cell||ectonucleotidas||zimmermann||müller cell||glial cell||retin slice||atp||retin vasculogenesi||leipzig||glial purinerg signal,0.248||0.237||0.201||0.199||0.192||0.189||0.18||0.177||0.164||0.159||0.157||0.153||0.152||0.15||0.149,0.2,0.2,0.26666666666666666
913,Exp_Brain_Res-4-1-2190788.txt,asynchron AV stimulu pair||respons||tempor ventriloqu||vroomen||locat||spatial dispar||effect||stimulu gener||short exposur phase||visual task||present studi||gelder||spatial separ||jnd||test stimuli||task||pss||exposur||tempor order judgment||keetel||trial||particip||shift||tempor recalibr||sound||result,sound||exposur sound||sound locat||tempor ventriloqu||test sound||tempor recalibr||tempor percept||sound alter||auditori||spatial ventriloqu||sound observ||sound local||auditori spatial percept||ventriloqu||bertelson,0.403||0.282||0.236||0.226||0.226||0.222||0.218||0.21||0.208||0.207||0.204||0.203||0.201||0.19||0.19,0.4,0.3,0.2
914,Eur_J_Clin_Pharmacol-3-1-1914304.txt,intern databas||case||databas||studi||apd||patient||ror||risk||bodi temperatur||case report||hypothermia||associ||factor||report||literatur search||hypotherm effect||number||drug||adr||risk factor||antipsychot||advers drug reaction||schizophrenia,hypothermia||hypothermia report||accident hypothermia||chlorpromazine-induc hypothermia||neuroleptic-induc hypothermia||hypothermia risk||hypothermia number||mild hypothermia||extrem hypothermia||s00228-007-0294-4 short commun hypothermia||apd||antipsychot||interv drug chang detect hypothermia||antipsychot drug||adr,0.814||0.435||0.426||0.416||0.416||0.415||0.411||0.41||0.41||0.21||0.203||0.192||0.187||0.145||0.125,0.2,0.1,0.26666666666666666
915,Int_J_Cardiovasc_Imaging-4-1-2233707.txt,control||LV dysfunct||mad||mitral annulu||studi||nccm patient||laef||noncompact||subject||maa||patient||noncompact cardiomyopathi||LA function||present studi||control subject||nccm||result,nccm||noncompact||mitral annulu||noncompact cardiomyopathi||3d-maa||ventricular noncompact||atrial systol||noncompact cardiomyopathi rt3de||3D||3D 3D||echocardiographi noncompact atrial function||mitral annulu diamet||mitral inflow||echocardiographi 3D||rt3de,0.317||0.291||0.251||0.216||0.205||0.204||0.203||0.202||0.2||0.2||0.198||0.192||0.183||0.183||0.173,0.8,0.4,0.26666666666666666
916,J_Headache_Pain-4-1-2245994.txt,level||olcegep||studi||cgrp receptor blocker||effect||human||increas||cgrp||migrain attack||receptor||relief||side effect||treatment||advers event||headach||trigemino-cerebrovascular system||pain||action||arteri||acut attack||trigemin ganglion||cardiovascular side effect||migrain||triptan||addit||mk-0974||coronari blood flow,migrain||cgrp||migrain headach||peptid cgrp||migrain attack||cgrp receptor||acut migrain attack migrain||cgrp antagonist||acut migrain||calcitonin||migrain drug||edvinsson||cgrp antibodi||migrain headach pathophysiolog||cgrp receptor antagonist,0.441||0.423||0.307||0.265||0.265||0.263||0.255||0.245||0.245||0.235||0.232||0.217||0.214||0.21||0.198,0.6,0.3,0.2
917,Neurosci_Lett-2-1-2330064.txt,p2i||adp||spinal cord,"p2y1||adp||receptor||self-ratio||spinal cord||1,12||gachet christian||techn||erk phosphoryl||gachet C. evan r.j||neurosci||neuron ca2||adp respons||dorsal spinal cord||human p2y1 receptor stimul",0.205||0.183||0.131||0.126||0.125||0.114||0.107||0.107||0.105||0.103||0.103||0.102||0.097||0.093||0.092,0.4,0.2,0.13333333333333333
918,J_Abnorm_Child_Psychol-3-1-1915626.txt,depress symptom||boy||behavior||good learner||problem||data||studi||earli adolesc||depress||school||peer||effect||human||sport||scale||domain||social hierarchi||relev||girl||research||gender||associ||gender differ||nomin||social group||classroom social statu||differ||high||statu||trail||adolesc||achievement-rel domain||area||depress problem||intermedi||children||result,peer||depress||peer statu||adolesc||statu||peer statu journal||depress girl||peer nomin||low peer statu||peer reject peer reject||peer reject||classroom peer statu||adolesc depress journal||high peer statu||depress boy,0.351||0.317||0.285||0.226||0.218||0.214||0.214||0.211||0.211||0.211||0.211||0.207||0.206||0.204||0.201,0.8,0.4,0.26666666666666666
919,Immunogenetics-4-1-2206249.txt,variat||major indel||dbb||databas||data||studi||gene annot||mann||annot data||loci||region||human genom||cluster||haplotyp sequenc||gene||pgf||annot||analysi||popul||popul level||mhc||cox||qbl||european popul||major histocompat complex||popul genet||segment||mcf||founder haplotyp||diseas||haplotyp||sequenc||mhc refer sequenc,haplotyp||hla haplotyp||mcf haplotyp||pgf haplotyp||ssto haplotyp||haplotyp apd||mhc haplotyp||hla||pgf haplotyp annot||sequenc hla haplotyp||haplotyp sequenc||sequenc haplotyp||mann haplotyp||pgf haplotyp sequenc||drb1 hla,0.243||0.202||0.186||0.183||0.176||0.173||0.168||0.161||0.157||0.155||0.152||0.152||0.146||0.142||0.141,0.2,0.1,0.13333333333333333
920,Neurosurg_Rev-2-2-1564192.txt,time||logist regress analysi||radiolog featur||patient||recurr||correl||volum||edema||mib-1||low densiti area||male||cell||growth||potenti||multipl||age||characterist||higher growth rate||tumor||growth potenti||meningioma||independ risk factor||high prolif potenti||index||skull base,meningioma||mib-1||incident meningioma||342 meningioma mib-1||recurr meningioma||342 meningioma||symptomat meningioma||intracrani meningioma||anaplast meningioma||asymptomat meningioma||iii meningioma||multipl meningioma||keyword growth meningioma mib-1||recurr intracrani meningioma||meningioma kasuya hidetoshi,0.757||0.428||0.417||0.414||0.409||0.407||0.402||0.396||0.39||0.39||0.388||0.385||0.305||0.284||0.274,0.4,0.2,0.13333333333333333
921,Purinergic_Signal-4-2-2377323.txt,chlorid channel||releas||data||channel||atp||effect||current||apic solut||treatment||cell||solut||enac||experi||apic||amilorid||activ||atp releas||addit||camp||cftr||monolay,sc||basal-i sc||as-i sc||ds-i sc||sc tg-initi tg-late||physiol renal physiol 275||physiol renal physiol 268||physiol renal physiol 271||physiol renal physiol 277||physiol renal physiol 286:682||physiol renal physiol 254||physiol renal physiol 287||physiol renal physiol 274||physiol renal physiol 280||physiol renal physiol 282,0.924||0.466||0.466||0.466||0.314||0.092||0.092||0.092||0.092||0.092||0.091||0.091||0.091||0.091||0.09,0.0,0.0,0.0
922,Histochem_Cell_Biol-4-1-2386528.txt,cancer||role||centriol||studi||centrosom cycl||katanin||complex||cell divis||mtoc||centrosom||mitosi||cell||sperm||cell cycl regul||aurora kinas||numa||research||protein||duplic||associ||spindl||schatten||cell cycl||accumul||centrosom protein||microtubul||number||scnt||centrosom function||formamid||diseas||plk||result,centrosom||human centrosom centrosom||mitot centrosom||centrosom protein||centrosom cycl||interphas centrosom||centrosom microsc||centrosom duplic||centrosom regul||centrosom anom||centrosom abnorm||abnorm centrosom||mammalian centrosom||centrosom complex||centrosom overdupl,0.858||0.575||0.47||0.452||0.448||0.445||0.443||0.443||0.442||0.44||0.439||0.439||0.438||0.437||0.437,0.6,0.3,0.2
923,Pediatr_Surg_Int-4-1-2248216.txt,time||major ccvd||abnorm||studi||patient||congenit malform||IM patient||mortal||risk||congenit defect||correct||morbid||age||associ||popul||ccvd||high morbid rate||intestin malrot||IM diagnosi||risk factor||IM surgeri||post-op morbid||cardiovascular complic||syndrom,ccvd||ccvd major ccvd minor ccvd||ccvd surgeri||minor ccvd||major ccvd||ccvd sign||co-exist ccvd||ccvd diagnosi||ccvd subgroup||mild ccvd||ccvd group||structur ccvd||malrot||physic ccvd sign||physic sign ccvd,0.811||0.501||0.443||0.426||0.421||0.416||0.415||0.412||0.41||0.407||0.406||0.406||0.314||0.283||0.283,0.4,0.2,0.13333333333333333
924,J_Interv_Card_Electrophysiol-4-1-2292477.txt,follow-up||chronic success rate||afl||cryoablat||histori||common type afl||data||patient||year||recurr||atrial fibril||atrial flutter||cti||long term follow-up||month||popul||late recurr||long term outcom||cavotricuspid isthmu||procedur||larg popul||acut success,atrial flutter||flutter||atrial ablat||atrial fibril||atrial flutter journal||S. atrial flutter||lone atrial flutter||atrial flutter pace||common atrial flutter||typic atrial flutter||atrial flutter ablat journal||isol atrial flutter||atrial flutter progress||atrial flutter trial||atrial isthmu ablat,0.502||0.442||0.43||0.399||0.35||0.346||0.344||0.344||0.343||0.342||0.337||0.335||0.335||0.335||0.328,0.4,0.2,0.13333333333333333
925,Mol_Immunol-1-5-2075531.txt,amino acid differ||antibodi||igg||condit||respons||glycan||pbs-t||equin||glycosyl||half molecul||ehv-1||chain||fcγr||region||pbl||reactiv||strong respiratori burst||nip||subclass||residu||hors||human serum||potent activ||bind||reqigg||human igg||elisa||molecul,reqigg||al.||reqigg subclass||subclass||igg subclass||equin igg subclass||igg||equin igg||equin||anti-hors igg||igg7 subclass||sheoran||igg7||equin igg1||igg4,0.276||0.273||0.261||0.246||0.241||0.239||0.236||0.235||0.234||0.234||0.233||0.232||0.221||0.216||0.213,0.4,0.4,0.26666666666666666
926,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-2082657.txt,attach area||arthroscop view||tunnel placement||line||anterior cruciat ligament||centr||studi||landmark||anatom posit||amb||bundl||anteromedi bundl||plb||double-bundl acl reconstruct||tibia||notch||distanc||arthroscop procedur||tibial attach||acl||femur||attach geometri||notch roof||posterolater bundl||tunnel posit||refer line||posit||intercondylar notch||shallow||knee||area||attach||result,cruciat ligament||ligament||anterior cruciat ligament||anterior cruciat||cruciat ligament reconstruct||anterior cruciat ligament reconstruct||anterior cruciat ligament attach||knee ligament||anterior cruciat ligament graft||posterior cruciat ligament||acl||human cruciat ligament||anterior cruciat ligament instabl||human anterior cruciat ligament||anatom anterior cruciat ligament reconstruct,0.412||0.379||0.354||0.342||0.331||0.308||0.302||0.291||0.287||0.283||0.278||0.276||0.268||0.267||0.265,0.2,0.1,0.13333333333333333
927,Eur_J_Clin_Pharmacol-4-1-2329724.txt,train programm||addit train||case||skill||session||classic curriculum||person formulari||studi||patient||univers||gener problem-bas curriculum||effect||posttest||treatment||facilit||train||formulari||ration prescrib||patient case||group||differ||prescrib||student||drug||score||result,formulari||student||person formulari||formulari group||oxford formulari||basic formulari||nation formulari||teach||person formulari group||pharmacolog teach||british nation formulari||medic student||posttest||pharmacolog||problem-bas teach,0.596||0.357||0.342||0.318||0.316||0.306||0.302||0.245||0.241||0.213||0.213||0.199||0.196||0.181||0.179,0.6,0.3,0.26666666666666666
928,J_Comput_Aided_Mol_Des-4-1-2270923.txt,metric||target||set||method||system||popular measur||measur||individu error bar||simpl||studi||valu||question||extens properti||extens quantiti||correl||virtual screen||exampl||intrins properti||test||compound||evid||cost||decoy||independ||properti||goal||approach||varianc||dud||curv||experi||averag properti||experiment design||activ||gener||auc||true posit rare||field||number||perform||screen||bedroc||procedur||extens||design||earli enrich||score||result,text||text TP||decoy||drug-lik decoy||var||auc||metric||virtual screen metric||virtual screen||bedroc||dud-self decoy||decoy type||decoy 2||drug-lik||virtual screen metric 26,0.329||0.168||0.135||0.101||0.092||0.089||0.085||0.085||0.085||0.08||0.078||0.069||0.068||0.067||0.064,0.2,0.5,0.3333333333333333
929,Semin_Immunopathol-4-1-2315689.txt,endotheli cell||role||inflamm||selectin||endothelium||integrin||inflam venul||local microenviron||bone marrow||leukocyt migrat||site||migrat||recruit||express||cystein molecul||separ anatom site||leukocyt adhes cascad||inflammatori site||rpe||cell||retina||adhes||retin pigment epithelium||inflammatori condit||tissu||tight junction||leukocyt||lymphocyt||brb||immun privileg||bind||monocyt||retin antigen||uveiti||eau||molecul||chemokin||function||barrier,leukocyt||liversidg||chemokin||retina||forrest JV liversidg||retin barrier||retina barrier||leukocyt migrat||autoimmun||leukocyt adhes||autoimmun uveiti||uveiti||forrest JV||autoimmun uveoretin||barrier,0.259||0.258||0.248||0.229||0.202||0.197||0.197||0.19||0.181||0.179||0.178||0.175||0.174||0.17||0.164,0.6,0.4,0.4
930,Matern_Child_Health_J-2-2-1592155.txt,program||safe motherhood||infant||pregnanc||intern||matern||reproduct health||inform||health promot||promot||recommend||intervent||countri||safe motherhood initi||health||child surviv||preconcept care||women||polici||care||declar||preconcept counsel||activ||numer factor||famili plan||pregnanc outcom||children,preconcept||preconcept care||preconcept health||preconcept counsel||preconcept health care||keyword preconcept||preconcept care program||preconcept care servic||preconcept care family-centr matern||preconcept health educ||preconcept health puzzl||preconcept care strategi||preconcept care activ||preconcept health initi||matern,0.633||0.42||0.416||0.349||0.346||0.317||0.307||0.288||0.285||0.285||0.283||0.283||0.282||0.281||0.251,0.4,0.2,0.2
931,Int_J_Parasitol-1-5-1885961.txt,method||subolesin||engorg femal||reduct||control group||studi||bm91||femal||egg||total rna||adult||bm86||day||gene||control||larva||analysi||rnai||rel humid||dsrna||group||oligonucleotid primer||tick||inject||rna||result,subolesin||bm86||bm91 subolesin bm86||bm86 bm91||bm91||dsrna bm86 bm91 subolesin bm86||bm86 bm91 subolesin bm86 subolesin B.||bm91 subolesin bm86 bm91 subolesin gene||egg bm86 bm91 subolesin bm86||subolesin dsrna||bm86 bm91 willadsen||boophilu microplu||bm86 subolesin 82||fig. 5 bm86 bm91 bm86 bm91||fig. 1 bm91 bm91 bm91 subolesin,0.462||0.433||0.424||0.405||0.376||0.376||0.371||0.355||0.348||0.318||0.303||0.302||0.299||0.271||0.266,0.6,0.3,0.2
932,Plant_Mol_Biol-3-1-1876254.txt,nerolidol synthas||monoterpen synthas||jasmon acid||petiol||linalool||trichom||amino acid||terpen||herbivori||leav||nerolidol||product||transcript||protein||enzym||min||cdna||tomato||emiss||spider mite||linalool emiss||root||plant,lemts1||lemts1 lemts2 lemts1||lemts1 lemts2 lemts1 lemts2 lemts1 lemts1||lemts1 lemts2||gel lemts1 lemts1 lemts1 9||lemts1 overexpress||lemts1 express||recombin lemts1||lemts1 function||discuss 2004 lemts1 lemts2 lemts1||result lemts1 lemts2||lemts2||lemts1 wipi-ii rce1||transgen tomato plant lemts1||lemts1 nahg rce1,0.681||0.559||0.559||0.498||0.411||0.351||0.351||0.344||0.343||0.336||0.332||0.314||0.293||0.274||0.268,0.0,0.0,0.0
933,Virchows_Arch-4-1-2329729.txt,follow-up||atyp intraduct epitheli prolifer||mammographi||core||carcinoma||studi||risk lesion||patient||excis||classic lobular neoplasia||core biopsi diagnosi||calcif||risk||diagnost surgic excis||pleomorph lci||dci||site||core biopsi||lesion||lci||surgic biopsi||women||fibrocyst chang||lobular neoplasia||literatur||biopsi||columnar cell chang||radiolog||malign||diagnosi||breast,lobular||lobular neoplasia||biopsi||lobular carcinoma||core biopsi||neoplasia lobular carcinoma||core||breast core biopsi||pleomorph lobular carcinoma||lobular hyperplasia||classic lobular neoplasia||core biopsi forty-nin core biopsi||breast biopsi||neoplasia||situ lobular carcinoma,0.5||0.384||0.368||0.342||0.334||0.317||0.299||0.279||0.274||0.274||0.271||0.269||0.269||0.267||0.261,0.6,0.4,0.3333333333333333
934,Int_J_Colorectal_Dis-4-1-2225996.txt,respect cytokin||role||respons||real-tim pcr||induct||import role||nuclear factor||strong synergist effect||combin||synergist effect||studi||data||inflammatori bowel diseas||effect||express||cell||protein secret||iec||protein||intestin epitheli cell||cytokin||secret||mrna||chemokin,cxcl10||ifn-γ||cxcl10 mrna||cxcl10 express||ifn-γ-induc cxcl10||cxcl10 gene||cxcl10 secret||cxcl10 promot||human cxcl10||cxcl10 protect||il-1β||cxcl10 mrna express||ifn-γ-induc cxcl10 mrna||cxcl10 gene express||ifn-gamma-induc cxcl10 express,0.584||0.336||0.323||0.323||0.315||0.315||0.314||0.305||0.304||0.296||0.272||0.236||0.231||0.231||0.229,0.0,0.0,0.0
935,J_Biol_Inorg_Chem-3-1-2099460.txt,serr||activ site||activ form||studi||state||amount||electrod||spectra||heme iron||electrod surfac||interfaci electr field||Ag electrod||cell||activ enzym||potenti||cyp||solut||enzym||protein||coat electrod||imidazol||potassium phosphat buffer||supplementari materi||intens||buffer||heme||band||presenc||substrat||experiment data||detail structur inform,cyp2d6||cyp2d6 heme||immobil cyp2d6||hildebrandt||ν 4||cyp2d6 substrat||heme||adsorb cyp2d6||electrod||imidazol||cyp2d6 inactiv||cyp2d6 escherichia||heme enzym||thiolat enzym cyp2d6||murgida DH hildebrandt,0.269||0.218||0.201||0.192||0.192||0.17||0.166||0.163||0.151||0.15||0.146||0.138||0.138||0.138||0.134,0.0,0.3,0.2
936,Environ_Manage-4-1-2359833.txt,water sector||government regul||provis||infrastructur||capit shortag||financi risk||servic qualiti||water||develop||maanshan||invest||tariff reform||current landscap||energi||public-priv partnership||water govern||urban water govern||manag||bot project||govern||public util||china||mwsl||servic||joint ventur||wastewat treatment||polici paper||contract||local offici||legal system||bcg||capit||macau||environment state||access||privat sector involv||privat||privat sector||public||particip||maswsc||local resid||construct,privat sector||water sector||privat||water||wastewat sector||water suppli sector||water sector reform||public sector||privat sector particip||chines water sector||privat sector involv||sector reform||privat sector participation.||privat sector role||infrastructur sector,0.46||0.438||0.398||0.353||0.341||0.326||0.325||0.322||0.32||0.32||0.313||0.311||0.31||0.309||0.294,0.8,0.4,0.3333333333333333
937,Exp_Brain_Res-3-1-1914263.txt,condit||muscl||trial block||magnitud||orient||effect||space||inform||percept||rel||test||limb orient||forearm||mass||line segment 1||pattern||joint angl||signal||kinesthesi||gravit torqu||mass vector||elbow||effort||static torqu||manipul||torqu||line segment||experi||propriocept||vertic plane||upper arm||limb||inerti eigenvector||trial||particip||error||angl||result,CM||CM CM||CM CM CM CM||arm CM||arm||3 CM 2005 CM CM CM||3 CM CM||forearm||arm orient||tan CM||curv CM||propriocept||solid curv CM CM||flex arm||limb propriocept,0.411||0.411||0.411||0.366||0.321||0.275||0.274||0.247||0.238||0.214||0.213||0.213||0.213||0.212||0.21,0.0,0.1,0.13333333333333333
938,Plant_Mol_Biol-4-1-2268718.txt,anim||categori||system||depend||environment situat||secondari activ transport||rice||membran transport||nucleosid||channel||ion||transport system||biolog activ||organ||increas||amino acid||diverg||transport||transport gene||specif||cell||gene||divers||control||arabidopsi||protein||environment condit||biolog system||prokaryot||pump||gradient||number||substanc||osmot pressur||bacteria||plasma membran||membran||plant,transport||plant||transport gene||anti||membran transport||ion transport||arabidopsi||membran transport gene||secondari transport||water transport||cation transport||arabidopsi peptid transport||transport system||channel transport gene||glutam transport,0.194||0.157||0.134||0.13||0.129||0.119||0.111||0.111||0.11||0.107||0.105||0.105||0.105||0.105||0.105,0.8,0.5,0.4
939,J_Comp_Physiol_A_Neuroethol_Sens_Neural_Behav_Physiol-3-1-1915583.txt,respons||feed respons||host plant||host||concentr||leaf disc||cold receptor||sensit||receptor||compound||behaviour||cell||stimuli||palp||group||rosacea||record||lepidoptera||evolutionari relict||speci||sensilla||adapt speciat||benzaldehyd||larva,yponomeuta cagnagellu||yponomeuta||yponomeuta Y. cagnagellu||Y. cagnagellu||Y. cagnagellu Y. cagnagellu Y.||Y. cagnagellu Y.||yponomeuta plumbellu||yponomeuta larva||yponomeuta caterpillar||yponomeuta speci||crataegu yponomeuta||Y. cagnagellu 1979 Y.||method insect Y. cagnagellu Y.||water tpm yponomeuta cagnagellu euonymu||lepidoptera,0.495||0.455||0.389||0.355||0.32||0.296||0.284||0.279||0.265||0.253||0.233||0.226||0.215||0.21||0.196,0.0,0.0,0.06666666666666667
940,Eur_J_Nutr-2-2-1705523.txt,anim||week||triglycerid level||model||studi||stanol ester||cholesterol||sesamin||effect||human||atherogen diet||intervent||analys||rat||lignan||mice||serum cholesterol||group||pure sesamin epim||cholesterol reduct||result,sesamin||dietari sesamin||sesamin epim||sesamin enterolignan||sesamin prepar||conclus sesamin||pure sesamin epim||appelqvist LA sesamin||sesamin 8 8.01||lignan||sesam lignan||sesam||sesam seed lignan||dietari lignan||sugano,0.758||0.417||0.413||0.388||0.381||0.38||0.28||0.26||0.258||0.246||0.235||0.224||0.171||0.161||0.161,0.2,0.3,0.2
941,Matern_Child_Health_J-2-2-1592141.txt,risk||cancer||ovarian stimul||chemotherapi||agent||ovarian failur||icsi||women||radiat therapi||ovarian tissu||radiat||fertil||rate||pregnanc||chemotherapi agent||young cancer survivor||treatment,fertil||cancer||pregnanc||breast cancer||ovarian failur||vitro fertil||childhood cancer||fertil issu||ovarian tissu||fertil rate||ovarian stimul||ivf||fertil preserv option||jncimonograph||ovarian surgeri,0.342||0.274||0.24||0.193||0.187||0.184||0.183||0.18||0.179||0.179||0.176||0.173||0.172||0.164||0.163,0.8,0.5,0.4
942,Pediatr_Nephrol-3-1-2100434.txt,igfbp||level||final adult height||ckd||growth hormon||renal failur||patient||end-stag renal diseas||insulin-lik growth factor||effect||ghrelin||rhgh||growth failur||treatment||growth||glomerular filtrat rate||protein||GH resist||renal function||linear growth||transplant||resist||igfbp displac||age 6 year||GH receptor||axi||children,growth||insulin-lik growth||growth hormon||growth failur||recombin growth hormon||renal failur||growth hormon resist||serum growth hormon||growth hormon treatment||igf-1||insulin-lik growth factor||growth hormon defici||growth hormon secret||insulin-lik growth factor-1||tonshoff,0.321||0.284||0.282||0.244||0.216||0.213||0.207||0.204||0.204||0.2||0.198||0.196||0.196||0.195||0.189,0.6,0.4,0.3333333333333333
943,J_Biomol_NMR-3-1-2039844.txt,variat||order paramet||bond||data||motion||residu dipolar coupl||ensembl||rdc-probe order paramet||addit motion||dynam||rdc||dma||rdc-probe dynam||liquid crystal nmr spectroscopi||protein||molecular align||charg distribut||direct||intern fluctuat||ubiquitin||net electr dipol moment||dispers||bond fluctuat||molecular align fluctuat||molecul||align,vartheta||document||rm||upomega||langl||rangl||align||documentclass||12pt||amsmath||amsfont||mathrsf||69pt||align fluctuat||dipolar coupl,0.092||0.065||0.065||0.058||0.058||0.058||0.053||0.048||0.048||0.048||0.048||0.048||0.048||0.046||0.045,0.0,0.1,0.06666666666666667
944,Purinergic_Signal-3-4-2072911.txt,antibodi||pma||oocyt||direct pkc-mediat phosphoryl||pkc site||atp||current||final concentr||immunoblot||pkc||receptor||phosphoryl||cell||reaction||p2x receptor||protein||min||sds-page||germani||site-direct elimin||immunoprecipit||result,X. laevi||p2x receptor||receptor||xenopu laevi||xenopu laevi oocyt||oocyt||X.||p2x subunit||p2x receptor subtyp||2 3 X. laevi oocyt||purinerg p2x receptor channel||p2x receptor channel desensit||p2x receptor channel function||direct pkc-mediat p2x receptor phosphoryl||receptor desensit,0.306||0.25||0.246||0.246||0.241||0.229||0.219||0.188||0.177||0.169||0.167||0.167||0.155||0.152||0.15,0.4,0.3,0.2
945,Pflugers_Arch-4-1-2270919.txt,fluoresc imag||order||sscm||pit||membran||method||caveola||fluoresc||endocytosi||high resolut||topograph imag||microscopi||topographi||imag||flotillin||high resolut imag||cell||endocyt pit||surfac||indent,pit||endocyt pit||clathrin-co pit||pit indent||nanopipett||topograph imag||sscm||139 pit||singl endocyt pit||endocyt pit rel||imag||fluoresc imag||fluoresc||korchev||imag caveola,0.389||0.289||0.256||0.246||0.23||0.221||0.204||0.197||0.195||0.194||0.186||0.185||0.183||0.179||0.176,0.4,0.4,0.4666666666666667
946,Int_J_Legal_Med-3-1-1794629.txt,y-str||divers||dys643||dys576||loci||tabl||individu||dys481||studi||dys570||intermedi allel||simpl loci||intermediate-s size,y-str||y-str loci||loci||allel||dys576||intermediate-s allel||simpl loci||single-copi simpl y-str||intermediate-s allel dys549||ten loci||peak||dys481 dys570 dys576 dys643 intermedi allel||dys481||dys570||dys643,0.335||0.291||0.247||0.194||0.168||0.154||0.134||0.131||0.13||0.129||0.129||0.128||0.126||0.126||0.126,0.6,0.4,0.4666666666666667
947,J_Mammary_Gland_Biol_Neoplasia-3-1-1820839.txt,upar||transgen model||cancer cell||cancer||role||person commun||transgen||unpublish data||involut||latent growth factor||breast cancer||mmp||studi||model||defici||heterogen genet background||plasminogen||develop||proteas intervent studi||dci||human||stromal cell||similar express pattern||transgen mous model||express||metastasi||similar||cell||singl transgen||protect role||growth factor||mammari epithelium||mice||proteas||extracellular proteas||gene defici||entir gland||activ||tumor||genet alter||mammari gland||PA system||gland||breast||stroma||mammari cancer,transgen||transgen mammari cancer||mammari cancer||mammari gland||mammari tumor||mmp||transgen breast cancer||mammari carcinogenesi||mammari carcinoma||mammari gland involut||proteas||mammari epithelium||breast||transgen mice||mammari gland growth,0.236||0.234||0.234||0.227||0.206||0.188||0.185||0.183||0.181||0.176||0.168||0.168||0.168||0.165||0.164,0.6,0.4,0.4666666666666667
948,Eur_J_Nucl_Med_Mol_Imaging-4-1-2275776.txt,collim||independ predictor||variat||delay||mibg||imag||centr||studi||patient||durat||heart failur||nyha classif||acquisit||present studi||neg correl||ratio||paramet||analysi||prognosi||associ||subject||acquisit paramet||differ||inject||result,123 123||123||123 123 123 123||heart||cardiac||collim||123 123 15 123||123 15 123 123||123i-mibg heart||late heart||123 14 123||conclus 123 123||cardiac metaiodobenzylguanidin imag||heart failur||cardiac iodin 123 mibg,0.243||0.243||0.243||0.216||0.21||0.201||0.183||0.183||0.169||0.164||0.163||0.162||0.155||0.153||0.148,0.0,0.1,0.13333333333333333
949,Pituitary-3-1-1915635.txt,cortisol level||week||surgic treatment||data||visual field defect||patient||year||defici||process||defect||pituitari macroadenoma||recoveri||improv||progress improv||non-funct pituitari macroadenoma||nerv compress||treatment||eye||visual outcom||assess||month||surgeri||visual field recoveri||optic chiasm||visual field||initi surgic treatment||visual acuiti||transsphenoid surgeri,pituitari pituitari||acuiti||visual acuiti||pituitari macroadenoma||transsphenoid surgeri||non-funct pituitari macroadenoma||pituitari adenoma||macroadenoma||transsphenoid treatment||impair visual acuiti||transsphenoid oper||transsphenoid remov||conclus visual acuiti||non-funct pituitari macroadenoma dekker||pituitari tumor,0.408||0.37||0.338||0.329||0.291||0.278||0.277||0.25||0.234||0.231||0.229||0.228||0.226||0.214||0.212,0.6,0.4,0.26666666666666666
950,Qual_Life_Res-3-1-2039790.txt,hospit anxieti||cancer||measur||endoscopi||time||level||upper GI endoscopi||burden||distress||baselin||patient||depress||cancer surveil test||potenti determin||potenti adapt||anxieti||surveil||pattern||signific||specif distress||lower distress||specif||sedat||gener distress||barrett esophagu||pain||upper gastrointestin||reason||group||differ||symptom||discomfort||procedur||depress score||time point||score||upper gastrointestin endoscopi,endoscopi||endoscopi procedur||previou endoscopi||endoscopi differ||endoscopi 320||endoscopi experi||endoscopi 166||multipl endoscopi||endoscopi result||upper GI endoscopi||upper gastrointestin endoscopi||patient request endoscopi||endoscopi endoscop surveil barrett||A. gastrointestin endoscopi||underw upper GI endoscopi,0.632||0.335||0.329||0.325||0.319||0.318||0.318||0.317||0.317||0.298||0.261||0.25||0.237||0.234||0.229,0.2,0.2,0.2
951,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-2042026.txt,follow-up||case||radiograph||bear||studi||year||surviv rate||patient||oper||anteromedi pain||averag||loos femor compon||pain||averag flexion||compon||tibial compon||osteoarthr||surgeon||knee||procedur||revis||score||outcom||result,knee||unicompartment knee||unicompartment knee arthroplasti||unicompartment knee replac||knee arthroplasti||unicompartment knee prosthesi||bear knee||unicompartment arthroplasti||mobile-bear unicompartment knee replac||knee prosthesi||seventeen knee||primari unicompartment knee replac||oper knee||knee societi||marmor knee,0.545||0.522||0.413||0.376||0.37||0.364||0.354||0.347||0.299||0.296||0.288||0.286||0.283||0.282||0.281,0.2,0.1,0.06666666666666667
952,Pediatr_Nephrol-3-1-1766478.txt,blood flow||acut renal failur||cathet||hypoglycemia||expertis||complic||ultrafiltr||rate||patient||dialysi therapi||glucos solut||multi-organ failur||clinic circumst||volum||blood pressur||continu supervis||guidelin||cvvh||arf||therapi||blood||solut||fluid||free flow||dialysi fluid||care||renal function||standard time||hemodialysi||choic||intens care unit||good practic||renal replac therapi||access||prefer therapi||hemofiltr||periton dialysi||blood flow rate||dialysi||extracorpor circuit||buffer-fre solut||extracorpor techniqu||circuit||renal unit||children||techniqu,dialysi||dialysi fluid||periton dialysi||cvvh||dialysi circuit||ultrafiltr||PD dialysi||dialysi therapi||arf||acut periton dialysi||single-needl dialysi||dialysi fluid flow||cvvh circuit||dialysi low||emerg dialysi,0.318||0.228||0.22||0.217||0.216||0.196||0.196||0.184||0.177||0.169||0.169||0.168||0.165||0.163||0.162,0.8,0.7,0.4666666666666667
953,Purinergic_Signal-1-2-2096532.txt,guanosine-depend neurit outgrowth||cyclic gmp||neurit outgrowth||heme oxygenas||pc12 cell||nitric oxid synthas||ngf||carbon monoxid||guanosin||PC 12 cell,guanosin||ngf||outgrowth ngf||ho-1||guanosin ho-1 express||guanosin induc||guanosin receptor||result guanosin||outgrowth||neurit outgrowth||cyclic gmp guanosin heme oxygenas||ngf addit||2.5 ngf||heme||pc12 cell,0.493||0.362||0.283||0.272||0.27||0.262||0.259||0.247||0.203||0.203||0.184||0.183||0.183||0.18||0.178,0.4,0.3,0.26666666666666666
954,Matern_Child_Health_J-2-2-1592153.txt,prevent||set||level||behavior||practic set||knowledg||practic||pregnanc||patient||folic acid||preconcept care visit||nonphysician hcp||variabl||provid||hcp||ntd||women||age||correct amount||care||predictor||multivitamin||health care provid||survey||public health servic||particip||physician,hcp||folic||nonphysician hcp||physician hcp||hcp knowledg||FA||hcp effort||elig nonphysician hcp||folic acid||multivitamin||gyn||fam||nonphysician||assess hcp knowledg||preconcept folic acid,0.463||0.328||0.319||0.286||0.261||0.254||0.243||0.222||0.209||0.208||0.194||0.181||0.176||0.175||0.162,0.4,0.4,0.26666666666666666
955,Purinergic_Signal-3-3-2096642.txt,wateri diarrhea||larg releas||pathogen||method||uss chamber||host||releas||studi||adenosin||effect||strain||diarrheal diseas||amp||cell||infect||host cell||enzym||experi||phosphat||supernat||activ||host cell death||type iii secret||zinc supplement||revers transcript||secret||cell surfac||minim medium||zinc||addit||inhibitor||rna||epec||phosphat releas,ecto-5′-nucleotidas||epec||espf||enteropathogen escherichia coli||ecto-5′-nucleotidas rna||escherichia coli||epec infect||enteropathogen E. coli||enteropathogen escherichia coli infect||enteropathogen escherichia coli sepz||epec diarrhea||E. coli||enteropathogen E. coli e2348||cell-bound ecto-5′-nucleotidas activ||glycosylphosphatidylinositol-anchor enzym ecto-5′-nucleotidas,0.396||0.284||0.227||0.219||0.207||0.205||0.202||0.197||0.194||0.192||0.174||0.172||0.162||0.151||0.148,0.2,0.1,0.06666666666666667
956,Extremophiles-4-1-2262144.txt,bacteri enzym||spite||metabol pathway||arginin||enzym gene||dkfp||archaea||prolin||threonin||pyruv||lipid||gene||complet||glucos||enzym||altern enzym||glycerol||phosphat||compar genom||menaquinon||synthesi||lysin||isoprenoid||folat||haloarcha genom||speci||pathway||isoleucin||bacteria||step||haloarchaea,halobacterium salinarum||H. salinarum||halobacterium||N. pharaoni H. salinarum||H. salinarum 1986||H. salinarum 1989||mete H. salinarum||H. marismortui H. walsbyi H. salinarum||3 N. pharaoni H. salinarum||green red H. salinarum||halobacterium 1994 halobacterium||aspart degrad H. salinarum H. marismortui||red H. salinarum bold||red border H. salinarum||H. marismortui H. salinarum 1988 2006,0.493||0.431||0.326||0.291||0.291||0.29||0.29||0.28||0.233||0.222||0.222||0.221||0.22||0.22||0.218,0.0,0.0,0.0
957,Qual_Life_Res-3-1-2039824.txt,follow-up||high level||measur||time||depress symptom||work absenc||work limit||due||data||return||studi||musculoskelet disord||recurr||baselin||mental||claim statu||health statu||worker||complet recoveri||mental health||disord||rtw||health||wage replac benefit||women||pain||trajectori||intern consist||month||injuri||function statu||multipl outcom measur||rtw statu||limit||statu||particip||disabl||health outcom||score||outcom||result,rtw||worker||rtw rtw-r||return||rtw statu||rtw trajectori||month post-injuri||rtw attempt||rtw intervent||rtw process||rtw experi||work||wsib||pain||worker health,0.334||0.227||0.223||0.217||0.204||0.2||0.197||0.175||0.171||0.17||0.169||0.168||0.167||0.163||0.161,0.8,0.4,0.3333333333333333
958,Eur_J_Pediatr-4-1-2234442.txt,joint contractur||clinic phenotyp||ert||earli development mileston||complic||joint||enzym replac therapi||hunter syndrom||studi||idursulfas||patient||life||spleen||placebo-control trial||infus||cn involv||involv result||improv||attenu form||disord||treatment||reaction||gene||gag||mucopolysaccharidosi type II||age||sever airway obstruct||death||challeng||infusion-rel reaction||sever||sever diseas||diseas||diagnosi||mp II||progress,mp||mp II||idursulfas||idursulfas idursulfas||sever mp||mp disord||mp societi||hunter||ert||attenu mp II||sever mp II||mp II spectrum||conclus mp II||hunter syndrom||mucopolysaccharidosi II,0.533||0.325||0.312||0.312||0.287||0.276||0.271||0.266||0.236||0.234||0.231||0.224||0.217||0.2||0.19,0.4,0.3,0.26666666666666666
959,Histochem_Cell_Biol-4-1-2248609.txt,mechan||dynamin||role||depend||intern||membran lipid||sandvig||ricin||endocyt mechan||raft||clathrin||actin||complex||toxin||shiga toxin||cell||cholera toxin||rhoa||protein||uptak||flotillin||instanc||caveola||macropinocytosi||plasma membran||membran||endocytosi,endocytosi||sandvig||clathrin-independ endocytosi||deur||apic endocytosi||clathrin-depend endocytosi||apic clathrin-independ endocytosi||receptor-medi endocytosi||caveolar endocytosi||caveolin-1-independ endocytosi||raft-depend endocytosi||endocytosi research||caveola||18046403 sandvig||toxin,0.448||0.361||0.334||0.325||0.255||0.244||0.243||0.239||0.237||0.232||0.232||0.226||0.198||0.188||0.16,0.4,0.2,0.26666666666666666
960,Evid_Based_Complement_Alternat_Med-2-4-1297501.txt,author||men||practic||data||posit result||studi||patient||chronic||acupunctur||chronic prostat||clinic trial||palmetto||treatment||complementari medicin||random||biofeedback||pain||abstract||altern medicin||hyperthermia||symptom||trial||exploratori studi||supplement||pollen extract||herbal||varieti,prostat||chronic prostat||prostat hyperplasia||prostat decoct||prostat massag||acut prostat||experiment prostat||prostat disord||acupunctur||prostat secret||prostat volum||prostat vari||prostat tissu||prostat 1||cpp,0.534||0.342||0.292||0.285||0.282||0.273||0.272||0.271||0.271||0.27||0.269||0.269||0.268||0.267||0.255,0.2,0.2,0.13333333333333333
961,Eur_Arch_Otorhinolaryngol-4-1-2217619.txt,specimen||valv||closur||bast||structur||open||utriculo-endolymphat valv||duct||3d-reconstruct||object||lip||wall||opfo||utricular side||endolymph,valv||utriculo-endolymphat valv||bast||valv lip||valv bast ’s||bast ’s valv||one-way valv||valv tip||bast ’s valv 13||3d-reconstruct||rigid valv lip||utricular duct||endolymphat duct||ar.1090400106 bast||ar.1090680106 bast,0.503||0.424||0.328||0.29||0.285||0.285||0.259||0.257||0.214||0.213||0.212||0.203||0.184||0.178||0.178,0.6,0.4,0.26666666666666666
962,Purinergic_Signal-3-4-2072914.txt,exocytosi||vesicl exocytosi||clone||camp||nucleotid||pc12 cell||protein||nucleotid releas||noradrenalin||receptor||atp releas||sampl||express||p2i receptor||valu||radioact||cell||cyclic amp synthesi,C1||releas||botulinum neurotoxin C1||nucleotid releas||nucleotid||bont||depolarization-evok nucleotid releas||botulinum neurotoxin||depolarization-evok releas||botulinum neurotoxin C1 light chain||atp releas||JO botulinum neurotoxin C1||spontan nucleotid releas||C1 light chain||neurotoxin,0.298||0.229||0.217||0.211||0.193||0.189||0.179||0.176||0.173||0.169||0.166||0.166||0.165||0.165||0.163,0.4,0.2,0.2
963,Photosynth_Res-3-1-2117338.txt,light-harvest complex||posit charg||electron||bond||dipol||water||chl||methylacetamid||complex||oxygenas||electrostat bond||chloroplast develop||backbon carbonyl group||feig||protein||dipol moment||plastid||sidechain||charg||group||specif locat||interact||electron densiti||assembl||lhcp||molecul||ligand||membran||chlorophyl,chlorophyl||light-harvest chlorophyl||light-harvest||light-harvest complex||light-harvest protein||chlorophyl biosynthesi||light-harvest antenna||major chlorophyl||chlorophyl synthesi||keyword chlorophyl||light-harvest complex lhc||higher-pl light-harvest||hoober JK||photosynth||chlorophyl chlorophyl 1991 boca raton,0.389||0.364||0.339||0.206||0.205||0.201||0.2||0.198||0.197||0.195||0.189||0.184||0.179||0.166||0.164,0.4,0.2,0.13333333333333333
964,Photosynth_Res-3-1-1769345.txt,edg||electron transfer||iron centr||iron geometri||measur||structur||complex||sampl||data||x-ray absorpt spectroscopi||energi||plastocyanin||spectra||cytochrom,plastocyanin||xa||díaz-moreno||nostoc||II||II II||iii II||iii||díaz-quintana||Pc||ubbink||iii panel||0.02 II||la rosa MA díaz-moreno||iii II 3,0.277||0.209||0.209||0.176||0.173||0.173||0.171||0.17||0.149||0.134||0.134||0.126||0.12||0.12||0.114,0.2,0.1,0.06666666666666667
965,Virchows_Arch-4-1-2329733.txt,valid studi||cancer||case||core||two-class||full section||kappa||marker||slide||paraffin block||express||tma||squamou cell carcinoma||molecular marker||donor block||tissu||escc||analysi||moder||tma core||tumor||agreement||posit,tma||κ κ κ κ κ||tma core||tma slide||tma technolog||total κ tma||esophag cancer tma||total κ tma ck5||microarray||tma paraffin block||ck5||carcinoma||tissu microarray||escc||ck14,0.453||0.292||0.283||0.283||0.263||0.256||0.239||0.23||0.188||0.178||0.151||0.151||0.146||0.144||0.144,0.4,0.2,0.2
966,Purinergic_Signal-3-4-2072920.txt,atp||microglia||role||nerv||spinal glial cell||neuropath pain||receptor||pain||releas||neuron||p2x||evid||phagocytosi||cell||rat,neuropath pain||pain||neuropath pain sensat||neuropath pain state||anion||neuropath pain model rat||pain mononeuropathi||pain sensat||pain signal||microglia||microgli cell||pain mononeuropathi brain||microgli activ||p2x7||anion gradient,0.362||0.281||0.254||0.243||0.221||0.203||0.178||0.159||0.152||0.148||0.137||0.13||0.126||0.125||0.124,0.4,0.3,0.2
967,Purinergic_Signal-3-4-2072926.txt,mechan||function consequ||striatum||blockad||bdnf protein||synapt transmiss||hippocampu||bdnf||receptor||bdnf function||bdnf level||hippocamp slice||normal bdnf tone||experiment model,2A 2A 2A||2A||2A KO mice 2A 2A||2A 4 2A Rs||2A 2A 15 16 2A Rs||17 27 28 2A 2A 2A||bdnf||2A Rs regul||2A receptor reduc||2A receptor facilit||bdnf modul||bdnf avaibl||42 43 2A 24||bdnf level||bdnf protein,0.741||0.741||0.464||0.393||0.386||0.371||0.364||0.281||0.278||0.277||0.202||0.191||0.188||0.186||0.185,0.0,0.1,0.2
968,Semin_Immunopathol-4-1-2315691.txt,crri||creg||inflamm||low level||anim model||studi||transgen mice||inform||mous model||altern||cfh||treatment||eye||complement system||amd||complement regulatori protein||normal tear||protein||vascular endotheli growth factor||rodent eye||activ||cornea||compon||import||age-rel macular degener||uveiti||diseas||result,complement||complement system complement||ocular complement||mous complement||hemolyt complement||complement inhibitor||intraocular complement||complement inhibit||complement activ||recombin complement||complement factor||complement system||complement compon||complement regul||complement deplet,0.55||0.372||0.331||0.29||0.288||0.288||0.288||0.287||0.287||0.287||0.284||0.283||0.283||0.28||0.28,0.0,0.0,0.06666666666666667
969,Eur_Radiol-4-1-2292493.txt,match||mammographi||case||sharp margin||brca-mc||rim-enhanc||sporad case||mri||control group||breast cancer||studi||risk||type 3 curv||dci||benign||enhanc kinet||radiologist||lesion||margin||women||carrier||enhanc pattern||age||characterist||brca2||tumor size||group||differ||size||brca1||malign||breast||detect,brca-mc||breast||breast lesion||breast tumor||breast cancer||brca1||breast malign||mammographi||breast ultrasound||brca-mc case||breast densiti||lesion||brca-mc group||hereditari breast cancer breast cancer||keyword breast mri mammographi brca1 brca2,0.369||0.361||0.277||0.244||0.237||0.236||0.231||0.214||0.2||0.199||0.195||0.193||0.193||0.193||0.187,0.6,0.5,0.4
970,J_Biomol_NMR-3-1-2048825.txt,type||nmr structur ensembl||set||pdb entri||constraint||inter-atom distanc||data||occurr||contact||spectra||inform||sequenc fragment||structur||total||hpc||file||entri||distanc||residu||atom||analysi||distanc inform||nmr||total number||pdb||import||constraint data||number||fragment||noesi spectra||nmr constraint list,Hβ||constraint||Hα Hβ||Hα||nmr||1.00 Hα Hβ||nmr distanc constraint||distanc constraint||0.16 Hα Hβ||0.28 Hα Hβ||nmr constraint list||nmr constraint data||experiment nmr constraint||constraint inform||deposit constraint,0.418||0.388||0.351||0.283||0.274||0.258||0.255||0.245||0.242||0.237||0.235||0.227||0.225||0.223||0.222,0.4,0.2,0.2
971,Neurogenetics-3-1-1820748.txt,myokymia||potassium channel||genet studi||function effect||muscl||clinic||electrophysiolog studi||current||epilepsi||oocyt||episod ataxia||transvers||mutat||mutant crna||famili,myokymia||kcna1||periorbit myokymia||hereditari myokymia||ataxia||kv1.1||myokymia syndrom||kcna1 mutat||episod ataxia||episod ataxia mutat||keyword myokymia potassium channel mutat||mutat||autosom domin myokymia||episod||potassium channel gene kcna1,0.468||0.301||0.264||0.26||0.245||0.242||0.241||0.239||0.205||0.196||0.192||0.176||0.166||0.166||0.159,0.2,0.2,0.2
972,Naturwissenschaften-4-1-2270370.txt,non-breed season||coastal||diversif||number||speci diversif||speci||popul||ecolog speciat||sub-speci||non-migr||wader||migratori||studi||environ||area||habitat||migrant||result,inland||migrant inland||migrant||non-migr||inland wetland||partial migrant inland||migrant coastal||inland habitat||whilst inland||winter inland||inland environ||migrant speci||wetland||long-dist migrant||coastal,0.571||0.502||0.434||0.425||0.396||0.346||0.326||0.311||0.289||0.288||0.287||0.23||0.22||0.22||0.219,0.4,0.2,0.2
973,J_Med_Internet_Res-1-suppl1-1761819.txt,visitor||inform||web site||peopl||telemedicin||internet,ndtm||internet||telemedicin||ndtm web site||web site||readership||visitor||internet hypermedia readership analysi telemedicin||telemedicin brigg||launch||internet address||200 web page||internet work||med internet||site,0.37||0.331||0.327||0.306||0.274||0.25||0.226||0.201||0.191||0.188||0.186||0.182||0.179||0.169||0.153,0.6,0.4,0.26666666666666666
974,J_Digit_Imaging-3-1-2039840.txt,interfac||document||technolog||time||system||phrase||search engin||radiolog report||problem||data||search queri||wildcard||inform||abil||radiologist||user||featur||binari oper||web||queri durat||pac integr||report warehous||solut||medic context||result||user interfac||ri||search interfac||implement||open sourc||report||word||design||index||queri||internet,ri||index||ri metadata||word||build index||queri||index solut||ri data||ri perform||search queri||nondistribut index||index system||index project||fuzzi index||index merg,0.352||0.323||0.23||0.229||0.21||0.194||0.191||0.182||0.18||0.175||0.175||0.175||0.172||0.171||0.169,0.6,0.5,0.3333333333333333
975,J_Neurooncol-4-1-2174521.txt,transfect||level||data||copi number rel||studi||immunoblot||gain||cell cultur||report plasmid||cell line||overexpress||cell||fish||isochromosom 17q||medulloblastoma||apoptosi||larg cell||chemotherapeut agent||sem||p53||tumor||medulloblastoma growth||amplif||copi gain||result,wip1||wip1 wip1||wip1 wip1 wip1 wip1 locu||24 wip1 wip1 wip1 wip1||i17q wip1 wip1 wip1||wip1 wip1 overexpress||wild-typ wip1 wip1 5 wip1||wip1 2 2 wip1 wip1||tp53 wip1 tp53 wip1||wip1 gain||overexpress wip1||wip1 phosphatas||wip1 rna||wip1 express||excess wip1,0.902||0.902||0.723||0.722||0.712||0.611||0.552||0.541||0.54||0.471||0.465||0.465||0.457||0.456||0.452,0.0,0.0,0.0
976,Qual_Life_Res-3-1-2039860.txt,demograph characterist||dutch colleg||refer popul||practic||qualiti||studi||depress||earli identif||life||patient||physic function||depress group||complaint||domain||chronic consequ||mental health||descript studi||dutch nation survey||consult||health||unexplain complaint||gp||characterist||popul||gener practic||gener practic popul||group||differ||fatigu,unexplain complaint||complaint||unexplain complaint patient||unexplain fatigu||unexplain complaint group||unexplain complaint categori||physic complaint||musculoskelet complaint||complaint group||abdomin complaint||main complaint||unexplain physic symptom||unexplain symptom journal||multipl unexplain symptom||gp,0.494||0.424||0.37||0.351||0.34||0.335||0.237||0.228||0.228||0.228||0.218||0.218||0.214||0.202||0.17,0.4,0.2,0.2
977,Eur_Radiol-3-1-2039819.txt,coronari fly-through||mdct||time||imag qualiti||coronari arteri||dual-sourc CT||high qualiti visualis||post-process||virtual angioscopi||major coronari arteri||major branch||patient||min,fly-through||coronari fly-through||coronari angioscopi||dual-sourc mdct||coronari arteri||virtual coronari angioscopi||autom fly-through||dual-sourc CT||noninvas coronari angioscopi||keyword virtual angioscopi coronari arteri coronari||rca||post-process dual-sourc CT||virtual angioscopi||vca||mdct,0.407||0.371||0.303||0.253||0.246||0.233||0.221||0.214||0.209||0.198||0.197||0.187||0.181||0.181||0.177,0.4,0.3,0.3333333333333333
978,J_Membr_Biol-3-1-1784061.txt,block||ionic strength depend||concentr||data||low affin||studi||channel||gallamin block||amino acid||outer vestibul||electrostat charg||tea||tetraethylammonium||ionic strength sensit||ionic strength||solut||residu||surfac||lysin||surfac electrostat||vestibul||electrostat potenti||interact||gallamin||quaternari ammonium ion||neg charg||result,channel||shaker shaker channel||kv2.1 channel||shaker||kv2.1||kv2.1 potassium channel||block kv2.1 channel||mutant kv2.1 channel||wild-typ kv2.1 channel||potassium channel||2007 shaker shaker||2005 shaker shaker shaker kavanaugh||kv3.1 channel||app||kv2.1 potassium channel pore,0.361||0.355||0.354||0.353||0.346||0.274||0.267||0.244||0.243||0.239||0.235||0.229||0.226||0.222||0.219,0.2,0.1,0.06666666666666667
979,Int_J_Biochem_Cell_Biol-2-1-2279807.txt,antibodi||role||stabl cell line||bind partner||rasgap||isoform||eef1a1||protein synthesi function||elut protein||complex||sh3 domain||sh2 domain||cell||phosphoryl||shp2||ciap||protein||bead||non-transl function||incub||interact||codon-depend bind||specif antibodi||eef1a2||function,eef1a2||eef1a1||eef1a2 protein||eef1a2 isoform||eef1a2 interact||eef1a2 sampl||eef1a2 molecul||3.4 eef1a2||eef1a2 prepar||eef1a2 isoform budkevich||eef1a2 form complex||purifi eef1a1||his-tag eef1a1||eef1a2 peptid sequenc||precipit eef1a1,0.653||0.419||0.357||0.353||0.341||0.334||0.331||0.328||0.328||0.26||0.23||0.223||0.223||0.223||0.215,0.4,0.2,0.13333333333333333
980,Eur_J_Pediatr-3-1-2151774.txt,case||alveolar wall ruptur||vomit||patient||chest||alveolar wall||neck||risk||anorexia nervosa||pneumomediastinum||subcutan emphysema||sign||disord||pressur||laryngopharyngoscopi||anorexia patient||literatur||malnutrit||adolesc||spontan pneumomediastinum||secondari pneumomediastinum,pneumomediastinum||spontan pneumomediastinum||anorexia nervosa||keyword pneumomediastinum anorexia||secondari pneumomediastinum||anorexia nervosa predispos||anorexia nervosa int||emphysema||bulimia nervosa||anorexia nervosa postgrad med||anorexia nervosa Br med||anorexia patient||s00431-007-0444-9 origin paper pneumomediastinum||subcutan emphysema||mediastin emphysema,0.632||0.392||0.362||0.325||0.319||0.246||0.243||0.224||0.202||0.194||0.188||0.179||0.167||0.139||0.132,0.8,0.4,0.4
981,Soc_Psychiatry_Psychiatr_Epidemiol-3-1-2039804.txt,asylum procedur||lower qualiti||center||preval||qualiti||studi||life||long asylum procedur||psychopatholog||netherland||iraq||physic diseas||iraqi asylum seeker||health||psychiatr disord||post-migr live problem||drug consumpt||servic||care||gener practition||group||factor||visit||import predictor||medic specialist||asylum seeker||physic health problem||disabl||pmlp,"asylum seeker||iraqi asylum seeker||seeker||22 asylum seeker||keyword asylum seeker servic||asylum procedur||2,352 iraqi asylum seeker||adult iraqi asylum seeker||servic||gener healthcar asylum seeker||biggest asylum seeker popul||health servic||long asylum procedur||mental health servic||iraqi refuge",0.485||0.408||0.369||0.324||0.314||0.314||0.309||0.307||0.287||0.254||0.247||0.224||0.218||0.206||0.17,0.4,0.4,0.3333333333333333
982,Purinergic_Signal-4-1-2245998.txt,blood flow||vascular tone||similar import||role||respons||hypertens||releas||studi||atp||effect||human||platelet||increas||angiogenesi||heart failur||purin||receptor||p2i||cell prolifer||ectonucleotidas||clinic import||pyrimidin||growth factor||catecholamin||erythrocyt||pathophysiolog||factor||myocardi infarct||purinerg||aspirin||human skelet muscl||heart||sympathet nerv||antagonist||cardiomyocyt||p2x||blood pressur regul,atp||atp receptor||utp atp||receptor||burnstock||atp circ||purinerg receptor||extracellular atp||atp releas||atp signal||signal atp||purinerg||P2 receptor||atp mrs2498||α-β-methylen atp,0.352||0.295||0.249||0.239||0.238||0.233||0.221||0.218||0.216||0.204||0.204||0.204||0.194||0.182||0.182,0.4,0.2,0.2
983,Eur_Radiol-3-1-1820761.txt,prospect studi||cancer||reoxygen||method||flow||imag||studi||human applic||perfus||develop||hypoxia-direct therapi||abil||radiotherapi||hypoxia imag||treatment||cell||therapi||oxygen||invas techniqu||hypoxia||tumour||cancer patient||blood||tissu||chang||chronic hypoxia||cu-atsm-pet||presenc||vessel||clinic translat||vascular||bold-mri||lead contend||function||tumour cell||techniqu,hypoxia||tumour hypoxia||hypoxia imag||tumor hypoxia||hypoxia statu||acut hypoxia||chronic hypoxia||region hypoxia||hypoxia map techniqu||human tumour hypoxia techniqu||kogel AJ tumor hypoxia||tumour||prostat gland hypoxia||imag||farwel DG krohn KA hypoxia,0.523||0.352||0.351||0.322||0.269||0.266||0.264||0.263||0.2||0.196||0.185||0.18||0.18||0.178||0.149,0.4,0.3,0.3333333333333333
984,Eur_J_Appl_Physiol-3-1-1914232.txt,chronic heart failur||recoveri kinet||method||breath||ventilatori threshold||interv||studi||patient||onset kinet||correl||threshold||test||recoveri||coeffici||chf||paramet||function impair||mono-exponenti model||exercis||onset||differ||clinic purpos||exercis test||respons time||kinet||rest||intra-class correl||reproduc,expandaft||ifmmod||fi||document||dot||text||documentclass||12pt||amsmath||amsfont||mathrsf||69pt||exercis||kinet||end,0.233||0.107||0.103||0.054||0.051||0.045||0.04||0.04||0.04||0.04||0.04||0.04||0.025||0.024||0.019,0.0,0.0,0.13333333333333333
985,Qual_Life_Res-4-1-2275305.txt,level||quantit posit||method||system||instrument||descriptor||isoform||direct quantif||eq-5d||studi||vignett||transform||health statu||mild depress||va scale||health||va continuum||extrem||pain||equidist||mobil||respons scale||untransform equidist||level descriptor||five-level version||respond||health state||dimens||indirect method||respons option||methodolog||sever||score,5L||3L||5L descriptor||5L dimens||3L descriptor||5L score||5L version||5L mobil||5L level descriptor||5L respons||5L system||5L answer||descriptor||5L classif||5L yield,0.572||0.446||0.43||0.37||0.367||0.317||0.298||0.296||0.295||0.293||0.289||0.289||0.288||0.288||0.287,0.0,0.0,0.06666666666666667
986,Eur_J_Nutr-3-1-1914246.txt,dutch polici||calcul||level||risk manag||afl||maximum level||public health||model||age group||folic acid||nation survey||risk||vitamin||netherland||fortif||intak||adult||exempt||dietari supplement||energi||msfl||dutch model||toler upper intak level||maximum safe amount||product||micronutri||food||popul||risk-assess model||maximum fortif level||sensit group||dutch commod act||group||european union||safe addit||maximum amount||miner||ul||maximum||rasmussen||children||result,msfl||fortif||micronutri fortif||vitamin||calcul msfl||food fortif||lowest msfl||lower msfl||msfl valid||0 µg vitamin||intak||micronutri intak||0 µg||154 µg vitamin||micronutri,0.442||0.321||0.258||0.241||0.235||0.228||0.226||0.223||0.222||0.214||0.208||0.201||0.2||0.2||0.195,0.6,0.3,0.3333333333333333
987,World_J_Urol-3-1-1913182.txt,cancer||time||case||men||patient||year||strategi||risk assess||mortal||inform||base||earli age||overdiagnosi||treatment||earli detect||popul||incid||random studi||prostat||possibl||invas treatment||biopsi||nomogram||activ surveil||psa||number||overtreat||screen||procedur||prostat cancer||radic prostatectomi||diseas||detect||result,prostat||prostat cancer||prostat cancer screen||indol prostat cancer||prostat biopsi||prostat cancer bangma||ml prostat||free-to-tot prostat||prostat cancer trial||prostat cancer diagnosi||prostat test||prostat diseas||earli prostat cancer||initi prostat||prostat adenocarcinoma,0.643||0.476||0.407||0.362||0.353||0.346||0.333||0.33||0.329||0.329||0.328||0.328||0.327||0.326||0.325,0.4,0.2,0.13333333333333333
988,Int_Arch_Occup_Environ_Health-3-1-1915641.txt,self-report questionnair||time||larg size||psychosoci risk factor||sick||baselin||model||studi||patient||potenti confound||baselin questionnair||effect||neck||risk||style||upper extrem||sick leav||complaint||increas||sex||effect modif||analys||decis author||regress model||pain||popul||upper extrem complaint||turn||musculoskelet co-morbid||heavi physic work||high||cox regress model||symptom||work||risk factor||long period||wildhagen,sick||sick leav||complaint||job||long-term sick leav||self-report sick||sick absenc||sick day||musculoskelet complaint||neck||outcom measur sick leav||job demand||work leav||neck pain||long-term sick absenc,0.453||0.366||0.275||0.253||0.248||0.244||0.239||0.229||0.199||0.187||0.186||0.172||0.171||0.169||0.164,0.6,0.4,0.26666666666666666
989,Qual_Life_Res-3-1-1915653.txt,cancer||measur||time||respons||studi||self-present||strategi||question||patient||bit||present||discrep group||chemotherapi||qol||treatment||ann||counter-intuit find||interview||respons shift||small-cel lung cancer||discrep||conflict find||explan||fatigu||respons categori||score||answer||result,aloud||interview||aloud then-test||self-present||fatigu||n’t||aloud T2||aloud then-test T1||discrep self-present||eortc qlq-c30||aloud respons||then-test||interview T1||interview patient||aloud manner,0.249||0.218||0.196||0.186||0.163||0.157||0.155||0.153||0.145||0.144||0.144||0.143||0.143||0.142||0.127,0.6,0.3,0.2
990,J_Mol_Biol-1-5-2082129.txt,condit||time||singl dna-bind cleft||concentr||activ form||plasmid||state||separ molecul||wt||subunit||hexachlorofluorescein||form||sfii||recognit site||complex||site||mixtur||dna||duplex||singl exponenti||fast phase||reaction||enzym||protein||hex||dimer||experi||copi||one-sit plasmid||auc||cleft||substrat||lin||linear product||OC,sfii||sfii endonucleas||endonucleas||sfii restrict endonucleas||restrict endonucleas sfii||mutant sfii endonucleas||wt sfii||sfii site||sfii restrict endonucleas embo||tetramer endonucleas sfii bound||y68f||halford s.e||dna||sfii cooper||ecorv endonucleas,0.448||0.42||0.392||0.325||0.325||0.291||0.28||0.257||0.249||0.246||0.243||0.24||0.237||0.235||0.231,0.2,0.1,0.13333333333333333
991,J_Med_Internet_Res-9-2-1913940.txt,hit||immigr||nation||translat||local languag||url||host||search engin||maiz||rate||human migrat||nutrit||turkish||languag||human health||linguist prefer||sourc||countri||indigen group||page||institut||websit||health||higher rate||tuberculosi||term||food agenc||effort||world||estim||result||english||food||food-rel institut||group||order||avian flu||googl search||world wide web||global agenc||french||onlin health inform||googl||diseas||peopl||schizophrenia||spanish||strong prefer||internet,english||english search||languag||languag search||search languag||search||french search||googl search||bahasa indonesia||immigr languag||english search rate||english avian flu||french||onlin search||local languag search,0.337||0.313||0.292||0.29||0.29||0.288||0.249||0.238||0.219||0.219||0.216||0.212||0.209||0.203||0.198,0.4,0.3,0.26666666666666666
992,Purinergic_Signal-3-4-2072916.txt,anim||inflamm||respons||spinal cord injuri||data||studi||effect||section||volum||recoveri||spinal cord||potenti mechan||present studi||treatment||guanosin||rat||day||myelin||microglia||apoptosi||potenti clinic import||inflammatori respons||injuri||cord||secondari patholog event||apoptot cell death||secondari injuri||sci||function,spinal cord||cord||guanosin||spinal cord injuri||injuri guanosin||spinal cord contus||contus spinal cord injuri||spinal cord trauma||injur spinal cord||spinal cord lesion||acut spinal cord injuri||traumat spinal cord injuri||secondari spinal cord injuri||spinal cord injuri micturit||spinal cord 8,0.443||0.438||0.416||0.388||0.346||0.326||0.313||0.304||0.302||0.302||0.301||0.299||0.297||0.296||0.295,0.8,0.4,0.26666666666666666
993,Pflugers_Arch-3-1-1950587.txt,target||respons||epi||stretch-activ channel||endo||wall thick||observ||express||stretch||stimuli||transmur differ||rat||cardiac myocyt||gene||myocyt||protein||mechan stimul||ventricl||region differ||rapid||slow inotrop respons||mrna||heart||gene express,epi||epi endo||endo||endo myocyt||endo region||endo strip||epi sampl||epi tissu||endo tissu||myocyt||_ m1 brain||_ m1 sodium||_ m1 endothelin-1 receptor||stretch||0.04 0.001 endo,0.378||0.378||0.378||0.28||0.213||0.199||0.198||0.194||0.194||0.182||0.176||0.174||0.164||0.151||0.144,0.4,0.3,0.26666666666666666
994,Intensive_Care_Med-3-1-1915615.txt,complet recoveri||csf||case||week||differenti diagnosi||lyme diseas||coma||protein||mri||lesion||cell count||diseas||full recoveri||treatment||patient,coma||encephalomyel||adem||prolong coma||csf||medic coma||encephalomyel neurol||coma rover jörgen||post-infecti encephalomyel||csf pressur||csf cultur||csf examin||csf analysi||encephalomyel postgrad med||springer-verlag 2007 keyword coma acut,0.469||0.318||0.28||0.252||0.243||0.241||0.218||0.188||0.186||0.135||0.132||0.125||0.122||0.121||0.119,0.4,0.2,0.13333333333333333
995,J_Med_Internet_Res-6-3-1550604.txt,level||high-school read profici||skill||basic search||grade level||search engin||navig||search term||individu||literaci level||studi||question||effect||read level||difficulti||inform||investig||rectum cancer||abil||site||health inform||web site||method subject||low literaci||health site||health educ||page||health materi||web||health||literaci||term||averag||strong read skill||read abil||experi||subject||text||weak search strategi||materi||group||word||order||search||access||lung cancer||read||particip||think-aloud||googl||answer||health question||internet,internet||literaci||internet skill||internet health web||internet readabl||self-direct internet search||internet prior||prior internet||search||internet experi||low-literaci subject||internet compet||med internet||internet health inform||low-literaci site,0.418||0.27||0.251||0.241||0.236||0.224||0.223||0.223||0.222||0.219||0.218||0.213||0.211||0.209||0.199,0.4,0.3,0.2
996,Intensive_Care_Med-4-1-2249616.txt,antimicrobi resist||grade||mechan ventil||acut respiratori distress syndrom||acut renal failur||children||protocol||mortal benefit||recent trial||rate||patient||studi||clinic outcom||strategi||sepsi||effect||mortal||risk||superior clinic outcom||organ||increas||failur||clinic assess||sever sepsi||recommend||pressur||insulin||sepsi bundl||guidelin||steroid therapi||evid||clinic trial||dobutamin inotrop therapi||infect||renal replac||shock||sedat||day||rct||strong||meta-analysi||blood cultur||random||septic patient||cardiac output||blood glucos||fluid challeng||fluid||popul||blood lactat concentr||peep||death||surviv sepsi campaign||literatur||fluid resuscit||group||mortal rate||committe||decreas||fluid administr||report||grade system||entir group||ali||resuscit||shorter intub time||trial||upper GI||critic ill||stress ulcer prophylaxi||support||tidal volum||earli goal-direct resuscit||septic shock||continu analysi||benefit||icu||ill children||outcom||sepsi syndrom,sepsi||septic shock||shock||septic shock recommend||sepsi campaign||sever sepsi||meningococc sepsi||sepsi syndrom||sepsi campaign sepsi bundl||catheter-rel sepsi||sepsi organ||sepsi bundl||septic shock patient||sepsi epidemiolog||sepsi institut,0.412||0.28||0.255||0.239||0.23||0.228||0.227||0.227||0.222||0.218||0.215||0.215||0.212||0.21||0.209,0.6,0.5,0.4
997,Matern_Child_Health_J-2-2-1592162.txt,prevent||risk||health||control||preconcept care||health insur||educ||import||women||diabet||commun||complic||age||provid||pregnanc||intervent||barrier||chw||gdm||african american,diabet||diabet women||gestat diabet||diabet prevent||recommend diabet||insulin-depend diabet||diabet control||pre-concept diabet||non-insulin-depend diabet||undiagnos diabet||diabet translat||influenc diabet||main diabet||futur diabet||preconcept,0.654||0.474||0.393||0.357||0.343||0.34||0.336||0.336||0.334||0.334||0.334||0.334||0.329||0.329||0.309,0.2,0.1,0.06666666666666667
998,J_Gastrointest_Surg-3-1-1852379.txt,type||cancer||case||stage IB||center||gastric surgeri||comp||data||studi||year||patient||medic school||hospit volum||mortal||high-volum center||gastric adenocarcinoma||node||gastrectomi||gastric cancer||signific||medic oncolog unit||treatment||institut||diagnost evalu||oper mortal||hospit||nation cancer data base||curv||stage IV diseas||lymphadenectomi||report||surviv||differ||number||ncdb||chcp||hospit type||outcom,cancer||gastric cancer||thcp||gastric cancer resect||gastric cancer patient||cancer mortal||gastric cancer treatment||cancer stage||cancer program||stomach cancer||cancer registri||gastric cancer Br||gastric cancer eur||thcp hospit||cancer surgeri,0.362||0.322||0.277||0.245||0.234||0.232||0.223||0.22||0.218||0.217||0.217||0.217||0.216||0.216||0.215,0.4,0.2,0.13333333333333333
999,Anal_Bioanal_Chem-3-1-2117337.txt,filter||apoglucos oxidas||applic||glucos||system||solut||apogox||enzym||flow system||acid treatment||flavin adenin dinucleotid||microreactor||fad||detector||low flow rate||devic||glucos oxidas||activ||electrochem detect||prepar,microreactor||korf||miniatur microreactor||apogox||robust microreactor||venema||enzym||gox||pe ultrafilt||pe||oxidas||ferrocen||glucos oxidas||expens enzym||reactor,0.302||0.269||0.208||0.168||0.164||0.156||0.14||0.134||0.101||0.1||0.1||0.091||0.086||0.085||0.084,0.4,0.3,0.26666666666666666
1000,Anal_Bioanal_Chem-3-1-1592252.txt,metabolit||biolog effect||type||method||biolog fate||data||characterist ion||structur inform||sulfat metabolit||compound||site||mass spectrometri||fragment pathway||rule||product||pharmaceut||carcinogen product||hydroxylamin||neg ion mode||relev properti||sulfat||group||allyl alcohol||bioactiv||structur featur||benzyl alcohol||fragment||drug||sulfat product||vivo,sulfat||sulfat metabolit||sulfat site||sulfat product||vinyl sulfat||hydrogen sulfat||sulfat conjug||unknown sulfat metabolit||relev sulfat site||sulfat site group||potenti sulfat site||sulfat facilit detoxif||3 indoxyl sulfat||100 14 benzyl sulfat||sulfat product group no. chemic,0.782||0.456||0.424||0.422||0.401||0.396||0.396||0.31||0.289||0.287||0.284||0.276||0.268||0.22||0.175,0.6,0.3,0.2
1001,Anal_Bioanal_Chem-4-1-2228378.txt,adduct||dna sequenc||product||electrospray mass spectrometri||guanin||fragment||gutingimycin||oligom||capillari exit voltag||dna||format||higher temperatur||hplc||oligonucleotid||trioxacarcin,4a||5d 4a||trioxacarcin||4a 4b 5a||5d||5a 5d||wickham||4b||materi 4a 4b 5a||adduct||5a||dna adduct||hurley||discuss 2 4a 4b 5a||sheil MM wickham,0.41||0.332||0.273||0.261||0.254||0.21||0.208||0.207||0.197||0.189||0.166||0.161||0.16||0.157||0.154,0.2,0.2,0.13333333333333333
1002,Anal_Bioanal_Chem-4-1-2226000.txt,dynam monitor||gold nanoparticl||concentr||wash solut||chip||studi||ser||cell||rang||spectra,kneipp||verrier||0003702021954557 kneipp||hench LL||microfluid chip||gold nanoparticl||haswel SJ||166 14. kneipp||polak JM||nl061517x 17034088 15. kneipp||ν δ deform vibrat||mazilu||dholakia||garcés-chávez||sibbett,0.254||0.17||0.147||0.135||0.124||0.104||0.096||0.093||0.085||0.084||0.081||0.08||0.08||0.08||0.08,0.0,0.1,0.06666666666666667
1003,Anal_Bioanal_Chem-3-1-1820759.txt,analyt bias||certif||sampl||standard solut||valu||mbt||extract||organotin compound||water||mae||crm||small amount||degrad||methanol||phenyltin analysi||solut||analyt result||uncertainti||materi||tube||upper toluen layer||between-method varianc||dpht||organotin||butyltin||result,organotin||organotin impur||118||organotin compound||organotin 118 4||icp||organotin 4||cdot||120 118 118||anal||ethyl organotin solut||text||bb||springer-verlag 2006 118 118 118 118||Sn,0.257||0.167||0.16||0.143||0.139||0.13||0.129||0.124||0.117||0.113||0.11||0.108||0.108||0.107||0.104,0.4,0.2,0.13333333333333333
1004,Anal_Bioanal_Chem-4-1-2270354.txt,melanin||hair||Cu liver statu||Cu determin||chemometr||princip compon analysi||sampl||studi||inaa||liver biopsi||hepat Cu concentr||dog||nail clip||analysi||Cu concentr||nail||pc||sick dog||thumb nail||hair sampl||Cu liver level||sampl mass||pca||raman||chronic hepat||result,nail||hair||nail clip||Cu||nail sampl||thumb nail||nail analysi||hair melanin||labrador dog nail||hair sampl||hair color||thumb nail hinder||hair disord||hair morpholog||nail reflect differ,0.522||0.358||0.34||0.326||0.286||0.283||0.265||0.264||0.251||0.204||0.196||0.193||0.183||0.182||0.18,0.6,0.5,0.3333333333333333
1005,Anal_Bioanal_Chem-3-1-1914286.txt,protein identif score||sampl||long-capillari monolith column||digest||mass spectromet||peak capac||increas||squar root||linear flow rate||gradient liquid chromatographi||separ||mascot||protein||flow rate||analysi||column||gradient||extern flow cell||min||bsa||score||long column||length||effici||protein identif||similar gradient slope,column||monolith column||750-mm column||trap column||longer column||long monolith column||0.1-mm column||0.2-mm column||long column||long-capillari monolith column||column diamet||60-cm column||short column||gradient||shorter column,0.371||0.294||0.256||0.227||0.212||0.211||0.209||0.209||0.208||0.204||0.2||0.197||0.195||0.195||0.19,0.2,0.3,0.26666666666666666
1006,Acta_Neuropathol-4-1-2386160.txt,antibodi||role||dysplast cortex||fcd||normal tempor cortex||case||immunocytochemistri||studi||patient||pyramid neuron||vegfb||patholog condit||observ||vegfa||receptor||dysplast neuron||express||immunoreact||cell||epilepsi||hippocampu||tissu||protein||neuron||vascular endotheli growth factor||intract epilepsi||similar pattern||primari antibodi,fcd||vegfb||vegfa||vegf||fcd tissu||fcd specimen||endotheli growth||vascular endotheli growth||fcd case||aronica||fcd cp sg||vegf receptor||vascular endotheli growth factor-b||vascular endotheli growth factor||vegfr-1,0.361||0.29||0.289||0.233||0.197||0.192||0.191||0.188||0.185||0.179||0.167||0.158||0.154||0.153||0.151,0.6,0.3,0.26666666666666666
1007,Acta_Neuropathol-4-1-2386158.txt,human brain||antibodi||low level||AD patholog||brain tissu||imag||insult||reactiv oxygen speci||specif cellular marker||control tissu||form||increas||region||astrocyt||molecular form||evid||specif||cell||control||diffus plaqu||oxid stress||gray matter||enzym||protein||neuron||gray||dens core||report||mous||number||plaqu||minor form||area||peroxiredoxin 6||patholog||peroxiredoxin||tau||goat,peroxiredoxin||peroxiredoxin isoform||peroxiredoxin 6||peroxiredoxin famili||peroxiredoxin 6 astrocyt||peroxiredoxin 6 stain||astrocyt||bovin 1-ci peroxiredoxin||stronger peroxiredoxin 6||peroxiredoxin 6 variant||peroxiredoxin 6 30||AD||tau||plaqu||springer-verlag 2008 peroxiredoxin 6,0.685||0.349||0.344||0.344||0.312||0.251||0.247||0.242||0.232||0.231||0.231||0.189||0.188||0.18||0.177,0.4,0.3,0.3333333333333333
1008,Anal_Bioanal_Chem-4-1-2259237.txt,regress tree||leutra river||biofilm sampl||Mg content||method||chemometr||predict abil||sampl||data||model||saal river||water||supervis method||node||discrimin||high sensit||variabl||test set||classif||dpl||biofilm||PC 2||percentag||environment condit||pc||order||munich||number||cart||object||river||result,biofilm||biofilm biofilm grown||biofilm sampl||sampl biofilm||sea biofilm||biofilm subgroup||biofilm charact||biofilm structur||15 biofilm||cart||stand water biofilm||flow water biofilm||biofilm water phase||uve-dpl||sea biofilm sampl,0.644||0.457||0.369||0.369||0.339||0.327||0.326||0.324||0.322||0.314||0.302||0.289||0.284||0.281||0.258,0.4,0.3,0.2
1009,AIDS_Behav-3-1-1847541.txt,pilot intervent||MC servic||men||bailey||mother||practic||circumcis||africa||studi||school||effect||region||clinic trial||non-circumcis commun||accept||cost||lukobo||signific impact||south africa||age||infant circumcis||tradit circumcis||sti||foreskin||non-circumcis ethnic group||unpublish report||male circumcis||medic practition||particip||procedur||submit||addit||hiv||ethnic||protect,circumcis||circumcis men||circumcis accept||male circumcis||tradit circumcis||circumcis servic||circumcis prefer||safe circumcis||infant circumcis||undergo circumcis||circumcis peni||circumcis group||pubert circumcis||433 circumcis||circumcis statu,0.918||0.509||0.492||0.487||0.474||0.472||0.472||0.472||0.463||0.462||0.462||0.462||0.461||0.46||0.46,0.6,0.4,0.26666666666666666
1010,Acta_Neuropathol-4-1-2270355.txt,case||clinic sign||ep||account||studi||region distribut||inclus||dlb||high likelihood categori||braak||dementia||mild||cohort||vulner nuclei||transentorhin region||subject||categor||materi||distribut||dmv||sever||diseas||stage||result,0||0 0 0||0 0||0 0 0 0||6 0 0 0 0||2 0 0 0 0||4 0 0 0||6 0 0 0||5 0 0 0||2 0 0 0||1 0 0 0||0 0 0 0 28 78||3 0 0||2 0 0||1 0,0.676||0.676||0.676||0.676||0.541||0.541||0.507||0.507||0.507||0.507||0.507||0.454||0.451||0.451||0.338,0.0,0.0,0.0
1011,Anal_Bioanal_Chem-4-1-2175028.txt,signific ree content||ree||method||la-mc-icpm analys||isobar interfer||mass bia correct||problem||sampl||data||studi||spot analysi||Sr isotop||mass spectromet||geolog materi||element fraction||high Sr content||carbon||correct||la-mc-icpm||marin carbon||Sr isotop analys||mc-icpm||ratio||dimer||analysi||accuraci||sampl materi||fraction||interfer||Kr correct||laser||Rb correct||precis||instrument mass discrimin||tim analys||Sr isotop ratio||techniqu,Sr||Sr isotop||Sr mass||Sr materi||Sr ratio||Sr isotop mass||Sr concentr||Sr isotop ratio||Sr isotop analys||report Sr isotop||Sr isotop analysi||Sr isotop data||2 Sr isotop mass||1 88 Sr||situ Sr isotop analysi,0.616||0.426||0.346||0.319||0.319||0.309||0.309||0.291||0.29||0.288||0.286||0.285||0.232||0.221||0.218,0.2,0.3,0.2
1012,Anal_Bioanal_Chem-3-1-1805043.txt,method||primari clarifi||wastewat||concentr||sampl||biotransform||remov||process||compound||elimin||mbr||treatment||membran bioreactor||ca effluent||diclofenac||hydrochlorothiazid||pharmaceut||hydraul retent time||analysi||effluent concentr||ca process||wastewat treatment||effluent||remov effici||sludg||averag daili flow||intern standard||drug||effici||attenu||membran,mbr||mbr effluent||mbr process||laboratory-scal mbr||mbr system||sludg||effluent||ca effluent||hydrochlorothiazid||ofloxacin||bezafibr||wwtp effluent||ketoprofen||ca||propyphenazon,0.376||0.263||0.199||0.195||0.19||0.165||0.15||0.128||0.123||0.12||0.12||0.114||0.108||0.106||0.102,0.2,0.5,0.3333333333333333
1013,Acta_Neuropathol-4-1-2270353.txt,antibodi||lewi neurit||section||control||method tissu sampl||case||lewi bodi||overnight||ampa receptor||cell death||protein||tissu section||sporad PD case||express||synapt plastic||dementia||alpha-synuclein||cell,nptx2||narp||nptx2 immunoreact||result nptx2||nptx2 mrna express||narp mrna||nigra||narp hypothesi||worley PF narp||semi-quantit rate nptx2 IR||nptx2 label lewi bodi||nptx2 microarray express data||neuron pentraxin||substantia nigra||parkinsonian nigra,0.549||0.33||0.29||0.275||0.21||0.187||0.183||0.167||0.157||0.154||0.154||0.154||0.149||0.142||0.131,0.0,0.0,0.0
1014,Anal_Bioanal_Chem-3-1-2117336.txt,capillari||gold-sensor disk||time||pH optimum||aceton||sampl||surfac modif||immobil||spr||liquid chromatographi||amount||digest||high activ||reactor||water||netherland||on-lin digest||dextran hydrogel||open-tubular reactor||protein||enzym||experi||gentl flow||spr sensor||surfac||order||carry-ov||buffer||high concentr||incub||protein digest||substrat||pda||surfac plasmon reson||fragment||disk||peptid||immobil enzym||complet digest||result,reactor||capillari reactor||digest||spr||open-tubular reactor||enzym reactor||open-tubular trypsin reactor||capillari enzym reactor||fused-silica capillari||capillari||on-lin digest||trypsin||immobil trypsin||chromatogr||immobil,0.263||0.21||0.185||0.177||0.173||0.165||0.164||0.162||0.162||0.157||0.156||0.145||0.144||0.143||0.143,0.8,0.5,0.4666666666666667
1015,Am_J_Community_Psychol-2-2-1705531.txt,lifestyl||case||secondari victim||respons||self-blam||neg experi||studi||neg reaction||disclosur||silenc||friend||legal||current studi||sourc||commun system personnel||impact||rape||natali||karen||reaction||interview||effort||neg social reaction||result||social reaction||experi||social class||support provid||assault||commun system||reason||religi commun||medic system||famili||legal system||woman||survivor||posit||rape survivor||fear||support||foster care system||mari||decis||shawna||step||polic||in-person interview,rape||assault||rape survivor||assault disclosur||rape victim||survivors’ assault||sexual assault||sexual assault survivor||survivor||rape journal||rape crisi||disclosur||rape myth||sexual assault victim||acquaint rape,0.507||0.482||0.39||0.373||0.365||0.332||0.28||0.278||0.272||0.268||0.264||0.264||0.263||0.261||0.26,0.6,0.4,0.3333333333333333
1016,Anal_Bioanal_Chem-3-1-1914274.txt,condit||measur||present pad system||system||off-lin batch format||concentr||optim||data||pro-oxid||effect||ascorb acid||pad system||ros-produc||increas||resolut||compound||mixtur||hplc separ||on-lin pad system||protein concentr||antioxid||harm effect||paper||flow-rat||flow rate||gradient||flow inject analysi||paraquat||min||organ modifi||fia||bioactiv||flow-rat gradient||individu compound||ro||hplc||mode||detect||result,pro-oxid||on-lin pad||antioxid||ros-produc pro-oxid compound||antioxid fia pad system||ros-produc||fia||on-lin pad assay||fia pad system||pad system||hplc pad system||hplc||on-lin pad system||paraquat||pad trace,0.34||0.297||0.256||0.237||0.229||0.226||0.225||0.224||0.22||0.217||0.216||0.215||0.213||0.204||0.199,0.4,0.5,0.5333333333333333
1017,Anal_Bioanal_Chem-3-1-1797063.txt,import||biofilm||quorum||stabil||signal product||system||commun||signal concentr||aip||endoproteas||growth condit||agr cascad||environ||studi||bacteria||biofilm format||signal diffus||quorum sens||molecul,S. aureu||_{||biofilm S. aureu biofilm||staphylococcu aureu||S. aureu S.||biofilm||P. aeruginosa S. aureu lifecycl||delta _{||40 65 S. aureu S.||_{ 0||S.||biofilm commun S.||quorum||69 fig. 4 S. aureu agr||stoodley,0.241||0.214||0.21||0.202||0.197||0.179||0.141||0.127||0.12||0.119||0.111||0.105||0.104||0.098||0.095,0.0,0.1,0.13333333333333333
1018,Anal_Bioanal_Chem-4-1-2259236.txt,bond||data||marin||ion||spectra||isom||nonrepetit complex materi||meaning molecular-level analysi||complex unknown||current inabl||discret analyt volumetr pixel space||complex mixtur||mass||oxygen||voxel||ratio||properti||separ||chemic structur||structur space||analysi||fticr mass spectra||nmr||complex system||limit bandwidth||materi||chemic bind||number||organ structur spectroscopi||peak||molecul||function,molecular-level||anal chem 70:3853||anal chem 35:2146||anal chem 75:5030||anal chem 66:3849||hertkorn||acc chem||nicholson||isom||anal bioanal chem analyt||cloarec||phi chem||chem soc 119:7928||chem soc 120:4763||chem soc 116:7098,0.182||0.17||0.17||0.17||0.17||0.165||0.144||0.142||0.135||0.134||0.132||0.129||0.109||0.109||0.109,0.0,0.1,0.06666666666666667
1019,Anal_Bioanal_Chem-2-2-1764597.txt,toxic equival quantiti||pcb||sampl type||method||concentr||dioxin-lik pcb||determin||tcdd||sampl||data||seri||toxic effect||pcdd||select||extract||toxic equival factor||discuss||dlpcb||human||review||tempor trend||compound||dioxin||sourc||mixtur||analyt||mass spectrometri||calux||applic||hite||furan||analysi||pcdf||concentr rang||report||order||emiss||number||chemic||congen||polychlorin dibenzofuran||tef||toxic||signific advanc||techniqu,"teq||dioxin teq||dioxin||pcb teq||pcb||furan||dioxin pcdd||2,3,7,8-substitut dioxin||chlorin dioxin||octa-chlorin dioxin||63 pg teq||6,670 pg teq||21.29 pg teq||1.061 pg teq||10.16 pg teq",0.37||0.361||0.353||0.323||0.276||0.253||0.229||0.217||0.205||0.197||0.195||0.194||0.194||0.193||0.193,0.4,0.3,0.2
1020,AIDS_Behav-2-2-1544374.txt,prevent||program||sexual behavior||level||time||campaign||africa||strategi||year||multipl channel||effect||inform||review||sexual activ||hiv preval||countri||health educ||condom||behavior chang||ugandan ministri||health||educ||vision||train||world health organ||iec||hiv||global aid crisi||educ campaign||activ||report||aid||uganda||note||ministri||support||major differ||plan||gpa||district,uganda||uganda hiv||uganda program||uganda messag||moh uganda||uganda acp||uganda aid program||uganda 89||2006 uganda||1 uganda||uganda hiv preval||uganda iec activ||uganda 3 unaid||uganda aid prevent activ||aid,0.723||0.482||0.429||0.407||0.383||0.383||0.368||0.365||0.362||0.362||0.327||0.28||0.256||0.253||0.245,0.2,0.1,0.13333333333333333
1021,Anal_Bioanal_Chem-3-1-2117333.txt,calcul||compil||set||higher level||method||time||sampl||solvent||polar||full-scan acquisit||retent time shift||amount||solid phase||process||toluen||effici extract||fortif||recoveri||calibr standard||degrad||sourc||methanol||valid||pesticid||mix solut||adsorpt||inject speed||solut||residu||analysi||liner||standard||ethyl acet||clean-up||gpc clean-up||minimum||intern standard||gcb||inject||matrix||step||multi-residu analysi||result,api3000||api2000||lettuc||lettuc pesticid||0||pesticid||lettuc extract||model api2000||orang||GC||102 102 0 0 92 12||unclean lettuc extract||46 lettuc bromopropyl GC||pesticid recoveri||140 pesticid,0.354||0.323||0.303||0.246||0.199||0.189||0.178||0.162||0.159||0.157||0.13||0.125||0.124||0.112||0.11,0.0,0.1,0.06666666666666667
1022,Anal_Bioanal_Chem-3-1-1802725.txt,condit||galleri||non-destruct analysi||instrument||mar virgin||analyt challeng||panel||experiment condit||exhibit galleri||larg dimens||investig||raman spectroscopi||museum object||exampl||mobil spectromet||artefact||pigment||indian kalighat||conserv||paint||analysi||spectrum||museum||antiqu egyptian sarcophagi||varnish layer||renaiss||laser||work||lid||area||mobil raman spectroscopi||earli keyboard instrument||object||textil banner||techniqu,museum||paint||raman spectroscopi||raman instrument||museum galleri||raman spectrum||vandenabeel||raman spectra||raman spectrosc 35||varnish paint||raman spectrosc 37||raman spectrosc 32||artefact||mobil raman spectroscopi||museum object,0.334||0.261||0.258||0.246||0.244||0.231||0.229||0.215||0.203||0.201||0.2||0.2||0.194||0.194||0.192,0.6,0.3,0.4
1023,Anal_Bioanal_Chem-4-1-2226005.txt,light mass ratio||variat||plasma||instrument||extern precis||element||sampl||data||mc-icp-m||isotop fraction||silic||ion beam||composit||ratio measur||mass spectrometri||ratio||larg variat||standard||intens||extern normal||isotop||high instabl||fraction||interfer||isotop ratio measur||light element||precis||techniqu,earth||isotop||chem geol||Mg isotop||planet sci lett||chem geol 226:280||Li isotop||isotop fraction||text||isotop composit||lithium isotop||Mg isotop ratio||lighter isotop||gali||Ca isotop ratio,0.199||0.187||0.173||0.136||0.131||0.118||0.114||0.113||0.109||0.106||0.104||0.101||0.1||0.1||0.099,0.2,0.2,0.13333333333333333
1024,Anal_Bioanal_Chem-3-1-1592466.txt,channel dimens||system||larg molecul||squar capillari||cas-chip||success separ||mix protein sampl||multilay flow||small molecul||capillary-assembl microchip||capillari electrophoresi||solut||protein||squar section channel||CE separ||fluoresc intens profil||microchip||feasibl studi||microchannel||deprotein||pretreat||sampl inject||inject||pdm||molecul||f-bsa||sampl solut,cas-chip||deprotein||diffusion-bas deprotein||terab||cas-chip technolog||molecul||capillari electrophoresi||squar capillari||separ capillari||diffusion-bas separ||diffusion-bas pretreat||deprotein attach||pdm||chemically-function capillari||rhodamine-bas molecul,0.362||0.263||0.235||0.208||0.188||0.168||0.155||0.151||0.145||0.145||0.143||0.143||0.139||0.137||0.133,0.4,0.5,0.4
1025,Anal_Bioanal_Chem-3-1-1705481.txt,individu congen||program||pcb||method||routin pop analysi||electron supplementari materi||concentr||sampl||low cost||data||solvent||strategi||pop||extract||low environment impact||water||air||GC column||review||analyt laboratori||abil||recoveri||scientist||pesticid||analyt||countri||lipid||field blank||manag||organochlorin||percentag||evapor||analysi||gpc||routin measur||analyt standard||analyt method||sediment||ocp||congen||limit||stockholm pop convent||lab||blank||step||analyt system||environment monitor||detect||techniqu,ocp||pcb||ocp contamin||ocp monitor||ocp recoveri||pcb congen||ocp analysi||ocp ancillari||15 ocp||routin pcb||ortho-subsitut pcb||pcb 100||total pcb||pcb number||singl pcb,0.411||0.383||0.224||0.224||0.22||0.217||0.209||0.208||0.206||0.199||0.195||0.194||0.193||0.193||0.193,0.4,0.2,0.13333333333333333
1026,Acta_Neuropathol-3-1-2080348.txt,astrocyt hypertrophi||find||case||pvl||pvl case||infant||perinat period||gray matter lesion||data||studi||neg group||cerebr cortex||dwmg||reactiv astrocyt||necrosi||signific||periventricular leukomalacia||cell||brain||gfap||basal ganglia||periventricular necrosi||gray matter||hippocampu||neuron loss||globu pallidu||white matter gliosi||age||frontal cortex||perinat panencephalopathi||incid||injuri||purkinj cell||group||sever||white matter injuri||gliosi||dwmg group||prematur infant||thalamu,pvl||dwmg||0||1.000 pvl||NS pvl dwmg||pvl dwmg neg||0.629 pvl dwmg||1.000 0||pvl case||pvl group||3 pvl dwmg neg||dwmg case||4 pvl||pvl versu dwmg demograph||dwmg group,0.447||0.423||0.377||0.306||0.304||0.302||0.296||0.271||0.237||0.229||0.227||0.225||0.224||0.219||0.217,0.4,0.3,0.26666666666666666
1027,Osteoporos_Int-4-1-2267485.txt,rheumatoid arthriti||clinic fractur||comput||data||model||studi||year||bmi||risk||continu variabl||increas||exampl||prior histori||fractur probabl||fractur||signific interact||signific||valid||absenc||cohort||osteoporot fractur||bmd||women||hip||assess||age||death||death hazard||osteoporosi||cost-effect||hazard function||clinic risk factor||probabl||clinic spine||fractur risk||hip fractur,fractur||hip fractur||fractur risk||osteoporot fractur||vertebr fractur||fractur probabl||fractur hazard||fragil fractur||perimenopaus fractur||forearm fractur||model fractur||clinic fractur||previou fractur||osteoporosis-rel fractur||nonvertebr fractur,0.701||0.452||0.424||0.397||0.38||0.38||0.371||0.365||0.364||0.363||0.359||0.359||0.356||0.355||0.354,0.8,0.5,0.4
1028,Sleep_Breath-4-1-2276561.txt,level||time||week||fat||weight loss||hypoxia group||hypox climat||train period||studi||bmi||effect||air||hypox condit||moder hypoxia||oxygen||hypoxia||mild||train||climat||bodi||subject||weight||min||group||normobar hypoxia||room||low intens physic exercis||simul altitud,hypoxia||sham hypoxia||normobar hypoxia||hypoxia train||acut hypoxia||moder hypoxia||hypoxia group||sham hypoxia group||acut hypobar hypoxia||sham hypoxia control protocol||sham hypoxia group 2||normobar sham hypoxia netzer nikolau||exercis||sham hypoxia group fig. 5||hypoxia group fig. 3,0.662||0.446||0.427||0.392||0.348||0.348||0.347||0.308||0.248||0.231||0.231||0.226||0.201||0.187||0.176,0.4,0.4,0.26666666666666666
1029,Purinergic_Signal-3-4-2072919.txt,subtyp||releas||modul||nerv termin||adenosin||pharmacolog profil||channel||patholog situat||atp||effect||synapt transmiss||spinal cord||receptor||excitatori amino acid||p2i receptor||nervou system||brain||p2x receptor||neurotransmitt releas||nucleotid||hippocampu||neuron||termin||activ||extracellular space||neurotransmitt||ligand-g cation channel||sympathet nerv||glutam||neuron activ,receptor||p2x receptor||p2x||atp p2x receptor||p2i receptor||atp receptor||p2i||atp||P2 receptor||atp releas||presynapt p2x receptor||presynapt p2i receptor||P2||facilitatori p2x receptor||presynapt P2 receptor,0.299||0.297||0.295||0.289||0.287||0.286||0.275||0.274||0.26||0.245||0.241||0.234||0.222||0.217||0.216,0.6,0.4,0.26666666666666666
1030,Intensive_Care_Med-4-1-2228379.txt,refractori shock||septic shock||supplementari materi||product||septic patient||urinari excret||benefici effect||short-term effect||proxim tubul injuri||septic shock patient||kidney damag||clinic paramet||MB treatment||renal tubular injuri marker||renal failur||studi||urin||continu infus||patient||day,methylen||methylen blue||septic shock||refractori septic shock||MB||MB infus||septic shock patient||infus||septic patient||MB excret||s00134-007-0867-9||human septic shock||excret||nijmegen||nitric oxid,0.281||0.21||0.208||0.163||0.158||0.155||0.152||0.152||0.15||0.15||0.144||0.142||0.142||0.138||0.135,0.2,0.3,0.2
1031,Diabetologia-4-1-2362134.txt,vitro techniqu||resorpt||coverslip||control group||rankl||studi||mediat||patient||observ||increas||receptor||opg||diabet control||osteoclast format||osteolysi||excess concentr||osteoclast||m-csf||dentin slice||activ||group||rankl-independ pathway||bone||cultur||presenc||number||healthi control||particip||addit||result,osteoclast||osteoclast resorpt||osteoclast format||osteoclast cultur||osteoclast precursor||osteoclast activ||activ osteoclast||osteoclast differenti||human osteoclast||osteoclast marker||m-csf osteoclast format||opg osteoclast format||0.0001 osteoclast resorpt||opg osteoclast osteolysi rankl resorpt||osteoclast resorpt 4,0.576||0.39||0.311||0.304||0.303||0.301||0.301||0.299||0.295||0.292||0.286||0.269||0.267||0.263||0.26,0.4,0.2,0.13333333333333333
1032,BMC_Bioinformatics-4-_-317283.txt,literatur mine||matrix tabl||modifi term||basic pubm search window||simpl||databas||search term||data||larg dataset||keyword term||combin||proteom approach||gene list||tool||term co-occurr||gene||approach||pubm||pair-wis comparison||list||tabl||keyword||queri||pubmatrix||result,pubmatrix||search||pubm||queri||implement pubmatrix||conclus pubmatrix||list||mine||search term||1471-2105-4-61 softwar pubmatrix||de-novo search||dp||pubmatrix search result tabl||gene list||simpl search,0.387||0.241||0.235||0.223||0.201||0.196||0.187||0.181||0.175||0.167||0.164||0.161||0.161||0.16||0.158,0.6,0.5,0.4
1033,Dev_Genes_Evol-3-1-1784541.txt,macrostomorpha||anim||organ system||triclad||postembryon develop||polyclad||amput||regener||divers taxa||head||develop||planarian||organ||main function||abil||pharynx||similar||nervou system||ovari||eye||cell||brain||egger||free-liv flatworm||platyhelminth||regener capac||acoela||neoblast||acoel||part||main nerv cord||anterior||flatworm||speci,regener||lignano||planarian regener||macrostomum lignano||planarian||flatworm macrostomum lignano||regener M.||über regener||turbellaria||M. lignano||M. lignano M. lignano||regener capac||brain regener||intercalari regener||posterior regener,0.392||0.368||0.32||0.288||0.247||0.238||0.219||0.214||0.209||0.207||0.207||0.207||0.203||0.203||0.202,0.4,0.2,0.2
1034,Int_J_Cardiovasc_Imaging-4-1-2233708.txt,viabl myocardium||cmr||system||flow||artifact||imag||element cardiac||quantit analysi||studi||cardiovascular magnet reson||imag qualiti||acut myocardi infarct||stent posit||repeat intervent||sequenc paramet||day||dark band artifact||patenc||field strength||acut||feasibl||chronic phase||cine||analysi||cine imag||dark band||scan||repeat catheter||puls sequenc||safeti,cmr||imag||3.0||lge imag||reson imag||cmr scan||stent artifact||reson 3.0||cine imag||magnet reson imag||imag artifact||magnet reson||lge imag qualiti||cine||artifact,0.359||0.252||0.244||0.242||0.24||0.238||0.238||0.236||0.222||0.221||0.22||0.206||0.199||0.191||0.189,0.4,0.3,0.3333333333333333
1035,Osteoporos_Int-3-1-1894753.txt,bone mass||measur||find||method||narrow age rang||boy||studi||periost growth||longitudin growth||humer AR||avon longitudin studi||fractur||analys||present studi||humer dimens||ratio||humeru||girl||width||humer width||age||gender differ||puberti||tanner stage 2||scan||differ||bone||height||dxa||tanner stage||periost||length||area||humer geometri||bone miner densiti||children||result,humer width||bone||humer AR||puberti||humer length||humer geometri||humer dimens||boy||boy girl||girl||periost||greater humer AR||prepubert boy||periost bone growth||bone length,0.298||0.289||0.285||0.285||0.279||0.266||0.257||0.247||0.243||0.239||0.208||0.203||0.197||0.187||0.186,0.8,0.8,0.6
1036,Virchows_Arch-4-1-2329735.txt,cell adhes||type||intestin||high level||find||case||tissu microarray||liver metastasi||carcinoma||studi||patient||patholog characterist||diffus distribut||diffus compon||high stage||muc2||express||classif||diffus part||present studi||mix type||lymph node||emmprin||analysi||lymph node metastasi||genet||group||MT case||invas||gastric carcinoma||statist signific||venou invas||periton||compon,gastric||gastric carcinoma||carcinoma||gastric MT carcinoma||diffuse-typ gastric carcinoma||intestinal-typ gastric carcinoma||gastric carcinoma anticanc||gastric carcinoma exhibit||carcinoma mixed-typ carcinoma diffuse-typ carcinoma||gastric carcinoma progress||gastric carcinoma Br||human gastric carcinoma||gastric carcinoma 4||gastric carcinoma 3||mixed-typ carcinoma,0.43||0.416||0.402||0.316||0.311||0.307||0.287||0.286||0.285||0.28||0.28||0.279||0.278||0.278||0.26,0.4,0.2,0.13333333333333333
1037,Neuroimage-2-1-2387200.txt,corpu callosum||group differ||method||mri||abnorm||studi||diffus process||patient||white matter pathway||fraction anisotropi||pdf||genu||pico||threshold||region||multipl linear regress||specif cortic region||first-episod psychosi||interhemispher connect||splenium||voxel||FA||control||psychosi||fiber||age||gender||subject||seed region||white matter||group||differ||cortex||tract||probabl||schizophrenia||focal abnorm||dti||result,al.||schizophrenia||corpu callosum||corpu||first-episod schizophrenia||corpu callosum abnorm||splenium||schizophrenia schizophr||corpu callosum mol||human corpu callosum||corpu callosum develop||corpu callosum growth||episod schizophrenia||genu||early-onset schizophrenia,0.491||0.282||0.256||0.235||0.211||0.194||0.183||0.175||0.174||0.173||0.172||0.172||0.149||0.146||0.145,0.4,0.3,0.26666666666666666
1038,Int_J_Cardiovasc_Imaging-3-1-2121120.txt,follow-up||wall motion abnorm||nwma||mri||imag||studi||patient||dobutamin stress cmr||lbbb||dose||examin||stress||wall motion analysi||perfus abnorm||cine||cardiac event||peak-dos dobutamin||coronari arteri diseas||ischemia||peak stress||perfus sequenc||min||cag||dobutamin||addit inform||segment||perfus imag||rest||normal first-pass perfus||perfus deficit,dobutamin||nwma||peak-dos dobutamin||dobutamin stress||perfus||dobutamin stress cmr||dobutamin test||myocardi perfus||peak-dos dobutamin stress cmr||perfus abnorm nwma||peak-dos dobutamin eighteen||peak-dos dobutamin 4||dobutamin stress mri||dobutamin stress cardiac-mr||myocardi perfus imag,0.561||0.386||0.373||0.35||0.307||0.297||0.283||0.282||0.269||0.259||0.256||0.249||0.248||0.239||0.226,0.6,0.4,0.26666666666666666
1039,Virchows_Arch-3-1-2082069.txt,tumor||ectop tissu||neoplasia||structur||case||paratesticular structur||mesotheli hyperplasia||pseudotumor||benign mimick||testicular||lesion||diagnosi||cyst||leydig cell||sertoli cell||testi||true neoplasia,testicular||testicular cyst||testi||testicular neoplasia||testicular tumor||testicular hematocel||testicular neoplasm||testicular vascul||testicular pseudolymphoma||testicular mass||testicular amyloidosi||testicular femin||testicular infarct||testicular microlithiasi||testicular polyarter,0.476||0.316||0.315||0.277||0.269||0.259||0.258||0.253||0.252||0.252||0.252||0.25||0.249||0.245||0.245,0.4,0.2,0.13333333333333333
1040,Matern_Child_Health_J-2-2-1592154.txt,preconcept||sara||infant||pregnanc||histori||year postpartum||depress||concept||risk||medic||postpartum period||counsel||mental health||earlier treatment||treatment||melani||women||month||care||famili||perinat||health care provid||episod||mood disord||addit||outcom,depress||postpartum depress||perinat depress||postpartum||depress episod||matern depress||postnat depress||depress symptom||antenat depress||comorbid depress||sever depress||postpartum women||perinat||neonat depress anxieti||matern depress effect,0.636||0.511||0.447||0.387||0.36||0.352||0.342||0.339||0.328||0.324||0.319||0.265||0.257||0.241||0.237,0.2,0.1,0.13333333333333333
1041,Ann_Surg_Oncol-3-1-1914262.txt,intern mammari lymph node||time||surgic treatment||rate||breast cancer||patient||node||visual||metastas||visual IM sln||parastern intercost incis||axillari sln||radiotherapi||primari tumor||IM sln||sentinel node||tumor||sln||stage procedur||surgic explor||patient IM sln||inject||lymphoscintigraphi||radiotherapeut treatment,sln||IM sln||bct||axillari sln||sln biopsi||IM sln biopsi||IM metastas IM sln||visual sln||sln procedur||visual IM sln||patient IM sln||axillari sln biopsi||sln identif||conclus sln||retriev IM sln,0.619||0.45||0.41||0.407||0.372||0.342||0.339||0.336||0.317||0.317||0.316||0.313||0.312||0.31||0.31,0.6,0.4,0.3333333333333333
1042,Support_Care_Cancer-4-1-2413096.txt,day-to-day hands-on caregiv||level||individu||data||model||studi||year||caregiv||patient||concept||inform||abil||proport||valid instrument||palli care||relationship||life-limit ill||south australia||unmet||popul||servic||death||respond||famili member||termin ill||long-term caregiv outcom||survey||health omnibu survey||special palli care servic||support||area||peopl||outcom,caregiv||spc||caregiv respond||cancer caregiv||end-of-lif caregiv||famili caregiv||905 caregiv||caregiv burden||long-term caregiv||inform caregiv||access caregiv||caregiv assess||caregiv strain||caregiv role||caregiv characterist,0.603||0.453||0.341||0.324||0.324||0.316||0.316||0.313||0.312||0.31||0.309||0.306||0.305||0.305||0.305,0.2,0.1,0.06666666666666667
1043,J_Gastrointest_Surg-3-1-1852391.txt,logist regress analysi||complic||logist regress||rate||studi||patient||effect||obes||anastomosi||variabl||peripher neuropathi||signific||gastric bypass||strictur||age||analysi||odd||surgeri||gerd||bariatr surgeri||group||factor||rygb||oper techniqu||gastrojejunostomi||obes patient||techniqu,strictur||gastrojejunostomi strictur||postop strictur||fewer strictur||strictur group||strictur rate||recurr strictur||predict strictur||JS strictur dilat||gastrojejunostomi||bypass||increas strictur rate||roux-en-i||gastric bypass||laparoscop roux-en-i gastric bypass,0.633||0.432||0.357||0.33||0.325||0.324||0.323||0.32||0.234||0.232||0.222||0.217||0.215||0.21||0.208,0.2,0.2,0.2
1044,J_Mol_Model-3-1-2039871.txt,type||attempt||set||emphasi||method||system||level||bond||pm6||molybdenum||incorrect structur||optim||element||data||valu||spin-fre energi level||orbit||effect||refer data||larg formal charg||water||structur||failur||transit metal complex||complex||parameter||compound||high level calcul||fault||electron state||geometri||group iva||core-cor express||potenti||distanc||main group||paramet||rule||atom||accuraci||rare ga atom||potenti sourc||weight||interatom separ||transit metal||group||hydrogen bond||hydrogen||import||core-cor interact||refer||semiempir method||interact||speci||error||heat||chemic bond||function||approxim||result,pm6||pm6 am1||_{||am1||no. pm6 am1||pm6 pm5 pm3 am1||element pm6 no.||element||pm6 level||pm6 function||pm6 definit||atom||3 pm6 paramet||statist pm6 pm3 am1 rm1||pm3,0.198||0.163||0.155||0.128||0.123||0.12||0.115||0.104||0.102||0.101||0.1||0.097||0.093||0.092||0.09,0.2,0.2,0.2
1045,Eur_J_Clin_Pharmacol-3-1-2071964.txt,type||aspect||ddd||daili dosag||pharmacotherapi audit meet||ptam||method||agreement||result||associ||pharmacist||meet||data||studi||tool||cost||group,ptam||ptam meet||ptam level||function ptam||84 ptam||ptam number||includ ptam||ptam 11||prescrib||ptam paramet number||total 824 ptam||du90||ddd||drug prescrib||ptam level descript level 1,0.793||0.43||0.416||0.402||0.401||0.401||0.398||0.397||0.274||0.268||0.268||0.249||0.213||0.198||0.175,0.2,0.1,0.13333333333333333
1046,Purinergic_Signal-3-4-2072921.txt,atp||confoc analysi||striatum||dopamin denerv||rat striatum||presenc||gray matter||rat brain||protein level||protein||receptor||green immunofluoresc||substantia nigra||experiment condit||express||lesion nigro-striat circuit||specif||brain||purinerg receptor,receptor||P2 receptor||volonté||purinerg receptor||P2||p2x receptor||p2i receptor||neuron p2x receptor||P2 receptor protein||P2 receptor subtyp||P2 receptor modul||p2y1 purinerg receptor||striatum||P2 receptor web||p2x atp receptor,0.25||0.23||0.224||0.214||0.211||0.198||0.192||0.177||0.17||0.167||0.163||0.162||0.162||0.156||0.156,0.4,0.2,0.2
1047,Eur_Arch_Psychiatry_Clin_Neurosci-3-1-1800370.txt,deficit||control group||fals belief||schizophren||mental state||studi||social cognit task||patient||brain damag||cognit profil||tactic strategi||human||abil||stori||tom||lesion||behaviour||damag||brain||social cognit||item||mental retard||frontal lobe lesion||task||statement||subject||ventromedi frontal lobe damag||group||order||lmpfc||differ||perform||healthi control||prefront cortex||signific correl||medial frontal lobe||peopl||schizophrenia||score||social situat,frontal lobe||frontal lesion||mind||frontal lobe lesion||frontal lobe lesion theori||medial frontal lobe||meningioma||mind task||frontal lobe excis||frontal lobe dysfunct||unilater frontal lobe lesion||prefront lobe lesion||lesion||frontal lobe function||frontal lobe surgeri,0.272||0.271||0.25||0.245||0.228||0.214||0.204||0.197||0.195||0.191||0.19||0.19||0.189||0.186||0.185,0.2,0.2,0.2
1048,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-1915597.txt,aitfl imping||fascicl||joint tissu||joint||studi||patient||contact||ankl joint||anterior talofibular ligament||ankl||aitfl||chronic ankl pain||talu||anterior aspect||pain||imping syndrom||imping||dorsiflexion||anterior||arthroscopi||ligament||anterior inferior tibiofibular ligament||talar dome||result,fascicl||ankl||ankl imping||imping||aitfl imping||imping distal fascicl||anterior ankl imping||ligament imping||distal fascicl||ankl arthroscopi||aitfl||inferior fascicl||ankl imping syndrom||keyword ankl imping||ankl joint,0.46||0.456||0.396||0.337||0.31||0.308||0.303||0.295||0.294||0.293||0.282||0.277||0.275||0.264||0.26,0.8,0.4,0.4
1049,J_Headache_Pain-4-1-2386847.txt,placebo||region cerebr blood flow||time||volunt||studi||patient||effect||infus||increas||cgrp||blood pressur||rcbf||mca||signific||treatment||present studi||heart rate||cerebr arteri||chang||min||arteri||decreas||migrain||cerebr blood flow,cgrp||cgrp placebo cgrp placebo cgrp||cgrp infus||cgrp receptor||cgrp antibodi||migrain||oral cgrp antagonist||mca||edvinsson||calcitonin||headach||placebo||calcitonin gene-rel peptid||olesen||mca territori,0.567||0.393||0.313||0.298||0.286||0.206||0.203||0.195||0.195||0.161||0.143||0.133||0.132||0.131||0.127,0.2,0.3,0.26666666666666666
1050,Surg_Endosc-4-1-2422865.txt,follow-up||week||questionnair||minim invas||randomis trial||complic||studi||patient||health statu||sic||bodi imag||test||total||small-incis cholecystectomi||preoper data||symptomat cholecystolithiasi||analys||method patient||oper||alloc sequenc||health||giqli||alloc conceal||surgeri||subscal||minim invas procedur||cholecystectomi||gener||group||gener short form||differ||order||trial||procedur||score||secondari outcom measur||techniqu,cholecystectomi||sic||laparoscop cholecystectomi||small-incis cholecystectomi||conv||laparoscop||open cholecystectomi||cholecystectomi rate||cholecystectomi Br||elect cholecystectomi||sic procedur||sic patient||sic 55.4||LC versu sic||0.100 sic,0.422||0.384||0.334||0.313||0.264||0.247||0.222||0.218||0.217||0.215||0.213||0.208||0.201||0.197||0.196,0.6,0.3,0.2
1051,Ann_Biomed_Eng-4-1-2413127.txt,csf||time||method||brain tissu||traumat brain injuri||model||studi||brain injuri||cerebr cortex||head||boundari constraint||increas||region||shear modulu||finit element model||injuri criteria||geometri||brain||stress||tbi||numer model||equival stress||gray matter||heterogen||simul||direct||part||cerebrum||injuri||load condit||cortex||influenc||mechan load||comput head model||materi properti||result,user2||rm||vec||document||documentclass||12pt||amsmath||amsfont||mathrsf||69pt||varvec||rm ve||tild||head||head injuri,0.077||0.076||0.068||0.066||0.049||0.049||0.049||0.049||0.049||0.049||0.045||0.042||0.037||0.031||0.031,0.0,0.0,0.06666666666666667
1052,Health_Care_Anal-3-1-2045690.txt,reflex consumer||type||social commun||non-profit organ||skill||respons||technolog||commun||internet technolog||practic||individu||state||patient||trust mark||consum||prescript||inform||percept||organ||exampl||user||site||tool||health profession||web||user tool||health||term||hon||non-government organ||reflex||care||activ||special toolbar||literatur||choic||actor||search||medic profession||question reliabl||reliabl||citizen||particip||diseas||polit actor||initi||internet,internet||internet user||hon||actor||inform||internet technolog||polit actor||internet empower||health inform||user||inform consum||polit||internet news||healthi internet user||citizen,0.291||0.232||0.23||0.22||0.211||0.209||0.192||0.183||0.182||0.174||0.171||0.165||0.158||0.157||0.156,0.8,0.7,0.5333333333333333
1053,Qual_Life_Res-4-1-2238782.txt,isrf||mhm||content domain||lower level||social health||measur||level||case||method||respons||questionnair||msp||polytom item||grade respons model||monoton||locat||model||nonparametr monoton homogen model||valu||monoton homogen model||patient||nonparametr irt analysi||data analysi||scale||parametr model||exampl||domain||point||psycholog well-b||dimension||item||latent variabl||estim||research||paramet||analysi||social limit||mokken model||grm||item respons theori||psycholog||whoqol-bref||patient group||unidimension scale||hrqol||result,θ||θ θ||θ θ θ||θ θ 1 θ θ||θ θ θ θ 1||3 θ θ θ||item||θ θ area||nonparametr item||θ α||5 6 θ θ θ scale||72 θ||0 θ||polytom item||73 θ,0.478||0.478||0.478||0.383||0.383||0.359||0.355||0.32||0.276||0.265||0.256||0.242||0.241||0.241||0.24,0.0,0.1,0.13333333333333333
1054,Clin_Rheumatol-4-1-2262146.txt,develop||chemotherapi||r-chop||microbiolog test||joint||arthriti||lymphoma||pain||knee||rheumat diseas||synovi fluid||tumor lysi syndrom||wrist||cours||diagnosi||patient||rituximab||treatment||nhl,r-chop||rituximab||r-chop chemotherapi||arthriti||nhl||r-chop administr||rituximab treatment||nhl intra-articular||rheumatoid arthriti||remitt arthriti||knee||reactiv arthriti||chemotherapi||discuss arthriti||keyword advers effect arthriti lymphoma rituximab,0.457||0.415||0.305||0.298||0.29||0.238||0.219||0.184||0.174||0.168||0.163||0.155||0.152||0.149||0.145,0.8,0.4,0.4
1055,Pediatr_Nephrol-4-1-2214826.txt,antibodi||proteinuria||sever immunosuppress||clinic respons||patient||year||system lupu erythematosu||rituximab||rituximab therapi||rtx||multipl cours||clinic diseas activ||dose||treatment||therapi||lupu nephriti||age||renal function||hemodialysi||sever sle||sle||clinic remiss||children,nephriti||lupu nephriti||rtx||rituximab||pediatr lupu nephriti||cyc||prolif lupu nephriti||BH lupu nephriti||rituximab nephriti class||rtx therapi||class IV lupu nephriti||lupu erythematosu refractori||mmf||rtx treatment||weekli rtx,0.38||0.375||0.358||0.288||0.278||0.273||0.253||0.252||0.228||0.216||0.203||0.2||0.198||0.193||0.183,0.6,0.3,0.2
1056,Intensive_Care_Med-3-1-1915647.txt,prematur neonat||subgroup||high-frequ ventil||time||gestat age||respiratori distress syndrom||infant||ventil||studi||rr||year||patient||effect||risk||depend variabl||lpv||protect ventil strategi||high lung volum strategi||cld||rel risk||analysi||death||meta-regress analysi||convent mechan ventil||factor||differ||cmv||import||chronic lung diseas||import variabl||rrr||sensormed ventil||trial||ventil strategi||public||hfv||explanatori variabl||random trial||public bia||outcom||result,ventil||cld||high-frequ ventil||hfv||cmv||rrr||sensormed ventil||high-frequ oscillatori ventil||ventil trial||convent ventil||hlv||ventil strategi||hlv lpv||mechan ventil||prolong ventil,0.435||0.383||0.32||0.312||0.278||0.268||0.255||0.252||0.245||0.243||0.238||0.236||0.226||0.223||0.222,1.0,0.7,0.5333333333333333
1057,J_Autism_Dev_Disord-4-1-2254472.txt,plaist||effect search strategi||target||fixat cross||stimulu element||stimulu discrimin||control group||enhanc abil||visuo-spati task||effect||search strategi||test||pdd||reaction time data||present studi||search task||control||fixat time||analysi||enhanc stimulu discrimin||subject||high function adult||group||fixat||number||eye movement||size||signific differ||particip||superior perform,pdd||autism||pdd group||pdd excel||plaist||pdd kemner chantal||fixat||autism journal||eye||autism depend||individu pdd subject adi||task||search task||search||autism quarterli journal,0.547||0.344||0.288||0.279||0.236||0.221||0.2||0.193||0.18||0.174||0.169||0.166||0.157||0.148||0.143,0.4,0.3,0.26666666666666666
1058,Mcgill_J_Med-11-1-2322926.txt,scaffold||patellar tendon||anterior cruciat ligament||heal||studi||patient||dacron prosthesi||review||acl reconstruct graft||replac||artifici ligament||biolog tissu autograft reconstruct||lad||cell||strength||techniqu||tissu||tissu engin principl||research||collagen||signific progress||graft||acl||surgeri||prosthet replac||implant||acl replac||carbon fibr||ligament||knee||reconstruct||prosthesi||tissu engin||prosthet,ligament||cruciat ligament||cruciat||anterior cruciat ligament||acl||prosthet ligament||cruciat ligament prosthesi||reconstruct anterior cruciat ligament||anterior cruciat ligament reconstruct||leeds-keio ligament||artifici ligament||ligament replac||anterior cruciat||acl reconstruct||alloplast ligament,0.553||0.477||0.401||0.382||0.364||0.36||0.359||0.338||0.338||0.334||0.304||0.296||0.296||0.287||0.285,0.6,0.3,0.26666666666666666
1059,FEMS_Microbiol_Ecol-1-_-2121141.txt,variat||statist packag||set||measur||method||commun||data matric||princip compon analysi||sampl||data||model||ordin||ordin diagram||multivari analys||distanc matric||observ||inform||scale||specif rule||test||complex||variabl||site||statist||cca||pattern||signific||cluster||origin varianc||nmd||ecolog hypothes||rank||distanc||relationship||approach||rda||varianc||multivari||environment condit||gradient||axe||environment gradient||row||instanc||cluster analysi||group||order||divers pattern||pca||tabl||canon correspond analysi||ecolog studi||speci||constrain ordin||object||microbi ecolog||hypothesi||interpret||techniqu,legendr||anosim legendr||1998 legendr||1936 legendr||1988 legendr||1990 legendr||1987 legendr||2002 legendr||2 legendr||1988 manova legendr||regress model legendr||2001 manova legendr||fig. 5 legendr||ter braak||1973 ward method legendr,0.64||0.348||0.329||0.326||0.325||0.325||0.322||0.321||0.32||0.228||0.226||0.225||0.216||0.168||0.166,0.0,0.0,0.0
1060,Behav_Genet-4-1-2257994.txt,person||level||behavior||anxious-depress||discord group||monozygot twin||twin pair||studi||comparison||valu||data||life||psychopatholog||life event||OC symptomatolog||pi-r abbr||environment factor||uniqu life event||OC twin pair||between-pair comparison||ocd||religi obsess||sexual assault||genet similar||alcohol||twin||concord MZ pair||age||pair||futur studi||parent||somat complaint||genet factor||obsessive-compuls symptom||group||factor||differ||uniqu||discord||report||symptom||previou report||concord||concord high pair||score,twin||n.||n. n.||OC twin||twin pair||OC twin pair||MZ twin||OC||concord MZ twin||MZ twin pair||discord twin pair||n.s. n.||high-scor twin||concord high-scor twin pair||n.s. n.s. n.,0.388||0.362||0.362||0.34||0.309||0.304||0.297||0.293||0.276||0.275||0.274||0.271||0.255||0.244||0.241,0.4,0.3,0.2
1061,Int_J_Hematol-4-1-2276241.txt,subtyp||categori||aml||data||normal karyotyp||patient||year||clinic featur||advers risk group||cytogenet risk group||classif||mld phenotyp||acut leukemia||mpo||fab||11q23 abnorm||age||analysi||acut myeloid leukemia||prognost factor||genet||mld||surviv||karyotyp||diagnosi||myeloperoxidas||result,leukemia||aml||acut leukemia||acut myeloid leukemia||acut myeloid leukemia classif||adult acut myeloid leukemia||acut myeloid leukemia differ||leukemia group||myelogen leukemia||cytogenet||aml subtyp||aml patient||leukemia 1 0.2 acut leukemia||leukemia 5 0.8 acut leukemia||acut basophil leukemia,0.434||0.385||0.311||0.307||0.261||0.239||0.231||0.226||0.226||0.222||0.22||0.219||0.215||0.215||0.213,0.6,0.3,0.2
1062,Planta-4-1-2249615.txt,total chlorophyl||carbohydr accumul||carbon export||maiz||doubl mutant||data||callos deposit||leaf tip||carbon||anilin blue||leav||carbohydr||chlorophyl level||sucros||leaf||tissu||starch||lack||mesophyl cell||accumul||sucros export||chlorot||mutant||vein||phenotyp||carbon partit||function||plant,tdy1-r||sxd1-1 tdy1-r||sxd1-1 tdy1-r sxd1-1||tdy1-r sxd1-1 sxd1-1||sxd1-1||sxd1-1 tdy1 tdy1||tdy1-r tdy1 sxd1||tdy1||tdy1-r sxd1-1 arrow||tdy1-r sxd1-1 2||tdy1 tdy1 sxd1 tdy1 sxd1 tdy1||tdy1 sxd1||sxd1 tdy1 sxd1||sxd1-1 plant||sxd1,0.611||0.578||0.566||0.566||0.544||0.445||0.44||0.395||0.388||0.385||0.368||0.354||0.34||0.327||0.313,0.0,0.0,0.0
1063,Aesthetic_Plast_Surg-4-1-2175019.txt,case||liposuct aspir||convent lipoinject||studi||patient||cal||adipos tissu||volum||increas||cosmet breast augment||aspir fat||cell||augment||asc||tissu||postop atrophi||materi||inject||breast augment||breast||lipoinject||result,asc||breast||fat||breast augment||lipoinject||cal||graft fat||fat graft||augment||aspir fat||inject fat||cosmet breast augment||supplement asc||autolog fat||soft breast,0.364||0.296||0.29||0.256||0.249||0.24||0.218||0.218||0.215||0.208||0.204||0.202||0.198||0.197||0.197,0.8,0.7,0.5333333333333333
1064,J_Hum_Genet-4-1-2413114.txt,gene||control||japanes||snp||obes||power||test||associ||genotyp rel risk||sever obes||genotyp||sever adult obes||bmi||japanes popul||group,fto||springer 2008 fto fto fto||fto gene||2 fto||fto 2 2 fto gene||obes||andrade-navarro MA fto||abecasi GR fto gene||s00125-007-0767-0 17657473 fto gene||302114 9867708 fto gene||schofield CJ fto gene||fto 2001 2002 2007||2 fto fig. 1||s10038-008-0283-1 origin articl fto gene||0.000001,0.625||0.386||0.344||0.313||0.263||0.217||0.216||0.182||0.181||0.181||0.177||0.162||0.157||0.15||0.121,0.0,0.1,0.06666666666666667
1065,Eur_Arch_Otorhinolaryngol-4-1-2217622.txt,ear||dpoae||perilymph||scala tympani||pressur increas||ear fluid volum||effect||cochlear function||CM potenti||pressur||signal||cmdp||acut||ear pressur||chang||2||decreas||cochlea||guinea pig||inject||diseas||artifici perilymph,ear||ear pressur||dpoae||ear fluid pressur||ear pressur recoveri||middl ear pressur||pressur||extern ear||ear function||ear pressur effect||ear pressur releas||acoust dpoae||normal ear||ear fluid compart||ear fluid volum,0.393||0.299||0.282||0.236||0.215||0.206||0.206||0.206||0.204||0.203||0.202||0.201||0.198||0.184||0.179,0.6,0.4,0.3333333333333333
1066,Neurochem_Res-3-1-1832150.txt,level||cerebellar ataxia||form||studi||coq10||diseas||patient||defici||skin fibroblast,coenzym q10||coenzym||coenzym q10 defici||coenzym q10 supplement||label coenzym q10||muscl coenzym q10 defici||primari coenzym q10 defici||muscl coenzym||dietari coenzym||dietari coenzym q10 biochem biophi||defici||ataxia||coq10 defici||naini||dimauro,0.518||0.501||0.402||0.351||0.348||0.309||0.304||0.267||0.261||0.216||0.168||0.148||0.138||0.135||0.122,0.0,0.0,0.06666666666666667
1067,Clin_Oral_Investig-4-1-2238790.txt,zinc phosphat cement||type||resin cement||retent||time||questionnair||diamet||core||high preval||stainless steel||resin composit||studi||year||amalgam||patient||clinic crown||restor materi||extent||failur||fractur resist||fractur||treatment||lute||post-retain restor||restor||materi||function time||practition||privat practition||factor||root||cement||survey||length||tooth||post,post||endodont post||cement post||prefabr post||post crown||cast post||fail post||post loosen||loosen post||taper post||parallel-sid post||titanium post||post length||tapered-parallel post||post-retain restor,0.519||0.377||0.344||0.328||0.321||0.31||0.305||0.301||0.301||0.3||0.294||0.285||0.274||0.273||0.273,0.2,0.1,0.13333333333333333
1068,Eur_J_Pediatr-4-1-2413085.txt,type||gene||role||human||rab||defect||bind||protein||function||transport||diseas||patient||rab protein||activ||griscelli syndrom||membran traffick||brain,rab||rab protein||rab geranylgeranyl||rab gtpase||endocyt rab||rab function||rab interact||rab27a||griscelli||rab escort protein-1||rab gene famili||mammalian rab famili||s00431-008-0740-z review rab protein||mild mental retard rab||keyword rab protein vesicl transport,0.53||0.321||0.313||0.303||0.29||0.272||0.269||0.239||0.212||0.199||0.198||0.188||0.168||0.161||0.152,0.4,0.2,0.13333333333333333
1069,Neurochem_Res-3-1-1794624.txt,arginyl residu||posit charg||import role||data||studi||amount||deimin||process||structur||increas||dna||brain||myelin||apoptosi||protein||neurolog diseas||myelin protein||mbp||citrullin||white matter||methyl||histon||multipl sclerosi||citrullin mbp||up-regul||demyelin||pad||result,myelin||moscarello||myelin protein||myelin sheath||immatur myelin||citrulline-contain myelin||myelin degrad||myelin constitu||myelin breakdown||citrullin||myelin assembl||deimin||pad||citrullin mbp||basic myelin protein,0.534||0.356||0.302||0.299||0.277||0.276||0.273||0.272||0.272||0.271||0.27||0.262||0.257||0.241||0.228,0.4,0.3,0.4
1070,Environ_Health_Perspect-116-2-2235228.txt,endocrin disrupt||de||diethylstilbestrol||summari estim||method||time||uniti||chi-squar test||qualiti||oral contracept||studi||sensit analysi||cryptorchid||risk||prenat exposur||random-effect model||test||testicular cancer||statist||subset||meta-analysi||estim||de exposur||heterogen||associ||hypospadia||environ||estrogen||exposur||pharmaceut estrogen||public||result,hypospadia||r-w hypospadia||cryptorchid||1977 hypospadia||1981 hypospadia||hypospadia Br||1991 hypospadia||1974 hypospadia||2005 hypospadia||1975 hypospadia||2003 hypospadia||1999 hypospadia||2002 hypospadia||estrogen||1998 hypospadia exposur,0.625||0.358||0.35||0.325||0.324||0.318||0.317||0.316||0.315||0.315||0.313||0.313||0.313||0.272||0.249,0.4,0.2,0.2
1071,Cancer_Causes_Control-3-1-1914283.txt,prospect cohort studi||follow-up||alcohol consumpt||cancer||data||studi||year||never-smok||bmi||endometri cancer||risk||prospect data||netherland||menopaus||cigarett||smoke||day||cohort||women||cohort studi||alcohol||estim||multivari||age||analysi||associ||endometri cancer risk||exposur||smoker||subcohort member||hrt||cigarett smoke||endometri carcinogenesi,smoke||endometri cancer||cigarett smoke||endometri cancer cancer||endometri cancer risk||postmenopaus endometri cancer||cigarett||endometri carcinogenesi||endometri cancer case||endometri cancer eur||endometri cancer Br||cancer||current cigarett smoke||cigarett smoke statu||cigarett smoke featur,0.387||0.364||0.326||0.323||0.269||0.264||0.264||0.248||0.247||0.246||0.244||0.24||0.228||0.227||0.22,0.8,0.6,0.4666666666666667
1072,Biol_Psychol-1-5-2075532.txt,attent||attent task||individu||individu differ||rate||data||studi||effect||anxieti||amygdala||facial express||manual respons||face||threat-process||emot intens||cognit||research||eye-mov data||task||bia||direct||intens||present find||similar pattern||attent bia||group||fear||signific differ||emot||result,mogg||face||al.||emot face||emot||fear||anxieti||gaze||bradley||whalen||emot face locat||mogg K. bradley b.p||1999 mogg||2001 mogg||keyword anxieti angri,0.335||0.286||0.271||0.261||0.236||0.224||0.221||0.219||0.2||0.192||0.177||0.174||0.171||0.171||0.168,0.4,0.4,0.26666666666666666
1073,Virchows_Arch-4-1-2234444.txt,case||rapamycin||aml||tsc||patient||uteru||gynaecolog origin||present||lymphangioleiomyomatosi||actin||site||lesion||featur||sugar tumor||cell||numer case||gene||term||pecoma||angiomyolipoma||mtor||pulmonari lymphangioleiomyomatosi||normal counterpart||tumor||epithelioid||pec||posit||diseas||ccst||clear epithelioid cell||lung||kidney,pecoma||epithelioid||epithelioid angiomyolipoma||angiomyolipoma||perivascular epithelioid||epithelioid aml||kidney pecoma||malign pecoma||pecoma uteru||pecoma lung||uterin pecoma||pecoma pelvic||malign epithelioid angiomyolipoma||pecoma ligamentum||pecoma retroperitoneum,0.561||0.485||0.41||0.335||0.33||0.315||0.313||0.308||0.308||0.307||0.298||0.293||0.292||0.291||0.29,0.6,0.3,0.2
1074,Arch_Dermatol_Res-4-1-2254658.txt,psoriasi||moderate-to-sever psoriasi||studi||patient||peripher blood||sever form||mild diseas||increas||lesion||total lymphocyt||subset||present studi||cell||mild||ratio||blood||mild psoriasi||percentag||moderate-to-sever diseas||analysi||lymphocyt||subject||pasi-scor||rel under-represent||differ||skin||diseas||absolut number||normal subject||result,psoriasi||moderate-to-sever psoriasi||mild psoriasi||psoriasi patient||psoriasi brit||sever psoriasi||keyword psoriasi||cd8||lymphocyt||cd45ro||stabl plaqu psoriasi||peripher lymphocyt||cd4||kuwaiti psoriasi vulgari patient||lymphocyt subset,0.613||0.4||0.349||0.327||0.322||0.316||0.307||0.241||0.238||0.232||0.214||0.187||0.18||0.177||0.161,0.6,0.4,0.26666666666666666
1075,Clin_Oral_Investig-4-1-2238791.txt,dental eros||case||shallow defect||studi||diagnost process||eros||wear||current criteria||criteria||epidemiolog||defect||risk group||teeth||tooth wear||lesion||current diagnost criteria||valid||epidemiolog studi||incis||occlus||adjac tooth surfac||shape||characterist||acid||subject||diagnost criteria||tissu loss||surfac||group||exposur||cup||clinic experi||diseas||loss||diagnosi,eros||dental eros||eros tooth||eros tooth wear||occlus eros||eros drink||eros lesion||eros 49||eros 35||eros 30||eros 5||eros 1||dental eros Br dent||tooth||eros aust dent,0.575||0.435||0.422||0.349||0.336||0.333||0.332||0.29||0.29||0.289||0.288||0.288||0.274||0.268||0.264,0.4,0.2,0.13333333333333333
1076,Virchows_Arch-4-1-2233709.txt,antibodi||line||tissu microarray||gastriti||downregul parafibromin express||studi||surviv rate||patient||pathogenesi||parafibromin||section||gastric tumour||adenoma||independ prognost factor||depth||cell line||express||metastasi||multivari analysi||larg tumour||prognosi||tumour tissu||tumour size||invas||gastric carcinoma||progress||parafibromin express,parafibromin||parafibromin express||parafibromin underexpress||parafibromin protein||parafibromin distinguish||parafibromin immunoreact||downregul parafibromin express||higher parafibromin express||distinct parafibromin express||result parafibromin express||1 parafibromin express||gastric||gastric carcinoma||parafibromin tumour suppressor protein||carcinoma,0.73||0.395||0.374||0.373||0.37||0.369||0.271||0.265||0.264||0.263||0.263||0.252||0.236||0.232||0.219,0.4,0.3,0.26666666666666666
1077,J_Hum_Genet-2-2-1705471.txt,logist regress analysi||variant||sampl||data||studi||allel||low statist power||region||upstream region||dopamin D4 receptor||gene||control||synergist interact||polymorph||associ||re-sequenc||haplotyp analysi||snp||genom variant||schizophrenia||linkag disequilibrium||result,drd4||schizophrenia||dopamin||drd4 gene||dopamin D4 receptor||dopamin D4 receptor gene||D4 dopamin receptor gene||dopamin D4 receptor vntr||dopamin D4 receptor gene polymorph||human dopamin D4 receptor||D4 dopamin receptor mrna||put D4 dopamin receptor||schizophrenia schizophr||multipl dopamin D4 receptor variant||D4 dopamin receptor gene map,0.443||0.33||0.293||0.262||0.252||0.209||0.209||0.194||0.194||0.192||0.191||0.191||0.189||0.173||0.172,0.4,0.2,0.13333333333333333
1078,Atherosclerosis-2-1-2292239.txt,aortic distens||atherosclerosi||mri||imag||baselin||patient||effect||atheroma burden||carotid||magnet reson imag||treatment||therapi||unselect coronari arteri diseas patient||statin||chang||small number||crp||regress||larg arteri stiff||plaqu size||coronari arteri||area||plaqu||time point||earli time point||brachial arteri||aorta||ldl-c||function,statin||carotid||carotid atherosclerosi||carotid arteri||atherosclerosi atherosclerosi||atherosclerosi||cholesterol||carotid plaqu||coronari atherosclerosi||coronari arteri||atheroma||brachial arteri||reson||simvastatin||atherosclerot plaqu,0.233||0.23||0.209||0.193||0.188||0.188||0.183||0.181||0.166||0.151||0.144||0.144||0.142||0.141||0.141,0.4,0.4,0.3333333333333333
1079,J_Headache_Pain-4-1-2386848.txt,week||headach frequenc||reduct||studi||patient||topiram||school||effect||frequenc||follow-up visit||aim||side effect||advers event||day||headach||paper||month||open studi||group||prophylact treatment||drug||prevent treatment||trial||adolesc||pediatr migrain||migrain||disabl||loss||children,migrain||topiram||migrain headach||headach||migrain disabl||pediatr migrain||migrain episod||migrain prophylaxi||migrain frequenc||migrain prevent||treat migrain||chronic migrain||topiram dosag||keyword migrain headach children pediatr topiram||headach pain,0.565||0.506||0.458||0.352||0.33||0.315||0.308||0.304||0.301||0.299||0.294||0.285||0.278||0.26||0.198,0.6,0.4,0.26666666666666666
1080,Evid_Based_Complement_Alternat_Med-4-1-1810360.txt,multiple-dos effect||condit||measur||immun system||children||behavior||mood||reduct||sampl||data||studi||depress||session||salivari cortisol||effect||MT research||MT session||child||review||pediatr MT||increas||anxieti||blind||statist||adult||treatment||therapi||research||scientif understand||pain||frequent failur||popul||parent||suffici data||trait anxieti||arthriti pain||report||single-dos effect||field||recipi||massag therapi||statist power||outcom||result,massag||MT||pediatr massag||massag therapi||massag therapist||massag student||massag tabl||swedish massag||pre-exercis massag||massag chair||massag reduc anxieti||pediatr MT||anxieti||massag therapi student||massag therapi lower,0.549||0.372||0.341||0.321||0.297||0.284||0.282||0.282||0.281||0.278||0.269||0.252||0.249||0.221||0.215,0.2,0.1,0.2
1081,Pediatr_Nephrol-4-1-2275777.txt,type||detrusor muscl||follow-up||irrevers renal damag||renal damag||detrusor overact||oxybutynin||intraves pressur||studi||year||intraves instil||detrusor||patient||effect||risk||secondari damag||bladder||earli diagnosi||intermitt catheter||treatment||safe urinari contin||nbsd||long-term outcom||manag||infect||anticholinerg||therapi||evalu||urodynam||renal function||cic||adequ medic treatment||neurogen bladder||standard therapi||upper||contin||long-term experi||nbsd manag||children,bladder||neurogen bladder||bladder dysfunct||dysfunct bladder||neurogen bladder dysfunct||oxybutynin||high-risk bladder||bladder outlet||bladder affer||low-compli bladder||bladder capac||bladder ultrasound||bladder dysfunct cic||bladder function||bladder dynam,0.495||0.396||0.301||0.301||0.3||0.271||0.257||0.257||0.256||0.256||0.255||0.253||0.252||0.252||0.251,0.4,0.3,0.2
1082,Oecologia-3-1-2039837.txt,thermal toler||measur||acclimat||respons||clam||rate||data||valu||bay||sensit||temperatur||north sea group||ambient condit||physiolog||genet group||metabol rate||popul||season variat||factor||specimen||taxa||limit||speci||data point||respir rate||mussel,mytilu||mytilu eduli||mytilu M. balthica mytilu||mytilu galloprovinciali||mytilu M.||mussel mytilu eduli||10 mytilu||5 mytilu||2 mytilu||mytilu eduli complex||mytilu galloprovinciali lmk||mytilu eduli mar environ||mediterranean mussel mytilu galloprovinciali||mytilu chilensi hupe||eduli,0.711||0.478||0.447||0.425||0.379||0.375||0.357||0.356||0.356||0.32||0.289||0.286||0.259||0.247||0.245,0.0,0.0,0.0
1083,Eur_J_Pediatr-3-1-2042510.txt,condit||case||logist regress analysi||children||infant||birth order||birth||rsv infect||studi||patient||higher likelihood||major epidem||rsv||respiratori syncyti viru infect||strong autocorrel||gestat age categori||control||hospit||season||age||young children||social characterist||predictor||famili||factor||bivari analysi||number||risk factor||hospit admiss||control-pati||rsv-induc lrti||sever rsv-induc lrti,rsv||rsv season||rsv infect||rsv epidem||respiratori syncyti viru||respiratori||respiratori tract infect rsv respiratori||respiratori syncyti viru infect||testpack rsv||rsv surveil||syncyti viru infect||rsv-induc||lrti||rsv-induc lrti||rsv detect,0.444||0.307||0.298||0.273||0.262||0.259||0.235||0.235||0.232||0.23||0.227||0.225||0.225||0.225||0.224,0.4,0.3,0.26666666666666666
1084,Eur_J_Epidemiol-4-1-2190784.txt,time||men||knot||preval||msm||sexual behaviour||studi||year||hsv transmiss||risk||homosexu contact||calendar year||western blot||increas||amsterdam cohort studi||time trend||blood sampl||age||orogenit contact||associ||sexual partner||sexual activ homosexu men||hsv-2||decreas||independ risk factor||sexual risk behaviour||hsv-1||risk factor||partner||hiv||hsv-infect||result,hsv-2||hsv-1||msm||hsv-2 infect||hiv||hsv-2 preval||hsv-1 infect hsv-1||hsv-2 seropreval||hsv-2 elisa||hsv-2 serolog||keyword hsv-1 hsv-2 hiv msm preval||hsv-2 index||0.81 hsv-2||hsv-2 antibodi||hiv infect,0.489||0.345||0.322||0.317||0.3||0.288||0.278||0.269||0.261||0.258||0.257||0.255||0.254||0.252||0.222,0.8,0.4,0.26666666666666666
1085,Ann_Surg_Oncol-4-1-2277445.txt,patent blue dye||case||liver metastas||figur||ovarian cancer||studi||patient||adopt immunotherapi||expans procedur||pancreat cancer||preoper lymphoscintigraphi||node||transfus||blue||increas||superior surfac||metastas||tumor homogen||malign melanoma||radioact tracer||immunotherapi||cell||antigen||partial right-sid liver resect||squamou cell carcinoma||squamou cellular cancer||averag||lymph node||lymphocyt||surgeri||local recurr||liver||sentinel node||tumor||lymphat vessel||lymphat||posit||success expans||inject||lymphoscintigraphi||diseas||lymphat map,node||metinel node||lymph node||metinel node metinel node po||drain lymph node||sentinel node||lymph node metastasi||node PB||perihepat metinel node||analyz metinel node||so-cal metinel node||metinel node studi||lymph||metastasis-drain lymph node||subcutan lymph node metastas,0.511||0.452||0.396||0.382||0.324||0.318||0.317||0.315||0.311||0.305||0.303||0.302||0.281||0.278||0.275,0.4,0.3,0.2
1086,Eur_Radiol-3-1-2077917.txt,week||limit bowel prepar||origin raw data||patient||CT colonographi||low-dos protocol||observ||sensit||imag qualiti||colonoscopi||dose-level||rectum||repeat CC||fecal tag||ctc||stool||polyp||experi||simul||bowel prepar||extens cleans||sixty-on patient||larg false-posit lesion||dose reduct||oral contrast agent||stool soften||moder sensit||segment||contrast||prefer||result,ctc||polyp||colonoscopi||colorect polyp||polyp sensit||miss polyp||30-mm polyp||CT colonographi||ctc examin||polyp detect||ctc bowel prepar||14-mm polyp||polyp visual||polyp size||larg polyp,0.448||0.438||0.289||0.264||0.234||0.234||0.234||0.23||0.23||0.228||0.228||0.226||0.226||0.224||0.221,0.6,0.4,0.26666666666666666
1087,J_Mol_Biol-1-5-1885968.txt,order paramet||ligand bind||data||bind site||hsqc||motion||structur||complex||domain||diffus tensor||free energi||dynam||rdc||abp||conform entropi||paramet||heteronuclear singl quantum coher||residu||protein||flexibl||analysi||simul||chang||bind||favour enthalp contribut||protein dynam||differ||entropi||consist||nmr relax||rotat diffus||interact||optimis||experiment data||entrop cost||molecul||molecular dynam simul||ligand||result,abp||apoabp||apo abp||backbon||ligand-bound abp||backbon dynam||dynam||abp sequenc||entropi||bind entropi||bind||nmr||protein backbon||0.017 apoabp||0.015 apoabp,0.393||0.327||0.239||0.208||0.206||0.205||0.202||0.198||0.19||0.184||0.178||0.171||0.17||0.168||0.168,0.2,0.3,0.26666666666666666
1088,Pediatr_Nephrol-4-1-2259254.txt,condit||muscl||chronic kidney diseas||complic||ckd||caspase-3||metabol acidosi||glucocorticoid||degrad||insulin||muscl wast||cell||kidney diseas||growth||muscl mass||protein||protein degrad||activ||uremia||muscl atrophi||acidosi||insulin resist||loss||result,acidosi||mitch||metabol acidosi||acidosi proteolysi||muscl||non-urem acidosi||urem acidosi||acidosi stimul||induc acidosi||acidosi increas||acidosi 3||protein metabol acidosi||muscl degrad||chronic metabol acidosi||acidosi stimul protein,0.468||0.287||0.28||0.266||0.255||0.251||0.251||0.246||0.244||0.24||0.234||0.232||0.218||0.212||0.21,0.6,0.3,0.2
1089,Doc_Ophthalmol-3-1-1820752.txt,type||standard method||minimum amplitud||method||respons||light adapt||data||valu||eog||electr potenti||electrod||refer data||difficulti||present||clinic eog||total dark||amplitud||test||norm data||dilat pupil||light peak||eye||retina||retin pigment epithelium||ratio||potenti||light rise||saccad||dark||standard||subject||chang||pupil||minimum||clinic electro-oculographi||report||record||eog record||peak||arden ratio||pupil dilat||result,eog||eog standard||eog record||eog potenti||clinic eog||eog respons||eog method||eog origin||light||arden||standard clinic eog||previou eog standard||earlier eog standard||true eog amplitud||dark,0.602||0.344||0.341||0.326||0.316||0.31||0.305||0.302||0.282||0.271||0.239||0.232||0.231||0.226||0.198,0.6,0.3,0.26666666666666666
1090,Qual_Life_Res-3-1-2062490.txt,refer point||cancer||measur||method||men||then-test score||studi||vignett||erectil dysfunct||patient||effect||qol||then-test||local prostat cancer||treatment||health||primari treatment||assess||month||respons shift||chang||respond||differ||prostat cancer||diagnosi||origin score||score||result,pre-diagnosi||then-test||pre-diagnosi health||prostat cancer||month post-diagnosi||vignett||7-month post-diagnosi||post-diagnosi assess||1-month post-diagnosi||pre-diagnosi assess||sf-36||i.e. pre-diagnosi||p-valu pre-diagnosi||prostat cancer treatment||pre-diagnosi health state,0.344||0.286||0.235||0.231||0.213||0.213||0.209||0.209||0.197||0.195||0.19||0.19||0.188||0.168||0.166,0.4,0.3,0.2
1091,Int_Arch_Occup_Environ_Health-4-1-2175021.txt,conceptu||role||measur||case||sick||emot process||sampl||posit result||strategi||sick absenc measur||durat||avoid||frequenc||effect||present||sick leav||excess risk||ucl||problem-solv||absenc||behaviour||day||social support||item||result||associ||employe||total number||sick absenc||cope||factor||short length||length||health outcom||day absent||stress situat,sick||cope||sick absenc||sick absenc sick absenc length||sick absente||sick absenc sick absenc data||sick leav||sick absenc histori||short-term sick||sick absenc behaviour||sick absenc risk||psychiatr sick absenc||futur sick absenc||sick absenc measur||sick absenc pattern,0.621||0.435||0.433||0.369||0.363||0.347||0.323||0.315||0.312||0.305||0.294||0.293||0.293||0.292||0.29,0.6,0.4,0.3333333333333333
1092,Eur_J_Pediatr-4-1-2254659.txt,organ||chelat||method||liver biopsi||ferritin serum ferritin||bodi||deferasirox||mri||iron overload||magnet reson imag||lic||liver||patient||therapi||day,iron||iron chelat||iron overload||liver iron||cardiac iron||iron burden||iron chelat therapi||excess iron||deferoxamin||tissu iron||iron complex||iron chelat treatment||chelat||hepat iron overload||transfusion iron overload,0.606||0.448||0.381||0.356||0.329||0.318||0.315||0.311||0.31||0.308||0.305||0.303||0.29||0.266||0.262,0.2,0.1,0.13333333333333333
1093,Behav_Genet-4-1-2257997.txt,motor task||measur||find||time||pac interview||famili vulner||deficit||abnorm||compar problem||studi||effect||tendenc||motor output||variabl||disord||genet underpin||motor speed||control||famili resembl||task||age||endophenotyp||accuraci||subject||motor||group||famili||proband||sibl||genet basi||famili suscept||screen||adhd||extern cue||speed||motor time||addit||non-affect sibl||children,adhd||motor||sibl||motor speed||non-affect sibl||motor speed motor variabl||keyword adhd sibl endophenotyp motor||motor task||motor output||adhd children||motor time||adhd subscal||adhd item||motor process||basic motor speed,0.424||0.417||0.342||0.314||0.306||0.286||0.276||0.275||0.267||0.253||0.234||0.219||0.217||0.216||0.215,1.0,0.7,0.5333333333333333
1094,J_Gastrointest_Surg-3-1-1852393.txt,surviv||demograph data||mitogen-activ protein kinas||chemotherapi||radiat therapi||mapk||studi||protein||cd24 express||radiat||month||prognost marker||cholangiocarcinoma||data||express||patient||treatment||cell||patient surviv||multivari analysi,cd24||cd24 express||cd24 overexpress||low cd24||cd24 overexpressor||high cd24||cholangiocarcinoma||cd24 antigen express||cytoplasm cd24 express||cell-associ antigen cd24||molecular marker cd24||metastasis-associ gene cd24||keyword cd24 express cholangiocarcinoma surviv||hilar cholangiocarcinoma||intrahepat cholangiocarcinoma,0.731||0.392||0.388||0.375||0.374||0.371||0.34||0.271||0.269||0.259||0.257||0.254||0.245||0.223||0.212,0.2,0.2,0.13333333333333333
1095,Pediatr_Nephrol-3-1-1766474.txt,ultrafiltr rate||ultrafiltr||session||patient||hemodiafiltr||permeabl||risk||volum||dialysi session||needl||blood volum||blood purif||mmhg||guidelin||dialys||blood||fluid||ultrapur dialys||normal||weight||newer machin||hemodialysi||continu blood volum||import||high flux||access||endotoxin||dialysi||urea||adequ||membran||children||high flux membran,dialysi||dialysi membran||dialysi session||optimum dialysi||periton dialysi||enabl dialysi||dialysi dose||dialysi machin||Kt||monthli dialysi||double-pump dialysi||single-needl dialysi||dialysi unit||dialysi time||optim dialysi,0.357||0.206||0.2||0.196||0.193||0.192||0.188||0.187||0.187||0.186||0.185||0.184||0.184||0.183||0.183,0.4,0.2,0.13333333333333333
1096,Cardiovasc_Intervent_Radiol-3-1-2039794.txt,qualiti||baselin||studi||patient||question||bodi imag||sexual||improv||treatment||sexual life||sexual function||women||analysi||fibroid||group||differ||bi||uae||uterin arteri embol||hysterectomi||score,hysterectomi||sexual||fibroid||vagin hysterectomi||hysterectomi sexual function||laparoscop hysterectomi||uterin fibroid||abdomin hysterectomi||hysterectomi patient||subtot hysterectomi||hysterectomi group||uterin||total hysterectomi||time uae hysterectomi||embol versu hysterectomi,0.541||0.35||0.319||0.306||0.302||0.298||0.298||0.289||0.286||0.285||0.278||0.276||0.275||0.254||0.247,0.6,0.3,0.2
1097,Bioprocess_Biosyst_Eng-2-2-1705492.txt,model paramet||primari human liver cell||system||bioreactor||data||model||valu||asp||amino acid||variabl||cell||amino acid metabol||liver cell bioreactor||oxid deamin||activ||part||liver||ly kinet||high||perform||run||princip compon||kinet||differenti equat system||medium,_{||cdot||_{ 0||bioreactor||zeiling||liver||text||liver cell bioreactor||0||schmidt-heck||run||3D bioreactor guthk||bioreactor system||guthk||pfaff,0.183||0.175||0.12||0.1||0.077||0.069||0.065||0.063||0.058||0.056||0.054||0.053||0.053||0.051||0.051,0.2,0.3,0.26666666666666666
1098,Purinergic_Signal-4-2-2377316.txt,guanylyl cyclas||concentr||data||studi||avoid||pkc||western blot||messeng pathway||cell||calcium||behavior assay||tyrosin phosphoryl||control||enzym||protein||chemorepel||tyrosin kinas||purin metabol||buffer||behavior buffer||pharmacolog inhibitor||gtp||inhibitor,tetrahymena||tetrahymena tetrahymena tetrahymena 33 tetrahymena||tetrahymena thermophila||tetrahymena cell||T. thermophila tetrahymena||tetrahymena cilia||tetrahymena thermophila eur||tetrahymena 50||28 tetrahymena 8 tetrahymena||result tetrahymena||1 2 tetrahymena tetrahymena||hennessey TM tetrahymena thermophila||tetrahymena J. biochem||2008 introduct tetrahymena||s11302-007-9052-4 origin paper tetrahymena thermophila,0.799||0.639||0.61||0.424||0.421||0.413||0.409||0.405||0.4||0.399||0.399||0.331||0.273||0.267||0.247,0.0,0.0,0.0
1099,J_Autism_Dev_Disord-4-1-2335292.txt,level||time||play||behavior||control group||qualiti||book||studi||account||autism||durat||asd||develop||disord||play behavior||control||relationship||manipul||age||month||group||differ||daili utensil||opportun||agreement||symbol||development disord||toy||object||attach||children,autism||autism autism||play||symbol play||play behavior||play behavior play behavior||autism journal||pretend play||child play||A. autism||autism develop||manipul play function play symbol play||symbol play behavior||pre-linguist autism||attach,0.483||0.483||0.416||0.293||0.288||0.288||0.267||0.266||0.265||0.259||0.252||0.249||0.248||0.248||0.248,0.6,0.3,0.26666666666666666
1100,Photosynth_Res-3-1-2117334.txt,photosystem II||effect||electron transfer||photosynthesi||level||fluoresc||uv-b radiat||increas||PS II||acceptor side||uv-b irradi||function||uv-b||irradi||chlorophyl||donor side||light||damag||plant,uv-b||uv-b radiat||chlorophyl||chlorophyl fluoresc||uv-b light||uv-b irradi||plant||fluoresc||uv-b stress||uv-b ultraviolet-b radiat||photosystem II||non-photochem chlorophyl fluoresc||chlorophyl fluoresc induct||chlorophyl fluoresc rise||chlorophyl fluoresc nomenclatur,0.425||0.275||0.251||0.24||0.236||0.233||0.23||0.229||0.222||0.214||0.197||0.196||0.172||0.17||0.167,0.6,0.6,0.4666666666666667
1101,Matern_Child_Health_J-2-2-1592144.txt,attent||commun health center||method||pregnanc||problem||data||state||pregnanc plan||counsel||avail||famili plan servic||preconcept care||healthi infant||percentag||women||care||servic||reason||facil||inadequ attent||famili||visit||access||famili plan||underutil,preconcept||preconcept servic||plan servic||pregnanc plan||famili plan||famili plan servic||preconcept care||preconcept counsel||preconcept advic||seek famili plan||servic||pregnanc||state-fund famili plan servic||famili||famili plan practic,0.501||0.376||0.351||0.349||0.345||0.313||0.306||0.302||0.268||0.254||0.25||0.247||0.243||0.239||0.235,0.4,0.4,0.4666666666666667
1102,Pediatr_Nephrol-3-1-2064944.txt,rrt||chronic kidney diseas||children||ckd||preval||kidney||data||patient||end-stag renal diseas||inform||epidemiolog||major||naprtc||preval rate||unit state||adult||countri||kidney diseas||esrd||renal transplant||earli detect||age||popul||incid||care||congenit renal disord||report||renal replac therapi||registri||dialysi||pediatr ckd,ckd||pediatr ckd||kidney||pediatr||renal diseas||renal transplant||chronic renal failur||end-stag renal diseas||renal insuffici||children||pediatr ckd worldwid||pediatr dialysi||pediatr nephrol pediatr nephrolog||chronic renal insuffici||pretermin ckd,0.338||0.284||0.264||0.231||0.215||0.214||0.201||0.201||0.2||0.197||0.193||0.191||0.19||0.182||0.179,0.6,0.6,0.4
1103,J_Mol_Med-3-1-1820750.txt,dcmi||quantit real-tim pcr analysi||cardiac express profil||microarray analysi||studi||patient||apn||wnt||standard clinic character||biolog function||human||heart failur||dcmi heart||express||molecular virolog analys||human inflammatori cardiomyopathi||cell||gene||local inflamm||dilat cardiomyopathi||gene network||cardiac inflamm||analysi||etiology-rel pathogen pathway||therapeut potenti||genom express profil||heart||cardiac diseas,apn||dcmi||cyr61||apn network||apn adipor1||apn sort1||apn fgf13||synonyma apn||abbrevi apn adiponectin cyr61||dcmi heart||apn gene downregul||local apn express||receptor apn pik3r1||cyr61 express||α apn syncrip,0.492||0.341||0.3||0.26||0.259||0.253||0.253||0.253||0.225||0.202||0.195||0.188||0.181||0.176||0.175,0.4,0.3,0.2
1104,Glycoconj_J-4-1-2234451.txt,array||antibodi||mab||epitop||glycan||cell wall||sampl||probe||polym||hybridoma supernat||pectic side chain||plant cell wall||hybridoma line||specif||cell||monoclon antibodi||carbohydr microarray||hierarch cluster||analysi||agp||materi||bind||order||plant,pectin||mab||knox||willat||A. thaliana||mab lm13||arabinogalactan-protein||lime||knox j.p||E1 pectin||mab lm14||B1 pectin||plant||willat w.g||glycan,0.341||0.24||0.215||0.213||0.2||0.191||0.189||0.188||0.177||0.175||0.175||0.175||0.171||0.155||0.149,0.2,0.1,0.2
1105,Eur_Arch_Otorhinolaryngol-3-1-1914267.txt,split skin graft||questionnair||non-donor site||subject complaint||studi||patient||total score||test||morbid||forearm||lower arm||frff||strength||forearm disabl||subject self-rat||radial forearm flap||donor site morbid||function result||differ||flap||skin||object function test||fasciocutan flap||reconstruct||object||free radial forearm flap||wrist||hand||cosmet||function||donor,flap||forearm flap||forearm||radial forearm flap||radial forearm||fasciocutan radial forearm flap||free radial forearm flap||fasciocutan flap||radial forearm flap donor site||radial forearm flap donor defect||free flap||radial forearm donor site||fasciomucos flap||bilob flap||flap Br,0.514||0.472||0.431||0.43||0.388||0.36||0.342||0.332||0.322||0.315||0.296||0.274||0.268||0.267||0.266,0.6,0.5,0.3333333333333333
1106,Mar_Biotechnol_(NY)-4-1-2263118.txt,method||microarray||studi||fish chip||gene express||fluoresc signal||probe||dna||cross-hybridis||gene||singl target hybridis||speci identif||oligonucleotid probe||spot||identif||european sea||fish speci||dna chip||dna microarray||fragment||signal intens||speci||suitabl||design||sequenc||oligonucleotid,marin||microarray||fish||dna microarray||fish speci||hybridis||oligonucleotid microarray||mitochondri dna microarray||speci||dna||microarray probe||marin biolog||marin biotechnolog||marin biol||marin research,0.277||0.242||0.211||0.2||0.186||0.186||0.172||0.161||0.161||0.159||0.153||0.15||0.146||0.143||0.14,0.6,0.5,0.3333333333333333
1107,Clin_Rheumatol-3-1-2039777.txt,function abil||measur||level||jafa||questionnair||final score||studi||patient||median diseas durat||perform test||present studi||individu item||chaq||item||jia||diseas activ||rom||childhood health assess questionnair||intern reliabl||rheumat diseas||spearman correl coeffici||children,jafa||chaq||28 patient jafa chaq chaq||disabl jafa||chaq item||ten jafa||1 jafa||chaq score||total chaq||chaq activ||chaq task||mild disabl jafa||moder disabl jafa||sever disabl jafa||chaq item number,0.598||0.54||0.343||0.337||0.331||0.312||0.299||0.296||0.279||0.278||0.277||0.227||0.227||0.225||0.223,0.4,0.2,0.13333333333333333
1108,Dev_Biol-2-1-2279743.txt,gata||bmp||induct||embryo||earli role||combin||earli express||effect||zebrafish correl||marker||myocardium||express||cardiac marker express||absenc||cell||somit||gene||zebrafish||gata factor||nkx||loop||gata activ||mous||vertebr||evolut||requir||feedback loop||phenotyp||zebrafish embryo||heart||function||network,al.||gata4||gata5||xenopu||nkx2.5||xenopu xenopu peterkin||xenopu peterkin||gata5 nemer||xenopu gata5 reiter||gata6||2000 gata6 gata4 xenopu||vivo xenopu xenopu||abstract xenopu xenopu gata5 faust||zebrafish xenopu peterkin||peterkin,0.417||0.338||0.326||0.325||0.322||0.285||0.265||0.25||0.245||0.244||0.228||0.218||0.213||0.208||0.205,0.0,0.0,0.0
1109,Bioprocess_Biosyst_Eng-2-2-1705518.txt,method||organel||time||nutrient||concentr||steadi state||rate||model||root mass||growth rate||hairi root growth||independ pathway||amino acid||tool||analys||cell build block||growth||cell||metabol regul||glucos||intracellular ammonium||sugar||primari metabol pathway||flux||plant cell||intracellular concentr||literatur||cultur||medium exchang cultur||secondari metabolit||metabol network||batch||minim medium||experiment data||root||metabol model,hbox||ntp||text||nu||C. roseu||catharanthu roseu||ndp||frac||Pi||document||rm ntp||DW C. roseu||catharanthu roseu cell||0.00254 C. roseu mmol||0.000585 C. roseu mmol,0.322||0.08||0.062||0.058||0.053||0.051||0.05||0.049||0.048||0.047||0.044||0.043||0.035||0.035||0.035,0.0,0.0,0.0
1110,Diabetologia-3-1-1849422.txt,person||futur||diabet||project||preval||individu||burden||data||model||studi||year||II mortal survey||mortal||risk||potenti impact||increas||proport||adult||nhane iii||substanti number||estim||age||popul||total number||nutrit examin survey||decreas||number||older age group||survey||high-risk group||hispan commun||score||result,diabet||diabet diabet burden||diabet preval||undiagnos diabet||diabet burden||diabet estim||diabet mortal||nhane||diabet risk||diagnos diabet||futur diabet||total diabet||diabet incid||diabet yield||diabet develop,0.706||0.508||0.442||0.415||0.41||0.402||0.399||0.398||0.392||0.379||0.377||0.363||0.361||0.361||0.359,0.2,0.1,0.06666666666666667
1111,Tuberculosis_(Edinb)-1-5-1913930.txt,glutamin||ammonia||extra-cellular GS||gene||control||strain||level||delet||nitrogen sourc||glutamin synthetas||mutant||protein||cultur filtrat||glnd||virul||nitrogen metabol||macrophag||activ||cell||growth,glnd||glnd 7 glnd glnd||tuberculosi||glnd M. tuberculosi||glnd mol||result glnd||glnd result||mycobacterium tuberculosi||glnd mutant hyg||figur 3 glnd glnd delet region||mycobacterium tuberculosi isocitr||figur 4 glnd mutant||streptomyc coelicolor M. tuberculosi 8 glnd||mycobacterium tuberculosi glutamin synthetas||parish,0.693||0.52||0.387||0.377||0.352||0.347||0.347||0.287||0.269||0.242||0.203||0.201||0.194||0.185||0.16,0.2,0.1,0.06666666666666667
1112,Pediatr_Radiol-2-2-1764599.txt,larger bone||databas||roi||low bmd||studi||patient||total bodi bmc||standard deviat||densiti||lumbar spine||norm data||radiologist||clinic pathologist||bmd||bodi composit||bone age||hip||standard deviat score||bodi||age||dxa result||chang||numer result||bmc||factor||import||height||dxa||osteoporosi||pediatr dxa||signific chang||interpret||children||result,dxa||bone||bone miner||pediatr dxa||bmd||lumbar bone||bodi dxa||dxa interpret||pediatr bone||absorptiometri||dxa acquisit||miner||dxa examin||bone miner densiti||dxa perform,0.445||0.355||0.294||0.29||0.288||0.282||0.263||0.246||0.245||0.245||0.239||0.232||0.228||0.226||0.224,0.6,0.3,0.2
1113,J_Med_Internet_Res-8-3-2018828.txt,time||effect relaps prevent intervent||cessat||individu||search engin||rate||data||studi||year||inform||quitnet||organ||total||time onlin||onlin||internet searcher||treatment||web||smoke||day||estim||result||popul||servic||reason||readi||search||smoker||survey||particip||peopl||queri||internet,cessat||smoke||internet||quit smoke||quit||smoke cessat websit||cessat inform||cessat servic||search||cessat treatment||encourag cessat||smoker||computer-tailor smoke cessat program||evidence-bas smoke cessat treatment||rate internet cessat servic,0.457||0.35||0.329||0.318||0.287||0.278||0.275||0.255||0.245||0.243||0.232||0.22||0.218||0.215||0.213,0.6,0.4,0.3333333333333333
1114,Purinergic_Signal-4-2-2377317.txt,mechan||hypoton solut||uridin triphosph||rel abund||concentr||releas mechan||studi||adenosin||perfus||exocytosi||nucleotid speci||udp||uridin nucleotid||nucleotid releas||Ca||cell||intracellular calcium||cell surfac hydrolysi||nucleotid||result||experi||major mechan||fluoresc||hypoton shock||plasma membran||calcium-depend exocytosi,nucleotid||uridin nucleotid||uridin nucleotid releas||nucleotid releas||fm1-43||nucleotid diphosph||uridin nucleotid concentr||utp||exocytosi||udp||uridin diphosph||nucleotid hydrolysi||nucleotid concentr||nucleotid sugar||nucleotid speci,0.325||0.289||0.237||0.229||0.227||0.224||0.208||0.195||0.195||0.192||0.188||0.188||0.185||0.184||0.175,0.6,0.5,0.4
1115,Pediatr_Nephrol-3-1-1805046.txt,attent||level||find||chronic kidney diseas||hypertens||ckd||sampl||gener popul||studi||patient||standard deviat||pediatr ckd popul||test||cognit impair||cognit function||memori||neurocognit deficit||mild||esrd||age||analysi||anemia||attent score||onset||clinic variabl||rang||age-bas standard score||memori score||cognit test||risk factor||sever||particip||diseas||cognit perform||IQ score||standard score||function||children,ckd||ckd onset||ckd durat||sever ckd||ckd literatur||ckd correl||ckd 69||5 ckd||pediatr ckd patient||pediatr ckd popul||children||typic pediatr ckd popul||cognit score||memori||neurocognit deficit,0.652||0.358||0.347||0.338||0.337||0.335||0.328||0.326||0.254||0.254||0.253||0.192||0.186||0.186||0.162,0.2,0.2,0.3333333333333333
1116,Exp_Brain_Res-3-1-2137946.txt,attent||condit||measur||visual depriv||visual feedback||postur sway||sampl||data||time seri||amount||opposit effect||effect||visual inform||cop trajectori||sampl entropi||concurr visual feedback||present studi||eye||postur control||control||cerebr palsi||posturogram||EC condit||task||analysi||neural control mechan||sway||regular||extern focu||function task||sen||function context||children||result,sway||postur sway||postur||regular postur sway||cop||regular sway||sway regular||postur sway fluctuat||children||visual postur sway inform||postur task||cop regular||postur control||CP children||bodi sway,0.416||0.409||0.402||0.325||0.294||0.286||0.286||0.279||0.249||0.23||0.227||0.225||0.218||0.213||0.211,0.4,0.3,0.26666666666666666
1117,Eur_J_Epidemiol-4-1-2190786.txt,mother||birth||young adulthood||urin sampl||pregnanc||fetal life||studi||develop||process||child||plate||genet determin||dna||medic ethic committe||biobank||blood||research||parent||erasmu medic center||tube||biolog specimen||partner||equal dna concentr||biolog sampl||children||laboratori,"rotterdam||dna||dna mother||urin||mother||erasmu univers rotterdam||dna sampl||pregnanc||partner mother partner||urin sampl||partner||star-mdc||8,821||biobank||specimen",0.256||0.199||0.181||0.168||0.162||0.162||0.16||0.145||0.145||0.144||0.136||0.132||0.132||0.132||0.126,0.4,0.4,0.4
1118,Diabetologia-4-1-2292420.txt,type 2 diabet||studi||patient||blood pressur||intervent||type 2 diabet mellitu||glycaem control||cardiovascular risk profil||cost||heart rate||exercis intervent||month||physic fit||exercis||medic fit programm||long-term efficaci||min||resist||differ||physic activ||programm||clinic benefit||medic fit||particip||adher||endur type exercis||brisk walk||physic therapist,brisk||brisk walk||brisk walk programm||group-bas brisk walk||group-bas brisk||brisk walk group||18 brisk walk||7.8 0.000 intragroup comparison brisk||3.6 0.000 intragroup comparison brisk||1.8 0.000 intragroup comparison brisk||0.06 0.239 intragroup comparison brisk||0.01 0.070 intragroup comparison brisk||0.01 0.035 intragroup comparison brisk||0.25 0.345 intragroup comparison brisk||0.04 0.570 intragroup comparison brisk,0.398||0.315||0.242||0.223||0.219||0.215||0.21||0.189||0.187||0.187||0.184||0.183||0.183||0.183||0.183,0.2,0.1,0.06666666666666667
1119,Eur_Arch_Otorhinolaryngol-4-1-2279156.txt,prospect studi||subject symptom||phpt||parathyroidectomi||asymptomat phpt||questionnair||asymptomat primari hyperparathyroid||symptom||forget||concentr||improv||surgeri||success parathyroidectomi||depress||medic observ||treatment||patient||subject neuropsycholog symptom||result,phpt||hyperparathyroid||parathyroidectomi||asymptomat phpt||phpt patient||patients’ phpt||mild phpt||hyperparathyroid subject symptom parathyroidectomi||asymptomat phpt patient||primari hyperparathyroid||asymptomat primari hyperparathyroid||parathyroidectomi improv||neuropsycholog symptom||symptom||success parathyroidectomi,0.458||0.407||0.362||0.323||0.277||0.275||0.269||0.259||0.247||0.238||0.221||0.214||0.213||0.201||0.187,0.6,0.3,0.4
1120,Mar_Biotechnol_(NY)-2-2-1475948.txt,tumor necrosi factor||transgen zebrafish||japanes flounder promot||studi||egg||region||promot||site||adult||pattern||induc promot||express||gene||tissu||zebrafish||tnf||liver||gfp||induc activ||keratin||japanes flounder||tissue-specif promot,japanes flounder||transgen japanes flounder||japanes flounder promot||flounder gene||transgen zebrafish||zebrafish||hirono||japanes flounder embryo||japanes flounder tnf promot||transgen fish||japanes flounder tnf gene promot||gfp||fish||paralichthi||paralichthi olivaceu,0.356||0.33||0.296||0.288||0.274||0.271||0.268||0.261||0.252||0.24||0.22||0.216||0.204||0.198||0.198,0.6,0.4,0.3333333333333333
1121,Soc_Psychiatry_Psychiatr_Epidemiol-2-2-1764203.txt,voluntari statu||time||non-convert||individu||legal statu||clinic factor||data||model||studi||treatment engag||patient||inv-inv||medic problem||voluntari||criteria||counti hospit||medic||variabl||compulsori||treatment||polytom logist regress model||psychot symptom||hospit||research||assess||analysi||data collect||commit||group||factor||differ||inv-vol||symptom||diagnost characterist||adher||outpati follow-up,discharg||inv-inv||discharg inv-vol||involuntari legal statu||admiss||discharg patient||involuntari statu||inv-vol||inv-inv patient||vol-vol||involuntari patient||involuntari psychiatr patient||legal statu||discharg plan||discharg merit,0.388||0.354||0.307||0.249||0.248||0.234||0.232||0.227||0.217||0.212||0.209||0.209||0.204||0.2||0.198,0.2,0.2,0.2
1122,Ann_Hematol-3-1-2082654.txt,case||molecular character||mutat||cml||peripher blood||allogen hematopoiet stem cell transplant||criteria||bone marrow||cel||disord||cytomorpholog||classif||cimf||diagnost||neg cmpd||cytogenet||chronic myelomonocyt leukemia||tyrosin kinas||cmpd||molecular diagnost||diagnosi||detect,jak2||jak2 v617f||cmpd||jak2 mutat||jak2 35 11 jak2 jak2 bcr||jak2 v617f-posit||jak2 11 bcr||jak2 v617f mutat||bcr||cmpd fip1l1||tyrosin kinas jak2||abl jak2 67||pdgfra||neg cmpd bcr||keyword cmpd bcr,0.545||0.34||0.322||0.315||0.313||0.279||0.263||0.255||0.243||0.229||0.221||0.207||0.198||0.193||0.188,0.2,0.1,0.06666666666666667
1123,Biochem_Biophys_Res_Commun-1-5-1899526.txt,anion||sensit||atrial myocyt||solut||myocyt||experi||drug-contain solut||chlorid current||data||heart||valu||human atrial cardiomyocyt||channel||cell,"anion||anion background||anion substitut||anion anion atrium atrial myocyt background||cardiac anion conduct||anion background conduct||myocyt||anion conduct affect action||atrial myocyt||chlorid||human atrial myocyt||cardiac myocyt||yamazaki J. horowitz B. anion transport||isol human atrial myocyt||13,14",0.64||0.328||0.327||0.274||0.242||0.227||0.172||0.171||0.169||0.128||0.12||0.117||0.115||0.095||0.094,0.2,0.3,0.2
1124,Intensive_Care_Med-3-1-1915596.txt,lo||find||case||reduct||demand cxr||abnorm||clinic indic||data||studi||patient||daili routin cxr||elimin||intervent||day||daili routin chest radiograph||chang||chest radiograph||mortal rate||differ||import||daili routin||number||cxr||icu patient||physician||readmiss rate||icu||result,cxr||routin cxr||demand cxr||cxr practic||formal cxr||daili routin cxr||demand cxr strategi||demand cxr practic||demand cxr increas||demand cxr 5||evid cxr find||daili routin cxr strategi||daili routin cxr practic||icu||demand cxr 2 3,0.876||0.498||0.49||0.445||0.443||0.374||0.332||0.332||0.328||0.327||0.299||0.284||0.284||0.259||0.245,0.4,0.3,0.26666666666666666
1125,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998878.txt,type||delay||normal tissu||time||figur||nuclear medicin||cur treatment||studi||effect||dose rate||receptor||narrow rang||analys||exposur time||low dose||cell||therapi||growth||day||radionuclid therapi||growth delay||radionuclid||low dose rate||dish||rang||irradi chamber||order||slower rate||beta particl||exposur||cultur||chamber||intrins radiosensit||cultur dish||exponenti growth||irradi||tumour cell,radiat||u-118mg||u-118mg cell||u-373mg||irradi u-118mg cell||u-373mg cell||cell||radionuclid||2gi||irradi||skbr-3 cell||a-431 cell||dose rate||low-dose-r radiat radiat||tumour cell,0.239||0.236||0.221||0.216||0.212||0.211||0.206||0.201||0.197||0.193||0.192||0.191||0.187||0.186||0.183,0.0,0.3,0.3333333333333333
1126,Pediatr_Nephrol-3-1-1805051.txt,inflamm||chronic kidney diseas||children||studi||patient||end-stag renal diseas||erythropoiesis-stimul agent||effect||ascorb acid||esa therapi||increas||erythropoiet respons||esa||guidelin||iron||advers event||therapi||esrd||acut||oxid stress||absolut||iron storag||anemia||hemoglobin level||hemodialysi||iron supplement||ferritin||parenter iron prepar||kidney function||iron statu||vitro studi||intern recommend||intraven iron,iron||intraven iron||parenter iron||iron sucros||iron therapi||iron defici||iron sacchar||iron supplement||oral iron||iron administr||serum iron||iron dextran||iron absorpt||iron statu||carbonyl iron,0.717||0.459||0.404||0.398||0.382||0.38||0.375||0.373||0.371||0.371||0.369||0.369||0.368||0.367||0.365,0.4,0.3,0.26666666666666666
1127,J_Behav_Med-3-1-2080858.txt,person||aspect||type||attempt||neg feel||awar||level||find||restraint||neg emot||divis||individu||feel||distress||studi||concept||posit aspect||style||tendenc||scale||repression-lik concept||memori||self-decept||definit||denial||empir find||traumat event||non-express||repressor||defens||term||gener approach||suppress||repress memori||research||alexithymia||social phobia||self-imag||other-decept||report||differ||act||repress||self-conceal||peopl||emot control||emot||social situat,repress||repress repress||repress cope||repress cope style repress||repress tendenc||repress memori||repress concept||J. repress||repress journal||W. repress||repress 1990||repress impli||B. repress||repress peopl||term repress,0.648||0.648||0.416||0.408||0.363||0.363||0.362||0.357||0.356||0.346||0.342||0.339||0.337||0.337||0.336,0.2,0.2,0.13333333333333333
1128,Neurochem_Res-3-1-1832151.txt,role||bind partner||lrp||beta amyloid||secretas||presenilin||studi||aspartyl proteas activ||gamma secretas||nicastrin||intramembran cleavag||substrat competit||interact protein||complex||evid||molecular clamp||calsenilin||enzym||protein||result||insect cell||activ||gener||amyloid precursor protein||cell surfac||interact||fragment||date||pathway||strong evid||transmembran domain||app||function||compon,presenilin||presenilin protein||presenilin complex||presenilin fragment||presenilin endoproteolysi||presenilin mutat||presenilin holoprotein||presenilin cofactor||presenilin interactor||mutant presenilin||presenilin dimer||presenilin origin||presenilin 2||presenilin 1||gamma-secretas,0.668||0.381||0.365||0.352||0.347||0.343||0.341||0.337||0.337||0.336||0.335||0.334||0.334||0.334||0.279,0.2,0.1,0.06666666666666667
1129,Breast_Cancer_Res_Treat-3-1-2001217.txt,placebo||adjuv||case||neoadjuv therapi||letrozol||individu||hormone-sensit breast cancer||breast cancer||breast cancer continuum||patient||tamoxifen||year||recurr||combin||effect||risk||regimen||chemotherapi||aromatas inhibitor||ai||sexual health||mbc||event||treatment||advers event||adjuv therapi||detriment effect||women||patient awar||long-term survivorship||anastrozol||tumor||trial||decis||benefit,breast cancer||breast cancer breast cancer||letrozol||receptor-posit breast cancer breast cancer||primari breast cancer breast||II breast cancer breast cancer||cancer||metastat breast cancer||cancer breast cancer group||breast cancer patient||breast cancer clin||receptor-posit breast cancer||node-neg breast cancer||earli breast cancer||advanc breast cancer,0.433||0.433||0.36||0.353||0.35||0.347||0.345||0.309||0.306||0.301||0.301||0.3||0.3||0.299||0.298,0.4,0.2,0.13333333333333333
1130,J_Neurol-3-1-1915648.txt,rand-36||placebo||measur||myoton dystrophi||hypersomnol||modafinil||patient||effect||percept||test||medic||mental health||sleepi||point||dose||present studi||interview||gener health||action||chang||activ||rang||insuffici effect||partner||double-blind placebo-control crossov studi||period,modafinil||modafinil dose||myoton dystrophi||dystrophi modafinil hypersomnol level||hypersomnol||sleepi||400 mg modafinil||housem||daytim sleepi||perceiv hypersomnol||excess sleepi||adult onset myoton dystrophi||excess daytim sleepi||ess||partner,0.625||0.335||0.286||0.284||0.277||0.263||0.217||0.208||0.193||0.177||0.159||0.15||0.147||0.126||0.117,0.6,0.4,0.3333333333333333
1131,Semin_Immunopathol-3-1-2071951.txt,antibodi||level||renal damag||complement||membran attack complex||glomerulonephr||mpgn type II||hemolyt urem syndrom||model||mutat||patient||defici||deposit||risk||mpgn||complex||inhibit||mbl||cell||damag||therapeut intervent||mice||protein||regul||format||cell membran||renal function||activ||bind||factor||membranoprolif glomerulonephr||diseas||fluid phase||immun complex||ligand||kidney||result,complement||complement deposit||complement defici||complement attack||complement activ||complement protect||complement factor||complement inhibit||complement regul||complement inhibitor||complement system||complement cascad||complement compon||complement scienc||homolog complement,0.527||0.325||0.287||0.285||0.284||0.281||0.276||0.272||0.272||0.271||0.27||0.269||0.269||0.266||0.266,0.2,0.1,0.06666666666666667
1132,Dev_Biol-1-5-2082130.txt,transgen||commun||core||polar||adjac cell||intercellular commun||failur||trichom||complex||polaris||planar polar||rotat||apf||signal||local coordin||cell||localis||clone||tissu||protein||lack||activ||stronger phenotyp||core polar protein||factor||distal cell edg||requir||development||interact||wing||asymmetri||cell polar||function||result,stbm||fz stbm||fz||vang pk stbm||vang fz||stan fz stbm||dgo pk stbm||pk-sple-13 stbm||2002 fz fz fz fz||fz pk-sple stbm||pk||vang dgo stbm||2002 fz stbm||fz stbm 6||dsh fz,0.559||0.497||0.435||0.395||0.36||0.355||0.354||0.352||0.348||0.348||0.343||0.335||0.332||0.332||0.329,0.0,0.0,0.0
1133,Crit_Care-5-4-37409.txt,technolog||system||databas||patient data||comput||data||studi||clinic scenario test||traine||patient||daili note||crossov studi||text entri||inform||process||resid||test||comput commun network||user||staff||palm devic||studi period||care||devic||patient manag||usa||medic refer inform||templat||refer||infrar||pda||handheld devic||physician||handheld comput||softwar||benefit||medic databas,pda||icu||pda user||pda platform||handheld comput||pda patient databas||handheld devic||handheld technolog||icu round||palm handheld devic||handheld system||icu team||icu rotat||previou pda experi||19 pda unit,0.449||0.292||0.278||0.232||0.228||0.215||0.208||0.205||0.186||0.182||0.178||0.169||0.164||0.163||0.159,0.4,0.3,0.2
1134,Int_Urogynecol_J_Pelvic_Floor_Dysfunct-3-1-2062491.txt,questionnair||univari analysi||biomed factor||preval||pregnanc||data||gener popul||studi||depress||year||stress urinari incontin||epidemiolog studi depress scale||urg urinari incontin||ces-d||deliveri||uui||signific increas||analys||over-act bladder syndrom||higher rate||urogenit symptom||women||clinic depress||associ||urinari incontin||oab||factor||sui||healthi nullipar women||symptom||urinari symptom||syndrom,depress||oab||incontin||depress symptom||urinari incontin||pregnanc||postpartum depress||postnat depress symptom||symptom||depress disord||depress mood||urinari symptom||major depress symptom||antenat depress||major depress,0.404||0.327||0.321||0.309||0.264||0.263||0.242||0.217||0.215||0.214||0.212||0.212||0.209||0.209||0.206,0.6,0.5,0.4
1135,Pediatr_Nephrol-4-1-2259258.txt,linkag analysi||chromosom 1||individu||npl||studi||patient||genet linkag||loci||region||linkag||pedigre||complex disord||total||evid||reflux||gene||averag||primari vur||vur||total npl||previou studi||addit marker||famili||lod||maximum lod||genet heterogen||haplotyp||score||children||result,vur||reflux||vesicoureter reflux||lod||famili vesicoureter reflux||primari vesicoureter reflux||nonsyndrom vesicoureter reflux||famili reflux||primari vur||nonsyndrom vur||hlod||vur patient||vesico-ureter reflux||lod score||maximum lod,0.361||0.318||0.311||0.292||0.245||0.223||0.218||0.216||0.204||0.197||0.195||0.193||0.183||0.168||0.161,0.6,0.4,0.3333333333333333
1136,Cell_Tissue_Res-3-1-2039796.txt,soft connect tissu||control group||data||bone regener||section||thrombin peptid||protein express||osteoblast lineag||osteopontin||bsp||adult||osteoblast differenti||bone sialoprotein||cell||osteoblast||tissu sampl||runx2||opn||distract gap||group||gap||bone||distract||area||distract osteogenesi,tp508||tp508 treatment||runx2||thrombin-rel peptid tp508||300 μg tp508 runx2||300 μg tp508||distract||distract osteogenesi||ml tp508 discuss 2005a||0 μg tp508 group||30 μg tp508 group||bone||runx2 express||runx2 protein||callu distract,0.629||0.316||0.284||0.265||0.248||0.236||0.229||0.193||0.181||0.176||0.176||0.174||0.156||0.148||0.146,0.2,0.3,0.26666666666666666
1137,Surg_Endosc-3-1-2169269.txt,pneumoperitoneum||ldn||induct||studi||patient||data analysi||infus||anesthesia||kidney extract||overnight infus||crcl||hour||oper||day||urin output||fluid regimen||devic||earli graft function||bolu||group||pre-hydr||periop fluid manag||kidney||donor,nephrectomi||crcl||pneumoperitoneum||donor nephrectomi||laparoscop donor nephrectomi||donor||laparoscop donor||laparoscop||live donor nephrectomi||crcl preop||laparoscop live-donor nephrectomi||open donor nephrectomi||postop crcl||pneumoperitoneum T6||anesthesia,0.355||0.318||0.309||0.297||0.275||0.239||0.235||0.232||0.21||0.203||0.203||0.202||0.172||0.163||0.157,0.4,0.3,0.26666666666666666
1138,Calcif_Tissue_Int-3-1-1914229.txt,index date||case||final model||β-blocker||histori||data||studi||patient||effect||risk||gprd||prescript||epidemiolog||variabl||pharmo rl||fractur||cumul dose||antihypertens agent||record||osteoporosi||drug||past||date||dutch pharmo record linkag system,β-blocker||fractur||gprd||β-blocker gprd pharmo rl case||gprd pharmo rl||femur fractur||pharmo rl||rl||osteoporot fractur||fractur risk||femur fractur risk||hip fractur risk||femur fractur case||femur||pharmo rl case,0.551||0.327||0.299||0.266||0.253||0.25||0.231||0.208||0.192||0.191||0.185||0.175||0.173||0.173||0.161,0.6,0.4,0.26666666666666666
1139,Appl_Microbiol_Biotechnol-4-1-2243256.txt,gene||polyamin||oxidas||putrescin||mutant||putrescin oxidas||plate||amin||enzym||enzym activ||substrat||room temperatur||substrat specif||oxid||spectrum||aromat cage||activ||substrat bind||bind||puo,Rh||Rh Rh||Rh Rh Rh||2 Rh Rh Rh Rh||Rh Rh Rh 1||Rh Rh lane||stabil Rh Rh||2005 Rh Rh||2 Rh Rh||1 Rh Rh||Rh Rh 2 2 Rh||Rh micrococcu||Rh puo Rh R.||Rh lane||1993 Rh Rh _,0.92||0.92||0.92||0.736||0.69||0.617||0.615||0.614||0.613||0.613||0.552||0.493||0.493||0.465||0.463,0.0,0.0,0.0
1140,Breast_Cancer_Res_Treat-3-1-2045691.txt,optic nerv head||data||breast cancer||studi||year||comparison||tamoxifen||anastrozol user||adjuv endocrin therapi||effect||astrocyt||eye||disk area||regress line||women||eye diseas||optic cup||age||analysi||subject||onh||group||anastrozol||report||predict||cup||hrt||visual acuiti||disk margin||tamoxifen-induc effect||contour line||result,tamoxifen||cup||tamoxifen user||anastrozol||optic cup||tamoxifen vision||cup volum||tamoxifen treatment||cup depth||tamoxifen side-effect||tamoxifen citrat||low-dos tamoxifen||cup area||0.612 cup||0.431 cup,0.483||0.441||0.296||0.296||0.287||0.259||0.25||0.248||0.248||0.246||0.246||0.246||0.24||0.228||0.227,0.8,0.4,0.26666666666666666
1141,Vision_Res-2-1-2386851.txt,respons||mjm||sensat varianc||paramet valu||data||model||valu||stimulu||finger error||contrast discrimin||observ||threshold||discrimin||increment||visual signal||pedest contrast||intrins uncertainti||fit||ratio||low threshold||estim||varianc||result||sensori threshold||uncertainti||second-respons accuraci||compress transduct||pedest||trial||ja||sigma-to-mean ratio||contrast||nois||detect||function||first-choic accuraci,ja||mjm||Ψ||ja mjm FV MT||swet||priori Ψ Ψ||ja ’s||mjm ’s||Ψ NP||pedest||pedest pedest||ψ||1961 swet||max Ψ||Ψ 3.4,0.407||0.398||0.348||0.278||0.235||0.234||0.213||0.209||0.205||0.201||0.201||0.2||0.189||0.178||0.178,0.4,0.3,0.2
1142,Int_Arch_Occup_Environ_Health-4-1-2175018.txt,emot role function||questionnair||qualiti||studi||patient||year||life||ill percept||percept||complaint||total||upper bodi region||rsi||person control||treatment||respect||work-rel upper extrem musculoskelet disord||health||averag||social function||pain||intens||group||order||differ||ill||treatment control||sick-list chronic rsi patient||work-abl,rsi||sick-list rsi patient||sick-list patient||sick-list group||sick-list chronic rsi patient||sick-list rsi patients’ perspect||rsi patient||rsi measur||sick-list patient group||sick-list chronic rsi patient sluiter judith||chronic rsi patient||rsi patients’ associ||umbrella term rsi||maatregelen rsi bij beeldschermwerk||dutch rsi patients’ associ,0.466||0.369||0.32||0.317||0.284||0.281||0.257||0.238||0.227||0.204||0.181||0.174||0.161||0.146||0.143,0.4,0.2,0.13333333333333333
1143,J_Med_Internet_Res-4-1-1761926.txt,document||level||technolog||system||diabet||commun||health care profession||lifemast||highest level||data||model||patient||inform||articl||mydiabet||abil||user||site||health inform||web site||criterion||manag||evalu||internet-bas diabet manag||relev||health care||solut||posit effect||internet||framework||more-complet solut||multi-rat kappa||blood glucos level||search||inform deliveri||diseas||result,diabet||internet diabet||lifemast||internet-bas diabet manag||mydiabet||internet-bas diabet care||internet||internet diabet technolog||diabet technolog||diabet care||internet-bas diabet system||feedback diabet||internet-bas diabet manag solut||internet-bas diabet manag system||insulin-depend diabet,0.322||0.271||0.265||0.23||0.227||0.221||0.22||0.215||0.212||0.208||0.2||0.19||0.182||0.181||0.173,0.8,0.5,0.3333333333333333
1144,J_Fluoresc-4-1-2266787.txt,sodium carbon solut||method||plasma||concentr||dosag form||determin||spike human plasma||pharmaceut prepar||standard deviat||experiment paramet||dilut time||mixtur||pH 10||fluoresc intens||reaction||solut||oxamniquin||analysi||concentr rang||oxm||drug||precis||dansyl chlorid||result,oxamniquin||oxamniquin enantiom||oxamniquin conclus||keyword oxamniquin||250 mg oxamniquin||dansyl chlorid||electrogener oxamniquin radic anion||reagent oxamniquin pure sampl||belal||dansyl hydroxid||dansyl chlorid effect||capsul||fluoresc||spectrofluorimetr microdetermin||chlorid dosag,0.548||0.307||0.275||0.274||0.192||0.174||0.159||0.157||0.155||0.131||0.118||0.108||0.096||0.091||0.087,0.2,0.2,0.13333333333333333
1145,Purinergic_Signal-3-4-2072922.txt,receptor-receptor interact||role||function role||ionotrop receptor||releas||presynapt inhibit||studi||adenosin||channel||neurotransmiss||atp||effect||current||synapt transmiss||receptor||adenosin receptor||cell||brain||gpcr||potenti||hippocampu||nmda||regul||neuron||recent studi||pathophysiolog condit||activ||gaba||famili||interact||receptor interact||antagonist||result,adenosin||adenosin receptor||adenosin A1||adenosin A1 receptor||adenosin a2a receptor||adenosin A3 receptor||A3 adenosin receptor||adenosin modul||atp-sensit adenosin receptor||receptor||excitatori adenosin receptor||adenosin receptor Br||inhibitori adenosin receptor||heterodimer adenosin receptor||uniqu adenosin receptor,0.49||0.374||0.299||0.285||0.276||0.267||0.267||0.261||0.261||0.258||0.255||0.254||0.253||0.252||0.25,0.4,0.3,0.2
1146,Cell_Tissue_Res-4-1-2386751.txt,type||complic||elastin||pregnanc||abnorm||patient||uteru||ehlers-danlo syndrom||uterin tissu||human||present||tenascin-x||day||complet defici||collagen||mice||obstetr complic||ed||age||differ||tnx||skin||vagin plug||elast fiber||signific differ||uterin connect tissu||postpartum hemorrhag||ed patient,tnx||tenascin-x||tnx KO||tnx fniii27-32||tnx haploinsuffici||tnx knockout||tnx domain||tnx KO mice||tnx KO mous||tenascin-x defici||ehlers-danlo syndrom||mous tenascin-x||tnx fniii27-32 protein||origin tnx KO mice||tnx KO mice show,0.535||0.382||0.339||0.306||0.281||0.277||0.274||0.272||0.241||0.222||0.219||0.214||0.207||0.205||0.205,0.4,0.2,0.2
1147,Neurosurg_Rev-4-1-2279160.txt,case||cranio-vertebr junction||surgic treatment||problem||studi||transor approach||mucosa||remov||compress||muscle-mucos flap||risk||irreduc atlanto-axi disloc||soft palat||nasal caviti||spinal cord||endoscop||endoscop dissect||applic||approach||atla||order||hard palat||anatom studi||clinic applic||endonas approach||endonas||procedur||oral caviti||odontoid process||middl turbin,endonas||endoscop endonas||endonas approach||endoscop endonas approach||endoscop||endoscop endonas surgeri||endonas techniqu||modifi endonas||endoscop endonas transsphenoid surgeri||extend endoscop endonas approach||innov endoscop endonas approach||extend endonas approach||endonas bipolar forcep||transor approach||clivu endoscop endonas transsphenoid surgeri 2003,0.575||0.455||0.34||0.338||0.335||0.322||0.292||0.289||0.274||0.26||0.255||0.235||0.226||0.217||0.198,0.6,0.3,0.26666666666666666
1148,J_Med_Internet_Res-8-2-1550702.txt,person||organiz task||author||technolog||organiz level||health care profession||practic||preval||rate||person digit assist||data||studi||year||nation sampl||inform||review||medic refer||articl||resid||clinic practic||profession||usag pattern||patient track||patient care||market research firm||adopt||male||medic resid||health||health care||age||handheld usag rate||characterist||care||present review||group||adopt rate||health care provid||pda||student||survey||handheld devic||physician||handheld comput||specialist||systemat review||specif task||result,pda||pda adopt||pda usag||profession pda||pda devic||pda technolog||pda usag rate pda||pda user||administr pda||pda applic||collect pda||futur pda||term pda||current pda||specif pda,0.737||0.407||0.401||0.4||0.397||0.394||0.39||0.386||0.379||0.376||0.374||0.373||0.373||0.372||0.372,0.2,0.1,0.06666666666666667
1149,Dig_Dis_Sci-3-1-1914244.txt,wide local excis||tumor||surviv||case||anu||melanoma||apr||local recurr||margin||wle||diagnosi||patient||abdominoperin resect||treatment,anorect||anorect melanoma||melanoma||metastat anorect melanoma||anorect melanoma int||anu||anal melanoma||primari anorect melanoma Br||anal-rect melanoma||mucos melanoma||apr||excis||benign anorect diseas||atyp anorect lesion||excis abdominoperin resect,0.481||0.445||0.409||0.307||0.298||0.238||0.231||0.23||0.224||0.224||0.214||0.193||0.177||0.176||0.158,0.2,0.2,0.2
1150,Mol_Genet_Genomics-2-2-1705487.txt,gene||rna polymeras II||role||level||strain||subunit||cell growth||special role||method strain||cell divis||promot||transcript||presenc||osmot stress||growth||data||express||cell||thiamin||stress condit,rpb4||rpb4 nmt1||nmt1 rpb4 1 rpb4 rpb4||rpb4 nmt1 nmt1 nmt1||rpb4 transcript||rpb4 subunit||cell separ rpb4 rpb4||rpb4 fba1||rpb4 strain||subcomplex rpb4||1 rpb4 fig. 1 rpb4 rpb4||S. pomb rpb4 rpb4 express||nmt1 fba1 rpb4||3 3 rpb4 nmt1 rpb4||600 rpb4 nmt1,0.796||0.571||0.547||0.458||0.432||0.419||0.414||0.413||0.407||0.402||0.399||0.394||0.39||0.388||0.384,0.0,0.0,0.0
1151,Arch_Microbiol-3-1-2111041.txt,isom||fraction||abil||group||compon||earth||speci||glycerol||data||bacteria||diabol acid||alkyl chain||lipid||mass rang||genu,thermotoga||thermotogal thermotoga||thermotogal||thermotoga lettinga||thermotoga maritima||thermotogal T.||thermotoga thermotogal 1986 T.||tlf-1||276 thermotoga maritima||result thermotogal thermotoga T. maritima T.||66 thermotoga||thermotoga maritima F. pennivoran||stetter KO thermotoga maritima||method thermotoga||T. maritima,0.451||0.414||0.376||0.359||0.358||0.276||0.254||0.243||0.241||0.241||0.23||0.23||0.228||0.226||0.22,0.0,0.0,0.0
1152,Breast_Cancer_Res_Treat-3-1-2092410.txt,gene||cancer||indonesian popul||amino acid||age||uv||popul||famili||breast cancer||mutat||protein function||brca||breast||specif popul||patient||famili member||group,brca2||brca1 brca2||brca1 brca2 brca1||brca1||mlpa brca1 brca2 brca1 brca2||brca1 brca2 30 brca1||mutat brca1 brca2 21 brca1 brca2||brca2 1 brca2||3 brca1 brca2||brca1 brca1 28||brca2 mutat||brca1 mutat||brca1 breast||brca1 brca2 germlin mutat||brca2 protein,0.654||0.631||0.624||0.609||0.514||0.468||0.444||0.436||0.421||0.406||0.396||0.374||0.366||0.364||0.333,0.0,0.0,0.0
1153,J_Med_Internet_Res-5-4-1550574.txt,clinic event||type||system||medic event||schema||simpl eav schema||databas||convent relat databas system||physic schema||model||patient||valu||clinic inform||larg clinic repositori||form||exampl||complex||domain||class||user||eav||metadata||convent design||medic informat||object-ori approach||web page||applic||gener design||logic schema||electron patient record||approach||flexibl||literatur||phone number||gener||gener eav tabl||field||record||number||attribut||tabl||data type||object||design||physic layout||larg number||eav model||queri||completely-gener physic schema,eav||eav databas||eav schema||databas||eav layout||databas schema||schema||eav design||simpl eav schema||eav tabl||enhanc eav schema||eav data||eav model||CR eav||eav approach,0.502||0.412||0.407||0.323||0.32||0.317||0.312||0.298||0.289||0.28||0.275||0.272||0.266||0.265||0.262,0.4,0.4,0.3333333333333333
1154,Crit_Care-6-5-130146.txt,antithrombin iii||subgroup||atiii||find||indic||congenit defici||italian hospit||heparin||clinic condit||data||studi||patient||sepsi||mortal||inform||dic||evid||treatment||rct||meta-analysi||hospit||italian ministri||observ studi||random||previou rct||intens care unit||dissemin intravascular coagul||drug||trial||septic shock||icu||outcom,atiii||atiii treatment||atiii concentr||women atiii||abbrevi atiii||congenit atiii defici||famili atiii defici||kyrl PA atiii||baselin atiii level||16.2 atiii level||sepsi||antithrombin||rct||icu||intravascular coagul sepsi,0.834||0.426||0.423||0.421||0.419||0.326||0.302||0.285||0.282||0.282||0.204||0.157||0.119||0.117||0.116,0.2,0.1,0.26666666666666666
1155,Plant_Mol_Biol-3-1-2039854.txt,goslim||orient group||evolutionari relev||categori||adjac pair||occurr||coexpress domain||coexpress||microsynteni||local microsynteni||well-defin categori||rice||orient||rank number||mpss||local coexpress domain||neighbor||express platform||chromosom||domain||MA data||cluster||MA express data||similar||analys||function categori||gene||distanc||annot||arabidopsi||inparanoid||pair||biolog background||list||import||fraction||coexpress pair||number||intergen distanc||signific fraction||well-defin goslim categori||plant||result,coexpress||coexpress pair||coexpress domain||coexpress tandemli||coexpress gene pair||coexpress quadruplet||local coexpress||coexpress triplet||coexpress adjac pair||explain coexpress||tissue-specif coexpress||coexpress analysi||coexpress relationship||singl coexpress pair||synten coexpress domain,0.664||0.488||0.41||0.401||0.385||0.369||0.364||0.356||0.342||0.335||0.335||0.334||0.334||0.326||0.315,0.6,0.3,0.2
1156,Dev_Genes_Evol-4-1-2362136.txt,antibodi||insect||develop||muscl||crustacea||present studi||myogenesi||embryo||western blot||limb||evolut||hoechst||speci||decapoda||adult||pattern||innerv pattern||studi||isopoda||muscl format,crustacean||crustacean limb||crustacea||crustacean neurobiolog||arthropod||crayfish muscl crustacean||decapod crustacean||crustacean taxa||arthropod muscl||arthropod limb||crustacean walk||crustacean relationship||primit crustacean||marin crustacean||futur crustacean,0.368||0.268||0.246||0.222||0.213||0.202||0.2||0.195||0.192||0.19||0.189||0.189||0.187||0.187||0.186,0.2,0.1,0.06666666666666667
1157,Appl_Microbiol_Biotechnol-3-1-2039825.txt,antibodi||method||human vh||advantag||VL domain||single-domain||high stabil||express||antigen||yeast||applic||product||protein||convent antibodi||antibodi fragment||molecular evolut||light chain||function antibodi devoid||egfr||vhh||effici||addit||antigen bind,muylderman||vhh||llama vhh||llama||single-domain||llama single-domain antibodi||single-domain antibodi||llama vhh antibodi fragment||llama single-domain antibodi fragment||antibodi||camel vhh||camel single-domain antibodi||vhh antibodi fragment||llama antibodi fragment||single-domain antibodi fragment,0.359||0.304||0.297||0.29||0.28||0.268||0.258||0.241||0.236||0.235||0.235||0.227||0.225||0.221||0.217,0.4,0.3,0.2
1158,Dig_Dis_Sci-3-1-2140097.txt,unreli result||studi||valu||medic measur system||diagnost accuraci||stenosi||acid product||chronic mesenter ischemia||diagnost evalu||gold standard||gastric||cgi||chronic gastrointestin ischemia||exercis||ischemia||stomach||meal||gastrointestin ischemia||patient group||gastric exercis tonometri||signific differ||diagnosi||chronic abdomin symptom||splanchnic stenosi||detect||result,tonometri||cgi||ischemia||24-h tonometri||gastrointestin tonometri||postprandi tonometri||hour tonometri||tonometri studi||suspect cgi||revascular 24-h tonometri||cgi surgeri||24-h tonometri test||24-h gastrojejun tonometri||24-h tonometri identifi||24-h tonometri combin,0.574||0.496||0.39||0.387||0.334||0.312||0.299||0.288||0.268||0.265||0.264||0.263||0.263||0.26||0.259,0.4,0.2,0.13333333333333333
1159,Ann_Surg_Oncol-4-1-2190342.txt,cancer||time||respons||tumor regress grade||studi||patient||regimen||mortal||esophag cancer||paclitaxel||transhiat esophag resect||radiotherapi||treatment||patholog complet tumor regress rate||chemoradi||postop complic||surgeri||stage II||tumor||surviv||neoadjuv chemoradi||trial||neoadjuv treatment,neoadjuv chemoradi||esophag||chemoradi||neoadjuv chemoradi regimen||neoadjuv chemoradiotherapi||esophag cancer||neoadjuv regimen||neoadjuv therapi||resect esophag cancer||neoadjuv treatment||paclitaxel-bas neoadjuv chemoradi regimen||esophag carcinoma||chemoradi regimen||locoregion esophag cancer||esophag adenocarcinoma,0.35||0.347||0.297||0.275||0.273||0.266||0.264||0.223||0.222||0.219||0.213||0.211||0.211||0.204||0.201,0.4,0.4,0.26666666666666666
1160,Clin_Auton_Res-2-2-1705534.txt,type||measur||method||respons||latenc||studi||contralater side||ipsilater||autonom nervou system||amplitud||stimuli||sympathet skin respons||stimul||electr stimul||reflex||subject||ssr record||ssr||compon||differ||type respons||record||millisecond||peak latenc||area||record site||magnet||side,ssr||ssr waveform||ssr onset||ssr record||ssr onset latenc||ssr vari||ssr data||sympathet skin||latenc||magnet||skin latenc||electr stimul||magnet stimul||sympathet sudomotor||electr stimulu,0.543||0.316||0.296||0.286||0.284||0.277||0.273||0.268||0.259||0.253||0.23||0.221||0.21||0.21||0.207,0.4,0.4,0.3333333333333333
1161,World_J_Urol-4-1-2295251.txt,target||vegf level||g250||vegf||combin||studi||patient||bevacizumab treatment||caix||renal cell carcinoma||effect||clinic trial||antigen||monoclon antibodi||treatment||therapi||partial respons||renal mass||bevacizumab||tumor cell||rcc||tumor||surviv||phase II trial||trial||diseas||result,bevacizumab||g250||rcc||metastat rcc||rcc cell||bevacizumab treatment||low-dos bevacizumab||monoclon antibodi g250||g250 treatment||chimer monoclon antibodi g250||131i-label chimer g250||iodine-131-label monoclon antibodi g250||metastat rcc patient||oosterwijk||anti-renal-cel carcinoma chimer antibodi g250,0.429||0.417||0.396||0.252||0.235||0.233||0.231||0.228||0.227||0.194||0.185||0.18||0.176||0.176||0.165,0.6,0.4,0.26666666666666666
1162,Graefes_Arch_Clin_Exp_Ophthalmol-3-1-2082065.txt,measur||tempor resolut||young control||studi||critic flicker fusion frequenc||stimulu||patient||motion||frequenc||threshold||sensit||color percept||test||region||visual function||motion sensit||contrast sensit||eye||retina||double-puls resolut||eccentr||subject||motion contrast threshold||light||arm||group||visual field||dynam process||peripher motion percept||age-match control||signific differ||visual acuiti||loss||function||result,age-rel maculopathi||flicker||maculopathi vi||age-rel macular degener||vi||strasburg||earli age-rel maculopathi||age-rel macular diseas||macular degener||bressler||flicker sensit||flicker frequenc||age-rel maculopathi eisenbarth werner||dpr||mackeben,0.182||0.175||0.153||0.14||0.139||0.135||0.125||0.115||0.112||0.109||0.106||0.102||0.099||0.095||0.095,0.0,0.0,0.0
1163,Oecologia-4-1-2373415.txt,intermedi depth||water depth||veget commun||swan||speci||fulltofta bay||graze intens||plot||tuber||distribut||treatment||ramet||plant,"P. perfoliatu||P. perfoliatu P. pectinatu||P. pectinatu P. perfoliatu||P. perfoliatu P. pectinatu P.||potamogeton pectinatu||2 P. pectinatu P. perfoliatu||1 potamogeton perfoliatu P. pectinatu||squar P. perfoliatu||experi P. perfoliatu||P. pectinatu 2002||P. pectinatu 2||2 potamogeton perfoliatu P. pectinatu shoot||5 potamogeton perfoliatu||august P. perfoliatu 1,10||june P. perfoliatu 1,10",0.358||0.349||0.349||0.316||0.3||0.279||0.263||0.241||0.239||0.227||0.226||0.22||0.213||0.201||0.199,0.0,0.0,0.0
1164,Cancer_Chemother_Pharmacol-4-1-2270367.txt,level||normal tissu||radiat||sampl||studi||AG adduct||patient||dna adduct||correl||infus||tumor tissu||dose||treatment||cell||schedul||adduct||buccal cell||analysi||concurr chemoradiotherapi schedul||format||total number||wbc||cisplatin||tumor||cervic cancer,adduct||cisplatin-dna adduct||platinum-dna adduct||dna adduct||AG adduct||GG adduct||adduct format||adduct level||pt-ag adduct||adduct induct||adduct measur||cisplatin-dna adduct format||cisplatin-dna adduct level||cisplatin-dna adduct measur||cisplatin-dna adduct determin,0.651||0.474||0.375||0.362||0.351||0.35||0.346||0.336||0.334||0.33||0.33||0.329||0.323||0.319||0.317,0.6,0.3,0.2
1165,Diabetologia-4-1-2362135.txt,vascular function||type 2 diabet mellitu,rhdl||rhdl infus||diabet mellitu||infus||apoa-i infus||apoa-i||hdl infus||high-dens lipoprotein||mellitu||volunt||hdl||3.5 mmol||1.2 hdl-cholesterol||type 2 diabet mellitu||nitric oxid rhdl,0.205||0.173||0.152||0.142||0.14||0.139||0.116||0.111||0.108||0.103||0.091||0.09||0.089||0.087||0.085,0.0,0.0,0.06666666666666667
1166,Antonie_Van_Leeuwenhoek-3-1-2140093.txt,immunogold||antibodi||igg||high accuraci||cbpp||membran||primari antibodi||host cell||amino acid||domain||immunogold label||lppq||mycoplasma||coverslip||outer surfac||peptid||integr membran domain||electron microscopi||cell||surfac,mycoplasma mycoid mycoid||mycoid M. mycoid||mycoplasma mycoid||2007 mycoplasma mycoid mycoid M. mycoid||M. mycoid||M. mycoid mycoid SC||mycoid SC||M. mycoid mycoid 2000 M. mycoid||mycoid 2000 M. mycoid||mycoid 2002 M. mycoid||mycoid 2004||mycoid 2005||M. mycoid mycoid SC strain||mycoid 2004 2006 M. mycoid||jb.187.19.6824-6831.2005 16166545 mycoplasma mycoid mycoid SC,0.668||0.611||0.554||0.491||0.469||0.467||0.466||0.463||0.46||0.459||0.449||0.448||0.374||0.367||0.344,0.0,0.0,0.0
1167,Emerg_Radiol-3-1-1914302.txt,manual||fast||line||radiograph||indic||spine||imag||pulmonari contus||patient||chest||lumbar spine||primari survey||radiologist||abdomen||convent radiographi||emerg measur||fractur||life-threaten injuri||diagnost imag||treatment||evalu||pelvic radiograph||care||chest radiograph||injuri||physic examin||adjunct||thorac||advanc trauma life support||trauma care||radiolog||pneumothorax||abdomin CT||clinic decis rule||trauma||atl,atl||trauma||dutch atl||atl guidelin||conclus atl||trauma patient||trauma care||blunt trauma||trauma victim||torso trauma||trauma chest pneumothorax||trauma set||trauma suit||trauma team||spine,0.515||0.407||0.26||0.26||0.258||0.23||0.225||0.225||0.222||0.218||0.208||0.208||0.207||0.207||0.205,0.4,0.3,0.26666666666666666
1168,Cancer_Causes_Control-2-2-1764866.txt,risk||calor restrict||cancer||human||cancer risk||transient,calor restrict||short-term calor restrict||restrict||sustain calor restrict||earli calor restrict||calor intak||calor restrict prevent cancer||cancer||short-term famin||famin exposur||1945 dutch famin||chines famin||famin observ||famin find||famin situat,0.383||0.274||0.267||0.265||0.26||0.26||0.252||0.23||0.229||0.228||0.21||0.207||0.205||0.205||0.204,0.2,0.2,0.13333333333333333
1169,Exp_Brain_Res-3-1-1914280.txt,intersensori||visual toj task||tempor ventriloqu||auditori||locat||effect||frequenc||intersensori interact||av-interv||auditori stream||jnd||experi||rhythm||flanker||light||auditori stimuli||intersensori pair||captur||stream||soa||central loudspeak||tone||sequenc||auditori group||sound,sound||flanker sound||captur sound||flanker||sound segreg||sound locat||flanker sound differ||case flanker sound||2 flanker sound||sound sequenc||sound enhanc||collision’ sound||26th sound||11th sound||sound burst,0.589||0.476||0.413||0.364||0.335||0.324||0.321||0.32||0.318||0.305||0.302||0.301||0.3||0.299||0.299,0.4,0.2,0.13333333333333333
1170,Cancer_Immunol_Immunother-3-1-1914259.txt,control||detect||studi||Hu antibodi||pbmc||individu||cytokin||peptid||patient||nervou system||pn||antigen||cell||hud,hu-pn||paraneoplast encephalomyel||dalmau||hud||paraneoplast encephalomyel antigen hud||paraneoplast neurolog syndrom||paraneoplast neurolog disord||cmv||hu-pn patient||paraneoplast cerebellar degener||benyahia||neurolog||hud t-cell respond||sfc||anti-hu-associ paraneoplast encephalomyel acta neuropathol,0.254||0.238||0.222||0.2||0.186||0.185||0.17||0.166||0.147||0.135||0.127||0.124||0.115||0.114||0.112,0.2,0.1,0.06666666666666667
1171,Mcgill_J_Med-11-1-2322923.txt,report||reaction||wasp sting||acut renal failur||case||direct nephrotox effect||haemolysi||wasp envenom||rhabdomyolysi||interstiti nephriti||direct nephrotox||atn||nepal||acut interstiti nephriti||acut tubular necrosi||intravascular haemolysi||wasp venom||hypersensit reaction||renal failur||patient,wasp||wasp sting||sting||wasp venom||wasp sting case||multipl wasp sting||conclus wasp sting||wasp envenom||multipl wasp||wasp attack||multipl european wasp sting||observ discuss wasp sting||multipl sting||massiv wasp venom||keyword wasp envenom rhabdomyolysi,0.525||0.492||0.458||0.349||0.341||0.336||0.328||0.312||0.276||0.27||0.254||0.247||0.242||0.238||0.196,0.4,0.3,0.2
1172,Pflugers_Arch-3-1-2082653.txt,condit||action potenti||lidocain||restitut||dynam compon||studi||valu||bcl||anti-arrhythm effect||slope||effect||frequenc||hypokalaemia||cycl||baselin cycl length||shortest bcl||hypokalaem langendorff-perfus murin heart||epicardium||map||analysi||experi||alternan||restitut curv||full agreement||critic DI||arrhythmia||record||waveform||heart||arrhythmogen||endocardium,alternan||t-wave alternan||wave alternan||electr alternan||cardiac alternan||TU alternan||durat alternan||restitut||discord alternan||cardiac alternan circ||repolar alternan circ||ventricular arrhythmia||ventricular fibril||electr restitut||heart,0.4||0.231||0.227||0.226||0.224||0.206||0.205||0.204||0.204||0.171||0.169||0.13||0.13||0.128||0.126,0.2,0.2,0.2
1173,Bioprocess_Biosyst_Eng-2-2-1705536.txt,induct||periplasm protein||hydrolas activ||sec pathway||growth rate||polyest||induct phase||hcdc||batch cultiv||cell||glucos||glucos concentr||protein||cultiv||periplasm||rtfh||activ||cytoplasm||extracellular space||solubl protein||mobil phase||batch||extracellular medium||purif||medium||result,rtfh||rtfh dcw||cytoplasm rtfh||rtfh product||rtfh releas||rtfh activ||dcw||rtfh solut||rtfh concentr||rtfh dcw 2||rtfh section||produc rtfh||gener rtfh||rtfh 11||periplasm,0.553||0.419||0.329||0.293||0.288||0.285||0.285||0.281||0.28||0.279||0.278||0.278||0.278||0.277||0.254,0.2,0.1,0.13333333333333333
1174,Antonie_Van_Leeuwenhoek-4-1-2268727.txt,sclerotia||applic||carrot||malt extract agar||cold-act enzym||enzym||mycelium||powder wood||hyalina vel fusca||temperatur||natamycin||activ||growth,fibulorhizoctonia psychrophila F. psychrophila||F. psychrophila||F. psychrophila F.||keyword fibulorhizoctonia psychrophila||F. psychrophila athelia arachnoidea F. carota||F. psychrophila F. carota athelia arachnoidea||2 F. psychrophila||rhizoctonia carota||F. psychrophila aspergillu niger||athelia arachnoidea||2 F. psychrophila F. carota A.||2 F. psychrophila A.||F. psychrophila aspergillu niger A.||F. psychrophila 2004 2005||3 3 F. psychrophila,0.437||0.428||0.34||0.298||0.297||0.297||0.285||0.265||0.264||0.231||0.225||0.222||0.218||0.215||0.214,0.0,0.0,0.0
1175,Anal_Bioanal_Chem-4-1-2045123.txt,assay||androgen||testosteron||yeast||yegfp||recombin yeast cell||progesteron||paper||primer||antagonist||pcr||compound||cell wall disrupt||yeast androgen bioassay||cell line||yeast cultur||yeast cell||transform||estradiol,β β β||β||β bold β||β lacz lacz||27 27 β β||2 cyc1 cyc1 termin||androgen||2 cyc1||NR NR||50 α β||yeast androgen||lacz||yeast androgen bioassay||yeast||NR NR bde-19 NR NR,0.414||0.414||0.278||0.252||0.209||0.203||0.202||0.202||0.199||0.196||0.184||0.171||0.171||0.166||0.163,0.0,0.1,0.2
1176,Eur_J_Clin_Pharmacol-3-1-2071966.txt,system||problem||patient||effect||inform||clinic practic||sexual problem||side effect||discontinu||patient report||impact||treatment||advers event||hcp||therapi||natur||relev||ineffect||experi||medicin||antidepress||issu||drug||spontan report||previou medic||advers drug reaction,antidepress||hcp||antidepress therapi||antidepress treatment||antidepress user||tricycl antidepress||initi antidepress||antidepress treatment issu||maintenance-phas antidepress medic||initi antidepress therapi||current antidepress therapi||event antidepress discontinu patient report||side effect||hcp rash||report side effect,0.607||0.359||0.319||0.315||0.313||0.313||0.306||0.235||0.215||0.215||0.214||0.199||0.189||0.187||0.177,0.4,0.2,0.2
1177,Histochem_Cell_Biol-4-1-2413113.txt,cell adhes||hemichannel||form||microtubul||protein||interact||brain tissu||migrat||heart||gap junction||connexon||adheren junction||cell||adhes||brain,junction||connexin||gap junction||gap||connexin43 gap junction||gap junction hemichannel||gap junction connexin 43||connexin 43 gap junction||gap junction channel||gap junction cardiovasc||gap junction protein||myocardi gap junction||connexon||gap junction plaqu||crest,0.352||0.338||0.313||0.275||0.261||0.249||0.245||0.245||0.226||0.22||0.217||0.217||0.216||0.215||0.215,0.2,0.1,0.13333333333333333
1178,Purinergic_Signal-4-2-2377326.txt,atp||ogd||solut||atp releas||maxi-anion channel||astrocyt||arachidon acid||experi||neuron||studi||cell||calibr curv,atp||atp releas||biosensor atp||astrocyt||glial atp||luciferin-luciferas atp||atp solut||atp Cl||extracellular atp||atp puf||astrocyte-deriv atp||ischemia-induc atp releas||swelling-induc atp releas||maxi-anion channel||atp releas maxi-anion channel oxygen-glucos depriv,0.515||0.354||0.333||0.316||0.296||0.286||0.28||0.275||0.273||0.272||0.27||0.252||0.252||0.233||0.217,0.6,0.3,0.26666666666666666
1179,Ann_Surg_Oncol-4-1-2277442.txt,tumor deposit||case||diamet||breast cancer||studi||patient||SN metastas||breast cancer patient||featur||invas breast cancer||lymph node dissect||lymph node||tumor-posit axillari SN||analysi||SN involv||itc||penetr depth||microanatom locat||sentinel node||ajcc||signific predictor||sn||subcapsular locat||morphometri,non-sn||non-sn metastas||non-sn involv||posit non-sn||non-sn characterist||non-sn 4939||enlarg non-sn metastas||SN||addit non-sn involv||sentinel||SN metastas||posit non-sn 474||sentinel node||node||sentinel lymph node,0.671||0.433||0.359||0.348||0.343||0.342||0.291||0.274||0.241||0.239||0.235||0.235||0.234||0.23||0.216,0.0,0.0,0.13333333333333333
1180,Glycoconj_J-4-1-2413117.txt,calcul||molecular shape||time||na-domain||random coil||isotrop||heparin||sampl||data||model||valu||polym||amid||anisotrop model||oligosaccharid||dynam||coupl||octasaccharid||analysi||experi||simul||nmr||polysaccharid||consist||central residu||nmr relax||diffus||tabl||experiment data||cross-peak||molecul||result,tau||tau _||nmr||document||omega||nmr relax||_||text||na-domain||carbohyd||documentclass||12pt||amsmath||amsfont||mathrsf,0.116||0.082||0.071||0.057||0.056||0.051||0.049||0.045||0.043||0.043||0.043||0.043||0.043||0.043||0.043,0.2,0.3,0.2
1181,Soc_Psychiatry_Psychiatr_Epidemiol-2-2-1764202.txt,find||import role||prodrom clinic||studi||patient||year||contact||durat||psychologist||mental health||featur||earli psychosi||health profession||privat psychiatrist||social withdraw||gp||psychosi||assess||prodrom servic||group||health system||symptom||number||posit||reliabl||pathway||schizophrenia||referr||untreat psychosi||help-seek pathway,psychosi||psychosi prodrom||first-episod psychosi||earli psychosi||help-seek pathway||non-affect psychosi||begin psychosi||untreat psychosi||psychosi studi||2006 psychosi||contact||help-seek patient||earli help-seek contact||klosterkött||schizophrenia spectrum psychosi,0.413||0.295||0.238||0.23||0.218||0.214||0.213||0.211||0.208||0.208||0.207||0.206||0.205||0.199||0.198,0.6,0.4,0.3333333333333333
1182,Clin_Exp_Metastasis-4-1-2413104.txt,antibodi||cancer||find||serum||carcinogenesi||sampl||studi||patient||potenti biomark||differenti express||npc||express||signific||saa||protein marker||maldi-tof-m identif||tissu||protein||confirm elisa||tumor cell||human serum||identif||group||nasopharyng carcinoma||serum level||healthi volunt||elisa||npc patient||biomark,npc||non-lnm npc||lnm npc||npc metastasi||npc cell||npc patient||npc stage||new-onset npc||npc progress||npc victim||npc statu||npc research||npc group||lnm npc patient||non-lnm npc group,0.624||0.371||0.371||0.359||0.334||0.327||0.324||0.319||0.318||0.317||0.316||0.316||0.314||0.257||0.249,0.2,0.2,0.13333333333333333
1183,Planta-4-1-2413075.txt,pme activ||role||pathogen||oxid stress toler||liquid nitrogen||suscept||pme||spore||wild-typ||abiot stress respons||antifung activ||inocul||seedl||pepper||express||leav||growth chamber||treatment||growth||gene||control||protein||molecular mass||hybrid||incub||cotyledon||hybrid signal||inhibitor||plant||result,capmei1||capmei1 capmei1 transcript||arabidopsi capmei1||capmei1 arabidopsi||capmei1 cabpr1||capmei1 arabidopsi capmei1 pr1||capmei1 protein capmei1 E. coli capmei1||capmei1 induct||capmei1 inhibit||capmei1 capmei1 xcv xcv 4||capmei1 function||crude capmei1||capmei1 capmei1 cabpr1 casar82a 32||xcv xcv capmei1 2 capmei1 C.||capmei1 hyaloperonospora parasitica capmei1 arabidopsi H.,0.857||0.573||0.497||0.497||0.468||0.466||0.438||0.435||0.433||0.431||0.43||0.43||0.367||0.36||0.334,0.0,0.0,0.0
1184,Apoptosis-4-1-2257993.txt,mechan||endotheli cell||pten||neg regul||wortmannin||apoptot nuclei||effect||atp||reperfus||jasplakinolid||akt activ||inhibit||treatment||cell||control||rho-kinas||apoptosi||cytochalasind||activ||y-27632||simul ischemia||latrunculina||akt||cytoskeleton,f-actin||rho-kinas||f-actin bundl||f-actin cytoskeleton||f-actin clump||f-actin rearrang||f-actin stain||pi3-kinas||a.u.||akt||apoptosi apoptosi||apoptosi||f-actin cytoskeleton play||rho-kinas inhibit||rho-kinas activ,0.452||0.314||0.314||0.283||0.255||0.255||0.235||0.216||0.21||0.201||0.199||0.199||0.192||0.188||0.171,0.2,0.2,0.2
1185,Support_Care_Cancer-3-1-2071950.txt,cancer||set||case||incur cancer||questionnair||problem||qualiti||studi||life||process||extent||rel||netherland||bereav rel||treatment||institut||end-of-lif care||cancer patient||health||interview||hospit||research||care||gener practition||death||medic treatment||home||symptom||number||physician||major differ||major concern,die||home||home care||bereav rel||home death||bereav rel place||care||palli care||end-of-lif care||hospital-bas home care||home care servic||home care set||home involv||patient||home set,0.4||0.278||0.231||0.219||0.2||0.193||0.184||0.179||0.171||0.167||0.161||0.16||0.153||0.152||0.148,0.4,0.4,0.26666666666666666
1186,Mol_Biochem_Parasitol-1-5-2075530.txt,mosquito bite||caspas activ||PS transloc||dna fragment||metacaspas||femal gametocyt||apoptosi||genom dna||cell death||proteas||posit||caspas||mosquito||involv||caspatag||ookinet||stage||result,pbmc1||plasmodium berghei||plasmodium plasmodium||plasmodium||plasmodium P. berghei pbmc1||P. berghei pbmc1||P. berghei||plasmodium metacaspas||plasmodium falciparum||4 discuss P. berghei pbmc1 pbmc1||pbmc1 knockout||ookinet||pbmc1 P. berghei sal hin||P. berghei P. falciparum||vitro P. berghei ookinet,0.449||0.409||0.362||0.362||0.35||0.347||0.295||0.271||0.26||0.248||0.235||0.224||0.222||0.221||0.206,0.0,0.0,0.06666666666666667
1187,Crit_Care-8-2-420020.txt,prone posit||mechan ventil||acut respiratori distress syndrom||high intrathorac pressur||overdistens||model||studi||arteri oxygen||strategi||patient||alveolar flood||effect||human||investig||increas||posit end-expiratori pressur||volum||rm||recruit||cyclic collaps||oxygen||lung injuri||low peep||ard||bacteri transloc||recruit maneuv||peep||injuri||mechan stress||alveolar unit||ali||lung infect||low tidal volum||acut lung injuri||alveolar collaps||lung||benefit||sigh,maneuv||lung||lung recruit maneuv||recruit maneuv||ard||ventil||lung recruit||recruit lung||alveolar recruit maneuv||lung injuri||period lung recruit maneuv||tidal ventil||reexpans maneuv||acut lung injuri||high-pressur recruit maneuv,0.372||0.313||0.292||0.282||0.276||0.271||0.252||0.252||0.247||0.225||0.22||0.203||0.194||0.193||0.192,0.6,0.4,0.3333333333333333
1188,Eur_Radiol-3-1-1797072.txt,treatment regimen||allogen transplant||neoplast cell||imag||patient||small molecular gd-chelat||inform||bone marrow||bone marrow cellular||increas||infiltr||articl||neoplast marrow||high risk||lymphoma||clinic practic||lesion||adult||specif question||treatment||neoplast infiltr||therapi||extracompartment tumor growth||anti-angiogen drug||contrast agent||cellular||uspio||treatment effect||hypercellular marrow||hematopoiet marrow||reconvers||chang||normal||nhl||long bone||tumor||bone||avn||hematolog malign||diffus||signal intens||irradi||addit||contrast||sequenc||clinic signific||techniqu,marrow||bone marrow||bone marrow infiltr||bone marrow reconvers||bone marrow transplant||neoplast marrow||bone||bone marrow lesion||hypercellular marrow||hematopoiet bone marrow||hematopoiet marrow||bone marrow convers||bone marrow angiogenesi||bone marrow cellular||normal bone marrow,0.691||0.532||0.388||0.381||0.379||0.374||0.373||0.371||0.369||0.368||0.366||0.365||0.365||0.362||0.362,0.2,0.4,0.4
1189,J_Gastrointest_Surg-3-1-1852381.txt,biliari ductal system||biliari fistula||hepat arteri thrombosi||approach||anastomosi||skin||tract||oper procedur||biliari surgeri||biliari cutan fistula||fistula tract||procedur||jejun loop||patient||liver||liver transplant||biliari drainag,fistula||biliari fistula||biliari cutan fistula||fistula tract||persist biliari fistula||biliary-cutan fistula||longstand biliari cutan fistula||long-stand biliari cutan fistula||chronic biliari cutan fistula||biliari drainag||cutan bile fistula||traumat intrahepatic-cutan biliari fistula||transabdomin fistula tract||post-traumat intrahepat cutan biliari fistula||biliari surgeri,0.626||0.542||0.417||0.408||0.365||0.347||0.319||0.319||0.318||0.299||0.293||0.292||0.291||0.259||0.257,0.6,0.4,0.3333333333333333
1190,Qual_Life_Res-3-1-1915610.txt,level||measur||categori||respons||permut||instrument||system||common dimens||frequenc distribut||problem||health statu||inform||shannon approach||shannon||classif||discriminatori power||hui||health||gener popul survey||gener popul sampl||absolut||popul||rel inform||total number||distribut||respond||health state||formal measur||differ||number||classif system||health classif system||reliabl,hui3||hui2 hui3||hui2||eq-5d||shannon||hui3 cognit||maui||hui2 cognit||hui2 hui3 mobil mobil ambul||euroqol eq-5d||shannon methodolog||shannon ’s||eq-5d health state||shannon indic||walk,0.396||0.374||0.352||0.306||0.247||0.223||0.203||0.201||0.178||0.17||0.134||0.134||0.133||0.132||0.126,0.2,0.1,0.06666666666666667
1191,Arch_Dermatol_Res-2-2-1705535.txt,placebo||chronic plaqu psoriasi||clinic respons||week||psoriasi||respons||long-term studi||data||studi||patient||previou histori||arthropathi ae||risk||open-label extens||increas||proport||psoriat arthriti||clinic trial||event||efalizumab treatment||joint diseas||treatment||ae||arthropathi||analysi||routin clinic practic||placebo group||incid||group||efalizumab group||long-term treatment||efalizumab-tr patient||arthriti||trial||efalizumab||result,efalizumab||arthropathi||arthropathi ae||efalizumab treatment||psoriat arthropathi||efalizumab group||efalizumab therapi||efalizumab retreat||arthropathi AE||arthropathi event||arthropathi data||ae||continu efalizumab treatment||psoriat arthropathi event||efalizumab 2 mg,0.632||0.559||0.407||0.345||0.333||0.326||0.325||0.321||0.294||0.286||0.283||0.255||0.233||0.226||0.224,0.8,0.5,0.4
1192,Histochem_Cell_Biol-4-1-2248610.txt,retrograd traffic||secretori rout||golgi apparatu stack||retrograd transport||endosom||golgi network||earli endosom||golgi apparatu||cisterna||toxin||compart||shiga toxin||ER||golgi cisterna||cell||protein||multipl detail||tgn||secretori pathway||stack||traffic||side||plasma membran||molecul||function||endocytosi,golgi||golgi apparatu||tran golgi||golgi transport||golgi cisterna||golgi network||golgi complex||mammalian golgi||golgi structur||earli golgi||nocodazole-induc golgi||golgi vesicul||golgi ribbon||golgi motil||golgi element,0.512||0.345||0.314||0.31||0.276||0.275||0.27||0.267||0.264||0.262||0.262||0.262||0.261||0.259||0.258,0.4,0.3,0.2
1193,Anal_Bioanal_Chem-3-1-1592253.txt,optic molecular imag||method||fluoresc probe||molecular probe||biomolecul||system||imag||abil||high spatial||oct||fc||power tool||dynam||specif||cell||biolog event||greater tissu penetr||fret||applic||tissu||fluoresc protein||protein||fp||real time||qd||chang||bind||red fluoresc||flim||fluoresc||system biolog||interact||shim||system level||omi||quantum dot||addit||vivo,omi||omi omi||fluoresc||fret||fret fp||fp||fret fp cell||fluoresc protein||1 omi||qd||decreas fret fluoresc||miyawaki||fluoresc probe||tsien RY chien||dynam dfi fp,0.296||0.296||0.221||0.206||0.198||0.191||0.157||0.151||0.148||0.143||0.143||0.143||0.133||0.133||0.131,0.6,0.6,0.4666666666666667
1194,Planta-3-1-2039816.txt,chromatin condens||time||preliminari experi||dna degrad||petal desicc||petal cell||sampl||dehydr||flower open||absciss||develop||petal||increas||floral life span||nuclear area||dna breakdown||lower sequenc||wilt||dna content||treatment||cell||program cell death||dapi||petal senesc||nuclear diamet||chang||agaros gel||flower||ethylen treatment||nuclear condens||nuclei||speci||stage||remark nuclear morpholog||flow cytometri||result,petal||petal absciss||desicc petal||petal desicc||D. belladonna P. yedoensi petal||petal senesc||alstroemeria petal||abscis petal||turgid petal||dianthu petal||P. yedoensi||petal FW||younger petal||petal cell||D. belladonna P. yedoensi,0.519||0.353||0.322||0.322||0.316||0.292||0.285||0.279||0.277||0.272||0.269||0.267||0.267||0.266||0.266,0.4,0.3,0.26666666666666666
1195,Eur_J_Nucl_Med_Mol_Imaging-3-1-1914264.txt,antibodi||target||respons||method||radiat||optim||data||model||studi||patient||amount||gbq||mci||bone marrow||abil||metastas||prospect trial||lymphoma||solid tumour||radiotherapi||whole-bodi||dose||thyroid carcinoma||dosimetri||cell||therapi||maximum toler dose||treatment||tumour||clinic dosimetri||radionuclid therapi||estim||radiat dosimetri||individu patient||phase||radionuclid||activ||abl approach||radiat dose||bone||import||toxic||neuro-endocrin tumour||result,dosimetri||radioiodin dosimetri||radiat dosimetri||marrow dosimetri||radionuclid therapi dosimetri||patient-specif dosimetri||radionuclid||whole-bodi dosimetri||clinic dosimetri||3-dimensional-intern dosimetri||pre-therapi dosimetri||dosimetri techniqu||voxel-bas dosimetri||dosimetri method||dosimetri result,0.45||0.289||0.275||0.271||0.266||0.241||0.241||0.239||0.234||0.231||0.231||0.23||0.23||0.226||0.226,0.4,0.4,0.26666666666666666
1196,Exp_Brain_Res-4-1-2373863.txt,condit||level||mechanoreceptor||touch||magnitud||tactil||studi||represent||stimulu||process||explor mode||convex||aftereffect||finger||concav||vogel||shape||experi||subject||curvatur||transfer||singl finger||neural represent||adapt||hand||result,finger||aftereffect||curvatur aftereffect||middl finger||index finger||aftereffect transfer||singl finger||haptic curvatur aftereffect||human finger||neighbor finger||distant finger||individu finger||curvatur||substanti aftereffect||similar aftereffect,0.549||0.474||0.365||0.304||0.304||0.293||0.285||0.283||0.282||0.281||0.28||0.277||0.256||0.241||0.24,0.4,0.3,0.26666666666666666
1197,Matern_Child_Health_J-2-2-1592161.txt,vlbw||program||follow-up||preconcept||commun assess||commun||infant||birth outcom||poor birth outcom||birth||pregnanc||ipc||magnolia project||pregnanc plan||concept||reproduct age||risk||risk reduct||feto-inf mortal rate||case manag||deliveri||intervent||commun outreach||commun develop||subcontractor||manag||infant mortal||gradi memori hospit||reproduct health outcom||poor nutrit||women||success||month||care||servic||prenat care||activ||poor health||clinic servic||northeast florida healthi start coalit||import||famili plan||initi home visit||particip||previou fetal||outcom,ipc||ipc program||ipc particip||gradi ipc program||ipc intervent||ipc team||initi ipc||women||singl ipc||vlbw||ipc program enrol||ipc program aim||pregnanc||magnolia project||vlbw deliveri,0.504||0.318||0.289||0.273||0.273||0.27||0.265||0.257||0.256||0.24||0.233||0.215||0.213||0.206||0.202,0.2,0.3,0.3333333333333333
1198,J_Struct_Biol-1-5-2048824.txt,antibodi||specif region||vesicl||NE assembl||nuclear pore complex||onm||ER membran||oocyt||membran protein||egg extract||sampl||ER tubul||chromatin||nuclear assembl reaction||structur||npc protein||nuclear envelop||npc||larg ER vesicl||larg sac||junction||stage iii oocyt||edg||scan electron microscopi||ultrathin section||protein||tubul||format||curvatur||incub||nuclei||assembl||pb||membran,rtn4a||al.||rtn4a antibodi||rtn4a label||2.2 rtn4a||2.1 rtn4a||2.5 rtn4a||voeltz||label show rtn4a||2.3 rtn4a localis||2.4 rtn4a localis||rtn4a prevent NE growth voeltz||goldberg||xenopu voeltz||rtn4a antibodi perturb NE growth,0.557||0.367||0.313||0.299||0.28||0.28||0.28||0.219||0.201||0.199||0.199||0.195||0.173||0.173||0.169,0.0,0.0,0.0
1199,Breast_Cancer_Res_Treat-3-1-2001223.txt,cancer||clinic respons||respons||neoadjuv therapi||letrozol||endocrin therapi||breast cancer||studi||tamoxifen||patient||diseas progress||letrozole-tr patient||effect||neoadjuv letrozol||chemotherapi||aromatas inhibitor||express||aromatas||postmenopaus women||treatment||women||surgeri||neoadjuv||tumor||trial||diseas||safeti,breast||letrozol||breast cancer||tamoxifen||cancer||postmenopaus breast cancer||neoadjuv letrozol||breast cancer clin cancer||oper breast cancer||breast cancer patient||breast cancer biomark||early-stag breast cancer||primari breast cancer||er-posit breast cancer||larg oper breast cancer breast cancer,0.419||0.353||0.351||0.316||0.283||0.275||0.272||0.258||0.251||0.248||0.247||0.245||0.245||0.245||0.243,0.8,0.5,0.3333333333333333
1200,Clin_Oral_Investig-4-1-2238786.txt,condit||dental eros||case||clinic phenomenon||preval||dental clinician||studi||eros||eros index||wear||oral health||develop||criteria||defect||tooth morpholog||dental practic||tooth wear||lesion||intern basi||current diagnost criteria||valid||occlus||basic eros wear examin||research||age||eros challeng||diagnost criteria||capabl||surfac||factor||exposur||eros tooth wear||loss||diagnosi||tooth||index||lesion characterist||progress||result,eros||eros wear||eros tooth||eros tooth wear||wear||tooth wear||tooth||contemporari eros tooth wear||dental eros||eros tooth lesion||tooth wear index||eros wear data||gradual tooth wear||tooth wear model||eros index,0.57||0.539||0.534||0.526||0.509||0.504||0.499||0.397||0.372||0.368||0.364||0.361||0.338||0.337||0.327,0.6,0.6,0.4666666666666667
1201,Pediatr_Nephrol-3-1-1989763.txt,serum albumin||level||method||fat||infant||eaa||studi||patient||nutrit||ccpd||increas||crf||intak||common practic guidelin||gastrostomi||dietari supplement||energi||growth||htsd||feed||glucos||bodi composit||protein||age||chronic renal failur||report||import||dialysi dose||height||doqi||appetit||fat mass||dialysi||acidosi||diseas||supplement||weight gain||children||result,dialysi||periton dialysi||children||chronic dialysi||nutrit||chronic periton dialysi||dialysi leptin||long-term dialysi||dialysi adequaci||dialysi dose||long-term periton dialysi||dialysi solut||dialysi clearanc||failur dialysi growth||pediatr dialysi patient,0.411||0.305||0.299||0.269||0.252||0.246||0.232||0.218||0.217||0.214||0.211||0.211||0.21||0.209||0.208,0.6,0.4,0.26666666666666666
1202,Eur_Arch_Otorhinolaryngol-3-1-2099165.txt,blood||fossa||case||day||boy||lingual arteri||pseudoaneurysm||embolis||mass||vessel wall||patient||posttonsillectomi haemorrhag||carotid arteri,pseudoaneurysm||posttonsillectomi pseudoaneurysm||posttonsillectomi haemorrhag||haemorrhag||pseudoaneurysm grow||conclus pseudoaneurysm||bleed||sever posttonsillectomi haemorrhag||delay posttonsillectomi haemorrhag||critic posttonsillectomi haemorrhag||tonsillectomi||lingual arteri||postop bleed||embolis||TE fournier NF pseudoaneurysm,0.523||0.45||0.324||0.273||0.268||0.263||0.245||0.228||0.227||0.219||0.203||0.177||0.175||0.159||0.144,0.4,0.2,0.26666666666666666
1203,Osteoporos_Int-4-1-2267486.txt,intern refer||data||previou fractur||fractur risk assess tool||lumbar spine||risk||threshold||clinic practic||femor neck||intervent||fractur probabl||fractur||tool||intervent threshold||present studi||therapeut intervent||bmd||women||age||gradient||equival||order||osteoporosis-rel fractur||japan||femor neck bmd||clinic risk factor||probabl||fractur outcom||hip fractur||bone miner densiti,fractur||hip fractur||fractur femor||fractur probabl||osteoporosis-rel fractur||osteoporot fractur||fractur risk||fractur predict||previou fractur||fractur outcom||hip fractur probabl||fractur number||hip fractur risk||osteoporosis-rel fractur femor||clinic spine fractur,0.547||0.373||0.351||0.312||0.311||0.31||0.304||0.285||0.276||0.275||0.275||0.274||0.269||0.259||0.236,0.8,0.6,0.4
1204,Neuroimage-2-1-2278232.txt,syntact process||left pariet lobe||neural system||superior portion||locat||experiment condit||data||phonolog process||bsl task||effect||deaf||languag||region||bsl||sign||phonolog||adult||pariet lobe||phonolog awar||precentr gyru||oral school||hear statu||medial portion||greater extent||primari school||non-n signer||item||neural network||task||analysi||pictur||hear group||english||activ||group||deaf peopl||bsl sign||rhyme||exposur||phonolog represent||left inferior frontal gyru||perform||particip||ifg||left ifg||smg||peopl||network,al.||deaf||rhyme||phonolog||deaf signer||rhyme task||phonolog task||languag||sign phonolog||deaf particip||signer||deaf nativ signer||rhyme judgement||spoken phonolog||phonolog process,0.345||0.343||0.331||0.328||0.273||0.244||0.242||0.232||0.219||0.203||0.202||0.199||0.194||0.192||0.185,0.6,0.4,0.3333333333333333
1205,Rheumatol_Int-3-1-2134974.txt,antibodi||follow-up||case||studi||patient||system lupu erythematosu||rituximab||rituximab therapi||autoimmun disord||thrombocytopen purpura||infus||refractori||cell-direct biolog therapi||pilot studi||small pilot studi||improv||treatment||cell||therapi||autoimmun diseas||vascul||month||autoimmun||potenti util||report||biolog therapi||sle||number||clinic benefit||cell deplet therapi||trial||diseas||clinic remiss||inadequ respons||result,rituximab||rituximab therapi||rituximab rheumatolog||rituximab treatment||rituximab toler||rituximab scand||rituximab group||rituximab failur||optim rituximab||rituximab 1||pt||rituximab infus therapi||success rituximab therapi||final rituximab infus||rituximab intern med,0.741||0.398||0.389||0.387||0.378||0.375||0.371||0.371||0.371||0.37||0.287||0.283||0.273||0.265||0.251,0.4,0.2,0.13333333333333333
1206,Biotechnol_Lett-3-1-2151841.txt,gene||protein fold||bip||target||heterolog protein||increas||holdas||pdi||substrat||protein||chaperon||chaperon system||molecular chaperon||unfold protein respons||activ||overexpress||cell||upr,upr||chaperon||bip||overexpress chaperon||bip overexpress||protein||upr activ||chaperon machineri||heterolog protein||calnexin||heterolog protein overexpress||redox-depend chaperon||inact chaperon||biotechnol bioeng||calnexin chaperon system,0.332||0.287||0.221||0.218||0.185||0.182||0.178||0.176||0.159||0.158||0.156||0.154||0.154||0.154||0.153,0.6,0.5,0.3333333333333333
1207,Health_Care_Anal-4-1-2244696.txt,futur||greater orient||individu||studi||valu||social depriv||expect||health inequ||discuss||gain||present orient||egalitarian||aim||impact||welfar||prioritarian||patern||futur orient||evalu||utilitarian||inform choic||autonomi||research||paper||inequ||time orient||uptak||ethic cost||choic||screen uptak||decreas||psycholog||screen||posit outcom||public health approach||particip||dilemma||peopl||greater social depriv||benefit||lower expect||result,inequ||choic||screen||zimbardo||health inequ||social depriv||choic increas inequ||screen uptak||inform choic||inform choic polici||mammographi screen||greater inequ||socioeconom inequ||social polici||A. zimbardo,0.3||0.293||0.293||0.242||0.227||0.221||0.201||0.201||0.186||0.179||0.175||0.172||0.17||0.169||0.168,0.8,0.7,0.4666666666666667
1208,Doc_Ophthalmol-4-1-2244701.txt,cone-rod dystrophi||cone||case||fmm||data||mutat||patient||retin dystrophi||parafov ring||autofluoresc||retin pigmentosa||visual field preserv||retin dysfunct||rpe||AF abnorm||high densiti autofluoresc||perg||function signific||genotype-phenotyp correl||lipofuscin||ring||field||visual acuiti||high correl||annulu,autofluoresc||fundu autofluoresc||rpgr||ophthalmol||retin dystrophi||rims1||bird AC fundu autofluoresc||abnorm fundu autofluoresc||retin pigmentosa||fundu autofluoresc imag||cone-rod dystrophi||retin guanyl||holder GE bird AC fitzk FW||bird AC holder GE fitzk FW||pigment epithelium autofluoresc,0.364||0.275||0.258||0.257||0.252||0.224||0.207||0.196||0.193||0.191||0.175||0.172||0.165||0.165||0.164,0.4,0.3,0.26666666666666666
1209,Arch_Dermatol_Res-3-1-1910889.txt,predefin evalu sheet||evalu||grade||non-allerg advers event||non-steroid anti-inflammatori drug||nsaid||reaction||urticaria||advers reaction||symptom||intoler||studi||drug||coxib||public||patient||advers event||articl,rofecoxib||rofecoxib toler||celecoxib||rofecoxib administr||high-dos rofecoxib||rofecoxib allergi eur||allergi||cox-2 inhibitor rofecoxib||cyclooxygenase-2 inhibitor rofecoxib||celecoxib toler||rofecoxib 37.5 mg||rofecoxib 25 mg||rofecoxib 50 mg||5 mg rofecoxib||nsaid,0.584||0.351||0.326||0.295||0.294||0.294||0.286||0.265||0.248||0.222||0.214||0.207||0.207||0.207||0.204,0.0,0.0,0.06666666666666667
1210,Clin_Auton_Res-3-1-1797062.txt,chronic mountain sick||respir||level||respons||week||pulmonari vasoconstrict||rate||pulmonari hypertens||high altitud||altitud||densiti||effect||autonom nervou system||sensit||increas||blood pressur||heart failur||baroreflex control||receptor||point||chemoreceptor||heart rate||hypoxia||day||control||acut hypoxia||blood||acut exposur||subject||recent studi||chang||barometr pressur||exposur||high altitud dweller||result,altitud||altitud dweller||high altitud||altitud resid||altitud 1982||simul altitud||extrem altitud||high altitud andean||high altitud dweller||healthi altitud dweller||hypoxia||high altitud exposur||high altitud anim||high altitud commun||high altitud research,0.663||0.392||0.351||0.339||0.335||0.334||0.334||0.289||0.274||0.267||0.264||0.25||0.238||0.235||0.234,0.4,0.3,0.26666666666666666
1211,Clin_Oral_Investig-4-1-2238792.txt,aspect||dental eros||method||instrument||children||indic||fill teeth||non-communic diseas||literatur analysi||world health report||qualiti||studi||eros||oral health||criteria||teeth||health promot||valid||countri||examin||gold standard||result||assess||diseas prevent||cardiovascular diseas||reliabl||diseas||index||qualiti criteria||oral health promot||oral diseas pattern,"eros||dental eros||eros tooth||eros index||dental eros index||dental||dental eros 18,555||e.g. dental eros||dental eros 153||dental eros process||oral dental eros index||eros tooth wear||k03.23 eros||eros 8||dental eros oral health",0.668||0.537||0.452||0.417||0.414||0.406||0.362||0.36||0.359||0.359||0.35||0.343||0.34||0.334||0.332,0.4,0.2,0.13333333333333333
1212,J_Abnorm_Child_Psychol-4-1-2206247.txt,level||measur||parent style||boy||behavior||commun||adolescence-limit delinqu||neglect style||sampl||data||theori||distinct delinqu trajectori||studi||risk||develop||style||child||pittsburgh youth studi||delinqu||demograph variabl||variabl||self-report||pattern||similar||neglect parent||analys||authoritarian||posit parent||childhood delinqu||full model||research||age||trajectori||characterist||parent||famili||famili factor||differ||group||late adolesc||delinqu trajectori,delinqu||delinqu trajectori||delinqu prior delinqu||gener delinqu delinqu||delinqu crime||persist delinqu||offici delinqu||childhood delinqu||self-report delinqu||adolesc delinqu trajectori||adolescence-limit delinqu||juvenil delinqu||delinqu journal||minor delinqu||prior delinqu,0.674||0.501||0.456||0.451||0.387||0.366||0.364||0.363||0.362||0.361||0.358||0.357||0.354||0.349||0.347,0.4,0.3,0.26666666666666666
1213,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998881.txt,anim||acut renal failur||technolog||outer medulla||acut tubular necrosi||imag||anim model||model||studi||apoptot cell||atn||cell||rat||apoptosi||analysi||ddc||injuri||experiment model||diagnost imag agent||detect||kidney,aposens||aposens aposens||aposens aposens aposens aposens aposens aposens||aposens aposens aposens aposens imag||interest aposens aposens||result aposens aposens aposens target||aposens aposens 3 aposens 18||aposens aposens aposens 1 2||sampl aposens||aposens synthesi||conclus aposens technolog||discuss aposens technolog||method aposens compound||0.05 result aposens||s00259-005-1905-x origin articl aposens,0.751||0.751||0.751||0.614||0.501||0.452||0.451||0.45||0.38||0.378||0.26||0.26||0.254||0.251||0.192,0.0,0.0,0.0
1214,Eur_J_Pediatr-4-1-2292481.txt,incid rate||case||clinic diagnost criteria||infant||birth||clinic decis||studi||life||torticolli||review||symptomat asymmetri||sign||disord||clinic syndrom||etiolog||current inform||month||literatur||posit prefer||plagiocephali||clinic specialti||craniosynostosi||symptom||differenti diagnosi||screen||movement||asymmetri||diagnosi||young infant||syndrom,torticolli||torticolli plagiocephali||asymmetri||plagiocephali||muscular torticolli||paroxysm torticolli||ocular torticolli||symptomat asymmetri||congenit muscular torticolli||idiopath asymmetri||deform plagiocephali||infant||pediatr||posterior plagiocephali||symptomat asymmetri disord,0.444||0.377||0.312||0.31||0.262||0.247||0.246||0.219||0.216||0.2||0.196||0.181||0.172||0.172||0.17,0.6,0.4,0.3333333333333333
1215,Immunome_Res-1-_-1289288.txt,antibodi||method||epitop||system||immun system||concentr||databas||data||experiment condit||experiment method||valu||search method||vaccin||complex||mhc molecul||protein antigen||databas system||specif allel||cell||blast search||entri||kinet||protein||immun||antijen||peptid interact||quantit specif data||bind||mhc||archiv||major histocompat complex||number||interact||peptid||tcr||link||sequenc,antijen||mhc||antijen databas||peptid||epitop||databas||antijen entri||1745-7580-1-4 databas antijen||mhc bind||antijen homepag||6 antijen databas||antijen 50||mhc kinet||mhc class||antijen store,0.447||0.376||0.354||0.307||0.304||0.262||0.252||0.248||0.248||0.238||0.236||0.234||0.232||0.226||0.226,0.8,0.5,0.3333333333333333
1216,Purinergic_Signal-3-1-2096770.txt,restenosi||role||atherosclerosi||releas||endothelium||studi||atp||smc||process||intim||receptor||nucleotid receptor||migrat||express||smooth muscl cell||vascular diseas||cell||utp||prolifer||nucleotid||previou studi||activ||earli stage||vascular||extracellular nucleotid||media||function,receptor||P2 receptor||P2||P2 nucleotid receptor||atp receptor||nucleotid receptor||P2 receptor express||receptor circ||sey CI P2 receptor||fibroblast P2 receptor||P2 receptor modul||endotheli receptor||adp receptor||sey||smooth muscl,0.297||0.274||0.251||0.233||0.228||0.224||0.194||0.194||0.193||0.192||0.188||0.187||0.178||0.177||0.173,0.2,0.2,0.13333333333333333
1217,Ann_Biomed_Eng-2-2-1705502.txt,mit||method||figur||center||case||conduct||border||imag||truncat level||data||model||valu||tsvd||magnet induct tomographi||voltag||increas||resolut||cnr||psf||paramet||regular scheme||radiu||cylind||spatial resolut||chang||imag reconstruct||gener||perturb||snr||regular||regular paramet||VU yield||homogen cylind||contrast||coil,bf||varvec||bf np||bf Gp||bf Ay||bf axa||bf agp||bf Mp||perturb||tsvd||kappa||document||reconstruct perturb||snr||kappa }_,0.271||0.165||0.145||0.142||0.138||0.138||0.138||0.138||0.072||0.067||0.064||0.061||0.059||0.057||0.055,0.0,0.2,0.2
1218,Ann_Biomed_Eng-2-2-1764593.txt,target||system||steadi state||rate||data||model||nucleu||sensit||increas||complex||dephosphoryl||nfat||calcium concentr||experiment result||nuclear local signal||rise||express||cell||calcium||export||control||averag||low calcium concentr||oscil frequenc||transloc||activ||cytoplasm||bind||factor||gene transcript||ikk||oscil||speci||calcineurin||show||initi||gene express||period||result,hbox||rm||rm ikk||nfat||rm dag||rm 7||nfat activ||activ nfat||nfat transloc||phosphoryl nfat||nfat model||nfat inhibitor||nfat mol||free nfat||nfat famili,0.443||0.352||0.199||0.196||0.181||0.176||0.104||0.104||0.103||0.101||0.1||0.099||0.099||0.099||0.098,0.2,0.1,0.06666666666666667
1219,Qual_Life_Res-3-1-1832149.txt,random design||subgroup||questionnair||effect size||child health questionnair||sampl||studi||secondari school||effect||scale||form||multi-item scale||test||internet version||valid||onlin questionnair||health||small effect||item||feasibl||chronic condit||paper||result||score differ||chq-cf||differ||standard paper version||chq-cf scale||number||reliabl||adolesc||mode||answer||internet administr||internet,chq-cf||internet||chq-cf administr||chq-cf scale||chq-cf score||chq-cf item||internet mode||web-bas chq-cf questionnair||internet administr||internet version||chq-cf scale score||internet versu||internet 79||internet 80||chq-cf scale number,0.559||0.425||0.331||0.325||0.314||0.305||0.28||0.273||0.264||0.244||0.239||0.23||0.222||0.221||0.22,0.6,0.5,0.3333333333333333
1220,Int_J_Parasitol-1-5-1906861.txt,mechan||condit||respons||huvec transcriptom||endothelium||data||studi||icam-1||huvec||signific regul||increas||abil||receptor||express||cluster||cell apoptosi||cell||adhes||gene||ec||term||vascular endothelium||malaria infect||critic factor||chang||tnf||sever malaria||human serum||co-cultur||surfac||EC activ||presenc||prbc||co-cultur experi||biolog process||molecul||up-regul||immun respons||result,al.||prbc||plasmodium||malaria||rbc||co-cultur||wautier||plasmodium falciparum||prbc sequestr||icam-1||sever plasmodium falciparum malaria||prbc retent||control prbc||uninfect rbc||huvec,0.407||0.305||0.222||0.221||0.22||0.208||0.202||0.2||0.176||0.158||0.156||0.155||0.154||0.15||0.149,0.2,0.3,0.26666666666666666
1221,J_Autism_Dev_Disord-4-1-2268724.txt,target||affect state||respons||accur||individu||complex pattern||attention-demand strategi||social cognit task||FR task||pdd-no||autism||process||criteria||anxieti||abil||complex condit||disord||pattern||express||social-cognit function||face recognit||emot recognit||pervas development disord||mcdd||emot||task||signific group differ||accuraci||diagnost criteria||cognit capac||identif||social interact||non-target condit||face process||group||facial express recognit||differ||symptom||speed||diagnosi||hypothesi||facial express||children||result,mcdd||pdd-no||mcdd children||pdd-no versu mcdd children||J. mcdd||mcdd criteria||mcdd group||mcdd symptom||mcdd diagnosi||complet mcdd||pure’ mcdd versu pdd-no children||pdd-no criteria||pdd-no journal||pdd-no group||pdd-no diagnosi,0.628||0.507||0.418||0.339||0.338||0.333||0.324||0.324||0.319||0.315||0.275||0.272||0.272||0.264||0.259,0.4,0.2,0.13333333333333333
1222,J_Mol_Biol-1-5-1892151.txt,condit||construct||recognit sequenc||OC form||concentr||koac||rate||bpli||plasmid||endonucleas||potassium||test enzym||form||singl polypeptid||site||r-m||double-strand break||dna||bcgi||duplex||SC||reaction||restrict enzym||enzym||individu circl||type iif categori||reaction rate||baei||copi||singl ring||act||fll||restrict endonucleas||catenan||cleavag||substrat||linear product||linear fragment||OC||sequenc,endonucleas||restrict endonucleas||bcgi||halford s.e||sfii endonucleas||sfii restrict endonucleas||dna||restrict endonucleas sgrai||sgrai restrict endonucleas||bcgi-lik restrict endonucleas||ecorii restrict endonucleas||ecori restrict endonucleas||dna restrict||eco57i restrict endonucleas||uniqu restrict endonucleas,0.409||0.306||0.253||0.246||0.242||0.229||0.219||0.217||0.217||0.213||0.212||0.212||0.211||0.209||0.206,0.6,0.4,0.26666666666666666
1223,Diabetologia-4-1-2292421.txt,mitochondria||fatti acid||adipocyt,adipocyt||adipos tissu||fatti||adipos compart||frozen-cut adipos tissu||human adipos tissu||diabetologia diabetologia||diabetologia||mitochondri uncoupl||sjöström||e444||fatti acid||adipocyt oxid capac||maassen||leiden,0.295||0.241||0.218||0.21||0.185||0.17||0.169||0.169||0.157||0.146||0.146||0.131||0.127||0.117||0.112,0.2,0.1,0.13333333333333333
1224,Eur_J_Clin_Pharmacol-4-1-2426925.txt,administr||amodiaquin||cross-ov studi||haematolog paramet||volunt||artesun||combin||sampl||patient||healthi normal volunt||clinic examin||malaria patient||uncompl falciparum malaria||dose||treatment||advers event||day||ratio||main activ metabolit||phase||pharmacokinet||dihydroartemisinin||group||toler||auc||healthi volunt||drug||pharmacokinet paramet||clinic signific,amodiaquin||artesun||amodiaquin pharmacokinet||amodiaquin monotherapi||oral amodiaquin||amodiaquin AQ||amodiaquin dose||amodiaquin prophylaxi||artesun administr||artesun tran||keyword amodiaquin artesun pharmacokinet toler healthi||quantifi amodiaquin concentr||desethylamodiaquin||volunt||artesun pharmacokinet paramet 1 max,0.652||0.549||0.406||0.346||0.344||0.343||0.339||0.329||0.286||0.276||0.236||0.222||0.194||0.175||0.165,0.4,0.2,0.2
1225,Bioinformation-2-5-2241933.txt,mesh||vector||set||method||biomed literatur||data||studi||gene annot sentenc||text mine||frequenc||sentenc||inform||process||gene express experi||structur||gene||term||annot||protein||analysi||associ||abstract||list||noun||initi test||keyword||larg number||function,sentenc||sentenc gene||gene||mesh||gene annot sentenc||gene annot||cluster||mesh term||gene annot term||annot cluster||sentence-level||irrelev sentenc||gene list||sentenc filter||common gene cluster,0.399||0.381||0.362||0.327||0.317||0.275||0.265||0.23||0.228||0.227||0.225||0.221||0.219||0.219||0.216,0.8,0.4,0.26666666666666666
1226,Eur_J_Pediatr-3-1-1914295.txt,program||pediatr exclus||adult market||pediatr studi||patent extens||fda||infant||data||studi||pharmaceut prepar||effect||develop||patent||prescript||pediatr popul||clinic pharmacolog review||pediatr||wide age rang||medic||adult||research||age||market exclus||literatur||usa||market||order||medicin||drug||industri||trial||children,drug||pediatr||drug prescript||off-label drug||pediatr drug label||pediatr drug trial||pediatr drug research||pediatr drug develop||pediatr drug studi||anti-rheumat drug||drug util||label drug||children||children drug categori||respiratori drug,0.441||0.353||0.308||0.295||0.284||0.274||0.274||0.268||0.268||0.258||0.253||0.25||0.247||0.242||0.242,0.4,0.2,0.2
1227,Cult_Med_Psychiatry-2-2-1705533.txt,person commun||muslim||islam||technolog||infertil husband||regard||sperm donat||fatwa||embryo||middl eastern region||practic||moral||patient||gamet donat||infertil muslim||muslim middl east||egg||infertil father||law||third-parti donat||medic anthropolog||jewish man||debat||adulteri||countri||ivf||coupl||marriag||sperm||ayatollah khamanei||scienc||women||world||recent year||lebanon||global||gamet||lebanes ivf clinic||muslim world||anonym donor||donat||cultur||local moral world||donor gamet||muslim marriag||iran||infertil coupl||ethnograph research||children,muslim||donat||shi’it muslim||donat islam||infertil muslim||gamet donat||sunni muslim||islam||sperm donat||ivf||muslim marriag||shi’it islam||gamet||third-parti gamet donat||muslim world,0.409||0.338||0.315||0.303||0.3||0.291||0.282||0.268||0.263||0.261||0.258||0.245||0.244||0.236||0.233,0.6,0.7,0.6666666666666666
1228,Immunome_Res-1-_-1312312.txt,amino acid differ||databas||mous IG||structur approach||data||hla||concept||allel||section||structur||chain||immunogenet||amino acid||domain||web resourc||tool||singl chain fragment variabl||on-lin tool||web||gene||annot||analysi||polymorph||mhc||immunoinformat||imgt||3D structur||immunoglobulin||number||locu||collier de perl,imgt||ligm-db imgt||imgt databas||imgt repertoir||imgt sequenc databas imgt||v-quest imgt||junctionanalysi imgt||imgt gene databas imgt||phylogen imgt||primer-db imgt||imgt collier||allele-align imgt||geneinfo imgt||mhc-db imgt||locusview imgt,0.879||0.473||0.463||0.46||0.458||0.458||0.458||0.457||0.456||0.455||0.453||0.452||0.452||0.449||0.449,0.2,0.1,0.06666666666666667
1229,Neurosci_Lett-1-5-1885960.txt,p53||tau,tau||p53||tau phosphoryl||anti-tot tau||fetal tau||tau protein||solubl tau||alzheim||human 2n4r tau||keyword p53 tau microtubul alzheim diseas||alzheim diseas tau protein||p53 ubiquitin||p53 suppress||abstract p53||p53 promot,0.493||0.356||0.317||0.287||0.262||0.26||0.254||0.212||0.205||0.193||0.19||0.189||0.184||0.183||0.182,0.4,0.2,0.13333333333333333
